Citrus Sinensis ID: 023058
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 288 | 2.2.26 [Sep-21-2011] | |||||||
| Q75H77 | 362 | Serine/threonine-protein | yes | no | 0.920 | 0.732 | 0.935 | 1e-148 | |
| Q940H6 | 362 | Serine/threonine-protein | yes | no | 0.916 | 0.729 | 0.939 | 1e-148 | |
| Q7Y0B9 | 371 | Serine/threonine-protein | no | no | 0.916 | 0.711 | 0.916 | 1e-145 | |
| Q39193 | 361 | Serine/threonine-protein | no | no | 0.916 | 0.731 | 0.901 | 1e-143 | |
| Q75V57 | 361 | Serine/threonine-protein | no | no | 0.913 | 0.728 | 0.890 | 1e-141 | |
| Q39192 | 362 | Serine/threonine-protein | no | no | 0.881 | 0.701 | 0.885 | 1e-138 | |
| A2YNT8 | 339 | Serine/threonine-protein | N/A | no | 0.854 | 0.725 | 0.865 | 1e-129 | |
| Q0D4J7 | 339 | Serine/threonine-protein | no | no | 0.854 | 0.725 | 0.861 | 1e-129 | |
| Q7XQP4 | 359 | Serine/threonine-protein | no | no | 0.854 | 0.685 | 0.841 | 1e-127 | |
| Q75LR7 | 342 | Serine/threonine-protein | no | no | 0.854 | 0.719 | 0.853 | 1e-127 |
| >sp|Q75H77|SAPKA_ORYSJ Serine/threonine-protein kinase SAPK10 OS=Oryza sativa subsp. japonica GN=SAPK10 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 525 bits (1352), Expect = e-148, Method: Compositional matrix adjust.
Identities = 248/265 (93%), Positives = 256/265 (96%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+A+TVGPGMDMPIMHD DRYELVRDIGSGNFGVARLMR + +LVAVKYIERGDKI
Sbjct: 1 MDRAALTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRSRADGQLVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EPKNFRKTI RIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKNFRKTIQRILGVQY 240
Query: 241 SIPDYVHISPECRHLISRIFVADPA 265
SIPDYVHISPECR LI+RIFVA+PA
Sbjct: 241 SIPDYVHISPECRDLIARIFVANPA 265
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 525 bits (1351), Expect = e-148, Method: Compositional matrix adjust.
Identities = 250/266 (93%), Positives = 262/266 (98%), Gaps = 2/266 (0%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR A++ GP MD+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQY
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 241 SIPDYVHISPECRHLISRIFVADPAK 266
+IPDYVHISPECRHLISRIFVADPAK
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAK 264
|
Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7Y0B9|SAPK8_ORYSJ Serine/threonine-protein kinase SAPK8 OS=Oryza sativa subsp. japonica GN=SAPK8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 513 bits (1322), Expect = e-145, Method: Compositional matrix adjust.
Identities = 242/264 (91%), Positives = 255/264 (96%)
Query: 2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
DR+A+TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRD++T ELVAVKYIERG+KID
Sbjct: 12 DRAALTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDRRTMELVAVKYIERGEKID 71
Query: 62 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 121
+NVQREIINHRSL+HPNI+RFKEVILTPTHLAIVMEYASGGELFERIC RFSEDEAR+
Sbjct: 72 DNVQREIINHRSLKHPNIIRFKEVILTPTHLAIVMEYASGGELFERICKNVRFSEDEARY 131
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT
Sbjct: 132 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 191
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241
PAYIAPEVLLKKEYDGK ADVWSCGVTLYVM+VGAYPFEDPEEPKNFRKTI RIL+VQYS
Sbjct: 192 PAYIAPEVLLKKEYDGKTADVWSCGVTLYVMVVGAYPFEDPEEPKNFRKTIQRILNVQYS 251
Query: 242 IPDYVHISPECRHLISRIFVADPA 265
IP+ V ISPECRHLISRIFV DP+
Sbjct: 252 IPENVDISPECRHLISRIFVGDPS 275
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1 | Back alignment and function description |
|---|
Score = 508 bits (1307), Expect = e-143, Method: Compositional matrix adjust.
Identities = 239/265 (90%), Positives = 256/265 (96%), Gaps = 1/265 (0%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI RILSV+Y
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 241 SIPDYVHISPECRHLISRIFVADPA 265
SIPD + ISPEC HLISRIFVADPA
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPA 264
|
Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 499 bits (1285), Expect = e-141, Method: Compositional matrix adjust.
Identities = 237/266 (89%), Positives = 254/266 (95%), Gaps = 3/266 (1%)
Query: 1 MDRSAMTVGP-GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK 59
M+R+A GP GM+MPIMHD DRYELV++IGSGNFGVARLMR++ + +LVAVKYI+RG+K
Sbjct: 1 MERAA--AGPLGMEMPIMHDGDRYELVKEIGSGNFGVARLMRNRASGDLVAVKYIDRGEK 58
Query: 60 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
IDENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERIC+AGRFSEDEA
Sbjct: 59 IDENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICSAGRFSEDEA 118
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTV
Sbjct: 119 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE+PKNFRKTI +IL VQ
Sbjct: 179 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIQKILGVQ 238
Query: 240 YSIPDYVHISPECRHLISRIFVADPA 265
YSIPDYVHISPECR LI+RIFV +PA
Sbjct: 239 YSIPDYVHISPECRDLITRIFVGNPA 264
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39192|SRK2D_ARATH Serine/threonine-protein kinase SRK2D OS=Arabidopsis thaliana GN=SRK2D PE=1 SV=1 | Back alignment and function description |
|---|
Score = 489 bits (1260), Expect = e-138, Method: Compositional matrix adjust.
Identities = 225/254 (88%), Positives = 248/254 (97%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
+D+PIMHDSDRY+ V+DIGSGNFGVARLM D+ T+ELVAVKYIERG+KIDENVQREIINH
Sbjct: 12 IDLPIMHDSDRYDFVKDIGSGNFGVARLMTDRVTKELVAVKYIERGEKIDENVQREIINH 71
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
RSLRHPNIVRFKEVILTP+HLAIVMEYA+GGEL+ERICNAGRFSEDEARFFFQQLISGVS
Sbjct: 72 RSLRHPNIVRFKEVILTPSHLAIVMEYAAGGELYERICNAGRFSEDEARFFFQQLISGVS 131
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
YCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE+LL
Sbjct: 132 YCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEILL 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
++EYDGK+ADVWSCGVTLYVMLVGAYPFEDP+EP+++RKTI RILSV YSIP+ +H+SPE
Sbjct: 192 RQEYDGKLADVWSCGVTLYVMLVGAYPFEDPQEPRDYRKTIQRILSVTYSIPEDLHLSPE 251
Query: 252 CRHLISRIFVADPA 265
CRHLISRIFVADPA
Sbjct: 252 CRHLISRIFVADPA 265
|
Together with SRK2I, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 461 bits (1187), Expect = e-129, Method: Compositional matrix adjust.
Identities = 213/246 (86%), Positives = 236/246 (95%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+++DIGSGNFGVA+L+RD +T+EL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL +KEYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI RILSVQY +PDYV +S ECRHL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIF 241
Query: 261 VADPAK 266
VA+P +
Sbjct: 242 VANPEQ 247
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 460 bits (1183), Expect = e-129, Method: Compositional matrix adjust.
Identities = 212/246 (86%), Positives = 236/246 (95%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+++DIGSGNFGVA+L+RD +T+EL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2 ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCHSMQ+CH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS APRLKICDFGYSKSS+LHSQPKSTVGTPAYIAPEVL +KEYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI RILSVQY +PDYV +S ECRHL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIF 241
Query: 261 VADPAK 266
VA+P +
Sbjct: 242 VANPEQ 247
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7XQP4|SAPK7_ORYSJ Serine/threonine-protein kinase SAPK7 OS=Oryza sativa subsp. japonica GN=SAPK7 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 454 bits (1169), Expect = e-127, Method: Compositional matrix adjust.
Identities = 207/246 (84%), Positives = 235/246 (95%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYEL++DIG+GNFGVARLMR+K+T+ELVA+KYI RG KIDENV REIINHRSLRHPNI+
Sbjct: 2 ERYELLKDIGAGNFGVARLMRNKETKELVAMKYIPRGLKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV++TPTHLAIVMEYA+GGELF+RICNAGRFSEDEAR+FFQQLI GVSYCH MQ+CH
Sbjct: 62 RFKEVVVTPTHLAIVMEYAAGGELFDRICNAGRFSEDEARYFFQQLICGVSYCHFMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYDGKTA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVGAYPFEDP++PKNFRKTI RI+S+QY IP+YVH+S +CR L+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDDPKNFRKTIGRIMSIQYKIPEYVHVSQDCRQLLSRIF 241
Query: 261 VADPAK 266
VA+PAK
Sbjct: 242 VANPAK 247
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75LR7|SAPK1_ORYSJ Serine/threonine-protein kinase SAPK1 OS=Oryza sativa subsp. japonica GN=SAPK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 453 bits (1166), Expect = e-127, Method: Compositional matrix adjust.
Identities = 210/246 (85%), Positives = 232/246 (94%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE++RDIGSGNFGVA+L+RD T L AVK+IERG KIDE+VQREI+NHRSL+HPNI+
Sbjct: 2 ERYEVMRDIGSGNFGVAKLVRDVATNHLFAVKFIERGLKIDEHVQREIMNHRSLKHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH
Sbjct: 62 RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL +KEYDGK+A
Sbjct: 122 RDLKLENTLLDGSVTPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRKEYDGKVA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVGAYPFEDP++P+NFRKTI RILSVQYSIPDYV +S +CRHL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDDPRNFRKTITRILSVQYSIPDYVRVSADCRHLLSRIF 241
Query: 261 VADPAK 266
V +P +
Sbjct: 242 VGNPEQ 247
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 288 | ||||||
| 356575154 | 364 | PREDICTED: serine/threonine-protein kina | 0.923 | 0.730 | 0.981 | 1e-154 | |
| 356521207 | 364 | PREDICTED: serine/threonine-protein kina | 0.923 | 0.730 | 0.969 | 1e-152 | |
| 255561655 | 363 | Serine/threonine-protein kinase SAPK10, | 0.923 | 0.732 | 0.958 | 1e-152 | |
| 356519681 | 369 | PREDICTED: serine/threonine-protein kina | 0.920 | 0.718 | 0.969 | 1e-152 | |
| 356575156 | 373 | PREDICTED: serine/threonine-protein kina | 0.923 | 0.713 | 0.949 | 1e-152 | |
| 404435147 | 362 | sucrose non-fermenting 1-related protein | 0.923 | 0.734 | 0.951 | 1e-151 | |
| 356521209 | 371 | PREDICTED: serine/threonine-protein kina | 0.923 | 0.716 | 0.945 | 1e-150 | |
| 225428695 | 363 | PREDICTED: serine/threonine-protein kina | 0.920 | 0.730 | 0.958 | 1e-150 | |
| 224123434 | 363 | predicted protein [Populus trichocarpa] | 0.923 | 0.732 | 0.947 | 1e-150 | |
| 356500078 | 354 | PREDICTED: serine/threonine-protein kina | 0.906 | 0.737 | 0.969 | 1e-149 |
| >gi|356575154|ref|XP_003555707.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1416), Expect = e-154, Method: Compositional matrix adjust.
Identities = 261/266 (98%), Positives = 264/266 (99%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILKVQY 240
Query: 241 SIPDYVHISPECRHLISRIFVADPAK 266
SIPDYVHISPECRHLISRIFVADPA+
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPAQ 266
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521207|ref|XP_003529248.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 545 bits (1403), Expect = e-152, Method: Compositional matrix adjust.
Identities = 258/266 (96%), Positives = 263/266 (98%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSD+YELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDKYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKE+ILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEIILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILKVQY 240
Query: 241 SIPDYVHISPECRHLISRIFVADPAK 266
SIPDYVHIS ECRHLISRIFVADPA+
Sbjct: 241 SIPDYVHISSECRHLISRIFVADPAQ 266
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561655|ref|XP_002521837.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538875|gb|EEF40473.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 545 bits (1403), Expect = e-152, Method: Compositional matrix adjust.
Identities = 255/266 (95%), Positives = 266/266 (100%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+T+GPGMD+PIMHDSDRYELV+DIG+GNFGVARLMRDK+T+ELVAVKYIERG+KI
Sbjct: 1 MDRSALTIGPGMDLPIMHDSDRYELVKDIGAGNFGVARLMRDKQTDELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 240
Query: 241 SIPDYVHISPECRHLISRIFVADPAK 266
SIPDYVHISPEC+HLISRIFVADPAK
Sbjct: 241 SIPDYVHISPECQHLISRIFVADPAK 266
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356519681|ref|XP_003528498.1| PREDICTED: serine/threonine-protein kinase SRK2E-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 542 bits (1396), Expect = e-152, Method: Compositional matrix adjust.
Identities = 257/265 (96%), Positives = 263/265 (99%)
Query: 2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
DRSAM+VGPGMD+PIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERG+KID
Sbjct: 13 DRSAMSVGPGMDLPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGEKID 72
Query: 62 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 121
ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF
Sbjct: 73 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 132
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
FFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT
Sbjct: 133 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 192
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241
PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQYS
Sbjct: 193 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYS 252
Query: 242 IPDYVHISPECRHLISRIFVADPAK 266
IPDYVHIS ECRHLISRIFVADPA+
Sbjct: 253 IPDYVHISSECRHLISRIFVADPAR 277
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575156|ref|XP_003555708.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 542 bits (1396), Expect = e-152, Method: Compositional matrix adjust.
Identities = 261/275 (94%), Positives = 264/275 (96%), Gaps = 9/275 (3%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVL 171
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK SSVL
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKVHFLRTVISSSVL 180
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231
HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT
Sbjct: 181 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 240
Query: 232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
IHRIL VQYSIPDYVHISPECRHLISRIFVADPA+
Sbjct: 241 IHRILKVQYSIPDYVHISPECRHLISRIFVADPAQ 275
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|404435147|gb|AFR68940.1| sucrose non-fermenting 1-related protein kinase 2 family member [Solanum tuberosum] | Back alignment and taxonomy information |
|---|
Score = 539 bits (1388), Expect = e-151, Method: Compositional matrix adjust.
Identities = 253/266 (95%), Positives = 264/266 (99%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+A+TVGPGMD+PIMHDSDRYELVRDIG+GNFGVARLMRD++T ELVAVKYIERG+KI
Sbjct: 1 MDRTAVTVGPGMDVPIMHDSDRYELVRDIGAGNFGVARLMRDRQTNELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVME+ASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEFASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI RIL+VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIQRILNVQY 240
Query: 241 SIPDYVHISPECRHLISRIFVADPAK 266
SIPDYVHISPECRHLISRIFVADPAK
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPAK 266
|
Source: Solanum tuberosum Species: Solanum tuberosum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521209|ref|XP_003529249.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1385), Expect = e-150, Method: Compositional matrix adjust.
Identities = 258/273 (94%), Positives = 263/273 (96%), Gaps = 7/273 (2%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSAMTVGPGMDMPIMHDSD+YELVRDIGSGNFGVARLMRDK TEELVAVKYIERGDKI
Sbjct: 1 MDRSAMTVGPGMDMPIMHDSDKYELVRDIGSGNFGVARLMRDKHTEELVAVKYIERGDKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKE+ILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVRREIINHRSLRHPNIVRFKEIILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHS 173
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK SSVLHS
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKVYFFLHTSSVLHS 180
Query: 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH
Sbjct: 181 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 240
Query: 234 RILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
RIL VQYSIPDYVHIS ECRHLISRIFVADPA+
Sbjct: 241 RILKVQYSIPDYVHISSECRHLISRIFVADPAQ 273
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225428695|ref|XP_002284959.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 1 [Vitis vinifera] gi|297741336|emb|CBI32467.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 537 bits (1383), Expect = e-150, Method: Compositional matrix adjust.
Identities = 254/265 (95%), Positives = 260/265 (98%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRSA+TVGP MD+PIMHDSDRYELVRDIGSGNFGVARLMRDK+T ELVAVKYIERG+KI
Sbjct: 1 MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF KTI RIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILKVQY 240
Query: 241 SIPDYVHISPECRHLISRIFVADPA 265
SIPDYVHISPECRHLISRIFVADPA
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPA 265
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123434|ref|XP_002330314.1| predicted protein [Populus trichocarpa] gi|222871349|gb|EEF08480.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 536 bits (1381), Expect = e-150, Method: Compositional matrix adjust.
Identities = 252/266 (94%), Positives = 261/266 (98%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDRS MTVGPGMDMPIMHD DRYELVRDIGSGNFGVARLMRDK+ +ELVAVKYIERG+KI
Sbjct: 1 MDRSVMTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRDKQADELVAVKYIERGEKI 60
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN+GRFSEDEAR
Sbjct: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNSGRFSEDEAR 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP STVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPTSTVG 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EP+NFR TIHRIL+VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPRNFRSTIHRILNVQY 240
Query: 241 SIPDYVHISPECRHLISRIFVADPAK 266
SIPDYVHISPEC+HLISRIFVADPAK
Sbjct: 241 SIPDYVHISPECQHLISRIFVADPAK 266
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500078|ref|XP_003518861.1| PREDICTED: serine/threonine-protein kinase SRK2E-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 535 bits (1377), Expect = e-149, Method: Compositional matrix adjust.
Identities = 253/261 (96%), Positives = 258/261 (98%)
Query: 6 MTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ 65
M+VGPGMD+PIMHDSDRYE VRDIGSGNFGVARLMRDK TEELVAVKYIERG+KIDENVQ
Sbjct: 1 MSVGPGMDLPIMHDSDRYEFVRDIGSGNFGVARLMRDKHTEELVAVKYIERGEKIDENVQ 60
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 125
REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ
Sbjct: 61 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 120
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 185
LISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI
Sbjct: 121 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 180
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245
APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQYSIPDY
Sbjct: 181 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYSIPDY 240
Query: 246 VHISPECRHLISRIFVADPAK 266
VHIS ECRHLISRIFVADPAK
Sbjct: 241 VHISSECRHLISRIFVADPAK 261
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 288 | ||||||
| TAIR|locus:2118929 | 362 | OST1 "OPEN STOMATA 1" [Arabido | 0.916 | 0.729 | 0.939 | 9.8e-135 | |
| TAIR|locus:2174999 | 361 | SNRK2.3 "sucrose nonfermenting | 0.930 | 0.742 | 0.888 | 5.7e-130 | |
| TAIR|locus:2160559 | 360 | SNRK2.5 "SNF1-related protein | 0.854 | 0.683 | 0.841 | 2.8e-114 | |
| TAIR|locus:2206046 | 361 | SNRK2.10 "SNF1-related protein | 0.854 | 0.681 | 0.833 | 1.5e-113 | |
| TAIR|locus:2159597 | 353 | SNRK2.1 "SNF1-related protein | 0.854 | 0.696 | 0.829 | 6.6e-113 | |
| TAIR|locus:2032075 | 343 | SNRK2-8 "SNF1-RELATED PROTEIN | 0.854 | 0.717 | 0.825 | 2e-111 | |
| TAIR|locus:2140104 | 350 | SNRK2.7 "SNF1-related protein | 0.854 | 0.702 | 0.813 | 4.2e-111 | |
| TAIR|locus:2045319 | 339 | SNRK2.9 "SNF1-related protein | 0.847 | 0.719 | 0.778 | 2.2e-105 | |
| DICTYBASE|DDB_G0277905 | 727 | snfA "AMP-activated protein ki | 0.895 | 0.354 | 0.430 | 1.2e-48 | |
| TAIR|locus:2179260 | 488 | CIPK25 "CBL-interacting protei | 0.802 | 0.473 | 0.447 | 2.3e-48 |
| TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1320 (469.7 bits), Expect = 9.8e-135, P = 9.8e-135
Identities = 250/266 (93%), Positives = 262/266 (98%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR A++ GP MD+PIMHDSDRYELV+DIGSGNFGVARLMRDK++ ELVAVKYIERG+KI
Sbjct: 1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+VQY
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 241 SIPDYVHISPECRHLISRIFVADPAK 266
+IPDYVHISPECRHLISRIFVADPAK
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAK 264
|
|
| TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1275 (453.9 bits), Expect = 5.7e-130, P = 5.7e-130
Identities = 240/270 (88%), Positives = 260/270 (96%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERGDKI
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI RILSV+Y
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 241 SIPDYVHISPECRHLISRIFVADPA-KVSM 269
SIPD + ISPEC HLISRIFVADPA ++S+
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPATRISI 269
|
|
| TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1127 (401.8 bits), Expect = 2.8e-114, P = 2.8e-114
Identities = 207/246 (84%), Positives = 231/246 (93%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+YE+V+D+G+GNFGVARL+R K+T+ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE EAR+FFQQLI GV YCHS+Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVG YPFEDP++P+NFRKTI RI++VQY IPDYVHIS ECRHL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQECRHLLSRIF 241
Query: 261 VADPAK 266
V + AK
Sbjct: 242 VTNSAK 247
|
|
| TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1120 (399.3 bits), Expect = 1.5e-113, P = 1.5e-113
Identities = 205/246 (83%), Positives = 231/246 (93%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+YELV+DIG+GNFGVARLMR K ++ELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2 DKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTH+AI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVL + EYDGK+A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKMA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVGAYPFED E+PKNF+KTI RI++V+Y IPDYVHIS +C+HL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKHLLSRIF 241
Query: 261 VADPAK 266
V + K
Sbjct: 242 VTNSNK 247
|
|
| TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1114 (397.2 bits), Expect = 6.6e-113, P = 6.6e-113
Identities = 204/246 (82%), Positives = 229/246 (93%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
D+Y++V+D+G+GNFGVARL+R K T+ELVA+KYIERG KIDENV REIINHRSL+HPNI+
Sbjct: 2 DKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEVILTPTHLAIVMEYASGGELF+RIC AGRFSE EAR+FFQQLI GV YCHS+Q+CH
Sbjct: 62 RFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK A
Sbjct: 122 RDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVGAYPFEDP +PKNFRKTI RI++VQY IPDYVHIS EC+HL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKHLLSRIF 241
Query: 261 VADPAK 266
V + AK
Sbjct: 242 VTNSAK 247
|
|
| TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1100 (392.3 bits), Expect = 2.0e-111, P = 2.0e-111
Identities = 203/246 (82%), Positives = 229/246 (93%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RYE+V+DIGSGNFGVA+L+RDK ++EL AVK+IERG KIDE+VQREI+NHRSL HPNI+
Sbjct: 2 ERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LT THLA+VMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGV+YCHS+Q+CH
Sbjct: 62 RFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGS APR+KICDFGYSKS VLHSQPK+TVGTPAYIAPEVL KEYDGKIA
Sbjct: 122 RDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKIA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVGAYPFEDP +PK+FRKTI RIL QY+IPDYV +S ECRHL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRIF 241
Query: 261 VADPAK 266
VA+P K
Sbjct: 242 VANPEK 247
|
|
| TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1097 (391.2 bits), Expect = 4.2e-111, P = 4.2e-111
Identities = 200/246 (81%), Positives = 227/246 (92%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+RY+++RD+GSGNFGVA+L+R+K E AVKYIERG KIDE+VQREIINHR L+HPNI+
Sbjct: 2 ERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNII 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV +TPTHLAIVMEYA+GGELFERICNAGRFSEDE R++F+QLISGVSYCH+MQ+CH
Sbjct: 62 RFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSP+ LKICDFGYSKSSVLHSQPKSTVGTPAY+APEVL +KEY+GKIA
Sbjct: 122 RDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKIA 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGVTLYVMLVGAYPFEDPE+P+N R TI RILSV Y+IPDYV IS EC+HL+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRILSVHYTIPDYVRISSECKHLLSRIF 241
Query: 261 VADPAK 266
VADP K
Sbjct: 242 VADPDK 247
|
|
| TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1043 (372.2 bits), Expect = 2.2e-105, P = 2.2e-105
Identities = 190/244 (77%), Positives = 219/244 (89%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++YE+V+D+G GNFG+ARLMR+K+T ELVAVK+I+RG KIDENV REIINHR+L HPNIV
Sbjct: 2 EKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
RFKEV+LTPTHL IVMEYA+GGELFERI + GRFSE EAR+FFQQLI GV Y H++Q+CH
Sbjct: 62 RFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQICH 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS PKSTVGTPAYIAPEV + EYDGK
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKSV 181
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
DVWSCGV LYVMLVGAYPFEDP++P+NFRKT+ +I++V Y IP YVHIS +CR L+SRIF
Sbjct: 182 DVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLLSRIF 241
Query: 261 VADP 264
VA+P
Sbjct: 242 VANP 245
|
|
| DICTYBASE|DDB_G0277905 snfA "AMP-activated protein kinase alpha subunit" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 508 (183.9 bits), Expect = 1.2e-48, P = 1.2e-48
Identities = 117/272 (43%), Positives = 156/272 (57%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPN 78
Y L + +G G+FG +L +T VA+K + R K+DE ++REI N + RHP+
Sbjct: 31 YRLDKTLGIGSFGKVKLAEHIRTGVKVAIKILNRTKIKNLKMDEKIRREIQNMKLFRHPH 90
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
I++ EVI T T + +VMEY +GGELFE I G+ EDE+R FQQ+ISGV YCH V
Sbjct: 91 IIKLYEVIETTTDIFMVMEYVTGGELFEYIVKNGKLLEDESRRLFQQMISGVDYCHHHMV 150
Query: 139 CHRDLKLENTLLDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
HRDLK EN LLD P + +KI DFG S K++ G+P Y APEV+ K Y G
Sbjct: 151 VHRDLKPENLLLD--PINKCIKIADFGLSNMMQDGDFLKTSCGSPNYAAPEVISGKLYAG 208
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
DVWSCGV LY L PF+D P F+K + +SIPD+V SP C LI
Sbjct: 209 PEVDVWSCGVILYAFLCAKLPFDDESIPMLFKKIREGV----FSIPDFV--SPSCADLIK 262
Query: 258 RIFVADPAK-VSMHFHATGVYMHTKLQLLVAS 288
++ V DP K +++H + KL ++S
Sbjct: 263 KMLVVDPVKRITIHEIRNHPWFQVKLPKYLSS 294
|
|
| TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 505 (182.8 bits), Expect = 2.3e-48, P = 2.3e-48
Identities = 115/257 (44%), Positives = 153/257 (59%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
+YE+ R +G G FG ++ T E VA+K I + D++ E ++REI R +RH
Sbjct: 42 KYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINK-DQVKREGMMEQIKREISIMRLVRH 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIV KEV+ T T + +MEY GGELF +I G+ ED AR +FQQLIS V +CHS
Sbjct: 101 PNIVELKEVMATKTKIFFIMEYVKGGELFSKIVK-GKLKEDSARKYFQQLISAVDFCHSR 159
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYS-------KSSVLHSQPKSTVGTPAYIAPEV 189
V HRDLK EN L+D + LK+ DFG S + +LH+Q GTPAY+APEV
Sbjct: 160 GVSHRDLKPENLLVDENGD--LKVSDFGLSALPEQILQDGLLHTQ----CGTPAYVAPEV 213
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
L KK YDG D+WSCG+ LYV+L G PF+D +N K +I ++ P + S
Sbjct: 214 LRKKGYDGAKGDIWSCGIILYVLLAGFLPFQD----ENLMKMYRKIFKSEFEYPPW--FS 267
Query: 250 PECRHLISRIFVADPAK 266
PE + LIS++ V DP K
Sbjct: 268 PESKRLISKLLVVDPNK 284
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| A2ZAB5 | SAPK3_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.8252 | 0.8541 | 0.7365 | N/A | no |
| Q02066 | AAIP_WHEAT | 2, ., 7, ., 1, 1, ., 1 | 0.8523 | 0.8229 | 0.7138 | N/A | no |
| Q39193 | SRK2I_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9018 | 0.9166 | 0.7313 | no | no |
| A2YNT8 | SAPK2_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.8658 | 0.8541 | 0.7256 | N/A | no |
| Q940H6 | SRK2E_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9398 | 0.9166 | 0.7292 | yes | no |
| Q75H77 | SAPKA_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.9358 | 0.9201 | 0.7320 | yes | no |
| Q7Y0B9 | SAPK8_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.9166 | 0.9166 | 0.7115 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00036529001 | SubName- Full=Chromosome chr3 scaffold_8, whole genome shotgun sequence; (363 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 288 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-94 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-81 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-64 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-64 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-59 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-55 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-51 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-50 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-49 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-45 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-43 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-43 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-43 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-43 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-42 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-42 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-41 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-41 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-41 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-41 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-41 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-40 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-40 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-40 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-39 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-39 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-38 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-38 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-38 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-38 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-37 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-37 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-37 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-37 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-36 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-36 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-36 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-36 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-36 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-36 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-35 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-35 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-35 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-35 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-35 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-35 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-34 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-34 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-34 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-34 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-34 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-34 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-34 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-34 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-34 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-34 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-34 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-34 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-33 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-33 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-33 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-33 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-33 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-32 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-32 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-32 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-32 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-32 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-31 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-31 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-31 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-31 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-31 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-31 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-31 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-30 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-30 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-30 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-29 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-29 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-28 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-28 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-28 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-28 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-27 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-27 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-27 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-27 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-27 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-27 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-26 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-26 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-26 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-26 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-26 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-26 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-26 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-26 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-26 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-25 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-25 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-25 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-25 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-25 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-25 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-25 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-24 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-24 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-24 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-24 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-24 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-24 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-24 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-24 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-24 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-24 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-23 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-23 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-23 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-23 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-23 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-23 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-22 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-22 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-22 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-22 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-22 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-22 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-22 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-21 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-21 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-21 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-21 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-21 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-20 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-20 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-20 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-20 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-19 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-19 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-18 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-18 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-18 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-18 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-18 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-17 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-15 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-15 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-14 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-12 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-12 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.002 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 277 bits (711), Expect = 7e-94
Identities = 103/247 (41%), Positives = 143/247 (57%), Gaps = 9/247 (3%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 80
YE++ +G G+FG L RDKKT +LVA+K I ++ K E + REI + L+HPNIV
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
R +V L +VMEY GG+LF+ + GR SEDEARF+ +Q++S + Y HS + H
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLK EN LLD +K+ DFG ++ + + VGTP Y+APEVLL K Y +
Sbjct: 121 RDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV- 177
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP-DYVHISPECRHLISRI 259
D+WS GV LY +L G PF ++ + +I + P ISPE + LI ++
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLL---ELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 260 FVADPAK 266
V DP K
Sbjct: 235 LVKDPEK 241
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 3e-81
Identities = 104/250 (41%), Positives = 139/250 (55%), Gaps = 9/250 (3%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPNI 79
YEL+R +GSG+FG + K T ++VAVK + K D+ +REI R L HPNI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
VR + HL +VMEY GG+LF+ + G SEDEA+ Q++ G+ Y HS +
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGK 198
HRDLK EN LLD + +KI DFG +K + S +T VGTP Y+APEVLL G
Sbjct: 121 HRDLKPENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECRHLI 256
DVWS GV LY +L G PF E + + I RIL +++ P + S E + LI
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 257 SRIFVADPAK 266
+ DP+K
Sbjct: 238 KKCLNKDPSK 247
|
Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 202 bits (516), Expect = 2e-64
Identities = 89/256 (34%), Positives = 136/256 (53%), Gaps = 22/256 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
+YE+++ IG G+FG L+R K +L +K I +K E+ E+ + L HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
I+++ E L IVMEYA GG+L ++I + F E++ +F QL + Y H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
S ++ HRD+K +N L +K+ DFG SK S+V + K+ VGTP Y++PE+
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQ 176
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISP 250
K Y+ K +D+WS G LY + +PFE +N + +IL QY IP S
Sbjct: 177 NKPYNYK-SDIWSLGCVLYELCTLKHPFEG----ENLLELALKILKGQYPPIPS--QYSS 229
Query: 251 ECRHLISRIFVADPAK 266
E R+L+S + DP +
Sbjct: 230 ELRNLVSSLLQKDPEE 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 9e-64
Identities = 86/188 (45%), Positives = 112/188 (59%), Gaps = 5/188 (2%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVI 86
+G G FG L RDKKT + VA+K I++ D E + REI + L HPNIV+ V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 87 LTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
HL +VMEY GG L + + N G+ SEDE Q++ G+ Y HS + HRDLK
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 146 ENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
EN LLD S ++K+ DFG SK + S K+ VGTPAY+APEVLL K Y + +D+WS
Sbjct: 121 ENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 205 CGVTLYVM 212
GV LY +
Sbjct: 180 LGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 191 bits (489), Expect = 2e-60
Identities = 94/245 (38%), Positives = 131/245 (53%), Gaps = 18/245 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 84
+G G+FG L+R K T +L A+K +++ I + R+ + HP IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L +V+EYA GGELF + GRFSE+ ARF+ +++ + Y HS+ + +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 145 LENTLLD--GSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
EN LLD G +K+ DFG +K S+ + GTP Y+APEVLL K Y GK D
Sbjct: 121 PENILLDADG----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVD 175
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261
WS GV LY ML G PF + + +IL P+++ SPE R LIS +
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRK----EIYEKILKDPLRFPEFL--SPEARDLISGLLQ 229
Query: 262 ADPAK 266
DP K
Sbjct: 230 KDPTK 234
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 9e-59
Identities = 85/255 (33%), Positives = 126/255 (49%), Gaps = 18/255 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
+ +G G+FG L DK T EL+AVK +E +E + +REI SL+HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 79 IVRFK--EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IVR+ E L I +EY SGG L + G+ E R + +Q++ G++Y HS
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ HRD+K N L+D +K+ DFG +K S GTP ++APEV+ +
Sbjct: 121 GIVHRDIKGANILVDSD--GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPE 251
EY AD+WS G T+ M G P+ + P +++I S IP+ H+S E
Sbjct: 179 EYGRA-ADIWSLGCTVIEMATGKPPWSELGNPMAA---LYKIGSSGEPPEIPE--HLSEE 232
Query: 252 CRHLISRIFVADPAK 266
+ + + DP K
Sbjct: 233 AKDFLRKCLRRDPKK 247
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 2e-55
Identities = 91/257 (35%), Positives = 142/257 (55%), Gaps = 29/257 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE-IINHR----SLR 75
D +E ++ +G+G+FG L+R K + + A+K + + KI + Q E ++N + S+R
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK-AKIVKLKQVEHVLNEKRILQSIR 59
Query: 76 HPNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
HP +V F++ ++L +VMEY GGELF + +GRF E ARF+ Q++ +
Sbjct: 60 HPFLVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y HS+ + +RDLK EN LLD G +KI DFG++K + + + GTP Y+APE+
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEI 169
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
+L K Y GK D W+ G+ +Y ML G PF D + P + +IL + P S
Sbjct: 170 ILSKGY-GKAVDWWALGILIYEMLAGYPPFFD-DNP---IQIYEKILEGKVRFP--SFFS 222
Query: 250 PECRHLISRIFVADPAK 266
P+ + LI + D K
Sbjct: 223 PDAKDLIRNLLQVDLTK 239
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-51
Identities = 77/249 (30%), Positives = 123/249 (49%), Gaps = 14/249 (5%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 81
+E++ IG G FG R K+T + VA+K I + E + EI + +HPNIV+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L L IVME+ SGG L + + + + +E + + ++L+ G+ Y HS + H
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
RD+K N LL DG +K+ DFG S + VGTP ++APEV+ K YD K
Sbjct: 122 RDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-SVQYSIPDYVHISPECRHLIS 257
AD+WS G+T + G P+ + K + +I + + + S E + +
Sbjct: 178 -ADIWSLGITAIELAEGKPPYSEL----PPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232
Query: 258 RIFVADPAK 266
+ +P K
Sbjct: 233 KCLQKNPEK 241
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 1e-50
Identities = 86/251 (34%), Positives = 126/251 (50%), Gaps = 20/251 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPNIVRFKE 84
I G +G L + K T ++ A+K I++ D I +N +++ R + P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+L +VMEY GG+L + N G ED AR + +++ + Y HS + HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSK---------SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+N L+D + LK+ DFG SK + + K VGTP YIAPEV+L + +
Sbjct: 121 PDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
K D WS G LY LVG PF E P + IL+ + P+ V +S E L
Sbjct: 179 -SKTVDWWSLGCILYEFLVGIPPFHG-ETP---EEIFQNILNGKIEWPEDVEVSDEAIDL 233
Query: 256 ISRIFVADPAK 266
IS++ V DP K
Sbjct: 234 ISKLLVPDPEK 244
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 1e-49
Identities = 81/275 (29%), Positives = 130/275 (47%), Gaps = 45/275 (16%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 76
++ + IG G+F L ++K+T + A+K + + K+ +++E++ R H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVL-TRLNGH 61
Query: 77 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
P I++ F++ +L V+EYA GEL + I G E RF+ +++ + Y
Sbjct: 62 PGIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 171
HS + HRDLK EN LLD +KI DFG +K
Sbjct: 118 LHSKGIIHRDLKPENILLDKD--MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231
+ S VGT Y++PE+L +K GK +D+W+ G +Y ML G PF E T
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEY----LT 230
Query: 232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
+IL ++YS P + P+ + LI ++ V DP
Sbjct: 231 FQKILKLEYSFPP--NFPPDAKDLIEKLLVLDPQD 263
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 156 bits (394), Expect = 4e-45
Identities = 90/268 (33%), Positives = 129/268 (48%), Gaps = 28/268 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRHP- 77
Y ++R +G G+FG L RD+K VA+K + + + REI SL HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCH 134
NIV+ + L +VMEY GG L + + G SE EA F Q++S + Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAP 187
S + HRD+K EN LLD +K+ DFG +K +S + + P ++VGTP Y+AP
Sbjct: 119 SKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 188 EVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------KNFRKTIHRILSV 238
EVLL Y +D+WS G+TLY +L G PFE + K + L+
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 239 QYSIPDYVHISPECRHLISRIFVADPAK 266
S + IS L+ ++ DP
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKN 265
|
Length = 384 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-43
Identities = 84/282 (29%), Positives = 129/282 (45%), Gaps = 43/282 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
++ ++ +G G+ G L+R K T +L A+K +++ + I N ++EI+ +L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATL 58
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 132
HP + T T+L +VM+Y GGELF + SE+ ARF+ +++ + Y
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 133 CHSMQVCHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSVLHSQP 175
H + + +RDLK EN LL S P P K G +SSV
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 176 -----------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
S VGT YIAPEV+ + + D W+ G+ LY ML G PF+
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKG--- 234
Query: 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
N +T IL + + P +S R LI ++ V DP+K
Sbjct: 235 -SNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSK 275
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-43
Identities = 85/257 (33%), Positives = 128/257 (49%), Gaps = 18/257 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGD-KIDENVQREIINHRSLRHPN 78
R++ IG G FG + T EL+AVK I + D K + + E+ L+HPN
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA--RFFFQQLISGVSYCHSM 136
+V++ V + + I MEY SGG L E + GR DE R + QL+ G++Y HS
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSH 118
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLL 191
+ HRD+K N LD + +K+ DFG + ++ + + +S GTPAY+APEV+
Sbjct: 119 GIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 192 KKEYDGKI--ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
+ G AD+WS G + M G P+ E F+ H + IPD + +S
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPW--SELDNEFQIMFHVGAGHKPPIPDSLQLS 234
Query: 250 PECRHLISRIFVADPAK 266
PE + + R +DP K
Sbjct: 235 PEGKDFLDRCLESDPKK 251
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 2e-43
Identities = 87/244 (35%), Positives = 126/244 (51%), Gaps = 15/244 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL AVK +++ + D++V+ + R L +HP + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L I +GRF E ARF+ +++ G+ + H + +RDL
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N LLD +KI DFG K +L ST GTP YIAPE+L + Y G D
Sbjct: 123 KLDNVLLDSE--GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
W+ GV LY ML G PFE +E + F IL + P +S E + ++
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELF----QSILEDEVRYP--RWLSKEAKSILKSFLTK 233
Query: 263 DPAK 266
+P K
Sbjct: 234 NPEK 237
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 8e-43
Identities = 76/207 (36%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
YE + +G G +GV RDKKT E+VA+K I R D +E + REI + L+HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ +VI T L +V EY +L + + G S + + QL+ G++YCHS +
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLK- 192
+ HRDLK +N L++ LK+ DFG +++ P T V T Y APE+LL
Sbjct: 119 ILHRDLKPQNILINRD--GVLKLADFGLARA---FGIPLRTYTHEVVTLWYRAPEILLGS 173
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPF 219
K Y + D+WS G M+ G F
Sbjct: 174 KHYSTAV-DIWSVGCIFAEMITGKPLF 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 7e-42
Identities = 88/247 (35%), Positives = 127/247 (51%), Gaps = 22/247 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSLRHPNIV 80
+G G FG L+R+K T + A+K I + + I + ++ + H ++ RHP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMK-ILKKEVI---IAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
K T L VMEYA+GGELF + FSED ARF+ +++S + Y HS V +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKI 199
RDLKLEN +LD +KI DFG K + T GTP Y+APEVL +Y G+
Sbjct: 119 RDLKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRA 175
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
D W GV +Y M+ G PF + + K F IL + P +SPE + L++ +
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFPR--TLSPEAKSLLAGL 229
Query: 260 FVADPAK 266
DP +
Sbjct: 230 LKKDPKQ 236
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 8e-42
Identities = 82/250 (32%), Positives = 129/250 (51%), Gaps = 15/250 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
D E ++ +G+G FG L+RD+ +E A+K + + I ++V E + + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P I+R L ++MEY GGELF + N+GRFS F+ +++ + Y HS
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
++ +RDLK EN LLD +K+ DFG++K L + + GTP Y+APEV+ K +
Sbjct: 121 EIVYRDLKPENILLDKE--GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH- 175
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
K D W+ G+ +Y MLVG PF D N +IL+ + P H+ + LI
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFD----DNPFGIYEKILAGKLEFPR--HLDLYAKDLI 229
Query: 257 SRIFVADPAK 266
++ V D +
Sbjct: 230 KKLLVVDRTR 239
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-41
Identities = 73/250 (29%), Positives = 124/250 (49%), Gaps = 14/250 (5%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPN 78
+EL+R IG G FG +++ + T+++ A+KY+ + +++ R ++N R L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V ++ +V++ GG+L + +FSE++ +F+ +++ + Y HS +
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRD+K +N LLD + I DF + + ST GTP Y+APEVL ++ Y
Sbjct: 122 IHRDIKPDNILLDEQ--GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SV 178
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDY-VHISPECRHLI 256
D WS GVT Y L G P+ + R +I + Q + Y S E I
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYR-----GHSRTIRDQIRAKQETADVLYPATWSTEAIDAI 233
Query: 257 SRIFVADPAK 266
+++ DP K
Sbjct: 234 NKLLERDPQK 243
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 90/284 (31%), Positives = 130/284 (45%), Gaps = 52/284 (18%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RH 76
D +E+++ IG G FG L+RDK T ++ A+K + + D I N + R +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 77 PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
P IV+ F++ HL +VMEY GG+L + F E+ ARF+ +L+ +
Sbjct: 61 PWIVKLYYSFQDE----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDS 116
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------------------------- 167
H + HRD+K +N L+D +K+ DFG K
Sbjct: 117 VHKLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 168 -SSVLHSQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222
H Q + STVGTP YIAPEVL Y + D WS GV LY ML G PF
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSD 233
Query: 223 EEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRIFVADP 264
++T ++I++ + S P +SPE LI R + DP
Sbjct: 234 ----TLQETYNKIINWKESLRFPPDPPVSPEAIDLICR-LLCDP 272
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 3e-41
Identities = 82/250 (32%), Positives = 125/250 (50%), Gaps = 18/250 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---VQREIINHRSLRHPN 78
Y+L IG G FGV + +T + VA+K I +E + +EI ++L+HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV++ I T L I++EYA G L + I G F E + Q++ G++Y H V
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K N L DG +K+ DFG + K + + S VGTP ++APEV+
Sbjct: 121 IHRDIKAANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRH 254
+D+WS G T+ +L G P+ D N + RI+ + +P+ ISPE +
Sbjct: 177 STA-SDIWSLGCTVIELLTGNPPYYD----LNPMAALFRIVQDDHPPLPE--GISPELKD 229
Query: 255 LISRIFVADP 264
+ + F DP
Sbjct: 230 FLMQCFQKDP 239
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 5e-41
Identities = 82/244 (33%), Positives = 123/244 (50%), Gaps = 15/244 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-----LRHPNIVRFK 83
IG G+FG L + K + AVK +++ + + Q+ I+ R+ ++HP +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD L DFG K + HS+ ST GTP Y+APEVL K+ YD + D
Sbjct: 123 KPENILLDSQGHVVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
W G LY ML G PF + + + +++ L ++ + IS RHL+ +
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN------ISVSARHLLEGLLQK 233
Query: 263 DPAK 266
D K
Sbjct: 234 DRTK 237
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 7e-41
Identities = 81/261 (31%), Positives = 124/261 (47%), Gaps = 27/261 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
YE++ IG G+FG R +R K +++ K I+ G + E ++++++ R L+HPN
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHPN 60
Query: 79 IVRF--KEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSY 132
IVR+ + + + L IVMEY GG+L + I E+ QL+ +
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 133 CH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIA 186
CH V HRDLK N LD + +K+ DFG +K S T VGTP Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDY 245
PE L YD K +D+WS G +Y + + PF +N + +I ++ IP
Sbjct: 179 PEQLNHMSYDEK-SDIWSLGCLIYELCALSPPF----TARNQLQLASKIKEGKFRRIPY- 232
Query: 246 VHISPECRHLISRIFVADPAK 266
S E +I + DP K
Sbjct: 233 -RYSSELNEVIKSMLNVDPDK 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 8e-41
Identities = 70/199 (35%), Positives = 109/199 (54%), Gaps = 10/199 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
IG G G D+ T + VA+K + + E + EI+ + +HPNIV + + L
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 89 PTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VMEY GG L + I N R +E + + ++++ G+ Y HS V HRD+K +N
Sbjct: 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDN 146
Query: 148 TLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DGS +K+ DFG++ + + S+ S VGTP ++APEV+ +K+Y K+ D+WS
Sbjct: 147 ILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKV-DIWS 201
Query: 205 CGVTLYVMLVGAYP-FEDP 222
G+ M G P +P
Sbjct: 202 LGIMCIEMAEGEPPYLREP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-40
Identities = 75/237 (31%), Positives = 119/237 (50%), Gaps = 15/237 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 84
+G G FG L++ K A+K +++ ++ Q I + + HP IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
++ ++MEY GGEL+ + + G F E ARF+ ++ Y H+ + +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
EN LLD + +K+ DFG++K + + GTP Y+APE++L K YD D WS
Sbjct: 121 PENLLLDSN--GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWS 177
Query: 205 CGVTLYVMLVGAYPF-EDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISR 258
G+ LY +L G PF ED E+P + + IL + P+Y I + LI +
Sbjct: 178 LGILLYELLTGRPPFGEDDEDP---MEIYNDILKGNGKLEFPNY--IDKAAKDLIKQ 229
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-40
Identities = 90/250 (36%), Positives = 127/250 (50%), Gaps = 12/250 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDEN-VQREIINHRSLRHPN 78
+YE +R +G G FG+ L R K ++LV +K I E+ K + Q E + L HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
I+ + E L L IVMEYA GG L E I ED FF Q++ + + H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK +N LLD +KI DFG SK S+ + VGTP YI+PE+ K Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
K +D+W+ G LY + F E N + +I+S ++ P SP+ R LI
Sbjct: 180 QK-SDIWALGCVLYELASLKRAF----EAANLPALVLKIMSGTFA-PISDRYSPDLRQLI 233
Query: 257 SRIFVADPAK 266
+ DP+K
Sbjct: 234 LSMLNLDPSK 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 5e-40
Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
RY+++ IG G G+ +D++T E VA+K + I REI ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
+V+ +V + +VMEY +L E + + R E + + + + L+ GV+Y H+
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL-KKE 194
+ HRDLK N L+ S LKI DFG ++ S V T Y APE+L ++
Sbjct: 120 IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 195 YDGKIADVWSCGVTLYVMLVGA 216
YD + D+W+ G +L G+
Sbjct: 178 YDPGV-DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-39
Identities = 89/246 (36%), Positives = 131/246 (53%), Gaps = 19/246 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T E A+K +++ D + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T HL VMEY +GG+L I ++GRF E ARF+ ++I G+ + H + +RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
LKL+N LLD +KI DFG K ++ ST GTP YIAPE+L ++Y+ + D
Sbjct: 122 LKLDNVLLDKD--GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV-D 178
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY-VHISPECRHLISRIF 260
WS GV LY ML+G PF +E + F S+ P + IS E + +S++F
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDELFD-------SILNDRPHFPRWISKEAKDCLSKLF 231
Query: 261 VADPAK 266
DP K
Sbjct: 232 ERDPTK 237
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 4e-39
Identities = 70/207 (33%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+ + L+ IG G+FG DK+T ++VA+K I E D+I++ +Q+EI R P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED-IQQEIQFLSQCRSP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
I ++ L + L I+MEY GG + + G+ E F ++++ G+ Y H
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRD+K N LL +G +K+ DFG S + S+ + VGTP ++APEV+ +
Sbjct: 119 KIHRDIKAANILLSEEGD----VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFED 221
YD K AD+WS G+T + G P D
Sbjct: 175 YDEK-ADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 1e-38
Identities = 79/252 (31%), Positives = 139/252 (55%), Gaps = 20/252 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
+Y V+ IG G+FG A L++ K+ + +K I + K E ++E+ +++HPN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHS 135
IV+++E +L IVM+Y GG+L+++I NA R F ED+ +F Q+ + + H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLK 192
++ HRD+K +N L +K+ DFG ++ VL+S ++ +GTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLTKDGT--IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICEN 175
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252
+ Y+ K +D+W+ G LY M + F E N + + +I+ Y P H S +
Sbjct: 176 RPYNNK-SDIWALGCVLYEMCTLKHAF----EAGNMKNLVLKIIRGSYP-PVSSHYSYDL 229
Query: 253 RHLISRIFVADP 264
R+L+S++F +P
Sbjct: 230 RNLVSQLFKRNP 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-38
Identities = 77/249 (30%), Positives = 113/249 (45%), Gaps = 12/249 (4%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
E V+ +G G+ GV +R K T ++ A+K I + Q RE+ RS P +V+
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK 63
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCH 140
++IV+EY GG L + + G+ E + +Q++ G+ Y H+ + H
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIH 123
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
RD+K N L+ G KI DFG SK +T VGT Y++PE ++ E
Sbjct: 124 RDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYS 178
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
AD+WS G+TL +G +PF P +P F I SPE R IS
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-ICDGPPPSLPAEEFSPEFRDFIS 237
Query: 258 RIFVADPAK 266
DP K
Sbjct: 238 ACLQKDPKK 246
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 75/222 (33%), Positives = 112/222 (50%), Gaps = 15/222 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
++++ +G G +G L + K T E+VA+K +++ N R ++ R + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+ +L + MEY GG+ + N G SED ARF+ ++ V H +
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRDLK EN L+D S +K+ DFG SK V + S VG+P Y+APEVL K YD
Sbjct: 123 IHRDLKPENFLIDAS--GHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFT 178
Query: 199 IADVWSCGVTLYVMLVGAYPF--EDPEEP----KNFRKTIHR 234
+ D WS G LY L G PF P E K +++T+ R
Sbjct: 179 V-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR 219
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-38
Identities = 79/248 (31%), Positives = 126/248 (50%), Gaps = 15/248 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHPN 78
+E+ +G+G+FG R+ + K T E A+K +++ + + + + +S L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + ++E+ GGELF + AGRF D A+F+ +L+ Y HS +
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
+RDLK EN LLD +K+ DFG++K + + + GTP Y+APEV+ K + GK
Sbjct: 140 IYRDLKPENLLLDNK--GHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSKGH-GK 194
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
D W+ GV LY + G PF D + P FR +IL+ + P++ R L+
Sbjct: 195 AVDWWTMGVLLYEFIAGYPPFFD-DTP--FR-IYEKILAGRLKFPNWF--DGRARDLVKG 248
Query: 259 IFVADPAK 266
+ D K
Sbjct: 249 LLQTDHTK 256
|
Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 1e-37
Identities = 85/243 (34%), Positives = 125/243 (51%), Gaps = 14/243 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+R+K T A+K + + I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L VMEYA+GGELF + F+E+ ARF+ +++S + Y HS V +RD+K
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
LEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y G+ D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263
GV +Y M+ G PF + + + F IL + P +SPE + L++ + D
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPR--TLSPEAKSLLAGLLKKD 233
Query: 264 PAK 266
P +
Sbjct: 234 PKQ 236
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 4e-37
Identities = 83/245 (33%), Positives = 126/245 (51%), Gaps = 17/245 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K E AVK +++ ID++V+ ++ R L +P +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T HL VME+ +GG+L I + GRF A F+ +++ G+ + HS + +RDL
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N +LD +KI DFG K +V ST GTP YIAPE+L +Y + D
Sbjct: 123 KLDNVMLDRD--GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV-DW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHLISRIFV 261
WS GV LY ML+G PF +E + F S++ P Y I+ E + ++ ++F
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFE-------SIRVDTPHYPRWITKESKDILEKLFE 232
Query: 262 ADPAK 266
DP +
Sbjct: 233 RDPTR 237
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-37
Identities = 81/206 (39%), Positives = 111/206 (53%), Gaps = 14/206 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHR------SLRHPNIVR 81
+G G+FG L KKT EL A+K +++GD I + V+ + R S RHP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T H+ VMEYA+GG+L I + FSE A F+ ++ G+ Y H ++ +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +KI DFG K + ST GTP ++APEVL + Y +
Sbjct: 126 DLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAV 182
Query: 201 DVWSCGVTLYVMLVGAYPF--EDPEE 224
D W GV +Y MLVG PF +D EE
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 6e-37
Identities = 84/256 (32%), Positives = 125/256 (48%), Gaps = 27/256 (10%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE----------RGDKIDENVQREIINHRSLRHPN 78
IGSG+FG L + + EL+AVK +E R + + + REI + L+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV++ L HL I +EY GG + + N G F E R F +Q++ G++Y H+ +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVLL 191
HRD+K N L+D +KI DFG SK S+ + S G+ ++APEV+
Sbjct: 128 IHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-VQYSIPDYVHISP 250
+ Y K AD+WS G + ML G +PF D + + I +I IP +IS
Sbjct: 186 QTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQ----LQAIFKIGENASPEIPS--NISS 238
Query: 251 ECRHLISRIFVADPAK 266
E + + F D K
Sbjct: 239 EAIDFLEKTFEIDHNK 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-36
Identities = 77/200 (38%), Positives = 109/200 (54%), Gaps = 19/200 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ YEL++ IGSG +G RD T ELVA+K I E GD + +Q+EI + RHPN
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI-IQQEISMLKECRHPN 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV + L L IVMEY GG L + G SE + + ++ + G++Y H
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVL-- 190
HRD+K N LL DG +K+ DFG S +++ ++ KS +GTP ++APEV
Sbjct: 122 KIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAV 175
Query: 191 -LKKEYDGKIADVWSCGVTL 209
K YDGK D+W+ G+T
Sbjct: 176 ERKGGYDGK-CDIWALGITA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 88/293 (30%), Positives = 135/293 (46%), Gaps = 61/293 (20%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLR---- 75
D +E ++ IG G FG RL++ K T + A+K + + + + ++E + H R+ R
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML----EKEQVAHVRAERDILA 56
Query: 76 ---HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+P +V+ +L ++MEY GG++ + F+E+E RF+ + I +
Sbjct: 57 EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 171
H + HRD+K +N LLD +K+ DFG
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 172 HSQPK------------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213
S+P STVGTP YIAPEV L+ Y K D WS GV +Y ML
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEML 233
Query: 214 VGAYPF--EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
VG PF ++P+E +RK I+ ++Q PD V +SPE + LI R +
Sbjct: 234 VGYPPFCSDNPQE--TYRKIINWKETLQ--FPDEVPLSPEAKDLIKR-LCCEA 281
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-36
Identities = 81/276 (29%), Positives = 124/276 (44%), Gaps = 38/276 (13%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNI 79
Y+ + IG G +GV RDK T E+VA+K I+ + I + REI + L HPNI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQV 138
++ +V L +V E+ +L++ I + R E + + QL+ G+++CHS +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLKKEY 195
HRDLK EN L++ LK+ DFG ++S S + V T Y APE+LL +
Sbjct: 120 LHRDLKPENLLINTEGV--LKLADFGLARS--FGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL----------------SVQ 239
D+WS G +L F E K I R L + +
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK-IFRTLGTPDPEVWPKFTSLARNYK 234
Query: 240 YSIPDYVHI---------SPECRHLISRIFVADPAK 266
+S P + SP+ L+S++ DP K
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHK 270
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 4e-36
Identities = 85/243 (34%), Positives = 125/243 (51%), Gaps = 14/243 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+R+K + + A+K +++ I + V + R L RHP + K
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
T L VMEY +GGELF + FSED RF+ +++S + Y HS ++ +RDLK
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYDGKIADVW 203
LEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y G+ D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263
GV +Y M+ G PF + + K F IL P +S + + L+S + + D
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEDIKFPRT--LSADAKSLLSGLLIKD 233
Query: 264 PAK 266
P K
Sbjct: 234 PNK 236
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 4e-36
Identities = 81/245 (33%), Positives = 131/245 (53%), Gaps = 17/245 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T + A+K +++ + D++V+ ++ R L HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T +L VMEY +GG+L I + +F A F+ ++I G+ + HS + +RDL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N LLD +KI DFG K ++L T GTP YIAPE+LL ++Y+ + D
Sbjct: 123 KLDNILLDTD--GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV-DW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHLISRIFV 261
WS GV LY ML+G PF +E + F+ S++ P Y ++ E + ++ ++FV
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQ-------SIRMDNPCYPRWLTREAKDILVKLFV 232
Query: 262 ADPAK 266
+P +
Sbjct: 233 REPER 237
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 7e-36
Identities = 73/204 (35%), Positives = 108/204 (52%), Gaps = 15/204 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKY---IERGDKIDENVQREIINHRSLRHP 77
++YE++ +G G +GV R+K T E+VA+K E + + + RE+ R LRH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV KE L +V EY EL E + G D R + QL+ ++YCHS
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLL 191
+ HRD+K EN L+ S + LK+CDFG++++ L ++P S V T Y APE+L+
Sbjct: 119 HNIIHRDIKPENILV--SESGVLKLCDFGFARA--LRARPASPLTDYVATRWYRAPELLV 174
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
GK DVW+ G + +L G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 1e-35
Identities = 88/244 (36%), Positives = 127/244 (52%), Gaps = 15/244 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 84
+G G FG L+++K T A+K +++ + + V + +R L RHP + K
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDL 143
T L VMEYA+GGELF + FSED ARF+ +++S + Y HS V +RDL
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
KLEN +LD +KI DFG K + + K+ GTP Y+APEVL +Y G+ D
Sbjct: 123 KLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
W GV +Y M+ G PF + + K F IL + P +SPE + L+S +
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPRT--LSPEAKSLLSGLLKK 233
Query: 263 DPAK 266
DP +
Sbjct: 234 DPKQ 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 79/243 (32%), Positives = 117/243 (48%), Gaps = 14/243 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVRFKE 84
IG G+FG +R + T+ + A+K I + + + + R++ P IV K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+P L +V+ + +GGELF + GRF ARF+ +L+ + H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVW 203
EN LLD + +CDFG K ++ +T GTP Y+APE+LL Y K D W
Sbjct: 121 PENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177
Query: 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263
+ GV LY ML G PF D + +RK IL PD + + L+ + D
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRK----ILQEPLRFPD--GFDRDAKDLLIGLLSRD 231
Query: 264 PAK 266
P +
Sbjct: 232 PTR 234
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 77/205 (37%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T+EL A+K I + D I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIK-ILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T L VMEY +GG+L I G+F E A F+ ++ G+ + HS + +RD
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRD 126
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
LKL+N +LD +KI DFG K ++ + T GTP YIAPE++ + Y GK D
Sbjct: 127 LKLDNVMLDAE--GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 202 VWSCGVTLYVMLVGAYPF--EDPEE 224
W+ GV LY ML G PF ED +E
Sbjct: 184 WWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-35
Identities = 73/209 (34%), Positives = 112/209 (53%), Gaps = 10/209 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV------QREIINHRSLRH-PNIVR 81
IG G FG +R K T + A+K + + + + + +R I+ L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
K T + L +V +Y SGGELF + GRFSED A+F+ +L+ + + H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLK EN LLD + + +CDFG SK+++ ++ +T GT Y+APEVLL ++ K
Sbjct: 121 DLKPENILLDAT--GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
D WS GV ++ M G PF + + +R
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAEDTQQMYR 207
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 75/217 (34%), Positives = 109/217 (50%), Gaps = 9/217 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-----SLRHPNIVRFK 83
IG G+FG L + K AVK +++ + + Q I+ R +L+HP +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD + + DFG K V + ST GTP Y+APEVL K+ YD + D
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
W G LY ML G PF + + + +H+ L +
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 7e-35
Identities = 74/212 (34%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 82
+G G+FG L K T+E+ A+K +++ D I D++V + R L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKK-DVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
T L VMEY +GG+L +I + +F E +RF+ ++ + + H V +RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIAD 201
LKL+N LLD K+ DFG K +L+ +T GTP YIAPE+L + EY + D
Sbjct: 122 LKLDNILLDAE--GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV-D 178
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
W+ GV +Y M+ G PFE E F +H
Sbjct: 179 WWALGVLMYEMMAGQPPFEADNEDDLFESILH 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 8e-35
Identities = 78/245 (31%), Positives = 121/245 (49%), Gaps = 21/245 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDEN----VQREIINHRSLRHPNIVRF 82
+G G FG L D T +AVK + + ++ EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
+ L+I MEY GG + +++ G +E R + +Q++ GV Y HS + HRD
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGK 198
+K N L D A +K+ DFG SK + S KS GTP +++PEV+ + Y G+
Sbjct: 130 IKGANILRDS--AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GR 186
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECRHLI 256
ADVWS G T+ ML P+ + E I +I + +P H+SP+ R+ +
Sbjct: 187 KADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIATQPTNPQLPS--HVSPDARNFL 240
Query: 257 SRIFV 261
R FV
Sbjct: 241 RRTFV 245
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-34
Identities = 72/257 (28%), Positives = 105/257 (40%), Gaps = 25/257 (9%)
Query: 24 ELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
L + +G G FG + E VAVK + + D ++ ++ RE R L H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 134
PNIV+ V L IVMEY GG+L + R S + F Q+ G+ Y
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEV 189
S HRDL N L+ + +KI DFG Y K + ++APE
Sbjct: 121 SKNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPES 175
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
L + ++ K +DVWS GV L+ + E N + L Y +P +
Sbjct: 176 LKEGKFTSK-SDVWSFGVLLWEIF--TLGEEPYPGMSNAE--VLEYLKKGYRLPKPPNCP 230
Query: 250 PECRHLISRIFVADPAK 266
PE L+ + + DP
Sbjct: 231 PELYKLMLQCWAEDPED 247
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-34
Identities = 80/251 (31%), Positives = 124/251 (49%), Gaps = 23/251 (9%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--------HP 77
++ I G FG L + + T + A+K +++ D I +N ++ N ++ R P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN---QVTNVKAERAIMMIQGESP 57
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ + + +L +VMEY +GG+ I G ED A+ + +++ GV H
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRD+K EN L+D LK+ DFG S++ + K VGTP Y+APE +L D
Sbjct: 118 IIHRDIKPENLLIDQ--TGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DD 171
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH--ISPECRHL 255
K++D WS G ++ L G PF E P ILS + + P+ V SPE L
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFH-AETPD---AVFDNILSRRINWPEEVKEFCSPEAVDL 227
Query: 256 ISRIFVADPAK 266
I+R+ DPAK
Sbjct: 228 INRLLCMDPAK 238
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 79/209 (37%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIV 80
R +G G+FG L R K++ L AVK +++ D I D++V+ + R L HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ TP L VME+ +GG+L I + RF E ARF+ ++ S + + H + +
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKI 199
RDLKL+N LLD K+ DFG K + + + ST GTP YIAPE+L + Y G
Sbjct: 120 RDLKLDNVLLDHE--GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPS 176
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228
D W+ GV LY ML G PFE E F
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 2e-34
Identities = 73/259 (28%), Positives = 109/259 (42%), Gaps = 30/259 (11%)
Query: 24 ELVRDIGSGNFGVARL----MRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
L + +G G FG + K + VAVK + + D ++ ++ RE R L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
PN+V+ V L IVMEY GG+L + N + S + F Q+ G+ Y S
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVL 190
HRDL N L+ + +KI DFG Y K + ++APE L
Sbjct: 121 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESL 175
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGA---YPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
+ ++ K +DVWS GV L+ + YP EE + K +R+ P
Sbjct: 176 KEGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRL-----PQPPNCP 229
Query: 248 ISPECRHLISRIFVADPAK 266
PE L+ + + DP
Sbjct: 230 --PELYDLMLQCWAEDPED 246
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 2e-34
Identities = 72/210 (34%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE----NVQREIINHRSLRHPN 78
YE + IG G +G R+KKT ELVA+K I R + E REI + LRHPN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPN 59
Query: 79 IVRFKEVILTPTHLAI--VMEYA----SGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
IVR KE++ + +I V EY +G L + +F+E + + + +QL+ G+ Y
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQY 115
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRD+K N L++ LK+ DFG ++ + T V T Y PE+L
Sbjct: 116 LHSNGILHRDIKGSNILINND--GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 191 L-KKEYDGKIADVWSCGVTLYVMLVGAYPF 219
L Y ++ D+WS G L + +G F
Sbjct: 174 LGATRYGPEV-DMWSVGCILAELFLGKPIF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-34
Identities = 83/251 (33%), Positives = 134/251 (53%), Gaps = 19/251 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 79
+Y ++R +G G+FG A L++ +++ A+K I + E+ ++E + ++HPNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
V FKE HL IVMEY GG+L ++I G+ F ED +F Q+ GV + H +
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLLKK 193
V HRD+K +N L + ++K+ DFG S+ L + P + VGTP Y+ PE+
Sbjct: 121 VLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENM 175
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
Y+ K +D+WS G LY + +PF + +++ I ++ Y P H S E R
Sbjct: 176 PYNNK-SDIWSLGCILYELCTLKHPF----QANSWKNLILKVCQGSYK-PLPSHYSYELR 229
Query: 254 HLISRIFVADP 264
LI ++F +P
Sbjct: 230 SLIKQMFKRNP 240
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 3e-34
Identities = 70/195 (35%), Positives = 105/195 (53%), Gaps = 20/195 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQ-REIINHRSLR----H 76
Y++++ +G G FG L R+K+T ELVA+K +++ +E + RE+ +SLR H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 134
PNIV+ KEV L V EY G L++ + FSE R Q++ G+++ H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK 192
HRDLK EN L+ S +KI DFG ++ + S+P T V T Y APE+LL+
Sbjct: 117 KHGFFHRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLR 172
Query: 193 -KEYDGKIADVWSCG 206
Y + D+W+ G
Sbjct: 173 STSYSSPV-DIWALG 186
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 5e-34
Identities = 78/254 (30%), Positives = 125/254 (49%), Gaps = 20/254 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRHP 77
Y +R +G G FG A L R + + LV K + + E +R+ +N L+HP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHS 135
NI+ + + L I MEYA+GG L+++I F E+ ++ Q++S VSY H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLK 192
+ HRD+K N L + A +K+ DFG SK S ++ + VGTP Y++PE+
Sbjct: 120 AGILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMAE--TVVGTPYYMSPELCQG 175
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252
+Y+ K +D+W+ G LY +L F + N + +I+ Y+ V+ S E
Sbjct: 176 VKYNFK-SDIWALGCVLYELLTLKRTF----DATNPLNLVVKIVQGNYTPVVSVY-SSEL 229
Query: 253 RHLISRIFVADPAK 266
L+ + DP K
Sbjct: 230 ISLVHSLLQQDPEK 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 5e-34
Identities = 85/254 (33%), Positives = 131/254 (51%), Gaps = 23/254 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 78
RYE+++ IG G+FG L + K E +K I + K E ++E+I ++HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHS 135
IV F L IVMEY GG+L +RI N R FSED+ +F Q+ G+ + H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 136 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 190
++ HRD+K +N L +G A K+ DFG ++ L+ + VGTP Y++PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA---KLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEIC 174
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
+ Y+ K D+WS G LY + +PFE N + + +I ++ P + S
Sbjct: 175 QNRPYNNK-TDIWSLGCVLYELCTLKHPFEG----NNLHQLVLKICQGYFA-PISPNFSR 228
Query: 251 ECRHLISRIFVADP 264
+ R LIS++F P
Sbjct: 229 DLRSLISQLFKVSP 242
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 7e-34
Identities = 78/244 (31%), Positives = 117/244 (47%), Gaps = 12/244 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVK---YIERGDKIDENVQ---REIINHRSLRHPNIVRF 82
+GSG+FG + + AVK + G E V+ +EI L+HPNIV++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
+L I +E GG L + + G F E R + +Q++ G+ Y H HRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
+K N L+D + +K+ DFG +K V S KS G+P ++APEV+ ++ G AD+
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
WS G T+ M G P+ E K I R + IPD H+S E + I +
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELP-PIPD--HLSDEAKDFILKCLQR 241
Query: 263 DPAK 266
DP+
Sbjct: 242 DPSL 245
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 7e-34
Identities = 81/244 (33%), Positives = 126/244 (51%), Gaps = 15/244 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 83
IG G+FG L R K E+ AVK +++ + + ++ I++ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V++Y +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD + + DFG K ++ H+ ST GTP Y+APEVL K+ YD + D
Sbjct: 123 KPENILLDSQ--GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262
W G LY ML G PF + + +++ L ++ P+ I+ RHL+ +
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK---PN---ITNSARHLLEGLLQK 233
Query: 263 DPAK 266
D K
Sbjct: 234 DRTK 237
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 8e-34
Identities = 77/246 (31%), Positives = 137/246 (55%), Gaps = 20/246 (8%)
Query: 29 IGSGNFGVARLMRDKKTEE---LVAVKYIERG-----DKIDENVQREIINHRSLRHPNIV 80
+G G+FG L+R + L A+K +++ D++ ++R+I+ + HP IV
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHPFIV 61
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ T L +++++ GG+LF R+ F+E++ +F+ +L + + HS+ + +
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIY 121
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKI 199
RDLK EN LLD +K+ DFG SK S+ H + S GT Y+APEV+ ++ + +
Sbjct: 122 RDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QS 178
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
AD WS GV ++ ML G+ PF+ K+ ++T+ IL + +P + +SPE + L+ +
Sbjct: 179 ADWWSFGVLMFEMLTGSLPFQG----KDRKETMTMILKAKLGMPQF--LSPEAQSLLRAL 232
Query: 260 FVADPA 265
F +PA
Sbjct: 233 FKRNPA 238
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 8e-34
Identities = 79/256 (30%), Positives = 130/256 (50%), Gaps = 17/256 (6%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERG-----DKIDENV--QREIINHR 72
+EL++ +G+G +G L+R T +L A+K +++ K E+ +R ++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ P +V T L ++++Y SGGE+F + FSEDE RF+ ++I + +
Sbjct: 62 R-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APE++
Sbjct: 121 LHKLGIVYRDIKLENILLDSE--GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
K GK D WS G+ ++ +L GA PF E + RIL P + I P
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF--IGP 236
Query: 251 ECRHLISRIFVADPAK 266
E + L+ ++ DP K
Sbjct: 237 EAQDLLHKLLRKDPKK 252
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 76/207 (36%), Positives = 114/207 (55%), Gaps = 9/207 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL A+K +++ I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L +I GRF E A F+ ++ G+ + HS + +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADV 202
KL+N +LD +KI DFG K ++ K+ GTP YIAPE++ + Y GK D
Sbjct: 128 KLDNVMLDSE--GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFR 229
W+ GV LY ML G PFE +E + F+
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQ 211
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-33
Identities = 61/205 (29%), Positives = 107/205 (52%), Gaps = 8/205 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ ++++ +G G++G K+T ++VA+K + + + + + +EI + P I
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYI 60
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
V++ T L IVMEY G + + +I N +E+E Q + G+ Y HS +
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
HRD+K N LL+ K+ DFG S + + ++ + +GTP ++APEV+ + Y+
Sbjct: 120 KIHRDIKAGNILLNEEGQA--KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 197 GKIADVWSCGVTLYVMLVGAYPFED 221
K AD+WS G+T M G P+ D
Sbjct: 178 NK-ADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-33
Identities = 78/246 (31%), Positives = 111/246 (45%), Gaps = 15/246 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE------RGDKIDENVQREIINHRSLRHPNIVRF 82
+G G FG + K T ++ A K ++ R + +++I+ S R IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSL 58
Query: 83 KEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCH 140
T L +VM +GG+L I N G F E A F+ Q+I G+ + H ++ +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RDLK EN LLD R I D G + + K GTP Y+APEVL + YD
Sbjct: 119 RDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-V 175
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260
D ++ G TLY M+ G PF +E + R L + PD SPE + L +
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEALL 233
Query: 261 VADPAK 266
DP K
Sbjct: 234 QKDPEK 239
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-33
Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 36/270 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
+ +E ++ I +G +G L+R K+T + A+K I + + I N V+R+I+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
+P +V T HL +VMEY GG+ + N G D AR +F + + + Y H
Sbjct: 60 -NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------------QPKST 178
+ + HRDLK +N L+ + +K+ DFG SK ++ K
Sbjct: 119 NYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRIL 236
GTP YIAPEV+L++ Y GK D W+ G+ LY LVG PF + PEE F + I
Sbjct: 177 CGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQVI---- 229
Query: 237 SVQYSIPDYVH-ISPECRHLISRIFVADPA 265
S P+ + + + LISR+ +P
Sbjct: 230 SDDIEWPEGDEALPADAQDLISRLLRQNPL 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 7e-33
Identities = 75/220 (34%), Positives = 117/220 (53%), Gaps = 9/220 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 83
+G G+FG L K T+EL A+K +++ I D++V+ ++ R L + P + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L VMEY +GG+L I G+F E +A F+ ++ G+ + H + +RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
KL+N +LD +KI DFG K ++ T GTP YIAPE++ + Y GK D
Sbjct: 128 KLDNVMLDSE--GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242
W+ GV LY ML G PF+ +E + F+ + +S S+
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSL 224
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 78/258 (30%), Positives = 127/258 (49%), Gaps = 20/258 (7%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERGD-----KIDENV--QREIINHR 72
+EL+R +G+G +G L+R +L A+K +++ K E+ +R+++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
R P +V T T L ++++Y +GGELF + F+E E R + +++ + +
Sbjct: 62 R-RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + DFG SK + + + S GT Y+APEV+
Sbjct: 121 LHQLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
Query: 191 LKKEYD-GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-HRILSVQYSIPDYVHI 248
K D WS GV + +L GA PF E +N + I RIL + P +
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKSKPPFPK--TM 235
Query: 249 SPECRHLISRIFVADPAK 266
S E R I ++ DP K
Sbjct: 236 SAEARDFIQKLLEKDPKK 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-32
Identities = 79/250 (31%), Positives = 128/250 (51%), Gaps = 22/250 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRS 73
++ +++++ IG G FG +L+R K ++++ A+K + + + I + +R+I+ H +
Sbjct: 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN 101
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
IV+ +L +VMEY GG+L + N E ARF+ +++ +
Sbjct: 102 --SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAI 158
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEV 189
HSM HRD+K +N LLD S LK+ DFG + ++ + VGTP YI+PEV
Sbjct: 159 HSMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEV 214
Query: 190 LLKKEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
L + D G+ D WS GV LY MLVG PF + K + S+ + PD +
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF--PDDI 272
Query: 247 HISPECRHLI 256
IS + + LI
Sbjct: 273 EISKQAKDLI 282
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 77/203 (37%), Positives = 104/203 (51%), Gaps = 30/203 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ-------REIINHRS 73
D YE + I G +GV RDKKT E+VA+K + K+++ + REI
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREINILLK 60
Query: 74 LRHPNIVRFKEVIL--TPTHLAIVMEYASGGE-----LFERICNAGRFSEDEARFFFQQL 126
L+HPNIV KEV++ + +VMEY E L E + F + E + QL
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSEVKCLMLQL 115
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAY 184
+SGV++ H + HRDLK N LL + LKICDFG ++ S L + V T Y
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172
Query: 185 IAPEVLL-KKEYDGKIADVWSCG 206
APE+LL KEY I D+WS G
Sbjct: 173 RAPELLLGAKEYSTAI-DMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 73/209 (34%), Positives = 110/209 (52%), Gaps = 14/209 (6%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRH--- 76
R EL IG G +G + T +VA+K I D+ ++QRE+ LR
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI ++ L L I+MEYA GG + + AG +E ++++ + Y H +
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK-KE 194
V HRD+K N L+ + +K+CDFG + +S +ST VGTP ++APEV+ + K
Sbjct: 121 GVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPE 223
YD K AD+WS G+T+Y M G P+ D +
Sbjct: 179 YDTK-ADIWSLGITIYEMATGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 7e-32
Identities = 80/248 (32%), Positives = 127/248 (51%), Gaps = 22/248 (8%)
Query: 29 IGSGNFG---VARLMRDKKTEELVAVKYIERG-------DKIDENVQREIINHRSLRHPN 78
+G G +G R + T ++ A+K +++ D +R I+ +++HP
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNIL--EAVKHPF 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV T L +++EY SGGELF + G F ED A F+ ++ + + H +
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
+RDLK EN LLD +K+ DFG K S+ T GT Y+APE+L++ + G
Sbjct: 122 IYRDLKPENILLDAQ--GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
K D WS G +Y ML GA PF +N +KTI +IL + ++P Y ++PE R L+
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPF----TAENRKKTIDKILKGKLNLPPY--LTPEARDLLK 232
Query: 258 RIFVADPA 265
++ +P+
Sbjct: 233 KLLKRNPS 240
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-31
Identities = 82/259 (31%), Positives = 120/259 (46%), Gaps = 29/259 (11%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-----------VQREIINHRSLRHP 77
IG G +G L + T E++AVK +E I ++ EI + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV++ T +L+I +EY GG + + GRF E RFF +Q++ G++Y HS
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEV--LLK 192
+ HRDLK +N L+D KI DFG SK S + Q S G+ ++APEV
Sbjct: 129 ILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS---IPDYV--H 247
+ Y K+ D+WS G + M G P+ D E K L + S IP V +
Sbjct: 187 QGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFK-----LGNKRSAPPIPPDVSMN 240
Query: 248 ISPECRHLISRIFVADPAK 266
+SP ++ F +P
Sbjct: 241 LSPVALDFLNACFTINPDN 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 81/254 (31%), Positives = 121/254 (47%), Gaps = 20/254 (7%)
Query: 22 RYELVRDIGSGNFG-VARLMR--DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+++++ +G G++G V ++ R D + L V K E+ EI S+ HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
I+ +KE L L IVMEYA G+L + I + E E F QL+ G+ H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKK 193
++ HRDLK N LL +KI D G SK VL K+ +GTP Y+APEV +
Sbjct: 121 EQKILHRDLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGR 176
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPEC 252
Y K +D+WS G LY M A PF E ++ + +++ +Y IP S +
Sbjct: 177 PYSYK-SDIWSLGCLLYEMATFAPPF----EARSMQDLRYKVQRGKYPPIPP--IYSQDL 229
Query: 253 RHLISRIFVADPAK 266
++ I + P
Sbjct: 230 QNFIRSMLQVKPKL 243
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 87/296 (29%), Positives = 124/296 (41%), Gaps = 68/296 (22%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRHPN 78
RYEL++ IGSG +GV DK+T VA+K I D ID + + REI R LRH N
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 79 IVRFKEVILTPT-----HLAIVMEYA---------SGGELFERICNAGRFSEDEARFFFQ 124
I+ +++ P+ + IV E S L ++D ++F
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL----------TDDHIQYFLY 110
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VG 180
Q++ G+ Y HS V HRDLK N L++ + LKICDFG ++ K V
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 181 TPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVML---------------------VGAYP 218
T Y APE+LL Y I D+WS G +L +G
Sbjct: 169 TRWYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227
Query: 219 FEDPEEPKNFRKTIHRILSVQYS--------IPDYVHISPECRHLISRIFVADPAK 266
ED + + K + + S+ P SPE L+ ++ V DP K
Sbjct: 228 EEDLKFITS-EKARNYLKSLPKKPKKPLSKLFPG---ASPEAIDLLEKMLVFDPKK 279
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 71/217 (32%), Positives = 112/217 (51%), Gaps = 9/217 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 83
IG G+FG L + K + AVK +++ ++ Q+ I+ R++ +HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
T L V+++ +GGELF + F E ARF+ ++ S + Y HS+ + +RDL
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 202
K EN LLD + + DFG K + S +T GTP Y+APEV+ K+ YD + D
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV-DW 179
Query: 203 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
W G LY ML G PF + + + +H+ L ++
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 7e-31
Identities = 74/252 (29%), Positives = 125/252 (49%), Gaps = 24/252 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV------QREIINHRSL 74
+++ +G G+FG +++R+K T ++ A+K +++ + + +R+I++ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 133
P I + + +L +VMEY GG+L + +F ED A+F+ +L+ +
Sbjct: 60 -SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL 191
H M HRD+K EN L+D + +K+ DFG + ++ K VGTP YIAPEVL
Sbjct: 119 HQMGYVHRDIKPENVLIDRT--GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176
Query: 192 KKEYDGKIA-----DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PD 244
DGK D WS GV Y M+ G PF + KT + I++ Q + P+
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE----GTSAKTYNNIMNFQRFLKFPE 232
Query: 245 YVHISPECRHLI 256
+S + LI
Sbjct: 233 DPKVSSDFLDLI 244
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-31
Identities = 80/242 (33%), Positives = 127/242 (52%), Gaps = 13/242 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + DK T VAVK ++ R + E + E++ R +HPNIV L
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +S+ H+ V HRD+K ++
Sbjct: 87 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDS 145
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y G D+WS
Sbjct: 146 ILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 200
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
G+ + M+ G P+ + E P K I L + + + +SP R + R+ V DP
Sbjct: 201 LGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPK--LKNLHKVSPRLRSFLDRMLVRDP 257
Query: 265 AK 266
A+
Sbjct: 258 AQ 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 8e-31
Identities = 78/251 (31%), Positives = 128/251 (50%), Gaps = 20/251 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKIDEN------VQREIINHRSLR 75
+ +R +G+G+FG L K + VA+K E+ I + +R+I+N+ +
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY--IN 89
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HP V ++L +V+E+ GGE F + RF D F+ Q++ Y S
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ + +RDLK EN LLD +K+ DFG++K V+ ++ + GTP YIAPE+LL +
Sbjct: 150 LNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNVGH 205
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
GK AD W+ G+ +Y +LVG PF E ++K + I+ P + + C+HL
Sbjct: 206 -GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII----YFPKF--LDNNCKHL 258
Query: 256 ISRIFVADPAK 266
+ ++ D K
Sbjct: 259 MKKLLSHDLTK 269
|
Length = 340 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-31
Identities = 66/210 (31%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLRHPN 78
E + ++G+GN GV + + T +++AVK I I+E +Q++I I H+ P
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKC-NSPY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS- 135
IV F ++I MEY GG L + GR E ++ G++Y H
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ HRD+K N L++ ++K+CDFG S V +S K+ VGT +Y+APE + +Y
Sbjct: 120 HKIIHRDVKPSNILVNSR--GQIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDY 176
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
K +D+WS G++L + G +P+ +P
Sbjct: 177 SVK-SDIWSLGLSLIELATGRFPYPPENDP 205
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-30
Identities = 71/219 (32%), Positives = 111/219 (50%), Gaps = 15/219 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
+E++ IG G+FGV + K + + A+K I+ K++ + E I+ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-SKMNRREREEAIDEARVLAKLDSSY 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R+ E L L IVMEYA G+L + + ED+ FF Q++ G+++ HS
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKK 193
++ HRD+K N LD +KI D G +K +L + VGTP Y++PE+ K
Sbjct: 121 KILHRDIKSLNLFLDAY--DNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
Y+ K +DVW+ GV LY G +PF+ + K I
Sbjct: 177 PYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKII 214
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 79/247 (31%), Positives = 125/247 (50%), Gaps = 16/247 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
+G G +G+ RD T+ +A+K I ER + + + EI H L+H NIV++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 88 TPTHLAIVMEYASGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 145 LENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIAD 201
+N L++ + + +KI DFG SK + ++ ++ GT Y+APEV+ K + Y G AD
Sbjct: 136 GDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAPAD 193
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKN--FRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
+WS G T+ M G PF + EP+ F+ + +I IP+ +S E ++ I R
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI---HPEIPE--SLSAEAKNFILRC 248
Query: 260 FVADPAK 266
F DP K
Sbjct: 249 FEPDPDK 255
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 79/252 (31%), Positives = 124/252 (49%), Gaps = 23/252 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 81
+G+G F RD KT L+AVK + +++ E +++EI L HP+I+R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
+H + +E+ +GG + + G F E + +QL+ G+SY H Q+ HR
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPEVLLKKE 194
D+K N L+D S RL+I DFG ++ L ++ +GT A++APEVL ++
Sbjct: 128 DVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPEC 252
Y G+ DVWS G + M P+ + E+ N I +I S SIP+ H+SP
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIASATTAPSIPE--HLSPGL 240
Query: 253 RHLISRIFVADP 264
R + R P
Sbjct: 241 RDVTLRCLELQP 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 84/293 (28%), Positives = 121/293 (41%), Gaps = 69/293 (23%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRH 76
+ ++ IG G FG L+R T L A+K + + D + N +R+I+ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--N 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ +L VM+Y GG++ + G F ED ARF+ +L + H M
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK---------------S 168
HRD+K +N L+D +K+ DFG Y K S
Sbjct: 121 GFIHRDIKPDNILIDRD--GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 169 SVLHSQPK----------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212
+ + K S VGTP YIAPEVLL+ Y ++ D WS GV LY M
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM 237
Query: 213 LVGAYPFEDPE------EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
LVG PF + N+ T+H IP +S E LI R+
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTLH--------IPSQAKLSREASDLILRL 282
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 61/211 (28%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 83
+G G FG +L VAVK ++ +E +E + L HPN+VR
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 84 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GVSYCH 134
V L +V+EY GG+L + R S +++ + L+S G+ Y
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLL 191
S + HRDL N L+ +KI DFG S+ + G I APE L
Sbjct: 123 SKKFVHRDLAARNCLVGED--LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLK 180
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS GV L+ + +GA P+
Sbjct: 181 DGIFTSK-SDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-29
Identities = 83/260 (31%), Positives = 115/260 (44%), Gaps = 20/260 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
D YEL+ IG G V E VA+K I+ +K +V +E+ HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL-EKCQTSVDELRKEVQAMSQCNHP 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCH 134
N+V++ + L +VM Y SGG L + G E ++++ G+ Y H
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 135 SMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAP 187
S HRD+K N LL DGS +KI DFG S S K+ VGTP ++AP
Sbjct: 120 SNGQIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 188 EVL-LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
EV+ YD K AD+WS G+T + GA P+ K T+ + DY
Sbjct: 176 EVMEQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234
Query: 247 HISPECRHLISRIFVADPAK 266
S R +IS DP+K
Sbjct: 235 KYSKSFRKMISLCLQKDPSK 254
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-29
Identities = 72/230 (31%), Positives = 110/230 (47%), Gaps = 42/230 (18%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---- 75
+ +ELV IG G +G R KKT +LVA+K ++ + +E ++ E LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY---NILRKYSN 61
Query: 76 HPNIVRFKEVILTPTH------LAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQ 125
HPNI F + L +VME GG +L + + G R E+ + ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 126 LISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST----- 178
+ G++Y H +V HRD+K +N LL + +K+ DFG S +Q ST
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNA----EVKLVDFGVS------AQLDSTLGRRN 171
Query: 179 --VGTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
+GTP ++APEV+ E YD + +DVWS G+T + G P D
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 74/204 (36%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRHPN 78
+E + IG G +G+ RD + E+VA+K + ER D I + REI +LRHPN
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPN 67
Query: 79 IVRFKEVILTPTHLA---IVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYC 133
IV KEV+ HL +VMEY L + + FSE + + QL+ G+ Y
Sbjct: 68 IVELKEVV-VGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYL 124
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLL- 191
H + HRDLK+ N LL LKI DFG +++ L ++P + V T Y APE+LL
Sbjct: 125 HENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
Y I D+W+ G L +L
Sbjct: 183 CTTYTTAI-DMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 81/241 (33%), Positives = 115/241 (47%), Gaps = 26/241 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
++ V IG G +GV R+K T E+VA+K I R D E V REI + L HPN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ +VI T L +V E+ + F + + QL+ G+++CHS +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLKK 193
V HRDLK +N L++ A +K+ DFG +++ + P T V T Y APE+LL
Sbjct: 121 VLHRDLKPQNLLINTEGA--IKLADFGLARAFGV---PVRTYTHEVVTLWYRAPEILLGC 175
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ--------YSIPD 244
+Y D+WS G M+ F D E + FR I R L S+PD
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSLPD 233
Query: 245 Y 245
Y
Sbjct: 234 Y 234
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 84/256 (32%), Positives = 124/256 (48%), Gaps = 22/256 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD-KIDENVQREIINH--RSLR 75
RY L + +G G+FG L++DKK E L +K I G+ +E VQ L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 131
HP IV+F L I+ EY G +L ++ SE++ +F QL+ GV
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
Y H ++ HRDLK +N L + LKI DFG S+ + +T GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHIS 249
+ YD K +D+WS G LY M A+ FE +NF + RI+ S+P+ S
Sbjct: 178 KHQGYDSK-SDIWSLGCILYEMCCLAHAFEG----QNFLSVVLRIVEGPTPSLPE--TYS 230
Query: 250 PECRHLISRIFVADPA 265
+ ++ + DP+
Sbjct: 231 RQLNSIMQSMLNKDPS 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-28
Identities = 67/227 (29%), Positives = 98/227 (43%), Gaps = 22/227 (9%)
Query: 24 ELVRDIGSGNFGV---ARL-MRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
EL + +G G FG L + TE VAVK ++ G ++ E E + L HP
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIVR V L IV EY GG+L F R + + + + Q+ G+ Y S
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 190
HRDL N L+ + +KI DFG S+ ++ + APE L
Sbjct: 121 KNFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED--PEEPKNFRKTIHR 234
++ K +DVWS GV L+ + +G P+ EE + +R
Sbjct: 177 KDGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYR 222
|
Length = 258 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-28
Identities = 72/258 (27%), Positives = 130/258 (50%), Gaps = 20/258 (7%)
Query: 23 YELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERGDKIDE-------NVQREIINHR 72
+EL++ +G+G +G L+R + +L A+K +++ + + +R+++ H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ P +V T T L ++++Y +GGELF + RF E E + + +++ + +
Sbjct: 62 R-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVL 190
H + + +RD+KLEN LLD + + + DFG SK + S GT Y+AP+++
Sbjct: 121 LHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 191 LKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
+ +D K D WS GV +Y +L GA PF E + + RIL + P +
Sbjct: 179 RGGDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EM 235
Query: 249 SPECRHLISRIFVADPAK 266
S + +I R+ + DP K
Sbjct: 236 SALAKDIIQRLLMKDPKK 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-28
Identities = 88/282 (31%), Positives = 139/282 (49%), Gaps = 45/282 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D+YE V IG G +GV RD+ T E +A+K I R ++ DE V REI + ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQQLISGVSYCH 134
NIVR ++V+ + L +V EY +L + + ++ F+++ + + Q++ G++YCH
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVL 190
S +V HRDLK +N L+D LK+ DFG +++ + P T V T Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGI---PVRTFTHEVVTLWYRAPEIL 175
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRILSVQY-------- 240
L + D+WS G ++ +V P D E + F+ I RIL
Sbjct: 176 LGSRHYSTPVDIWSVGC-IFAEMVNQKPLFPGDSEIDELFK--IFRILGTPNEETWPGVT 232
Query: 241 SIPDYVH----------------ISPECRHLISRIFVADPAK 266
S+PDY + P L+S++ DP+K
Sbjct: 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSK 274
|
Length = 294 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 80/268 (29%), Positives = 116/268 (43%), Gaps = 51/268 (19%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVK--YIERGDKIDENVQREIINHRSLRHPNIVR 81
E V IGSG G + + T L A+K Y D + + REI R + HPN+V+
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
++ + +++E+ GG L +F D AR Q++SG++Y H + HR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHR 192
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV----LLKKEYD 196
D+K N L++ A +KI DFG S+ P S+VGT AY++PE L YD
Sbjct: 193 DIKPSNLLINS--AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD 250
Query: 197 GKIADVWSCGVTLYVMLVGAYPF------------------EDPEEPKNFRKTIHRILSV 238
G D+WS GV++ +G +PF + PE P
Sbjct: 251 GYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT----------- 299
Query: 239 QYSIPDYVHISPECRHLISRIFVADPAK 266
S E RH IS +PAK
Sbjct: 300 ---------ASREFRHFISCCLQREPAK 318
|
Length = 353 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 92/277 (33%), Positives = 130/277 (46%), Gaps = 40/277 (14%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
Y+ V IG G +GV RDK T E+VA+K I R + DE V REI + L HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSM 136
IVR +V+ + L +V E+ +L + + ++ D + QL+ G++YCHS
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+V HRDLK +N L+D A LK+ DFG +++ V V T Y APE+LL
Sbjct: 119 RVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQ 176
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILS---------VQYSIPDY 245
D+WS G M+ F D E + FR I R L V S+PDY
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR--IFRTLGTPDEDVWPGVT-SLPDY 233
Query: 246 V----------------HISPECRHLISRIFVADPAK 266
++ + L+S++ V DPAK
Sbjct: 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAK 270
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 69/196 (35%), Positives = 101/196 (51%), Gaps = 17/196 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHP 77
+ +R+IG G+FG RD +T E+VA+K + K ++II + LRHP
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 78 NIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
N + +K L +VMEY S ++ E + E E + G++Y HS
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHS 133
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---K 192
+ HRD+K N LL + +K+ DFG S+ L S S VGTP ++APEV+L +
Sbjct: 134 HERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVILAMDE 188
Query: 193 KEYDGKIADVWSCGVT 208
+YDGK DVWS G+T
Sbjct: 189 GQYDGK-VDVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 83/248 (33%), Positives = 125/248 (50%), Gaps = 18/248 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
++ YE+V+ IG G FG +L+R K T ++ A+K + + + I + R +
Sbjct: 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P +V+ +L +VMEY GG+L + N E ARF+ +++ + HS
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 160
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
M HRD+K +N LLD S LK+ DFG +K ++ + VGTP YI+PEVL
Sbjct: 161 MGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLK 216
Query: 192 KK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
+ Y G+ D WS GV LY MLVG PF + K ++ S+ + PD I
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDI 274
Query: 249 SPECRHLI 256
S E ++LI
Sbjct: 275 SKEAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 3e-27
Identities = 74/280 (26%), Positives = 119/280 (42%), Gaps = 43/280 (15%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLR 75
RYE + +G G + V RDK+T +VA+K I+ G++ I+ REI + L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 133
HPNI+ +V +++ +V E+ +L E++ + + + + + G+ Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-DL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEV 189
HS + HRDLK N L+ LK+ DFG ++S P V T Y APE+
Sbjct: 119 HSNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYRAPEL 173
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYS 241
L + G D+WS G +L+ PF + + I L S
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232
Query: 242 IPDYVHISP---------------ECRHLISRIFVADPAK 266
+PDYV P + L+ R+ +P K
Sbjct: 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNK 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 67/204 (32%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
D +E++ ++G G FG + K+T A K I+ + D V+ +I++ +HP
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS--ECKHP 62
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
NIV E L I++E+ GG L + R +E + R+ +Q++ +++ HS
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-- 191
+V HRDLK N LL DG +K+ DFG S + Q + T +GTP ++APEV+
Sbjct: 123 KVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 192 ---KKEYDGKIADVWSCGVTLYVM 212
YD K AD+WS G+TL +
Sbjct: 179 TFKDNPYDYK-ADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-27
Identities = 73/259 (28%), Positives = 118/259 (45%), Gaps = 22/259 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
+++ + IG G F V +VA+K ++ + +D ++ +EI + L H
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 132
PN++++ + L IV+E A G+L I + + E +F QL S + +
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAP 187
HS ++ HRD+K N + + +K+ D G SK++ HS VGTP Y++P
Sbjct: 122 MHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSP 175
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
E + + Y+ K +D+WS G LY M PF + N +I Y H
Sbjct: 176 ERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEKCDYPPLPADH 232
Query: 248 ISPECRHLISRIFVADPAK 266
S E R L+SR DP K
Sbjct: 233 YSEELRDLVSRCINPDPEK 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-27
Identities = 64/200 (32%), Positives = 104/200 (52%), Gaps = 9/200 (4%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREI-INHRSLRHPNIVR 81
R IG G++ L+ KKT + A+K I++ D+ VQ E + + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L V+E+ SGG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L ++Y +
Sbjct: 121 DLKLDNVLLDAE--GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV- 177
Query: 201 DVWSCGVTLYVMLVGAYPFE 220
D W+ GV ++ M+ G PF+
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-27
Identities = 68/196 (34%), Positives = 103/196 (52%), Gaps = 12/196 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+++E++ +G G +GV R K+T+E+VA+K E +++ E RE+ R+L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV KE L +V EY EL E + N ++ R + QLI + +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHK 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 193
+ HRD+K EN L+ S LK+CDFG++++ S T V T Y +PE+LL
Sbjct: 119 NDIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 194 EYDGKIADVWSCGVTL 209
Y GK D+WS G L
Sbjct: 177 PY-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKY-IERGDKIDE-NVQREIINHRSLR-HPNI 79
Y+++ IG G F + +KT + A+K + +++ N REI R L HPNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 80 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
+R EV+ LA+V E L+E I R E + + QL+ + + H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 194
+ HRD+K EN L+ LK+ DFG + ++S+P T + T Y APE LL
Sbjct: 120 GIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 195 YDGKIADVWSCGVTLYVML 213
Y G D+W+ G + +L
Sbjct: 175 YYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 66/206 (32%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSLR-- 75
YE + +IG G +G RD T VA+K + E G I + REI + L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58
Query: 76 -HPNIVRFKEVILTP-----THLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLIS 128
HPNIVR +V P L +V E+ + C + + +QL+
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 129 GVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
GV + HS ++ HRDLK +N L+ DG ++KI DFG ++ S V T Y A
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLARIYSFEMALTSVVVTLWYRA 174
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVM 212
PEVLL+ Y + D+WS G +
Sbjct: 175 PEVLLQSSYATPV-DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-26
Identities = 76/248 (30%), Positives = 125/248 (50%), Gaps = 18/248 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----R 75
++ Y++V+ IG G FG +L+R K ++++ A+K + + + I + R +
Sbjct: 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P +V+ +L +VMEY GG+L + N E A+F+ +++ + HS
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHS 160
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 191
M + HRD+K +N LLD LK+ DFG ++ ++ + VGTP YI+PEVL
Sbjct: 161 MGLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVLK 216
Query: 192 KK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
+ Y G+ D WS GV L+ MLVG PF + K + S+ + P+ V I
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF--PEDVEI 274
Query: 249 SPECRHLI 256
S ++LI
Sbjct: 275 SKHAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-26
Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K + + E + EI+ R +HPNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 138
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 198 KIADVWSCGVTLYVMLVGAYPF--EDP 222
K+ D+WS G+ M+ G P+ E+P
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 67/201 (33%), Positives = 105/201 (52%), Gaps = 8/201 (3%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIIN 70
D+ + + +EL++ IGSG +G R+ T EL A+K I E G+ VQ+EII
Sbjct: 1 DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIM 59
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ +H NIV + L L I ME+ GG L + G SE + + ++ + G+
Sbjct: 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEV 189
Y HS HRD+K N LL + +K+ DFG S + ++ KS +GTP ++APEV
Sbjct: 120 YYLHSKGKMHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177
Query: 190 LLKKEYDG--KIADVWSCGVT 208
+ G ++ D+W+ G+T
Sbjct: 178 AAVERKGGYNQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 85/260 (32%), Positives = 125/260 (48%), Gaps = 42/260 (16%)
Query: 14 MPIMHDS-----DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQR- 66
MP +D + YE+++ IG+G FG L++ K+T+E K I RG K E Q
Sbjct: 1 MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV 60
Query: 67 -EIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNA----GRFSEDEA 119
E+ R L+H NIVR+ + L + L I+ME+ G+L I G+ E
Sbjct: 61 IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 120 RFFFQQLISGVSYCHSMQ-------VCHRDLKLENTLLDG---------------SPAPR 157
+QL+ ++YCH+++ V HRDLK +N L + P
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 158 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVG 215
KI DFG SK+ + S S VGTP Y +PE+LL K YD K +D+W+ G +Y + G
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSG 239
Query: 216 AYPFEDPEEPKNFRKTIHRI 235
PF + NF + I +
Sbjct: 240 KTPF---HKANNFSQLISEL 256
|
Length = 1021 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 74/232 (31%), Positives = 108/232 (46%), Gaps = 23/232 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHP 77
RY+ + +IGSG +GV D ++ + VA+K I + +R E+ R +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 78 NIVRFKEVILTP----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
NI+ ++++ P + +VM+ +L I + +E+ R+F QL+ G+ Y
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQ-PKSTVGTPAYIAPE 188
HS V HRDLK N L++ L+I DFG S S H V T Y APE
Sbjct: 124 HSANVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV 238
+LL EY I D+WS G ML F P KN+ + ILSV
Sbjct: 182 LLLSLPEYTTAI-DMWSVGCIFAEMLGRRQLF-----PGKNYVHQLKLILSV 227
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 6e-26
Identities = 68/197 (34%), Positives = 106/197 (53%), Gaps = 9/197 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + AG F E + ++++ G+ Y HS + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEYDGKIADVWS 204
N LL S +K+ DFG + + +Q K + VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK-ADIWS 186
Query: 205 CGVTLYVMLVGAYPFED 221
G+T + G P D
Sbjct: 187 LGITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-26
Identities = 76/277 (27%), Positives = 126/277 (45%), Gaps = 38/277 (13%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHP 77
+YE + IG G +G ++++T E+VA+K + R D DE V REI + L+H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHS 135
NIVR +V+ + L +V EY + ++ ++ G + + F QL+ G+++CHS
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCD--QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-KK 193
V HRDLK +N L++ + LK+ DFG +++ + + V T Y P+VL K
Sbjct: 118 HNVLHRDLKPQNLLINKN--GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------YSIPDY 245
Y I D+WS G + P + + K I R+L +PDY
Sbjct: 176 LYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234
Query: 246 V----------------HISPECRHLISRIFVADPAK 266
++ R L+ + V +P +
Sbjct: 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQ 271
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 7e-26
Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
++ + +G G G R K T + A+K I + + + RE+ ++S + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 79 IVRFKEVILTP--THLAIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLISGVS 131
IV++ L + + I MEY GG L + I GR E + ++ G+S
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y HS ++ HRD+K N LL +K+CDFG S V S + GT Y+APE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQ 176
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
K Y +DVWS G+TL + +PF EP
Sbjct: 177 GKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEP 209
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 65/200 (32%), Positives = 106/200 (53%), Gaps = 9/200 (4%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 81
R IG G++ L+R KKTE + A+K +++ + ID + + ++ HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L V+EY +GG+L + + E+ ARF+ ++ ++Y H + +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L ++Y G
Sbjct: 121 DLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 201 DVWSCGVTLYVMLVGAYPFE 220
D W+ GV ++ M+ G PF+
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 1e-25
Identities = 79/252 (31%), Positives = 126/252 (50%), Gaps = 21/252 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR------EIINHRSLRH 76
+ L + +G G FG L D T +AVK ++ + E + EI ++L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 77 PNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
IV++ + P L+I ME+ GG + +++ + G +E+ R + +Q++ GVSY H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVL 190
S + HRD+K N L D +K+ DFG SK + + KS GTP +++PEV+
Sbjct: 124 SNMIVHRDIKGANILRDS--VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY-VHIS 249
+ Y G+ AD+WS G T+ ML P+ + E K ++ Q + P H+S
Sbjct: 182 SGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-----IATQPTNPVLPPHVS 235
Query: 250 PECRHLISRIFV 261
CR + RIFV
Sbjct: 236 DHCRDFLKRIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 79/273 (28%), Positives = 125/273 (45%), Gaps = 18/273 (6%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRHPN 78
++ + +G G + R++ T E+VA+K I E G REI + L+H N
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHEN 59
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IVR +VI T L +V EY + + G + + F QL+ G+++CH
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-KKE 194
+V HRDLK +N L++ LK+ DFG +++ + + + V T Y AP+VLL +
Sbjct: 120 RVLHRDLKPQNLLINKR--GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--QYSIPDYVHISPEC 252
Y I D+WS G + M+ G F K I RI+ + + P + PE
Sbjct: 178 YSTSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLK-IFRIMGTPTESTWPG-ISQLPEY 234
Query: 253 RHLISRIFVADPAKVSMHFHATGV-YMHTKLQL 284
+ R D ++ H G+ +H LQL
Sbjct: 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQL 267
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 62/200 (31%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 81
R IG G++ L+R KK +++ A+K +++ + ID + + ++ +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
T + L +V+EY +GG+L + + E+ ARF+ ++ +++ H + +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIA 200
DLKL+N LLD +K+ D+G K + ST GTP YIAPE+L +EY G
Sbjct: 121 DLKLDNVLLDAD--GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 201 DVWSCGVTLYVMLVGAYPFE 220
D W+ GV ++ M+ G PF+
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 77/280 (27%), Positives = 128/280 (45%), Gaps = 49/280 (17%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-- 78
D +E ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ +L ++ME+ GG++ + SE+ +F+ + + + H +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK--------- 176
HRD+K +N LLD +K+ DFG ++ H+ P
Sbjct: 121 GFIHRDIKPDNLLLDAK--GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 177 ----------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF- 219
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237
Query: 220 -EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
E P+E +RK ++ ++ + P V IS + + LI R
Sbjct: 238 SETPQE--TYRKVMNWKETLVF--PPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-25
Identities = 81/253 (32%), Positives = 119/253 (47%), Gaps = 28/253 (11%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+E+VA+K I+ + DE ++Q+EI P I R+
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + G E ++++ G+ Y HS + HRD+K
Sbjct: 72 LKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSC 205
N LL S +K+ DFG + ++T VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK-ADIWSL 187
Query: 206 GVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSVQYSIP--DYVH--------I 248
G+T + G P D PKN T L QYS P ++V
Sbjct: 188 GITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT----LEGQYSKPFKEFVEACLNKDPRF 243
Query: 249 SPECRHLISRIFV 261
P + L+ F+
Sbjct: 244 RPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 8e-25
Identities = 67/191 (35%), Positives = 104/191 (54%), Gaps = 8/191 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 80
YEL++ +GSG +G R+ T EL AVK I E GD +Q+EI + +H NIV
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIV 69
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L+ L I MEY GG L + G SE + + ++ + G++Y HS H
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG-- 197
RD+K N LL + +K+ DFG +K + ++ KS +GTP ++APEV ++ G
Sbjct: 130 RDIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 198 KIADVWSCGVT 208
++ D+W+ G+T
Sbjct: 188 QLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-24
Identities = 73/250 (29%), Positives = 125/250 (50%), Gaps = 33/250 (13%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + R+K + VAVK ++ R + E + E++ R +H N+V + L
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L ++ME+ GG L + I + R +E++ + ++ + Y HS V HRD+K ++
Sbjct: 89 VGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147
Query: 148 TL--LDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
L LDG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y ++ D+WS
Sbjct: 148 ILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV-DIWS 202
Query: 205 CGVTLYVMLVGAYPF--EDP--------EEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
G+ + M+ G P+ + P + P K H+ ISP R
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHK-------------ISPVLRD 249
Query: 255 LISRIFVADP 264
+ R+ +P
Sbjct: 250 FLERMLTREP 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-24
Identities = 79/245 (32%), Positives = 122/245 (49%), Gaps = 19/245 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI------ERGDKIDENVQREIINHRSLRHPNIVRF 82
+G G FG L D T +AVK + + K ++ EI ++LRH IV++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 83 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ P L+I +EY GG + +++ G +E+ R + +Q++ GVSY HS + H
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 196
RD+K N L D A +K+ DFG SK ++ S KS GTP +++PEV+ + Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY- 186
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
G+ ADVWS T+ ML P+ + E K + +PD +S CR +
Sbjct: 187 GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPM--LPD--GVSDACRDFL 242
Query: 257 SRIFV 261
+IFV
Sbjct: 243 KQIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 1e-24
Identities = 75/209 (35%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D+++++ IG G +G RDK T ELVA+K + R D E REI R L H
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNH 65
Query: 77 PNIVRFKEVILTPTHLA-----------IVMEYASG---GELFERICNAGRFSEDEARFF 122
NIV KE I+T A +V EY G L + + FSED + F
Sbjct: 66 RNIVNLKE-IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSF 121
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VG 180
+QL+ G++YCH HRD+K N LL+ ++K+ DFG ++ T V
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNK--GQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTL 209
T Y PE+LL +E G DVWSCG L
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 3e-24
Identities = 67/221 (30%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 25 LVRDIGSGNFGVARLMR----DKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
++ +G G+FG L R T E VAVK + ++ + +REI R+L H N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 79 IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
IV++K V P L ++MEY G L + + + + + F Q+ G+ Y S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA-YIAPEVLL 191
+ HRDL N L++ +KI DFG +K K +P + APE L
Sbjct: 128 QRYIHRDLAARNILVESE--DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
++ +DVWS GVTLY + P + P P F + I
Sbjct: 186 TSKFSSA-SDVWSFGVTLYELFTYGDPSQSP--PAEFLRMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-24
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 86
IG G+FG D +T+++VA+K I+ + DE ++Q+EI P + ++
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L T L I+MEY GG + + G E + ++++ G+ Y HS + HRD+K
Sbjct: 72 LKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 130
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKIADVWS 204
N LL S +K+ DFG + + +Q K VGTP ++APEV+ + YD K AD+WS
Sbjct: 131 NVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWS 186
Query: 205 CGVTLYVMLVGAYPFED 221
G+T + G P +
Sbjct: 187 LGITAIELAKGEPPHSE 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 4e-24
Identities = 79/295 (26%), Positives = 132/295 (44%), Gaps = 65/295 (22%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDE----NVQREIINHRSL 74
+ + V+ IG G FG RL++ K T ++ A+K + + + K D+ +R+++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P +V +L ++ME+ GG+L + FSED RF+ + + + H
Sbjct: 60 -SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK-------------- 167
+ HRD+K +N L+D +K+ DFG Y K
Sbjct: 119 KLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 168 --------SSVLHSQPK-------------STVGTPAYIAPEVLLKKEYDGKIADVWSCG 206
+ + S+ + STVGTP YIAPE+ L++ Y G+ D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLG 235
Query: 207 VTLYVMLVGAYPF--EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
++ L+G PF E+ E +RK I+ ++ + PD +H+S E LI R+
Sbjct: 236 AIMFECLIGWPPFCSENSHE--TYRKIINWRETLYF--PDDIHLSVEAEDLIRRL 286
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 4e-24
Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---- 65
+ P + +YE + IG G FG R KKT+++VA+K + + EN +
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEGFP 55
Query: 66 ----REIINHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAG- 112
REI + L+H N+V E+ T +V E+ +L + N
Sbjct: 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNV 114
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSV 170
+F+ E + + L++G+ Y H ++ HRD+K N L+ DG LK+ DFG +++
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFS 170
Query: 171 LHSQPKST-----VGTPAYIAPEVLLKKEYDGKIADVWSCG 206
L K V T Y PE+LL + G D+W G
Sbjct: 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 4e-24
Identities = 76/245 (31%), Positives = 118/245 (48%), Gaps = 19/245 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR------EIINHRSLRHPNIVRF 82
+G G FG L D T +A K ++ + E + EI ++L+H IV++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 83 KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ L I MEY GG + +++ G +E R + +Q++ G+SY HS + H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLKKEYD 196
RD+K N L D A +K+ DFG SK ++ S +S GTP +++PEV+ + Y
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY- 186
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
G+ ADVWS G T+ ML P+ + E I +I + + HIS R +
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQPTNPQLPSHISEHARDFL 242
Query: 257 SRIFV 261
IFV
Sbjct: 243 GCIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-24
Identities = 83/290 (28%), Positives = 123/290 (42%), Gaps = 65/290 (22%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 79
++ +G G FG L T L A+K + + D ++ N +R+I+ + +
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWV 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
V+ +L VM+Y GG++ + F E ARF+ +L + H M
Sbjct: 64 VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123
Query: 140 HRDLKLENTL--LDGSPAPRLKICDFG-------------YSKSSVLHS---QPK----- 176
HRD+K +N L LDG +K+ DFG Y K S + +P
Sbjct: 124 HRDIKPDNILIDLDG----HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 177 ---------------------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTL 209
S VGTP YIAPEVLL+K Y ++ D WS GV L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVIL 238
Query: 210 YVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
+ MLVG PF P + K I+ ++ IP V +SPE LI+++
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLH--IPPQVKLSPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 5e-24
Identities = 77/261 (29%), Positives = 117/261 (44%), Gaps = 27/261 (10%)
Query: 23 YELVRDIGSGNFG-VARLMRDKKTEELVAVKYI------------ERGDKIDENVQREII 69
Y ++ +GSG FG V ++ + + L+A+K I ER I + V I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQ 125
LRHPNIVR+ + L L IVM+ G L E + RF+E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 126 LISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
++ + Y H ++ HRDL N +L ++ I DFG +K S+ S VGT Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IP 243
PE++ + Y G+ ADVW+ G LY M PF N +I+ Y +P
Sbjct: 180 SCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYS----TNMLSLATKIVEAVYEPLP 234
Query: 244 DYVHISPECRHLISRIFVADP 264
+ ++ S + +I+ D
Sbjct: 235 EGMY-SEDVTDVITSCLTPDA 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 7e-24
Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 49/278 (17%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN---- 78
+E ++ IG G FG RL++ K T + A+K + + D +++ I R +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+ +L ++ME+ GG++ + +E+E +F+ + + + H +
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK----------- 176
HRD+K +N LLD +K+ DFG ++ HS P
Sbjct: 123 IHRDIKPDNLLLDSK--GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 177 --------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--E 220
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF E
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 221 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258
P+E ++K ++ ++ + P V IS + + LI R
Sbjct: 240 TPQE--TYKKVMNWKETLIF--PPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 8e-24
Identities = 67/192 (34%), Positives = 102/192 (53%), Gaps = 17/192 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
+R+IG G+FG RD +T E+VA+K + K ++II + ++HPN +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+K L +VMEY S +L E + E E + G++Y HS +
Sbjct: 90 YKGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL + ++K+ DFG S+ + S S VGTP ++APEV+L + +YD
Sbjct: 148 HRDIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEGQYD 202
Query: 197 GKIADVWSCGVT 208
GK+ DVWS G+T
Sbjct: 203 GKV-DVWSLGIT 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 8e-24
Identities = 76/247 (30%), Positives = 116/247 (46%), Gaps = 14/247 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN---IVRFKE 84
+G G FG + + T +L A K + + K + + ++ R L + IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCH 140
T T L +VM +GG+L I N F E A F+ Q+ISG+ + H ++ +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
RDLK EN LLD ++I D G + + S+ K GTP ++APE+L +EYD +
Sbjct: 121 RDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
D ++ GVTLY M+ PF E ++ RIL+ + PD SP + +
Sbjct: 179 -DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFCEAL 235
Query: 260 FVADPAK 266
DP K
Sbjct: 236 LAKDPEK 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 8e-24
Identities = 66/192 (34%), Positives = 100/192 (52%), Gaps = 17/192 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
+R+IG G+FG RD + E+VA+K + K ++II + LRHPN ++
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
++ L +VMEY S +L E + E E + G++Y HS +
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL S +K+ DFG S+ + + VGTP ++APEV+L + +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 197 GKIADVWSCGVT 208
GK+ DVWS G+T
Sbjct: 193 GKV-DVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 1e-23
Identities = 62/183 (33%), Positives = 104/183 (56%), Gaps = 17/183 (9%)
Query: 92 LAIVMEYASGGELFERICN---AGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
+A+V++YA+ G+L + I + R F E EA F Q++ V + HS + HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 148 TLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL + +K+ DFG+SK ++V ++ GTP Y+APE+ +K Y K AD++S
Sbjct: 174 ILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFS 230
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRHLISRIFVAD 263
GV LY +L PF+ +N + +H+ L+ +Y +P ISPE + +++ + +D
Sbjct: 231 LGVLLYELLTLKRPFDG----ENMEEVMHKTLAGRYDPLPP--SISPEMQEIVTALLSSD 284
Query: 264 PAK 266
P +
Sbjct: 285 PKR 287
|
Length = 496 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 1e-23
Identities = 64/205 (31%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 81
+G G +G +L+AVK +E +K E +Q E+ +SL+H NIV+
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
+ L ++I ME+ GG + + G E + +Q++ GV+Y H+ V HR
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQP-KSTVGTPAYIAPEVLLKKE 194
D+K N +L P +K+ DFG ++ HS KS GTP ++APEV+ +
Sbjct: 127 DIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPF 219
Y G+ +D+WS G T++ M G P
Sbjct: 185 Y-GRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 2e-23
Identities = 68/207 (32%), Positives = 105/207 (50%), Gaps = 12/207 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K + + E + EI+ R ++PNIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIH 138
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 198 KIADVWSCGVTLYVMLVGAYPF--EDP 222
K+ D+WS G+ M+ G P+ E+P
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-23
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK-YIERGDK--IDENVQREIINHRSLRHP 77
++YE + IG G++GV R+++T ++VA+K ++E D I + REI + L+HP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
N+V EV L +V EY L E N E + Q + V++CH
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLKKE 194
HRD+K EN L+ + ++K+CDFG+++ +L V T Y APE+L+
Sbjct: 121 CIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 195 YDGKIADVWSCGVTLYVMLVG 215
G DVW+ G +L G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 3e-23
Identities = 71/209 (33%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA+K I + E + EI+ + L++PNIV
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQV 138
F + L L +VMEY +GG L + + DEA+ ++ + + + H+ QV
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQV 136
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
HRD+K +N LL DGS +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 137 IHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192
Query: 196 DGKIADVWSCGVTLYVMLVGAYPF--EDP 222
K+ D+WS G+ M+ G P+ E+P
Sbjct: 193 GPKV-DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-23
Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 37/277 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRH 76
++RY ++ +G G FG+ RD+ T + VA+K I + + + RE+ + LRH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 77 PNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
NI+ ++ ++P + V E G R+ + + ++F Q++ G+ Y HS
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS 126
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KE 194
V HRDLK N L++ + LKICDFG ++ + Q V T Y APE++L ++
Sbjct: 127 AGVVHRDLKPSNILINEN--CDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQK 182
Query: 195 YDGKIADVWSCGVTLYVMLVGA--YPFEDP------------EEPKNFRKTI--HRILSV 238
YD ++ D+WS G ML G +P +D P + TI L
Sbjct: 183 YDVEV-DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241
Query: 239 QYSIPD---------YVHISPECRHLISRIFVADPAK 266
S+P + + P L+ ++ V DP K
Sbjct: 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQK 278
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 3e-23
Identities = 65/204 (31%), Positives = 108/204 (52%), Gaps = 16/204 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK-YIERGDKIDENVQ----REIINHRSLR 75
++YE + +G G++G+ + K+T ++VA+K ++E D D+ V+ REI + LR
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLR 58
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H N+V EV L +V E+ L E+ N E R + Q++ G+ +C
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFC 116
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 191
HS + HRD+K EN L+ S + +K+CDFG+++ ++ T V T Y APE+L+
Sbjct: 117 HSHNIIHRDIKPENILV--SQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLV 173
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
G+ D+W+ G + ML G
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 4e-23
Identities = 75/242 (30%), Positives = 126/242 (52%), Gaps = 13/242 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + K + +LVAVK ++ R + E + E++ R +H N+V L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +S H+ V HRD+K ++
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DG R+K+ DFG+ ++ S + KS VGTP ++APE++ + Y G D+WS
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
G+ + M+ G P+ + E P K I L + + + +SP + + R+ V DP
Sbjct: 202 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPK--LKNLHKVSPSLKGFLDRLLVRDP 258
Query: 265 AK 266
A+
Sbjct: 259 AQ 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 5e-23
Identities = 67/202 (33%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNI 79
+ +E++ ++G G FG ++K+T L A K I+ + ++ E+ EI S HPNI
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQV 138
V+ + +L I++E+ +GG + + R +E + R +Q + ++Y H ++
Sbjct: 65 VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124
Query: 139 CHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL---- 191
HRDLK N L LDG +K+ DFG S + Q + S +GTP ++APEV++
Sbjct: 125 IHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 192 -KKEYDGKIADVWSCGVTLYVM 212
+ YD K ADVWS G+TL M
Sbjct: 181 KDRPYDYK-ADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 95.6 bits (237), Expect = 5e-23
Identities = 66/207 (31%), Positives = 108/207 (52%), Gaps = 12/207 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 80
+Y IG G G D T + VA++ + + E + EI+ R ++PNIV
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ + L L +VMEY +GG L + + E + ++ + + + HS QV H
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 141 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
RD+K +N LL DGS +K+ DFG+ ++ + S+ + VGTP ++APEV+ +K Y
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 198 KIADVWSCGVTLYVMLVGAYPF--EDP 222
K+ D+WS G+ M+ G P+ E+P
Sbjct: 196 KV-DIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 6e-23
Identities = 65/207 (31%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHP 77
RY+ + IG G +G+ K T VA+K I + + REI R +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYC 133
NI+ + I+ P + EL E ++ S D ++F Q++ G+ Y
Sbjct: 64 NIIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYI 122
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV 189
HS V HRDLK N LL+ LKICDFG ++ + V T Y APE+
Sbjct: 123 HSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180
Query: 190 LLK-KEYDGKIADVWSCGVTLYVMLVG 215
+L K Y I D+WS G L ML
Sbjct: 181 MLNSKGYTKAI-DIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 6e-23
Identities = 81/277 (29%), Positives = 133/277 (48%), Gaps = 39/277 (14%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 78
Y + IG G +GV R+KKT ++VA+K I R + +E V REI + L+HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++V++ + L ++ E+ S + + + + + + Q++ G+ +CHS
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLKKEY 195
+V HRDLK +N L+D +K+ DFG +++ + + + V T Y APEVLL
Sbjct: 121 RVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRILSVQ--------YSIPDY 245
D+WS G T++ + P D E + FR I RIL S+PDY
Sbjct: 179 YSTPVDIWSIG-TIFAEMATKKPLFHGDSEIDQLFR--IFRILGTPTEDVWPGVTSLPDY 235
Query: 246 VHISPECR----------------HLISRIFVADPAK 266
+ P+ + L+ ++ + DPAK
Sbjct: 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAK 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-22
Identities = 67/192 (34%), Positives = 101/192 (52%), Gaps = 17/192 (8%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQ---REIINHRSLRHPNIVR 81
+ +IG G+FG + T E+VAVK + G + +E Q +E+ + L+HPN +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 82 FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+K L +VMEY S +L E + E E + G++Y HS +
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---KKEYD 196
HRD+K N LL + ++K+ DFG S+ S S VGTP ++APEV+L + +YD
Sbjct: 144 HRDIKAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 197 GKIADVWSCGVT 208
GK+ DVWS G+T
Sbjct: 199 GKV-DVWSLGIT 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-22
Identities = 82/295 (27%), Positives = 122/295 (41%), Gaps = 69/295 (23%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRH 76
+ ++ +G G FG L R T+ L A+K + + D + N +R+I+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--N 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR +L VM+Y GG++ + G F ED ARF+ +L V H M
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 137 QVCHRDLKLENTLLD--------------------------GSPAPRLKICDFGYS---- 166
HRD+K +N L+D R DF
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 167 --------------KSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
+++ H + S VGTP YIAPEVLL+ Y ++ D WS GV LY
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239
Query: 211 VMLVGAYPF--EDPEEPK----NFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259
MLVG PF + P E + N++ ++H IP +SPE LI ++
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVINWQTSLH--------IPPQAKLSPEASDLIIKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 75/249 (30%), Positives = 114/249 (45%), Gaps = 21/249 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 81
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
TP L +++ +GG+L + G FSE E RF+ ++I G+ + H+ V +R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 142 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
DLK N LLD R+ CDF K P ++VGT Y+APEVL K
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGTAYD 174
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
AD +S G L+ +L G PF + K+ + L+V +PD SPE + L+
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTVNVELPD--SFSPELKSLLE 231
Query: 258 RIFVADPAK 266
+ D +K
Sbjct: 232 GLLQRDVSK 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-22
Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 15/203 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
++ +E++ ++G G FG ++K+T L A K IE + + E+ EI + HP
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV+ L I++E+ GG + + R +E + + +Q++ + Y HSM+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL--- 191
+ HRDLK N LL DG +K+ DFG S +V Q + S +GTP ++APEV++
Sbjct: 131 IIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 192 --KKEYDGKIADVWSCGVTLYVM 212
YD K AD+WS G+TL M
Sbjct: 187 MKDTPYDYK-ADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-22
Identities = 75/255 (29%), Positives = 117/255 (45%), Gaps = 22/255 (8%)
Query: 23 YELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN 78
+++ + IG G F A + D+K L V+ E D K ++ +EI + L HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
++++ + + L IV+E A G+L + I + E +F QL S V + H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 189
S +V HRD+K N + + +K+ D G SK++ H S VGTP Y++PE
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPER 177
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
+ + Y+ K +D+WS G LY M PF + N +I Y H S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLFSLCQKIEQCDYPPLPTEHYS 234
Query: 250 PECRHLISRIFVADP 264
+ R L+S DP
Sbjct: 235 EKLRELVSMCIYPDP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 87/282 (30%), Positives = 130/282 (46%), Gaps = 43/282 (15%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKID-ENVQREIINHRSLRHPN 78
+Y ++ IG G +G+ ++ +T E VA+K I ++ID + REI R L H N
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 79 IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++ K+ I+ P H + IV E +L + I ++ S+D ++F QL+ G+ Y
Sbjct: 66 VIAIKD-IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLL 191
HS V HRDLK N LL+ + LKICDFG ++ +S V T Y APE+LL
Sbjct: 124 IHSANVLHRDLKPSNLLLNAN--CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 192 K-KEYDGKIADVWSCG---------------------VTLYVMLVGAYPFEDPE--EPKN 227
EY I DVWS G + L L+G+ ED +
Sbjct: 182 NCSEYTTAI-DVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240
Query: 228 FRKTIHRILSVQYSIP---DYVHISPECRHLISRIFVADPAK 266
R+ I R L + H +P L+ ++ V DP+K
Sbjct: 241 ARRYI-RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSK 281
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 5e-22
Identities = 78/257 (30%), Positives = 121/257 (47%), Gaps = 20/257 (7%)
Query: 40 MRDKKTEELVAVKYIERGDKIDENVQR-EIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98
R +E V K++ D+ R E+ + H IV+ + + L ++MEY
Sbjct: 87 TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146
Query: 99 ASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154
SGG+L ++I + F E E F Q++ + HS ++ HRDLK N L P
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL--MP 204
Query: 155 APRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYV 211
+K+ DFG+SK SV S GTP Y+APE+ +K Y K AD+WS GV LY
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYE 263
Query: 212 MLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHF 271
+L PF+ P + R+ + ++L +Y P +S + L+ + +PA
Sbjct: 264 LLTLHRPFKGPSQ----REIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRP--- 315
Query: 272 HATGVYMHTKLQLLVAS 288
T +HT+ VA+
Sbjct: 316 -TTQQLLHTEFLKYVAN 331
|
Length = 478 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 6e-22
Identities = 72/269 (26%), Positives = 124/269 (46%), Gaps = 30/269 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE------NVQREIINHRSL 74
D +E+++ IG G FG +++ K TE + A+K + + + + +R ++ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 133
+ I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 QW--ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
H + HRD+K +N LLD + R LK+ G +SSV VGTP YI+
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-------AVGTPDYIS 171
Query: 187 PEVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242
PE+L E G D WS GV +Y ML G PF + + K ++ ++
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EERFQF 229
Query: 243 PDYV-HISPECRHLISRIFVADPAKVSMH 270
P ++ +S E + LI R+ + ++ +
Sbjct: 230 PSHITDVSEEAKDLIQRLICSRERRLGQN 258
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 7e-22
Identities = 63/262 (24%), Positives = 120/262 (45%), Gaps = 22/262 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-- 76
++ E + D+G+GN G ++ T ++A K + G K +V+++I+ + H
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHEC 60
Query: 77 --PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P IV F L ++ + ME+ G L G + ++ G++Y +
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 135 SM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 193
++ ++ HRD+K N L++ ++K+CDFG S +++S + VGT Y++PE +
Sbjct: 121 NVHRIMHRDIKPSNILVNS--RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGG 177
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSVQYSIPDY- 245
+Y K +DVWS G+++ + +G +PF P + +I VQ P
Sbjct: 178 KYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI--VQEPPPRLP 234
Query: 246 -VHISPECRHLISRIFVADPAK 266
+ R + + DP +
Sbjct: 235 SSDFPEDLRDFVDACLLKDPTE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-21
Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSL 74
H +YE+++ +G G +G+ D++T+E+VA+K I + + QR EI+ + L
Sbjct: 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQEL 63
Query: 75 R-HPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISG 129
HPNIV+ VI I + + E E + A + R+ QL+
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIMYQLLKA 119
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPA 183
+ Y HS V HRDLK N LL+ R+K+ DFG ++S + V T
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
Y APE+LL K D+WS G L ML+G
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 47/150 (31%), Positives = 76/150 (50%), Gaps = 6/150 (4%)
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+PN ++ + T ++M+Y G+LF+ + G+ SE E + +QL+ ++ H
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ H D+KLEN L D + R+ +CD+G K P GT Y +PE + Y
Sbjct: 128 HNIIHNDIKLENVLYDRA-KDRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNY 183
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFE-DPEE 224
D D W+ GV Y +L G +PF+ D +E
Sbjct: 184 DVSF-DWWAVGVLTYELLTGKHPFKEDEDE 212
|
Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-21
Identities = 77/262 (29%), Positives = 123/262 (46%), Gaps = 26/262 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPN 78
+D +E++ IG G +G + +KK L AVK ++ +DE ++ E +SL HPN
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80
Query: 79 IVRFKEVILTPTHLA-----IVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 129
+V+F + L +V+E +GG EL + + G R E + + G
Sbjct: 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPE 188
+ + H+ ++ HRD+K N LL +K+ DFG S + + ++VGTP ++APE
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 189 VL-LKKEYDGKI---ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
V+ +++YD DVWS G+T + G P D K K I R P
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK-IPRNPP-----PT 252
Query: 245 YVHISPECR---HLISRIFVAD 263
+H CR H IS+ + D
Sbjct: 253 LLHPEKWCRSFNHFISQCLIKD 274
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-21
Identities = 74/242 (30%), Positives = 124/242 (51%), Gaps = 13/242 (5%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
IG G+ G+ + +K T + VAVK ++ R + E + E++ R H N+V L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 88 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 147
L +VME+ GG L + I R +E++ ++ +SY H+ V HRD+K ++
Sbjct: 90 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148
Query: 148 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 204
LL DG R+K+ DFG+ ++ S + KS VGTP ++APEV+ + Y G D+WS
Sbjct: 149 ILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 203
Query: 205 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 264
G+ + M+ G P+ + E P + I L + + D +S R + + V +P
Sbjct: 204 LGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPR--VKDSHKVSSVLRGFLDLMLVREP 260
Query: 265 AK 266
++
Sbjct: 261 SQ 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-21
Identities = 69/215 (32%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
RY +R +G G+ G+ D ++ VAVK I D ++ REI R L H N
Sbjct: 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDN 63
Query: 79 IVRFKEVILT-----------PTHLA---IVMEYASGGELFERICNAGRFSEDEARFFFQ 124
IV+ EV+ T L IV EY + G SE+ AR F
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMY 121
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVG 180
QL+ G+ Y HS V HRDLK N ++ + LKI DFG ++ H K +
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
T Y +P +LL K D+W+ G ML G
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 4e-21
Identities = 75/240 (31%), Positives = 113/240 (47%), Gaps = 23/240 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 81
IG G FG R T ++ A+K +++ + + +N R + P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
TP L+ +++ +GG+L + G FSE E RF+ ++I G+ + H+ V +R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 142 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYD 196
DLK N LLD R+ CDF K P ++VGT Y+APEVL K YD
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYD 174
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
AD +S G L+ +L G PF + K+ + L++ +PD SPE R L+
Sbjct: 175 SS-ADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPD--SFSPELRSLL 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 8e-21
Identities = 67/192 (34%), Positives = 98/192 (51%), Gaps = 9/192 (4%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G + R K TE LVA+K I E + RE+ ++L+H NIV ++I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
T L +V EY +L + + N G S + F QL+ G+SYCH ++ HRDLK
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKP 131
Query: 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVW 203
+N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY I D+W
Sbjct: 132 QNLLINEK--GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI-DMW 188
Query: 204 SCGVTLYVMLVG 215
G LY M G
Sbjct: 189 GVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 8e-21
Identities = 78/257 (30%), Positives = 121/257 (47%), Gaps = 28/257 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVK------YIERGDKIDENVQREIINHRSL 74
D +E+++ IG G FG +++ K T ++ A+K ++R + +R+++ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYC 133
R I +L +VM+Y GG+L + R ED ARF+ +++ +
Sbjct: 61 RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAP 187
H + HRD+K +N LLD + RL DFG S L T VGTP YI+P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISP 172
Query: 188 EVLLKKEYDGK-----IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242
E+L E DGK D WS GV +Y ML G PF + + K ++ Q+
Sbjct: 173 EILQAME-DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP- 230
Query: 243 PDYVHISPECRHLISRI 259
PD +S E + LI R+
Sbjct: 231 PDVTDVSEEAKDLIRRL 247
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-20
Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 21/219 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN 78
SD +E++ IG G +G + +KK AVK ++ IDE ++ E ++L HPN
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN 76
Query: 79 IVRF-----KEVILTPTHLAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 129
+V+F K+ + L +V+E +GG +L + G R E + + + G
Sbjct: 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAP 187
+ + H + HRD+K N LL + +K+ DFG S +S + ++VGTP ++AP
Sbjct: 137 LQHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAP 193
Query: 188 EVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
EV+ L YD + DVWS G+T + G P D
Sbjct: 194 EVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-20
Identities = 66/227 (29%), Positives = 116/227 (51%), Gaps = 19/227 (8%)
Query: 11 GMDMPIMHD-SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI- 68
+D+ + D + +ELV +G+G +G R KT +L A+K ++ + +E ++ EI
Sbjct: 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEIN 64
Query: 69 INHRSLRHPNIVRFKEVILT---PTH---LAIVMEYASGGELFERICN--AGRFSEDEAR 120
+ + H NI + + P H L +VME+ G + + + N ED
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA 124
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-V 179
+ ++++ G+++ H+ +V HRD+K +N LL + +K+ DFG S ++T +
Sbjct: 125 YICREILRGLAHLHAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFI 182
Query: 180 GTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
GTP ++APEV+ E YD + +D+WS G+T M GA P D
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-20
Identities = 73/225 (32%), Positives = 109/225 (48%), Gaps = 21/225 (9%)
Query: 22 RY-ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIER--GDKIDENVQREIINHRSL 74
RY + +R +G G+FG L + T E+VAVK ++R G + ++EI ++L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 75 RHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
H NIV++K L ++MEY G L + + + + + F QQ+ G++Y
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAY 122
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAY-IAPE 188
HS HRDL N LLD +KI DFG +K+ + + + +P + A E
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 189 VLLKKEYDGKIA-DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
L KE A DVWS GVTLY +L + P PK F + I
Sbjct: 181 CL--KENKFSYASDVWSFGVTLYELLTHCDSKQSP--PKKFEEMI 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-20
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------REIINHRSLR 75
RY++ IG G++GV D T E VA+K I + + E+V REI R LR
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLR 57
Query: 76 HPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
HP+IV K ++L P+ + +V E +L + I + + +FF QL+ +
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIA 186
Y H+ V HRDLK +N L + +LKICDFG ++ + + V T Y A
Sbjct: 117 KYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 187 PEVL--LKKEYDGKIADVWSCGVTLYVMLVG 215
PE+ +Y I D+WS G +L G
Sbjct: 175 PELCGSFFSKYTPAI-DIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-20
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNIVR 81
+G G FG ++ K T ++ A K +++ G+K+ +++EI+ + P IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKM-ALLEKEIL--EKVNSPFIVN 57
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYCHSMQVC 139
+ THL +VM +GG+L I N G + R + Q+ G+ + HSM +
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
+RD+K EN LLD RL D G + GT Y+APE+L ++ Y +
Sbjct: 118 YRDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEE 224
D ++ G ++Y M+ G PF+D +E
Sbjct: 176 -DWFAMGCSIYEMVAGRTPFKDHKE 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-20
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV + K + ++A K I +I ++ +II + H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ +D+WS G++L M +G YP P+
Sbjct: 180 SVQ-SDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-20
Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV ++ K + ++A K I +I ++ +II + H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV F + ++I ME+ GG L + + A R E+ ++ G++Y
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
Q+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 123 HQIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ +D+WS G++L + +G YP P+
Sbjct: 180 SVQ-SDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-19
Identities = 71/257 (27%), Positives = 112/257 (43%), Gaps = 22/257 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPN 78
+ + + IG G F VA+K ++ D +D + + I + L HPN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 134
++++ + L IV+E A G+L I + + E +F QL S + + H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEV 189
S +V HRD+K N + + +K+ D G SK++ H S VGTP Y++PE
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPER 177
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
+ + Y+ K +D+WS G LY M PF + N +I Y H S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYS 234
Query: 250 PECRHLISRIFVADPAK 266
E R L++ DP K
Sbjct: 235 EELRQLVNMCINPDPEK 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-19
Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 14/215 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G + R K T+ LVA+K I E + RE+ + L+H NIV ++I
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 87 LTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145
T L +V EY +L + + + G + + F QL+ G++YCH +V HRDLK
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKP 132
Query: 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVW 203
+N L++ LK+ DFG +++ + ++ S V T Y P++LL +Y +I D+W
Sbjct: 133 QNLLINER--GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI-DMW 189
Query: 204 SCGVTLYVMLVGA--YPFEDPEEPKNFRKTIHRIL 236
G Y M G +P EE +F I RIL
Sbjct: 190 GVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRIL 221
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-19
Identities = 72/257 (28%), Positives = 124/257 (48%), Gaps = 27/257 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSLRHPNI 79
Y VR +G G++G L+R + + +K + + + ++E L+HPNI
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 80 VRFKEVIL-TPTHLAIVMEYASGGELFERIC-NAGRF-SEDEARFFFQQLISGVSYCHSM 136
V ++E L IVM + GG+L+ ++ G+ E++ +F Q+ + Y H
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKK 193
+ HRDLK +N L + +K+ D G ++ VL +Q + +GTP Y++PE+ K
Sbjct: 122 HILHRDLKTQNVFLTRTNI--IKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNK 177
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP----DYVHIS 249
Y+ K +DVW+ G +Y M + F K+ ++RI ++ +P DY S
Sbjct: 178 PYNYK-SDVWALGCCVYEMATLKHAF----NAKDMNSLVYRI--IEGKLPPMPKDY---S 227
Query: 250 PECRHLISRIFVADPAK 266
PE LI+ + P K
Sbjct: 228 PELGELIATMLSKRPEK 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 31/212 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR----- 75
DRY+ + +GSG +G D KT VA+K K+ Q I R+ R
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK------KLSRPFQSAIHAKRTYRELRLL 68
Query: 76 ----HPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQ 125
H N++ +V + L +V G +L I + S+D +F Q
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQ 126
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 183
++ G+ Y HS + HRDLK N ++ LKI DFG ++ H+ + T V T
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNED--CELKILDFGLAR----HTDDEMTGYVATRW 180
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
Y APE++L + + D+WS G + +L G
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-19
Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 19/214 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR--SLRH 76
D + E + +IGSG G MR KKT ++AVK + R +EN +R +++ H
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSH 71
Query: 77 --PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSY 132
P IV+ +T + + I ME S +L +RI G ED ++ + Y
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHY 129
Query: 133 C-HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVL 190
V HRD+K N LLD S +K+CDFG S V S+ K+ + G AY+APE +
Sbjct: 130 LKEKHGVIHRDVKPSNILLDAS--GNVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPERI 186
Query: 191 ----LKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+YD + ADVWS G++L + G +P++
Sbjct: 187 DPPDPNPKYDIR-ADVWSLGISLVELATGQFPYK 219
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-19
Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 26 VRDIGSGNFGVARLMR----DKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPNI 79
+RD+G G+FG L R T E VAVK + E G ++++EI R+L H NI
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 80 VRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSM 136
V++K + + ++ME+ G L E + N + + + + Q+ G+ Y S
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLLK 192
Q HRDL N L++ ++KI DFG +K+ + K + +P + APE L++
Sbjct: 129 QYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 193 KEYDGKIADVWSCGVTLYVML 213
++ +DVWS GVTLY +L
Sbjct: 187 SKF-YIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-19
Identities = 68/254 (26%), Positives = 120/254 (47%), Gaps = 20/254 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE------NVQREIINHRSLRH 76
+E+++ IG G FG +++ K +++ A+K + + + + +R+++ + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS 135
I +L +VM+Y GG+L + R ED ARF+ +++ + H
Sbjct: 63 --ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 193
+ HRD+K +N L+D + RL DFG + +S+ VGTP YI+PE+L
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 194 EYDGK-----IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
E DGK D WS GV +Y ML G PF + + K ++ Q+ +
Sbjct: 179 E-DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP-AQVTDV 236
Query: 249 SPECRHLISRIFVA 262
S + + LI R+ +
Sbjct: 237 SEDAKDLIRRLICS 250
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 6e-19
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 24 ELVRDIGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL+ IG + L + K T LVAVK I E++ Q+EII R L+HPN
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 79 IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
I+ + + + L +V M Y S +L + G E F + +++ + Y HS
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPAYIAP 187
HR +K + LL G ++ + YS + V+H PKS+V +++P
Sbjct: 120 KGFIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 188 EVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
EVL + + Y+ K D++S G+T + G PF+D
Sbjct: 178 EVLQQNLQGYNEKS-DIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 7e-19
Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVR 81
+ELV +G+G +G R KT +L A+K ++ +E +++EI + + H NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 82 FKEVILTPT------HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 133
+ + L +VME+ G + + I N E+ + ++++ G+S+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK 192
H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++APEV+
Sbjct: 128 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 193 KE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
E YD K +D+WS G+T M GA P D
Sbjct: 186 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 7e-19
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
++++G+G FGV + + + + VA+K I+ G ++ E L H +V+
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 85 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSMQ 137
V + IV EY S G C E RF QL+ G++Y S Q
Sbjct: 67 VCTKQRPIYIVTEYMSNG------CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKE 194
HRDL N L+D +K+ DFG S+ VL + S+VG+ + PEVLL +
Sbjct: 121 FIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
+ K +DVW+ GV ++ V +G P+E
Sbjct: 178 FSSK-SDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-19
Identities = 72/223 (32%), Positives = 108/223 (48%), Gaps = 13/223 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRH 76
+ Y+ + +G G++ R K T +LVA+K I E G RE + L+H
Sbjct: 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKH 62
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHS 135
NIV ++I T L +V EY +L + + + G S R F QL+ G++YCH
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KK 193
+V HRDLK +N L+ S LK+ DFG +++ + S+ S V T Y P+VLL
Sbjct: 122 RRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 236
EY + D+W G Y M G F + ++ I R+L
Sbjct: 180 EYSTSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL 221
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 71/306 (23%), Positives = 112/306 (36%), Gaps = 64/306 (20%)
Query: 22 RYELVRDIGSGNFGVARLMRDK--KTEELVAVKYIE----RGDKIDENVQREIINHRSLR 75
+YE+ IG G +G + K K + A+K + + I ++ REI R L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 76 HPNIVRFKEVILTPTHLAIVM--EYASGGEL----FERICNAGRFSEDEARFFFQQLISG 129
H N+V EV L ++ + +YA F R + Q+++G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 130 VSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS------TVGT 181
V Y HS V HRDLK N L+ +G +KI D G ++ + ++ K V T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVT 178
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCG------VTLYVMLVGA------------------- 216
Y APE+LL + K D+W+ G +TL + G
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238
Query: 217 ----YPFED--------PEEPKNFRKTIHRILSVQYSIPDYVHI----SPECRHLISRIF 260
P E PE K S+ ++ + L+ ++
Sbjct: 239 EVLGTPTEKDWPDIKKMPEYDT-LMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL 297
Query: 261 VADPAK 266
DP K
Sbjct: 298 EYDPTK 303
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 9/200 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ Y + +G G + R K TE LVA+K I E + RE+ + L+H N
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV +++ T L +V EY +L + + + G S + F Q++ G++YCH +
Sbjct: 66 IVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEY 195
V HRDLK +N L++ LK+ DFG +++ + ++ S V T Y P+VLL EY
Sbjct: 125 VLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 196 DGKIADVWSCGVTLYVMLVG 215
+I D+W G + M G
Sbjct: 183 STQI-DMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 2e-18
Identities = 63/240 (26%), Positives = 118/240 (49%), Gaps = 20/240 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
Y +++ + G+ G + + V +K ++G + E + + +NH P+++R
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNH-----PSVIRM 122
Query: 83 KEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
K+ +++ +V+ + S +L+ + + D+A +Q++ G+ Y H+ ++ HR
Sbjct: 123 KDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
D+K EN ++ ++ I D G ++ V+ GT APEVL + +Y+ K AD
Sbjct: 182 DVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK-AD 238
Query: 202 VWSCGVTLYVMLVGAYP---FEDP----EEP-KNFRKTIHRILSVQYSIPDYVHISPECR 253
+WS G+ L+ ML AYP FEDP EE K+ + +I+S P+ P R
Sbjct: 239 IWSAGIVLFEML--AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296
|
Length = 357 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-18
Identities = 83/302 (27%), Positives = 119/302 (39%), Gaps = 52/302 (17%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
D YE + IG G +G RDK T +LVA+K R + +E + REI + L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSE 59
Query: 77 -PNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGR-----FSEDEARFFFQQ 125
IVR +V L +V EY +L + + + GR + F Q
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAY 184
L+ GV++CH V HRDLK +N L+D LKI D G ++ S+ + T Y
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLWY 177
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-------- 236
APEVLL + D+WS G M F E + I ++L
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH-IFKLLGTPTEQVW 236
Query: 237 ------------------SVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278
+ ++PD +SPE L+ ++ DPAK A
Sbjct: 237 PGVSKLRDWHEFPQWKPQDLSRAVPD---LSPEGLDLLQKMLRYDPAK---RISAKAALT 290
Query: 279 HT 280
H
Sbjct: 291 HP 292
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 72/223 (32%), Positives = 105/223 (47%), Gaps = 39/223 (17%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKT--EELVAVKYIERGDKIDENVQREIINHRSLR---- 75
RYEL++++G G +G+ R+ +T EE VA+K KI ++I+ R+LR
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIK------KITNVFSKKILAKRALRELKL 54
Query: 76 ------HPNIVRFKEV-ILTPTHLAIVMEYASGGELFE----RICNAG-RFSEDEARFFF 123
H NI ++ I+ P + + Y EL E +I +G ++ + F
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYE---ELMEADLHQIIRSGQPLTDAHFQSFI 111
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKS-SVLH--SQPKST 178
Q++ G+ Y HS V HRDLK N L D LKICDFG ++ S + T
Sbjct: 112 YQILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLARGFSENPGENAGFMT 167
Query: 179 --VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
V T Y APE++L + K DVWS G L L+G P
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL-AELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-18
Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 11/209 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D +E + ++G+GN GV + + + ++A K I +I ++ +II + H
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL--EIKPAIRNQIIRELKVLHECNS 58
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS- 135
P IV F + ++I ME+ GG L + + AGR E+ ++ G++Y
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 119 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
+ +D+WS G++L M +G YP P+
Sbjct: 176 TVQ-SDIWSLGLSLVEMAIGRYPIPPPDA 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-18
Identities = 67/243 (27%), Positives = 106/243 (43%), Gaps = 16/243 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHP 77
+D YE + +G G++ + K +LVA+K I + + RE + L+H
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV ++I T L +V EY + G + + F QL+ G+SY H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 196
+ HRDLK +N L+ S LK+ DFG +++ + S S V T Y P+VLL
Sbjct: 124 ILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------YSIPDYVHI 248
D+W G M+ G F ++ ++ + I +L +S+P H
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP---HF 238
Query: 249 SPE 251
PE
Sbjct: 239 KPE 241
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 6e-18
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRFKE 84
+G GN G T ++AVK I I +Q++I++ + + P I+ F
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 85 VILTPTHLAIVMEYASGGEL--FERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCH 140
++I E+ GG L + +I GR + ++ G++Y S+++ H
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIA--------VAVVKGLTYLWSLKILH 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 200
RD+K N L++ ++K+CDFG S V +S K+ VGT AY+APE + ++Y G +
Sbjct: 119 RDVKPSNMLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQY-GIHS 174
Query: 201 DVWSCGVTLYVMLVGAYPFEDPEEPKN 227
DVWS G++ + +G +P+ P+ KN
Sbjct: 175 DVWSLGISFMELALGRFPY--PQIQKN 199
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-18
Identities = 64/260 (24%), Positives = 119/260 (45%), Gaps = 22/260 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---- 76
D E++ ++G GN+G + + T +A+K I ++DE+ +II + H
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVS 58
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYC 133
P IV F + + MEY G +L+ ED R ++ G+ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 134 -HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
+ HRD+K N L++G+ ++K+CDFG S +++ S K+ +G +Y+APE +
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 193 KEYDGKI-----ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-SVQYSIPDYV 246
+ +DVWS G+++ M +G YP+ PE N + I+ ++P
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP-PETYANIFAQLSAIVDGDPPTLPS-- 232
Query: 247 HISPECRHLISRIFVADPAK 266
S + + +++ P +
Sbjct: 233 GYSDDAQDFVAKCLNKIPNR 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 9e-18
Identities = 58/187 (31%), Positives = 85/187 (45%), Gaps = 15/187 (8%)
Query: 29 IGSGNFGVARL--MRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
IG G FG L R +K VAVK ++ + E +LRHPN+V+ V+
Sbjct: 14 IGKGEFGDVMLGDYRGQK----VAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 87 LTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
L L IV EY + G L + + + GR + + F + G+ Y HRDL
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLA 129
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
N L+ K+ DFG +K + K V + APE L +K++ K +DVW
Sbjct: 130 ARNVLVSEDLVA--KVSDFGLAKEASQGQDSGKLPV---KWTAPEALREKKFSTK-SDVW 183
Query: 204 SCGVTLY 210
S G+ L+
Sbjct: 184 SFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 5e-17
Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 20/226 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPN 78
RY ++ +GSG +G DK+T E VA+K + R + + RE+ + ++H N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 79 IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++ +V + +VM Y ++I SED+ ++ Q++ G+ Y
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQMLCGLKY 132
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
HS + HRDLK N L + LKI DFG ++ + ++ V T Y APEV+L
Sbjct: 133 IHSAGIIHRDLKPGN--LAVNEDCELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILN 188
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238
+ + D+WS G + ML G F+ K++ + +IL V
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKV 230
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-17
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARL---MRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
LV++IGSG FG+ L + +K VA+K I G +E+ E L
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRK----VAIKTIREGAMSEEDFIEEAQVMMKLS 57
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
HP +V+ V + + +V E+ G L + + G+FS++ + G++Y
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLL 191
S V HRDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV
Sbjct: 118 SSNVIHRDLAARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFS 174
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+Y K +DVWS GV ++ V G P+E+
Sbjct: 175 FSKYSSK-SDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-17
Identities = 65/197 (32%), Positives = 95/197 (48%), Gaps = 21/197 (10%)
Query: 29 IGSGNFGVARLMR----DKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFK 83
+G GNFG L R T E+VAVK ++ + +REI +SL+H NIV++K
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 84 EVILTP--THLAIVMEYASGGELFER-ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V + +L +VMEY G L + + R + + Q+ G+ Y S + H
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVH 131
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPA-----YIAPEVLLKK 193
RDL N L++ R+KI DFG +K + Q K V P + APE L +
Sbjct: 132 RDLATRNILVESE--NRVKIGDFGLTK---VLPQDKEYYKVREPGESPIFWYAPESLTES 186
Query: 194 EYDGKIADVWSCGVTLY 210
++ +DVWS GV LY
Sbjct: 187 KFS-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 7e-17
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
DRY ++ +GSG +G D++T VA+K + R + + RE+ + ++H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 78 NIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V L +VM + G ++ + SED +F Q++ G+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y H+ + HRDLK N L + LKI DFG ++ + S+ V T Y APEV+L
Sbjct: 133 YIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEVIL 188
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ + D+WS G + ML G F+
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 9e-17
Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 85
++++GSG FGV L + + + VA+K I G +E+ E L HP +V+ V
Sbjct: 9 MKELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 86 ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
L IV E+ G L + G+ S+D Q + G+ Y HRDL
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127
Query: 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGKIAD 201
N L+ S +K+ DFG ++ VL + S+ G + PEV +Y K +D
Sbjct: 128 ARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-SD 183
Query: 202 VWSCGVTLY-VMLVGAYPFE 220
VWS GV ++ V G PFE
Sbjct: 184 VWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-16
Identities = 63/201 (31%), Positives = 96/201 (47%), Gaps = 25/201 (12%)
Query: 28 DIGSGNFGVARLMRDKKTEEL-----VAVKYIERGDKIDENVQ---REIINHRSLRHPNI 79
+G G+FGV R R + + VAVK + DK+ + + +E SL H N+
Sbjct: 2 KLGDGSFGVVR--RGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNA-GRFSEDEARFFFQQLISGVSYCHSMQ 137
+R V+LT L +V E A G L +R+ +A G F + Q+ +G+ Y S +
Sbjct: 59 IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTP-AYIAPEVLL 191
HRDL N LL + ++KI DFG ++ + + V P A+ APE L
Sbjct: 118 FIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173
Query: 192 KKEYDGKIADVWSCGVTLYVM 212
+ + +DVW GVTL+ M
Sbjct: 174 TRTFS-HASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-16
Identities = 70/252 (27%), Positives = 115/252 (45%), Gaps = 23/252 (9%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 79
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + R +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSRF--V 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ 137
V T L +V+ +GG+L I + G F E A F+ ++ G+ H +
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ +RDLK EN LLD ++I D G + K VGT Y+APEV+ + Y
Sbjct: 123 IVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---VQYSIPDYVHISPECRH 254
D W+ G LY M+ G PF+ + K R+ + R++ +YS SP+ R
Sbjct: 181 S-PDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVQEEYS----EKFSPDARS 234
Query: 255 LISRIFVADPAK 266
L + DP +
Sbjct: 235 LCKMLLCKDPKE 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-16
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSLR--- 75
+YE V +IG G +G RD + VA+K + D + + RE+ + L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 76 HPNIVRFKEVILT-----PTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLIS 128
HPNIVR +V T T + +V E+ +++ G + + +Q +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLR 119
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
G+ + H+ + HRDLK EN L+ + ++K+ DFG ++ V T Y APE
Sbjct: 120 GLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177
Query: 189 VLLKKEYDGKIADVWSCGVTLYVML 213
VLL+ Y + D+WS G M
Sbjct: 178 VLLQSTYATPV-DMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-16
Identities = 62/251 (24%), Positives = 105/251 (41%), Gaps = 13/251 (5%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
+ R +G G FG + + T ++ A K +E+ + +N + +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
+V T L +V+ +GG+L I N G F E+ A F+ ++ G+ H
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEY 195
++ +RDLK EN LLD ++I D G + + + + VGT Y+APEV+ + Y
Sbjct: 122 RIVYRDLKPENILLDDY--GHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNERY 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
D W G +Y M+ G PF +E + R+ Q + S R +
Sbjct: 179 -TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAARSI 235
Query: 256 ISRIFVADPAK 266
++ DP
Sbjct: 236 CRQLLTKDPGF 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 5e-16
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 84
IG G FG M K + ++AVK I R ++ +R +++ RS P IV+F
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 85 VILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYC--------- 133
+ I ME S + ++ + + ++++ ++
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNYLK 124
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 191
+++ HRD+K N LLD + +K+CDFG S V S K+ G Y+APE +
Sbjct: 125 EELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDP 181
Query: 192 --KKEYDGKIADVWSCGVTLYVMLVGAYPF 219
+ YD + +DVWS G+TLY + G +P+
Sbjct: 182 SARDGYDVR-SDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-16
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 10/201 (4%)
Query: 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 84
++++GSG FGV L + + + VA+K I G +++ E L HPN+V+
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 85 VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
V + IV EY + G L + G+ + + + Y S HRDL
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKKEYDGKIA 200
N L+ +K+ DFG ++ VL Q S+ GT + PEV + K +
Sbjct: 127 AARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK-S 182
Query: 201 DVWSCGVTLY-VMLVGAYPFE 220
DVWS GV ++ V G P+E
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-16
Identities = 61/179 (34%), Positives = 85/179 (47%), Gaps = 11/179 (6%)
Query: 47 ELVAVKYIERGDKIDENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102
+LVA+K I K +E V RE + L+H NIV ++I T L V EY
Sbjct: 31 QLVALKVISM--KTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTD 88
Query: 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162
I + G R F QL+ G++Y H + HRDLK +N L+ S LK+ D
Sbjct: 89 LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI--SYLGELKLAD 146
Query: 163 FGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPF 219
FG +++ + SQ S+ V T Y P+VLL +Y + D+W G ML G F
Sbjct: 147 FGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSAL-DIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-16
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 27 RDIGSGNFGVAR--LMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRS----LRHPNI 79
+++G GNFG + K +E+ VAVK +++ + I ++E + S L HP I
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ-EHIAAG-KKEFLREASVMAQLDHPCI 58
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
VR V L +VME A G L + + + + Q+ G++Y S
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGT--P-AYIAPEVLLKKEY 195
HRDL N LL + KI DFG S++ ++T P + APE + ++
Sbjct: 118 HRDLAARNVLLVNR--HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 196 DGKIADVWSCGVTLYVML-VGAYPFED 221
K +DVWS GVTL+ GA P+ +
Sbjct: 176 SSK-SDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-15
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLR 75
D E++ ++G G +GV MR T ++AVK I E Q+ + I+ RS+
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVD 58
Query: 76 HPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE--ARFFFQQLISGVS 131
P V F + + I ME S + ++++ + G ++ + ++ +
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAV-SIVKALE 117
Query: 132 YCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE- 188
Y HS + V HRD+K N L++ ++K+CDFG S V S K+ G Y+APE
Sbjct: 118 YLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPER 174
Query: 189 ---VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
L +K YD K +DVWS G+T+ + G +P++
Sbjct: 175 INPELNQKGYDVK-SDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 6/149 (4%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
+ +V+ I G FG L R K +L AVK +++ D I++N+ ++ R + P
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + ++ +VMEY GG++ + G F E+ A + ++ + Y H +
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI 125
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK 167
HRDLK +N L+ S +K+ DFG SK
Sbjct: 126 IHRDLKPDNMLI--SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ Y+L IG+G+FGV T E VA+K + + + RE++ ++L H NI
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK---NRELLIMKNLNHINI 121
Query: 80 VRFKEVILTPT--------HLAIVMEYASGG-----ELFERICNAGRFSEDEARFFFQQL 126
+ K+ T L +VME+ + + R N + + QL
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR--NNHALPLFLVKLYSYQL 179
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKSTVGTPA 183
++Y HS +CHRDLK +N L+D P LK+CDFG +K+ + + S + +
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218
Y APE++L D+WS G + M++G YP
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YP 269
|
Length = 440 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 59/209 (28%), Positives = 98/209 (46%), Gaps = 17/209 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
+RY+ + +GSG +G D KT VAVK + R + + RE+ + ++H
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 78 NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
N++ +V L ++ + G +L I + ++D +F Q++ G+ Y
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRDLK N L + LKI DFG ++ H+ + T V T Y APE++
Sbjct: 136 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
L + + D+WS G + +L G F
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-15
Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 24/219 (10%)
Query: 19 DSDRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
D+ ++ + IG+G FG RL K E VA+K ++ G E +R+ ++ S+
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRDFLSEASIM 59
Query: 76 ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
HPNI+ + V+ + IV EY G L F R + G+F+ + + + SG
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASG 118
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
+ Y M HRDL N L++ + K+ DFG S+ VL P++ T
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 174
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ APE + +++ +DVWS G+ ++ VM G P+ +
Sbjct: 175 WTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHP 77
+RY+ + +GSG +G D + + VAVK + R + RE+ + ++H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 78 NIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
N++ +V T + E G +L I + S++ +F QL+ G+ Y
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADL-NNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
HS + HRDLK N ++ L+I DFG ++ + + V T Y APE++L
Sbjct: 134 IHSAGIIHRDLKPSNVAVNED--CELRILDFGLARQA--DDEMTGYVATRWYRAPEIMLN 189
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPF 219
+ + D+WS G + +L G F
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 78/285 (27%), Positives = 111/285 (38%), Gaps = 54/285 (18%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR------ 75
RY+++R IG G G L D VA+K I R D + ++ R LR
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSEN----PLLKKRFLREAKIAA 57
Query: 76 ---HPNIVRFKEVILTPTHLAIVMEYASG---GELFERICNAGRFSEDEAR------FF- 122
HP IV + + M Y G L + + S++ A F
Sbjct: 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 123 -FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----------------Y 165
F ++ + + Y HS V HRDLK +N LL + I D+G
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 166 SKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222
+ ++ +S P VGTP Y+APE LL D+++ GV LY ML ++P+
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRR- 233
Query: 223 EEPKNFRKTI--HRILSVQYSIPDYVHISPECRHLISRIFVADPA 265
K RK ILS P Y I P + + DPA
Sbjct: 234 ---KKGRKISYRDVILSPIEVAP-YREIPPFLSQIAMKALAVDPA 274
|
Length = 932 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-15
Identities = 65/249 (26%), Positives = 108/249 (43%), Gaps = 17/249 (6%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 79
R +G G FG + + T ++ A K +E+ G+ + N +++I+ + + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQF--V 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ 137
V T L +V+ +GG+L I N G F E+ A F+ +++ G+ H
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+RDLK EN LLD ++I D G + + VGT Y+APEVL + Y
Sbjct: 123 TVYRDLKPENILLDDY--GHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-T 179
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
D W G +Y M+ G PF +E + R+L + S E + +
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSICK 237
Query: 258 RIFVADPAK 266
+ DP +
Sbjct: 238 MLLTKDPKQ 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 6e-15
Identities = 77/283 (27%), Positives = 116/283 (40%), Gaps = 47/283 (16%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSLRHP 77
E R IG G FGV + D + + VA+K + + +N V RE+ +H
Sbjct: 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMP---NVFQNLVSCKRVFRELKMLCFFKHD 59
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFER-----ICNAGRFSEDEARFFFQQLISGVSY 132
N++ + IL P H+ E EL + I + S D + F Q++ G+ Y
Sbjct: 60 NVLSALD-ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
HS + HRD+K N L++ + LKICDFG ++ T V T Y APE+L
Sbjct: 119 LHSAGILHRDIKPGNLLVNSN--CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176
Query: 191 L-KKEYDGKIADVWSCGVTLYVMLVGAYPFE----------------DP--EEPKNFRK- 230
+ + Y + D+WS G +L F+ P E ++ +
Sbjct: 177 MGSRHYTSAV-DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235
Query: 231 TIHRILSVQYSIPD----YVHISP---ECRHLISRIFVADPAK 266
IL + P Y S E HL+ R+ V DP K
Sbjct: 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDK 278
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-15
Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRD-KKTEELVAVKYI-----ERGDKIDENVQREIINH-RSL 74
+YE V +IG G +G RD K VA+K + E G + + ++ H +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 75 RHPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLI 127
HPN+VR +V T L +V E+ +++ G +E FQ L+
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 120
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVML 213
EVLL+ Y + D+WS G M
Sbjct: 179 EVLLQSSYATPV-DLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 35/218 (16%)
Query: 25 LVRDIGSGNFG---VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 79
+ + IG G FG RL K E VA+K ++ G DK + E HPNI
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 80 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLI-------SGV 130
+R + V+ + I+ EY G L F R E++ +F QL+ SG+
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIASGM 119
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-----PA-Y 184
Y M HRDL N L++ + K+ DFG S+ L ++T T P +
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSN--LVCKVSDFGLSR--RLED-SEATYTTKGGKIPIRW 174
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
APE + +++ +DVWS G+ ++ VM G P+ D
Sbjct: 175 TAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 18/194 (9%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
R + S N G + E L+A K ++ G + ++ EI+ L H NI++ +E++
Sbjct: 180 RGVNSTNQGKPK------CERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232
Query: 87 LTPTHLAIVMEYASGGELFERICNAGRFSED-----EARFFFQQLISGVSYCHSMQVCHR 141
+ + ++ + +L+ + + +D + R +QL+ V Y H ++ HR
Sbjct: 233 RSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHR 291
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGKI 199
D+KLEN L+ L DFG + + VGT A +PE+L Y +I
Sbjct: 292 DIKLENIFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEI 348
Query: 200 ADVWSCGVTLYVML 213
D+WSCG+ L ML
Sbjct: 349 TDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 21/226 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D VAVK + R + + +R E++ + + H N
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 79 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
I+ V TP + +VME +C D R + Q++ G
Sbjct: 82 IISLLNV-FTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCG 135
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HS + HRDLK N ++ LKI DFG ++++ + V T Y APEV
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
+L Y + D+WS G + ++ G+ F+ + + K I ++
Sbjct: 194 ILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQL 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 21/226 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D E VA+K + R + + +R E++ + + H N
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 79 IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 129
I+ V TP + IVME +C + D R + Q++ G
Sbjct: 85 IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HS + HRDLK N ++ LKI DFG ++++ V T Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
+L Y + D+WS G + M+ G F + + K I ++
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-14
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 29 IGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 81
IG+G FG RL K E VA+K ++ G E +R+ ++ S+ HPNI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
+ V+ + I+ E+ G L F R N G+F+ + + + +G+ Y M
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEVLL 191
HRDL N L++ + K+ DFG S+ L T + + APE +
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+++ +DVWS G+ ++ VM G P+ D
Sbjct: 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-14
Identities = 65/251 (25%), Positives = 107/251 (42%), Gaps = 21/251 (8%)
Query: 27 RDIGSGNFGVARLMRDKKTEELVAVKYIER-------GDKIDENVQR--EIINHRSLRHP 77
R +G G FG + + T ++ A K +E+ G+ + N +R E +N R
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF---- 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 135
+V T L +V+ +GG+L I N G F E A F+ +L G+
Sbjct: 62 -VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
++ +RDLK EN LLD ++I D G + + VGT Y+APEV+ ++Y
Sbjct: 121 ERIVYRDLKPENILLDDR--GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
D W G +Y M+ G PF +E + R+ Q + S + + +
Sbjct: 179 TFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE--KFSEDAKSI 235
Query: 256 ISRIFVADPAK 266
+ +P +
Sbjct: 236 CRMLLTKNPKE 246
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 4e-14
Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 45/228 (19%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRSLRH 76
YE++ +G G FG R KT +VA+K I E+ D REI + L+H
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKH 66
Query: 77 PNIVRFKEVIL--------TPTHLAIVMEYA----SGGELFE--RICNAGRFSEDEARFF 122
PN+V ++ + + +V Y SG L E + + +E + + +
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLENPSV----KLTESQIKCY 120
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------ 176
QL+ G++Y H + HRD+K N L+D LKI DFG ++ P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR--PYDGPPPNPKGGG 176
Query: 177 --------STVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
+ V T Y PE+LL ++ Y + D+W G M
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-14
Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 27/210 (12%)
Query: 25 LVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
L R +G+G FG V + T+ VAVK ++ G E +E + LRH +V+
Sbjct: 10 LERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLY 67
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFF-FQQLI-------SGVSYCHS 135
V + IV EY S G L + + E + QL+ G++Y S
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMAYLES 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTP-AYIAPEVLL 191
HRDL N L+ + KI DFG ++ ++ + P + APE
Sbjct: 122 RNYIHRDLAARNILVGENLV--CKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAAN 177
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
+ K +DVWS G+ L ++ G P+
Sbjct: 178 YGRFTIK-SDVWSFGILLTEIVTYGRVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-14
Identities = 67/236 (28%), Positives = 103/236 (43%), Gaps = 30/236 (12%)
Query: 29 IGSGNFGVARLMR--DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G +G + D K E+ A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 87 LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHSM 136
L+ + + ++ +YA F R A + + Q++ G+ Y H+
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 187
V HRDLK N L+ +G R+KI D G+++ L + P V T Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-----RILSV 238
E+LL + K D+W+ G +L F +E H RI SV
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-13
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 29 IGSGNFG-VAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 81
IG+G FG V R L + E VA+K ++ G E +++ ++ S+ H NI+R
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 82 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
+ V+ I+ EY G L + + + G FS + + + +G+ Y M H
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLKKE 194
RDL N L++ + K+ DFG S+ VL P+ T T + APE + ++
Sbjct: 131 RDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVWS G+ ++ VM G P+ D
Sbjct: 187 FTSA-SDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-13
Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 17/207 (8%)
Query: 23 YELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIV 80
+ L R +GSG FG + K VA+K ++ D + ++ Q+E+ + LRH +++
Sbjct: 8 FTLERKLGSGYFG--EVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQV 138
V + I+ E G L + + A Q+ G++Y
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS 125
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYS---KSSV-LHSQPKSTVGTPAYIAPEVLLKKE 194
HRDL N L+ K+ DFG + K V L S K + APE
Sbjct: 126 IHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY---KWTAPEAASHGT 180
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFE 220
+ K +DVWS G+ LY + G P+
Sbjct: 181 FSTK-SDVWSFGILLYEMFTYGQVPYP 206
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-13
Identities = 73/245 (29%), Positives = 104/245 (42%), Gaps = 25/245 (10%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 85
IG G FG +++ + T + VAVK I K D Q E L H N+VR V
Sbjct: 14 IGEGEFGA--VLQGEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 86 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSMQVCHRDL 143
IL L IVME S G L + GR + F + G+ Y S ++ HRDL
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADV 202
N L+ S K+ DFG ++ + S P + APE L K++ K +DV
Sbjct: 127 AARNILV--SEDGVAKVSDFGLAR---VGSMGVDNSKLPVKWTAPEALKHKKFSSK-SDV 180
Query: 203 WSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261
WS GV L+ V G P+ PK K + + Y + + L++ +
Sbjct: 181 WSYGVLLWEVFSYGRAPY-----PKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWE 235
Query: 262 ADPAK 266
+P K
Sbjct: 236 TEPKK 240
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-13
Identities = 69/287 (24%), Positives = 118/287 (41%), Gaps = 45/287 (15%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 78
RY+ ++ IGSG G+ D + VA+K + R + + +R E++ + + H N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHS 135
I+ V L + EL + +C + D R + Q++ G+ + HS
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK N ++ LKI DFG ++++ V T Y APEV+L Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIPDYVH 247
+ D+WS G + M+ F + + K I ++ + +Q ++ +YV
Sbjct: 196 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 248 ISP----------------------------ECRHLISRIFVADPAK 266
P + R L+S++ V DPAK
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-13
Identities = 49/218 (22%), Positives = 87/218 (39%), Gaps = 34/218 (15%)
Query: 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDE-----N 63
S+RY +G G +G D T ++VA+K + + +
Sbjct: 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66
Query: 64 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 123
RE+ ++H NI+ +V + + +VM+ + +L + + R +E + +
Sbjct: 67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCIL 125
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----------H 172
Q+++G++ H HRDL N ++ KI DFG ++
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDET 183
Query: 173 SQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCG 206
Q + S V T Y APE+L+ E D+WS G
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221
|
Length = 335 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 8e-13
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------REIINHRSLR 75
RY+ ++ IGSG G+ D T + VA+K + R +NV RE++ + +
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVN 73
Query: 76 HPNIVRFKEVILTP-------THLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQL 126
H NI+ V TP + +VME A+ ++ + + R S + Q+
Sbjct: 74 HKNIIGLLNV-FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQM 127
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
+ G+ + HS + HRDLK N ++ LKI DFG ++++ V T Y A
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRA 185
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 219
PEV+L Y + D+WS G + M+ G F
Sbjct: 186 PEVILGMGYKENV-DIWSVGCIMGEMIRGTVLF 217
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 29 IGSGNFG-VARLMR-DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 86
+G G +G V + R D K + A+K IE G I + REI R L+HPN++ ++V
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 87 LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHSM 136
L+ + ++ +YA F R A + + Q++ G+ Y H+
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 187
V HRDLK N L+ +G R+KI D G+++ L + P V T Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224
E+LL + K D+W+ G +L F +E
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 34/225 (15%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-- 73
++ L+R++G G+FG +A+ + + E VA+K + + E E +N S
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVM 63
Query: 74 --LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF-------- 121
++VR V+ T +VME + G+L + R R +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPEAENNPGLGPPTLQK 120
Query: 122 FFQ---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
F Q ++ G++Y + + HRDL N ++ +KI DFG ++ +
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRKG 178
Query: 179 VGT--PA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPF 219
P ++APE L + K +DVWS GV L+ M + P+
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 21 DRYELVRDIGSGNFGVAR--LMRDKKTEEL-VAVKY--IERGDKIDENVQREIINHRSLR 75
+ L R IG G FG + + E++ VAVK + E +E R
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
HP+IV+ VI T + IVME A GEL + N + QL + ++Y
Sbjct: 66 HPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-P-AYIAPEVLLK 192
S + HRD+ N L+ SP +K+ DFG S+ S K++ G P ++APE +
Sbjct: 125 SKRFVHRDIAARNVLV-SSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ + +DVW GV ++ ++++G PF
Sbjct: 183 RRFTSA-SDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 65/233 (27%), Positives = 93/233 (39%), Gaps = 41/233 (17%)
Query: 24 ELVRDIGSGNFGV----------------ARLMRDKKTEELVAVKYIERG--DKIDENVQ 65
V +G G FG + LVAVK + D E+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER---------ICNAGRF 114
+E+ L PNI R V L ++MEY G+L F + CN+
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
S + Q+ SG+ Y S+ HRDL N L+ +KI DFG S++ L+S
Sbjct: 128 SFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG--KNYTIKIADFGMSRN--LYSS 183
Query: 175 PKSTVG--TPAYI---APEVLLKKEYDGKIADVWSCGVTLY--VMLVGAYPFE 220
V P I A E +L ++ K +DVW+ GVTL+ + L P+E
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYE 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-12
Identities = 58/200 (29%), Positives = 85/200 (42%), Gaps = 14/200 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 84
IG GNFG R + VAVK + + +++ + + + HPNIVR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 85 VILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143
V + IVME GG+ + G R E + +G+ Y S HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLLKKEYDGKIA 200
N L+ LKI DFG S+ +++ P + APE L Y + +
Sbjct: 121 AARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE-S 177
Query: 201 DVWSCGVTLY-VMLVGAYPF 219
DVWS G+ L+ +GA P+
Sbjct: 178 DVWSFGILLWEAFSLGAVPY 197
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-12
Identities = 63/217 (29%), Positives = 87/217 (40%), Gaps = 45/217 (20%)
Query: 27 RDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL---RHPNIV 80
IG GNFG L K VAVK R + ++ + L HPNIV
Sbjct: 1 EKIGKGNFGDVYKGVL----KGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIV 55
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYC 133
+ V + + IVME GG L + + + R ++L+ +G+ Y
Sbjct: 56 KLIGVCVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYL 109
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG---------YSKSSVLHSQP-KSTVGTPA 183
S HRDL N L+ + LKI DFG Y+ S L P K T
Sbjct: 110 ESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWT----- 162
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
APE L Y + +DVWS G+ L+ +G P+
Sbjct: 163 --APEALNYGRYTSE-SDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-12
Identities = 59/193 (30%), Positives = 90/193 (46%), Gaps = 15/193 (7%)
Query: 28 DIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 81
++GSGNFG + + + KK+E+ VAVK I + D D ++ E++ + L +P IVR
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
I +VME A G L + + +E Q+ G+ Y HR
Sbjct: 61 MIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPA-YIAPEVLLKKEYDG 197
DL N LL KI DFG SK + + + K+ P + APE + ++
Sbjct: 120 DLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 198 KIADVWSCGVTLY 210
K +DVWS GV ++
Sbjct: 178 K-SDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-11
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 24 ELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL+ IG G + L R K T E V V+ I +E V Q E+ + HPN
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++ + L +V + + G + IC SE + Q ++ + Y H M
Sbjct: 61 IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120
Query: 137 QVCHRDLKLENTL--LDGSPAPRLKICDFGY----------SKSSVLHSQPKSTVGTPAY 184
HR +K + L +DG K+ G + V+H PK +V +
Sbjct: 121 GYVHRSVKASHILISVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPW 174
Query: 185 IAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 221
++PEVL + + YD K +D++S G+T + G PF+D
Sbjct: 175 LSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-11
Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 29 IGSGNFG------VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL----RHPN 78
+GSG FG ++ VAVK + +G E ++E + L HPN
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVS 131
IV+ V L I+ME GG+L + +A ++L+ G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPR-LKICDFGYSK---SSVLHSQPKSTVGTPAYI 185
Y M HRDL N L+ G A R +KI DFG ++ S + + + ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180
Query: 186 APEVLLKKEYDGKI---ADVWSCGVTLY-VMLVGAYPF 219
APE LL DGK +DVWS GV ++ ++ +G P+
Sbjct: 181 APESLL----DGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 22 RYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINH----RS 73
E ++ +GSG FG + + + ++ VA+K + ++ +EI++ S
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKANKEILDEAYVMAS 65
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 132
+ HP++VR + L+ ++ + G L + + + + Q+ G+SY
Sbjct: 66 VDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG-TP-AYIAPEV 189
++ HRDL N L+ +P +KI DFG +K V + + G P ++A E
Sbjct: 125 LEEKRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 190 LLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+L + Y K +DVWS GVT++ +M GA P+E
Sbjct: 183 ILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 47/161 (29%), Positives = 65/161 (40%), Gaps = 16/161 (9%)
Query: 45 TEELVAVKYIERGDKIDE-----NVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY 98
T VA+K + R D +E +RE L HPNIV P L V EY
Sbjct: 2 TGHEVAIKLL-RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APR 157
G L E + G E Q++ ++ H+ + HRDLK +N ++ + P
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 158 LKICDFGYSK-----SSVLHSQPKST---VGTPAYIAPEVL 190
K+ DFG + T +GTP Y APE L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 23/213 (10%)
Query: 19 DSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP 77
D +L+R +G+G FG V + + T VAVK ++ G ++ E + LRHP
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 130
+++ V + IV E G L E + QLI SG+
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG-----GAGRALKLPQLIDMAAQVASGM 116
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---AP 187
+Y + HRDL N L+ + K+ DFG ++ + ++ G I AP
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLAR-VIKEDIYEAREGAKFPIKWTAP 173
Query: 188 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
E L + K +DVWS G+ L ++ G P+
Sbjct: 174 EAALYNRFSIK-SDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 50/186 (26%), Positives = 76/186 (40%), Gaps = 32/186 (17%)
Query: 72 RSLRHPNIVRFKEVILTPTHLAI--------VMEYASGGEL--FERIC------NAGRFS 115
L H NI L H+ I + Y + G L F + C N S
Sbjct: 63 YGLSHQNI-------LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLH 172
+ Q+ G+SY H V H+D+ N ++D ++KI D S+ H
Sbjct: 116 TQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE--LQVKITDNALSRDLFPMDYH 173
Query: 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE--DPEEPKNFR 229
+ ++A E L+ KEY +DVWS GV L+ +M +G P+ DP E +
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL 232
Query: 230 KTIHRI 235
K +R+
Sbjct: 233 KDGYRL 238
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 28 DIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVR 81
++GSGNFG + + + +K + VA+K ++ + +++V+ E++ + H P IVR
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 82 FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V L +VME ASGG L + + + Q+ G+ Y H
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLLKKEYD 196
RDL N LL KI DFG SK+ + + +S P + APE + +++
Sbjct: 119 RDLAARNVLLVNQHYA--KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 197 GKIADVWSCGVTLYVML-VGAYPFEDPEEPK 226
+ +DVWS G+T++ G P++ + P+
Sbjct: 177 SR-SDVWSYGITMWEAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-10
Identities = 59/225 (26%), Positives = 93/225 (41%), Gaps = 35/225 (15%)
Query: 18 HDSDRYELVRDIGSGNFGV---ARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIIN 70
+ + E VRDIG G FG AR E +VAVK ++ + + QRE
Sbjct: 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------------------RICN 110
HPNIV+ V + ++ EY + G+L E R C
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 111 AGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK- 167
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRN 179
Query: 168 --SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
S+ + ++ ++ PE + Y + +DVW+ GV L+
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 223
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-10
Identities = 48/189 (25%), Positives = 80/189 (42%), Gaps = 13/189 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
+G G +G KK VAVK ++ E +E + ++HPN+V+ V
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ--QLISGVSYCHSMQVCHRDLKLE 146
I+ E+ + G L + + R + + Q+ S + Y HRDL
Sbjct: 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 133
Query: 147 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
N L+ +K+ DFG S+ + H+ K + + APE L ++ K +D
Sbjct: 134 NCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 187
Query: 202 VWSCGVTLY 210
VW+ GV L+
Sbjct: 188 VWAFGVLLW 196
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 11/205 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+ +LV+ +G+G FG M VAVK ++ G + E ++L+H +V
Sbjct: 6 ESIKLVKKLGAGQFGEV-WMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 81 RFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
R V+ + I+ EY + G L F + G+ + F Q+ G++Y
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEY 195
HRDL+ N L+ S + KI DFG ++ + ++ + G + APE + +
Sbjct: 125 IHRDLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPF 219
K +DVWS G+ LY ++ G P+
Sbjct: 182 TIK-SDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-10
Identities = 60/227 (26%), Positives = 92/227 (40%), Gaps = 38/227 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEE--------------LVAVKYIERGDKIDENVQ- 65
+ L +G G FG L + E LVAVK + R D + + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RAD-VTKTARN 62
Query: 66 ---REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL------------FERICN 110
+EI L++PNI+R V ++ L ++ EY G+L F N
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--- 167
S + Q+ SG+ Y S+ HRDL N L+ +KI DFG S+
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLY 180
Query: 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 214
S + V ++A E +L ++ +DVW+ GVTL+ M
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-10
Identities = 62/216 (28%), Positives = 91/216 (42%), Gaps = 20/216 (9%)
Query: 19 DSDRYELVRDIGSGNFG-VAR--LMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D+ ++ R +G+G FG + R L K E VA+ + G DK E +
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
H NIVR + VI + IV EY S G L F R + G+ + L SG+
Sbjct: 63 FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMK 121
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG---YSKSSVLHS--QPKSTVGTPAYIA 186
Y M H+ L L++ KI F KS +++ KS V + A
Sbjct: 122 YLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPV---LWAA 176
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
PE + + +DVWS G+ ++ VM G P+ D
Sbjct: 177 PEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-10
Identities = 63/202 (31%), Positives = 89/202 (44%), Gaps = 39/202 (19%)
Query: 29 IGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFK 83
+G GNFG ++DK VAVK + D E + + R L+ HPNIV+
Sbjct: 3 LGKGNFGEVFKGTLKDKTP---VAVKTCKE-DLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHSM 136
V + IVME GG+ + R +DE + +QL+ +G++Y S
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESK 112
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 188
HRDL N L+ + LKI DFG S+ SS L P + APE
Sbjct: 113 NCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPE 164
Query: 189 VLLKKEYDGKIADVWSCGVTLY 210
L Y + +DVWS G+ L+
Sbjct: 165 ALNYGRYSSE-SDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 8e-10
Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 45/230 (19%)
Query: 21 DRYELVRDIGSGNFGVARL-----MRDKKTEE-----------LVAVKYIERGDKIDENV 64
R +G G FG L M ++ LVAVK + R D ++N
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDA-NKNA 62
Query: 65 Q----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC----------- 109
+ +EI L+ PNI+R V +T L ++ EY G+L + +
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 110 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
+ S F Q+ SG+ Y S+ HRDL N L+ + +KI DFG S++
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRN- 179
Query: 170 VLHS------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213
L+S Q ++ + +LL K +DVW+ GVTL+ +L
Sbjct: 180 -LYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA--SDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 8e-10
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 31/212 (14%)
Query: 25 LVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
L R++G G FG L + + +ELVAVK ++ + ++ +RE + +H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI--------------CNAGRFSEDEARFFF 123
NIV+F V +V EY G+L + + G + +
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
Q+ SG+ Y S HRDL N L+ +KI DFG S+ +++ VG
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSRD--VYTTDYYRVGGHT 184
Query: 184 -----YIAPEVLLKKEYDGKIADVWSCGVTLY 210
++ PE ++ +++ + +DVWS GV L+
Sbjct: 185 MLPIRWMPPESIMYRKFTTE-SDVWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 9e-10
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 26/218 (11%)
Query: 25 LVRDIGSGNFGVARLMR-----DKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 78
L R++G G FG L ++ + LVAVK + + D ++ RE +L+H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQ 125
IV+F V + L +V EY G+L + + G ++ + QQ
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 182
+ +G+ Y S HRDL N L+ + +KI DFG S+ S+ + T+
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ PE ++ +++ + +DVWS GV L+ + G P+
Sbjct: 187 RWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 65/247 (26%), Positives = 105/247 (42%), Gaps = 46/247 (18%)
Query: 29 IGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVR 81
+G G FG A ++ + VAVK ++ E ++ E + + HP++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FERIC---------------NAGRFSEDEARFFFQ 124
L +++EYA G L F R ++ + DE
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 125 QLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVL 171
LIS G+ Y M++ HRDL N L+ + ++KI DFG S+ S V
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSRDVYEEDSYVK 185
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNF 228
S+ + V ++A E L Y + +DVWS GV L+ ++ +G YP PE N
Sbjct: 186 RSKGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL 241
Query: 229 RKTIHRI 235
KT +R+
Sbjct: 242 LKTGYRM 248
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 72/271 (26%), Positives = 113/271 (41%), Gaps = 47/271 (17%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDENVQREI 68
DR L + +G G FG A + + VAVK + + D + E ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 69 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF------- 121
I +H NI+ V L +V+EYA+ G L + + A R + A
Sbjct: 72 IG----KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRPPE 126
Query: 122 ----------FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171
F Q+ G+ + S + HRDL N L+ + +KI DFG ++ +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--TEDHVMKIADFGLARD--I 182
Query: 172 HSQP---KSTVG-TPA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPE 223
H K+T G P ++APE L + Y + +DVWS GV L+ + +G YP E
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVE 241
Query: 224 EPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
E K +R+ Q + H+ +C H
Sbjct: 242 ELFKLLKEGYRMEKPQNCTQELYHLMRDCWH 272
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 24/220 (10%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINH 71
D L+R +G G FG + R E VAVK + D+ D ++ I++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS- 64
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERIC--NAGRFSE---DEARFFFQ 124
H NIVR V I++E +GG+L F R R S + F +
Sbjct: 65 -KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKS---SVLHSQPKSTVG 180
+ G Y HRD+ N LL R+ KI DFG ++ + + + +
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ PE L + K DVWS GV L+ + +G P+
Sbjct: 184 PIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 16/213 (7%)
Query: 24 ELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKIDENV---QREIINHRSLRHPN 78
EL +IG G N L R T LV V+ + + +E++ Q E++ RHPN
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60
Query: 79 IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
I+ V T + L ++ M Y S L + G SE + G++Y H
Sbjct: 61 IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQ 119
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEV 189
HR++K + L+ G L YS K+ V++ P+ + +++PE+
Sbjct: 120 NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179
Query: 190 LLKKEYDGKI-ADVWSCGVTLYVMLVGAYPFED 221
L + Y + +D++S G+T + G PF+D
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 71/272 (26%), Positives = 118/272 (43%), Gaps = 41/272 (15%)
Query: 21 DRYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRS 73
D+ L + +G G FG + +DK E + VAVK ++ D E ++++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEME 72
Query: 74 L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDEAR--- 120
+ +H NI+ L +++EYAS G L E + A R +S D AR
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDIARVPD 131
Query: 121 --FFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SS 169
F+ L+S G+ Y S + HRDL N L+ + +KI DFG ++ ++
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNN 189
Query: 170 VLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV---GAYPFEDPEEP 225
+ + + + P ++APE L + Y + +DVWS GV ++ + YP EE
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248
Query: 226 KNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
K HR+ + + +C H I
Sbjct: 249 FKLLKEGHRMDKPANCTNELYMMMRDCWHAIP 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 80/295 (27%), Positives = 123/295 (41%), Gaps = 57/295 (19%)
Query: 29 IGSGNFG-VARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 81
IG GNFG V R M K ++ A+K ++ + EN R+ + HPNI+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA---------RFFFQQLI----- 127
+L I +EYA G L + + + D A QQL+
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 128 --SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 183
+G+ Y Q HRDL N L+ + A KI DFG S+ ++ K T+G P
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMGRLPVR 183
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF----------EDP-----EEPKN 227
++A E L Y K +DVWS GV L+ ++ +G P+ + P E+P+N
Sbjct: 184 WMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRN 242
Query: 228 FRKTIHRILSV-----QYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277
++ ++ Y P + IS + +SR+ A A V+M Y
Sbjct: 243 CDDEVYELMRQCWRDRPYERPPFAQISVQ----LSRMLEARKAYVNMALFENFTY 293
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 8e-09
Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 33/217 (15%)
Query: 29 IGSGNFG-VARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 81
IG GNFG V + K + A+K ++ + ++ R+ + HPNI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 82 FKEVILTPTHLAIVMEYASGGELFE-----RIC-----------NAGRFSEDEARFFFQQ 125
+L + +EYA G L + R+ A S + F
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 183
+ G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+G P
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 176
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y +DVWS GV L+ ++ +G P+
Sbjct: 177 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-09
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 29/221 (13%)
Query: 25 LVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPN 78
L R++G G FG L + K + LVAVK ++ ++ QRE +L+H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FER--------------ICNAGRFSEDEARFF 122
IV+F V L +V EY G+L F R G +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTV 179
Q+ SG+ Y S HRDL N L+ + +KI DFG S+ S+ + T+
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRVGGHTM 186
Query: 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ PE ++ +++ + +DVWS GV L+ + G P+
Sbjct: 187 LPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 30/223 (13%)
Query: 24 ELVRDIGSGNFG-VAR----LMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRH 76
+ ++G G FG V + ++ + VA+K ++ K+ + ++E L+H
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFE------RICNAGRFSED-------EARFFF 123
PNIV V ++ EY + G+L E + G S D + F
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 124 Q---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKS 177
Q+ +G+ Y S HRDL N L+ +KI DFG S+ S+ +
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ ++ PE +L ++ + +D+WS GV L+ + G P+
Sbjct: 186 SLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 39/224 (17%)
Query: 25 LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREI-------INHRSL 74
L + +G G FG +L +D ++ VAVK + K+D + EI +
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDF 58
Query: 75 RHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLI- 127
HPN+++ V + L +++ + G+L + R + Q L+
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLK 117
Query: 128 ------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPK 176
G+ Y + HRDL N +L + +C DFG SK S + Q +
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSKKIYSGDYYRQGR 173
Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+IA E L + Y K +DVW+ GVT++ + G P+
Sbjct: 174 IAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 77/263 (29%), Positives = 115/263 (43%), Gaps = 37/263 (14%)
Query: 27 RDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
R IG G+FG L+ + AVK + R ++E Q +E I + HPN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 82 FKEVILTPTHLA-IVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVC 139
+ L +V+ Y G+L I + + + F Q+ G+ Y S +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120
Query: 140 HRDLKLENTLLDGSPAPRLKICDFG-----YSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
HRDL N +LD S +K+ DFG Y K S H+ K V ++A E L
Sbjct: 121 HRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALESLQ 175
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRILSVQYSIPDYV-- 246
+++ K +DVWS GV L+ +M GA YP D + + R+L +Y PD +
Sbjct: 176 TQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYC-PDPLYE 233
Query: 247 ------HISPECR----HLISRI 259
H PE R L+SRI
Sbjct: 234 VMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 54/217 (24%), Positives = 87/217 (40%), Gaps = 32/217 (14%)
Query: 29 IGSGNFGVARLMRDKKTEE-----LVAVKYIERGDKIDENVQ----REIINHRSLRHPNI 79
+G G FG L + K EE LV VK +++ DEN+Q RE+ R L H N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNV 70
Query: 80 VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GV 130
VR + +++EY G+L F R + +Q ++ G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 131 SYCHSMQVCHRDLKLENTLLDGS-----PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 185
+ + + HRDL N L+ L Y+ + ++
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSL--SKDVYNSEYYKLRNALIPL---RWL 185
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
APE + + ++ K +DVWS GV ++ V G PF
Sbjct: 186 APEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYG 221
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 29/218 (13%)
Query: 27 RDIGSGNFG------VARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPN 78
+IG+G FG R M + V VK + DE + +E+ +R L HPN
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKAR----VVVKELRASATPDEQLLFLQEVQPYRELNHPN 56
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL-----FERICNAGRFSEDEARFFFQQLISGVSYC 133
+++ + +V+E+ G+L R A +D + ++ SG+ +
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTP-AYIAPEVL 190
H H DL L N L + +KI D+G + + K P ++APE++
Sbjct: 117 HQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 191 LKKEYDGKIAD------VWSCGVTLYVML-VGAYPFED 221
+ D D +WS GVT++ + P+ D
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 74/270 (27%), Positives = 118/270 (43%), Gaps = 41/270 (15%)
Query: 22 RYELVRDIGSGNFGVARLM------RDKKTEEL-VAVKYIERGDKIDENVQREIINHRSL 74
R L + +G G FG + +DK + + VAVK + + D D+++ ++++ +
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLS-DLVSEMEM 70
Query: 75 -----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----EA 119
+H NI+ L +++EYAS G L E + A R +S D E
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEE 129
Query: 120 RFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL 171
+ F+ L+S G+ Y S + HRDL N L+ +KI DFG ++ +
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNI 187
Query: 172 HSQPKSTVGT-PA-YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV---GAYPFEDPEEPK 226
K+T G P ++APE L + Y + +DVWS GV L+ + YP EE
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
Query: 227 NFRKTIHRILSVQYSIPDYVHISPECRHLI 256
K HR+ + I EC H +
Sbjct: 247 KLLKEGHRMDKPANCTHELYMIMRECWHAV 276
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-08
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 83
+LV+ +G+G FG M VA+K +++G E E + L+HP +VR
Sbjct: 9 KLVKKLGAGQFGEV-WMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLY 67
Query: 84 EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 141
V+ T + I+ EY G L F + + + ++ Q+ G+++ HR
Sbjct: 68 AVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLKKEYDGK 198
DL+ N L+ S KI DFG ++ + ++ + G + APE + + K
Sbjct: 127 DLRAANILV--SETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 199 IADVWSCGVTLY-VMLVGAYPF---EDPEEPKNFRK 230
+DVWS G+ L ++ G P+ +PE +N +
Sbjct: 184 -SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER 218
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 28 DIGSGNFGVARL-----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 81
++G G FG L + ++ + LVAVK + E + ++ QRE L+H +IVR
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 82 FKEVILTPTHLAIVMEYASGGEL--FER-------------ICNAGRFSEDEARFFFQQL 126
F V L +V EY G+L F R G+ + + Q+
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 183
SG+ Y S+ HRDL N L+ +KI DFG S+ ++S VG
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRTMLP 187
Query: 184 --YIAPEVLLKKEYDGKIADVWSCGVTLY 210
++ PE +L +++ + +D+WS GV L+
Sbjct: 188 IRWMPPESILYRKFTTE-SDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-08
Identities = 52/228 (22%), Positives = 97/228 (42%), Gaps = 19/228 (8%)
Query: 39 LMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98
L+ D +T++ +K + + + + II H PN+V + I++ + +V+++
Sbjct: 11 LVMDTRTQQTFILKGLRKSSEYSRE-RLTIIPHCV---PNMVCLHKYIVSEDSVFLVLQH 66
Query: 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158
A GG+L+ I E+ + + +++ + H + RDL N LLD +L
Sbjct: 67 AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL 126
Query: 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 218
+S+ S + Y APEV E + + D WS G L+ +L G
Sbjct: 127 TY----FSRWSEVEDSCDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTGKTL 181
Query: 219 FEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
E N T+ +IP+ +S E R L+ ++ +P +
Sbjct: 182 VECHPSGINTHTTL--------NIPE--WVSEEARSLLQQLLQFNPTE 219
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-08
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ +L++ +G+G FG V + T+ VAVK ++ G E+ E + LRH +
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSE-----DEARFFFQQLISGVSYC 133
V+ V+ + + IV EY S G L + + + GR + D A Q+ +G++Y
Sbjct: 64 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYI 118
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 188
M HRDL+ N L+ KI DFG ++ L + T A + APE
Sbjct: 119 ERMNYIHRDLRSANILVGDGLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 173
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLV-GAYPF 219
L + K +DVWS G+ L ++ G P+
Sbjct: 174 AALYGRFTIK-SDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 14/139 (10%)
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K +
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGSAR 237
Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH---RI 235
P ++APE + K Y + +DVWS GV L+ + +GA P+ + + F + + R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 236 LSVQYSIPDYVHISPECRH 254
+ + + P+ I C
Sbjct: 297 RAPENATPEIYRIMLACWQ 315
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 23/204 (11%)
Query: 16 IMHDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL 74
I +S R E+ +G G FG V + T VA+K ++ G E +E + L
Sbjct: 3 IPRESLRLEV--KLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL 58
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE----DEARFFFQQLISGV 130
RH +V+ V+ + + IV EY S G L + + G + + Q+ SG+
Sbjct: 59 RHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGM 115
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YI 185
+Y M HRDL+ N L+ + K+ DFG ++ L + T A +
Sbjct: 116 AYVERMNYVHRDLRAANILVGENLV--CKVADFGLAR---LIEDNEYTARQGAKFPIKWT 170
Query: 186 APEVLLKKEYDGKIADVWSCGVTL 209
APE L + K +DVWS G+ L
Sbjct: 171 APEAALYGRFTIK-SDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 18/219 (8%)
Query: 24 ELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 82
+L + +G+G FG V +K T+ VAVK ++ G E E ++L+H +V+
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL 66
Query: 83 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V+ T + I+ E+ + G L F + + + F Q+ G+++ H
Sbjct: 67 HAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
RDL+ N L+ S + KI DFG ++ K + + APE + +
Sbjct: 126 RDLRAANILV--SASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAINFGSF 180
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH 233
K +DVWS G+ L ++ G P+ P+ R
Sbjct: 181 TIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 218
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 17/179 (9%)
Query: 42 DKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM-EYAS 100
D KT E V +K +RG E I+ R++ HP+I++ K +++ Y +
Sbjct: 113 DNKTCEHVVIKAGQRGGTATE---AHIL--RAINHPSIIQLKGTFTYNKFTCLILPRYKT 167
Query: 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160
+L+ + + + + ++ + Y H ++ HRD+K EN ++ P +
Sbjct: 168 --DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN-HPG---DV 221
Query: 161 C--DFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
C DFG + V + K GT A APE+L + Y G D+WS G+ L+ M
Sbjct: 222 CLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 43/139 (30%), Positives = 70/139 (50%), Gaps = 14/139 (10%)
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 236
Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNF-RKTIH--RI 235
P ++APE + K Y + +DVWS GV L+ + +GA P+ + + F R+ R+
Sbjct: 237 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295
Query: 236 LSVQYSIPDYVHISPECRH 254
+ +Y+ P+ I +C H
Sbjct: 296 RAPEYATPEIYSIMLDCWH 314
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 44/146 (30%), Positives = 62/146 (42%), Gaps = 20/146 (13%)
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGY------SKSSVLHSQP 175
+QL+S + Y H + HRD+K EN L++G IC DFG S S+ H
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN--FRKTI 232
TV T APEVL Y + D+WS G+ ++ V A F + + I
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI 378
Query: 233 HRILSVQYSIPDYVHISPECRHLISR 258
RI+ D R L+S+
Sbjct: 379 LRIIRQAQVHVDEFPQHAGSR-LVSQ 403
|
Length = 461 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 19/182 (10%)
Query: 49 VAVKYIERGDKIDENVQREIINHR----SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104
VA+K I+ D+ +EI +H SL H IVR + + L +V + + G L
Sbjct: 39 VAIKTIQ--DRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSL 95
Query: 105 FERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163
+ + + + Q+ G+ Y ++ HR+L N LL S + ++I DF
Sbjct: 96 LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK-SDS-IVQIADF 153
Query: 164 GYSKSSVLHSQPK----STVGTP-AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAY 217
G + +L+ K S TP ++A E +L Y + +DVWS GVT++ M+ GA
Sbjct: 154 GVA--DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAE 210
Query: 218 PF 219
P+
Sbjct: 211 PY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 40/139 (28%), Positives = 68/139 (48%), Gaps = 14/139 (10%)
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 180
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 242
Query: 181 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH---RI 235
P ++APE + + Y + +DVWS GV L+ + +GA P+ + + F + + R+
Sbjct: 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 236 LSVQYSIPDYVHISPECRH 254
+ Y+ P+ +C H
Sbjct: 302 RAPDYTTPEMYQTMLDCWH 320
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 52/240 (21%), Positives = 92/240 (38%), Gaps = 31/240 (12%)
Query: 41 RDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100
E V +K + + L H ++V+ V + ++ +V EY
Sbjct: 25 VGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVK 83
Query: 101 GGEL-----FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL----- 150
G L E+ + + D A +QL S + Y ++ H ++ +N L+
Sbjct: 84 FGPLDVFLHREKNNVSLHWKLDVA----KQLASALHYLEDKKLVHGNVCGKNILVARYGL 139
Query: 151 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA-DVWSCGVTL 209
+ P +K+ D G + + + + +IAPE + + IA D WS G TL
Sbjct: 140 NEGYVPFIKLSDPGIPITVLSREERVERI---PWIAPECIRNGQASLTIAADKWSFGTTL 196
Query: 210 Y-VMLVGAYPFE--DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
+ G P E + F + HR+ +PD E +LI++ + DP K
Sbjct: 197 LEICSNGEEPLSTLSSSEKERFYQDQHRL-----PMPD----CAELANLINQCWTYDPTK 247
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ R++++ +G G FG D+K +E AVK + K + + EI +R +
Sbjct: 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADP 187
Query: 80 V-RFKEVILT------PTHLAIVMEYASGGELFERICNAGRFSEDE-ARFFFQQLISGVS 131
RF + + H+ IVM G L + I G FS A+ FQ ++ +
Sbjct: 188 ADRFPLMKIQRYFQNETGHMCIVMP-KYGPCLLDWIMKHGPFSHRHLAQIIFQTGVA-LD 245
Query: 132 YCHS-MQVCHRDLKLENTLLDGS-------------PAP-RLKICDFGYSKSSVLHSQPK 176
Y H+ + + H DLK EN L++ S P P R++ICD G HS+
Sbjct: 246 YFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSR-T 303
Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+ V T Y +PEV+L + D+WS G +Y + G
Sbjct: 304 AIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-07
Identities = 60/217 (27%), Positives = 92/217 (42%), Gaps = 33/217 (15%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVK----YIERGDKIDENVQREIINHRSLRHPNIVR 81
IG GNFG AR+ +D + A+K Y + D D + E++ + HPNI+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLC-KLGHHPNIIN 72
Query: 82 FKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSEDEARFFFQQ 125
+L + +EYA G L + + A S + F
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 183
+ G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+G P
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 188
Query: 184 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y +DVWS GV L+ ++ +G P+
Sbjct: 189 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 51/211 (24%), Positives = 101/211 (47%), Gaps = 19/211 (9%)
Query: 23 YELVRDIGSGNFG-VARLMRDKKTEEL---VAVKYIERGD--KIDENVQREIINHRSLRH 76
++ ++ +GSG FG V + + + E++ VA+K + K ++ + E S+ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHS 135
P++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 69 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE 127
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVL 190
++ HRDL N L+ +KI DFG +K +L + K ++A E +
Sbjct: 128 RRLVHRDLAARNVLVKT--PQHVKITDFGLAK--LLGADEKEYHAEGGKVPIKWMALESI 183
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 220
L + Y + +DVWS GVT++ +M G+ P++
Sbjct: 184 LHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-07
Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 31/210 (14%)
Query: 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-------ENVQREIINHRSLRHP 77
L + +G G FG +M + ++ +K + KI E+ E + + HP
Sbjct: 3 LGKTLGEGEFG--SVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 78 NIVRFKEVILTPTHL------AIVMEYASGGEL-----FERICNAGRFSEDEARF-FFQQ 125
N++R V L +++ + G+L + R+ + ++ + F
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKSTVG 180
+ SG+ Y S HRDL N +L+ + + +C DFG SK + + Q +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNEN----MNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210
+IA E L + Y K +DVWS GVT++
Sbjct: 177 PVKWIAIESLADRVYTTK-SDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 26 VRDIGSGNFGVAR---LMRDKKTEEL-VAVKYIER--GDKIDENVQREIINHRSLRHPNI 79
V+ +GSG FG + + +T ++ VA+K + G K + E + S+ HP++
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQV 138
VR V L+PT + +V + G L + + + + Q+ G+ Y ++
Sbjct: 72 VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLKK 193
HRDL N L+ SP +KI DFG ++ +L K ++A E + +
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFE 220
++ + +DVWS GVT++ +M G P++
Sbjct: 187 KFTHQ-SDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 11/182 (6%)
Query: 41 RDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100
+ + V VK + G + REI +++ H I+ + + +VM
Sbjct: 114 HGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169
Query: 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160
+LF + +G ++A ++L+ ++Y H + HRD+K EN LD L
Sbjct: 170 C-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG- 227
Query: 161 CDFGYSKSSVLHS-QPKST--VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217
DFG + H P+ GT +PE+L Y K D+WS G+ L+ M V
Sbjct: 228 -DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNV 285
Query: 218 PF 219
Sbjct: 286 TL 287
|
Length = 392 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 64/232 (27%), Positives = 108/232 (46%), Gaps = 39/232 (16%)
Query: 21 DRYELVRDIGSGNFG-VARLMR---DKKTEE---LVAVKYIERGDKIDENVQREIINHRS 73
DR L + +G G FG V R DK + VAVK + + + D+++ ++I+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLA-DLISEME 69
Query: 74 L-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----E 118
L +H NI+ V L +++EYA+ G L E + A R ++ D E
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPE 128
Query: 119 ARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--S 169
+ F+ L+S G+ Y S + HRDL N L+ +KI DFG ++
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHD 186
Query: 170 VLHSQPKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ + + S P ++APE L + Y + +DVWS G+ ++ + +G P+
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 15/143 (10%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 178
F Q+ +G+ + S HRDL N L+ +KICDFG ++ + S ST
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGST 301
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKN--FRKTIHRI 235
++APE + Y ++DVWS G+ L+ + +G P+ PE P N F I R
Sbjct: 302 FLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPY--PELPMNEQFYNAIKR- 357
Query: 236 LSVQYSIPDYVHISPECRHLISR 258
Y + H S E ++ +
Sbjct: 358 ---GYRMAKPAHASDEIYEIMQK 377
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 64/261 (24%), Positives = 106/261 (40%), Gaps = 23/261 (8%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINH 71
+ + +G+G FG A + VAVK ++ E + +I++H
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 129
H NIV + ++ EY G+L F R + ++ F Q+ G
Sbjct: 95 LG-NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA-YIA 186
+++ S HRDL N LL + +KICDFG ++ + S K P ++A
Sbjct: 154 MAFLASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMA 211
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245
PE + Y + +DVWS G+ L+ + +G+ P+ F K I Y +
Sbjct: 212 PESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE----GYRMAQP 266
Query: 246 VHISPECRHLISRIFVADPAK 266
H E ++ + ADP K
Sbjct: 267 EHAPAEIYDIMKTCWDADPLK 287
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 26 VRDIGSGNFG-VARLMRDKKTEEL---VAVKYIERGD--KIDENVQREIINHRSLRHPNI 79
V+ +GSG FG V + + E + VA+K + K ++ + E + P +
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 71
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQV 138
R + LT T + +V + G L + + N R + + Q+ G+SY +++
Sbjct: 72 CRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRL 130
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLLKKEY 195
HRDL N L+ SP +KI DFG ++ + G ++A E +L + +
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFE 220
+ +DVWS GVT++ +M GA P++
Sbjct: 189 THQ-SDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 69/251 (27%), Positives = 105/251 (41%), Gaps = 43/251 (17%)
Query: 21 DRYELVRDIGSGNFGVARL-----MRDKKTEEL--VAVKYIER-------GDKIDENVQR 66
DR L + +G G FG + + +K + VAVK ++ D I E
Sbjct: 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 77
Query: 67 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED----- 117
++I +H NI+ L +++EYAS G L E R + +
Sbjct: 78 KMIG----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 118 EARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-S 169
E + F+ L+S G+ Y S + HRDL N L+ +KI DFG ++
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIH 191
Query: 170 VLHSQPKSTVGT-PA-YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV---GAYPFEDPEE 224
+ K+T G P ++APE L + Y + +DVWS GV L+ + YP EE
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEE 250
Query: 225 PKNFRKTIHRI 235
K HR+
Sbjct: 251 LFKLLKEGHRM 261
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 31/222 (13%)
Query: 23 YELVRDIGSGNFGVAR---LMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRH 76
+ L R +G G FG R L + + + VAVK ++ +++ RE + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 77 PNIVRFKEVIL---TPTHLAIVM---EYASGGELFERICNAGRFSEDEARFFFQQLI--- 127
PN+++ V L L I M + G+L + R E+ Q L+
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFM 119
Query: 128 ----SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKST 178
SG+ Y S HRDL N +L+ + + +C DFG SK S + Q ++
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNEN----MTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L Y +DVW+ GVT++ +M G P+
Sbjct: 176 KLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 4e-06
Identities = 23/56 (41%), Positives = 33/56 (58%), Gaps = 1/56 (1%)
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234
+GTP Y+APE+LL K + G D W+ GV L+ L G PF D + F+ ++R
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNR 595
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-06
Identities = 31/103 (30%), Positives = 52/103 (50%), Gaps = 9/103 (8%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
F Q+ G+ + S HRDL N LL + +KICDFG ++ ++H + G+
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLAR-DIMHDSNYVSKGS 298
Query: 182 P----AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++APE + Y ++DVWS G+ L+ + +G P+
Sbjct: 299 TFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPY 340
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 25/202 (12%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
I G G + + K VK I + I + EI + L+HPNIV+ + +
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS---EIADMGKLQHPNIVKLIGLCRS 754
Query: 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS------YCH-SMQVCHR 141
++ EY G L E + N E R +++ G++ +C S V
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRNLSW----ERR---RKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 201
+L E ++DG P L++ S +L + K + + AY+APE K+ K +D
Sbjct: 808 NLSPEKIIIDGKDEPHLRL-----SLPGLLCTDTKCFISS-AYVAPETRETKDITEK-SD 860
Query: 202 VWSCGVTLYVMLVGAYPFEDPE 223
++ G+ L +L G P D E
Sbjct: 861 IYGFGLILIELLTGKSP-ADAE 881
|
Length = 968 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 8e-06
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 27 RDIGSGNFGVARL--MRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRF 82
++IG+G FG L + T V VK + + E ++ E +RSL+H N+++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 83 KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ---QLISGVSYCHSMQ 137
T +VME+ G+L + R C + + ++ G+ + H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEV 189
H DL L N LL +KI D+G S H++ K +IAPE+
Sbjct: 121 FIHSDLALRNCLLTADLT--VKIGDYGLS-----HNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 190 LLKKEYDG--------KIADVWSCGVTLYVML-VGAYPF 219
+ E G K ++VWS GVT++ + +G+ P+
Sbjct: 174 V--DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 9e-06
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 39/203 (19%)
Query: 48 LVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 103
LVAVK I R D ++N + + + L+ PNI+R V + L ++ EY G+
Sbjct: 48 LVAVK-ILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 104 LFERICNAGRFSEDEAR--------------------FFFQQLISGVSYCHSMQVCHRDL 143
L + ++ + E Q+ SG+ Y S+ HRDL
Sbjct: 106 L-NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164
Query: 144 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLKKEYDGK 198
N L+ + +KI DFG S++ L++ + A ++A E +L ++
Sbjct: 165 ATRNCLVGENLT--IKIADFGMSRN--LYAGDYYRIQGRAVLPIRWMAWECILMGKFT-T 219
Query: 199 IADVWSCGVTLY--VMLVGAYPF 219
+DVW+ GVTL+ +ML P+
Sbjct: 220 ASDVWAFGVTLWEILMLCKEQPY 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 17/152 (11%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV 179
F Q+ G+S+ S HRDL N LL + KICDFG ++ S K
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 180 GTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTI---HR 234
P ++APE + Y + +DVWS G+ L+ + +G+ P+ F K I +R
Sbjct: 277 RLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335
Query: 235 ILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
+LS + + + I C + ADP K
Sbjct: 336 MLSPECAPSEMYDIMKSC-------WDADPLK 360
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 47/197 (23%), Positives = 89/197 (45%), Gaps = 29/197 (14%)
Query: 47 ELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102
+ VA+K ++ DK + E + E + L+HPNIV V+ L+++ Y S
Sbjct: 36 QAVAIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS 93
Query: 103 ELFERIC------NAGRFSEDE--------ARFF--FQQLISGVSYCHSMQVCHRDLKLE 146
+L E + + G +D+ A F Q+ +G+ + S V H+DL
Sbjct: 94 DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATR 153
Query: 147 NTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
N L+ +KI D G + ++ + +++ +++PE ++ ++ +D+W
Sbjct: 154 NVLV--FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIW 210
Query: 204 SCGVTLY-VMLVGAYPF 219
S GV L+ V G P+
Sbjct: 211 SYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 43/135 (31%), Positives = 63/135 (46%), Gaps = 12/135 (8%)
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQ 174
+D RF Q + G+ + S HRD+ N LL DG A KICDFG ++ + S
Sbjct: 212 DDLLRFSSQ-VAQGMDFLASKNCIHRDVAARNVLLTDGRVA---KICDFGLARDIMNDSN 267
Query: 175 --PKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 230
K P ++APE + Y + +DVWS G+ L+ + +G P+ F K
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326
Query: 231 TIHRILSVQYSIPDY 245
+ R Q S PD+
Sbjct: 327 MVKR--GYQMSRPDF 339
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 16/199 (8%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 88
+G G FG + T + VA+K ++ G + E +E + LRH +V V+ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-S 71
Query: 89 PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
+ IV E+ G L F + + + Q+ G++Y M HRDL+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAA 131
Query: 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLKKEYDGKIAD 201
N L+ + KI DFG ++ L + T A + APE L + K +D
Sbjct: 132 NILVGDNLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SD 185
Query: 202 VWSCGVTLYVMLV-GAYPF 219
VWS G+ L ++ G P+
Sbjct: 186 VWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 5e-05
Identities = 50/197 (25%), Positives = 87/197 (44%), Gaps = 28/197 (14%)
Query: 47 ELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104
+LVA+K ++ + + Q+E L HPNIV V+ + ++ EY + G+L
Sbjct: 35 QLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94
Query: 105 FERI----------CNAG-----RFSEDEARFFFQ--QLISGVSYCHSMQVCHRDLKLEN 147
E + C++ + S D F Q+ +G+ Y S H+DL N
Sbjct: 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN 154
Query: 148 TLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVW 203
L+ +KI D G S+ + QPKS + ++ PE ++ ++ +D+W
Sbjct: 155 ILI--GEQLHVKISDLGLSREIYSADYYRVQPKSLLPI-RWMPPEAIMYGKFSSD-SDIW 210
Query: 204 SCGVTLY-VMLVGAYPF 219
S GV L+ + G P+
Sbjct: 211 SFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-05
Identities = 41/170 (24%), Positives = 73/170 (42%), Gaps = 25/170 (14%)
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ----QL 126
+R L+HPNI++ + +V EY G+L + + Q ++
Sbjct: 49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI 108
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS----KSSVLHSQPKSTVGTP 182
+GV++ H H DL L N L +K+ D+G K + ++ V
Sbjct: 109 AAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPL- 165
Query: 183 AYIAPEVLLKKEYDG-------KIADVWSCGVTLYVMLVGAYPFEDPEEP 225
++APE L+ + + G K ++VW+ GVTL+ + FE+ +P
Sbjct: 166 RWLAPE-LVGEFHGGLITAEQTKPSNVWALGVTLWEL------FENAAQP 208
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 33/215 (15%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
++ L+R++G G+FG AR + + E VAVK + + E + E +N S+
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 63
Query: 76 HP----NIVRFKEVILTPTHLAIVMEYASGGEL--FERIC------NAGRFSE--DEARF 121
++VR V+ +VME + G+L + R N GR E
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 178
++ G++Y ++ + HRDL N ++ +KI DFG ++ + + +
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRDIYETDYYRKGGKG 181
Query: 179 VGTPAYIAPEVLLKKEYDGKI---ADVWSCGVTLY 210
+ ++APE L DG +D+WS GV L+
Sbjct: 182 LLPVRWMAPESL----KDGVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.002
Identities = 27/83 (32%), Positives = 39/83 (46%), Gaps = 13/83 (15%)
Query: 133 CHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+++ HR K N LL DG G SV P+ + P ++APEV+
Sbjct: 27 LGALRELHRQAKSGNILLTWDGLLKL------DG----SVAFKTPEQSRPDPYFMAPEVI 76
Query: 191 LKKEYDGKIADVWSCGVTLYVML 213
+ Y K AD++S G+TLY L
Sbjct: 77 QGQSYTEK-ADIYSLGITLYEAL 98
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 288 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.93 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.63 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.57 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.52 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.46 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.46 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.41 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.32 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.31 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.3 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.24 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.2 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.05 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.0 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.99 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.86 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.83 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.68 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.66 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.57 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.57 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.56 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.54 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.45 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.37 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.37 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.34 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.32 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.3 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.18 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.18 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.18 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.17 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.13 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.07 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.05 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.99 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.96 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.86 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.78 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.57 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.54 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.53 | |
| PLN02236 | 344 | choline kinase | 97.52 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.44 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.37 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.31 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.25 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.14 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.07 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.01 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.0 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.77 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.69 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.6 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.59 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.3 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.29 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.1 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.87 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-55 Score=360.21 Aligned_cols=267 Identities=37% Similarity=0.572 Sum_probs=230.7
Q ss_pred CCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc--------chHHHHHHHHHHhhCCCCceeeE
Q 023058 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--------IDENVQREIINHRSLRHPNIVRF 82 (288)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~ 82 (288)
.+..+.....+.|.+.+.||+|+||.|-+|..+.+++.||||++..... ....+.+|+++|++++|||||++
T Consensus 162 ~~~~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~ 241 (475)
T KOG0615|consen 162 SSKVPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRI 241 (475)
T ss_pred hccCccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEE
Confidence 4445555577899999999999999999999999999999999975321 22346799999999999999999
Q ss_pred eEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCC-CCCCEEEe
Q 023058 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKIC 161 (288)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~-~~~~~~l~ 161 (288)
+++|..++.+|+||||++||.|.+.+..++.+.+..-+.+++|++.|+.|||++||+||||||+||+++.+ ....+||+
T Consensus 242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 242 KDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred eeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999766 33469999
Q ss_pred ecCCCcccccCCCCCCCcCCCcccCCccccCcc--cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc
Q 023058 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239 (288)
Q Consensus 162 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (288)
|||++..........+.+|||.|.|||++.+.. +.+.+.|+|||||++|-+++|.+||........ ...++..+.
T Consensus 322 DFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---l~eQI~~G~ 398 (475)
T KOG0615|consen 322 DFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---LKEQILKGR 398 (475)
T ss_pred ccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---HHHHHhcCc
Confidence 999999888778888999999999999997654 344457999999999999999999987644332 334456667
Q ss_pred cCCC--CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 240 YSIP--DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 240 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+.+. .|..++++..+||.+||..||++|||+.++++ |+|+.
T Consensus 399 y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~---hpW~~ 441 (475)
T KOG0615|consen 399 YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN---HPWFK 441 (475)
T ss_pred ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc---Chhhh
Confidence 6554 46789999999999999999999999988866 77765
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-55 Score=352.54 Aligned_cols=257 Identities=29% Similarity=0.468 Sum_probs=227.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeec--CccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe-EEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIVM 96 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~ 96 (288)
....+.+..||+|..|+||+++|+.+++.+|+|++.. +....+.+.+|+++++.++|||||.+++.|..+.. ..++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 3578899999999999999999999999999999954 45556789999999999999999999999999984 99999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|||++|+|..++...+++++..+..++.++++||.|||+ .+|+||||||+||+++..+. +||||||.+...... ..
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-~a 234 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-IA 234 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-hc
Confidence 999999999999988999999999999999999999995 99999999999999987776 999999999876655 66
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCC-CCchhHHHHHHHHhhcc-cCCCCCCCCCHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIHRILSVQ-YSIPDYVHISPECR 253 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 253 (288)
.+..||-.|||||.+.+..|+.+ +||||||++++|+++|..||... .....+...+..+.... +.+|.. .++++++
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef~ 312 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEFR 312 (364)
T ss_pred ccccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHHH
Confidence 78889999999999999999988 99999999999999999999875 33345566666666644 455553 5999999
Q ss_pred HHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 254 HLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
+||..||+.||.+|||+.|+++ |+|+..
T Consensus 313 ~FV~~CL~Kdp~~R~s~~qLl~---Hpfi~~ 340 (364)
T KOG0581|consen 313 SFVSCCLRKDPSERPSAKQLLQ---HPFIKK 340 (364)
T ss_pred HHHHHHhcCCcccCCCHHHHhc---CHHHhh
Confidence 9999999999999999988876 555543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-54 Score=368.49 Aligned_cols=246 Identities=38% Similarity=0.614 Sum_probs=229.5
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeec----CccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER----GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
.+|...+.||+|||+.+|.+++..+|..||+|++.+ .....+.+.+|+++.++++|||||+++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 789999999999999999999999999999999987 5666778999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (288)
|.|..++|-.++...+++++.+++.+++||+.||.|||+.+|+|||||..|++++++.+ +||+|||+|...... ...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCccccc
Confidence 99999999999998899999999999999999999999999999999999999988877 999999999987765 455
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
.+.+|||.|.|||++.+...+-. +||||+||++|-|+.|.+||.. +.....+..+....+.+|. .++.+.++|
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFet----k~vkety~~Ik~~~Y~~P~--~ls~~A~dL 248 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFET----KTVKETYNKIKLNEYSMPS--HLSAEAKDL 248 (592)
T ss_pred ceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCccc----chHHHHHHHHHhcCccccc--ccCHHHHHH
Confidence 67789999999999998888777 9999999999999999999987 4567777778888999888 899999999
Q ss_pred HHHhcccCcCCccccccccc
Q 023058 256 ISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~ 275 (288)
|.++|++||.+|||+.++++
T Consensus 249 I~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 249 IRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHHHhcCCcccCCCHHHHhc
Confidence 99999999999999999988
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=340.96 Aligned_cols=254 Identities=36% Similarity=0.562 Sum_probs=220.8
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
+...++|.+.+.||+|+|++||+++++.++..||||.+... ....+.+..|+.+|+.++|||||.+++++..++.+|
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 34468999999999999999999999999999999999765 344556789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCC-CC---CCEEEeecCCCccc
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PA---PRLKICDFGYSKSS 169 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~-~~---~~~~l~df~~~~~~ 169 (288)
+|||||++|+|.++++..+.+++..++.++.||+.|+++||+++|+||||||+||+++.+ .. +.+||.|||+++..
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999999999999999999999999764 22 56999999999998
Q ss_pred ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
.+.....+.+|+|.|||||++....|+.+ +|+||+|+++|+|++|..||...+..+.+....+. ......++. .++
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~-~~~~~~~~~--~~s 241 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG-NEIVPVLPA--ELS 241 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc-ccccCchhh--hcc
Confidence 88888889999999999999999999999 99999999999999999999988776655533222 222222223 566
Q ss_pred HHHHHHHHHhcccCcCCcccccccc
Q 023058 250 PECRHLISRIFVADPAKVSMHFHAT 274 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l 274 (288)
....+++...|+.+|..|.+..+..
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhh
Confidence 6777899999999999888875443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-51 Score=330.51 Aligned_cols=245 Identities=36% Similarity=0.596 Sum_probs=217.3
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
....+.|++++.||.|+||+||.++.+++++.||+|++++. ....+...+|..++.+++||.||+++..|.+++.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 45678999999999999999999999999999999998764 34556788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc-cc
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VL 171 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~-~~ 171 (288)
|+|++|+.||.|...+++.+.+++..++.++..|+.||.|||+.||+||||||+|||++.+++ ++|+|||++... ..
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcccC
Confidence 999999999999999999999999999999999999999999999999999999999998887 999999999844 44
Q ss_pred CCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
+......+||+.|+|||++.+..++.. .|.||||+++|+|++|..||...+. .+....+.......+. ..++.+
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~----~~~~~~I~~~k~~~~p-~~ls~~ 252 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDV----KKMYDKILKGKLPLPP-GYLSEE 252 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccH----HHHHHHHhcCcCCCCC-ccCCHH
Confidence 455666799999999999999999888 9999999999999999999998654 3444444555522222 148999
Q ss_pred HHHHHHHhcccCcCCccc
Q 023058 252 CRHLISRIFVADPAKVSM 269 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt 269 (288)
.+++|.++|..||.+|..
T Consensus 253 ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 253 ARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred HHHHHHHHhccCHHHhcC
Confidence 999999999999999974
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=344.94 Aligned_cols=258 Identities=49% Similarity=0.783 Sum_probs=230.9
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----c--cchHHHHHHHHHHhhCC-CCceeeEeEEEEcC
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----D--KIDENVQREIINHRSLR-HPNIVRFKEVILTP 89 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 89 (288)
....++|++.+.||+|+||.|+.+.+..++..||+|++.+. . ...+.+.+|+.++++++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 35568999999999999999999999999999999977653 1 24556778999999998 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCC-CCCCEEEeecCCCcc
Q 023058 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKS 168 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~-~~~~~~l~df~~~~~ 168 (288)
..+++||||+.+|+|.+++.+.+++.+.+...+++|++.|++|+|+.||+||||||+||+++.+ ++ +||+|||++..
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~--~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN--LKLSDFGLSAI 170 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC--EEEeccccccc
Confidence 9999999999999999999998999999999999999999999999999999999999999988 55 99999999987
Q ss_pred c-ccCCCCCCCcCCCcccCCccccCcc-cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCC
Q 023058 169 S-VLHSQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (288)
Q Consensus 169 ~-~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
. .........+|++.|+|||++.+.. |+.+++|+||+|+++|.|++|..||...+. ......+....+.+|.+.
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~----~~l~~ki~~~~~~~p~~~ 246 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV----PNLYRKIRKGEFKIPSYL 246 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH----HHHHHHHhcCCccCCCCc
Confidence 7 4666778889999999999999988 998889999999999999999999998444 344444777888888853
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
. ++++++||++||..||.+|+|+.+++ .|+|++.
T Consensus 247 ~-S~~~~~Li~~mL~~~P~~R~t~~~i~---~h~w~~~ 280 (370)
T KOG0583|consen 247 L-SPEARSLIEKMLVPDPSTRITLLEIL---EHPWFQK 280 (370)
T ss_pred C-CHHHHHHHHHHcCCCcccCCCHHHHh---hChhhcc
Confidence 3 99999999999999999999997776 5888775
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=340.42 Aligned_cols=254 Identities=31% Similarity=0.530 Sum_probs=223.7
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCe
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 91 (288)
....+.|...+.||+|+|++|++|++..+++.||||++.+.. .-.+-+..|-+.|.+| +||+|++++-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 455689999999999999999999999999999999987642 2234466788888888 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
+|+|+||+++|+|.+++...+.|++...+.++.+|+.||+|||+.||+||||||+||+++.++. ++|+|||.+....+
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSP 226 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCCh
Confidence 9999999999999999999999999999999999999999999999999999999999998887 99999999874433
Q ss_pred CCCC--------------CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 023058 172 HSQP--------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237 (288)
Q Consensus 172 ~~~~--------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (288)
.... ....||..|.+||++.....+.. +|||+|||++|+|+.|.+||.+.++...+++ +..
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~-sDiWAlGCilyQmlaG~PPFra~NeyliFqk----I~~ 301 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS-SDLWALGCILYQMLAGQPPFRAANEYLIFQK----IQA 301 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc-cchHHHHHHHHHHhcCCCCCccccHHHHHHH----HHH
Confidence 2221 33568999999999988877776 9999999999999999999999877555555 466
Q ss_pred cccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc-cchh
Q 023058 238 VQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG-VYMH 279 (288)
Q Consensus 238 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~ 279 (288)
..+.+|. +.|+.+++||.++|..||.+|+|+.++.+ .|++
T Consensus 302 l~y~fp~--~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~ 342 (604)
T KOG0592|consen 302 LDYEFPE--GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFE 342 (604)
T ss_pred hcccCCC--CCCHHHHHHHHHHHccCccccccHHHHhhCcccc
Confidence 7888888 79999999999999999999999999888 4443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=321.69 Aligned_cols=248 Identities=31% Similarity=0.478 Sum_probs=213.3
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeE-EEEc-CCeEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKE-VILT-PTHLAI 94 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~-~~~~~l 94 (288)
-..|+|+++||.|+||+||+++...+|+.+|.|.++.+. ...+...+|+.+|++++|||||++++ .+.. ...+++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 467999999999999999999999999999999998654 33456889999999999999999988 3333 445899
Q ss_pred EEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhh--cC--ceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 95 VMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS--MQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~--~~--i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
|||+|+.|+|.+.++. .+.+++..+|.++.|++.||.++|. .. ++||||||.||+++.++. +||+|||++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~ 175 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLG 175 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccchhH
Confidence 9999999999888754 4469999999999999999999998 44 999999999999998887 999999999
Q ss_pred cccccCCC-CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccC-CCC
Q 023058 167 KSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPD 244 (288)
Q Consensus 167 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 244 (288)
+....... .....|||.||+||.+.+..|+.+ |||||+||++|||+..+.||.+. .+..+...+.++.++ +|
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd~~~~p- 249 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGDYPPLP- 249 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCCCCCCc-
Confidence 86655443 345679999999999999999988 99999999999999999999985 566777777777764 33
Q ss_pred CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 245 YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 245 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
...+|.++.++|..|+..||..||+...++.
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 2367899999999999999999999644443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-51 Score=320.06 Aligned_cols=259 Identities=24% Similarity=0.442 Sum_probs=216.4
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
+.|+.+.++|+|+||+||++++++||+.||||+|.-++. ..+-..+|+++|++++|+|+|.++++|...+.+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 679999999999999999999999999999999875433 23456799999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc-cCCCC
Q 023058 98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQP 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~-~~~~~ 175 (288)
||+. ++.+-++... ..+...+..+++|++.|+.++|+.+++||||||+||+++.++. +||||||+++... ++...
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcchh
Confidence 9977 5555555544 5899999999999999999999999999999999999998888 9999999999776 55555
Q ss_pred CCCcCCCcccCCccccC-cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc---------------
Q 023058 176 KSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------------- 239 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 239 (288)
.....|.+|.|||.+.+ .+|..+ .|||++||++.||++|+..|.+..+-+....+........
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~p-VDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKP-VDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCc-ccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 66778999999999988 556665 9999999999999999999999887666555543322111
Q ss_pred cCCCC----------CCCCCHHHHHHHHHhcccCcCCccccccccc-cchhhhhh
Q 023058 240 YSIPD----------YVHISPECRHLISRIFVADPAKVSMHFHATG-VYMHTKLQ 283 (288)
Q Consensus 240 ~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~~~~~ 283 (288)
..+|. +..++.-+.+|+..||..||.+|++.++++. .++..|.+
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 12222 2456678899999999999999999999988 55555544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=341.24 Aligned_cols=256 Identities=36% Similarity=0.690 Sum_probs=238.3
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
..+.|++.+.||.|+.|.|-+|++..||..+|||++... +.....+.+|+.+++.+.|||++++++++.....+|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 347899999999999999999999999999999998654 4455679999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
|.||+++|-|.+++-..+++++.+...+++||+.|+.|+|..+|+|||+||+|++++..++ |||+|||.|....++.-
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKL 167 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCcc
Confidence 9999999999999999999999999999999999999999999999999999999998887 99999999998888888
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
..+.+|+|+|.|||++.|.+|+..++||||-|+++|.|++|.+||.+ ++.+.++..+..+.+..|. +++.+.++
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~~G~f~MPs--~Is~eaQd 241 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQRGVFEMPS--NISSEAQD 241 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHHcCcccCCC--cCCHHHHH
Confidence 89999999999999999999999999999999999999999999985 6778888888889988886 89999999
Q ss_pred HHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 255 LISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
||.+||..||.+|.|.+|++. |+|++..
T Consensus 242 LLr~ml~VDp~~RiT~~eI~k---HP~l~g~ 269 (786)
T KOG0588|consen 242 LLRRMLDVDPSTRITTEEILK---HPFLSGY 269 (786)
T ss_pred HHHHHhccCccccccHHHHhh---CchhhcC
Confidence 999999999999999987755 7777643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=330.59 Aligned_cols=260 Identities=33% Similarity=0.535 Sum_probs=227.3
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
..+.|+++..||+|+||.||+|+.+.||+.||+|++.++. ...+.++.|-.+|....+|.||+++..|.+.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 5689999999999999999999999999999999998764 444678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc---
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 171 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~--- 171 (288)
||||++||++..++.+.+.|++..++.++.+++.|++.||+.|++||||||+|++||..|+ +||+|||++.....
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--Eeeccccccchhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999998887 99999999842110
Q ss_pred -------------------CCCC--------------------------CCCcCCCcccCCccccCcccCCCccchhhHH
Q 023058 172 -------------------HSQP--------------------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCG 206 (288)
Q Consensus 172 -------------------~~~~--------------------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG 206 (288)
.... ....|||.|+|||++.+..|+.. .|.||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-ccHHHHH
Confidence 0000 01248999999999999999888 9999999
Q ss_pred HHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 207 VTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 207 ~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
|++|||+.|.+||.+.+....+++++.. ...+.+|....++++.++||.+||+ ||.+|....-+-++-.|+||.-
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nw--r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNW--RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHH--hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 9999999999999998887777777544 3345677777889999999999998 9999998666666666777753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=333.81 Aligned_cols=258 Identities=31% Similarity=0.455 Sum_probs=220.9
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchH--HHHHHHHHHhhCC-CCceeeEeEEEEcCC-
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--NVQREIINHRSLR-HPNIVRFKEVILTPT- 90 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--~~~~e~~~l~~l~-~~~i~~~~~~~~~~~- 90 (288)
+..+..++|.++++||.|+||.||+|+...+++.||||.++..-...+ .-.+|+..|++++ ||||+++.+++.+.+
T Consensus 4 ~~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 4 TQVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred eehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 445667899999999999999999999999999999999876543333 3568999999998 999999999999887
Q ss_pred eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 91 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
.+++|||||+. +|.+++..++ .|++..++.|++||++||+|+|..|+.|||+||+||++..+.. +||+|||+|+..
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARev 160 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLAREV 160 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEeccccccccc
Confidence 99999999955 9999997654 5999999999999999999999999999999999999986666 999999999988
Q ss_pred ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-----------
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV----------- 238 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 238 (288)
...........|.+|.|||++....+-+...|+|++||+++|+.+-+..|.+.++.+.+.+++.=+...
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 887777788899999999998665544444999999999999999999999988877777766332221
Q ss_pred ----ccCCCC---------CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 239 ----QYSIPD---------YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 239 ----~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++.+|. ...++.+..++|.+|++.||.+|||+.++++
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 223332 1347789999999999999999999999988
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=321.56 Aligned_cols=250 Identities=34% Similarity=0.503 Sum_probs=208.0
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC--eEEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVM 96 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~ 96 (288)
..+|...+.||+|+||.||++.+..+|..+|+|.+...+ ...+.+.+|+.+|++++|||||++++...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 578999999999999999999999989999999987652 22456899999999999999999999855444 699999
Q ss_pred eccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC-CCCCCEEEeecCCCccccc---
Q 023058 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVL--- 171 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~-~~~~~~~l~df~~~~~~~~--- 171 (288)
||+++|+|.+++.+.+ .+++..+..+.+||++||.|||++|++|+||||+||+++. ++. +||+|||++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKGT 173 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCccccccccccc
Confidence 9999999999998877 7999999999999999999999999999999999999987 466 99999998876553
Q ss_pred -CCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCC-CCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 172 -HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 172 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
........||+.|+|||++..+....+.+|||||||++.||+||..||... ......... ......+.+|. .+|
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i--g~~~~~P~ip~--~ls 249 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI--GREDSLPEIPD--SLS 249 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH--hccCCCCCCCc--ccC
Confidence 222345679999999999986433334599999999999999999999864 211111111 11112235555 699
Q ss_pred HHHHHHHHHhcccCcCCccccccccc
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++.++||.+||..+|.+|||+.++|+
T Consensus 250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 250 DEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 99999999999999999999998877
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-49 Score=307.16 Aligned_cols=256 Identities=31% Similarity=0.556 Sum_probs=228.2
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
...++|++++.||.|+||.|.+++++.+|..||+|++.... ...+...+|..+|+.+.||.++++.+.+.+.+.++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 45589999999999999999999999999999999988653 44466889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
+||||++||.|..++.+.+++++...+.++.||+.||+|||+++|++|||||+|||+|.+|. +|++|||++.....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSG-- 196 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEecC--
Confidence 99999999999999999999999999999999999999999999999999999999998888 99999999985543
Q ss_pred CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
...+.+|||.|+|||.+....++.. .|-|+||+++|||+.|.+||...+. .+....+..+...+|. ..+.+++
T Consensus 197 rT~TlCGTPeYLAPEii~sk~ynka-vDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v~fP~--~fs~~~k 269 (355)
T KOG0616|consen 197 RTWTLCGTPEYLAPEIIQSKGYNKA-VDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKVKFPS--YFSSDAK 269 (355)
T ss_pred cEEEecCCccccChHHhhcCCCCcc-hhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCcccCCc--ccCHHHH
Confidence 3677889999999999999998776 9999999999999999999998665 5666677888999998 6899999
Q ss_pred HHHHHhcccCcCCcccccc--ccccchhhhhhh
Q 023058 254 HLISRIFVADPAKVSMHFH--ATGVYMHTKLQL 284 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~--~l~~~~~~~~~~ 284 (288)
+||+++|+.|-.+|..-.. .-++-.|+|+.-
T Consensus 270 dLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 270 DLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999999999943322 233555777653
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=321.07 Aligned_cols=262 Identities=34% Similarity=0.540 Sum_probs=219.9
Q ss_pred CCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---------------cchHHHHHHHHHHhhCCC
Q 023058 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------------KIDENVQREIINHRSLRH 76 (288)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------------~~~~~~~~e~~~l~~l~~ 76 (288)
.........++|++.+.||+|.||.|-+|++..+++.||||++.+.. ...++..+|+.+++++.|
T Consensus 88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H 167 (576)
T KOG0585|consen 88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH 167 (576)
T ss_pred cCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence 33444455689999999999999999999999999999999986421 223578999999999999
Q ss_pred CceeeEeEEEEcC--CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC
Q 023058 77 PNIVRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154 (288)
Q Consensus 77 ~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~ 154 (288)
||||+++++..+. +.+|+|+|||..|.+...-.....+.+.+.+.++++++.||+|||.+||+||||||+|++++.++
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence 9999999999875 58999999998887754443333489999999999999999999999999999999999999887
Q ss_pred CCCEEEeecCCCcccccCC------CCCCCcCCCcccCCccccC---cccCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 023058 155 APRLKICDFGYSKSSVLHS------QPKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (288)
Q Consensus 155 ~~~~~l~df~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~ 225 (288)
. +||.|||.+....... ......|||.|+|||...+ ..+..++.||||+|+++|.|+.|+.||-+...
T Consensus 248 ~--VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~- 324 (576)
T KOG0585|consen 248 T--VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE- 324 (576)
T ss_pred c--EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-
Confidence 6 9999999987553331 1234679999999999876 45677778999999999999999999987554
Q ss_pred hhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 226 KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
......+......+|....+.+++++||.+||++||.+|.++.++.. |+|.
T Consensus 325 ---~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~---Hpwv 375 (576)
T KOG0585|consen 325 ---LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL---HPWV 375 (576)
T ss_pred ---HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee---ccee
Confidence 44445567778888887788999999999999999999999977754 5554
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=330.25 Aligned_cols=253 Identities=34% Similarity=0.584 Sum_probs=226.4
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++|-+.+.||+|+||.||+++.+.+...||+|.+.+.. ...+.+.+|+++++.++||||+.++++|+....+|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 68999999999999999999999999999999997654 444668899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC-
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 176 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~- 176 (288)
|+.+ +|..+++..+.++++.+..++.+++.||.|||+.+|.|+|+||.||++..++. +|+||||+++.........
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceeee
Confidence 9977 99999999999999999999999999999999999999999999999998887 9999999999777655433
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (288)
...|||.|||||...+.+|+.. +|+|||||++||++.|++||.. ..+....+.+......+|. ..+..+..|+
T Consensus 159 sikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a----~si~~Lv~~I~~d~v~~p~--~~S~~f~nfl 231 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYA----RSITQLVKSILKDPVKPPS--TASSSFVNFL 231 (808)
T ss_pred eccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchH----HHHHHHHHHHhcCCCCCcc--cccHHHHHHH
Confidence 3459999999999999999888 9999999999999999999987 4456666677777777776 7899999999
Q ss_pred HHhcccCcCCccccccccc-cchhhhhh
Q 023058 257 SRIFVADPAKVSMHFHATG-VYMHTKLQ 283 (288)
Q Consensus 257 ~~~l~~~p~~Rpt~~~~l~-~~~~~~~~ 283 (288)
..+|..||.+|.|..+++. .|.+..+.
T Consensus 232 ~gLL~kdP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 232 QGLLIKDPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred HHHhhcChhhcccHHHHhcChHHhhhhh
Confidence 9999999999999988887 55555443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=321.18 Aligned_cols=256 Identities=31% Similarity=0.441 Sum_probs=214.6
Q ss_pred CCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcE-EEEEEeecCccc---hHHHHHHHHHHhhCCCCceeeEeEEEEcC
Q 023058 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEEL-VAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP 89 (288)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~-~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (288)
....+......+.+.||+|+||+||++... |.. ||+|++...... .+.+.+|+.++++++|||||++++++..+
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 344555677788888999999999999986 444 999998765433 45899999999999999999999999988
Q ss_pred C-eEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcC-ceecCCCCCceEecCCC-CCCEEEeecC
Q 023058 90 T-HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ-VCHRDLKLENTLLDGSP-APRLKICDFG 164 (288)
Q Consensus 90 ~-~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~-i~H~dl~p~nilv~~~~-~~~~~l~df~ 164 (288)
. .+++||||+++|+|.+++.. ...++...+..++.||+.|++|||+++ |+||||||+||+++.+. + +||+|||
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~--~KI~DFG 189 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKT--LKIADFG 189 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCE--EEECCCc
Confidence 7 79999999999999999988 578999999999999999999999999 99999999999999886 5 9999999
Q ss_pred CCcccccC-CCCCCCcCCCcccCCcccc--CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccC
Q 023058 165 YSKSSVLH-SQPKSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241 (288)
Q Consensus 165 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
+++..... .......||+.|||||++. +..++.+ +|+||+|+++|||++|..||...... .....+......
T Consensus 190 lsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~~----~~~~~v~~~~~R 264 (362)
T KOG0192|consen 190 LSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAPV----QVASAVVVGGLR 264 (362)
T ss_pred cceeeccccccccCCCCCccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhcCCC
Confidence 99866554 3334478999999999999 5678777 99999999999999999999987652 222223322322
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 242 IPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.+....+++.+..++.+||+.||.+||+..++...+.
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~ 301 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLE 301 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence 2223369999999999999999999999999877443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=327.45 Aligned_cols=249 Identities=28% Similarity=0.480 Sum_probs=220.8
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccch-HHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
...|....+||+|..|.||.|....++..||+|.+....... +-+.+|+.+++..+|+|||.+++.|..++.+|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 378999999999999999999999999999999998754433 4578999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CCCC
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~~~ 177 (288)
+++++|.+.+... .+++.++..+++.++.||+|||.+||+|||||.+||+++.++. +||+|||++....... ....
T Consensus 352 m~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred cCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCcccc
Confidence 9999998888554 5899999999999999999999999999999999999998888 9999999998776665 4456
Q ss_pred CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 023058 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (288)
..|||.|||||+.....|+.+ .||||||++++||+.|++||-..+. .+.++.-..++.+.+.....+++.+++|+.
T Consensus 429 mVGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~P---lrAlyLIa~ng~P~lk~~~klS~~~kdFL~ 504 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENP---LRALYLIATNGTPKLKNPEKLSPELKDFLD 504 (550)
T ss_pred ccCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCCh---HHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence 679999999999999999999 9999999999999999999987443 333333345556666666689999999999
Q ss_pred HhcccCcCCccccccccc
Q 023058 258 RIFVADPAKVSMHFHATG 275 (288)
Q Consensus 258 ~~l~~~p~~Rpt~~~~l~ 275 (288)
+||+.|+.+|+++.++|+
T Consensus 505 ~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 505 RCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHhhcchhcCCCHHHHhc
Confidence 999999999999999987
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=296.15 Aligned_cols=252 Identities=28% Similarity=0.437 Sum_probs=212.7
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc---hHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++|...+.||+|.||+||+|++..+|+.||||++...+.. .-...+|+..|+.++|+||+.++|+|.+.+.+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 6899999999999999999999999999999999876433 4578899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
|++. +|...+.... .++..+++.++.+++.||+|||+..|+|||+||.|++++.++. +||.|||+++...+.....
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCccc
Confidence 9955 8998886554 6999999999999999999999999999999999999998888 9999999999766555443
Q ss_pred -CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-CCCCC---------
Q 023058 177 -STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDY--------- 245 (288)
Q Consensus 177 -~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~--------- 245 (288)
...-|.+|.|||.+.|...-....|+||.||++.||+.|.+-|.+.++-+....+......... .+|+.
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 3468899999999987654344499999999999999999888887776665555443322221 22221
Q ss_pred ------------CCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 246 ------------VHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 246 ------------~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
..++.+..+|+..||.+||.+|+|+.|+++
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 235677899999999999999999999987
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=321.03 Aligned_cols=256 Identities=29% Similarity=0.492 Sum_probs=216.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcC--CeEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAI 94 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 94 (288)
.+.|+.+++||+|+||.||+|++..+|+.||+|++..+. .......+|+.+|++++||||+++.++.... +.+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 477999999999999999999999999999999997654 4445677999999999999999999999876 68999
Q ss_pred EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 95 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
|+|||+. +|..++...+ .|++.+++-+++||+.||+|+|++|++|||||.+||+++.++. +||+|||+++......
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSG 272 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCCC
Confidence 9999976 8888887644 7999999999999999999999999999999999999998888 9999999998655544
Q ss_pred C--CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc------CCCC-
Q 023058 174 Q--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY------SIPD- 244 (288)
Q Consensus 174 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~- 244 (288)
. .....-|.+|.|||.+.|..--..+.|+||.||++.||++|.+.|.+.++.+....+..-+-.... .+|.
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 3 344557999999999987654444499999999999999999999998887777766644332221 1221
Q ss_pred ----------------CCCCCHHHHHHHHHhcccCcCCccccccccc-cch
Q 023058 245 ----------------YVHISPECRHLISRIFVADPAKVSMHFHATG-VYM 278 (288)
Q Consensus 245 ----------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~ 278 (288)
....|+...+|+..||+.||.+|.|+.++++ .|+
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 1346788999999999999999999999988 444
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=313.08 Aligned_cols=258 Identities=25% Similarity=0.357 Sum_probs=212.3
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
.|++.+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.++++++|+|++++.+.+...+..+++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4889999999999999999999999999999987542 222357789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|+++++|...+... ..++...+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETV 158 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCee
Confidence 99999998777543 35899999999999999999999999999999999999987776 999999998765443334
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...............+......++. .+++++.+|
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~l 235 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE--KFSEDAKSI 235 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCc--cCCHHHHHH
Confidence 45568999999999988888777 999999999999999999998765544333343333333333333 688999999
Q ss_pred HHHhcccCcCCcccccc--ccccchhhhhhh
Q 023058 256 ISRIFVADPAKVSMHFH--ATGVYMHTKLQL 284 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~--~l~~~~~~~~~~ 284 (288)
|.+||+.||.+||++.+ +.+.+.|+|++.
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 99999999999998432 233455676653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=309.95 Aligned_cols=264 Identities=28% Similarity=0.415 Sum_probs=218.3
Q ss_pred CCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEc
Q 023058 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT 88 (288)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (288)
..........+.|++.+.||.|..++||+|+...++..||||++..+ +...+.+.+|+..++.++||||++++..|..
T Consensus 16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred cccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 34445566689999999999999999999999999999999998754 3446789999999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 89 PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
+..+|+||.+|.+|++.+++...- .+++..+..|+++++.||.|||++|.+|||||+.||+++.+|. ++|+|||.+
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvs 173 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVS 173 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceee
Confidence 999999999999999999997643 4899999999999999999999999999999999999999988 999999987
Q ss_pred cccccCCCC-----CCCcCCCcccCCcccc--CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc
Q 023058 167 KSSVLHSQP-----KSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239 (288)
Q Consensus 167 ~~~~~~~~~-----~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (288)
......+.. ....++++|+|||++. ...|+.+ +||||||++..||.+|..||........ +...+.+..
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfK-aDIwSfGITA~ELA~G~aPf~k~pPmkv---Ll~tLqn~p 249 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFK-ADIWSFGITACELAHGHAPFSKYPPMKV---LLLTLQNDP 249 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCccch-hhhhhhhHHHHHHhcCCCCcccCChHHH---HHHHhcCCC
Confidence 644443321 4457999999999953 4567777 9999999999999999999987644322 222222222
Q ss_pred c-------CCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 240 Y-------SIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 240 ~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+ +..+....+..++++|..||+.||.+|||+.+++. |+||+
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk---h~FFk 297 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK---HAFFK 297 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc---cHHHh
Confidence 2 22223446678999999999999999999988877 44444
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=320.46 Aligned_cols=241 Identities=32% Similarity=0.532 Sum_probs=208.7
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
..++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++..++..++
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 3589999999999999999999999999999999987542 334568899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
+|||+.+++|.+.+...+.+++..+..++.||+.||+|||+.|++|+||||+||+++.++. ++|+|||++......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCCC--
Confidence 9999999999999988888999999999999999999999999999999999999988776 999999998754322
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
.....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...... .....+......++. .+++.+++
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~----~~~~~i~~~~~~~p~--~~~~~~~~ 244 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPF----RIYEKILAGRLKFPN--WFDGRARD 244 (329)
T ss_pred cceecCChhhcCHHHHcCCCCCCc-ceeechHHHHHHHHcCCCCCCCCCHH----HHHHHHhcCCcCCCC--CCCHHHHH
Confidence 234568899999999988877666 99999999999999999999765432 233344445555554 58899999
Q ss_pred HHHHhcccCcCCcccc
Q 023058 255 LISRIFVADPAKVSMH 270 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~ 270 (288)
||.+||+.||.+||++
T Consensus 245 li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 245 LVKGLLQTDHTKRLGT 260 (329)
T ss_pred HHHHHhhcCHHHcCCC
Confidence 9999999999999984
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=303.41 Aligned_cols=258 Identities=34% Similarity=0.588 Sum_probs=222.4
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeec---CccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
....++|++.+.||+|.|++|+++.+..+|..+++|.+.. ....-+++.+|+.+.+.++||||+++++.+...+..+
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 3456899999999999999999999999999999998764 3446678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEec-CCCCCCEEEeecCCCcccccC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~-~~~~~~~~l~df~~~~~~~~~ 172 (288)
+|+|++.|++|-.-+-..-.+++..+-..++||+++|.|+|.+||||||+||+|+++- .+..+.+||+|||++.....+
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 9999999999965554445678888889999999999999999999999999999993 344446999999999887755
Q ss_pred CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCC--CCCCCCCH
Q 023058 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISP 250 (288)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 250 (288)
....-..|+|.|+|||++...+++.+ +|||+-|+++|-|+.|.+||.+.+....+ .++..+.+++ +.+..+++
T Consensus 167 ~~~~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~rly----e~I~~g~yd~~~~~w~~is~ 241 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLY----EQIKAGAYDYPSPEWDTVTP 241 (355)
T ss_pred cccccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHHHH----HHHhccccCCCCcccCcCCH
Confidence 55566779999999999999999887 99999999999999999999986654444 4455555544 45889999
Q ss_pred HHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
+.++||++||..||.+|.|+.|+|. |+|+
T Consensus 242 ~Ak~LvrrML~~dP~kRIta~EAL~---HpWi 270 (355)
T KOG0033|consen 242 EAKSLIRRMLTVNPKKRITADEALK---HPWI 270 (355)
T ss_pred HHHHHHHHHhccChhhhccHHHHhC---Cchh
Confidence 9999999999999999999988876 6665
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=315.54 Aligned_cols=253 Identities=35% Similarity=0.624 Sum_probs=228.8
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
..+|++.+.||.|.||.|-+|.....|+.||||.+.++. ...-.+.+|+++++.++||||+.++++|...+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 468999999999999999999998899999999988753 2333588999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|||..+|.|.+++.+.+.+++.+.+.+++||+.|+.|+|..+++|||||.+||++|.|++ +||.|||++-........
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFL 209 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHH
Confidence 999999999999999999999999999999999999999999999999999999998888 999999999888777778
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
.+.+|+|.|.+||...+.+|..+..|.||||+++|-|+.|.+||.+.+ ...+.+++.++.+.-|. -|.+..-|
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D----hk~lvrQIs~GaYrEP~---~PSdA~gL 282 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD----HKRLVRQISRGAYREPE---TPSDASGL 282 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch----HHHHHHHhhcccccCCC---CCchHHHH
Confidence 889999999999999999999888999999999999999999998855 45566666777776555 57788899
Q ss_pred HHHhcccCcCCccccccccccchhhh
Q 023058 256 ISRIFVADPAKVSMHFHATGVYMHTK 281 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~~~~~~~ 281 (288)
|++||-.||.+|-|++++..-|+-.|
T Consensus 283 IRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 283 IRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred HHHHHhcCcccchhHHHHhhhheeec
Confidence 99999999999999999877554444
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=316.94 Aligned_cols=249 Identities=32% Similarity=0.543 Sum_probs=212.0
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.++..+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999987542 23456788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
||+++++|.+++...+.+++..+..++.|++.||++||+.|++||||+|+||+++.++. ++|+|||++..... ...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~~--~~~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLRD--RTW 156 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEEecCcchhccC--Ccc
Confidence 99999999999988888999999999999999999999999999999999999987776 99999999875432 223
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (288)
...+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+... ....+......++. ..++.++++|
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~--~~~~~~~~li 229 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFG----IYEKILAGKLEFPR--HLDLYAKDLI 229 (291)
T ss_pred cccCChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCcCCCc--cCCHHHHHHH
Confidence 3468899999999988777666 999999999999999999998755433 33334444555555 5789999999
Q ss_pred HHhcccCcCCccc-----cccccccchhhhhh
Q 023058 257 SRIFVADPAKVSM-----HFHATGVYMHTKLQ 283 (288)
Q Consensus 257 ~~~l~~~p~~Rpt-----~~~~l~~~~~~~~~ 283 (288)
.+||+.||.+||+ +.+++ .|+|+.
T Consensus 230 ~~~l~~dp~~R~~~~~~~~~~~l---~h~~~~ 258 (291)
T cd05612 230 KKLLVVDRTRRLGNMKNGADDVK---NHRWFK 258 (291)
T ss_pred HHHcCCCHHHccCCccCCHHHHh---cCcccc
Confidence 9999999999996 65555 466664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=316.02 Aligned_cols=247 Identities=31% Similarity=0.520 Sum_probs=210.0
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCch
Q 023058 29 IGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (288)
Q Consensus 29 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 104 (288)
||+|+||.||++.+..+++.||+|++... ......+.+|+.++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999998753 23345677899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCCCCCcCCCc
Q 023058 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 183 (288)
Q Consensus 105 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~ 183 (288)
.+.+...+.++...+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++...... .......+++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcc
Confidence 999988888999999999999999999999999999999999999987776 999999998743222 22334568999
Q ss_pred ccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccC
Q 023058 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263 (288)
Q Consensus 184 ~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 263 (288)
|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.. .....+......++. .+++++.++|.+||+.|
T Consensus 159 y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~~----~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~d 231 (312)
T cd05585 159 YLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDENVN----EMYRKILQEPLRFPD--GFDRDAKDLLIGLLSRD 231 (312)
T ss_pred cCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCCHH----HHHHHHHcCCCCCCC--cCCHHHHHHHHHHcCCC
Confidence 999999988888776 99999999999999999999865432 333334444555555 68999999999999999
Q ss_pred cCCccccccccccchhhhhhh
Q 023058 264 PAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 264 p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
|.+||+..++.+.+.|+|+..
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCC
Confidence 999998777777777777654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=315.96 Aligned_cols=244 Identities=35% Similarity=0.562 Sum_probs=205.7
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (288)
+.||+|+||.||++.+..+++.||+|++.... .......+|+.++++++||||+++++++...+..++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999987532 23345778999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc-CCCCCCCcCC
Q 023058 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 181 (288)
Q Consensus 103 ~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~~ 181 (288)
+|...+...+.+++..+..++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++..... ........++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecC
Confidence 99999988888999999999999999999999999999999999999987776 99999999874322 2223345689
Q ss_pred CcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcc
Q 023058 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261 (288)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 261 (288)
+.|+|||.+.+..++.+ +|+|||||++|+|++|..||...+.. .....+......++. .+++++.++|.+||+
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~ 231 (323)
T cd05571 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEEIRFPR--TLSPEAKSLLAGLLK 231 (323)
T ss_pred ccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCCHH----HHHHHHHcCCCCCCC--CCCHHHHHHHHHHcc
Confidence 99999999988888776 99999999999999999999765432 222333444445554 689999999999999
Q ss_pred cCcCCcc-----ccccccccchhhhh
Q 023058 262 ADPAKVS-----MHFHATGVYMHTKL 282 (288)
Q Consensus 262 ~~p~~Rp-----t~~~~l~~~~~~~~ 282 (288)
.||.+|| ++.++++ |+|+
T Consensus 232 ~dP~~R~~~~~~~~~~ll~---h~~f 254 (323)
T cd05571 232 KDPKQRLGGGPEDAKEIME---HRFF 254 (323)
T ss_pred CCHHHcCCCCCCCHHHHHc---CCCc
Confidence 9999999 6666655 5554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=313.87 Aligned_cols=258 Identities=31% Similarity=0.520 Sum_probs=209.6
Q ss_pred CeeeeeeeeccCceEEEEEEEc---CCCcEEEEEEeecC-----ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeE
Q 023058 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERG-----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (288)
+|++.+.||+|+||.||++++. .+++.||+|++... ....+.+.+|+.+++.+ +|+||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998874 46889999998753 22335677899999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
++||||+++++|.+.+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCcccccc
Confidence 999999999999999988888999999999999999999999999999999999999988776 999999998754332
Q ss_pred CC--CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 173 SQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 173 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
.. .....+++.|+|||.+.+......++|+||||+++|+|++|..||...............+......++. .+++
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 236 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS--FIGP 236 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCH
Confidence 22 2234689999999998765533444999999999999999999997654444444444444444444444 6899
Q ss_pred HHHHHHHHhcccCcCCccccc--cccccchhhhhh
Q 023058 251 ECRHLISRIFVADPAKVSMHF--HATGVYMHTKLQ 283 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~--~~l~~~~~~~~~ 283 (288)
.+.++|.+||+.||.+||++. .+.+.+.|+|++
T Consensus 237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 271 (332)
T cd05614 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK 271 (332)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcC
Confidence 999999999999999999554 333344466554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=308.49 Aligned_cols=260 Identities=25% Similarity=0.400 Sum_probs=202.9
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
..++|++.+.||+|+||.||++.+..+++.||+|++.... .......+|+.++++++||||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 4589999999999999999999999999999999987543 22346778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CC
Q 023058 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~ 174 (288)
||+.+ +|.+.+... +.++...+..++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++...... ..
T Consensus 83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 159 (303)
T cd07869 83 EYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHT 159 (303)
T ss_pred ECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCcc
Confidence 99965 777666543 56899999999999999999999999999999999999987776 999999988643322 22
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc--cCC----------
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--YSI---------- 242 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~---------- 242 (288)
.....+++.|+|||.+.+......++|+||||+++|+|++|..||....+............... ..+
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 23456788999999987654334449999999999999999999987543222111111100000 000
Q ss_pred --------C-------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 243 --------P-------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 243 --------~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
+ .....++++.+||.+||+.||.+|||+.++++ |+|+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~---h~~f~~ 293 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS---HEYFSD 293 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc---Cccccc
Confidence 0 00124578899999999999999999988876 666543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=314.32 Aligned_cols=248 Identities=30% Similarity=0.474 Sum_probs=210.0
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++++++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999987542 23356788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
||+++++|.+++...+.+++..+..++.||+.||.+||+.|++||||+|+||+++.++. ++|+|||++..... ...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YAN 156 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccC
Confidence 99999999999988888999999999999999999999999999999999999987776 99999999875433 334
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCC----CCCCHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY----VHISPEC 252 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l 252 (288)
...+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+............ .....+.. ..+++++
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~s~~~ 233 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK--ETLQRPVYDDPRFNLSDEA 233 (333)
T ss_pred CcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc--ccccCCCCCccccccCHHH
Confidence 4568999999999988877766 999999999999999999998765433333322111 11111211 2468999
Q ss_pred HHHHHHhcccCcCCccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.++|.+||+.+|.+||++.+++.
T Consensus 234 ~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 234 WDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred HHHHHHHhhChhhhcCCHHHHHh
Confidence 99999999999999999988876
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=319.00 Aligned_cols=256 Identities=32% Similarity=0.542 Sum_probs=209.1
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++.+.||.|+||+||++++..+++.||+|++.... .....+.+|+.+++.++||||+++++++..+..+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997542 33345778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC--
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-- 174 (288)
||+.+++|.+++...+.+++..+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccc
Confidence 99999999999988888999999999999999999999999999999999999988777 99999998864322110
Q ss_pred -------------------------------------CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCC
Q 023058 175 -------------------------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217 (288)
Q Consensus 175 -------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~ 217 (288)
.....||+.|+|||.+.+..++.+ +|+|||||++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCCC
Confidence 012358999999999988888766 999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 218 PFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 218 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
||...+.......... ......++....+++++.++|.+||. +|.+|++...+.+.+.|+|+
T Consensus 238 Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~ 299 (364)
T cd05599 238 PFCSDNPQETYRKIIN--WKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299 (364)
T ss_pred CCCCCCHHHHHHHHHc--CCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCc
Confidence 9987654332222211 11223444444678999999999996 99999983333334445554
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=309.33 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=210.7
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
..++|++.+.||.|+||.||++++..++..+++|.+.... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 3589999999999999999999999999999999987642 33457889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc-CceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||||+||+++.++. ++|+|||++...... ..
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~-~~ 159 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-MA 159 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCccccccccc-cc
Confidence 9999999999998888899999999999999999999986 5999999999999988776 999999988754322 22
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH--------------------------
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR-------------------------- 229 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~-------------------------- 229 (288)
....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+......
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence 34568899999999988877776 999999999999999999997543211110
Q ss_pred ----------------HHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 230 ----------------KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 230 ----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.....+.............++++.+||.+||+.||++|||+.++++ |+|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~---h~~~~ 305 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN---HTFIK 305 (331)
T ss_pred cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc---ChHHh
Confidence 0011111111111112246889999999999999999999998876 55554
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=311.90 Aligned_cols=258 Identities=38% Similarity=0.601 Sum_probs=228.1
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCC-CCceeeEeEEEEcCCe
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTH 91 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 91 (288)
......|++.+.||.|.||.||.+++..+|+.+|+|.+.+.. ...+.+.+|+.+++++. ||||+.+.+.|.+...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 344578999999999999999999999999999999997643 24468999999999998 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC--CCCEEEeecCCCccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSS 169 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~--~~~~~l~df~~~~~~ 169 (288)
+++|||++.|+.|.+.+... .+++.....++.|++.++.|||+.|++|+|+||+|+++.... .+.++++|||++...
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999988776 499999999999999999999999999999999999997553 346999999999987
Q ss_pred ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc--CCCCCCC
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVH 247 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 247 (288)
..........|++.|+|||++....++.. .|+||+|+++|.|++|..||...+.......+ ..+.+ ..+.+..
T Consensus 190 ~~~~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i----~~~~~~f~~~~w~~ 264 (382)
T KOG0032|consen 190 KPGERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLAI----LRGDFDFTSEPWDD 264 (382)
T ss_pred cCCceEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHH----HcCCCCCCCCCccc
Confidence 77556677889999999999988888888 99999999999999999999998876665543 44444 4556778
Q ss_pred CCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
++..++++|+.||..||.+|+|+.++++ |+|+.
T Consensus 265 is~~akd~i~~ll~~dp~~R~ta~~~L~---HpWi~ 297 (382)
T KOG0032|consen 265 ISESAKDFIRKLLEFDPRKRLTAAQALQ---HPWIK 297 (382)
T ss_pred cCHHHHHHHHHhcccCcccCCCHHHHhc---Ccccc
Confidence 9999999999999999999999999987 77765
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=305.19 Aligned_cols=258 Identities=27% Similarity=0.425 Sum_probs=205.6
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
..++|++.+.||.|+||.||++.+..++..||+|.+.... .....+.+|+.++++++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 3478999999999999999999999999999999986542 23446779999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-C
Q 023058 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~ 174 (288)
|++++ +|.+.+...+ .++...+..++.||+.||++||+.||+||||||+||+++.++. ++|+|||++....... .
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKT 159 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCcc
Confidence 99976 8888876544 5789999999999999999999999999999999999987776 9999999987543322 2
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc---------------
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------------- 239 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 239 (288)
.....+++.|+|||.+.+......++|+||+|+++|+|++|..||...+..+.............
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 23446788999999987644334449999999999999999999987654333332222111000
Q ss_pred cCCCC---------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 240 YSIPD---------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 240 ~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
..++. ...+++++.+||.+||+.||.+|||+.|+++ |+|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~---hp~f 288 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR---HSYF 288 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc---CCCC
Confidence 00111 1246789999999999999999999988876 5553
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=286.32 Aligned_cols=260 Identities=34% Similarity=0.566 Sum_probs=231.6
Q ss_pred CCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEE
Q 023058 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVI 86 (288)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (288)
|+.....-..++|++.+.||.|.||.||.|+...++-.+|+|++.+++ .....+.+|+++.+.++||||++++++|
T Consensus 12 ~~~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 12 GSRATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred ccccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 555556666799999999999999999999999999999999998754 4456788999999999999999999999
Q ss_pred EcCCeEEEEEeccCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecC
Q 023058 87 LTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (288)
Q Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~ 164 (288)
.+....|+++||...+.+...++ ...++++.....+.+|++.|+.|+|..+++||||||+|++++..+. +|+.|||
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfG 169 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFG 169 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCC
Confidence 99999999999999999999998 5567999999999999999999999999999999999999988877 9999999
Q ss_pred CCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC
Q 023058 165 YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244 (288)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (288)
.+.... .......+||..|.+||...+...+.. .|+|++|++.||++.|..||.... ....++.+......+|.
T Consensus 170 wsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~----~~etYkrI~k~~~~~p~ 243 (281)
T KOG0580|consen 170 WSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQS----HSETYKRIRKVDLKFPS 243 (281)
T ss_pred ceeecC-CCCceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhh----hHHHHHHHHHccccCCc
Confidence 987554 555677889999999999999999888 999999999999999999998865 34555566777888885
Q ss_pred CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 245 YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 245 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.++.+.+++|++||..+|.+|.+..|+++ |+|..
T Consensus 244 --~is~~a~dlI~~ll~~~p~~r~~l~~v~~---hpwI~ 277 (281)
T KOG0580|consen 244 --TISGGAADLISRLLVKNPIERLALTEVMD---HPWIV 277 (281)
T ss_pred --ccChhHHHHHHHHhccCccccccHHHHhh---hHHHH
Confidence 89999999999999999999999977765 66654
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=312.39 Aligned_cols=249 Identities=30% Similarity=0.476 Sum_probs=210.6
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEcCCC-cEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCC
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (288)
.....++|++.+.||+|+||.||+|.+..++ ..||+|.+... ....+.+.+|+.+++.++||||+++++++..++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4445689999999999999999999876554 68999998653 233456788999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.+++||||+.+++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~ 182 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVD 182 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCeecC
Confidence 99999999999999999988888999999999999999999999999999999999999987776 9999999987543
Q ss_pred cCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
. ......+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+.... ...+......++. .+++
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~~~ 253 (340)
T PTZ00426 183 T--RTYTLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEPLLI----YQKILEGIIYFPK--FLDN 253 (340)
T ss_pred C--CcceecCChhhcCHHHHhCCCCCcc-ccccchhhHHHHHhcCCCCCCCCCHHHH----HHHHhcCCCCCCC--CCCH
Confidence 2 2234568999999999988777666 9999999999999999999987554322 2333444444554 6889
Q ss_pred HHHHHHHHhcccCcCCcc-----ccccccc
Q 023058 251 ECRHLISRIFVADPAKVS-----MHFHATG 275 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rp-----t~~~~l~ 275 (288)
.+.++|++||+.||.+|+ ++.++++
T Consensus 254 ~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 254 NCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred HHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 999999999999999996 6777665
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=305.57 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=206.3
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++|++.+.||+|+||.||++++..++..||+|++.... ...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999999999999999987542 334567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC--C
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~--~ 175 (288)
|++++.+..+......++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccccc
Confidence 9988776655555567999999999999999999999999999999999999987776 99999999876533222 2
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh----------c-----cc
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS----------V-----QY 240 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------~-----~~ 240 (288)
....+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+..+........... . ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGKA-VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCCCCc-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 23457889999999988777666 99999999999999999999876543332222111000 0 00
Q ss_pred CCCC-----------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 241 SIPD-----------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 241 ~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
.++. ...+|+++.+||.+||+.||.+|||+.++++ |+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~---hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN---HPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc---CCCC
Confidence 0111 1136788999999999999999999988866 6653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=317.00 Aligned_cols=249 Identities=34% Similarity=0.542 Sum_probs=212.1
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|.+.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 57999999999999999999999999999999987542 34456788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC---
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~--- 173 (288)
||+++++|.+++...+.++...++.++.||+.||++||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccc
Confidence 99999999999988888999999999999999999999999999999999999988776 9999999987544333
Q ss_pred ---------------------------CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 023058 174 ---------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (288)
Q Consensus 174 ---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~ 226 (288)
......+++.|+|||.+.+..++.. +|||||||++|+|++|..||...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCHHH
Confidence 2234458999999999988888777 999999999999999999998766433
Q ss_pred hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccc-cccccc
Q 023058 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSM-HFHATG 275 (288)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-~~~~l~ 275 (288)
........ .....++....+++++.++|.+||+ ||.+||+ +.+++.
T Consensus 238 ~~~~i~~~--~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 238 TYNKIINW--KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred HHHHHhcc--CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 33332211 1233455544579999999999997 9999999 888876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=290.59 Aligned_cols=257 Identities=26% Similarity=0.395 Sum_probs=214.5
Q ss_pred CCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcC---
Q 023058 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP--- 89 (288)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 89 (288)
-...++.++|++.+.||+|||+.||+++.-.+++.||+|++.... ...+...+|++..++++|||+++++++...+
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 345678899999999999999999999999999999999998765 6777899999999999999999998876544
Q ss_pred --CeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC--ceecCCCCCceEecCCCCCCEEEe
Q 023058 90 --THLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKIC 161 (288)
Q Consensus 90 --~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~--i~H~dl~p~nilv~~~~~~~~~l~ 161 (288)
...|++++|...|+|.+.+... ..+++.+++.|+.++++||++||+.. ++|+||||.||++++++. +++.
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl~ 171 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVLM 171 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEEE
Confidence 3489999999999999887642 36999999999999999999999999 999999999999988776 9999
Q ss_pred ecCCCcccccCCCCCC----------CcCCCcccCCccccC---cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 023058 162 DFGYSKSSVLHSQPKS----------TVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (288)
Q Consensus 162 df~~~~~~~~~~~~~~----------~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~ 228 (288)
|||.++.....-.... ...+..|.|||.+.- ...+.+ +|||||||++|.|+.|..||...-....
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~er-tDIWSLGCtLYa~mf~~sPfe~~~~~Gg- 249 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITER-TDIWSLGCTLYAMMFGESPFERIYQQGG- 249 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccc-cchhhhhHHHHHHHHcCCcchHHhhcCC-
Confidence 9999876554433322 237889999999853 334455 9999999999999999999974322110
Q ss_pred HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
...-.+.+..+.+|+....|+.+.++|.+||+.||.+||++.+++.
T Consensus 250 -SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~ 295 (302)
T KOG2345|consen 250 -SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLS 295 (302)
T ss_pred -eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 0112345567788888889999999999999999999999988865
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=315.32 Aligned_cols=261 Identities=28% Similarity=0.412 Sum_probs=224.7
Q ss_pred CCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcC
Q 023058 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (288)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (288)
...........|...+.||.|+||.||++.+..+++.||+|++.... ...+++.+|+.++.+++++||.++++.+..+
T Consensus 4 ~~~~~~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g 83 (467)
T KOG0201|consen 4 SDVLKIDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG 83 (467)
T ss_pred chhhcCCcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec
Confidence 33444556688999999999999999999999999999999998754 4456899999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
..++++||||.+|++.+.+.....+.+..+.-++++++.|+.|||..+.+|+|||+.||++..++. ++|+|||.+.+.
T Consensus 84 ~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql 161 (467)
T KOG0201|consen 84 TKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQL 161 (467)
T ss_pred ccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeee
Confidence 999999999999999999988888899999999999999999999999999999999999998876 999999998765
Q ss_pred ccCCC-CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCC
Q 023058 170 VLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 170 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
..... .....|||.|||||++....|+.+ +||||||++.+||++|.+|+........... +....+...+. .+
T Consensus 162 ~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmrvlfl----Ipk~~PP~L~~-~~ 235 (467)
T KOG0201|consen 162 TNTVKRRKTFVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMRVLFL----IPKSAPPRLDG-DF 235 (467)
T ss_pred echhhccccccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcceEEEe----ccCCCCCcccc-cc
Confidence 55433 367789999999999998899999 9999999999999999999988766332221 22222222222 78
Q ss_pred CHHHHHHHHHhcccCcCCccccccccc-cchhh
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATG-VYMHT 280 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~~ 280 (288)
++.+++||..||+.||+.||++.+++. .|+++
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 899999999999999999999999988 55544
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=298.68 Aligned_cols=260 Identities=31% Similarity=0.461 Sum_probs=212.0
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEee---cCccchHHHHHHHHHHhhCCCCceeeEeEEEEcC-----C
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSLRHPNIVRFKEVILTP-----T 90 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 90 (288)
....|...+.||.|.||.|+.|.++.+|+.||+|++. ......++..+|+.+++.++|+||+.+.+++..+ .
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3466777899999999999999999999999999987 3456678899999999999999999999998762 4
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.+|+|+|+| +.+|...+..+..+++..+..+++|++.||.|+|+.|++||||||.|++++.+.. .|++|||+++...
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLD 176 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeecc
Confidence 789999999 5599999988888999999999999999999999999999999999999977766 9999999999765
Q ss_pred cC---CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH-------------
Q 023058 171 LH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR------------- 234 (288)
Q Consensus 171 ~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~------------- 234 (288)
.. ........|.+|.|||.+.+...-+++.||||.||++.||++|...|.+.+..+....+..-
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 43 22234567899999999865544455599999999999999999999876553333322211
Q ss_pred ------HhhcccCCCC------CCCCCHHHHHHHHHhcccCcCCccccccccc-cchhhh
Q 023058 235 ------ILSVQYSIPD------YVHISPECRHLISRIFVADPAKVSMHFHATG-VYMHTK 281 (288)
Q Consensus 235 ------~~~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~~~ 281 (288)
........+. ..++++...+|+.+||..||.+|+|++|+++ +++..+
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 1111111111 2467899999999999999999999999988 555443
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=303.71 Aligned_cols=249 Identities=25% Similarity=0.363 Sum_probs=208.3
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
+|++.+.||+|+||+||++.+..+++.||+|++.... .....+.+|+.++++++||||+++++.+..+...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 5899999999999999999999899999999987542 222346789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|+.+++|...+... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--IRISDLGLAVEIPEGETI 158 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--EEEeeCCCceecCCCCcc
Confidence 99999998877543 35899999999999999999999999999999999999987776 999999998765443333
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....+++.|+|||.+.+..++.+ +|+||+|+++|++++|..||...............+.......+. .+++.+.++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 235 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAARSI 235 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCc--ccCHHHHHH
Confidence 44568899999999988777776 999999999999999999998766544444444444433333333 588999999
Q ss_pred HHHhcccCcCCcc-----ccccccc
Q 023058 256 ISRIFVADPAKVS-----MHFHATG 275 (288)
Q Consensus 256 i~~~l~~~p~~Rp-----t~~~~l~ 275 (288)
|.+||+.||.+|| ++.+++.
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 236 CRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred HHHHccCCHHHhcCCCCCCHHHHhc
Confidence 9999999999999 5656655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=317.81 Aligned_cols=253 Identities=29% Similarity=0.500 Sum_probs=207.5
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|.+++.||+|+||.||++.+..+++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999986532 23356788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC--
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-- 174 (288)
||+++++|.+++...+.+++..+..++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeecccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987776 99999998853211000
Q ss_pred ----------------------------------------------CCCCcCCCcccCCccccCcccCCCccchhhHHHH
Q 023058 175 ----------------------------------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVT 208 (288)
Q Consensus 175 ----------------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 208 (288)
.....+++.|+|||.+.+..++.+ +|+|||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEecchh
Confidence 002358899999999988888766 999999999
Q ss_pred HHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCcc---ccccccccchhhhh
Q 023058 209 LYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVS---MHFHATGVYMHTKL 282 (288)
Q Consensus 209 ~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~~l~~~~~~~~ 282 (288)
+|+|++|..||............... .....++....++.++.+||.+||. +|.+|+ ++.+++. |+|+
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~---hp~~ 308 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINW--RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS---HPFF 308 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHcc--CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc---CCCc
Confidence 99999999999876543333332211 2233455555688999999999997 777765 7766655 5554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=309.87 Aligned_cols=240 Identities=34% Similarity=0.567 Sum_probs=202.4
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (288)
+.||+|+||.||++++..++..||+|++.... .....+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999999999999999987532 23345678999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCCCCCcCC
Q 023058 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 181 (288)
Q Consensus 103 ~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~ 181 (288)
+|...+.....+++..++.++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++...... .......++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCC
Confidence 99998888888999999999999999999999999999999999999987776 999999987643222 222345689
Q ss_pred CcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcc
Q 023058 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261 (288)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 261 (288)
+.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+..... ..+......++. .+++++.++|.+||+
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~~~----~~~~~~~~~~p~--~~~~~~~~li~~~L~ 231 (323)
T cd05595 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSPEAKSLLAGLLK 231 (323)
T ss_pred cCcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCCCCCC--CCCHHHHHHHHHHcc
Confidence 99999999988888766 99999999999999999999865543322 233334444554 689999999999999
Q ss_pred cCcCCcc-----ccccccc
Q 023058 262 ADPAKVS-----MHFHATG 275 (288)
Q Consensus 262 ~~p~~Rp-----t~~~~l~ 275 (288)
.||.+|+ ++.++++
T Consensus 232 ~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 232 KDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCHHHhCCCCCCCHHHHHc
Confidence 9999998 6655554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=300.66 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=207.4
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCch
Q 023058 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (288)
Q Consensus 29 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 104 (288)
||+|+||.||++.+..+++.|++|.+.... ........|++++++++||||+++.+++..+...+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999999999999999986432 1223455699999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCcCCC
Q 023058 105 FERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182 (288)
Q Consensus 105 ~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 182 (288)
.+.+.... .++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++.............+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTN 158 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCC
Confidence 88875543 5888999999999999999999999999999999999987776 9999999987654443334456889
Q ss_pred cccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhccc
Q 023058 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262 (288)
Q Consensus 183 ~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 262 (288)
.|+|||.+.+..++.+ +|+||||+++|+|++|..||........................ ...+++++.++|.+||+.
T Consensus 159 ~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 159 GYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRLFLAK 236 (277)
T ss_pred CccCHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHHHHHhcc
Confidence 9999999988887666 99999999999999999999765443333333333333333222 235789999999999999
Q ss_pred CcCCccccccccc-cchhhhhhh
Q 023058 263 DPAKVSMHFHATG-VYMHTKLQL 284 (288)
Q Consensus 263 ~p~~Rpt~~~~l~-~~~~~~~~~ 284 (288)
||.+||++.|.++ .+.|+|++.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 9999999988776 778888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=313.53 Aligned_cols=254 Identities=27% Similarity=0.458 Sum_probs=207.8
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++.+.||+|+||+||++.+..+++.||+|++.... .....+.+|+.++.+++|+||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999987532 23346778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC--
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-- 174 (288)
||+++++|.+++...+.+++..+..++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC--EEEeeccCccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999987776 99999999864321100
Q ss_pred ----------------------------------CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCC
Q 023058 175 ----------------------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (288)
Q Consensus 175 ----------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~ 220 (288)
.....||+.|+|||.+.+..++.+ +|+||||+++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCCC
Confidence 112468999999999988888776 999999999999999999998
Q ss_pred CCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCC---ccccccccccchhhhhh
Q 023058 221 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK---VSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~---Rpt~~~~l~~~~~~~~~ 283 (288)
..+........... .....++....++++++++|.+|+. +|.+ ||++.++++ |+|++
T Consensus 238 ~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~---hp~f~ 297 (363)
T cd05628 238 SETPQETYKKVMNW--KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT---NPFFE 297 (363)
T ss_pred CCCHHHHHHHHHcC--cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC---CCCCC
Confidence 76543333332211 1233455545678999999999775 5554 577877766 55543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=309.49 Aligned_cols=240 Identities=33% Similarity=0.560 Sum_probs=203.2
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (288)
+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.++||||+++.+.+..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999987542 33356778999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCCCCCcCC
Q 023058 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 181 (288)
Q Consensus 103 ~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~ 181 (288)
+|...+.....+++.++..++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++...... .......++
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCC
Confidence 99998888888999999999999999999999999999999999999987776 999999998643222 222345689
Q ss_pred CcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcc
Q 023058 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261 (288)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 261 (288)
+.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+... ....+......++. .+++++.++|.+||+
T Consensus 159 ~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~~~~----~~~~~~~~~~~~p~--~~~~~~~~li~~~L~ 231 (328)
T cd05593 159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILMEDIKFPR--TLSADAKSLLSGLLI 231 (328)
T ss_pred cCccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCCHHH----HHHHhccCCccCCC--CCCHHHHHHHHHHcC
Confidence 99999999988877766 999999999999999999997654322 22333344445554 689999999999999
Q ss_pred cCcCCcc-----ccccccc
Q 023058 262 ADPAKVS-----MHFHATG 275 (288)
Q Consensus 262 ~~p~~Rp-----t~~~~l~ 275 (288)
.||.+|+ ++.++++
T Consensus 232 ~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 232 KDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCHHHcCCCCCCCHHHHhc
Confidence 9999998 6766665
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=311.93 Aligned_cols=251 Identities=27% Similarity=0.395 Sum_probs=213.9
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
+.-+..+.+..++.||+|-||+||.+.... ...||+|.+.......+.+.+|++++++|+|++||++++++..++.+++
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 333444566779999999999999999974 3479999999988888899999999999999999999999999889999
Q ss_pred EEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 95 VMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
||||++.|+|.+++.. +..+...+.+.++.||++|++||+++++|||||...||+|+.+.. +||+|||+++.....
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIGDD 356 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccCCC
Confidence 9999999999999986 457999999999999999999999999999999999999998887 999999999933222
Q ss_pred CCCCC--CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 173 SQPKS--TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 173 ~~~~~--~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
.-... ..-...|.|||.+..+.++.+ ||+||||++++|++| |+.|+...+..+.... ....+..|.+..+|
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-----le~GyRlp~P~~CP 430 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-----LERGYRLPRPEGCP 430 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHHHH-----HhccCcCCCCCCCC
Confidence 21111 112346999999999999888 999999999999998 8889887766554443 34456677777999
Q ss_pred HHHHHHHHHhcccCcCCcccccccc
Q 023058 250 PECRHLISRIFVADPAKVSMHFHAT 274 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l 274 (288)
+.+.+++..||..+|++|||.+.+.
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHH
Confidence 9999999999999999999998443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=295.56 Aligned_cols=252 Identities=30% Similarity=0.434 Sum_probs=210.0
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---chHHHHHHHHHHhhCCCCc-eeeEeEEEEcCC-----
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPN-IVRFKEVILTPT----- 90 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~----- 90 (288)
...|..+++||+|+||+||+|++..+|+.||+|++..... ......+|+.+++.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 5678999999999999999999999999999999986544 5567899999999999999 999999998877
Q ss_pred -eEEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCC
Q 023058 91 -HLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (288)
Q Consensus 91 -~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~ 165 (288)
.+++|+|+++. +|..++.... .++...++.+++||+.||+|||+.||+||||||+||+++.++. +||+|||+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGl 166 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGL 166 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--Eeeeccch
Confidence 89999999965 8999987655 4778899999999999999999999999999999999998776 99999999
Q ss_pred CcccccCCC-CCCCcCCCcccCCccccCc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc-cCC
Q 023058 166 SKSSVLHSQ-PKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSI 242 (288)
Q Consensus 166 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~ 242 (288)
++....+.. ..+...|.+|.|||++.+. .|++. .||||+||++.||+++...|.+..+.+....+-.-..... ..+
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~-vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTS-VDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCC-cchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 986664433 5667789999999999887 45555 9999999999999999999988776454444432221111 112
Q ss_pred CC-------------C----------CCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 243 PD-------------Y----------VHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 243 ~~-------------~----------~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
|. + ...+++..+++.+||+++|.+|.|+..++.
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 21 1 123358999999999999999999988877
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=292.89 Aligned_cols=259 Identities=29% Similarity=0.376 Sum_probs=215.8
Q ss_pred CCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcC-
Q 023058 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP- 89 (288)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 89 (288)
+..+-..++|+.+..|++|+||.||+|+++.+++.||+|.++.+. ...=.-.+|+.++.+++|||||.+.++....
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 556677799999999999999999999999999999999997654 2223578999999999999999999987654
Q ss_pred -CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 90 -THLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 90 -~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
+.+|+|||||+. +|..++..-+ +|...+++-++.|++.|++|||+..|+||||||+|++++..+. +|++|||+|+
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR 225 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAR 225 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhh
Confidence 579999999966 9999998765 8999999999999999999999999999999999999998888 9999999999
Q ss_pred ccccCCCCC-CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-CCCC-
Q 023058 168 SSVLHSQPK-STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPD- 244 (288)
Q Consensus 168 ~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~- 244 (288)
....+...- ...-|.+|.|||.+.+...-+.+.|+||+||++.||+++.+.|.+..+.+...++......... -+|.
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 776664433 3457899999999988765555599999999999999999999988776666655533221110 1111
Q ss_pred ------------------------CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 245 ------------------------YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 245 ------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
...+++.-.+|+..+|.+||.+|.|+.++|+
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0125578889999999999999999999987
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=291.04 Aligned_cols=248 Identities=33% Similarity=0.546 Sum_probs=218.1
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-----c----chHHHHHHHHHHhhC-CCCceeeEeEEEEcCC
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----K----IDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 90 (288)
.+|.--+.||.|..++|-++.++.+++.+++|++.... . ..+...+|+.+|+++ .||+|+.+.+++.++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 57888899999999999999999999999999986421 1 123456799999998 7999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.+++|+|.|+.|.|.+++...-.+++...+.|++|++++++|||.++||||||||+||+++++.+ ++|+|||++++..
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccC
Confidence 99999999999999999998888999999999999999999999999999999999999998887 9999999999999
Q ss_pred cCCCCCCCcCCCcccCCccccCc------ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc--CC
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SI 242 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~ 242 (288)
++......+|||.|+|||.+... .|+.. .|+|+.|+++|-|+.|..||+-... --+.+.+..+.+ ..
T Consensus 175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~E-VD~Wa~GVImyTLLaGcpPFwHRkQ----mlMLR~ImeGkyqF~s 249 (411)
T KOG0599|consen 175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKE-VDEWACGVIMYTLLAGCPPFWHRKQ----MLMLRMIMEGKYQFRS 249 (411)
T ss_pred CchhHHHhcCCCcccChhheeeecccCCCCccch-hhHHHHHHHHHHHHcCCCchhHHHH----HHHHHHHHhcccccCC
Confidence 98888899999999999998643 23333 8999999999999999999985432 233455566665 55
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 243 PDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
|+|+++++..++||++||+.||.+|.|++|+|+
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 678999999999999999999999999999977
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=299.05 Aligned_cols=257 Identities=32% Similarity=0.482 Sum_probs=211.7
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcC--C---eEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--T---HLAIV 95 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~---~~~lv 95 (288)
-.|.-.+.+|.|+||.||.+....+++.||||+.-.+... .-+|+++++.++|||||++.-+|... + ...+|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4688899999999999999999999999999998776542 34799999999999999999888653 2 45799
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 96 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
|||++. +|.+.+.. +.+++.-.++-+.+||++||.|||+.||+||||||+|++||.+ ++.+||||||+|.....
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~-tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD-TGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC-CCeEEeccCCcceeecc
Confidence 999977 78777753 5679999999999999999999999999999999999999855 34699999999999988
Q ss_pred CCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH--------hhcccC--
Q 023058 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI--------LSVQYS-- 241 (288)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~--------~~~~~~-- 241 (288)
+........+..|.|||.+.+...-+.+-||||.||++.||+-|++-|.+.+..+....+.+-+ ...+.+
T Consensus 179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 8888888999999999999887654444999999999999999999999877655555444211 111111
Q ss_pred ---CC----------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 242 ---IP----------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 242 ---~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
++ -....+++..+|+.++|.++|.+|.++.+++. |++++.+
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~---h~fFdel 312 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA---HPFFDEL 312 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc---chhhHHh
Confidence 11 12457899999999999999999999977765 5555544
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=306.88 Aligned_cols=248 Identities=31% Similarity=0.511 Sum_probs=205.8
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||+|+||+||++.+..+++.||+|++... ....+....|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999998753 23334566788888776 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCCCCCcC
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 180 (288)
++|...+.....+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCccccccc
Confidence 999999988888999999999999999999999999999999999999988876 999999988743322 22334568
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhc
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (288)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+... ....+.......+. .+++++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~----~~~~i~~~~~~~~~--~~~~~~~~li~~~L 231 (320)
T cd05590 159 TPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENEDD----LFEAILNDEVVYPT--WLSQDAVDILKAFM 231 (320)
T ss_pred CccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHH----HHHHHhcCCCCCCC--CCCHHHHHHHHHHc
Confidence 999999999988877776 999999999999999999998765433 33334444444444 58899999999999
Q ss_pred ccCcCCccccccc---cccchhhhhh
Q 023058 261 VADPAKVSMHFHA---TGVYMHTKLQ 283 (288)
Q Consensus 261 ~~~p~~Rpt~~~~---l~~~~~~~~~ 283 (288)
+.||.+||++.++ .+.+.|+|+.
T Consensus 232 ~~dP~~R~~~~~~~~~~~~~~h~~f~ 257 (320)
T cd05590 232 TKNPTMRLGSLTLGGEEAILRHPFFK 257 (320)
T ss_pred ccCHHHCCCCCCCCCHHHHHcCCCcC
Confidence 9999999999443 2245566654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=315.48 Aligned_cols=257 Identities=32% Similarity=0.487 Sum_probs=208.8
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++++.||+|+||+||++++..+++.||+|++.... .....+.+|+.++++++|+||+++++.+..++.+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999987542 23356788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC---
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~--- 173 (288)
||+++++|.+++...+.+++..+..++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999988776 9999999864221000
Q ss_pred ---------------------------------------------CCCCCcCCCcccCCccccCcccCCCccchhhHHHH
Q 023058 174 ---------------------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVT 208 (288)
Q Consensus 174 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 208 (288)
......+++.|+|||++.+..++.. +|+|||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechHH
Confidence 0012357899999999988888776 999999999
Q ss_pred HHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 209 LYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 209 ~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+|+|++|..||...+.......... .......+....+++++.++|.+|+ .+|.+|++...+.+.+.|+|+.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~ 309 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVIN--WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFK 309 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHc--cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcC
Confidence 9999999999987654332222211 1122344444568999999999987 5999999843334445566654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=313.48 Aligned_cols=250 Identities=30% Similarity=0.458 Sum_probs=206.2
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
..|++++.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.++++++||||+++++++..++.+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999999999999999987542 33456788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC---
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~--- 173 (288)
||+++++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC--EEEeeCcCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987776 9999999874221000
Q ss_pred ---------------------------------------------CCCCCcCCCcccCCccccCcccCCCccchhhHHHH
Q 023058 174 ---------------------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVT 208 (288)
Q Consensus 174 ---------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 208 (288)
......|++.|+|||.+.+..++.+ +|+|||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~i 237 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGVI 237 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhhH
Confidence 0012358899999999988888766 999999999
Q ss_pred HHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhc--ccCcCCccccccccc
Q 023058 209 LYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF--VADPAKVSMHFHATG 275 (288)
Q Consensus 209 ~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~~p~~Rpt~~~~l~ 275 (288)
+|+|++|..||...+.......... .......+....+++++.+||.+|+ ..+|..|+++.+++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVIN--WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHc--cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999987654333222211 1223345555568999999999955 455556999988877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=310.98 Aligned_cols=248 Identities=31% Similarity=0.477 Sum_probs=221.0
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe-EEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv 95 (288)
.++|.+++++|.|.||.++.++++.+++.|++|.+.... .......+|+.+++++.|||||.+.+.|..++. +++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 478999999999999999999999999999999987543 334467899999999999999999999999887 9999
Q ss_pred EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 96 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
|+|++||++.+.+...+ .++++.+..++.|++.|++|||++.|+|||||+.|||++.++. ++|+|||+++...+..
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPED 160 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCch
Confidence 99999999999886544 6999999999999999999999999999999999999999888 9999999999888876
Q ss_pred -CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
......|||.|++||.+.+.+|+.+ +|||||||++|||++-..+|...+-.....++... . -.|.....+.++
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~----~-~~Plp~~ys~el 234 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG----L-YSPLPSMYSSEL 234 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHHHhhc----c-CCCCCccccHHH
Confidence 6778899999999999999999999 99999999999999999999987655544444333 3 223334789999
Q ss_pred HHHHHHhcccCcCCccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+.+|..||+.+|..||++.+++.
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~ 257 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLR 257 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhh
Confidence 99999999999999999999988
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=306.92 Aligned_cols=252 Identities=28% Similarity=0.446 Sum_probs=204.7
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|..++.++ +||||+++++++..+..+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999997632 2334577899999888 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc-cCCCCCCCcC
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG 180 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~-~~~~~~~~~~ 180 (288)
++|...+...+++++..+..++.||+.||.|||+.|++||||+|+||+++.++. ++|+|||++.... .........+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccC
Confidence 999998888888999999999999999999999999999999999999987776 9999999886432 2223334568
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCc-----hhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----KNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...... .........+.......|. .++..+.++
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~l 235 (329)
T cd05588 159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKASSV 235 (329)
T ss_pred CccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CCCHHHHHH
Confidence 999999999988888766 99999999999999999999642211 1112223333444445554 688999999
Q ss_pred HHHhcccCcCCcccccc---ccccchhhhhh
Q 023058 256 ISRIFVADPAKVSMHFH---ATGVYMHTKLQ 283 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~---~l~~~~~~~~~ 283 (288)
|.+||+.||.+|+|+.. +.+.+.|+|+.
T Consensus 236 i~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~ 266 (329)
T cd05588 236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266 (329)
T ss_pred HHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence 99999999999998531 22344455553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=311.85 Aligned_cols=256 Identities=20% Similarity=0.278 Sum_probs=203.8
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
....++|++.+.||+|+||.||++.+..+++.||+|... ...+.+|++++++++||||+++++++..+...++++
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 345578999999999999999999999999999999643 235678999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC--C
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~--~ 174 (288)
+++. ++|...+.....++..+++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++....... .
T Consensus 163 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 163 PRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANK 239 (391)
T ss_pred ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCcccccccccccc
Confidence 9995 588888877778999999999999999999999999999999999999987776 9999999986432221 2
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCc-------hhHHHHHHH-------------
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------KNFRKTIHR------------- 234 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~-------~~~~~~~~~------------- 234 (288)
.....+++.|+|||++.+..++.+ +|+||||+++|+|++|..||...... .........
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 233468999999999988887766 99999999999999999887543210 111111100
Q ss_pred ---------Hhhccc----CCC---CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 235 ---------ILSVQY----SIP---DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 235 ---------~~~~~~----~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
...... ..+ ....++.++.+||.+||+.||.+|||+.|+++ |+|++.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~---hp~f~~ 381 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD---FAAFQD 381 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc---Chhhcc
Confidence 000000 000 01135678999999999999999999988876 666654
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=304.61 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=208.4
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
..++|++.+.||.|+||.||++.+..++..+++|.+.... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 4589999999999999999999999999999999887542 23356889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc-CceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
||+.+++|.+++...+.++...+..++.|++.|+.|||+. +++|+||||+||+++.++. ++|+|||++..... ...
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~~ 159 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA 159 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhh-hcc
Confidence 9999999999998888899999999999999999999975 7999999999999987776 99999998864422 222
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH--------------------------
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR-------------------------- 229 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~-------------------------- 229 (288)
....++..|+|||.+.+..++.+ +|+||||+++|+|++|..||..........
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence 33467889999999988777666 999999999999999999997543211100
Q ss_pred --------------HHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 230 --------------KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 230 --------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.....+.............+.++.+||.+||+.||.+|||+.+++. |+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~---h~~~~ 303 (333)
T cd06650 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV---HAFIK 303 (333)
T ss_pred hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh---CHHHh
Confidence 0001111111111111235788999999999999999999988865 55554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=312.82 Aligned_cols=257 Identities=28% Similarity=0.467 Sum_probs=213.0
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++.+.||+|+||.||++.+..+++.||+|++... ......+.+|+.++.+++||||+++++.+..++.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999999999999999998753 233456778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC---
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~--- 173 (288)
||+++++|.+++...+.+++..+..++.|++.||++||+.||+||||||+||+++.++. ++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEeeccCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987776 9999999876332110
Q ss_pred ---------------------------------CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCC
Q 023058 174 ---------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (288)
Q Consensus 174 ---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~ 220 (288)
......|++.|+|||++.+..++.. +|+|||||++|+|++|..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCCC
Confidence 0112458899999999988888776 999999999999999999998
Q ss_pred CCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 221 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
..+.......... ......++....++++++++|.+|+ .||.+|++...+.+.+.|+|++
T Consensus 238 ~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~ 297 (360)
T cd05627 238 SETPQETYRKVMN--WKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFE 297 (360)
T ss_pred CCCHHHHHHHHHc--CCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCC
Confidence 7655433333221 1122344544457899999999987 5999999876666667777765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=311.41 Aligned_cols=249 Identities=27% Similarity=0.456 Sum_probs=207.7
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|.+.+.||+|+||+||++.+..+++.||+|++.... ...+.+.+|+.+++.++|+||+++++++..+...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999987643 23456788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-
Q 023058 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~- 174 (288)
||+++++|.+++... ..+++..+..++.||+.||.+||+.|++||||+|+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCce
Confidence 999999999999776 67999999999999999999999999999999999999987776 99999999875443322
Q ss_pred -CCCCcCCCcccCCccccC------cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 175 -PKSTVGTPAYIAPEVLLK------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
.....+++.|+|||.+.. ..++.+ +|+||||+++|+|++|..||............... .....++....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~ 235 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVE-CDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFLKFPEDPK 235 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCc-ceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCccCCCCCCC
Confidence 223468899999999863 334444 99999999999999999999876554433333221 11234455456
Q ss_pred CCHHHHHHHHHhcccCcCCccccccccc
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+++++.+||..||+ +|.+|||+.+++.
T Consensus 236 ~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 236 VSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 89999999999997 9999999988866
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=316.70 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=201.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcC--------Ce
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--------TH 91 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~ 91 (288)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 468999999999999999999999999999999886543 2345799999999999999999887432 24
Q ss_pred EEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 92 LAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
+++||||+++ ++...+. ....++...++.++.||+.||.|||+.||+||||||+||+++.++. .++|+|||++.
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla~ 219 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAK 219 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC-ceeeeccccch
Confidence 6799999976 6665553 3457999999999999999999999999999999999999985542 39999999998
Q ss_pred ccccCCCCCCCcCCCcccCCccccCc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc--------
Q 023058 168 SSVLHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------- 238 (288)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------- 238 (288)
............+++.|+|||.+.+. .++.+ +|+|||||++|+|++|..||......+............
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTH-IDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 66555555556789999999998765 45555 999999999999999999998766544444333211100
Q ss_pred -----ccCCCC----------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 239 -----QYSIPD----------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 239 -----~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
...++. ....|+++.+||.+||++||.+|||+.|++. |+|++.
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~---hp~f~~ 356 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA---DPFFDD 356 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC---ChhHHh
Confidence 001111 1246789999999999999999999988866 666554
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=308.86 Aligned_cols=261 Identities=28% Similarity=0.419 Sum_probs=206.1
Q ss_pred CCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEc
Q 023058 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT 88 (288)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (288)
+.........++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+++++.++|+||+++++++..
T Consensus 64 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 143 (353)
T PLN00034 64 GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH 143 (353)
T ss_pred CCCCCCCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc
Confidence 334444555688999999999999999999999999999999986543 234568899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcc
Q 023058 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~ 168 (288)
.+.+++||||+.+++|... ....+..+..++.||+.||.|||+.|++|+||||+||+++.++. ++|+|||++..
T Consensus 144 ~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~ 217 (353)
T PLN00034 144 NGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRI 217 (353)
T ss_pred CCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccccccee
Confidence 9999999999999888542 24567888899999999999999999999999999999988776 99999999875
Q ss_pred cccCC-CCCCCcCCCcccCCccccC----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC
Q 023058 169 SVLHS-QPKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243 (288)
Q Consensus 169 ~~~~~-~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
..... ......++..|+|||.+.. ..+...++||||||+++|+|++|..||....... .......+... ....
T Consensus 218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~-~~~~ 295 (353)
T PLN00034 218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WASLMCAICMS-QPPE 295 (353)
T ss_pred cccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhcc-CCCC
Confidence 43322 2234568999999998743 2333445999999999999999999998443322 22222222111 1112
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 244 DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
....++.++.+||.+||+.||.+|||+.|+++ |+|+
T Consensus 296 ~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~---hp~~ 331 (353)
T PLN00034 296 APATASREFRHFISCCLQREPAKRWSAMQLLQ---HPFI 331 (353)
T ss_pred CCCccCHHHHHHHHHHccCChhhCcCHHHHhc---Cccc
Confidence 22367899999999999999999999988876 5544
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=314.76 Aligned_cols=254 Identities=31% Similarity=0.482 Sum_probs=208.1
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
+.|++++.||+|+||.||++++..+++.||+|++.... .....+.+|+.++++++|+||+++++.+..++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986532 23456788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC----
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 172 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~---- 172 (288)
||+++++|.+++...+.+++..+..++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987776 999999987422100
Q ss_pred ----------------------------------------CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHH
Q 023058 173 ----------------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212 (288)
Q Consensus 173 ----------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l 212 (288)
.......|++.|+|||.+.+..++.+ +|+|||||++|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeeeh
Confidence 00012358899999999988888766 9999999999999
Q ss_pred HhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCcc---ccccccccchhhhhh
Q 023058 213 LVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVS---MHFHATGVYMHTKLQ 283 (288)
Q Consensus 213 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp---t~~~~l~~~~~~~~~ 283 (288)
++|..||.............. .......+....+++++.++|.+|+ .+|.+|+ ++.+++. |+|+.
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~---h~~~~ 305 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVIN--WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA---HPFFK 305 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhc--cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC---CCCcC
Confidence 999999987654333222211 1122334444568999999999987 5999999 6666654 55553
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=303.68 Aligned_cols=240 Identities=32% Similarity=0.533 Sum_probs=203.5
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCC-ceeeEeEEEEcCCeEEEEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~ 96 (288)
+|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+..|..++..++|+ +++++++++...+.+++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999998753 23345677888999888765 5888999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc-CCCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~-~~~~ 175 (288)
||+++++|...+.....+++..+..++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++..... ....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCce
Confidence 99999999999988888999999999999999999999999999999999999988776 99999998864322 2223
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....+++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||....... ....+......++. .++.++.++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~----~~~~i~~~~~~~~~--~~~~~~~~l 231 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDE----LFQSIMEHNVSYPK--SLSKEAVSI 231 (324)
T ss_pred eeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCC--CCCHHHHHH
Confidence 34568999999999988888766 999999999999999999998655432 33334444455554 689999999
Q ss_pred HHHhcccCcCCcccc
Q 023058 256 ISRIFVADPAKVSMH 270 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~ 270 (288)
|.+||..||.+|++.
T Consensus 232 i~~~l~~~P~~R~~~ 246 (324)
T cd05587 232 CKGLLTKHPAKRLGC 246 (324)
T ss_pred HHHHhhcCHHHcCCC
Confidence 999999999999987
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=309.11 Aligned_cols=249 Identities=30% Similarity=0.526 Sum_probs=206.8
Q ss_pred eeeeeccCceEEEEEEEc---CCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 26 VRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
++.||+|+||.||++.+. .++..||+|++.... .......+|++++++++||||+++++++..++..++||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 367999999999999863 578999999987532 22345678999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCCCCC
Q 023058 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 178 (288)
Q Consensus 100 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~~~~ 178 (288)
.+++|.+.+.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||++...... ......
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecc
Confidence 99999999988888999999999999999999999999999999999999987776 999999998754433 223345
Q ss_pred cCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 023058 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258 (288)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 258 (288)
.+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+... ....+.......+. .+++++.++|.+
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~li~~ 231 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQGKDRKE----TMTMILKAKLGMPQ--FLSPEAQSLLRA 231 (318)
T ss_pred cCChhhcCHHHHcCCCCCCc-cceeccceEeeeeccCCCCCCCCCHHH----HHHHHHcCCCCCCC--CCCHHHHHHHHH
Confidence 68899999999987777666 999999999999999999998654322 23333444444554 689999999999
Q ss_pred hcccCcCCcccccc--ccccchhhhhh
Q 023058 259 IFVADPAKVSMHFH--ATGVYMHTKLQ 283 (288)
Q Consensus 259 ~l~~~p~~Rpt~~~--~l~~~~~~~~~ 283 (288)
||+.||.+||++.+ +.+.+.|+|++
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~ 258 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFS 258 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcC
Confidence 99999999999776 44455666654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=304.41 Aligned_cols=239 Identities=34% Similarity=0.550 Sum_probs=198.6
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHH---hhCCCCceeeEeEEEEcCCeEEEE
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINH---RSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|..++ +.++||||+++++++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999999999999999987542 2334566666554 566899999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc-CCC
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~-~~~ 174 (288)
|||+++++|...+.. +.+++..+..++.||+.||+|||+.|++||||||+||+++.++. ++|+|||++..... ...
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCc
Confidence 999999999877754 57899999999999999999999999999999999999988876 99999998764322 222
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
.....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.... ...+.......+. .+++.+.+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~ 230 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDDEEEV----FDSIVNDEVRYPR--FLSREAIS 230 (324)
T ss_pred ccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCC--CCCHHHHH
Confidence 344568999999999988877766 9999999999999999999987554332 2333444444554 68999999
Q ss_pred HHHHhcccCcCCccccc
Q 023058 255 LISRIFVADPAKVSMHF 271 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~ 271 (288)
+|.+||+.||.+||+..
T Consensus 231 li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 231 IMRRLLRRNPERRLGSG 247 (324)
T ss_pred HHHHHhhcCHhHcCCCC
Confidence 99999999999999643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=304.45 Aligned_cols=241 Identities=31% Similarity=0.517 Sum_probs=202.1
Q ss_pred eeeeeccCceEEEEEEEc---CCCcEEEEEEeecCc-----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 26 VRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++.||+|+||.||++++. .+++.||+|++.... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 468899999987532 233456789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CCC
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (288)
|+++++|.+.+...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++....... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccCCCccc
Confidence 9999999999988888999999999999999999999999999999999999987776 9999999986433222 223
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (288)
...+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+... ....+......++. .+++++.++|
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~pf~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~li 231 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKK----TIDKILKGKLNLPP--YLTPEARDLL 231 (323)
T ss_pred ccCCCccccChhhccCCCCCCc-ceecccHHHHHHHhcCCCCCCCCCHHH----HHHHHHcCCCCCCC--CCCHHHHHHH
Confidence 3468999999999988777666 999999999999999999998755433 33334444555554 6889999999
Q ss_pred HHhcccCcCCcc-----ccccccc
Q 023058 257 SRIFVADPAKVS-----MHFHATG 275 (288)
Q Consensus 257 ~~~l~~~p~~Rp-----t~~~~l~ 275 (288)
.+||+.||.+|| ++.++++
T Consensus 232 ~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 232 KKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHcccCHhHcCCCCCCCHHHHhc
Confidence 999999999999 6766655
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=295.35 Aligned_cols=251 Identities=28% Similarity=0.455 Sum_probs=217.7
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
...+.|++++.||.|.-|+||+++...++..+|+|++.+.. ....+...|-++|+.++||.++.++..|..++..+
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 34478999999999999999999999999999999998753 33356778999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 94 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
++||||+||+|..+++.. +.+++..++.++..++-||+|||-+|||.|||||+||||..+|+ +.|.||+++.....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRCPV 231 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccCCC
Confidence 999999999999988765 46999999999999999999999999999999999999998888 99999998741100
Q ss_pred ---------------------------------C-C-----------------------CCCCCcCCCcccCCccccCcc
Q 023058 172 ---------------------------------H-S-----------------------QPKSTVGTPAYIAPEVLLKKE 194 (288)
Q Consensus 172 ---------------------------------~-~-----------------------~~~~~~~~~~~~aPE~~~~~~ 194 (288)
. . ......||-.|.|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 001123788999999999988
Q ss_pred cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccc----c
Q 023058 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSM----H 270 (288)
Q Consensus 195 ~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~ 270 (288)
.+.. .|.|+||+.+|||+.|..||.+.+....+..+ ......+|....++-.+++||+++|.+||.+|.. +
T Consensus 312 HgsA-VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI----v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 312 HGSA-VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI----VGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred CCch-hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH----hcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccch
Confidence 8777 99999999999999999999998887766654 5567788888788999999999999999999998 6
Q ss_pred ccccc
Q 023058 271 FHATG 275 (288)
Q Consensus 271 ~~~l~ 275 (288)
.|+.+
T Consensus 387 ~eIK~ 391 (459)
T KOG0610|consen 387 AEIKR 391 (459)
T ss_pred HHhhc
Confidence 66655
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=314.14 Aligned_cols=256 Identities=30% Similarity=0.392 Sum_probs=214.1
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC-C-----CceeeEeEEEEcCCeEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-H-----PNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~~~~~~~~l 94 (288)
.+|+|++.||+|+||+|.+|.+..|++.||||+++...........|+.+|..++ | -|+|+++++|...+++++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 4889999999999999999999999999999999998888888999999999996 3 379999999999999999
Q ss_pred EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 95 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
|+|... .+|.+++..+. .++...++.+++||+.+|..||+.||+|+||||+|||+.......+|++|||+++.....
T Consensus 266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~ 344 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR 344 (586)
T ss_pred eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc
Confidence 999994 49999998765 488999999999999999999999999999999999998877778999999999855443
Q ss_pred CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh---------------
Q 023058 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------------- 237 (288)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------- 237 (288)
.- ....+..|.|||++.|.+|+.. -|+|||||++.||++|.+.|.+.++.+.+..++.-+..
T Consensus 345 vy--tYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kf 421 (586)
T KOG0667|consen 345 VY--TYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKF 421 (586)
T ss_pred ce--eeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccccee
Confidence 32 6677889999999999999998 99999999999999999888876664444443311000
Q ss_pred ---------------------------------cccCCC-C--------CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 238 ---------------------------------VQYSIP-D--------YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 238 ---------------------------------~~~~~~-~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.....| . ...-...+.+||.+||..||.+|+|+.++++
T Consensus 422 f~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 422 FTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN 501 (586)
T ss_pred hhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000011 0 0012246899999999999999999988877
Q ss_pred cchhhhhh
Q 023058 276 VYMHTKLQ 283 (288)
Q Consensus 276 ~~~~~~~~ 283 (288)
|+|+.
T Consensus 502 ---Hpfl~ 506 (586)
T KOG0667|consen 502 ---HPFLT 506 (586)
T ss_pred ---Ccccc
Confidence 55554
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=309.74 Aligned_cols=252 Identities=29% Similarity=0.459 Sum_probs=208.7
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
...++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45689999999999999999999999999999999987532 23345678999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
+||||+++++|.+++... .+++..+..++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCC
Confidence 999999999999888653 6889999999999999999999999999999999999988776 9999999987543322
Q ss_pred C--CCCCcCCCcccCCccccCcc----cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 174 Q--PKSTVGTPAYIAPEVLLKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 174 ~--~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
. .....+++.|+|||.+.+.. ++.+ +|+|||||++|+|++|..||............... .....++....
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~ 273 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRE-CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH--KNSLTFPDDIE 273 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCc-eeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCcCCCCCcCC
Confidence 1 23456899999999986532 4444 99999999999999999999876543333333211 12244555556
Q ss_pred CCHHHHHHHHHhcccCcCC--ccccccccc
Q 023058 248 ISPECRHLISRIFVADPAK--VSMHFHATG 275 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~--Rpt~~~~l~ 275 (288)
++.++.++|.+||+.+|.+ |+|+.++++
T Consensus 274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 8999999999999999988 999988876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=305.17 Aligned_cols=240 Identities=30% Similarity=0.479 Sum_probs=199.1
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999987642 2334567788888776 899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc-CCCCCCCcC
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (288)
++|...+.....+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccC
Confidence 999988888888999999999999999999999999999999999999988876 99999999864322 222334568
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCC-----chhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-----PKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||..... ..........+......+|. .++..+.++
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~l 235 (329)
T cd05618 159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASV 235 (329)
T ss_pred CccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC--CCCHHHHHH
Confidence 999999999988888776 9999999999999999999963211 11122223333444445555 688999999
Q ss_pred HHHhcccCcCCccccc
Q 023058 256 ISRIFVADPAKVSMHF 271 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~ 271 (288)
|.+||+.||.+||++.
T Consensus 236 l~~~L~~dP~~R~~~~ 251 (329)
T cd05618 236 LKSFLNKDPKERLGCH 251 (329)
T ss_pred HHHHhcCCHHHcCCCC
Confidence 9999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=306.72 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=203.9
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCC-----
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 90 (288)
..++|++.+.||+|+||.||++.+..++..||+|++... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 358999999999999999999999999999999998653 233456778999999999999999999986543
Q ss_pred -eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 91 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 91 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
.++++|||+++ +|...+. ..++...+..++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++...
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~ 173 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 173 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCcccc
Confidence 57999999976 5655553 34788999999999999999999999999999999999988776 999999998754
Q ss_pred ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH--------------
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-------------- 235 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~-------------- 235 (288)
..........+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+....+.......
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 44333445567899999999988888777 999999999999999999998765433322221110
Q ss_pred ----hhcccCCC------------------CCCCCCHHHHHHHHHhcccCcCCccccccccc-cchhhhh
Q 023058 236 ----LSVQYSIP------------------DYVHISPECRHLISRIFVADPAKVSMHFHATG-VYMHTKL 282 (288)
Q Consensus 236 ----~~~~~~~~------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~~~~ 282 (288)
.......+ .....++.+++||.+||+.||.+|||+.|+++ .++..|+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 00110000 01124678999999999999999999998877 4444443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=306.33 Aligned_cols=254 Identities=23% Similarity=0.378 Sum_probs=201.6
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEE-----cCCCcEEEEEEeecCc--cchHHHHHHHHHHhhC-CCCceeeEeEEEEcC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (288)
+..++|++.+.||.|+||.||+|.+ ..++..||+|.+.... ...+.+.+|+.+++.+ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3458999999999999999999975 2345789999987532 2335688999999999 899999999988764
Q ss_pred -CeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 023058 90 -THLAIVMEYASGGELFERICNA--------------------------------------------------------- 111 (288)
Q Consensus 90 -~~~~lv~e~~~~~~L~~~~~~~--------------------------------------------------------- 111 (288)
..++++|||+++++|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999888642
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC---CCCCcCCCc
Q 023058 112 -----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 183 (288)
Q Consensus 112 -----~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~ 183 (288)
..++...+..++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++........ .....+++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcchhcccCCCCCcc
Confidence 23677888999999999999999999999999999999987776 99999999875432211 122345678
Q ss_pred ccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhccc
Q 023058 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262 (288)
Q Consensus 184 ~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 262 (288)
|+|||.+.+..++.+ +|+||||+++|+|++ |..||............. .... .......+++++.++|.+||+.
T Consensus 242 y~aPE~~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~l~~li~~cl~~ 316 (338)
T cd05102 242 WMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL---KDGT-RMRAPENATPEIYRIMLACWQG 316 (338)
T ss_pred ccCcHHhhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH---hcCC-CCCCCCCCCHHHHHHHHHHccC
Confidence 999999988888777 999999999999997 999998755433322221 1111 1222336789999999999999
Q ss_pred CcCCccccccccccch
Q 023058 263 DPAKVSMHFHATGVYM 278 (288)
Q Consensus 263 ~p~~Rpt~~~~l~~~~ 278 (288)
||.+|||+.++++.+.
T Consensus 317 dp~~RPs~~el~~~l~ 332 (338)
T cd05102 317 DPKERPTFSALVEILG 332 (338)
T ss_pred ChhhCcCHHHHHHHHH
Confidence 9999999999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=304.73 Aligned_cols=247 Identities=32% Similarity=0.513 Sum_probs=201.8
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHH-HHhhCCCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||+|+||+||++.+..+++.||+|++.... .....+.+|.. +++.++||||+++++.+...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999999999999999987532 22233444544 45788999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc-CCCCCCCcC
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (288)
++|...+...+.+++..+..++.||+.||+|||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccC
Confidence 999999988888999999999999999999999999999999999999988776 99999998864322 222334568
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhc
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (288)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.. .....+.......+. .+++.+.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~--~~~~~~~~li~~~l 231 (323)
T cd05575 159 TPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDTA----EMYDNILNKPLRLKP--NISVSARHLLEGLL 231 (323)
T ss_pred ChhhcChhhhcCCCCCcc-ccccccchhhhhhhcCCCCCCCCCHH----HHHHHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence 999999999988887776 99999999999999999999875432 233333333444433 57999999999999
Q ss_pred ccCcCCcccccccc-ccchhhhh
Q 023058 261 VADPAKVSMHFHAT-GVYMHTKL 282 (288)
Q Consensus 261 ~~~p~~Rpt~~~~l-~~~~~~~~ 282 (288)
+.||.+||++.+.. +.+.|+|+
T Consensus 232 ~~~p~~R~~~~~~~~~il~~~~~ 254 (323)
T cd05575 232 QKDRTKRLGAKDDFLEIKNHVFF 254 (323)
T ss_pred hcCHHhCCCCCCCHHHHHcCCCc
Confidence 99999999996333 24556655
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=305.74 Aligned_cols=255 Identities=29% Similarity=0.445 Sum_probs=201.0
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcC-----CeEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLA 93 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 93 (288)
+|++.+.||+|+||.||++.+..++..||+|.+... ......+.+|+.++++++||||+++++++... ..++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 699999999999999999999999999999988643 23334678999999999999999999988643 2589
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
+||||+. ++|.+.+.....++...+..++.||+.||.|||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCcccccccccc
Confidence 9999995 589988888888999999999999999999999999999999999999988776 9999999987443222
Q ss_pred C----CCCCcCCCcccCCccccC--cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH---------------
Q 023058 174 Q----PKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI--------------- 232 (288)
Q Consensus 174 ~----~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~--------------- 232 (288)
. .....+++.|+|||.+.+ ..++.+ +|+||||+++|+|++|..||...+.........
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~-~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPA-IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCch-hHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 1 123468899999999865 455555 999999999999999999997654322111110
Q ss_pred --------HHHhhccc-CC-CCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 233 --------HRILSVQY-SI-PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 233 --------~~~~~~~~-~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
..+..... .+ .....+++++.++|.+||+.||.+|||+.++++ |+|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~---hp~f~ 294 (338)
T cd07859 237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA---DPYFK 294 (338)
T ss_pred hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc---Cchhh
Confidence 00000000 00 011246788999999999999999999988876 55553
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=296.56 Aligned_cols=251 Identities=30% Similarity=0.421 Sum_probs=202.2
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCcc----chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCch
Q 023058 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (288)
Q Consensus 29 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 104 (288)
||+|+||+||++.+..+++.||+|.+..... ..+.+..|+.++++++|+|++++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6899999999999999999999999875422 224567899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-CCCCc
Q 023058 105 FERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV 179 (288)
Q Consensus 105 ~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~~~~~ 179 (288)
...+.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||++........ .....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCccccccC
Confidence 877643 346899999999999999999999999999999999999987776 99999999865433322 23346
Q ss_pred CCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 023058 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259 (288)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 259 (288)
+++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||...............+.......+. .+++.+.+++.+|
T Consensus 159 g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~ 235 (280)
T cd05608 159 GTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFCEAL 235 (280)
T ss_pred CCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcc--cCCHHHHHHHHHH
Confidence 8899999999988888766 999999999999999999998755433333333333333333333 6889999999999
Q ss_pred cccCcCCccccccc--cccchhhhhhh
Q 023058 260 FVADPAKVSMHFHA--TGVYMHTKLQL 284 (288)
Q Consensus 260 l~~~p~~Rpt~~~~--l~~~~~~~~~~ 284 (288)
|+.||.+||++++. .+.+.|+|++-
T Consensus 236 l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 236 LAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred hcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 99999999955431 22444666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=306.56 Aligned_cols=240 Identities=35% Similarity=0.562 Sum_probs=202.2
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (288)
+.||+|+||.||++.+..+++.||+|++.... .......+|+.+++.++||||+++.+++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999987532 23345678999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCCCCCcC
Q 023058 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (288)
Q Consensus 103 ~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 180 (288)
+|...+.....+++..+..++.||+.||.|||+ .|++||||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccC
Confidence 999988888889999999999999999999997 79999999999999988776 999999988643222 22234568
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhc
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (288)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+... ....+......++. .+++++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tG~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~li~~~L 231 (325)
T cd05594 159 TPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILMEEIRFPR--TLSPEAKSLLSGLL 231 (325)
T ss_pred CcccCCHHHHccCCCCCc-cccccccceeeeeccCCCCCCCCCHHH----HHHHHhcCCCCCCC--CCCHHHHHHHHHHh
Confidence 999999999988888766 999999999999999999997654322 22333334444554 68999999999999
Q ss_pred ccCcCCcc-----ccccccc
Q 023058 261 VADPAKVS-----MHFHATG 275 (288)
Q Consensus 261 ~~~p~~Rp-----t~~~~l~ 275 (288)
+.||.+|+ ++.++++
T Consensus 232 ~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 232 KKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred hcCHHHhCCCCCCCHHHHhc
Confidence 99999997 6766655
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=302.31 Aligned_cols=240 Identities=32% Similarity=0.520 Sum_probs=203.2
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
+|.+.+.||+|+||.||++.+..++..||+|++.... ........|..++..+ .|++++++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999999999999999987542 2223456677777777 5889999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (288)
||+++++|...+...+.+++.++..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++...... ...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCcc
Confidence 99999999999988888999999999999999999999999999999999999988876 999999998743322 223
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.... ...+......++. .++.++.++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~l 231 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDEL----FQSIMEHNVAYPK--SMSKEAVAI 231 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCC--cCCHHHHHH
Confidence 34568999999999988888776 9999999999999999999987554332 3334444455554 689999999
Q ss_pred HHHhcccCcCCcccc
Q 023058 256 ISRIFVADPAKVSMH 270 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~ 270 (288)
+.+||+.||.+|++.
T Consensus 232 i~~~l~~~p~~R~~~ 246 (323)
T cd05616 232 CKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHcccCHHhcCCC
Confidence 999999999999996
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=297.89 Aligned_cols=251 Identities=29% Similarity=0.412 Sum_probs=199.4
Q ss_pred CCeeeeeeeeccCceEEEEEEEcC-CCcEEEEEEeecCc---cchHHHHHHHHHHhhC---CCCceeeEeEEEEc-----
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILT----- 88 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~----- 88 (288)
++|++.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 56889999886532 2233556677777665 69999999999853
Q ss_pred CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 89 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
....+++||++++ +|.+++... ..++...+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccce
Confidence 3568999999964 888888653 35899999999999999999999999999999999999987776 999999998
Q ss_pred cccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc-cCCCC-
Q 023058 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPD- 244 (288)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~- 244 (288)
.............+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||......+............. ..++.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCCcccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 76554444445568999999999988777776 9999999999999999999988766555444433211000 00000
Q ss_pred -------------------CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 245 -------------------YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 245 -------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
...+++.+.++|.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 1246788999999999999999999988876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=307.97 Aligned_cols=257 Identities=29% Similarity=0.448 Sum_probs=208.5
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
..++|++.+.||+|+||.||++.+..+++.+|+|++... ......+.+|+.+++.++||||+++++++..+..+++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 458999999999999999999999999999999998652 2233457789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
||||+++++|.+++... .+++..+..++.||+.||++||+.||+||||||+||+++.++. ++|+|||++........
T Consensus 121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETGM 197 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCCc
Confidence 99999999999988654 5899999999999999999999999999999999999987776 99999999875433222
Q ss_pred --CCCCcCCCcccCCccccCcc---cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 175 --PKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 175 --~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
.....+++.|+|||.+.+.. ....++|+||+|+++|+|++|..||...+........... .....++....++
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s 275 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH--KNSLNFPEDVEIS 275 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcccCCCCcccCC
Confidence 23456899999999986543 1234499999999999999999999876543333332211 1234556655789
Q ss_pred HHHHHHHHHhcccCcCC--ccccccccccchhhhhh
Q 023058 250 PECRHLISRIFVADPAK--VSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~--Rpt~~~~l~~~~~~~~~ 283 (288)
..++++|..||+.++.+ |+|+.++++ |+|+.
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~---hp~~~ 308 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQ---HPFFK 308 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhc---CcccC
Confidence 99999999999755543 788887766 55543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=294.67 Aligned_cols=257 Identities=25% Similarity=0.370 Sum_probs=210.1
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
.|+..+.||.|+||+||.+.+..+++.+|+|.+.... .....+.+|++++++++|+|++++.+.+..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 4788999999999999999999999999999987543 223346789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|+.+++|...+... ..++...+..++.|++.||.+||+.||+|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--IRISDLGLAVKIPEGESI 158 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC--EEEecCCcceecCCCCcc
Confidence 99999998877543 36999999999999999999999999999999999999987776 999999988755443333
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....+++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||...............+.......+. .++.++.+|
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 235 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSA--KFSEEAKSI 235 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCc--cCCHHHHHH
Confidence 44568899999999988877776 999999999999999999998765433333443333333333333 678999999
Q ss_pred HHHhcccCcCCccccccccc--cchhhhhh
Q 023058 256 ISRIFVADPAKVSMHFHATG--VYMHTKLQ 283 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~--~~~~~~~~ 283 (288)
+.+||+.||.+||++.+... .+.|+|+.
T Consensus 236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~ 265 (285)
T cd05632 236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265 (285)
T ss_pred HHHHccCCHhHcCCCcccChHHHHcChhhh
Confidence 99999999999999543321 44555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=299.00 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=206.6
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
..++|.+.+.||+|+||.||++.+..+++.+|+|.+.... .......+|+.++++++||||+++++++..++..++||
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 3478999999999999999999999999999999987542 23346778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-
Q 023058 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~- 174 (288)
||+++ +|.+.+... ..++...+..++.||+.||.+||+.|++||||+|+||+++.++. ++|+|||++........
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKT 160 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCccc
Confidence 99976 777776554 45899999999999999999999999999999999999987776 99999999865433222
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc---------------c
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------Q 239 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~ 239 (288)
.....+++.|+|||.+.+......++|+||||+++|+|++|..||...+..+............ .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 2334578899999998765433444999999999999999999998765544433332211100 0
Q ss_pred cCCC---------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 240 YSIP---------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 240 ~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
...+ ....+++++.++|.+||+.||.+|||+.|++. |+|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~---h~~~~~ 291 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK---HAYFRS 291 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc---Chhhhh
Confidence 0111 11247889999999999999999999988876 555553
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=301.25 Aligned_cols=240 Identities=35% Similarity=0.568 Sum_probs=202.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||+|+||+||++.+..++..||+|++... ........+|..+++.+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999998754 23334567788888877 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc-CCCCCCCcC
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (288)
++|...+...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceec
Confidence 999999988888999999999999999999999999999999999999988776 99999998864322 222334468
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhc
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (288)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+... ....+......++. .+++.+.++|.+||
T Consensus 159 ~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~~~~----~~~~i~~~~~~~~~--~~~~~~~~li~~~l 231 (318)
T cd05570 159 TPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDE----LFQSILEDEVRYPR--WLSKEAKSILKSFL 231 (318)
T ss_pred CccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCCHHH----HHHHHHcCCCCCCC--cCCHHHHHHHHHHc
Confidence 899999999988888776 999999999999999999997654322 22333444444444 68999999999999
Q ss_pred ccCcCCcccc-----ccccc
Q 023058 261 VADPAKVSMH-----FHATG 275 (288)
Q Consensus 261 ~~~p~~Rpt~-----~~~l~ 275 (288)
+.||.+|||+ .++++
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhc
Confidence 9999999999 66665
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=309.04 Aligned_cols=244 Identities=34% Similarity=0.553 Sum_probs=217.5
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCe
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 91 (288)
....++|..++.||.|+||+|+++..+.+++.||||+++++. ...+....|.+++... +||.++.++..|.++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 456689999999999999999999999999999999998763 4456677888888877 59999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc-
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV- 170 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~- 170 (288)
+|+||||+.||++. .++..+.|++..+..++..++.||.|||+.||++||||.+||++|.+|. +||.|||+++..-
T Consensus 444 l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMG 520 (694)
T ss_pred EEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCC
Confidence 99999999999843 3345578999999999999999999999999999999999999998888 9999999998654
Q ss_pred cCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
.+..+.+.+|||.|+|||++.+..|+.. .|-||||+++|+|+.|+.||.+.++.+.+.. +......+|. .++.
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee~Fds----I~~d~~~yP~--~ls~ 593 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEEEVFDS----IVNDEVRYPR--FLSK 593 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HhcCCCCCCC--cccH
Confidence 5566788899999999999999999887 9999999999999999999998877665554 4556777777 6899
Q ss_pred HHHHHHHHhcccCcCCcccc
Q 023058 251 ECRHLISRIFVADPAKVSMH 270 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~ 270 (288)
+..++++++|..+|.+|..+
T Consensus 594 ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 594 EAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHHHHHHhccCcccccCC
Confidence 99999999999999999988
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=300.70 Aligned_cols=240 Identities=32% Similarity=0.511 Sum_probs=199.8
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||+|+||.||++.+..+++.||+|++.... ...+....|..++... +||||+++++++...+.+++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999987642 2334566777777654 899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CCCCCcC
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVG 180 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~~~~~~ 180 (288)
++|...+.....++...+..++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++....... ......+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCC
Confidence 999999988888999999999999999999999999999999999999988776 9999999886432222 2234568
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhc
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (288)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+... ....+......++. .++.+++++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~li~~~l 231 (316)
T cd05620 159 TPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDEDE----LFESIRVDTPHYPR--WITKESKDILEKLF 231 (316)
T ss_pred CcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCC--CCCHHHHHHHHHHc
Confidence 999999999988888766 999999999999999999998654422 22233333444444 57899999999999
Q ss_pred ccCcCCccccc-cccc
Q 023058 261 VADPAKVSMHF-HATG 275 (288)
Q Consensus 261 ~~~p~~Rpt~~-~~l~ 275 (288)
+.||.+||++. ++++
T Consensus 232 ~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 232 ERDPTRRLGVVGNIRG 247 (316)
T ss_pred cCCHHHcCCChHHHHc
Confidence 99999999985 4443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=301.93 Aligned_cols=240 Identities=30% Similarity=0.475 Sum_probs=200.6
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||+|+||.||++.+..+++.||+|++.... ...+....|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999999999999999987642 2334566788888766 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCCCCCcC
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 180 (288)
++|...+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCcccccccc
Confidence 999999988888999999999999999999999999999999999999988776 999999988743322 22334458
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhc
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (288)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.... ...+.......+. .++.++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~ll~~~L 231 (321)
T cd05591 159 TPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADNEDDL----FESILHDDVLYPV--WLSKEAVSILKAFM 231 (321)
T ss_pred CccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence 899999999988888776 9999999999999999999987654333 3333444444444 57899999999999
Q ss_pred ccCcCCcc-------ccccccc
Q 023058 261 VADPAKVS-------MHFHATG 275 (288)
Q Consensus 261 ~~~p~~Rp-------t~~~~l~ 275 (288)
+.||.+|| ++.++++
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhc
Confidence 99999999 5555554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=299.95 Aligned_cols=253 Identities=29% Similarity=0.490 Sum_probs=208.0
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCC-CCceeeEeEEEEcCCeEEEEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 96 (288)
+|+..+.||+|+||+||+|++..+++.||+|++.... ...+....|..++..+. |++++++++++...+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999987532 23345667888888875 577888999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~ 175 (288)
||+++++|.+.+...+.+++.++..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++....... ..
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccc
Confidence 99999999999988888999999999999999999999999999999999999988776 9999999887433222 23
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....+++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||....... ....+.......+. .++.++.++
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~l 231 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPPFDGEDEDE----LFQSIMEHNVSYPK--SLSKEAVSI 231 (323)
T ss_pred cCccCCccccCHHHHcCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCc--cCCHHHHHH
Confidence 34558999999999988877766 999999999999999999998755432 33334444445554 688999999
Q ss_pred HHHhcccCcCCcccccccc--ccchhhhhh
Q 023058 256 ISRIFVADPAKVSMHFHAT--GVYMHTKLQ 283 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l--~~~~~~~~~ 283 (288)
+.+||+.+|.+|++..+.. +...|+|++
T Consensus 232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~ 261 (323)
T cd05615 232 CKGLMTKHPSKRLGCGPEGERDIREHAFFR 261 (323)
T ss_pred HHHHcccCHhhCCCCCCCCHHHHhcCcccC
Confidence 9999999999999975321 244455544
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=295.50 Aligned_cols=254 Identities=36% Similarity=0.538 Sum_probs=206.9
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHH---HHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~---~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
|++.+.||+|+||+||++.+..++..||+|.+......... ..+|+..+++++||||+++++++......+++|+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 88999999999999999999999999999999887544433 345999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc-ccCCCCCCC
Q 023058 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKST 178 (288)
Q Consensus 100 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~-~~~~~~~~~ 178 (288)
.+++|.+++...+.++..++..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+... .........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPF 158 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence 99999999987888999999999999999999999999999999999999997776 999999998753 223334456
Q ss_pred cCCCcccCCcccc-CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-ccCCCCCCCCCHHHHHHH
Q 023058 179 VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLI 256 (288)
Q Consensus 179 ~~~~~~~aPE~~~-~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li 256 (288)
.+++.|.|||.+. +...+.+ +|+||||+++++|++|..||......+............ ..........+..+.++|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~-~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRK-SDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTH-HHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccc-ccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 6888999999988 5555555 999999999999999999998763222222222121111 111111112348999999
Q ss_pred HHhcccCcCCccccccccccchhhhh
Q 023058 257 SRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 257 ~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
.+||+.||.+|||+.++++ |+|+
T Consensus 238 ~~~l~~~p~~R~~~~~l~~---~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLK---HPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHT---SGGG
T ss_pred HHHccCChhHCcCHHHHhc---CCCC
Confidence 9999999999999987765 5554
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=293.83 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=206.9
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc----chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
.|++.+.||+|+||.||++.+..+++.||+|.+..... ..+.+.+|+.++++++|++++++.+.+...+..+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999875422 22346789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|+.+++|.+.+...+ .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTI 158 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccc
Confidence 999999988885433 5899999999999999999999999999999999999987776 999999998755444433
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....+++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||.......................+. .+++++.+|
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l 235 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSE--KFSPDARSL 235 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCc--cCCHHHHHH
Confidence 44578899999999988887766 999999999999999999998654322222221111111222222 578999999
Q ss_pred HHHhcccCcCCccc-----cccccccchhhhhh
Q 023058 256 ISRIFVADPAKVSM-----HFHATGVYMHTKLQ 283 (288)
Q Consensus 256 i~~~l~~~p~~Rpt-----~~~~l~~~~~~~~~ 283 (288)
|.+||+.||.+||| +.++++ |+|+.
T Consensus 236 i~~~l~~~p~~R~s~~~~~~~~~~~---h~~~~ 265 (285)
T cd05630 236 CKMLLCKDPKERLGCQGGGAREVKE---HPLFK 265 (285)
T ss_pred HHHHhhcCHHHccCCCCCchHHHHc---Chhhh
Confidence 99999999999999 556655 55553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=299.62 Aligned_cols=240 Identities=32% Similarity=0.523 Sum_probs=199.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||+|+||+||++++..+++.||+|++... ....+....|..+++.. +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999998764 23334566677777754 899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCCCCCcC
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 180 (288)
++|...+.....++..++..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecC
Confidence 999999988778999999999999999999999999999999999999988776 999999988643222 22334568
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhc
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (288)
++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||...+.... ...+......++. .++.++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~li~~~l 231 (316)
T cd05619 159 TPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDEEEL----FQSIRMDNPCYPR--WLTREAKDILVKLF 231 (316)
T ss_pred CccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCc--cCCHHHHHHHHHHh
Confidence 899999999988887776 9999999999999999999987554322 2223333334444 57899999999999
Q ss_pred ccCcCCccccc-cccc
Q 023058 261 VADPAKVSMHF-HATG 275 (288)
Q Consensus 261 ~~~p~~Rpt~~-~~l~ 275 (288)
+.||.+||++. ++++
T Consensus 232 ~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 232 VREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCHhhcCCChHHHHc
Confidence 99999999996 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=301.32 Aligned_cols=247 Identities=31% Similarity=0.483 Sum_probs=201.0
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHH-HHhhCCCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||+|+||.||++++..+++.||+|++.... .....+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999999999999999987532 22233445544 57888999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc-CCCCCCCcC
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (288)
++|...+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccC
Confidence 999988888888999999999999999999999999999999999999988776 99999998864322 222334568
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhc
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (288)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+. ......+......++. ..+..+.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l 231 (321)
T cd05603 159 TPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDV----SQMYDNILHKPLQLPG--GKTVAACDLLVGLL 231 (321)
T ss_pred CcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCH----HHHHHHHhcCCCCCCC--CCCHHHHHHHHHHc
Confidence 899999999988877776 9999999999999999999987543 2233333444444444 67899999999999
Q ss_pred ccCcCCccccc-cccccchhhhh
Q 023058 261 VADPAKVSMHF-HATGVYMHTKL 282 (288)
Q Consensus 261 ~~~p~~Rpt~~-~~l~~~~~~~~ 282 (288)
+.||.+||++. ++++.+.|.|+
T Consensus 232 ~~~p~~R~~~~~~~~~~~~~~~~ 254 (321)
T cd05603 232 HKDQRRRLGAKADFLEIKNHVFF 254 (321)
T ss_pred cCCHhhcCCCCCCHHHHhCCCCc
Confidence 99999999875 33334445544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=297.95 Aligned_cols=240 Identities=35% Similarity=0.549 Sum_probs=198.7
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhh-CCCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||+|+||.||++.+..+++.||+|++.... ...+....|..++.. .+||||+++++++..++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987532 223344556666654 4899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCCCCCcC
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 180 (288)
++|...+.....++...+..++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccC
Confidence 999999988888999999999999999999999999999999999999987776 999999998754322 22334568
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhc
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (288)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+... ....+......++. .++.++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~~~~----~~~~i~~~~~~~~~--~~~~~~~~ll~~~l 231 (316)
T cd05592 159 TPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDEDE----LFDSILNDRPHFPR--WISKEAKDCLSKLF 231 (316)
T ss_pred CccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCC--CCCHHHHHHHHHHc
Confidence 999999999988887766 999999999999999999998765422 22233333444444 57899999999999
Q ss_pred ccCcCCccccc-cccc
Q 023058 261 VADPAKVSMHF-HATG 275 (288)
Q Consensus 261 ~~~p~~Rpt~~-~~l~ 275 (288)
+.||.+||++. ++++
T Consensus 232 ~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 232 ERDPTKRLGVDGDIRQ 247 (316)
T ss_pred cCCHHHcCCChHHHHc
Confidence 99999999975 4434
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=301.08 Aligned_cols=247 Identities=32% Similarity=0.530 Sum_probs=200.2
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHH-HHHhhCCCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||+|+||+||++++..+++.||+|++.... .....+.+|. .+++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999987532 2222334443 356788999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc-CCCCCCCcC
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (288)
++|...+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~--~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEEccCCCCcccccCCCCcccccC
Confidence 999999988888999999999999999999999999999999999999987776 99999999864322 222344568
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhc
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (288)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+...... .+.......+. .+++.+.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~----~i~~~~~~~~~--~~~~~~~~li~~~l 231 (325)
T cd05602 159 TPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYD----NILNKPLQLKP--NITNSARHLLEGLL 231 (325)
T ss_pred CccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCCHHHHHH----HHHhCCcCCCC--CCCHHHHHHHHHHc
Confidence 999999999988887766 999999999999999999998655433322 22333333333 68999999999999
Q ss_pred ccCcCCccccccccc-cchhhhh
Q 023058 261 VADPAKVSMHFHATG-VYMHTKL 282 (288)
Q Consensus 261 ~~~p~~Rpt~~~~l~-~~~~~~~ 282 (288)
+.||.+|+++.+.+. ...|.|+
T Consensus 232 ~~~p~~R~~~~~~~~~i~~~~~~ 254 (325)
T cd05602 232 QKDRTKRLGAKDDFMEIKNHIFF 254 (325)
T ss_pred ccCHHHCCCCCCCHHHHhcCccc
Confidence 999999999975432 3344443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=302.66 Aligned_cols=248 Identities=29% Similarity=0.461 Sum_probs=202.9
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHH-HHhhCCCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||+|+||+||++.+..+++.+|+|++.... .....+..|.. +++.++||||+++++.+..++..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999999999999999987532 22234445544 46778999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc-CCCCCCCcC
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (288)
++|...+.....+++..+..++.||+.||+|||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccC
Confidence 999999888888999999999999999999999999999999999999988876 99999999864322 222334568
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhc
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (288)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+...... .+.......+. ..+..+.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~ll~~ll 231 (325)
T cd05604 159 TPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAEMYD----NILHKPLVLRP--GASLTAWSILEELL 231 (325)
T ss_pred ChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCCHHHHHH----HHHcCCccCCC--CCCHHHHHHHHHHh
Confidence 999999999988888776 999999999999999999998765433322 33333333333 57899999999999
Q ss_pred ccCcCCccccccccc-cchhhhhh
Q 023058 261 VADPAKVSMHFHATG-VYMHTKLQ 283 (288)
Q Consensus 261 ~~~p~~Rpt~~~~l~-~~~~~~~~ 283 (288)
+.+|.+||++.+.++ .+.|+|+.
T Consensus 232 ~~~p~~R~~~~~~~~~i~~h~~f~ 255 (325)
T cd05604 232 EKDRQRRLGAKEDFLEIQEHPFFE 255 (325)
T ss_pred ccCHHhcCCCCCCHHHHhcCCCcC
Confidence 999999999974433 55566654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=301.31 Aligned_cols=258 Identities=36% Similarity=0.628 Sum_probs=230.1
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
-+...+=|.+.+.||+|-|++|.+|++.-+|+.||+|++.+.. .....+.+|++-++.++|||||+++++......+
T Consensus 13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence 3344578999999999999999999999999999999997643 3445688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
|+|.|.-++|+|.+++..+. .+.+.....++.||+.|+.|+|+.-+|||||||+||++-. ..+-+||.|||++-...+
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE-KlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE-KLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee-ecCceEeeeccccccCCC
Confidence 99999999999999986654 5899999999999999999999999999999999998852 233499999999999999
Q ss_pred CCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
+......+|+..|.|||++.+..|+.++.||||||+++|.|++|+.||...++.+ -...+....++.|. .++.+
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----TLTmImDCKYtvPs--hvS~e 245 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----TLTMIMDCKYTVPS--HVSKE 245 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----hhhhhhcccccCch--hhhHH
Confidence 9999999999999999999999999999999999999999999999999877644 44556788888888 79999
Q ss_pred HHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.++||.+||..||.+|.+.+++.. ++|++
T Consensus 246 CrdLI~sMLvRdPkkRAslEeI~s---~~Wlq 274 (864)
T KOG4717|consen 246 CRDLIQSMLVRDPKKRASLEEIVS---TSWLQ 274 (864)
T ss_pred HHHHHHHHHhcCchhhccHHHHhc---ccccc
Confidence 999999999999999999988765 66665
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=286.69 Aligned_cols=256 Identities=34% Similarity=0.515 Sum_probs=222.8
Q ss_pred CCCCeeee-eeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEEEEcC----CeE
Q 023058 19 DSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP----THL 92 (288)
Q Consensus 19 ~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~----~~~ 92 (288)
..+.|++- +.||-|-.|.|-.+.++.+++.+|+|++..+ ....+|+++..+. .|||||.++++|... +.+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 34667663 6789999999999999999999999986543 3567899998777 699999999998653 468
Q ss_pred EEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC-CCCCCEEEeecCCCccc
Q 023058 93 AIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 169 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~-~~~~~~~l~df~~~~~~ 169 (288)
.+|||+++||.|.+.++..+. +++.++..|++||..|+.|||+.+|+||||||+|+++.. ..++.+||+|||++...
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 899999999999999988765 999999999999999999999999999999999999954 33456999999999988
Q ss_pred ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC--CCCC
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVH 247 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 247 (288)
.......+.+.||.|.|||++....|+-. .|+||+|+++|-|++|.+||.+.......-.....+..+.+.|| +|.+
T Consensus 215 ~~~~~L~TPc~TPyYvaPevlg~eKydks-cdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~ 293 (400)
T KOG0604|consen 215 QEPGDLMTPCFTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSC 293 (400)
T ss_pred CCCccccCCcccccccCHHHhCchhcCCC-CCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhH
Confidence 87778888999999999999988888777 89999999999999999999987776666666677788888776 4889
Q ss_pred CCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
+|++.+++|+.+|..+|.+|.|+.++.+ |+|+
T Consensus 294 VSe~aKdlIR~LLkt~PteRlTI~~~m~---hpwi 325 (400)
T KOG0604|consen 294 VSEAAKDLIRKLLKTEPTERLTIEEVMD---HPWI 325 (400)
T ss_pred HHHHHHHHHHHHhcCCchhheeHHHhhc---Cchh
Confidence 9999999999999999999999987766 6665
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=299.57 Aligned_cols=240 Identities=28% Similarity=0.473 Sum_probs=200.0
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|..++.++ +||||+++++++.....+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999998642 2334577888888888 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc-CCCCCCCcC
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 180 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~-~~~~~~~~~ 180 (288)
++|...+...+.+++..++.++.||+.||+|||+.|++||||||+||+++.++. ++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccC
Confidence 999998888888999999999999999999999999999999999999988777 99999998864322 223344568
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCc---hhHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (288)
++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...... .........+......++. .++..+.++|.
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~ 235 (327)
T cd05617 159 TPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR--FLSVKASHVLK 235 (327)
T ss_pred CcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC--CCCHHHHHHHH
Confidence 999999999988888766 99999999999999999999643221 1122223333333444444 68899999999
Q ss_pred HhcccCcCCccccc
Q 023058 258 RIFVADPAKVSMHF 271 (288)
Q Consensus 258 ~~l~~~p~~Rpt~~ 271 (288)
+||+.||.+|+++.
T Consensus 236 ~~L~~dP~~R~~~~ 249 (327)
T cd05617 236 GFLNKDPKERLGCQ 249 (327)
T ss_pred HHhccCHHHcCCCC
Confidence 99999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=311.37 Aligned_cols=248 Identities=29% Similarity=0.430 Sum_probs=205.0
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCC-CcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
...|.+.+.||.|++|.||.|.+..+ +..+++|.+.... .....+.+|+.+++.++||||+++++++..++.+++|||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 35599999999999999999998877 7888999775543 223457789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 98 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
|+++++|.+.+.. ..++++.++..++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++.......
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCcc
Confidence 9999999887643 346899999999999999999999999999999999999987776 9999999987543322
Q ss_pred C---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 174 Q---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 174 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
. .....+++.|+|||.+.+..++.+ +|+|||||++|+|++|..||......... ..+...... +....+++
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~Pf~~~~~~~~~----~~~~~~~~~-~~~~~~s~ 297 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQREIM----QQVLYGKYD-PFPCPVSS 297 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCC-CCCccCCH
Confidence 1 234458999999999988877766 99999999999999999999765432222 222222221 12236789
Q ss_pred HHHHHHHHhcccCcCCccccccccc
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++.++|.+||+.||.+||++.+++.
T Consensus 298 ~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 298 GMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHh
Confidence 9999999999999999999998876
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=287.47 Aligned_cols=248 Identities=31% Similarity=0.465 Sum_probs=206.9
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc------chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
++|++.+.||+|++|.||.+.+..++..+++|.+..... ..+.+.+|++++++++||||+++++++..+...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 679999999999999999999998999999999875421 22457789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
++|++++++|.+.+...+.++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecccccc
Confidence 9999999999999988888999999999999999999999999999999999999987776 99999999865433221
Q ss_pred C----CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 175 P----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 175 ~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
. ....++..|+|||.+.+..++.+ +|+||||+++|++++|..||...+.......... .......+. .++.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~--~~~~ 234 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRK-ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT--QPTNPQLPS--HVSP 234 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCch-hhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc--cCCCCCCCc--cCCH
Confidence 1 23456788999999988776666 9999999999999999999976544333222111 111222333 6889
Q ss_pred HHHHHHHHhcccCcCCccccccccc
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+.++|.+||..+|.+|||+.+++.
T Consensus 235 ~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 235 DARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHhh
Confidence 9999999999999999999988866
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=304.33 Aligned_cols=258 Identities=26% Similarity=0.392 Sum_probs=204.8
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcC------
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 89 (288)
..++|++.+.||+|+||.||.+.+..+++.||+|++... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 458999999999999999999999999999999998653 23345677899999999999999999987643
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
..+++||||+++ +|...+.. .++...+..++.|++.||.+||+.||+||||||+||+++.++. ++|+|||++...
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCcccc
Confidence 357999999966 67666643 4788999999999999999999999999999999999988776 999999999765
Q ss_pred ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh-------------
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL------------- 236 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~------------- 236 (288)
..........+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.............
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 44444445578899999999988888776 9999999999999999999987654443333322110
Q ss_pred -----hcccCC--------------C----CCCCCCHHHHHHHHHhcccCcCCccccccccc-cchhhhh
Q 023058 237 -----SVQYSI--------------P----DYVHISPECRHLISRIFVADPAKVSMHFHATG-VYMHTKL 282 (288)
Q Consensus 237 -----~~~~~~--------------~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~~~~ 282 (288)
.....+ + .....+..+++||.+||+.||.+|||+.++++ .++..|.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~ 325 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence 000000 0 00113467899999999999999999999877 4444443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=317.68 Aligned_cols=248 Identities=28% Similarity=0.471 Sum_probs=209.7
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC-ccchHHHHHHHHHHhhCC-CCceeeEeE-EEEcC------C
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLR-HPNIVRFKE-VILTP------T 90 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~-~~~i~~~~~-~~~~~------~ 90 (288)
..+++|.+.|.+|||+.||+|++...+..||+|++... ....+.+.+|++++++|+ |+|||.++| ..... .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 46788999999999999999999988799999987654 445567889999999996 999999999 33221 2
Q ss_pred eEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcC--ceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 91 HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~--i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
.+.|+||||.++.|.+++.. ...|++.++++|+.++++|+.+||... |+|||||-+|||++.++. +||||||.+
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCccccc
Confidence 57899999999999999974 346999999999999999999999998 999999999999998887 999999998
Q ss_pred cccccCCCCC----------CCcCCCcccCCccc---cCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 023058 167 KSSVLHSQPK----------STVGTPAYIAPEVL---LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (288)
Q Consensus 167 ~~~~~~~~~~----------~~~~~~~~~aPE~~---~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 233 (288)
+......... ..-.|+.|+|||.+ .+...+.+ +|||+|||++|.|+....||......
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK-sDIWALGclLYkLCy~t~PFe~sg~l-------- 264 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK-SDIWALGCLLYKLCYFTTPFEESGKL-------- 264 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch-hHHHHHHHHHHHHHHhCCCcCcCcce--------
Confidence 7544433221 12378999999986 35556666 99999999999999999999865332
Q ss_pred HHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.|..+.+.+|....++..+.+||..||+.||.+||++.+++..+.
T Consensus 265 aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 265 AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 467888999998889999999999999999999999999887544
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=305.02 Aligned_cols=251 Identities=32% Similarity=0.461 Sum_probs=204.6
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
...++|++.+.||+|+||.||++++..+++.+|+|++.... ...+.+.+|+.+++.++||||+++++.+..+..++
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34589999999999999999999999999999999986422 22345678999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
+||||+++++|.+++... .++...+..++.||+.||.+||+.||+||||||+||+++.++. ++|+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCC
Confidence 999999999999888654 5899999999999999999999999999999999999987776 9999999987554322
Q ss_pred C--CCCCcCCCcccCCccccCcc----cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 174 Q--PKSTVGTPAYIAPEVLLKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 174 ~--~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
. .....+++.|+|||.+.+.. ++.+ +|+||||+++|+|++|..||...+.......+... .....++....
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~ 273 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRE-CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--KNSLTFPDDND 273 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCc-cceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCcccCCCcCC
Confidence 2 23456899999999986543 4444 99999999999999999999876543333332211 12234555557
Q ss_pred CCHHHHHHHHHhcccCcCC---ccccccccc
Q 023058 248 ISPECRHLISRIFVADPAK---VSMHFHATG 275 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~---Rpt~~~~l~ 275 (288)
++..++++|.+||+ +|.. |+++.++++
T Consensus 274 ~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 274 ISKEAKNLICAFLT-DREVRLGRNGVEEIKR 303 (371)
T ss_pred CCHHHHHHHHHHcC-ChhhhcCCCCHHHHhc
Confidence 89999999999997 5544 667777666
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=303.78 Aligned_cols=256 Identities=26% Similarity=0.384 Sum_probs=203.3
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcC------
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 89 (288)
..++|++.+.||+|+||.||++.+..+++.+|+|.+.... .......+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4589999999999999999999999899999999987532 3345677899999999999999999998654
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
...+++||++++ ++.+.+.. .++...+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++...
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~ 169 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 169 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccC
Confidence 357999999966 66666643 4788999999999999999999999999999999999988776 999999999765
Q ss_pred ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh-------------
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL------------- 236 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~------------- 236 (288)
..........+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.............
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 54444455678999999999988888777 9999999999999999999987554333222221110
Q ss_pred -----hcccC--------------CC----CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 237 -----SVQYS--------------IP----DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 237 -----~~~~~--------------~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
..... ++ .....+.++++||.+||+.||.+|||+.|+++ |+|++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~---hp~~~ 315 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ---HPYIN 315 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc---Ccchh
Confidence 00000 00 01123567899999999999999999988877 44443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=293.39 Aligned_cols=254 Identities=27% Similarity=0.393 Sum_probs=200.2
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhC---CCCceeeEeEEEEc-----CC
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILT-----PT 90 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----~~ 90 (288)
+|++.+.||+|+||+||++.+..+++.||+|.+.... .......+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 6899999999999999999999999999999886532 2223456677776665 79999999998864 24
Q ss_pred eEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcc
Q 023058 91 HLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~ 168 (288)
..+++||++.+ +|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARI 157 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCcccc
Confidence 68999999975 8888876543 4899999999999999999999999999999999999987776 99999999876
Q ss_pred cccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-------ccC
Q 023058 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------QYS 241 (288)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------~~~ 241 (288)
...........+++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||..........+........ ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred ccCcccCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 554444445567889999999988777776 999999999999999999997765544433333221100 000
Q ss_pred -----CC---------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 242 -----IP---------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 242 -----~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
+. ....+++.+.++|.+||+.||.+|||+.+++. |+|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~---hp~f 288 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ---HPFF 288 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc---CCCC
Confidence 00 01246788999999999999999999988865 5553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=291.26 Aligned_cols=249 Identities=35% Similarity=0.590 Sum_probs=210.4
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++.+.||.|++|.||++.+..+++.+++|++.... ...+.+.+|++++++++||||+++++++..+...+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 57999999999999999999999999999999987532 33456888999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
|++++++|.+++.....++...+..++.|++.+|.+||+.|++|+||+|.||+++.++. ++|+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TY 156 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CC
Confidence 99999999999988888999999999999999999999999999999999999988776 999999998755433 33
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (288)
...+++.|+|||.+.+...+.. +|+||||+++|+|++|..||...+.. .....+......++. ..+..++++|
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~--~~~~~l~~li 229 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAGYPPFFDDNPI----QIYEKILEGKVRFPS--FFSPDAKDLI 229 (290)
T ss_pred CCCCCccccChhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCCccCCc--cCCHHHHHHH
Confidence 4467889999999877766555 99999999999999999999765532 222233344444444 5789999999
Q ss_pred HHhcccCcCCcc-----ccccccccchhhhhh
Q 023058 257 SRIFVADPAKVS-----MHFHATGVYMHTKLQ 283 (288)
Q Consensus 257 ~~~l~~~p~~Rp-----t~~~~l~~~~~~~~~ 283 (288)
.+||+.||.+|+ +++++++ |+|++
T Consensus 230 ~~~l~~~p~~R~~~~~~~~~~l~~---~~~~~ 258 (290)
T cd05580 230 RNLLQVDLTKRLGNLKNGVNDIKN---HPWFA 258 (290)
T ss_pred HHHccCCHHHccCcccCCHHHHHc---Ccccc
Confidence 999999999999 5555544 55544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=305.03 Aligned_cols=256 Identities=27% Similarity=0.377 Sum_probs=203.0
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCC-----eEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 93 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 93 (288)
+|++.+.||+|+||.||++.+..+++.||+|.+... ....+++.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478999999999999999999989999999988643 223456889999999999999999999998776 789
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
+|+||+. ++|...+.....++...+..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDE 157 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCc
Confidence 9999996 478888877778999999999999999999999999999999999999988776 9999999987543322
Q ss_pred C--CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH-----------------
Q 023058 174 Q--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR----------------- 234 (288)
Q Consensus 174 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~----------------- 234 (288)
. .....+++.|+|||.+.+......++|+||+||++++|++|..||...+.......+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 1 223457889999999877553344499999999999999999999876543322222110
Q ss_pred --HhhcccCC-------CCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 235 --ILSVQYSI-------PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 235 --~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+....... ......++++.+||.+||+.||.+|||+.+++. |+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~---hp~~~ 292 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA---HPYLD 292 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc---CHhhC
Confidence 00001100 111246789999999999999999999988866 55543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=290.11 Aligned_cols=248 Identities=19% Similarity=0.185 Sum_probs=202.3
Q ss_pred CCCCeeee--eeeeccCceEEEEEEEcCCCcEEEEEEeecCccch----HHHHHHHHHHhhCCCCceeeEeEEEEc----
Q 023058 19 DSDRYELV--RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILT---- 88 (288)
Q Consensus 19 ~~~~y~~~--~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 88 (288)
..+++... ..|++|+++.||++.. +|+.||+|.+....... +.+.+|+.++++++||||+++++++.+
T Consensus 16 ~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~ 93 (283)
T PHA02988 16 ESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93 (283)
T ss_pred CHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccC
Confidence 34455555 6789999999999998 58899999987654333 556799999999999999999999876
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc-CceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
...++++|||+++++|.+++...+.++......++.+++.|+.+||+. +++|+||+|+||+++.++. ++|+|||++.
T Consensus 94 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~ 171 (283)
T PHA02988 94 LPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEK 171 (283)
T ss_pred CCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHh
Confidence 347899999999999999998888899999999999999999999984 9999999999999998776 9999999987
Q ss_pred ccccCCCCCCCcCCCcccCCccccC--cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCC
Q 023058 168 SSVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245 (288)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (288)
..... .....+++.|+|||.+.+ ..++.+ +||||||+++|+|++|..||...+..... ..+.......+..
T Consensus 172 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k-~Di~SlGvil~el~~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~ 244 (283)
T PHA02988 172 ILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIK-DDIYSLGVVLWEIFTGKIPFENLTTKEIY----DLIINKNNSLKLP 244 (283)
T ss_pred hhccc--cccccCcccccCHHHhhhccccccch-hhhhHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhcCCCCCCC
Confidence 44322 234557889999999876 456666 99999999999999999999876543322 2232222223322
Q ss_pred CCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 246 VHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 246 ~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
..+++.+.++|.+||+.||.+|||+.++++.+
T Consensus 245 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 245 LDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 36899999999999999999999999998743
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=321.27 Aligned_cols=257 Identities=31% Similarity=0.513 Sum_probs=206.8
Q ss_pred CCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcC
Q 023058 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (288)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (288)
........++|.+++.||.|+||+||++.+..++..+++|++... ......+..|+.++++++||||++++++|...
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 334445568999999999999999999999999999999998753 23345688899999999999999999988653
Q ss_pred --CeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhc-------CceecCCCCCceEecCC---
Q 023058 90 --THLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-------QVCHRDLKLENTLLDGS--- 153 (288)
Q Consensus 90 --~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~-------~i~H~dl~p~nilv~~~--- 153 (288)
..+++||||+++++|..++.. ...+++..++.|+.||+.||.|||+. +|+|+||||+||+++.+
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 578999999999999988864 25699999999999999999999985 49999999999999642
Q ss_pred ------------CCCCEEEeecCCCcccccCCCCCCCcCCCcccCCccccCc--ccCCCccchhhHHHHHHHHHhCCCCC
Q 023058 154 ------------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPF 219 (288)
Q Consensus 154 ------------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~~~~l~~g~~pf 219 (288)
+.+.++|+|||++.............+++.|+|||++.+. .++.+ +|||||||++|+|++|..||
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~K-SDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCch-hHHHHHHHHHHHHHHCCCCC
Confidence 2334899999998765444444455789999999998643 34555 99999999999999999999
Q ss_pred CCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 220 EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
......... ...+.. ...++. ...+.++.+||..||+.+|.+||++.+++.
T Consensus 244 ~~~~~~~ql---i~~lk~-~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 244 HKANNFSQL---ISELKR-GPDLPI-KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcCCcHHHH---HHHHhc-CCCCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 765443322 222222 222222 256899999999999999999999988876
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=292.60 Aligned_cols=260 Identities=25% Similarity=0.414 Sum_probs=206.5
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
..++|++.+.||.|++|.||++.+..++..|++|.+.... .......+|+.++++++||||+++++++..+...++||
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 4578999999999999999999999899999999987542 23346778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-
Q 023058 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~- 174 (288)
||+++ +|...+... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKT 160 (301)
T ss_pred ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCc
Confidence 99975 888777653 46899999999999999999999999999999999999988776 99999998875433222
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc---------------c
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------Q 239 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~ 239 (288)
.....+++.|+|||.+.+......++|+||||+++|+|++|..||...+..+............ .
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 2334568899999998765544445999999999999999999998765433332222111000 0
Q ss_pred cCCCC---------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 240 YSIPD---------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 240 ~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
...+. ...+++++.+||.+||+.||.+|||+.++++ |+|++-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~---h~~f~~ 291 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK---HPYFHC 291 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc---Cccccc
Confidence 01111 1247889999999999999999999987766 665543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=292.97 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=199.8
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcC----------------CCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceee
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKK----------------TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVR 81 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~----------------~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~ 81 (288)
.++|++.+.||+|+||.||++.+.. ++..||+|.+.... .....+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4789999999999999999998642 33479999887643 23346889999999999999999
Q ss_pred EeEEEEcCCeEEEEEeccCCCchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHhhcCceecC
Q 023058 82 FKEVILTPTHLAIVMEYASGGELFERICNAG-------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRD 142 (288)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~d 142 (288)
+++++...+..+++|||+.+++|.+++.... .++...++.++.||+.||.+||+.|++|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 9999999999999999999999998885431 356778999999999999999999999999
Q ss_pred CCCCceEecCCCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh--CCC
Q 023058 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAY 217 (288)
Q Consensus 143 l~p~nilv~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~--g~~ 217 (288)
|||+||+++.++. ++|+|||++........ .....++..|+|||.+.+..++.+ +|+||||+++|+|++ +..
T Consensus 164 lkp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 164 LATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cchhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch-hhhHHHHHHHHHHHHccCCC
Confidence 9999999987776 99999999875433221 223334678999999888777776 999999999999986 567
Q ss_pred CCCCCCCchhHHHHHHHHhhc--ccCCCCCCCCCHHHHHHHHHhcccCcCCcccccccccc
Q 023058 218 PFEDPEEPKNFRKTIHRILSV--QYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 218 pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
||................... .........+|..+.++|.+||+.||.+|||+.++.+.
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~ 301 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAF 301 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 887655433333222211111 11111223678999999999999999999999988553
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=301.42 Aligned_cols=247 Identities=31% Similarity=0.499 Sum_probs=198.2
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhC---CCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL---RHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 29 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
||+|+||+||++++..+++.||+|++.... ........|..++.+. +||||+++++++.....+++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999999999999999987532 1222344566666555 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCCCCCcC
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 180 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~ 180 (288)
++|...+...+.+++..+..++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccC
Confidence 999999988888999999999999999999999999999999999999988776 999999998753322 22344568
Q ss_pred CCcccCCccccCcc-cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 023058 181 TPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259 (288)
Q Consensus 181 ~~~~~aPE~~~~~~-~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 259 (288)
++.|+|||.+.+.. ++.. +|+||||+++|+|++|..||...+.. .....+......++.. .+++++.++|.+|
T Consensus 159 t~~y~aPE~~~~~~~~~~~-~DvwslGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~-~~~~~~~~li~~~ 232 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKH-VDFWSLGVLVFEMCCGWSPFYAEDTQ----QMYRNIAFGKVRFPKN-VLSDEGRQFVKGL 232 (330)
T ss_pred CccccCHHHHcCCCCCCCc-cceeccccEEEEeccCCCCCCCCCHH----HHHHHHHcCCCCCCCc-cCCHHHHHHHHHH
Confidence 99999999987654 4444 99999999999999999999765432 2233333344444432 4789999999999
Q ss_pred cccCcCCccccccc-cccchhhhhh
Q 023058 260 FVADPAKVSMHFHA-TGVYMHTKLQ 283 (288)
Q Consensus 260 l~~~p~~Rpt~~~~-l~~~~~~~~~ 283 (288)
|+.||.+||++.+. .+.+.|+|+.
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~~~~ 257 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHPFFA 257 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCcccc
Confidence 99999999965432 2355566654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=310.62 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=200.0
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCC------CceeeEeEEEEcC-Ce
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH------PNIVRFKEVILTP-TH 91 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~-~~ 91 (288)
..++|++.+.||+|+||+||++.+..+++.||+|++............|+.+++.++| .+++.+++++..+ ..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 3578999999999999999999999999999999987654444556678887777754 4588899988765 57
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCC--------------C
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPA--------------P 156 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~--------------~ 156 (288)
+++||+++ +++|.+++...+.++...+..++.||+.||+|||+ .||+||||||+||+++.++. +
T Consensus 207 ~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 207 MCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 89999988 56888888887889999999999999999999997 59999999999999976542 2
Q ss_pred CEEEeecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 023058 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 236 (288)
Q Consensus 157 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (288)
.+||+|||.+.... .......+++.|+|||++.+..++.. +|||||||++|+|++|..||...+..+....+.....
T Consensus 286 ~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g 362 (467)
T PTZ00284 286 RVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLG 362 (467)
T ss_pred eEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcC
Confidence 48999999875322 22334568999999999998888777 9999999999999999999987654332222111100
Q ss_pred h-------------------cccCC-C----------------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhh
Q 023058 237 S-------------------VQYSI-P----------------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHT 280 (288)
Q Consensus 237 ~-------------------~~~~~-~----------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~ 280 (288)
. ....+ + .....++.+.+||.+||++||.+|||+.|+++ |+
T Consensus 363 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~---Hp 439 (467)
T PTZ00284 363 RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT---HP 439 (467)
T ss_pred CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc---Cc
Confidence 0 00000 0 00012456889999999999999999998876 55
Q ss_pred hhhh
Q 023058 281 KLQL 284 (288)
Q Consensus 281 ~~~~ 284 (288)
|+..
T Consensus 440 ~~~~ 443 (467)
T PTZ00284 440 YVLK 443 (467)
T ss_pred cccc
Confidence 5543
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=308.98 Aligned_cols=252 Identities=29% Similarity=0.454 Sum_probs=206.2
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC--
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-- 90 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 90 (288)
.....++|.+.+.||+|+||+||++.+..+++.||+|++.... .....+.+|+..+..++|+|++++++.+....
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3445589999999999999999999999999999999987643 23345778999999999999999988775432
Q ss_pred ------eEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEE
Q 023058 91 ------HLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (288)
Q Consensus 91 ------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l 160 (288)
.+++||||+++++|.+.+... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++. ++|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL 184 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKL 184 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEE
Confidence 368999999999999888542 36899999999999999999999999999999999999988776 999
Q ss_pred eecCCCcccccC---CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 023058 161 CDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237 (288)
Q Consensus 161 ~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (288)
+|||++...... .......+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+... ....+..
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~~~~----~~~~~~~ 259 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEE----VMHKTLA 259 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHhc
Confidence 999998754322 22234568999999999988888776 999999999999999999997654322 2222222
Q ss_pred cccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 238 VQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 238 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.... +....+++++.++|.+||+.||.+||++.++++
T Consensus 260 ~~~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 260 GRYD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 2221 122368999999999999999999999988876
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=286.11 Aligned_cols=252 Identities=20% Similarity=0.311 Sum_probs=209.1
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
+....|.+.+.||+|++|.||++.+..+++.+++|.+..+....+.+.+|++.+++++|+|++++++++..+..++++||
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 34577999999999999999999999889999999988766666778899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|+++++|.+++... ..++...+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYT 160 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceee
Confidence 99999999988654 35899999999999999999999999999999999999987776 999999998754433221
Q ss_pred C--CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 176 K--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 176 ~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
. ....+..|+|||.+.+..++.. +|+||||+++|+|++ |..||...+........ .. ....+....+|..+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~ 234 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EK-GYRMERPEGCPPKV 234 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----HC-CCCCCCCCCCCHHH
Confidence 1 1223567999999888777766 999999999999998 89998765433322222 11 12222233688999
Q ss_pred HHHHHHhcccCcCCccccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.++|.+||+.+|.+|||+.++++.+
T Consensus 235 ~~li~~cl~~~p~~Rp~~~~l~~~l 259 (263)
T cd05052 235 YELMRACWQWNPSDRPSFAEIHQAF 259 (263)
T ss_pred HHHHHHHccCCcccCCCHHHHHHHH
Confidence 9999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=287.91 Aligned_cols=251 Identities=27% Similarity=0.400 Sum_probs=205.3
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
.++|++.+.||+|+||.||++.+..+++.+++|++.... .....+.+|+.++++++|||++++++.+..+...++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 478999999999999999999999899999999987543 3345677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-CCC
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~~~ 177 (288)
+++++|.+++...+.++...+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++........ ...
T Consensus 88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd06646 88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRKS 165 (267)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccCc
Confidence 999999999887788999999999999999999999999999999999999987776 99999999875533222 233
Q ss_pred CcCCCcccCCccccC---cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc---CCCCCCCCCHH
Q 023058 178 TVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY---SIPDYVHISPE 251 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 251 (288)
..+++.|+|||.+.. ..++. ++|+||+|+++++|++|..||............ ..... .......++..
T Consensus 166 ~~~~~~y~~PE~~~~~~~~~~~~-~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 166 FIGTPYWMAPEVAAVEKNGGYNQ-LCDIWAVGITAIELAELQPPMFDLHPMRALFLM----SKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred cccCccccCHhHcccccCCCCcc-hhhHHHHHHHHHHHHhCCCCccccchhhhheee----ecCCCCCCCCccccccCHH
Confidence 457788999998743 33444 499999999999999999998654322211111 11111 11222357889
Q ss_pred HHHHHHHhcccCcCCccccccccccc
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
+.++|.+||+.+|.+|||+.++++.+
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 99999999999999999999988743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=287.43 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=204.4
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEc---CCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
+..++|++.+.||+|+||.||++... ..+..+++|.+.... .....+.+|+..+++++||||+++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 35678999999999999999999764 345689999887643 2234678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
++||||+++++|.+++... ..++...++.++.|++.||++||+.|++|+||+|+||+++.++. ++++|||.+.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~ 159 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKS 159 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc--EEECCCcccccccc
Confidence 9999999999999888764 47899999999999999999999999999999999999987776 99999997654322
Q ss_pred CCCC--CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCC
Q 023058 172 HSQP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 172 ~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
.... ....++..|+|||.+.+..++.+ +|+||||+++|++++ |..||.......... .+.. ....+....+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~ 233 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIK----AVED-GFRLPAPRNC 233 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH----HHHC-CCCCCCCCCC
Confidence 2111 12234567999999988877776 999999999999775 999998765433222 2222 2223344478
Q ss_pred CHHHHHHHHHhcccCcCCccccccccccc
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
|..+.+++.+||+.+|.+||++.++.+.+
T Consensus 234 ~~~~~~li~~c~~~~p~~RP~~~~i~~~l 262 (266)
T cd05064 234 PNLLHQLMLDCWQKERGERPRFSQIHSIL 262 (266)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHHHH
Confidence 99999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=295.50 Aligned_cols=254 Identities=26% Similarity=0.473 Sum_probs=201.1
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++.+.||+|+||+||++.+..+++.||+|++... ....+.+.+|..+++.++|+||+++++++..++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 5799999999999999999999999999999998752 223345778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
||+.+++|.+++.. ...+++..+..++.||+.||+|||++|++||||||+||+++.++. ++|+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTV 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCc
Confidence 99999999999876 457999999999999999999999999999999999999987776 999999988654333222
Q ss_pred --CCCcCCCcccCCccccC-----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC-CCC
Q 023058 176 --KSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVH 247 (288)
Q Consensus 176 --~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 247 (288)
....+++.|+|||.+.+ ..++.+ +|+||+|+++|+|++|..||............... .....++. ...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~ 235 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--KEHFQFPPDVTD 235 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCc-ceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCcccCCCccCC
Confidence 22458999999999863 223344 99999999999999999999765433332222111 11122222 234
Q ss_pred CCHHHHHHHHHhcccCcCC--ccccccccccchhhhh
Q 023058 248 ISPECRHLISRIFVADPAK--VSMHFHATGVYMHTKL 282 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~--Rpt~~~~l~~~~~~~~ 282 (288)
+++.++++|.+||+.++.+ |+++.++++ |+|+
T Consensus 236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~---hp~~ 269 (331)
T cd05597 236 VSEEAKDLIRRLICSPETRLGRNGLQDFKD---HPFF 269 (331)
T ss_pred CCHHHHHHHHHHccCcccccCCCCHHHHhc---CCCC
Confidence 7899999999998754433 667766655 5554
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=287.49 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=211.4
Q ss_pred CCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
.+..+...++|++.+.||+|++|.||++.+..++..+++|.+.... ...+.+.+|+.+++.++|+|++++++.+..+..
T Consensus 12 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~ 91 (296)
T cd06654 12 IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (296)
T ss_pred ccccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE
Confidence 4556666799999999999999999999998899999999887643 334567889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
.++||||+++++|.+++.. ..++..++..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 92 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~ 168 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITP 168 (296)
T ss_pred EEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhccc
Confidence 9999999999999998854 46899999999999999999999999999999999999987776 99999998775433
Q ss_pred CCC-CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 172 HSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 172 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
... .....+++.|+|||.+.+..++.. +|+||||+++|+|++|..||............ ........+....+++
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 244 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSA 244 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH---hcCCCCCCCCccccCH
Confidence 222 223457889999999887777665 99999999999999999999765542222211 1112222223336789
Q ss_pred HHHHHHHHhcccCcCCccccccccc
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+.++|.+||..+|.+|||+.++++
T Consensus 245 ~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 245 IFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHHHHHHHCcCCcccCcCHHHHhh
Confidence 9999999999999999999988877
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=300.53 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=201.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEE-----cCCCcEEEEEEeecCc--cchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCe
Q 023058 20 SDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 91 (288)
.++|++.+.||+|+||.||++++ ..++..||+|++.... ...+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 46899999999999999999974 3456789999986543 2335678899999999 89999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC-----------------------------------------------------------
Q 023058 92 LAIVMEYASGGELFERICNAG----------------------------------------------------------- 112 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~----------------------------------------------------------- 112 (288)
.++||||+++++|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999988875421
Q ss_pred ----------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC--
Q 023058 113 ----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (288)
Q Consensus 113 ----------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-- 174 (288)
.++...+..++.||+.||.|||+.|++|+||||+||+++.+.. ++|+|||++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccceeccCccccc
Confidence 3677889999999999999999999999999999999987766 99999999875433221
Q ss_pred -CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
.....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||..........+... . ..........+.++
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~l 346 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK---E-GYRMLSPECAPSEM 346 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH---h-CccCCCCCCCCHHH
Confidence 112234567999999988888776 999999999999997 8899976544333333222 1 11122223568899
Q ss_pred HHHHHHhcccCcCCccccccccccch
Q 023058 253 RHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.++|.+||+.||.+|||+.++++.+.
T Consensus 347 ~~li~~cl~~dP~~RPs~~eil~~l~ 372 (375)
T cd05104 347 YDIMKSCWDADPLKRPTFKQIVQLIE 372 (375)
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHH
Confidence 99999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=298.19 Aligned_cols=253 Identities=23% Similarity=0.389 Sum_probs=197.7
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
..+|++.+.||+|+||.||++.+..++..||+|+.... ....|+.++++++||||+++++++......++|++++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 45799999999999999999999999999999974432 2356899999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCC
Q 023058 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (288)
Q Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~ 178 (288)
.+ +|..++.. ...++...+..++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++............
T Consensus 140 ~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~ 216 (357)
T PHA03209 140 SS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGL 216 (357)
T ss_pred CC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCcccccc
Confidence 65 77777654 457899999999999999999999999999999999999987776 999999998754433333445
Q ss_pred cCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCC-CCCCCc---------hhHHHHHHHHhhcccCCC-----
Q 023058 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEP---------KNFRKTIHRILSVQYSIP----- 243 (288)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf-~~~~~~---------~~~~~~~~~~~~~~~~~~----- 243 (288)
.+++.|+|||.+.+..++.+ +|+||||+++|+|+++..|+ ...... ................++
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 295 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295 (357)
T ss_pred cccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCcc
Confidence 68899999999988888777 99999999999999865554 322111 001111111000000111
Q ss_pred -----------------------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 244 -----------------------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 244 -----------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
....++.++.+||.+||+.||.+|||+.|+++ |+|++.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~---hp~f~~ 356 (357)
T PHA03209 296 RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN---YPMFAQ 356 (357)
T ss_pred HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc---Cchhcc
Confidence 11245778888999999999999999987755 777753
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=301.07 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=202.7
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCc--cchHHHHHHHHHHhhC-CCCceeeEeEEEEcC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (288)
...++|++.+.||+|+||.||++.+.. ++..||+|.+.... ...+.+.+|+.+++.+ +|+||+++++.+...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 345789999999999999999998643 34579999987543 2234678899999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------------------------------------------------------
Q 023058 90 THLAIVMEYASGGELFERICNA---------------------------------------------------------- 111 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~---------------------------------------------------------- 111 (288)
...++||||+++++|.+++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999998887532
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC---CC
Q 023058 112 ------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PK 176 (288)
Q Consensus 112 ------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~---~~ 176 (288)
.+++...++.++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++........ ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccCCcceeecc
Confidence 23678889999999999999999999999999999999987776 99999999875432221 11
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
...++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||............. ............++++.++
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~l 347 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV----KRGYQMSRPDFAPPEIYSI 347 (374)
T ss_pred CCCCccceeCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH----HcccCccCCCCCCHHHHHH
Confidence 2234567999999988887776 999999999999997 999998755433333322 2222222223578999999
Q ss_pred HHHhcccCcCCccccccccccch
Q 023058 256 ISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
|.+||+.||.+|||+.++++.+.
T Consensus 348 i~~cl~~dp~~RPs~~~l~~~l~ 370 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQLIQ 370 (374)
T ss_pred HHHHcCCChhhCcCHHHHHHHHH
Confidence 99999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=286.21 Aligned_cols=248 Identities=28% Similarity=0.462 Sum_probs=210.3
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
+|++.+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|++.+++++|||++++++.+..+...++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 6899999999999999999999899999999987543 344678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCC
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (288)
++.+++|...+.....++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccc
Confidence 9999999999987778999999999999999999999999999999999999988777 99999999876655544455
Q ss_pred CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 023058 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (288)
..++..|+|||.+.+..++.+ +|+||||+++|+|++|..||...... ................+. .++.++.++|.
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~ 234 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQETADVLYPA--TWSTEAIDAIN 234 (258)
T ss_pred cCCChhhcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhccccccCcc--cCcHHHHHHHH
Confidence 667889999999987776666 99999999999999999999876642 112222222212333333 67899999999
Q ss_pred HhcccCcCCcccc--ccccc
Q 023058 258 RIFVADPAKVSMH--FHATG 275 (288)
Q Consensus 258 ~~l~~~p~~Rpt~--~~~l~ 275 (288)
+||+.||.+||+. .++++
T Consensus 235 ~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 235 KLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred HHccCChhHcCCccHHHHhc
Confidence 9999999999999 66554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=283.46 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=204.8
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+.+.|++.+.||+|+||.||++.... +..+++|.+.......+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 34779999999999999999998764 56799998876666667889999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC-
Q 023058 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 176 (288)
Q Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~- 176 (288)
+++++|.+.+... ..++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCceecc
Confidence 9999999988653 46899999999999999999999999999999999999987776 9999999887543222211
Q ss_pred -CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 177 -STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 177 -~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
...++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||...+........ ..... .......+..+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i----~~~~~-~~~~~~~~~~~~~ 232 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI----SRGFR-LYRPKLASMTVYE 232 (256)
T ss_pred CCCCCchhhCChhhcccCccchh-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----HCCCC-CCCCCCCCHHHHH
Confidence 1234457999999887777666 999999999999999 89999776543333322 22221 1122256889999
Q ss_pred HHHHhcccCcCCccccccccccc
Q 023058 255 LISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
++.+||+.+|.+||++.++++.+
T Consensus 233 li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 233 VMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHccCCcccCcCHHHHHHhh
Confidence 99999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=289.39 Aligned_cols=255 Identities=31% Similarity=0.490 Sum_probs=210.6
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++.+.||.|++|.||++.+..+++.|++|.+.... ...+.+.+|+++++.++||||+++++.+..++..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987643 22346778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC---
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~--- 173 (288)
|++++++|.+++...+.+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCcccc
Confidence 99999999999988888999999999999999999999999999999999999987776 9999999875311100
Q ss_pred -------------CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc
Q 023058 174 -------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240 (288)
Q Consensus 174 -------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (288)
......++..|+|||.+.+..++.+ +|+||||+++|++++|..||......... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~~~~~----~~~~~~~~ 233 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELF----GQVISDDI 233 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhccc
Confidence 0112346778999999888777666 99999999999999999999765433222 22222222
Q ss_pred CCCC-CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 241 SIPD-YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 241 ~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
..+. ...+++++.++|.+||+.+|.+||++.++++.+.++|+
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 234 EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 2222 12578999999999999999999998888887778876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=288.60 Aligned_cols=254 Identities=26% Similarity=0.440 Sum_probs=205.6
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
++|++.+.||+|+||.||++.+..++..+++|.+.... .....+.+|++++++++||||+++++++..++.++++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999999999999999887542 2334678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCC
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (288)
+++++|.+++...+.++...+..++.|++.||.|||+ .+++|+||+|+||+++.++. ++|+|||++...... ....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~-~~~~ 157 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-MANS 157 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCccccccc-cccc
Confidence 9999999999888889999999999999999999997 58999999999999988776 999999988644322 2234
Q ss_pred CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH------------------------
Q 023058 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------------------------ 233 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~------------------------ 233 (288)
..+++.|+|||.+.+..++.+ +|+||||+++++|++|..||...+.... .....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPDAKEL-EAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred CCCCcCccChhHhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCcchhhH-HHhhcCccccccccCCcccccCCCCCccc
Confidence 567889999999877777666 9999999999999999999865432111 11110
Q ss_pred ---------HHhh-cccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc-cchhh
Q 023058 234 ---------RILS-VQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG-VYMHT 280 (288)
Q Consensus 234 ---------~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~~ 280 (288)
.... .....+. ..++.+++++|.+||+.+|.+|||+.+++. .|+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 0000 0111111 136788999999999999999999988877 44433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=283.93 Aligned_cols=246 Identities=33% Similarity=0.480 Sum_probs=204.7
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc----------hHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
+|.+...||.|++|.||.|.+..++..+++|.+...... .+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 578899999999999999999888999999988654321 2457789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
.++++||+++++|.+++...+.++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccc
Confidence 9999999999999999988888999999999999999999999999999999999999987776 99999998875542
Q ss_pred CCC-------CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC
Q 023058 172 HSQ-------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244 (288)
Q Consensus 172 ~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (288)
... .....++..|+|||.+.+..++.. +|+||||+++|+|++|..||...+......... .......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~ 234 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG---ENASPEIPS 234 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh---ccCCCcCCc
Confidence 111 112346788999999988777666 999999999999999999998764433222211 111222333
Q ss_pred CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 245 YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 245 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.++..+.++|.+||+.||.+||++.++++
T Consensus 235 --~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 235 --NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 67899999999999999999999988876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=290.54 Aligned_cols=253 Identities=32% Similarity=0.499 Sum_probs=209.8
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc----chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++.+.||+|++|.||++.+..+++.|++|.+..... ..+.+.+|++.++.++|+||+++++.+......+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 479999999999999999999999999999999876532 3356788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 97 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
|++.+++|.+++... ..+++..+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhccccccc
Confidence 999999999988754 46899999999999999999999999999999999999988776 99999998764322211
Q ss_pred ------------------------------CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 023058 175 ------------------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 224 (288)
Q Consensus 175 ------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~ 224 (288)
.....++..|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCch-HHHHHHHHHHHHHhhCCCCCCCCch
Confidence 112346778999999988777665 9999999999999999999987655
Q ss_pred chhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccc----cccccccchhhhhh
Q 023058 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSM----HFHATGVYMHTKLQ 283 (288)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~~~l~~~~~~~~~ 283 (288)
...... +......++.....++.+.++|.+||+.||.+||| +.++++ ++|++
T Consensus 238 ~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~---~~~~~ 293 (316)
T cd05574 238 DETFSN----ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ---HPFFR 293 (316)
T ss_pred HHHHHH----HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc---Cchhh
Confidence 433333 23334444544457999999999999999999999 666555 66654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=284.07 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=206.8
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
+..++|++.++||+|++|.||++... ++..|++|.+.......+.+.+|+.++++++|+|++++++.+...+..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 45689999999999999999999976 45679999887766666788999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
++++++|.+++... ..++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEYT 159 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCcee
Confidence 99999999988653 46888999999999999999999999999999999999987776 999999998754332211
Q ss_pred --CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 176 --KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 176 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||........... +.. ....+....++.++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~ 233 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA----LQR-GYRMPRMENCPDEL 233 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCCCHHH
Confidence 12234567999999887777666 999999999999998 9999976544332222 222 22334444688999
Q ss_pred HHHHHHhcccCcCCccccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.+++.+||+.+|.+||++.++.+.+
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~i~~~l 258 (261)
T cd05072 234 YDIMKTCWKEKAEERPTFDYLQSVL 258 (261)
T ss_pred HHHHHHHccCCcccCcCHHHHHHHH
Confidence 9999999999999999998886643
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=285.36 Aligned_cols=253 Identities=27% Similarity=0.422 Sum_probs=203.9
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++|++.+.||+|++|.||++.+..+++.|++|++.... ...+.+.+|+.++++++|+|++++++++..+...+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 57999999999999999999999889999999886542 223457789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CCC
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (288)
|+++++|..+......++...+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc--EEECccccceecCCCccccc
Confidence 9999888877766667999999999999999999999999999999999999987776 9999999987554433 223
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc---------------ccC
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QYS 241 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~ 241 (288)
...++..|+|||.+.+......++|+||||+++++|++|..||......+............ ...
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 34567889999998764433344999999999999999999998765433333222111000 000
Q ss_pred CCC----------CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 242 IPD----------YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 242 ~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+. ...++..+.+||.+||+.+|.+|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 010 1246788999999999999999999988765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=286.84 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=199.4
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+|++.+.||+|++|.||++.+..++..|++|.+.... ...+.+.+|+.++++++|||++++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5899999999999999999999899999999986542 2335678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-
Q 023058 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (288)
Q Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~- 174 (288)
+. ++|.+.+... ..++...++.++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRV 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCccc
Confidence 97 4787777543 45899999999999999999999999999999999999988776 99999998864433221
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc--------------cc
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------------QY 240 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~ 240 (288)
.....+++.|+|||.+.+......++|+||||+++++|++|..||................... ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 2234567889999988765543444999999999999999999998654433222211111000 00
Q ss_pred CC---------CCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 241 SI---------PDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 241 ~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.. .....+++++.++|.+||+.||.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 012347899999999999999999999988866
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=281.36 Aligned_cols=249 Identities=31% Similarity=0.485 Sum_probs=208.2
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+|++.+.||+|++|.||++.+..++..|++|.+..... ..+.+.+|+.++++++|+||+++++++.....+++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 68999999999999999999988899999999876544 456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC--
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-- 176 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~-- 176 (288)
+++++|.+++.....++...+..++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccc
Confidence 999999999988777899999999999999999999999999999999999988776 9999999987554433221
Q ss_pred ---CCcCCCcccCCccccCcc---cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 177 ---STVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 177 ---~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
...+++.|++||.+.+.. .+.+ +|+||+|++++++++|..||.......... ..........++....+++
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~-~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 235 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKRPWSELDNEFQIM--FHVGAGHKPPIPDSLQLSP 235 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcc-cchHHHHHHHHHHHhCCCCccCCcchHHHH--HHHhcCCCCCCCcccccCH
Confidence 235678899999987665 4455 999999999999999999997654322211 1111223344555555689
Q ss_pred HHHHHHHHhcccCcCCccccccccc
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+.++|.+||+.+|.+|||+.+++.
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 236 EGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhc
Confidence 9999999999999999999987755
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=315.68 Aligned_cols=255 Identities=27% Similarity=0.374 Sum_probs=204.2
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++.+.||+|+||.||++.+..+++.||+|++.... ...+++.+|++++++++|||++++++++..++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 78999999999999999999999999999999986532 22356888999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCC
Q 023058 97 EYASGGELFERICNA-----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (288)
Q Consensus 97 e~~~~~~L~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~ 165 (288)
||+++++|.+++... ...+...+..++.||+.||++||+.||+||||||+||+++.++. ++|+|||+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFGL 159 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWGA 159 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecCc
Confidence 999999999888642 23456778899999999999999999999999999999988777 99999999
Q ss_pred CcccccCC-------------------CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 023058 166 SKSSVLHS-------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (288)
Q Consensus 166 ~~~~~~~~-------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~ 226 (288)
+....... ......|++.|+|||.+.+..++.+ +|+||||+++|+|++|..||.......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k-SDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 87541110 0112358999999999988877666 999999999999999999997644322
Q ss_pred hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhh
Q 023058 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTK 281 (288)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~ 281 (288)
.... ..............+|+.+.+++.+||+.||.+|++..+.+..-++++
T Consensus 239 i~~~---~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 ISYR---DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhhh---hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2111 111111122233468899999999999999999988766554333333
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=283.59 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=205.1
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++.+.||+|+||.||++++..+++.|++|.+.... .....+.+|++++++++|||++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999876422 22345788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 97 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
|++++++|.+++.. ...++...+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~ 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccch
Confidence 99999999887753 334889999999999999999999999999999999999987776 999999988754332
Q ss_pred CC-CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 173 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
.. .....+++.|+|||.+.+...+.+ +|+||+|+++++|++|..||...... .......+.............+..
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEHYSEK 236 (267)
T ss_pred hHHHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHhcCCCCCCChhhcCHH
Confidence 22 123457788999999987777666 99999999999999999999754321 122222222222111112256789
Q ss_pred HHHHHHHhcccCcCCccccccccccch
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
+.++|.+||+.+|.+||++.++++.+.
T Consensus 237 ~~~li~~cl~~~p~~Rp~~~~vl~~~~ 263 (267)
T cd08228 237 LRELVSMCIYPDPDQRPDIGYVHQIAK 263 (267)
T ss_pred HHHHHHHHCCCCcccCcCHHHHHHHHH
Confidence 999999999999999999999987553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=284.80 Aligned_cols=254 Identities=28% Similarity=0.399 Sum_probs=205.7
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
...++|++.+.||+|++|.||++.+..+++.|++|.+.... .....+.+|+.+++.++|||++++++.+...+.+++++
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 34579999999999999999999999999999999987653 23345778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~ 175 (288)
||+++++|.+++...+.+++.++..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAKR 163 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCccccc
Confidence 99999999999988888999999999999999999999999999999999999987776 9999999876443222 22
Q ss_pred CCCcCCCcccCCcccc---CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 176 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
....+++.|+|||.+. ...++.+ +|+||||+++|+|++|..||............... ............++..+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~-~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQL-CDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS-NFQPPKLKDKMKWSNSF 241 (267)
T ss_pred ccccCcccccChhhhccccCCCCCch-hhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-CCCCCcccccCCCCHHH
Confidence 3446888999999874 3345444 99999999999999999998765432222211111 00011111223467899
Q ss_pred HHHHHHhcccCcCCccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.++|.+||+.+|.+|||+.++++
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhc
Confidence 99999999999999999988765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=283.82 Aligned_cols=247 Identities=23% Similarity=0.376 Sum_probs=200.3
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
++|++.+.||.|++|.||++.+..++..|++|.+..+. .....+.+|++++++++|||++++++.+......+++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 46899999999999999999999999999999987542 2235678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCC
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~ 178 (288)
+++++|... ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++...... .....
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~~-~~~~~ 153 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNS-IAKTY 153 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceecccc-cccCC
Confidence 999888543 35788899999999999999999999999999999999988777 999999988754322 22345
Q ss_pred cCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchh---HHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN---FRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
.++..|+|||.+.+..++.+ +|+||||+++|+|++|..||........ .......+.............++++.++
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232 (279)
T ss_pred CCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence 67889999999988777666 9999999999999999999975332111 1111111111111111122478899999
Q ss_pred HHHhcccCcCCccccccccc
Q 023058 256 ISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~ 275 (288)
|.+||+.+|.+||++.++++
T Consensus 233 i~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 233 ITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred HHHHhhCChhhCCCHHHHhc
Confidence 99999999999999988876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=284.03 Aligned_cols=258 Identities=28% Similarity=0.426 Sum_probs=212.0
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
+...++|++.+.||.|++|.||++.+..+++.|++|.+.... ...+.+.+|+..++.++|||++++++++......++|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 334578999999999999999999999899999999887543 3345678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~- 174 (288)
+|++++++|..++.. ..++..++..++.|++.++++||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhccccccc
Confidence 999999999988754 46899999999999999999999999999999999999987776 99999998775433322
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
.....++..|+|||.+.+..++.+ +|+||||+++|+|++|..||...+......... ............+++.+.+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSPIFRD 247 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCcccCCcccCCHHHHH
Confidence 223457888999999887777666 999999999999999999998765433222221 1112223334468899999
Q ss_pred HHHHhcccCcCCccccccccccchhhhhhh
Q 023058 255 LISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
+|.+||..||.+|||+.+++. ++|+..
T Consensus 248 li~~~l~~dp~~Rpt~~~il~---~~~~~~ 274 (296)
T cd06655 248 FLNRCLEMDVEKRGSAKELLQ---HPFLKL 274 (296)
T ss_pred HHHHHhhcChhhCCCHHHHhh---ChHhhh
Confidence 999999999999999987765 555543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=284.82 Aligned_cols=250 Identities=31% Similarity=0.439 Sum_probs=203.3
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCch
Q 023058 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (288)
Q Consensus 29 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 104 (288)
||+|+||+||++.+..+++.|++|.+.... .....+.+|++++++++|||++++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999999999999999987532 2234567899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCcCCC
Q 023058 105 FERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182 (288)
Q Consensus 105 ~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 182 (288)
.+.+.... .++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+.............++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~ 158 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTP 158 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCC
Confidence 99887655 6899999999999999999999999999999999999988776 9999999887554433334455778
Q ss_pred cccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhccc
Q 023058 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262 (288)
Q Consensus 183 ~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 262 (288)
.|++||.+.+..++.+ +|+||+|+++++|++|..||.......................+. ..++.+.++|.+||+.
T Consensus 159 ~y~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~ 235 (277)
T cd05577 159 GYMAPEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEALLQK 235 (277)
T ss_pred CcCCHHHhcCCCCCch-hhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCc--cCCHHHHHHHHHHccC
Confidence 8999999887776655 999999999999999999998765433333333333333333333 5789999999999999
Q ss_pred CcCCcccccc-ccc-cchhhhhh
Q 023058 263 DPAKVSMHFH-ATG-VYMHTKLQ 283 (288)
Q Consensus 263 ~p~~Rpt~~~-~l~-~~~~~~~~ 283 (288)
+|.+||+..+ ..+ .+.|+|+.
T Consensus 236 ~p~~R~~~~~~~~~~ll~h~~~~ 258 (277)
T cd05577 236 DPEKRLGCRGGSADEVREHPLFK 258 (277)
T ss_pred ChhHccCCCcccHHHHHhChhhh
Confidence 9999995555 222 34566664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=279.57 Aligned_cols=245 Identities=30% Similarity=0.460 Sum_probs=205.3
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+|.+.+.||+|++|.||++.+..+++.|++|.+... ......+.+|++++++++|||++++++.+...+..+++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 588999999999999999999999999999998753 34456688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-C
Q 023058 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (288)
Q Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (288)
+++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchh
Confidence 9999999988764 56899999999999999999999999999999999999987776 99999998775443322 2
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc-cCCCCCCCCCHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHISPECRH 254 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 254 (288)
....+++.|+|||.+.+..++.+ +|+||||+++++|++|..||.......... .+.... ...+. .++.++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~ 231 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGALIL----KIIRGVFPPVSQ--MYSQQLAQ 231 (256)
T ss_pred hccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCCcc--ccCHHHHH
Confidence 23457888999999988877766 999999999999999999998665322222 222222 22222 67899999
Q ss_pred HHHHhcccCcCCccccccccc
Q 023058 255 LISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+|.+||+.+|++||++.++++
T Consensus 232 ~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 232 LIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HHHHHccCCcccCcCHHHHhh
Confidence 999999999999999987765
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=300.58 Aligned_cols=254 Identities=19% Similarity=0.238 Sum_probs=198.6
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
.....+|.+.+.||.|+||.||++.+..++..|++|... .....+|++++++++|+||+++++++..++..+++|
T Consensus 165 ~~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 165 VVAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred ccccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 344568999999999999999999999999999999533 234678999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-
Q 023058 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~- 174 (288)
+++. ++|..++... ..++..+++.++.|++.||.|||+.||+|+||||+||+++.++. ++|+|||+++.......
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWST 316 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceeccccccc
Confidence 9995 5787777553 46999999999999999999999999999999999999987776 99999999875433221
Q ss_pred --CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCc-------hhHHHHHHHHhhcccC----
Q 023058 175 --PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------KNFRKTIHRILSVQYS---- 241 (288)
Q Consensus 175 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~---- 241 (288)
.....+++.|+|||++.+..++.+ +|||||||++|+|++|..|+...... ....+...........
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 123458999999999988888776 99999999999999987655332211 1111111111000000
Q ss_pred -------------------------CCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 242 -------------------------IPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 242 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
+.....++.++.+||.+||+.||.+|||+.|+++ |+||
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~---hp~f 458 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR---LPLF 458 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh---Cccc
Confidence 1111235678999999999999999999988877 5554
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=289.21 Aligned_cols=254 Identities=23% Similarity=0.313 Sum_probs=201.9
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcE--EEEEEeecC--ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~--~~iK~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (288)
+..++|++.+.||+|+||.||+|.+..++.. +++|.+... ......+.+|+.++.++ +|+|++++++++..++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 3457999999999999999999998777654 466665532 22334678899999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCC
Q 023058 93 AIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~ 156 (288)
+++|||+++++|.+++.... .++..+++.++.|++.|+++||+.|++|+||+|+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~- 162 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV- 162 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc-
Confidence 99999999999999886432 4789999999999999999999999999999999999987776
Q ss_pred CEEEeecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHH
Q 023058 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRI 235 (288)
Q Consensus 157 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~ 235 (288)
++|+|||++..............+..|+|||.+.+..++.+ +|+||||+++++|++ |..||...+....... +
T Consensus 163 -~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----~ 236 (303)
T cd05088 163 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----L 236 (303)
T ss_pred -EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCccc-ccchhhhhHHHHHHhcCCCCcccCChHHHHHH----H
Confidence 99999998863322222222233567999999877776666 999999999999998 9999976544332222 1
Q ss_pred hhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
. ...........++++.++|.+||+.+|.+||++.+++..+..
T Consensus 237 ~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 237 P-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred h-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1 122222333578999999999999999999999999885543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=292.81 Aligned_cols=250 Identities=25% Similarity=0.468 Sum_probs=200.0
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++.+.||+|+||+||++.+..+++.+|+|++... ......+.+|+.++..++|++|+++++.+..+..+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4799999999999999999999999999999998642 222334778899999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-
Q 023058 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~- 174 (288)
||+.+++|.+++.. ...+++..+..++.||+.||.+||+.|++||||||+||+++.++. ++|+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTV 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcc
Confidence 99999999999976 457899999999999999999999999999999999999987776 99999998864433222
Q ss_pred -CCCCcCCCcccCCccccC-----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC-CCC
Q 023058 175 -PKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVH 247 (288)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 247 (288)
.....+++.|+|||.+.+ ..++.+ +|+||||+++|+|++|..||...+........... .....++. ...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~ 235 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--KERFQFPAQVTD 235 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCc-CCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC--CccccCCCcccc
Confidence 223468999999999863 334455 99999999999999999999876543333332211 11122222 235
Q ss_pred CCHHHHHHHHHhcccCcCC--ccccccccc
Q 023058 248 ISPECRHLISRIFVADPAK--VSMHFHATG 275 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~--Rpt~~~~l~ 275 (288)
++++++++|.+||+.++.+ |+++.++++
T Consensus 236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~ 265 (332)
T cd05623 236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265 (332)
T ss_pred CCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence 7999999999999765544 577777765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=279.57 Aligned_cols=255 Identities=30% Similarity=0.498 Sum_probs=213.7
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
++|++.+.||.|++|.||++.+..+++.+++|.+..... ....+.+|+..+++++|+|++++.+++..+...++++|+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 478999999999999999999999999999999876543 456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC-
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 176 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~- 176 (288)
+++++|.+++.....++...++.++.|++.++.+||+ .|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCN 158 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCccc
Confidence 9999999999887889999999999999999999999 99999999999999988776 9999999887554433332
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-CCCCCCCCCHHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPECRHL 255 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 255 (288)
...++..|+|||.+.+..++.+ +|+||||+++|+|++|..||...... ........+..... ..+. ..++..+.++
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~l~~l 235 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYA-ADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPPPSLPA-EEFSPEFRDF 235 (264)
T ss_pred ceeecccccCHhhhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcCCCCCCCc-ccCCHHHHHH
Confidence 4457788999999887766666 99999999999999999999876531 22233333332222 2222 1278999999
Q ss_pred HHHhcccCcCCccccccccccchhhhhh
Q 023058 256 ISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
|.+||..+|.+|||+.++++ ++|++
T Consensus 236 i~~~l~~~p~~R~~~~~ll~---~~~~~ 260 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQ---HPFIK 260 (264)
T ss_pred HHHHccCChhhCCCHHHHHh---CHHHH
Confidence 99999999999999988866 66654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=286.08 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=205.9
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
++|++++.||+|++|.||++.+..++..|++|.+... ......+.+|++++++++|+|++++++.+..++..+++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 4789999999999999999999989999999988653 23335688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
+++++|..++... ..++...+..++.|++.++.|||+ .|++|+||+|+||+++.++. ++|+|||.+...... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~-~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVAS-L 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC--EEEeecCCcccccCC-c
Confidence 9999998888663 368999999999999999999997 59999999999999987666 999999988644222 2
Q ss_pred CCCCcCCCcccCCccccCccc-----CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-ccCCCCCCCC
Q 023058 175 PKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHI 248 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 248 (288)
.....+++.|+|||.+.+... ...++|+||+|+++|+|++|..||........... ...+... ....+. .+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~--~~ 234 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ-LSAIVDGDPPTLPS--GY 234 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH-HHHHhhcCCCCCCc--cc
Confidence 233457788999999865433 13349999999999999999999976544332222 2222222 223333 58
Q ss_pred CHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
++++.++|.+||+.+|.+||++.++++ ++|+..
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~---~~~~~~ 267 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLE---HPWLVK 267 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhc---Chhhhh
Confidence 899999999999999999999988876 555543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=286.49 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=205.8
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCccc--hHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
..++|.+.+.||+|++|.||++.+.. ++..|++|.+...... .+.+.+|++++++++|+|++++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 35789999999999999999998743 3578999998765332 4678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCC
Q 023058 92 LAIVMEYASGGELFERICNAG--------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~ 157 (288)
.+++|||+++++|.+++...+ .++...+..++.|++.++.+||+.|++|+||+|+||+++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~-- 160 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV-- 160 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--
Confidence 999999999999999986542 3788899999999999999999999999999999999988876
Q ss_pred EEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 023058 158 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (288)
Q Consensus 158 ~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (288)
++|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||..........
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~~~---- 235 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE---- 235 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH----
Confidence 99999998864432221 223345678999999988888776 999999999999998 999997665433322
Q ss_pred HHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.+....... ....++..+.+++.+||+.||.+|||+.++++.+
T Consensus 236 ~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 236 CITQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred HHHcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 222222222 1236889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=283.24 Aligned_cols=251 Identities=29% Similarity=0.459 Sum_probs=208.6
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
++|++.+.||.|++|.||++.+..++..+++|.+.... .....+.+|+++++.++|+|++++.+++..+...++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 47999999999999999999999999999999987543 2335678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCCCC
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~~~ 177 (288)
+++++|.+++... +++...+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++...... .....
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccccc
Confidence 9999999988765 7899999999999999999999999999999999999988776 999999998755443 22334
Q ss_pred CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc-cCCCCCCCCCHHHHHHH
Q 023058 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHISPECRHLI 256 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li 256 (288)
..+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+...... .+.... ...+. ..++.++.+++
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~-sDv~slG~il~~l~tg~~p~~~~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~l 231 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHPMRVLF----LIPKNNPPSLEG-NKFSKPFKDFV 231 (274)
T ss_pred ccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccCchHHHHH----HhhhcCCCCCcc-cccCHHHHHHH
Confidence 567888999999988776666 999999999999999999997654322221 112222 22222 12789999999
Q ss_pred HHhcccCcCCccccccccccchhhhhh
Q 023058 257 SRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 257 ~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.+||..+|.+|||+.+++. ++|+.
T Consensus 232 ~~~l~~~p~~Rpt~~~il~---~~~~~ 255 (274)
T cd06609 232 SLCLNKDPKERPSAKELLK---HKFIK 255 (274)
T ss_pred HHHhhCChhhCcCHHHHhh---Chhhc
Confidence 9999999999999988866 55543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=287.60 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=204.2
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCC-----cEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTE-----ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
.++|++.+.||+|++|.||++.....+ ..+++|.+.... .....+.+|+..+++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 468999999999999999999976544 679999886543 2335678999999999999999999999998999
Q ss_pred EEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCC
Q 023058 93 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~ 156 (288)
+++|||+++++|.+++... ..++..+++.++.|++.||.+||+.|++|+||+|+||+++.++.
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~- 162 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT- 162 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc-
Confidence 9999999999999988654 34788899999999999999999999999999999999987776
Q ss_pred CEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 023058 157 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (288)
Q Consensus 157 ~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~ 232 (288)
++|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||......+...
T Consensus 163 -~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~slG~il~el~~~g~~p~~~~~~~~~~~--- 237 (283)
T cd05048 163 -VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE--- 237 (283)
T ss_pred -EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---
Confidence 99999999875433221 223345778999999888777776 999999999999997 999998755433222
Q ss_pred HHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.+.... ..+....+|+++.+|+.+||+.||.+||++.++++.+
T Consensus 238 -~i~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l 280 (283)
T cd05048 238 -MIRSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280 (283)
T ss_pred -HHHcCC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 222222 1222336899999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=281.57 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=208.0
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
.++|++.+.||.|++|.||++.+..++..+++|.+..... .+.+.+|++++++++|+|++++.+++..+...++++|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 3789999999999999999999998899999999876544 678999999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CCCC
Q 023058 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (288)
Q Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~~~ 177 (288)
++++|.+++.. ...++...+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++....... ....
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCcccccc
Confidence 99999999865 446899999999999999999999999999999999999988776 9999999987654433 2233
Q ss_pred CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 023058 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (288)
..++..|+|||.+.+..++.+ +|+||+|+++++|++|..||............. ......+.....++..+.++|.
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP---NKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred ccCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc---cCCCCCCCchhhcCHHHHHHHH
Confidence 457888999999988777666 999999999999999999998654322221111 1111122222356789999999
Q ss_pred HhcccCcCCccccccccc
Q 023058 258 RIFVADPAKVSMHFHATG 275 (288)
Q Consensus 258 ~~l~~~p~~Rpt~~~~l~ 275 (288)
+||+.||.+|||+.++++
T Consensus 235 ~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHhcChhhCcCHHHHhc
Confidence 999999999999988866
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=279.94 Aligned_cols=252 Identities=32% Similarity=0.449 Sum_probs=206.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
.++|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|+.++++++|||++++++.+.....++++||+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 478999999999999999999999889999999987653 3446788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CCC
Q 023058 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (288)
Q Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (288)
+++++|..++... ..++..++..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ...
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhccc
Confidence 9999999988766 68999999999999999999999999999999999999998776 9999999887544332 223
Q ss_pred CCcCCCcccCCccccCc---ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 177 STVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
...++..|+|||.+.+. .++.. +|+||+|+++++|++|..||................. ...........+.++.
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~-~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGK-CDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF-PPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccCCccccCchhhcccccCCcCch-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCccccchhhhhHHHH
Confidence 34577889999998766 56655 9999999999999999999976553332222111100 0111112224578899
Q ss_pred HHHHHhcccCcCCccccccccc
Q 023058 254 HLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++|.+||+.+|.+|||+.+++.
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhc
Confidence 9999999999999999988865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=286.45 Aligned_cols=251 Identities=26% Similarity=0.447 Sum_probs=197.8
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+|++.+.||.|++|.||++.+..+|+.+++|.+.... .....+.+|+.++++++|||++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 6899999999999999999999999999999986532 2234677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-CC
Q 023058 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (288)
Q Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~~ 176 (288)
+++ +|...+.. ...++...++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||++........ ..
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcC
Confidence 975 77776654 567999999999999999999999999999999999999987776 99999998875433222 22
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCch-hHHHHHHHHhh--------------c--c
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-NFRKTIHRILS--------------V--Q 239 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~-~~~~~~~~~~~--------------~--~ 239 (288)
...+++.|+|||.+.+......++|+||||+++|+|++|..|+....... ........... . .
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence 34567889999998775543444999999999999999998865433322 11111111000 0 0
Q ss_pred cCCC-------CCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 240 YSIP-------DYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 240 ~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
...+ ....++++++++|.+||+.||.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 01246789999999999999999999988876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=280.00 Aligned_cols=250 Identities=22% Similarity=0.309 Sum_probs=205.9
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
..++|++.+.||.|++|.||++.+.. ++.|++|.+.......+.+.+|+.++++++|||++++++++...+..+++||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 45789999999999999999999764 56799999887666667789999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 99 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
+.+++|.+++.... .++...+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++..........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEA 160 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCcccc
Confidence 99999999986644 6899999999999999999999999999999999999988776 9999999887554221111
Q ss_pred C--CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 177 S--TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 177 ~--~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
. ......|+|||.+.+..++.+ +|+||||+++++|++ |..||.......... .+.. ....+....++..+.
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~ 234 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ----QVDQ-GYRMPCPPGCPKELY 234 (261)
T ss_pred cCCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHHc-CCCCCCCCcCCHHHH
Confidence 1 122357999999887777766 999999999999998 999997654332222 2222 222233336789999
Q ss_pred HHHHHhcccCcCCccccccccccc
Q 023058 254 HLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
+++.+|++.+|.+||++.++...+
T Consensus 235 ~li~~~l~~~P~~Rp~~~~l~~~l 258 (261)
T cd05068 235 DIMLDCWKEDPDDRPTFETLQWKL 258 (261)
T ss_pred HHHHHHhhcCcccCCCHHHHHHHH
Confidence 999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=286.11 Aligned_cols=260 Identities=26% Similarity=0.405 Sum_probs=212.0
Q ss_pred CCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
+......++|++.+.||.|++|.||++.+..++..|++|.+.... ...+.+.+|+.+++.++|+|++++++++..++..
T Consensus 12 ~~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 12 VSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred cccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 344555699999999999999999999998899999999987643 3335677899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
++||||+++++|.+++.. ..++..++..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPE 168 (297)
T ss_pred EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCC
Confidence 999999999999998854 46889999999999999999999999999999999999987776 999999988754333
Q ss_pred CC-CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 173 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
.. .....+++.|+|||.+.+..++.+ +|+||||+++|++++|..||...+........ .............+++.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 244 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPERLSAV 244 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCcchheeee---ccCCCCCCCCccccCHH
Confidence 22 223457888999999988777666 99999999999999999999765442221111 11112222223367899
Q ss_pred HHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+.++|.+||..+|.+||++.++++ ++|++
T Consensus 245 ~~~li~~~l~~~p~~Rps~~~il~---~~~~~ 273 (297)
T cd06656 245 FRDFLNRCLEMDVDRRGSAKELLQ---HPFLK 273 (297)
T ss_pred HHHHHHHHccCChhhCcCHHHHhc---Cchhc
Confidence 999999999999999999988877 55543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=292.18 Aligned_cols=255 Identities=27% Similarity=0.466 Sum_probs=201.1
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++.+.||+|+||.||++++..+++.||+|++... ......+.+|..++..++|+||+.+++++..++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5799999999999999999999999999999998753 222344778899999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
||+.+++|.+++.. ...+++..+..++.|++.||++||+.||+|+||||+||+++.++. ++|+|||++.........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTV 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCce
Confidence 99999999999976 457899999999999999999999999999999999999987776 999999998654333221
Q ss_pred --CCCcCCCcccCCccccC-----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC-CCC
Q 023058 176 --KSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVH 247 (288)
Q Consensus 176 --~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 247 (288)
....+++.|+|||.+.+ ..++.+ +|+||+|+++|+|++|..||...+........... .....++. ...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~ 235 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EERFQFPSHITD 235 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCc-ccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC--CCcccCCCcccc
Confidence 23468999999999865 334444 99999999999999999999865543333222211 11122232 235
Q ss_pred CCHHHHHHHHHhcccCcCC--ccccccccccchhhhhh
Q 023058 248 ISPECRHLISRIFVADPAK--VSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~--Rpt~~~~l~~~~~~~~~ 283 (288)
++++++++|.+||+.++.+ |+++.+++ .|+|++
T Consensus 236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~---~h~~f~ 270 (331)
T cd05624 236 VSEEAKDLIQRLICSRERRLGQNGIEDFK---KHAFFE 270 (331)
T ss_pred CCHHHHHHHHHHccCchhhcCCCCHHHHh---cCCCcC
Confidence 7899999999999865543 34555554 455543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=282.33 Aligned_cols=250 Identities=26% Similarity=0.398 Sum_probs=203.7
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEEEEcC------Ce
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP------TH 91 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~------~~ 91 (288)
..+.|++.+.||.|+||.||++.+..+++.+++|.+.........+.+|+.+++++ +|+|++++.+++... ..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 35789999999999999999999999999999999987766667888999999998 699999999998753 46
Q ss_pred EEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 92 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
.+++|||+++++|.+++... ..+++..+..++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~ 161 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQL 161 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceec
Confidence 89999999999999988763 35899999999999999999999999999999999999988776 999999998754
Q ss_pred ccC-CCCCCCcCCCcccCCccccC-----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC
Q 023058 170 VLH-SQPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243 (288)
Q Consensus 170 ~~~-~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
... .......+++.|+|||.+.+ ..++.+ +|+||+|+++|+|++|..||........... .........
T Consensus 162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~ 236 (272)
T cd06637 162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRL 236 (272)
T ss_pred ccccccCCcccccccccCHhHhccccCcCCCCCch-hhHHHHHHHHHHHHhCCCCccccCHHHHHHH----HhcCCCCCC
Confidence 332 22234557889999999863 234445 9999999999999999999975443222211 112222222
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 244 DYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
....++.++.+||.+||+.+|.+|||+.++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 22357899999999999999999999987765
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=280.96 Aligned_cols=250 Identities=30% Similarity=0.428 Sum_probs=206.3
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
++|++.+.||.|++|+||++....++..+++|++.... ...+.+.+|++.++.++|+|++++++.+..+...++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 57999999999999999999998889999999986543 3456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 99 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
+++++|.+.+... ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDR 158 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccc
Confidence 9999999998764 35899999999999999999999999999999999999988776 999999988655443322
Q ss_pred -----CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC---CCC
Q 023058 176 -----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD---YVH 247 (288)
Q Consensus 176 -----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 247 (288)
....++..|++||.+......+.++|+||||+++++|++|..||..........+.... ....++. ...
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 235 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGADYKK 235 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCcccccc
Confidence 23357788999999877633344499999999999999999999876554433333222 1112222 235
Q ss_pred CCHHHHHHHHHhcccCcCCccccccccc
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+++.+.+++.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 236 YSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 7889999999999999999999988866
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=280.64 Aligned_cols=249 Identities=23% Similarity=0.358 Sum_probs=203.7
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
..+.|.+.+.||+|++|+||.+.... +..+++|.+.......+.+.+|+.++++++||||+++++++......+++|||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 45789999999999999999998764 45699998886665567789999999999999999999999988899999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC--
Q 023058 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (288)
Q Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~-- 175 (288)
+.+++|.+++... ..++...++.++.||+.||.+||+.|++|+||+|.||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC--EEECCCccceecCCCceeec
Confidence 9999999988764 36899999999999999999999999999999999999987776 999999988654332211
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
....++..|++||.+.+..++.+ +|+||||+++|+|++ |..||............ ..... .......+..+.+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~ 232 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV----SQGLR-LYRPHLASEKVYA 232 (256)
T ss_pred CCCccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH----hcCCC-CCCCCCCCHHHHH
Confidence 11234567999999987777776 999999999999998 99999765543322222 22211 1122256899999
Q ss_pred HHHHhcccCcCCcccccccccc
Q 023058 255 LISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
++.+||+.+|.+|||+.++++.
T Consensus 233 li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 233 IMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHcCCCcccCCCHHHHHHh
Confidence 9999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=285.38 Aligned_cols=253 Identities=24% Similarity=0.358 Sum_probs=204.9
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEE-----cCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
+...+|.+.+.||+|+||.||++.. ..++..+++|.+.... ...+.+.+|++++++++|||++++++++.....
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 3467899999999999999999985 2345678999876543 334568899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCE
Q 023058 92 LAIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~ 158 (288)
.+++|||+++++|.+++...+ .+++..+..++.|++.||++||+.|++||||+|+||+++.++. +
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~ 159 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--V 159 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--E
Confidence 999999999999999886543 3899999999999999999999999999999999999987776 9
Q ss_pred EEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 023058 159 KICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHR 234 (288)
Q Consensus 159 ~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~ 234 (288)
+|+|||++........ .....++..|+|||.+.+..++.+ +|+||||+++++|++ |..||.......... .
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~t~g~~p~~~~~~~~~~~----~ 234 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE----C 234 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----H
Confidence 9999999875433221 223334678999999987777666 999999999999998 899997665433222 2
Q ss_pred HhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 235 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
+..... .+.....+.++.+++.+||+.||.+|||+.++.+.+.
T Consensus 235 i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~ 277 (288)
T cd05093 235 ITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277 (288)
T ss_pred HHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 222221 1222257899999999999999999999999977543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=278.46 Aligned_cols=246 Identities=32% Similarity=0.506 Sum_probs=204.5
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
+|++.+.||.|++|.||++.+..++..+++|.+... ....+.+.+|+.++++++|+|++++++.+..++.++++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 589999999999999999999999999999998643 334467788999999999999999999999999999999999
Q ss_pred CCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-CC
Q 023058 100 SGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (288)
Q Consensus 100 ~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~~ 176 (288)
++++|.+.+.. ...++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++++|||.+........ ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccc
Confidence 99999888754 235899999999999999999999999999999999999987776 99999998865433222 23
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (288)
...+++.|+|||.+.+...+.+ +|+||||+++++|++|..||...+.... ...+...... +....++..+.++|
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~li 232 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSWKNL----ILKVCQGSYK-PLPSHYSYELRSLI 232 (255)
T ss_pred cccCCccccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCCCCHHHH----HHHHhcCCCC-CCCcccCHHHHHHH
Confidence 3457888999999988777666 9999999999999999999976443222 2222222221 11236789999999
Q ss_pred HHhcccCcCCccccccccc
Q 023058 257 SRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 257 ~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+||+.||.+|||+.+++.
T Consensus 233 ~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 233 KQMFKRNPRSRPSATTILS 251 (255)
T ss_pred HHHHhCCcccCCCHHHHhh
Confidence 9999999999999998876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=295.08 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=199.6
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcC------C
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 90 (288)
.++|++.+.||.|+||+||++.+..+++.||+|.+.... .....+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 589999999999999999999999999999999987542 2234577899999999999999999987543 3
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
..+++++++ +++|..++. ...++...+..++.||+.||.|||+.||+|+||||+||+++.++. ++|+|||++....
T Consensus 94 ~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~ 169 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQAD 169 (343)
T ss_pred cEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecC
Confidence 578999988 668877764 456999999999999999999999999999999999999988777 9999999987543
Q ss_pred cCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh-------------
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------- 237 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------- 237 (288)
. ......+++.|+|||.+.+......++|+||||+++|+|++|..||...+..............
T Consensus 170 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 170 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred C--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 2 2234467899999999877443344499999999999999999999765433332222111000
Q ss_pred ------cccCCCC------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 238 ------VQYSIPD------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 238 ------~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.....+. ....++.+.+||.+||+.||.+|||+.++++ |+|+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~---hp~~~ 302 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA---HPYFS 302 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc---Ccchh
Confidence 0000010 1245678899999999999999999988876 55554
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=286.14 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=199.7
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCc--EEEEEEeecC--ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~--~~~iK~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 95 (288)
++|++.+.||.|+||.||++....++. .+++|.+... ....+.+.+|+.+++++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 689999999999999999999877654 4688877632 23345688899999999 799999999999999999999
Q ss_pred EeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEE
Q 023058 96 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~ 159 (288)
+||+++++|.+++.... .++...++.++.|++.||++||+.|++|+||||+||+++.++. ++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~k 159 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--SK 159 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--EE
Confidence 99999999999986532 4788999999999999999999999999999999999987766 99
Q ss_pred EeecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhc
Q 023058 160 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV 238 (288)
Q Consensus 160 l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 238 (288)
|+|||++..............+..|+|||.+.+..++.+ +|+||||+++|+|++ |..||............ ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~----~~- 233 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL----PQ- 233 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----hc-
Confidence 999998864322212222223456999999887777666 999999999999997 99999765543332222 21
Q ss_pred ccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 239 QYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
....+....++..+.+||.+||+.+|.+|||+.++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 272 (297)
T cd05089 234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272 (297)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 122222236889999999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=279.80 Aligned_cols=250 Identities=22% Similarity=0.362 Sum_probs=204.3
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
...+|++.+.||+|++|.||++.+. ++..+++|.+.........+.+|++++++++|||++++++++...+..+++||+
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 3467999999999999999999886 466799999876665566788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC-
Q 023058 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 176 (288)
Q Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~- 176 (288)
+++++|.+++... ..++...+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceeccccccccc
Confidence 9999999988653 46899999999999999999999999999999999999988776 9999999886543221111
Q ss_pred -CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 177 -STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 177 -~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
....+..|+|||.+.+..++.+ +|+||||+++|++++ |..||........... +.. ....+....+|..+.+
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~ 232 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVES----VSA-GYRLYRPKLAPTEVYT 232 (256)
T ss_pred CCCCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH----HHc-CCcCCCCCCCCHHHHH
Confidence 1123357999999988877776 999999999999998 8999976544332222 221 2222233368999999
Q ss_pred HHHHhcccCcCCccccccccccc
Q 023058 255 LISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
++.+||+.+|.+|||+.++++.+
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHHh
Confidence 99999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=279.87 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=202.1
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
..++|++.++||+|++|.||++.+..+ ..+++|.+.......+.+.+|++++++++||||+++++.+. ....+++||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 457899999999999999999998755 45999998876655677899999999999999999999874 4567999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC-
Q 023058 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (288)
Q Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~- 175 (288)
+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeecccccccc
Confidence 9999999998753 35789999999999999999999999999999999999988776 999999988654332221
Q ss_pred -CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 176 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
....++..|+|||...+..++.. +|+||||+++|+|++ |..||.......... .+.. ....+....++..+.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~l~ 233 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVER-GYRMPCPPECPESLH 233 (262)
T ss_pred ccCCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHHH----HHhc-CCCCCCccccCHHHH
Confidence 12335567999999887777766 999999999999999 888887654433222 2211 122233346889999
Q ss_pred HHHHHhcccCcCCcccccccccc
Q 023058 254 HLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
++|.+|++.+|.+||++.++++.
T Consensus 234 ~li~~~l~~~p~~Rp~~~~~~~~ 256 (262)
T cd05071 234 DLMCQCWRKEPEERPTFEYLQAF 256 (262)
T ss_pred HHHHHHccCCcccCCCHHHHHHH
Confidence 99999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=294.29 Aligned_cols=253 Identities=22% Similarity=0.313 Sum_probs=201.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcC--CCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKK--TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
..+|++++.||.|+||.||++.... ++..|++|.+... ....+|++++++++||||+++++++......+++|+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 4579999999999999999997643 4678999987643 245689999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC---
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 174 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~--- 174 (288)
++. ++|..++.....++...++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++........
T Consensus 167 ~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 167 KYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred hcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCccccccc
Confidence 996 588888877778999999999999999999999999999999999999987776 99999999875443322
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchh---HHHHHHHHhhcc------------
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN---FRKTIHRILSVQ------------ 239 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~------------ 239 (288)
.....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||........ ............
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred ccccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 123468999999999988888776 9999999999999999999976543221 111111111000
Q ss_pred -------------cCCCC---CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 240 -------------YSIPD---YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 240 -------------~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+..+. ....+.++.++|.+||..||.+|||+.+++. |+|+.
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~---~p~f~ 379 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS---LPLFT 379 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh---Cchhh
Confidence 00110 1235678999999999999999999988866 55553
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=278.73 Aligned_cols=247 Identities=30% Similarity=0.495 Sum_probs=205.9
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCch
Q 023058 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (288)
Q Consensus 29 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 104 (288)
||.|++|.||++.+..++..+++|++.... ...+.+.+|+.++++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999999889999999987543 3345688999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCcCCCcc
Q 023058 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184 (288)
Q Consensus 105 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 184 (288)
.+++.....++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.............+++.|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~ 158 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEY 158 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCc
Confidence 999988878999999999999999999999999999999999999988776 999999998766544333445678899
Q ss_pred cCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh--hcccCCCCCCCCCHHHHHHHHHhccc
Q 023058 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL--SVQYSIPDYVHISPECRHLISRIFVA 262 (288)
Q Consensus 185 ~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~ 262 (288)
++||.+.+..++.+ +|+||+|+++|++++|..||...... .......+. ......+. ..++++.++|.+||+.
T Consensus 159 ~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 159 VAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRR 233 (262)
T ss_pred cChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHccC
Confidence 99999887777766 99999999999999999999876531 122222223 22334444 4589999999999999
Q ss_pred CcCCccc-----cccccccchhhhhhhh
Q 023058 263 DPAKVSM-----HFHATGVYMHTKLQLL 285 (288)
Q Consensus 263 ~p~~Rpt-----~~~~l~~~~~~~~~~~ 285 (288)
+|.+||+ +++++ .|+|+..+
T Consensus 234 ~p~~R~~~~~~~~~~l~---~~~~~~~~ 258 (262)
T cd05572 234 NPEERLGNLKGGIKDIK---KHKWFNGF 258 (262)
T ss_pred ChhhCcCCcccCHHHHh---cChhhhCC
Confidence 9999999 55554 47776543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=285.87 Aligned_cols=251 Identities=26% Similarity=0.402 Sum_probs=202.6
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc------hHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
+|.+.+.||.|++|.||++.+..+++.|++|.+...... ...+.+|++++++++|+|++++++++......++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588999999999999999999988999999998765322 34567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 96 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
||++ +++|.+++.... .++...+..++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc
Confidence 9999 889999997766 7999999999999999999999999999999999999988776 99999999875544322
Q ss_pred -CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-C------C----
Q 023058 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-S------I---- 242 (288)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~------~---- 242 (288)
.....+++.|+|||.+.+......++|+||||+++++|++|..||......+.............. . .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 233456788999998866544444599999999999999998888765554433333221100000 0 0
Q ss_pred --------C---CCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 243 --------P---DYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 243 --------~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+ .....+..+.++|.+||+.+|.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0 01245788999999999999999999988877
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=279.58 Aligned_cols=252 Identities=29% Similarity=0.415 Sum_probs=203.6
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc------cchHHHHHHHHHHhhCCCCceeeEeEEEEcC--CeE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 92 (288)
.+|++.+.||+|++|.||++.+..++..|++|.+.... .....+.+|+.++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999886432 2234577899999999999999999998753 578
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
++++|++++++|.+.+.....++...+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccc
Confidence 899999999999999988778999999999999999999999999999999999999987776 999999988644321
Q ss_pred C----CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCC
Q 023058 173 S----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 173 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
. ......++..|+|||.+.+..++.. +|+||+|+++|+|++|..||.............. ......++. .+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~--~~ 234 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTNPQLPS--HI 234 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCch-hhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc--CCCCCCCch--hc
Confidence 1 1122347788999999988777666 9999999999999999999986544333322211 111222232 56
Q ss_pred CHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
++.+.++| +|+..+|.+||++++++. |+|++
T Consensus 235 ~~~~~~li-~~~~~~p~~Rp~~~eil~---hp~~~ 265 (266)
T cd06651 235 SEHARDFL-GCIFVEARHRPSAEELLR---HPFAQ 265 (266)
T ss_pred CHHHHHHH-HHhcCChhhCcCHHHHhc---Ccccc
Confidence 88899999 677799999999988866 66554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=282.69 Aligned_cols=255 Identities=27% Similarity=0.440 Sum_probs=205.9
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+|++.+.||.|++|.||+|.+..++..|++|++.... ...+.+.+|+.++++++|||++++++++..+...++|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5899999999999999999999899999999987543 3345788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC--C
Q 023058 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (288)
Q Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~--~ 175 (288)
+ +++|.+.+.. ...++..+++.++.||+.+|++||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCCCcc
Confidence 9 8899988865 356899999999999999999999999999999999999988766 99999998875544332 3
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc---------------cc
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QY 240 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~ 240 (288)
....++..|+|||.+.+......++|+||+|+++++|++|..||................... ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 345678899999998766554455999999999999999988887655433333332221110 00
Q ss_pred CCCC---------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 241 SIPD---------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 241 ~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
.++. ....+.++.++|.+||+.+|.+|||+.+++. |+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~---h~~~ 285 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR---HPYF 285 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh---CcCc
Confidence 0110 1245789999999999999999999987765 5554
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=281.90 Aligned_cols=257 Identities=28% Similarity=0.431 Sum_probs=206.1
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEEEEcC-----C
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP-----T 90 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-----~ 90 (288)
....++|.+.+.||+|++|.||++.+..+++.+++|++.........+.+|+.+++++ +|||++++++++... +
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 3446899999999999999999999999999999999877655567788899999998 899999999998753 3
Q ss_pred eEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 91 HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
..++|+||+++++|.+++.. ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~ 175 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVS 175 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccc
Confidence 68999999999999887753 456899999999999999999999999999999999999987776 999999988
Q ss_pred cccccCCC-CCCCcCCCcccCCccccCcc-----cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc
Q 023058 167 KSSVLHSQ-PKSTVGTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240 (288)
Q Consensus 167 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~-----~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (288)
........ .....++..|+|||.+.... ++.+ +|+||||+++|+|++|..||.............. ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~ 251 (291)
T cd06639 176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDAR-CDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPP 251 (291)
T ss_pred hhcccccccccCccCCccccChhhhcCCCCcccccCCc-cchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CCCC
Confidence 75443222 23345788899999875433 3444 9999999999999999999976544333222211 1111
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 241 SIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 241 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
........+..+.++|.+||+.+|.+||++.++++ |+|+
T Consensus 252 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~---~~~~ 290 (291)
T cd06639 252 TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE---HPFI 290 (291)
T ss_pred CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc---Cccc
Confidence 22222246788999999999999999999988766 5554
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=281.39 Aligned_cols=251 Identities=28% Similarity=0.411 Sum_probs=203.8
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
..++|++++.||.|++|.||++++..++..+++|.+.... ...+.+.+|+.+++.++|+|++++++.+..++..++|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 3478999999999999999999999999999999987543 334567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCC
Q 023058 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (288)
|+++++|...+.. ...++...+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+...... ...
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~ 167 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTLQRR 167 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC--EEEccCccceecccccccc
Confidence 9999999877654 456899999999999999999999999999999999999987776 999999987643222 222
Q ss_pred CCCcCCCcccCCccccC-----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 176 KSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
....+++.|+|||.+.+ ..++.+ +|+||||+++|+|++|..||...+........ .............++.
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 243 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---AKSEPPTLSQPSKWSM 243 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCch-hhhHhHHHHHHHHhcCCCCCccccHHHHHHHH---hcCCCccCCCCcccCH
Confidence 34457788999999853 233444 99999999999999999999765432222211 1111222233346788
Q ss_pred HHHHHHHHhcccCcCCccccccccc
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++.++|.+||+.+|.+||++.++++
T Consensus 244 ~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 244 EFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhc
Confidence 9999999999999999999988877
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=278.46 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=202.2
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc-------chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
+|.+.+.||.|+||.||++.+. ++..+++|.+..... ....+.+|++.+++++|+|++++.+++...+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5889999999999999999875 688899998865321 22457889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC--
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 172 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-- 172 (288)
++||+++++|.+++.....++...+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccc
Confidence 9999999999999988788999999999999999999999999999999999999987776 999999988643211
Q ss_pred -----CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 173 -----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 173 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
.......++..|+|||.+.+..++.+ +|+||||+++++|++|..||...+........... .......+ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~--~~ 233 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH-RGLMPRLP--DS 233 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc-cCCCCCCC--CC
Confidence 11223457888999999988777666 99999999999999999999765433222211110 01112222 36
Q ss_pred CCHHHHHHHHHhcccCcCCccccccccc
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++.++.++|.+||+.+|.+||++.+++.
T Consensus 234 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 234 FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 7899999999999999999999988766
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=282.75 Aligned_cols=257 Identities=27% Similarity=0.474 Sum_probs=210.2
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
++|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|++++++++|||++++++.+..+..+++++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46889999999999999999999999999999987653 3345688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
+++++|.+++... ..++...+..++.|++.++++||+ .|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC--EEEeecccchhhHHHHhh-
Confidence 9989999999776 689999999999999999999999 99999999999999988776 999999988654332222
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCC-chhHHHHHHHHhhcc-cCCCCCCCCCHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRILSVQ-YSIPDYVHISPECRH 254 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 254 (288)
...++..|+|||.+.+..++.+ +|+||||+++++|++|..||..... ............... ...+.. .++.++.+
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 235 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG-KFSPDFQD 235 (265)
T ss_pred cccCChhccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChh-hcCHHHHH
Confidence 2667888999999988777666 9999999999999999999976531 112222222222222 222221 27889999
Q ss_pred HHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 255 LISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
+|.+||..+|.+|||+.+++. ++|++..
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~---~~~~~~~ 263 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLE---HPFIKKY 263 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhh---Cchhhcc
Confidence 999999999999999988765 6666543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=284.41 Aligned_cols=256 Identities=24% Similarity=0.350 Sum_probs=204.7
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCC----------------cEEEEEEeecCc--cchHHHHHHHHHHhhCCCCcee
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTE----------------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIV 80 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~----------------~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~ 80 (288)
..++|++.+.||+|+||.||++.+...+ ..+++|.+.... ...+.+.+|++++++++|||++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 4578999999999999999999876543 457999887543 3345688899999999999999
Q ss_pred eEeEEEEcCCeEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceE
Q 023058 81 RFKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (288)
Q Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nil 149 (288)
++++++..+...+++||++.+++|.+++.... .++...++.++.|++.||.+||+.|++|+||+|+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 99999999999999999999999999987655 6899999999999999999999999999999999999
Q ss_pred ecCCCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh--CCCCCCCCCC
Q 023058 150 LDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEE 224 (288)
Q Consensus 150 v~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~--g~~pf~~~~~ 224 (288)
++.++. ++|+|||++........ .....+++.|+|||.+.+..++.. +|+||||+++|+|++ +..||.....
T Consensus 163 i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 163 VGKNYT--IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ecCCCc--eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc-chhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 988766 99999999875433221 223345678999999887777666 999999999999998 6788876554
Q ss_pred chhHHHHHHHHh--hcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 225 PKNFRKTIHRIL--SVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 225 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
............ ......+....+|.++.++|.+||+.||.+|||+.++++.|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L 294 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL 294 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence 333332221111 11112223335789999999999999999999999886643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=274.93 Aligned_cols=246 Identities=30% Similarity=0.484 Sum_probs=207.0
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+|++.+.||.|++|.||.+++..++..+++|.+... ......+.+|+.++++++|+|++++++++...+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 699999999999999999999999999999988754 33345678999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CC
Q 023058 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (288)
Q Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~ 175 (288)
+++++|.+.+... ..++..++..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMA 158 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccc
Confidence 9999999988764 46899999999999999999999999999999999999988776 9999999887543333 22
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....+++.|.|||.+.+..++.. +|+||||+++++|++|..||.......... .+....... ....++.++.++
T Consensus 159 ~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVV----KIVQGNYTP-VVSVYSSELISL 232 (256)
T ss_pred cccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHcCCCCC-CccccCHHHHHH
Confidence 34557889999999887776666 999999999999999999997654333222 223333222 123678999999
Q ss_pred HHHhcccCcCCccccccccc
Q 023058 256 ISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~ 275 (288)
|.+||+.+|.+||++.++++
T Consensus 233 i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred HHHHcccCcccCCCHHHHhh
Confidence 99999999999999998877
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=281.41 Aligned_cols=252 Identities=27% Similarity=0.387 Sum_probs=205.2
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++.+.||.|++|.||++++..+++.+++|.+.... ...+.+.+|+.+++.++|+|++++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999998899999999876432 23356788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 97 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
|++++++|.+++.. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhccccC
Confidence 99999999988763 345899999999999999999999999999999999999987776 999999987654333
Q ss_pred CC-CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 173 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
.. .....++..|+|||.+.+..++.+ +|+||||+++++|++|..||...... .......+.............++.
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEE 236 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccHH
Confidence 22 123457888999999987777666 99999999999999999999754321 122222222222221122357889
Q ss_pred HHHHHHHhcccCcCCccccccccccc
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
+.++|.+||+.+|.+|||+.++++.+
T Consensus 237 ~~~li~~~l~~~p~~Rpt~~~i~~~~ 262 (267)
T cd08229 237 LRQLVNMCINPDPEKRPDITYVYDVA 262 (267)
T ss_pred HHHHHHHhcCCCcccCCCHHHHHHHH
Confidence 99999999999999999999877644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=282.10 Aligned_cols=249 Identities=22% Similarity=0.325 Sum_probs=206.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc-chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
.++|++.+.||.|++|.||++.+.. +..+++|.+..... ....+.+|+.+++.++|+|++++++++......+++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3679999999999999999999987 88899999876554 456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+..........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLS 161 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCccccc
Confidence 9999999998753 46899999999999999999999999999999999999988776 9999999887543322211
Q ss_pred -CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 177 -STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 177 -~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
...++..|++||.+.+..++.+ +|+||||+++++|++ |..||............. . ....+....+++.+.+
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~ 235 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT----A-GYRMPCPAKCPQEIYK 235 (261)
T ss_pred cCCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH----h-CCcCCCCCCCCHHHHH
Confidence 2234567999999887777666 999999999999998 899997655433333322 1 2222333478999999
Q ss_pred HHHHhcccCcCCccccccccccc
Q 023058 255 LISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
+|.+||+.||.+|||+.++++.+
T Consensus 236 ~i~~~l~~~p~~Rpt~~~l~~~L 258 (261)
T cd05148 236 IMLECWAAEPEDRPSFKALREEL 258 (261)
T ss_pred HHHHHcCCCchhCcCHHHHHHHH
Confidence 99999999999999999887744
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=276.95 Aligned_cols=245 Identities=27% Similarity=0.472 Sum_probs=201.7
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEc-CCeEEEEEe
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVME 97 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 97 (288)
+|++.+.||.|++|.||++.+..+++.+++|.+.... ...+.+.+|++++++++|+|++++.+.+.. +..+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999999889999999987543 333567889999999999999999998764 446899999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-C
Q 023058 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (288)
Q Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~ 174 (288)
++++++|.+.+... ..++..+++.++.+++.++++||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDM 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccCCc
Confidence 99999999888653 35899999999999999999999999999999999999987776 9999999887543322 2
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-CCCCCCCCCHHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPECR 253 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 253 (288)
.....+++.|+|||.+.+..++.+ +|+||||++++++++|..||...+.... ...+..... ..+ ...++.+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~ 231 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSL----VYRIIEGKLPPMP--KDYSPELG 231 (257)
T ss_pred cccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHhcCCCCCc--cccCHHHH
Confidence 233457889999999988877776 9999999999999999999975443222 222222222 222 36789999
Q ss_pred HHHHHhcccCcCCccccccccc
Q 023058 254 HLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++|.+|++.+|.+|||+.+++.
T Consensus 232 ~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 232 ELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHHHHhccCcccCCCHHHHhc
Confidence 9999999999999999988766
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=282.55 Aligned_cols=253 Identities=23% Similarity=0.411 Sum_probs=208.3
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
..++|++.+.||+|++|+||++.+..++..|++|++.... ...+.+.+|+++++.++||||+++++.+.....+++||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 4578999999999999999999999899999999876542 33467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
||+++++|..++...+.++...+..++.+++.++.|||+ .|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~~-~~~ 159 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGELIN-SIA 159 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc--EEEccCCcccchhh-hcc
Confidence 999999999998887889999999999999999999997 58999999999999987776 99999998764322 222
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCc-------hhHHHHHHHHhhcccCCCCCCCC
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------KNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
....++..|+|||.+.+..++.+ +|+||||++++++++|..||...... .........+.............
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF 238 (284)
T ss_pred CccccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhc
Confidence 34567889999999887777666 99999999999999999999865432 11112222222222111111237
Q ss_pred CHHHHHHHHHhcccCcCCccccccccc
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+.++.+||.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~ 265 (284)
T cd06620 239 PEDLRDFVDACLLKDPTERPTPQQLCA 265 (284)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 889999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=281.30 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=202.4
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEEEE-----cCCe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVIL-----TPTH 91 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~-----~~~~ 91 (288)
...++|++.+.||+|++|.||++.+..+++.+++|++.........+.+|+.+++++ +|||++++++++. .+..
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 356899999999999999999999999999999998876555556788899999999 6999999999874 3457
Q ss_pred EEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 92 LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
.+++|||+++++|.+++.. ...+++..+..++.|++.||.+||+.+++|+||+|+||+++.++. ++|+|||++.
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~ 172 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSA 172 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCcee
Confidence 8999999999999887642 346889999999999999999999999999999999999988776 9999999987
Q ss_pred ccccCC-CCCCCcCCCcccCCccccCc-----ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccC
Q 023058 168 SSVLHS-QPKSTVGTPAYIAPEVLLKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241 (288)
Q Consensus 168 ~~~~~~-~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
...... ......+++.|+|||.+... .++.+ +|+||+|+++|+|++|..||............. ......
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~---~~~~~~ 248 (286)
T cd06638 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFKIP---RNPPPT 248 (286)
T ss_pred ecccCCCccccccCCCcccChhhhchhhhccccccch-hhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc---ccCCCc
Confidence 543322 22344588899999987532 34444 999999999999999999997654323222111 111112
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 242 IPDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
......++..+.++|.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 2222246789999999999999999999988876
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=288.90 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=193.0
Q ss_pred eeeeeecc--CceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 25 LVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 25 ~~~~lg~g--~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
+++.||+| ++++||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 67899999999999999999987542 33346778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC---
Q 023058 100 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 174 (288)
Q Consensus 100 ~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~--- 174 (288)
++++|.+++... ..++...++.++.|++.||+|||+.|++|+||||+||+++.++. +++.||+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhcccccccccc
Confidence 999999988653 45899999999999999999999999999999999999988776 99999976432211111
Q ss_pred -----CCCCcCCCcccCCccccCc--ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc--------
Q 023058 175 -----PKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-------- 239 (288)
Q Consensus 175 -----~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 239 (288)
.....++..|+|||.+.+. .++.+ +|+||||+++++|++|..||....................
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCch-hhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 1223456679999998763 45555 9999999999999999999976443222111111000000
Q ss_pred --------------------------------cCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 240 --------------------------------YSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 240 --------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
...+....+++.+.+||.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000011235678999999999999999999998877
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=276.54 Aligned_cols=248 Identities=26% Similarity=0.392 Sum_probs=206.4
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
..++|++.+.||.|++|.||++... ++.+++|.+.......+++.+|+.++++++|+|++++++++......+++||+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 4678999999999999999999874 78899999987655567888999999999999999999999989999999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 99 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
+++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEcccccccccccccc--
Confidence 99999999987665 6899999999999999999999999999999999999987776 99999999875532222
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
.......|.|||.+.+..++.+ +|+||||++++++++ |..||........ ...+.. ..........|+.+.++
T Consensus 158 ~~~~~~~~~ape~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~l 231 (256)
T cd05039 158 SGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDV----VPHVEK-GYRMEAPEGCPPEVYKV 231 (256)
T ss_pred cCCCcccccCchhhcCCcCCcH-HHHHHHHHHHHHHHhcCCCCCCCCCHHHH----HHHHhc-CCCCCCccCCCHHHHHH
Confidence 2334567999999887777666 999999999999997 9999976543222 122121 12222223678999999
Q ss_pred HHHhcccCcCCccccccccccch
Q 023058 256 ISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
|.+||+.+|.+|||+.++++.+.
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~~l~ 254 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLREQLA 254 (256)
T ss_pred HHHHhccChhhCcCHHHHHHHHh
Confidence 99999999999999999887553
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=280.92 Aligned_cols=253 Identities=27% Similarity=0.384 Sum_probs=198.2
Q ss_pred CCe-eeeeeeeccCceEEEEEE----EcCCCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcC--Ce
Q 023058 21 DRY-ELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (288)
Q Consensus 21 ~~y-~~~~~lg~g~~~~v~~~~----~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 91 (288)
++| ++.+.||.|+||+||++. ...++..+++|.+..... ..+.+.+|++.+++++|||++++.+++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 455 999999999999998765 334678899999876432 445678999999999999999999987653 46
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
.+++||++++++|.+++... .++..+++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~ 159 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPE 159 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeecccccccCC
Confidence 89999999999999988664 5899999999999999999999999999999999999987776 99999999875443
Q ss_pred CCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchh-----------HHHHHHHHh
Q 023058 172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-----------FRKTIHRIL 236 (288)
Q Consensus 172 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~-----------~~~~~~~~~ 236 (288)
... .....++..|+|||.+.+...+.+ +|+||||+++++|++|..||........ .... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 237 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL-IELL 237 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcc-cccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh-hhhh
Confidence 222 122234567999999887777766 9999999999999999999865432100 0000 0001
Q ss_pred hcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 237 SVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 237 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
......+....++..+.+++.+||+.+|++|||+.++++.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~ 279 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 111122223467899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=280.31 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=202.5
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
+-|++.+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|+++++.++|||++++++++..+...++++||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 34789999999999999999999999999999886543 33456788999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCCCC
Q 023058 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (288)
Q Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~~~ 177 (288)
++++|...+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... .....
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEcccccccccccccccccc
Confidence 99999887754 456899999999999999999999999999999999999987776 999999988644322 22234
Q ss_pred CcCCCcccCCcccc-----CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 178 TVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 178 ~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
..+++.|+|||.+. +..++.. +|+||+|+++|+|++|..||...+......... ............++.++
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 238 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPPTLAQPSRWSSEF 238 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCcc-chhhhHHHHHHHHccCCCCccccCHHHHHHHHh---hcCCCCCCCccccCHHH
Confidence 45788999999974 2334444 999999999999999999997654322222221 11122223334678999
Q ss_pred HHHHHHhcccCcCCccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.++|.+||+.||.+|||+.++++
T Consensus 239 ~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 239 KDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999988766
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=290.76 Aligned_cols=259 Identities=26% Similarity=0.390 Sum_probs=205.0
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcC------
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 89 (288)
..++|++.+.||+|++|.||++.+..+++.|++|.+... ......+.+|+.++++++|||++++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 358899999999999999999999999999999998643 23334677899999999999999999988644
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
...++|||++.+ +|.+.+... ++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeC
Confidence 357999999965 787777543 899999999999999999999999999999999999988776 999999998765
Q ss_pred ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh------------
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------ 237 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 237 (288)
..........+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+..............
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 44333344557888999999988888766 99999999999999999999866543332222111000
Q ss_pred ------ccc--------------CCCC-----CCCCCHHHHHHHHHhcccCcCCccccccccc-cchhhhhh
Q 023058 238 ------VQY--------------SIPD-----YVHISPECRHLISRIFVADPAKVSMHFHATG-VYMHTKLQ 283 (288)
Q Consensus 238 ------~~~--------------~~~~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~~~~~ 283 (288)
... .++. ....++.++++|.+||+.||.+|||+.++++ .|++.|+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 000 0000 1134667899999999999999999999987 55555543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=278.04 Aligned_cols=243 Identities=26% Similarity=0.364 Sum_probs=196.4
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCch
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 104 (288)
+.||+|+||.||++.+..+++.+++|.+... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4689999999999999989999999987643 23345688999999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC---CCCcC
Q 023058 105 FERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 180 (288)
Q Consensus 105 ~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~ 180 (288)
.+++.... .++...++.++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++......... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccccccCCCCCC
Confidence 99886544 5899999999999999999999999999999999999987776 999999988643321111 11122
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 259 (288)
+..|+|||.+.+..++.+ +|+||||+++|++++ |..||.......... .+.. ....+....++..+.+++.+|
T Consensus 159 ~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~li~~~ 232 (252)
T cd05084 159 PVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQTRE----AIEQ-GVRLPCPELCPDAVYRLMERC 232 (252)
T ss_pred ceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHHHHH----HHHc-CCCCCCcccCCHHHHHHHHHH
Confidence 456999999988777776 999999999999997 888887654322211 1111 112222336789999999999
Q ss_pred cccCcCCccccccccccc
Q 023058 260 FVADPAKVSMHFHATGVY 277 (288)
Q Consensus 260 l~~~p~~Rpt~~~~l~~~ 277 (288)
|+.+|.+|||+.++++.+
T Consensus 233 l~~~p~~Rps~~~~~~~l 250 (252)
T cd05084 233 WEYDPGQRPSFSTVHQEL 250 (252)
T ss_pred cCCChhhCcCHHHHHHHH
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=280.70 Aligned_cols=250 Identities=19% Similarity=0.290 Sum_probs=199.8
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
..++|++.+.||+|++|.||.+.+.. ++..+++|.+..... ....+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46889999999999999999998642 356799998764332 23457789999999999999999999998899
Q ss_pred EEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEe
Q 023058 92 LAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~ 161 (288)
.++||||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l~ 161 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIG 161 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEEC
Confidence 999999999999999886532 2567788999999999999999999999999999999987776 9999
Q ss_pred ecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 023058 162 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILS 237 (288)
Q Consensus 162 df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 237 (288)
|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||.......... .+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~p~~~~~~~~~~~----~~~~ 236 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQVLR----FVME 236 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHc
Confidence 9998864332211 122334678999999988777666 999999999999998 788987654432222 2222
Q ss_pred cc-cCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 238 VQ-YSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 238 ~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.. ...+. .+++.+.++|.+||+.+|.+|||+.++++.+
T Consensus 237 ~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 275 (277)
T cd05062 237 GGLLDKPD--NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275 (277)
T ss_pred CCcCCCCC--CCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence 22 22333 6789999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=283.55 Aligned_cols=245 Identities=31% Similarity=0.454 Sum_probs=194.5
Q ss_pred eeeeeeeccCceEEEEEEEc----CCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 24 ELVRDIGSGNFGVARLMRDK----KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 24 ~~~~~lg~g~~~~v~~~~~~----~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
.+.+.||.|.||.||+|... ..+..|++|.+.... ...+.+.+|++.+++++||||+++++++...+..++|+|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 56789999999999999988 456789999996533 235788999999999999999999999998888999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC--
Q 023058 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (288)
Q Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-- 173 (288)
|+++++|.+++... ..++...+..++.||+.||.|||+.+++|++|+++||+++.++. +||+|||++.......
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccc
Confidence 99999999999886 67999999999999999999999999999999999999998776 9999999987552221
Q ss_pred -CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
..........|+|||.+.+..++.+ +||||||++++|+++ |..||......... ..+... ...+....++..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~k-sDVysfG~~l~ei~~~~~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~ 233 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKK-SDVYSFGMLLYEILTLGKFPFSDYDNEEII----EKLKQG-QRLPIPDNCPKD 233 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHH-HHHHHHHHHHHHHHTTSSGTTTTSCHHHHH----HHHHTT-EETTSBTTSBHH
T ss_pred cccccccccccccccccccccccccc-cccccccccccccccccccccccccccccc----cccccc-ccceeccchhHH
Confidence 1233446678999999988777666 999999999999999 67898766432222 222222 222333368999
Q ss_pred HHHHHHHhcccCcCCcccccccccc
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
+.++|..||+.+|.+|||+.++++.
T Consensus 234 ~~~li~~C~~~~p~~RPs~~~i~~~ 258 (259)
T PF07714_consen 234 IYSLIQQCWSHDPEKRPSFQEILQE 258 (259)
T ss_dssp HHHHHHHHT-SSGGGS--HHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHhc
Confidence 9999999999999999999988764
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=275.06 Aligned_cols=247 Identities=36% Similarity=0.525 Sum_probs=206.4
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|++++++++|||++++++.+..+...++|||+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 6899999999999999999999999999999987542 3345688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
+++++|.+++... ..+++..+..++.+++.++++||++|++|+||+|+||+++.++. .++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCcccc
Confidence 9999999998763 35899999999999999999999999999999999999975443 37999999988665544444
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (288)
...++..|+|||.+.+...+.+ +|+||+|+++++|++|..||...+......... .......+. .++.++.++|
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~--~~~~~l~~li 233 (256)
T cd08220 160 TVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKIM---SGTFAPISD--RYSPDLRQLI 233 (256)
T ss_pred ccccCCcccCchhccCCCCCcc-cchHHHHHHHHHHHhCCCCcccCchHHHHHHHH---hcCCCCCCC--CcCHHHHHHH
Confidence 4567889999999987776666 999999999999999999997655433222221 111222333 5789999999
Q ss_pred HHhcccCcCCccccccccc
Q 023058 257 SRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 257 ~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+||+.+|.+|||+.+++.
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHccCChhhCCCHHHHhh
Confidence 9999999999999988866
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=281.44 Aligned_cols=254 Identities=28% Similarity=0.421 Sum_probs=206.8
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
.++|++.+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|++++++++|||++++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 368999999999999999999998889999999987543 3345678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-CC
Q 023058 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (288)
Q Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~~ 176 (288)
+++++|..++... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+........ ..
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhcccccccc
Confidence 9999999988664 46999999999999999999999999999999999999987776 99999998764433222 23
Q ss_pred CCcCCCcccCCccccC-----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-ccCCCCCCCCCH
Q 023058 177 STVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISP 250 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 250 (288)
...+++.|++||.+.. ..++.+ +|+||||+++|+|++|..||...+....... +... ...+.....++.
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~-sDi~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 236 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYK-ADIWSLGITLIELAQMEPPHHELNPMRVLLK----ILKSEPPTLDQPSKWSS 236 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCcc-ccHHHHHHHHHHHHhCCCCcccCCHHHHHHH----HhcCCCCCcCCcccCCH
Confidence 3457888999998753 233444 9999999999999999999976543332222 2222 122223336789
Q ss_pred HHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
++.++|.+||+.+|.+||++.+++. |+|+.
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~---~~~~~ 266 (280)
T cd06611 237 SFNDFLKSCLVKDPDDRPTAAELLK---HPFVS 266 (280)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhc---Chhhc
Confidence 9999999999999999999988866 55543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=280.23 Aligned_cols=251 Identities=27% Similarity=0.438 Sum_probs=204.3
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCC------e
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPT------H 91 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~------~ 91 (288)
..++|++.+.||.|++|.||++.+..++..+++|++.......+.+.+|+.+++++ +|+|++++++++.... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 45899999999999999999999988899999999987776667899999999999 7999999999997644 5
Q ss_pred EEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 92 LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
++++|||+++++|.+++.. ...++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~ 161 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSA 161 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCccce
Confidence 8999999999999888764 347899999999999999999999999999999999999987776 9999999876
Q ss_pred ccccCC-CCCCCcCCCcccCCccccCc-----ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccC
Q 023058 168 SSVLHS-QPKSTVGTPAYIAPEVLLKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241 (288)
Q Consensus 168 ~~~~~~-~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
...... ......++..|+|||.+... .++.+ +|+||||+++++|++|..||.............. .....
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~ 237 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPT 237 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCcccc-ccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCC
Confidence 443322 22344578889999987542 23344 9999999999999999999976543332222211 11222
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 242 IPDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
......++..+.++|.+||..||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2223347789999999999999999999988866
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=292.19 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=201.0
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCcc--chHHHHHHHHHHhhCC-CCceeeEeEEEEcCCe
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTPTH 91 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 91 (288)
.++|.+.+.||.|+||.||++.+.. ++..||+|++..... ..+.+.+|+.++++++ ||||+++++++.....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 5789999999999999999998743 234699999875432 2356889999999996 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc------------------------------------------------------------
Q 023058 92 LAIVMEYASGGELFERICNA------------------------------------------------------------ 111 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~------------------------------------------------------------ 111 (288)
.++||||+++++|.+++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999998877532
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCC
Q 023058 112 ------------------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155 (288)
Q Consensus 112 ------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~ 155 (288)
..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCE
Confidence 13677788999999999999999999999999999999987776
Q ss_pred CCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 023058 156 PRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKT 231 (288)
Q Consensus 156 ~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~ 231 (288)
++|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||............
T Consensus 276 --~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 276 --VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL-SDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred --EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 99999999874432221 122345678999999988777776 999999999999997 99999765433322222
Q ss_pred HHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
. . .....+....++.++.+++.+||+.+|.+|||+.++.+.+.
T Consensus 353 ~---~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 353 I---K-SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred H---h-cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 1 1 22223333478999999999999999999999988876443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=277.50 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=207.0
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
...++|.+.+.||+|++|.||++.+. ++..+++|.+.......+.+.+|+..+++++|+|++++++++......+++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 34689999999999999999999976 45779999998777777889999999999999999999999998899999999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
++++++|.+++.... .++...+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYT 159 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhh
Confidence 999999999986643 6899999999999999999999999999999999999988776 999999988754322111
Q ss_pred --CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 176 --KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 176 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
.....+..|+|||.+.+...+.. +|+||+|++++++++ |..||...+....... +.. ....+.....|.++
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~ 233 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ----VER-GYRMPRPPNCPEEL 233 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCCCHHH
Confidence 12224567999999987777666 999999999999998 9999976544332222 222 22223333578999
Q ss_pred HHHHHHhcccCcCCccccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.+++.+||+.+|.+||++.++.+.+
T Consensus 234 ~~~i~~~l~~~p~~Rp~~~~l~~~l 258 (261)
T cd05034 234 YDLMLQCWDKDPEERPTFEYLQSFL 258 (261)
T ss_pred HHHHHHHcccCcccCCCHHHHHHHH
Confidence 9999999999999999998887643
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=275.57 Aligned_cols=247 Identities=30% Similarity=0.456 Sum_probs=205.8
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc------cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
+|+..+.||.|++|.||++.+..++..|++|.+.... ...+.+.+|+.++++++|+|++++.+++..+..++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 5788899999999999999998889999999986543 2345688899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
+||+++++|.+++.....++...+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccc
Confidence 999999999999988878999999999999999999999999999999999999987776 999999988755444333
Q ss_pred CCCcCCCcccCCccccCcc-cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
....++..|++||.+.... ++.+ +|+||||+++++|++|..||.............. .......+. .+++++.+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~-~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~--~~~~~~~~ 233 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLA-ADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR--SKELPPIPD--HLSDEAKD 233 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCch-hhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh--cccCCCcCC--CcCHHHHH
Confidence 4556788899999987666 5555 9999999999999999999976553222222111 011122222 57899999
Q ss_pred HHHHhcccCcCCccccccccc
Q 023058 255 LISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++.+||+.+|.+||++.+++.
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhc
Confidence 999999999999999988866
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=278.03 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=204.8
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCC---CcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
..++|++.+.||+|+||.||+|.+..+ ...+++|.+.... .....+.+|+..+++++||||+++++++...+..+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 357899999999999999999998643 4579999876543 23346788999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
++||++++++|.+++... +.++...+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 159 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhccccc
Confidence 999999999999988664 46899999999999999999999999999999999999987776 999999998765421
Q ss_pred CCC---CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCC
Q 023058 173 SQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 173 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
... ....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||.......... .+.. ....+....+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~ 233 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVIK----AVED-GYRLPPPMDC 233 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCCHHHHHH----HHHc-CCCCCCCCCC
Confidence 111 11234567999999988777766 999999999999997 999997655433222 2222 2222333468
Q ss_pred CHHHHHHHHHhcccCcCCccccccccccch
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
++.+.+++.+||+.+|.+||++.++++.+.
T Consensus 234 ~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~ 263 (266)
T cd05033 234 PSALYQLMLDCWQKDRNERPTFSQIVSTLD 263 (266)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 999999999999999999999999877554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=276.05 Aligned_cols=253 Identities=28% Similarity=0.404 Sum_probs=205.9
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++.+.||+|++|.||++.+..+++.|++|.+... ....+.+.+|++++++++|+|++++++.+......+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 6899999999999999999999989999999988642 223457889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 97 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
||+++++|..++.. ...++..++..++.+++.++.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~ 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccCC
Confidence 99999999988854 235899999999999999999999999999999999999987776 999999987644332
Q ss_pred CC-CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 173 SQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 173 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
.. .....+++.|.|||.+.+..++.+ +|+||||+++++|++|..||..... ......................+..
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEKCDYPPLPADHYSEE 236 (267)
T ss_pred CcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCc--cHHHHHhhhhcCCCCCCChhhcCHH
Confidence 22 223457788999999988777766 9999999999999999999965432 1222222222222111111257789
Q ss_pred HHHHHHHhcccCcCCccccccccccch
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
+.++|.+||..+|.+|||+.++++.+.
T Consensus 237 ~~~~i~~cl~~~p~~Rp~~~~il~~~~ 263 (267)
T cd08224 237 LRDLVSRCINPDPEKRPDISYVLQVAK 263 (267)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHHHH
Confidence 999999999999999999999887554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=277.96 Aligned_cols=251 Identities=28% Similarity=0.436 Sum_probs=205.2
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc-------chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
+|+..+.||+|++|.||++.+..++..+++|++..... ..+.+.+|+..+++++|+|++++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 58889999999999999999999999999999875331 23568899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
++|++.+++|.+++...+++++..+..++.|++.||++||+.|++|+||+|+||+++.++. .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccc
Confidence 9999999999999988888999999999999999999999999999999999999975542 389999999865443211
Q ss_pred -----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 175 -----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 175 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
.....++..|+|||.+.+..++.. +|+||||+++++|++|..||............ ................+
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHLALI-FKIASATTAPSIPEHLS 237 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcchHHHH-HHHhccCCCCCCchhhC
Confidence 122356788999999877777666 99999999999999999999755433222222 12111122222222578
Q ss_pred HHHHHHHHHhcccCcCCccccccccc
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+++.+++.+||..+|.+|||+.+++.
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 99999999999999999999988866
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=285.54 Aligned_cols=252 Identities=20% Similarity=0.322 Sum_probs=203.0
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCc----EEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
....+|++.+.||+|+||.||++.+..++. .|++|.+.... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 345789999999999999999999765554 38999886432 3345788899999999999999999998765 5
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.+++++++.+++|.+.+... ..++...+..++.||+.||+|||+.|++|+||||+||+++.++. ++|+|||++....
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~ 160 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLG 160 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEcccccccccc
Confidence 67899999999999988764 36889999999999999999999999999999999999987776 9999999997554
Q ss_pred cCCCCC---CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCC
Q 023058 171 LHSQPK---STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (288)
Q Consensus 171 ~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
...... ....+..|++||.+.+..++.+ +|+||||+++|+|++ |..||....... ... +.......+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~----~~~~~~~~~~~~ 234 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE-ISS----ILEKGERLPQPP 234 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHH----HHhCCCCCCCCC
Confidence 332221 1223567999999988887766 999999999999997 999997653322 222 222333334444
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.++.++.+++.+||+.+|.+||++.+++..+.
T Consensus 235 ~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~ 266 (316)
T cd05108 235 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 266 (316)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 67899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=280.54 Aligned_cols=252 Identities=20% Similarity=0.310 Sum_probs=203.6
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCC-----CcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (288)
+..++|.+.+.||+|+||.||++.+... +..+++|.+..... ....+.+|+.+++.++|+|++++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 3467999999999999999999998643 47899999865432 2346778999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEE
Q 023058 91 HLAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l 160 (288)
..+++||++++++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl 160 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKI 160 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEE
Confidence 9999999999999999886432 3677889999999999999999999999999999999988877 999
Q ss_pred eecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHh
Q 023058 161 CDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRIL 236 (288)
Q Consensus 161 ~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 236 (288)
+|||++........ .....++..|+|||.+.+..++.+ +|+||||+++|++++ |..||...+......... .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~---~ 236 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI---D 236 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh---c
Confidence 99998875433221 223345678999999887777666 999999999999998 899997655433222221 1
Q ss_pred hcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 237 SVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 237 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
......+. .++..+.++|.+||+.+|.+|||+.++++.+
T Consensus 237 ~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 275 (277)
T cd05032 237 GGHLDLPE--NCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275 (277)
T ss_pred CCCCCCCC--CCCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence 12223333 5789999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=277.28 Aligned_cols=242 Identities=26% Similarity=0.390 Sum_probs=202.9
Q ss_pred eeeeccCceEEEEEEEcCC---CcEEEEEEeecCccc--hHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||+|+||.||++.+... +..+++|.+...... .+.+.+|+..++.++|+|++++++++.....++++||++++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4689999999999999866 889999998875443 46788999999999999999999999999999999999999
Q ss_pred CchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 102 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 102 ~~L~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
++|.+.+... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~ 158 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDD 158 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEcccccccccccc
Confidence 9999999875 67999999999999999999999999999999999999998876 999999998755443
Q ss_pred C---CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCC
Q 023058 173 S---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 173 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
. ......+++.|+|||.+....++.+ +|+||||+++|+|++ |..||............ .. ....+....+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~ 232 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL----RK-GYRLPKPEYC 232 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchh-hccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----Hc-CCCCCCCccC
Confidence 2 2334456788999999887776666 999999999999998 69999876443322222 22 2222233367
Q ss_pred CHHHHHHHHHhcccCcCCcccccccccc
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
|.++.+++.+||+.+|.+|||+.++++.
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 233 PDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 8999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=279.33 Aligned_cols=250 Identities=20% Similarity=0.318 Sum_probs=200.8
Q ss_pred CCCeeeeeeeeccCceEEEEEEEc----CCCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDK----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
.+.|++.+.||+|+||.||++... .++..+++|.+..... ....+.+|+.++++++||||+++++++..+...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 368999999999999999999853 3567899998875332 2346788999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCC
Q 023058 94 IVMEYASGGELFERICNA-----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~ 156 (288)
++|||+++++|.+++... ..++..++..++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~- 162 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH- 162 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc-
Confidence 999999999999888532 23788889999999999999999999999999999999987776
Q ss_pred CEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 023058 157 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (288)
Q Consensus 157 ~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~ 232 (288)
++|+|||++........ .....++..|+|||.+.+..++.. +|+||||+++|+|++ |..||........ .
T Consensus 163 -~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~g~~p~~~~~~~~~----~ 236 (283)
T cd05090 163 -VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQEV----I 236 (283)
T ss_pred -EEeccccccccccCCcceecccCCCccceecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHHH----H
Confidence 99999999875433221 122334567999999987777666 999999999999998 9899976543222 1
Q ss_pred HHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
..+. .....+....+++.+.+++.+||+.||.+||++.++++.+
T Consensus 237 ~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 237 EMVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred HHHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 1211 1222233346899999999999999999999999886643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=294.36 Aligned_cols=256 Identities=39% Similarity=0.634 Sum_probs=230.0
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccch---HHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
.+.|.+...||.|.|++|.++.+..++..||||.+.+..-.. ..+.+|+++++.++|||||+++.+...+..+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 478999999999999999999999999999999998764333 45789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
||+.++.+.+++.+.++..+.....++.|++.|++|||+.+|+|||||++|++++.+.+ +||+|||++..........
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~lq 212 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLMLQ 212 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeeccccccc
Confidence 99999999999999999999999999999999999999999999999999999998887 9999999999888888889
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (288)
..+|++.|.|||.+.+..++.+..|+||+|+++|.|+.|.+||.+.+-... ...+..+.+.++. .++.+..++|
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L----r~rvl~gk~rIp~--~ms~dce~lL 286 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL----RPRVLRGKYRIPF--YMSCDCEDLL 286 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc----cchheeeeecccc--eeechhHHHH
Confidence 999999999999999999998889999999999999999999987554333 3344556666666 6889999999
Q ss_pred HHhcccCcCCccccccccc-cchhhhhh
Q 023058 257 SRIFVADPAKVSMHFHATG-VYMHTKLQ 283 (288)
Q Consensus 257 ~~~l~~~p~~Rpt~~~~l~-~~~~~~~~ 283 (288)
+++|-.+|.+|++..++.. .|...+++
T Consensus 287 rk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 287 RKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred HHhhccCccccCCHHHhhhhcccchhhh
Confidence 9999999999999999877 55555444
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=277.51 Aligned_cols=248 Identities=31% Similarity=0.458 Sum_probs=201.3
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCccc----hHHHHHHHHH-HhhCCCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||.|++|.||+|.+..+++.|++|.+...... ......|... ....+|+|++++++++...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999999999989999999998654321 1223444443 4455899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCcCC
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 181 (288)
++|..++...+.++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..... .....++
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~~~~~~~ 156 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVGT 156 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---cccCCCC
Confidence 999999988888999999999999999999999999999999999999987766 99999998764332 2334577
Q ss_pred CcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC--CCCCCCHHHHHHHHHh
Q 023058 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRI 259 (288)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~ 259 (288)
..|++||.+.+..++.+ +|+||+|+++|+|++|..||...+........ ......++ ....+++.+.++|.+|
T Consensus 157 ~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 157 PDYLAPETILGVGDDKM-SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI----LSRRINWPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred cCccChhhhcCCCCcch-hhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH----HhcccCCCCcccccCCHHHHHHHHHH
Confidence 88999999887776555 99999999999999999999765543332222 22222222 1225789999999999
Q ss_pred cccCcCCccccccccccchhhhhhh
Q 023058 260 FVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 260 l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
|+.+|.+||++.++.+.+.|+|+..
T Consensus 232 l~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 232 LCMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred ccCCHHHccCCCcHHHHHcChHhhc
Confidence 9999999999987777788888754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=280.79 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=203.6
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
..++|.+.+.||+|++|.||++.+.. ++..|++|.+.... .....+.+|+.++++++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45789999999999999999999976 67889999876433 223468889999999999999999999998889
Q ss_pred EEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-CCCEEEeec
Q 023058 92 LAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDF 163 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~-~~~~~l~df 163 (288)
.+++||++.+++|.+++.... .++...+..++.||+.+|++||+.|++|+||+|+||+++.++ ...++|+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 999999999999999886643 488999999999999999999999999999999999998654 234899999
Q ss_pred CCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcc
Q 023058 164 GYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQ 239 (288)
Q Consensus 164 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (288)
|++........ ......+..|+|||.+.+..++.+ +|+||||+++|+|++ |..||...+...... .+...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~~~~~~~~~----~~~~~- 237 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVME----FVTGG- 237 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHcC-
Confidence 99875422211 112223457999999988888776 999999999999996 999998655433221 22211
Q ss_pred cCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 240 YSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
........+|..+.+++.+||+.+|.+|||+.++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l 275 (277)
T cd05036 238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275 (277)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence 11222236789999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=282.25 Aligned_cols=253 Identities=32% Similarity=0.431 Sum_probs=203.2
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---chHHHHHHHHHHhhCCCCceeeEeEEEEcC--CeEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--THLA 93 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 93 (288)
..++|++.+.||.|++|.||+|.+..+++.+++|.+..... ....+.+|+.++++++|||++++++++..+ ...+
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 34789999999999999999999998999999999875432 223567899999999999999999998877 8999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
+++|++.+ +|.+++.... .++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~ 159 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSP 159 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCC
Confidence 99999975 8888886644 5899999999999999999999999999999999999988776 999999988755443
Q ss_pred -CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh--------------
Q 023058 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-------------- 237 (288)
Q Consensus 173 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------- 237 (288)
.......+++.|+|||.+.+......++|+||||+++++|++|..||..........+.......
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 22334456788999999876554344499999999999999999999876654444333221110
Q ss_pred ---c----------ccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 238 ---V----------QYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 238 ---~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
. ...++. ..+++.+.++|.+||+.+|.+|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPA-LSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccc-cCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 001111 015888999999999999999999988866
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=278.48 Aligned_cols=249 Identities=31% Similarity=0.469 Sum_probs=201.3
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc-----------chHHHHHHHHHHhhCCCCceeeEeEEEEcCC
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----------IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (288)
+|.+.+.||.|++|.||++.+..+++.+++|.+..... ..+.+.+|+.++++++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 68899999999999999999988899999998764211 1235778999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
..++|||++++++|.+++...+.++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeecccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999987776 9999999887543
Q ss_pred cCCC---CCCCcCCCcccCCccccCcc--cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC-
Q 023058 171 LHSQ---PKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD- 244 (288)
Q Consensus 171 ~~~~---~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 244 (288)
.... .....++..|+|||.+.+.. ++.+ +|+||||++++++++|..||...+......+.... .....++.
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~ 236 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAK-VDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK--RSAPPIPPD 236 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCcc-chhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc--ccCCcCCcc
Confidence 2211 22334678899999987654 4444 99999999999999999999654432222221111 11112222
Q ss_pred -CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 245 -YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 245 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
...++..+.++|.+||.++|.+|||+.++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 2356899999999999999999999977765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=275.13 Aligned_cols=247 Identities=31% Similarity=0.446 Sum_probs=200.6
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc------cchHHHHHHHHHHhhCCCCceeeEeEEEEcC--CeE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 92 (288)
.+|++.+.||+|++|.||.+.+..++..|++|.+.... ...+.+.+|+.++++++||||+++++++... ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 68999999999999999999999999999999886432 1234677899999999999999999998764 468
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
+++||++++++|.+++.....++...+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||.+......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCccccccccc
Confidence 899999999999999988778899999999999999999999999999999999999987776 999999988744321
Q ss_pred C----CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCC
Q 023058 173 S----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 173 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
. ......++..|+|||.+.+..++.. +|+||||+++|+|++|..||........... ..............
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~ 234 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRK-ADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPVLPPHV 234 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcc-hhHHHHHHHHHHHhhCCCCCCccchHHHHHH----HhcCCCCCCCchhh
Confidence 1 1223457788999999987777666 9999999999999999999976543332222 11111111112256
Q ss_pred CHHHHHHHHHhcccCcCCccccccccc
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+..+.++|.+|+ .+|.+||++.++++
T Consensus 235 ~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 235 SDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred CHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 788999999999 59999999988876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=280.39 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=203.6
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEEEEc------C
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT------P 89 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~------~ 89 (288)
....++|++.+.||.|+||.||++.+..+++.+++|.+.........+..|+.+++++ +|+|++++++++.. .
T Consensus 12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 3455899999999999999999999999999999999887666667788899999998 79999999999853 4
Q ss_pred CeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 90 THLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
...+++|||+++++|.+++... ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~ 169 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSA 169 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchh
Confidence 5789999999999999888653 35888889999999999999999999999999999999987776 9999999877
Q ss_pred ccccC-CCCCCCcCCCcccCCccccC-----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccC
Q 023058 168 SSVLH-SQPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241 (288)
Q Consensus 168 ~~~~~-~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
..... .......+++.|+|||.+.. ..++.+ +|+||||+++|+|++|..||............ ......
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~-~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~----~~~~~~ 244 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCDMHPMRALFLI----PRNPPP 244 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcc-cchhHHHHHHHHHHhCCCCccccCHHhhhhhH----hhCCCC
Confidence 54322 22334557889999998752 334445 99999999999999999999765432222211 111111
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 242 IPDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
......++.++.++|.+||+.||.+|||+.++++
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1122357899999999999999999999988765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=282.21 Aligned_cols=255 Identities=23% Similarity=0.350 Sum_probs=205.7
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCc--cchHHHHHHHHHHhhC-CCCceeeEeEEEEc
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILT 88 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (288)
....++|.+.+.||+|+||.||++.+. .++..+++|.+.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 455679999999999999999999752 345679999876543 2335688999999999 79999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 89 PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
.+..+++|||+.+++|.+++.... .++..++..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~dfg~~ 188 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI--VKICDFGLA 188 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe--EEECCCccc
Confidence 999999999999999999986543 3899999999999999999999999999999999999987665 999999998
Q ss_pred cccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCC
Q 023058 167 KSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSI 242 (288)
Q Consensus 167 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
........ .....++..|+|||.+.+..++.+ +|+||+|+++|+|++ |..||........+..... .....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~ 263 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----EGYRM 263 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH----cCCcC
Confidence 74433221 122345678999999988877766 999999999999998 9999976654433333222 11222
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 243 PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
......++.+.+++.+||+.+|.+|||+.++++.+.
T Consensus 264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~ 299 (302)
T cd05055 264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299 (302)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 223357899999999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=276.15 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=203.5
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
..+.|++.++||+|+||.||+|... ++..|++|.+.......+.+.+|+.++++++|+|++++++++. .+..+++||+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 4578999999999999999999976 4678999999877766778999999999999999999999874 4578999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC-
Q 023058 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (288)
Q Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~- 175 (288)
+.+++|.+.+... ..++..++..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCccc
Confidence 9999999888653 35889999999999999999999999999999999999988776 999999988654322211
Q ss_pred -CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 176 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
....++..|+|||.+.+..++.+ +|+||||+++|++++ |..||...+........ . .....+.....+.++.
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~ 233 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL----E-RGYRMPRPDNCPEELY 233 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH----H-cCCCCCCCCCCCHHHH
Confidence 12234567999999887777666 999999999999998 99999865543222221 1 1222233346789999
Q ss_pred HHHHHhcccCcCCccccccccccc
Q 023058 254 HLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
++|.+||+.+|.+|||+.++...+
T Consensus 234 ~li~~~l~~~p~~Rp~~~~l~~~l 257 (260)
T cd05067 234 ELMRLCWKEKPEERPTFEYLRSVL 257 (260)
T ss_pred HHHHHHccCChhhCCCHHHHHHHh
Confidence 999999999999999998886643
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=279.97 Aligned_cols=249 Identities=28% Similarity=0.422 Sum_probs=196.5
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCC-CCceeeEeEEEEcC--CeEEEEEe
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIVME 97 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv~e 97 (288)
|++.+.||+|++|.||++.+..++..+++|.+.... .......+|+..+.++. |+|++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 788999999999999999999899999999886542 22234457888888885 99999999999987 88999999
Q ss_pred ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
|+.+ ++.+.+.. ...+++.++..++.|++.||.+||+.|++|+||+|+||+++. +. ++|+|||++..........
T Consensus 81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~--~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DI--LKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CC--eEEEecccccccccCCCcC
Confidence 9975 77777655 357899999999999999999999999999999999999987 44 9999999987654444434
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh--------------hcccCC
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL--------------SVQYSI 242 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------~~~~~~ 242 (288)
...++..|+|||.+........++|+||||+++|+|++|..||...+..+.......... .....+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 455788999999875544444459999999999999999999987654333322221110 001111
Q ss_pred CC---------CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 243 PD---------YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 243 ~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+. ...++.++.++|.+||+++|.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 11 1246789999999999999999999988765
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=282.96 Aligned_cols=253 Identities=26% Similarity=0.445 Sum_probs=202.4
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++|++.+.||.|++|.||++.+..+++.|++|.+..... ..+.+.+|+++++.++|||++++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 579999999999999999999998899999998765322 23567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-CC
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~~ 176 (288)
|+++++|.........++..++..++.|++.+|.|||+.|++|+||+|+||+++.++. ++|+|||++........ ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccC
Confidence 9999888877766667999999999999999999999999999999999999988776 99999998875433322 22
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc---------------ccC
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QYS 241 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~ 241 (288)
...++..|+|||.+.+......++|+||||+++++|++|..||......+............ ...
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 34467889999998765444445999999999999999999997654333222222100000 000
Q ss_pred CC----------CCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 242 IP----------DYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 242 ~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+ ....++..+.+++.+||+.+|.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 12357889999999999999999999987765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=273.25 Aligned_cols=246 Identities=34% Similarity=0.512 Sum_probs=208.8
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcC--CeEEEEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 96 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 96 (288)
+|.+.+.||+|++|.||++.+..++..+++|++.... ...+.+.+|+..+++++|+|++++++.+... ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5889999999999999999999899999999987654 3456788999999999999999999999988 8999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC--
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-- 174 (288)
|++++++|.+++.....++...++.++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEcccccEEecccccccc
Confidence 99999999999988878999999999999999999999999999999999999988666 99999999876655543
Q ss_pred -CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh--cccCCCCCCCCCHH
Q 023058 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPE 251 (288)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 251 (288)
.....++..|++||.+.+...+.+ +|+||||+++++|++|..||...... ......... .....+. ..++.
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~--~~~~~ 232 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNP---MAALYKIGSSGEPPEIPE--HLSEE 232 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCch---HHHHHhccccCCCcCCCc--ccCHH
Confidence 345568889999999877776666 99999999999999999999876521 112222221 1222333 56899
Q ss_pred HHHHHHHhcccCcCCccccccccc
Q 023058 252 CRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+.++|.+||+.+|.+||++.+++.
T Consensus 233 l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 233 AKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHHHHhCcCChhhCCCHHHHhh
Confidence 999999999999999999977765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=277.59 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=198.6
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc--chHHHHHHHHH-HhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++|++.+.||+|+||.||++.+..+++.||+|.+..... ....+..|+.. ++.++|||++++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 479999999999999999999999999999999876432 23345556665 566789999999999999999999999
Q ss_pred ccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhc-CceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 98 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 98 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~-~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
|++ ++|.+++.. ...+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence 996 477776643 24689999999999999999999997 9999999999999988776 999999998755433
Q ss_pred CCCCCCcCCCcccCCccccC----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCC
Q 023058 173 SQPKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
.......++..|+|||.+.+ ..++.+ +|+||+|+++|+|++|..||...... ...............+. ..+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~-~~~ 233 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEEPSPQLPA-EKF 233 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCcc-ccchhhHHHHHHHHhCCCCCCccccC--HHHHHHHHhcCCCCCCc-ccc
Confidence 22233457888999998864 233444 99999999999999999999754321 12221122222223332 257
Q ss_pred CHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
|.++.++|.+||..+|.+||++.++++ ++|++.
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~---~~~~~~ 266 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQ---HPFFEL 266 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc---Cchhhh
Confidence 899999999999999999999988876 555543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=282.30 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=201.0
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCC--------------CcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKT--------------EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRF 82 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~--------------~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~ 82 (288)
..++|++.+.||+|+||.||++.+..+ ...|++|.+.... .....+.+|++++++++|+|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 357899999999999999999987543 2358999886542 233468889999999999999999
Q ss_pred eEEEEcCCeEEEEEeccCCCchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEe
Q 023058 83 KEVILTPTHLAIVMEYASGGELFERICNAG------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (288)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv 150 (288)
++++......++||||+.+++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 999999999999999999999998885432 36788999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh--CCCCCCCCCCc
Q 023058 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEP 225 (288)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~--g~~pf~~~~~~ 225 (288)
+.++. ++|+|||++........ .....++..|+|||.+.+..++.+ +|+||||+++++|++ +..||......
T Consensus 163 ~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 163 GNHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred cCCCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCch-hhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 87766 99999998865433221 122234568999999888777666 999999999999988 66788766543
Q ss_pred hhHHHHHHHHhhc-c-cCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 226 KNFRKTIHRILSV-Q-YSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 226 ~~~~~~~~~~~~~-~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
............. . .........|+.+.+||.+||+.+|.+|||+.++++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 4333322211111 1 11222335789999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=275.67 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=201.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
.++|++.+.||+|++|.||++.+..+ ..+++|.+.......+.+.+|+.++++++|+|++++++++. ....+++||++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 47899999999999999999998754 46899988766666677889999999999999999999875 45678999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC--
Q 023058 100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (288)
Q Consensus 100 ~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~-- 175 (288)
.+++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCccccc
Confidence 9999999886543 4788999999999999999999999999999999999988776 999999998654332211
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
....++..|+|||...+...+.+ +|+||||+++|+|++ |..||............ .. ....+.....+..+.+
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMVNREVLEQV----ER-GYRMPCPQGCPESLHE 234 (260)
T ss_pred CCCccchhhCCHHHhccCCcChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----Hc-CCCCCCCcccCHHHHH
Confidence 12234567999999887777666 999999999999999 89999875543322221 11 2222223367899999
Q ss_pred HHHHhcccCcCCccccccccccc
Q 023058 255 LISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
++.+||+.||.+||++.++++.+
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~~l 257 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQSFL 257 (260)
T ss_pred HHHHHccCCcccCcCHHHHHHHH
Confidence 99999999999999998887644
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=276.34 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=201.4
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
..++|++.+.||+|++|.||++.+. ++..+++|.+.......+.+.+|+.++++++|+|++++++++. ....+++||+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 4578999999999999999999876 4566999998876666678899999999999999999999875 4567899999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC-
Q 023058 99 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (288)
Q Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~- 175 (288)
+++++|.+++... ..++..++..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIEDNEYTA 159 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce--EEeCCceeeeeccCccccc
Confidence 9999999988653 35899999999999999999999999999999999999987776 999999998754332211
Q ss_pred -CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 176 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||...+..+... .+.. ....+.....+..+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~ 233 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLE----QVER-GYRMPCPQDCPISLH 233 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHHc-CCCCCCCCcCCHHHH
Confidence 11224457999999887777666 999999999999999 889997654333222 2222 222233346789999
Q ss_pred HHHHHhcccCcCCcccccccccc
Q 023058 254 HLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
+++.+||+.+|.+|||+.++.+.
T Consensus 234 ~li~~~l~~~p~~Rpt~~~l~~~ 256 (260)
T cd05070 234 ELMLQCWKKDPEERPTFEYLQSF 256 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHHH
Confidence 99999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=271.86 Aligned_cols=248 Identities=31% Similarity=0.475 Sum_probs=209.0
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc-chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccC
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (288)
.|.+.+.||.|++|.||++.+..++..+++|++..... ..+.+.+|++.+++++|+|++++.+++......++++|+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 48889999999999999999998899999999877654 55678899999999999999999999999999999999999
Q ss_pred CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCc
Q 023058 101 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179 (288)
Q Consensus 101 ~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 179 (288)
+++|.+++... ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+.............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeecccccccccccccccee
Confidence 99999998776 57999999999999999999999999999999999999987766 9999999887655543334556
Q ss_pred CCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 023058 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259 (288)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 259 (288)
++..|++||.+.+...+.+ +|+||||+++++|++|..||...+......... .......+....++..+.++|.+|
T Consensus 159 ~~~~~~~PE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~ 234 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFKIA---TNGPPGLRNPEKWSDEFKDFLKKC 234 (253)
T ss_pred cCCcccCHHHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hcCCCCcCcccccCHHHHHHHHHH
Confidence 7889999999887776655 999999999999999999998664333222211 122223333334589999999999
Q ss_pred cccCcCCccccccccc
Q 023058 260 FVADPAKVSMHFHATG 275 (288)
Q Consensus 260 l~~~p~~Rpt~~~~l~ 275 (288)
|+.||.+|||+.++++
T Consensus 235 l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 235 LQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccCChhhCCCHHHHhc
Confidence 9999999999988765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=274.88 Aligned_cols=246 Identities=29% Similarity=0.510 Sum_probs=203.9
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+|++.+.||.|++|.+|.+.+..+++.|++|.+... ....+.+.+|+..+++++|||++++.+++......++|+|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 589999999999999999999999999999998753 23345788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC-
Q 023058 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (288)
Q Consensus 99 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~- 175 (288)
+.+++|.+.+.... .++..++..++.|++.++.+||+.|++|+||+|+||+++.++. ++++|||.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELA 158 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhh
Confidence 99999998886543 5789999999999999999999999999999999999987776 999999988754332221
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....+++.|+|||.+.+...+.+ +|+||||+++++|++|..||...+........ ...... +.....+.++.++
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~l 232 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI----IRGSYP-PVSSHYSYDLRNL 232 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccCCCHHHHHHHH----hcCCCC-CCcccCCHHHHHH
Confidence 23347788999999887777666 99999999999999999999765433222222 222211 1223678999999
Q ss_pred HHHhcccCcCCccccccccc
Q 023058 256 ISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~ 275 (288)
|.+||+.+|.+||++.++++
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHHHhhCChhhCcCHHHHhh
Confidence 99999999999999988866
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=275.25 Aligned_cols=243 Identities=26% Similarity=0.320 Sum_probs=197.4
Q ss_pred eeeeccCceEEEEEEEcCCC---cEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKKTE---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~---~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||+|+||.||++....++ ..+++|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++||++++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999876544 7899999876544 4567889999999999999999999876 4567999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCC----
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---- 177 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~---- 177 (288)
++|.+++.....+++..+..++.|++.++++||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccC
Confidence 999999988878999999999999999999999999999999999999988776 99999999875543332211
Q ss_pred CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 023058 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (288)
..++..|+|||.+.+..++.+ +|+||||+++|++++ |..||...+...... .+... ...+....++..++++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~l~~li 231 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA----MLESG-ERLPRPEECPQEIYSIM 231 (257)
T ss_pred ccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCCHHHHHH----HHHcC-CcCCCCCCCCHHHHHHH
Confidence 112357999999988777776 999999999999997 999997655422222 22222 22233346889999999
Q ss_pred HHhcccCcCCccccccccccch
Q 023058 257 SRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 257 ~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.+||+.+|.+||++.++++.+.
T Consensus 232 ~~cl~~~p~~Rp~~~~l~~~l~ 253 (257)
T cd05060 232 LSCWKYRPEDRPTFSELESTFR 253 (257)
T ss_pred HHHhcCChhhCcCHHHHHHHHH
Confidence 9999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=280.21 Aligned_cols=251 Identities=29% Similarity=0.437 Sum_probs=200.7
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+|++.+.||.|++|.||++.+..++..|++|.+.... ...+.+.+|++++++++|||++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5899999999999999999999899999999886542 2235688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-C
Q 023058 99 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (288)
Q Consensus 99 ~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (288)
+. ++|..++.. ...++...+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 157 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcccc
Confidence 96 578887755 346899999999999999999999999999999999999988876 99999998865433222 2
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc--------------ccC
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------------QYS 241 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~ 241 (288)
....+++.|+|||.+.+......++|+||||+++|+|++|..||...+..+...+........ ...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 233467889999988766544455999999999999999999998765433333322211100 001
Q ss_pred CCC---------CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 242 IPD---------YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 242 ~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++. ...++++++++|.+||+.||.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 111 1246789999999999999999999988865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=283.78 Aligned_cols=252 Identities=27% Similarity=0.398 Sum_probs=187.3
Q ss_pred eeeeeccCceEEEEEEEcC--CCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEc--CCeEEEEEeccCC
Q 023058 26 VRDIGSGNFGVARLMRDKK--TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG 101 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 101 (288)
..+||+|+||+||+|.+.. +++.+|+|.+.... ......+|+.++++++||||+++++++.. +..++++||++.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 4689999999999999653 66889999886543 33567889999999999999999999864 4578999999865
Q ss_pred CchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCC--CCCCEEEeecCCCcccc
Q 023058 102 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV 170 (288)
Q Consensus 102 ~~L~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~--~~~~~~l~df~~~~~~~ 170 (288)
+|..++... ..++...++.++.||+.||.|||+.|++|+||||+||++..+ ..+.++|+|||++....
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 787776432 248999999999999999999999999999999999999532 23359999999987543
Q ss_pred cCCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchh-----HHHHHHHHhhc---
Q 023058 171 LHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-----FRKTIHRILSV--- 238 (288)
Q Consensus 171 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~--- 238 (288)
.... .....+++.|+|||.+.+......++|+||+||++++|++|..||........ .......+...
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCC
Confidence 3221 23446789999999987755334449999999999999999999975432100 00000000000
Q ss_pred -------------------------ccCC--------CCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 239 -------------------------QYSI--------PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 239 -------------------------~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
.... ......+.++.+||.+||+.||.+|||++|+++ |+|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~---hp~f 317 (317)
T cd07868 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ---DPYF 317 (317)
T ss_pred CChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc---CCCC
Confidence 0000 001123567889999999999999999988876 5553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=281.58 Aligned_cols=253 Identities=24% Similarity=0.327 Sum_probs=204.4
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCcc-chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
..++|.+.+.||+|++|.||++.+. .++..+++|.+..... ..+.+.+|++.+++++|+||+++++++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 3578999999999999999999854 2456688888765432 235688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCC
Q 023058 93 AIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~ 156 (288)
++||||+++++|.+++...+ .++...++.++.||+.|+++||+.|++|+||+|+||+++.++.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~- 161 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL- 161 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc-
Confidence 99999999999999986532 3788999999999999999999999999999999999988776
Q ss_pred CEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 023058 157 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (288)
Q Consensus 157 ~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~ 232 (288)
++|+|||++........ .....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||..........
T Consensus 162 -~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~--- 236 (291)
T cd05094 162 -VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIE--- 236 (291)
T ss_pred -EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---
Confidence 99999999875433221 233445678999999888777666 999999999999998 999987655433222
Q ss_pred HHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
.+...... ......|..+.+++.+||+.+|.+|||+.++++.+..
T Consensus 237 -~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~ 281 (291)
T cd05094 237 -CITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHA 281 (291)
T ss_pred -HHhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence 22222221 1223578999999999999999999999999886544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=275.11 Aligned_cols=240 Identities=26% Similarity=0.341 Sum_probs=193.7
Q ss_pred eeeccCceEEEEEEE--cCCCcEEEEEEeecCcc---chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCC
Q 023058 28 DIGSGNFGVARLMRD--KKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (288)
Q Consensus 28 ~lg~g~~~~v~~~~~--~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (288)
.||+|+||.||++.+ ..++..+++|++..... ..+.+.+|+.+++.++||||+++++++. .+..+++||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 45678899998865432 3356788999999999999999999875 45678999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC----CCC
Q 023058 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KST 178 (288)
Q Consensus 103 ~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~----~~~ 178 (288)
+|.+++.....++...+..++.|++.|+++||+.|++|+||+|.||+++.++. ++|+|||.+......... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe--EEECCCccccccCCCCCeeeecCCC
Confidence 99999988778999999999999999999999999999999999999987776 999999998754333221 122
Q ss_pred cCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhc-ccCCCCCCCCCHHHHHHH
Q 023058 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLI 256 (288)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li 256 (288)
.++..|+|||.+.+..++.. +|+||||+++|+|++ |..||........... +... ....+ ..+++++.++|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----i~~~~~~~~~--~~~~~~l~~li 231 (257)
T cd05116 159 KWPVKWYAPECMNYYKFSSK-SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM----IESGERMECP--QRCPPEMYDLM 231 (257)
T ss_pred CCCccccCHhHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHCCCCCCCC--CCCCHHHHHHH
Confidence 23468999999877766666 999999999999997 9999987554332222 2222 22333 36899999999
Q ss_pred HHhcccCcCCccccccccccc
Q 023058 257 SRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 257 ~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.+||++||.+||++.++...+
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~~l 252 (257)
T cd05116 232 KLCWTYGVDERPGFAVVELRL 252 (257)
T ss_pred HHHhccCchhCcCHHHHHHHH
Confidence 999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=279.98 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=202.6
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
..++|.+.++||+|+||.||++... .++..+++|.+.... ...+.+.+|++.+++++|+||+++++++......
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 4578999999999999999999743 346678999876433 3345788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCC
Q 023058 93 AIVMEYASGGELFERICNAG---------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~ 157 (288)
+++||++++++|.+++...+ .++...+..++.|++.|++|||+.|++|+||+|+||+++.++.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~-- 160 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV-- 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC--
Confidence 99999999999999886543 3788999999999999999999999999999999999987776
Q ss_pred EEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 023058 158 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (288)
Q Consensus 158 ~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (288)
++|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||............
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-- 237 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI-- 237 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH--
Confidence 99999998864432221 122334678999999888877776 999999999999998 89999765543332222
Q ss_pred HHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.... .......+|+.+.++|.+||+.||.+||++.++++.+
T Consensus 238 --~~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l 278 (280)
T cd05092 238 --TQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278 (280)
T ss_pred --HcCc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 1111 1222236889999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=286.77 Aligned_cols=254 Identities=22% Similarity=0.360 Sum_probs=200.4
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCc--cchHHHHHHHHHHhhC-CCCceeeEeEEEEcC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (288)
...++|++.+.||+|+||.||+|... .+++.||+|++.... ...+.+.+|+.+++++ +|+||+++++++...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 34579999999999999999999743 345789999887532 2234577899999999 899999999988654
Q ss_pred -CeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 023058 90 -THLAIVMEYASGGELFERICNA--------------------------------------------------------- 111 (288)
Q Consensus 90 -~~~~lv~e~~~~~~L~~~~~~~--------------------------------------------------------- 111 (288)
..+++++||+++++|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 5788999999999998887532
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC---CCCCcCCCcc
Q 023058 112 ----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAY 184 (288)
Q Consensus 112 ----~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~ 184 (288)
..++...+..++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++........ .....++..|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcchhhccCCCCCccc
Confidence 25788899999999999999999999999999999999987776 99999999875432221 1223345679
Q ss_pred cCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccC
Q 023058 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263 (288)
Q Consensus 185 ~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 263 (288)
+|||.+.+..++.+ +|+|||||++|+|++ |..||............. .. ..........++++.+++.+||+.+
T Consensus 242 ~aPE~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~l~~~cl~~~ 316 (337)
T cd05054 242 MAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL---KE-GTRMRAPEYATPEIYSIMLDCWHNN 316 (337)
T ss_pred cCcHHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH---hc-cCCCCCCccCCHHHHHHHHHHccCC
Confidence 99999988888777 999999999999997 999997654333222221 11 1111222367899999999999999
Q ss_pred cCCccccccccccch
Q 023058 264 PAKVSMHFHATGVYM 278 (288)
Q Consensus 264 p~~Rpt~~~~l~~~~ 278 (288)
|.+||++.++++.+.
T Consensus 317 p~~RPs~~ell~~l~ 331 (337)
T cd05054 317 PEDRPTFSELVEILG 331 (337)
T ss_pred hhhCcCHHHHHHHHH
Confidence 999999999887443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=277.33 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=196.0
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
..++|.+.+.||+|++|.||++.+..++..|++|.+.... .......+|+.+++.++|+||+++.+++..++..++++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3488999999999999999999999899999999986543 22346778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-C
Q 023058 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~ 174 (288)
|++. +++...+.. ...++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQT 159 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCC
Confidence 9996 566665544 346788899999999999999999999999999999999987776 9999999886433322 2
Q ss_pred CCCCcCCCcccCCccccCcc-cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh---------------c
Q 023058 175 PKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------V 238 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------~ 238 (288)
.....+++.|+|||.+.+.. ++.. +|+||||+++++|++|..||.................. .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~-~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSA-LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCccccccccCCceeecCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 23345688999999987644 4444 99999999999999999999765432111100000000 0
Q ss_pred ccC-C----C-------CCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 239 QYS-I----P-------DYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 239 ~~~-~----~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
... . + .....++++.+++.+|++.||.+|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 0 0 00123678999999999999999999988765
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=279.17 Aligned_cols=252 Identities=28% Similarity=0.462 Sum_probs=203.0
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++|++.+.||+|++|.||++.+..++..|++|.+... ....+.+.+|++++++++|+|++++++++..++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4799999999999999999999999999999988653 2334678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC--CC
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~--~~ 175 (288)
|++++.+..+......++..++..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPL 158 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccc
Confidence 9988766666666667999999999999999999999999999999999999988776 9999999987654443 22
Q ss_pred CCCcCCCcccCCccccCc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc------------c--
Q 023058 176 KSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------------Y-- 240 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------~-- 240 (288)
....++..|+|||.+.+. .++.+ +|+||||+++++|++|..||......+............. .
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~-~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKP-VDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 344577889999999877 45444 9999999999999999999976544332222211100000 0
Q ss_pred -CCC-----------CCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 241 -SIP-----------DYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 241 -~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
..+ ....++.++.++|.+||+.+|.+|||+.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 01134889999999999999999999988765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=281.42 Aligned_cols=261 Identities=29% Similarity=0.453 Sum_probs=204.9
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc---hHHHHHHHHHHhhCCCCceeeEeEEEEcC--Ce
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 91 (288)
+...++|++.+.||.|++|.||++.+..++..||+|.+...... .....+|+.++++++|+|++++++++... +.
T Consensus 3 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred cccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 34568999999999999999999999999999999998754322 23466899999999999999999998765 56
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 92 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.++|||++.+ +|..++.. ...++..++..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~ 159 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYG 159 (309)
T ss_pred EEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccceeeecC
Confidence 8999999965 78777765 356899999999999999999999999999999999999987776 9999999987554
Q ss_pred cCCCC-CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-----------
Q 023058 171 LHSQP-KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV----------- 238 (288)
Q Consensus 171 ~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 238 (288)
..... .....++.|+|||.+.+......++|+||||+++|+|++|..||...+...............
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 43222 223357789999998765443444999999999999999999998766544433333211100
Q ss_pred ----ccCCCC---------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 239 ----QYSIPD---------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 239 ----~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
....+. ....++.+.++|.+||+.||.+|||+.+++. |+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~---h~~f~ 294 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE---SSYFK 294 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc---Chhhc
Confidence 000010 0125788999999999999999999988876 66664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=286.63 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=202.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc-hHHHHHHHHHHhhCCCCceeeEeEEEEcCC-eEEEEEe
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVME 97 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e 97 (288)
.++|.-...||+|+||.||++.-.+ +..||||.+...... ..++.+|++++.+++|||+|+++|+|...+ ...+|+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 3788888999999999999999875 488999988776554 567999999999999999999999999988 5999999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC---ceecCCCCCceEecCCCCCCEEEeecCCCccccc-
Q 023058 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~---i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~- 171 (288)
|++.|+|.+.+.... .+++..+..|+.++|.||+|||... |+|||||++||++|.+.. .||+|||++.....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEG 230 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCcc
Confidence 999999999997765 8999999999999999999999854 999999999999998887 99999999965544
Q ss_pred CCCCCCC-cCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCC--Cch-hHHHHHHHHhhccc------C
Q 023058 172 HSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--EPK-NFRKTIHRILSVQY------S 241 (288)
Q Consensus 172 ~~~~~~~-~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~--~~~-~~~~~~~~~~~~~~------~ 241 (288)
....... .+|..|++||++..+..+.+ +|+||+|+++.|+++|..+..... ... ........+..... .
T Consensus 231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~ 309 (361)
T KOG1187|consen 231 DTSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPR 309 (361)
T ss_pred ccceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCC
Confidence 3332333 79999999999988888777 999999999999999998877532 111 12211112222111 1
Q ss_pred CCCCCCCC--H---HHHHHHHHhcccCcCCccccccccccc
Q 023058 242 IPDYVHIS--P---ECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 242 ~~~~~~~~--~---~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
+.. ...+ . .+..+..+|++.+|.+||++.++.+.+
T Consensus 310 l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 310 LKE-GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred ccC-CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 110 1223 2 366777899999999999999986655
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=277.55 Aligned_cols=252 Identities=20% Similarity=0.325 Sum_probs=202.1
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCc----EEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
...++|++.+.||.|+||+||++.+..++. .||+|.+.... ...+.+.+|+.+++.++|||++++++++... .
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 356889999999999999999999876665 48999886432 3345678899999999999999999998754 4
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.+++++++++++|.+.+... +.++...+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~ 160 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLD 160 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeecc
Confidence 67899999999999988664 46899999999999999999999999999999999999987776 9999999987554
Q ss_pred cCCCC---CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCC
Q 023058 171 LHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (288)
Q Consensus 171 ~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
..... ....+++.|++||...+..++.+ +|+||||+++|+|++ |..||......... . . .......+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~---~-~~~~~~~~~~~ 234 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPAREIP-D---L-LEKGERLPQPP 234 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-H---H-HHCCCcCCCCc
Confidence 32221 12234567999999988777766 999999999999998 88998765432221 1 1 22222233334
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.++.++.++|.+||+.||.+||++.++++.+.
T Consensus 235 ~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~ 266 (279)
T cd05109 235 ICTIDVYMIMVKCWMIDSECRPRFRELVDEFS 266 (279)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 68899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=277.98 Aligned_cols=248 Identities=34% Similarity=0.535 Sum_probs=207.6
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCch
Q 023058 29 IGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (288)
Q Consensus 29 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 104 (288)
||.|++|.||++.+..+++.+++|.+.... ...+.+.+|++++++++|||++++++.+..+...++++|++++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 688999999999999889999999987543 3445788899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC---------C
Q 023058 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---------P 175 (288)
Q Consensus 105 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~---------~ 175 (288)
.+++...+.++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccc
Confidence 999988778999999999999999999999999999999999999998876 99999998875443321 1
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....++..|++||...+...+.. +|+||||++++++++|..||......... ..+......++.....++.+.++
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQGHSKT-VDWWSLGCILYEFLVGIPPFHGETPEEIF----QNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred cCcccCccccCHHHhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCcCCCccccCCHHHHHH
Confidence 23346778999999877776555 99999999999999999999766543322 22333344455533458999999
Q ss_pred HHHhcccCcCCccccccccccchhhhhh
Q 023058 256 ISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+.+||+.+|.+|||+.++.+.+.++|+.
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~ 261 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFK 261 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhcCcccc
Confidence 9999999999999997777777788875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=276.99 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=204.6
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCC---cEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
..++|++.+.||.|+||.||++.+..++ ..+++|.+.... ...+.+.+|+..+++++||||+++++++..++..+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 4578999999999999999999876443 378999886532 33457888999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
++||++++++|.+++... +.++..++..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~~ 159 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe--EEeCCCCcccccccc
Confidence 999999999999998764 46899999999999999999999999999999999999987776 999999988755433
Q ss_pred CCCC----CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 173 SQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 173 ~~~~----~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
.... ....+..|++||.+.+..++.+ +|+||||+++|++++ |..||........... +... ...+....
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~ 233 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA----IEEG-YRLPAPMD 233 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH----HhCC-CcCCCCCC
Confidence 2211 1122457999999988777766 999999999999886 9999976554332222 2222 23344446
Q ss_pred CCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
+|+.+.+++.+|++.+|.+||++.++++.+.
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 264 (267)
T cd05066 234 CPAALHQLMLDCWQKDRNERPKFEQIVSILD 264 (267)
T ss_pred CCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence 8899999999999999999999999887554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=276.86 Aligned_cols=255 Identities=28% Similarity=0.451 Sum_probs=212.7
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
......++|++...||+|++|.||++.+..++..+++|++.......+.+.+|++.+++++|+|++++++.+......++
T Consensus 13 ~~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 13 SEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred CCCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 33456688999999999999999999999889999999998765556678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 95 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
++|++++++|.+++.... .++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEK 170 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccch
Confidence 999999999999998876 8999999999999999999999999999999999999987776 9999999876443322
Q ss_pred C-CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 174 Q-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 174 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
. .....++..|++||.+.+..++.+ +|+||||+++|+|++|..||............ .............++..+
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l 246 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLI---TTKGIPPLKNPEKWSPEF 246 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcCCCCCcchhhCCHHH
Confidence 1 223346788999999888777666 99999999999999999999765433222221 111222333333478999
Q ss_pred HHHHHHhcccCcCCccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.++|.+||+.+|.+|||+.++++
T Consensus 247 ~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 247 KDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHHHHhccChhhCcCHHHHhh
Confidence 99999999999999999988866
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=279.79 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=203.3
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCC-----CcEEEEEEeecCc--cchHHHHHHHHHHhhC-CCCceeeEeEEEEc
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILT 88 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (288)
....++|++.+.||+|++|.||++.+... ...+++|.+.... .....+.+|+++++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 34457899999999999999999997643 3789999887542 2334677899999999 89999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC
Q 023058 89 PTHLAIVMEYASGGELFERICN----------------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~----------------~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~ 152 (288)
++.++++|||+.+++|..++.. ...++...+..++.|++.||+|||+.|++|+||+|+||+++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 9999999999999999998854 235889999999999999999999999999999999999987
Q ss_pred CCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhH
Q 023058 153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (288)
Q Consensus 153 ~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~ 228 (288)
++. ++|+|||++........ .....++..|+|||.+.+..++.+ +|+||||+++|++++ |..||.........
T Consensus 168 ~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~ 244 (293)
T cd05053 168 DHV--MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELF 244 (293)
T ss_pred CCe--EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc-cceeehhhHHHHHhcCCCCCCCCCCHHHHH
Confidence 776 99999999875443221 112224467999999887777766 999999999999997 99998765443322
Q ss_pred HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
... ............+.++.+|+.+||+.||.+|||+.++++.+
T Consensus 245 ~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 245 KLL-----KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred HHH-----HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 222 11222222336789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=276.42 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=202.5
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCc---EEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
.+.|++.+.||.|+||.||++....+++ .|++|.+... ......+..|+.++++++||||+++.+++..+...++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 4679999999999999999999876654 6999988653 2334578899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
+||++++++|.+++... +.++..+++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc--EEECCCccccccccCc
Confidence 99999999999888653 46899999999999999999999999999999999999987766 9999999876443322
Q ss_pred CCCC---Cc---CCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCC
Q 023058 174 QPKS---TV---GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (288)
Q Consensus 174 ~~~~---~~---~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
.... .. .+..|++||.+.+..++.+ +|+||||+++|++++ |..||......+... .+. .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~----~i~-~~~~~~~~~ 234 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIN----AIE-QDYRLPPPM 234 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHHHHH----HHH-cCCcCCCcc
Confidence 2111 11 1346999999988877766 999999999999886 999997655432222 221 223333344
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.+|..+.+++.+||+.+|.+||++.+++..+
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 265 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 6889999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=280.35 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=201.3
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcC----------------CCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceee
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKK----------------TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVR 81 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~----------------~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~ 81 (288)
.++|++.+.||+|+||.||++.+.. +...+++|.+.... .....+.+|+.+++.++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4679999999999999999986432 34568999887542 23356889999999999999999
Q ss_pred EeEEEEcCCeEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEe
Q 023058 82 FKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (288)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv 150 (288)
+++++...+..+++||++++++|.+++.... .++..++..++.|++.||++||+.|++|+||+|+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 9999999999999999999999999886543 35677899999999999999999999999999999999
Q ss_pred cCCCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh--CCCCCCCCCCc
Q 023058 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEP 225 (288)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~--g~~pf~~~~~~ 225 (288)
+.++. ++|+|||++........ ......++.|++||...+..++.+ +|+||||+++|+|++ |..||...+..
T Consensus 164 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 164 GKNYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA-SDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred cCCCC--EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccch-hhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 87766 99999999875433221 122234567999998877777666 999999999999998 77888766544
Q ss_pred hhHHHHHHHHhh--cccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 226 KNFRKTIHRILS--VQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 226 ~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
............ .....+....+++.+.+++.+||+.||.+||++.++.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 433322211111 1112333446789999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=276.70 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=199.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEE----cCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcC--CeE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRD----KKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~----~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 92 (288)
...|++.+.||+|+||.||.+.. ..++..|++|.+.... ...+.+.+|++++++++|||++++.+++... ..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46899999999999999999973 4568899999987543 3345788999999999999999999987543 468
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
++|+||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~ 160 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCcccccccC
Confidence 9999999999999998764 46899999999999999999999999999999999999987776 99999999875543
Q ss_pred CCCC----CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCch-----------hHHHHHHHHh
Q 023058 172 HSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-----------NFRKTIHRIL 236 (288)
Q Consensus 172 ~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~-----------~~~~~~~~~~ 236 (288)
.... ........|+|||.+.+..++.+ +|+||||+++++|++|..++....... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChH-HHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 3221 11123345899999987777666 999999999999999887765432110 0000111112
Q ss_pred hcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 237 SVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 237 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
......+....++.++.++|.+||+.+|.+|||+.++++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQV 280 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 22223333446889999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=278.45 Aligned_cols=256 Identities=30% Similarity=0.378 Sum_probs=199.3
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---chHHHHHHHHHHhhCC-CCceeeEeEEEEcCCe-----
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLR-HPNIVRFKEVILTPTH----- 91 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~----- 91 (288)
++|++.+.||.|++|.||++.+..+++.|++|....... ....+.+|+.+++++. |+|++++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 479999999999999999999999999999998765432 2356788999999995 6999999999887655
Q ss_pred EEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC-CCCCCEEEeecCC
Q 023058 92 LAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGY 165 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~-~~~~~~~l~df~~ 165 (288)
.+++|||+++ +|.+++... ..+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++. ++|+|||.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~--~kl~dfg~ 157 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL--LKIADLGL 157 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCe--EEEeeccc
Confidence 8999999976 787777542 35799999999999999999999999999999999999987 554 99999998
Q ss_pred CcccccCC-CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc-cC--
Q 023058 166 SKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YS-- 241 (288)
Q Consensus 166 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~-- 241 (288)
+....... ......+++.|+|||.+.+......++|+||||+++|+|++|..||...+................ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 87543322 223345678899999886644334449999999999999999999987654443333322111000 00
Q ss_pred ----------CC---------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 242 ----------IP---------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 242 ----------~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
.+ ....+++.+.++|.+||++||.+||++.+++. |+|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~---~~~~ 294 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT---HPYF 294 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc---CCCc
Confidence 00 01247889999999999999999999987765 5554
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=276.31 Aligned_cols=252 Identities=21% Similarity=0.370 Sum_probs=205.3
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
..++|++.+.||.|+||.||+++... +.+.+++|.+..... ..+.+.+|++++++++|+|++++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 34789999999999999999999753 346799998765433 34678899999999999999999999998899
Q ss_pred EEEEEeccCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEee
Q 023058 92 LAIVMEYASGGELFERICNAG---------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~d 162 (288)
.++|||++++++|.+++.... .++...+..++.|++.+|.|||+.|++|+||+|+||+++.++. ++++|
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~ 160 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSL 160 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEcc
Confidence 999999999999999987655 6899999999999999999999999999999999999988776 99999
Q ss_pred cCCCcccccCC--CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcc
Q 023058 163 FGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQ 239 (288)
Q Consensus 163 f~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (288)
||++....... ......+++.|++||.+.+...... +|+||||++++++++ |..||....... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~~~~~p~~~~~~~~----~~~~~~~~~ 235 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDEE----VLNRLQAGK 235 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccchHH----HHHHHHcCC
Confidence 99876332211 1223345667999999877776655 999999999999998 788987654422 222333333
Q ss_pred cCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 240 YSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
..++....+|..+.+++.+||+.+|.+|||+.+++..+
T Consensus 236 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l 273 (275)
T cd05046 236 LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273 (275)
T ss_pred cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 33433446899999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=294.89 Aligned_cols=244 Identities=27% Similarity=0.413 Sum_probs=209.2
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
+.|+-++.||+|+||-||.|++..+...||||++..+. ....++.+|+.+|++++|||++.+.++|..+...|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 56788999999999999999999999999999987643 33357889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|||-| +-.+++.- .+++.+.++..|+.+.+.||.|||+.+.+|||||..||+++.++. +||+|||.+... ...
T Consensus 106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi~---~PA 179 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASIM---APA 179 (948)
T ss_pred HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhhc---Cch
Confidence 99955 77777754 357899999999999999999999999999999999999998888 999999988744 345
Q ss_pred CCCcCCCcccCCcccc---CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 176 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
....|||.|||||++. .+.|+.+ .||||||++..+|..+.+|+...+..+...-+ ..+..+.+. ...+++.+
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSALYHI---AQNesPtLq-s~eWS~~F 254 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNESPTLQ-SNEWSDYF 254 (948)
T ss_pred hcccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHHHHHH---HhcCCCCCC-CchhHHHH
Confidence 6789999999999975 6788888 99999999999999999998876553333222 122333333 34789999
Q ss_pred HHHHHHhcccCcCCccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+.|+..||+.-|.+|||+++++.
T Consensus 255 ~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 255 RNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHHHHhhCcccCCcHHHHhh
Confidence 99999999999999999999887
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=277.22 Aligned_cols=252 Identities=30% Similarity=0.488 Sum_probs=197.2
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
.++|++.+.||.|++|.||++.+..+++.|++|.+..... ....+.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 4889999999999999999999998899999999875432 23456789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-C
Q 023058 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (288)
|+.+ +|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKTY 160 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCccc
Confidence 9975 898887654 46899999999999999999999999999999999999988776 99999998864432222 1
Q ss_pred CCCcCCCcccCCccccCcc-cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc----------------
Q 023058 176 KSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------- 238 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 238 (288)
....++..|+|||.+.+.. ++.+ +|+||+|+++|+|++|..||...................
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTS-LDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred cccccccccCCcHHhhcCcccCcH-HHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 2234577899999987644 4444 999999999999999999997654211111111100000
Q ss_pred ccCCC---------CCCCCC--HHHHHHHHHhcccCcCCccccccccc
Q 023058 239 QYSIP---------DYVHIS--PECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 239 ~~~~~---------~~~~~~--~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
....+ ....++ .++.++|.+||+.+|.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 001233 78899999999999999999988765
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=285.83 Aligned_cols=260 Identities=30% Similarity=0.444 Sum_probs=203.3
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcC-----Ce
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 91 (288)
.++|++.+.||.|++|+||++.+..+++.|++|.+... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 47899999999999999999999999999999998653 23345677899999999999999999987654 35
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
.++++||+. ++|.+.+...+.++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCC
Confidence 899999996 589888888788999999999999999999999999999999999999987776 99999999875543
Q ss_pred CC-CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH---------------
Q 023058 172 HS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI--------------- 235 (288)
Q Consensus 172 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~--------------- 235 (288)
.. ......++..|+|||.+.+......++|+||||+++|+|++|..||...+............
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 32 22334578889999988654333444999999999999999999997654322111111000
Q ss_pred ----hhcc-----cCC-CCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 236 ----LSVQ-----YSI-PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 236 ----~~~~-----~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
.... ..+ .....+++++.++|.+||+.+|.+|||+.++++ |+|+..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~---h~~~~~~ 297 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA---HPYLASL 297 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc---Ccchhhh
Confidence 0000 000 012357889999999999999999999988766 6666543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=271.55 Aligned_cols=255 Identities=30% Similarity=0.457 Sum_probs=212.6
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc-chHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEEeccCCCc
Q 023058 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGE 103 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 103 (288)
.+.||+|.++.|-.+.+-.++..||+|++.+... ...++.+|++++.++ .|+||+.++++|+++..+|+|||-+.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4678999999999999999999999999987543 346799999999999 69999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-CCCEEEeecCCCcccccCCCC-------
Q 023058 104 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQP------- 175 (288)
Q Consensus 104 L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~-~~~~~l~df~~~~~~~~~~~~------- 175 (288)
|...+++..-|++.+...+.++|+.||.+||.+||+|||+||+||+....+ ...+|||||++..........
T Consensus 163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~ 242 (463)
T KOG0607|consen 163 LLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPE 242 (463)
T ss_pred HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCcc
Confidence 999999999999999999999999999999999999999999999996433 346899999997654333322
Q ss_pred -CCCcCCCcccCCcccc---C-cccCCCccchhhHHHHHHHHHhCCCCCCCCCCc-----------hhHHHHHHHHhhcc
Q 023058 176 -KSTVGTPAYIAPEVLL---K-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----------KNFRKTIHRILSVQ 239 (288)
Q Consensus 176 -~~~~~~~~~~aPE~~~---~-~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~-----------~~~~~~~~~~~~~~ 239 (288)
-++.|+..|||||+.. + ..+-.++.|+||||+++|-|+.|..||.+.... .-...+...+..+.
T Consensus 243 L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk 322 (463)
T KOG0607|consen 243 LLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 322 (463)
T ss_pred ccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC
Confidence 2345777899999853 2 223344499999999999999999999865431 12345556778888
Q ss_pred cCCCC--CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 240 YSIPD--YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 240 ~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+.+|+ |..++.+.+++|+.+|..|+..|.++.+++. |+|++
T Consensus 323 YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln---hPw~~ 365 (463)
T KOG0607|consen 323 YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN---HPWVQ 365 (463)
T ss_pred CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC---Ccccc
Confidence 88885 7889999999999999999999999966554 66654
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=275.65 Aligned_cols=250 Identities=28% Similarity=0.446 Sum_probs=203.3
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC--ccchHHHHHHHHHHhhCC---CCceeeEeEEEEcCCeEEEEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~ 96 (288)
.|++.+.||.|++|.||++.+..+++.+++|.+... ....+.+.+|+.++++++ |||++++++++..+...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 588899999999999999999989999999988654 233456888999999996 999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-C
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (288)
||+++++|.+++.. ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC--EEEccCCceeecCCCcccc
Confidence 99999999988865 47899999999999999999999999999999999999988766 99999998875544332 2
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc-cCCCCCCCCCHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHISPECRH 254 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 254 (288)
....++..|+|||.+.++.....++|+||||+++|+|++|..||...+...... ...... ..++. ...+.++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~ 233 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM----LIPKSKPPRLED-NGYSKLLRE 233 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh----ccccCCCCCCCc-ccCCHHHHH
Confidence 334578889999998765543445999999999999999999997654322211 111111 12222 137889999
Q ss_pred HHHHhcccCcCCccccccccccchhhhh
Q 023058 255 LISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
++.+||+.||.+||++.+++. ++|+
T Consensus 234 ~i~~~l~~~p~~R~~~~~il~---~~~~ 258 (277)
T cd06917 234 FVAACLDEEPKERLSAEELLK---SKWI 258 (277)
T ss_pred HHHHHcCCCcccCcCHHHHhh---ChHh
Confidence 999999999999999988876 4554
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=275.78 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=201.0
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcC--CeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 96 (288)
++|+..+.||.|++|.||++.+..++..+++|.+..... ....+.+|++++++++||||+++++++... ..++++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 479999999999999999999998999999999875433 345688999999999999999999998654 4789999
Q ss_pred eccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 97 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
||+++++|.+++.. ...++...+..++.|++.+|.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS 158 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc
Confidence 99999999887643 345889999999999999999999999999999999999987776 999999987644332
Q ss_pred CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCc-hhHHHHHHHHhhcc-cCCCC----CC
Q 023058 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQ-YSIPD----YV 246 (288)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~-~~~~~----~~ 246 (288)
.. ....++..|++||.+.+..++.+ +|+||||+++|+|++|..||...... .........+.... ...+. ..
T Consensus 159 ~~-~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 159 LA-GTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred cc-ccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 22 23456778999999988888776 99999999999999999999865321 11111222222211 11111 12
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
..++.+.++|.+||..+|.+|||+.|++.
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 35678999999999999999999988877
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=294.09 Aligned_cols=248 Identities=23% Similarity=0.338 Sum_probs=202.9
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
.+..+...+.+.||+|.||+||++.+.. .||||++... +...+.+++|+..+++-+|.||+-+.|++..+.. .
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 3445777889999999999999999864 3999998764 3455679999999999999999999999988877 9
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc---
Q 023058 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS--- 169 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~--- 169 (288)
+|..+|.|.+|..+++-. .+|.....+.|++||++|+.|||.++|+|+|||..||++.+++. |+|+|||++...
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKTRW 541 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeeeee
Confidence 999999999999888654 47999999999999999999999999999999999999987766 999999998632
Q ss_pred ccCCCCCCCcCCCcccCCccccC---cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc--c-CCC
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--Y-SIP 243 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~-~~~ 243 (288)
..........+...|+|||++.. .+|+.. +||||+|+++|||++|..||..... .+++..+.++. . ...
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~q-SDVYaFGiV~YELltg~lPysi~~~----dqIifmVGrG~l~pd~s~ 616 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQ-SDVYAFGIVWYELLTGELPYSIQNR----DQIIFMVGRGYLMPDLSK 616 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcc-cchhhhhHHHHHHHhCcCCcCCCCh----hheEEEecccccCccchh
Confidence 22333455678889999999864 344444 9999999999999999999984322 23333323331 1 111
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 244 DYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
...+++.++++|+..||.+++++||...+++.
T Consensus 617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 617 IRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 23467889999999999999999999999988
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=280.23 Aligned_cols=249 Identities=20% Similarity=0.317 Sum_probs=200.7
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCC-----CcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
...|++.+.||.|+||.||++.+..+ +..||+|++..... ..+.+.+|+.++..++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 45789999999999999999987543 57899999875432 235678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCC
Q 023058 93 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~ 156 (288)
+++++++.+++|..++... ..++...+..++.|++.||.+||+.|++|+||||+||+++.++.
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~- 162 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN- 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc-
Confidence 9999999999999887532 24788889999999999999999999999999999999987766
Q ss_pred CEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 023058 157 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 232 (288)
Q Consensus 157 ~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~ 232 (288)
++|+|||++........ .....+++.|+|||.+.+..++.. +|+||||+++|+|++ |..||....... ..
T Consensus 163 -~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~ 236 (283)
T cd05091 163 -VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQD----VI 236 (283)
T ss_pred -eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCCHHH----HH
Confidence 99999998875433221 223345678999999987777666 999999999999998 888887654322 22
Q ss_pred HHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCcccccccccc
Q 023058 233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
..+..... .+....++..+.+++.+||+.+|.+||++.+++..
T Consensus 237 ~~i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 237 EMIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 22233222 12223689999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=299.08 Aligned_cols=254 Identities=28% Similarity=0.418 Sum_probs=217.6
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeec-CccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
+-|.|+..||.|.||.||+|.++.++...|.|++.- +....+++.-|+++|..++||+||++++.|..++.+|++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 557899999999999999999999998899998874 3455677888999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc-ccCCCCCC
Q 023058 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKS 177 (288)
Q Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~-~~~~~~~~ 177 (288)
.||....++-. ...+++.++.-+|+|++.||+|||+.+|+|||||..||+++.+|. ++|.|||.+... ........
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhhcc
Confidence 99999887755 457999999999999999999999999999999999999999998 999999987532 23334467
Q ss_pred CcCCCcccCCcccc-----CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 178 TVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 178 ~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
.+|||.|||||+.. ..+|+.+ +||||||+++.+|..+.+|-...+....+.++ .....+++..++.++..+
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDyk-aDiWSlGITLIEMAqiEPPHhelnpMRVllKi---aKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---AKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhh-hhHHhhhhHHHHHhccCCCccccchHHHHHHH---hhcCCCcccCcchhhhHH
Confidence 88999999999864 4567777 99999999999999999998776554444333 344555666777899999
Q ss_pred HHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 253 RHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.+|+.+||..||..||++.++++ |+|++
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~---Hpfv~ 293 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLK---HPFVQ 293 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhh---Ccccc
Confidence 99999999999999999988765 55554
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=282.51 Aligned_cols=257 Identities=26% Similarity=0.443 Sum_probs=208.4
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
...+.|.....||.|+||.||++.+..++..|++|.+.... ...+.+.+|+..++.++|+|++++++.+...+..+++|
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 33467777889999999999999999899999999886543 33456789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-C
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (288)
|++++++|..++.. +.++..++..++.||+.++.+||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccC
Confidence 99999999887754 46899999999999999999999999999999999999988776 99999998864332221 2
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....++..|+|||.+.+..++.+ +|+||+|+++|+|++|..||............... .....+.....+..+.++
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l 251 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN---LPPRVKDSHKVSSVLRGF 251 (292)
T ss_pred ceeecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---CCCccccccccCHHHHHH
Confidence 23457889999999877777665 99999999999999999999865543333222111 112222333578899999
Q ss_pred HHHhcccCcCCccccccccccchhhhhhh
Q 023058 256 ISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
+.+||..||.+|||+.++++ ++|+..
T Consensus 252 i~~~l~~~P~~Rpt~~~il~---~~~~~~ 277 (292)
T cd06658 252 LDLMLVREPSQRATAQELLQ---HPFLKL 277 (292)
T ss_pred HHHHccCChhHCcCHHHHhh---Chhhhc
Confidence 99999999999999988876 566543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=274.66 Aligned_cols=252 Identities=22% Similarity=0.344 Sum_probs=204.1
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCc---EEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
..++|...+.||+|++|.||++.+..++. .+++|.+.... ...+.+.+|++++++++|+|++++.+++...+..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 35689999999999999999999876554 78999886542 33456888999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
++||++++++|..++... +.++..++..++.|++.|+++||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~ 160 (268)
T cd05063 83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc--EEECCCccceecccc
Confidence 999999999999988654 56899999999999999999999999999999999999987766 999999988654332
Q ss_pred CCCC----CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 173 SQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 173 ~~~~----~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
.... .......|+|||.+.+..++.+ +|+||||+++|++++ |..||...+...... .+... ...+....
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~~~~----~i~~~-~~~~~~~~ 234 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMK----AINDG-FRLPAPMD 234 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH----HHhcC-CCCCCCCC
Confidence 2111 1112346999999987777666 999999999999997 999997655433222 22222 23333346
Q ss_pred CCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
++.++.+++.+|++.+|.+||++.++++.+.
T Consensus 235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~ 265 (268)
T cd05063 235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265 (268)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 7899999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=272.73 Aligned_cols=248 Identities=25% Similarity=0.425 Sum_probs=196.9
Q ss_pred CCeeeeeee--eccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhh-CCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDI--GSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~l--g~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++|.+.+.+ |+|+||.||++.+..++..+++|.+....... .|...... .+|||++++++.+...+.+++|||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 567777776 99999999999999999999999987543221 12222222 279999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCC
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (288)
|+++++|.+++.....++..++..++.|++.||.+||+.|++|+||+|+||+++.++. .++|+|||++..... ...
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~~l~dfg~~~~~~~---~~~ 165 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD-RIYLCDYGLCKIIGT---PSC 165 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC-eEEEecCccceecCC---Ccc
Confidence 9999999999988778999999999999999999999999999999999999987771 399999998764432 223
Q ss_pred CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 023058 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (288)
..++..|+|||.+.+..++.+ +|+||+|+++++|++|..||...................... .....++.+.++|.
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~ 242 (267)
T PHA03390 166 YDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLP--FIKNVSKNANDFVQ 242 (267)
T ss_pred CCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCC--cccccCHHHHHHHH
Confidence 457889999999988777766 999999999999999999998654432211111111222222 22368999999999
Q ss_pred HhcccCcCCcccc-ccccccchhhhh
Q 023058 258 RIFVADPAKVSMH-FHATGVYMHTKL 282 (288)
Q Consensus 258 ~~l~~~p~~Rpt~-~~~l~~~~~~~~ 282 (288)
+||+.+|.+||+. .++++ |+|+
T Consensus 243 ~~l~~~p~~R~~~~~~~l~---h~~~ 265 (267)
T PHA03390 243 SMLKYNINYRLTNYNEIIK---HPFL 265 (267)
T ss_pred HHhccChhhCCchHHHHhc---CCcc
Confidence 9999999999974 77765 6655
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=277.88 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=208.5
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC-ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
...++|.+.+.||+|+||.||++.+..++..|++|.+... ....+.+.+|+.++++++|||++++++.+......++|+
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 3358999999999999999999999888999999998643 333456788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-C
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (288)
||+++++|.+++... .++..++..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 96 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred ecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceeccccccccc
Confidence 999999999888653 5789999999999999999999999999999999999987776 99999998764433322 2
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....+++.|++||.+.+..++.. +|+||||++++++++|..||...+......... ......++....++..+.++
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAIFRDF 248 (293)
T ss_pred ccccCChhhcCchhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChhhheeehh---cCCCCCCCCccccCHHHHHH
Confidence 33457788999999987777666 999999999999999999997654322211111 11222333334578899999
Q ss_pred HHHhcccCcCCccccccccccchhhhhh
Q 023058 256 ISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
|.+||+.+|.+||++.+++. |+|++
T Consensus 249 i~~~l~~~p~~Rp~~~~il~---h~~~~ 273 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQ---HPFLK 273 (293)
T ss_pred HHHHccCChhhCcCHHHHhc---CHHHh
Confidence 99999999999999988766 54543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=278.77 Aligned_cols=259 Identities=27% Similarity=0.418 Sum_probs=199.5
Q ss_pred CCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcC
Q 023058 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (288)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (288)
+++.....++|++.+.||+|++|.||++.+..++..|++|.+.... .......+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (310)
T cd07865 4 EFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 83 (310)
T ss_pred cCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence 4556666789999999999999999999999999999999886532 2233567899999999999999999998764
Q ss_pred C--------eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEE
Q 023058 90 T--------HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (288)
Q Consensus 90 ~--------~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l 160 (288)
. ..++|||++.+ +|...+.... .++..+++.++.|++.||++||+.|++|+||+|+||+++.++. ++|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl 160 (310)
T cd07865 84 ATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LKL 160 (310)
T ss_pred cccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EEE
Confidence 3 45999999965 7777776543 6899999999999999999999999999999999999987776 999
Q ss_pred eecCCCcccccCCCC-----CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH
Q 023058 161 CDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235 (288)
Q Consensus 161 ~df~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (288)
+|||++......... ....++..|+|||.+.+......++|+||||+++|+|++|..||...+......... .+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~-~~ 239 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS-QL 239 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HH
Confidence 999998754332221 223467789999988665433344999999999999999999997654322221111 11
Q ss_pred hhc-c---------------cCCCC-----------CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 236 LSV-Q---------------YSIPD-----------YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 236 ~~~-~---------------~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
... . ...+. ....+..+.++|.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 100 0 00000 0113567889999999999999999988865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=275.77 Aligned_cols=260 Identities=29% Similarity=0.434 Sum_probs=202.8
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++|++.+.||.|++|.||++.+..+++.|++|.+.... ...+.+.+|++++++++|||++++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 68999999999999999999999899999999886542 223567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-
Q 023058 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~- 174 (288)
|+++ +|...+.... .++...++.++.||+.||++||+.|++|+||+|+||+++.++. .++|+|||++........
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC-EEEEcccccccccCCCccc
Confidence 9965 7777765543 3578888999999999999999999999999999999985432 489999999865433221
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc--------------c
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------------Y 240 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------~ 240 (288)
.....+++.|+|||.+.+......++|+||||+++|+|++|..||...+..+...+......... .
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 23345678899999887654434449999999999999999999987654443333221111000 0
Q ss_pred CCC---------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 241 SIP---------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 241 ~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
..+ .....++++.++|.+||+.+|.+||++.++++ ++|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~---~~~~~~~ 290 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE---HEYFKDL 290 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc---CchHhHH
Confidence 000 01246789999999999999999999988876 6666544
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=274.63 Aligned_cols=241 Identities=31% Similarity=0.461 Sum_probs=190.5
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeecCcc----chHHHHHHHHHHh---hCCCCceeeEeEEEEcCCeEEEEEeccC
Q 023058 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHR---SLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (288)
Q Consensus 28 ~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~---~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (288)
.||+|+||.||++.+..+++.+|+|.+..... ......+|...++ ..+|||++.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 38999999999999999999999998865421 1122334443333 3479999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCcC
Q 023058 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (288)
Q Consensus 101 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 180 (288)
+++|...+...+.++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ......+
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc-CccCcCC
Confidence 9999999888888999999999999999999999999999999999999987776 999999988644322 2233468
Q ss_pred CCcccCCccccCc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 023058 181 TPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259 (288)
Q Consensus 181 ~~~~~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 259 (288)
++.|+|||.+.++ .++.+ +|+||+|+++|+|++|..||........ ..............+. .+++++.++|.+|
T Consensus 158 ~~~y~aPE~~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~li~~~ 233 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELPD--SFSPELKSLLEGL 233 (279)
T ss_pred CcCccCHHHhcCCCCCCch-hhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCcc--ccCHHHHHHHHHH
Confidence 8999999998643 44555 9999999999999999999976543222 2222222222233333 6889999999999
Q ss_pred cccCcCCcc-----ccccccc
Q 023058 260 FVADPAKVS-----MHFHATG 275 (288)
Q Consensus 260 l~~~p~~Rp-----t~~~~l~ 275 (288)
|+.||.+|| |+.++++
T Consensus 234 l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 234 LQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred hcCCHHHhcCCCCCCHHHHHh
Confidence 999999999 4766655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=274.63 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=196.3
Q ss_pred eeeeeeeeccCceEEEEEEEcCC---CcEEEEEEeecCcc---chHHHHHHHHHHhhCCCCceeeEeEEEEcCCe-----
Q 023058 23 YELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH----- 91 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----- 91 (288)
|.+.+.||+|+||.||.+....+ +..+|+|.+..... ..+.+.+|++.++.++|||++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 57889999999999999987653 47899999875432 23467889999999999999999998866543
Q ss_pred -EEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecC
Q 023058 92 -LAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (288)
Q Consensus 92 -~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~ 164 (288)
.++++||+++++|..++... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT--VCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe--EEECCcc
Confidence 79999999999998887432 25899999999999999999999999999999999999987766 9999999
Q ss_pred CCcccccCCCC---CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhc-c
Q 023058 165 YSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV-Q 239 (288)
Q Consensus 165 ~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~-~ 239 (288)
++......... .....+..|++||.+.+..++.+ +|+||||+++|+|++ |..||.......... .+... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~----~~~~~~~ 233 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYD----YLRHGNR 233 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHcCCC
Confidence 98754433221 12234567999999877777666 999999999999998 889987654432222 22222 2
Q ss_pred cCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 240 YSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
...+ ..+++.+.+++.+||+.||.+|||+.++++.+
T Consensus 234 ~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l 269 (273)
T cd05035 234 LKQP--EDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269 (273)
T ss_pred CCCC--cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2233 36889999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=268.69 Aligned_cols=246 Identities=31% Similarity=0.471 Sum_probs=208.0
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|++++++++|+|++++++++..+...+++|++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5899999999999999999999889999999987764 3456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-CCC
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~~~ 177 (288)
+++++|.+++.....++...+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+........ ...
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC--EEEeccccceecCCCcccccc
Confidence 999999999988888999999999999999999999999999999999999987665 99999998875544332 233
Q ss_pred CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 023058 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (288)
..++..|++||...+...+.+ +|+||+|+++++|++|..||............ ........+. .+++.+.++|.
T Consensus 159 ~~~~~~y~~pe~~~~~~~~~~-~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~--~~~~~~~~~i~ 232 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIELLTGNPPYYDLNPMAALFRI---VQDDHPPLPE--GISPELKDFLM 232 (254)
T ss_pred cccchhhcCHhhhcCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---hccCCCCCCC--CCCHHHHHHHH
Confidence 457888999999877765555 99999999999999999999865532222221 1222223333 67899999999
Q ss_pred HhcccCcCCccccccccc
Q 023058 258 RIFVADPAKVSMHFHATG 275 (288)
Q Consensus 258 ~~l~~~p~~Rpt~~~~l~ 275 (288)
+||..+|.+|||+.+++.
T Consensus 233 ~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHhCChhhCcCHHHHhc
Confidence 999999999999988865
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=277.18 Aligned_cols=259 Identities=31% Similarity=0.499 Sum_probs=210.2
Q ss_pred CeeeeeeeeccCceEEEEEEEc---CCCcEEEEEEeecCc-----cchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeE
Q 023058 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (288)
+|++.+.||.|++|.||++.+. .++..+++|.+.... ...+.+.+|+.++.++ +|||++++.+.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5889999999999999999864 467889999887432 2335677899999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
++||||+++++|...+.....++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEEECccccccccc
Confidence 999999999999999887778999999999999999999999999999999999999987766 999999988754433
Q ss_pred CCC--CCCcCCCcccCCccccCcc--cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCC
Q 023058 173 SQP--KSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 173 ~~~--~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
... ....++..|++||.+.+.. .+.. +|+||||+++++|++|..||...............+.......+. .+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 235 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKA-VDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPK--TM 235 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcch-hhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCc--cc
Confidence 221 2234788999999986654 3444 999999999999999999997544333333333333333333333 57
Q ss_pred CHHHHHHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
+..+.++|.+||+.||.+|||+.++.+.+.++|++-+
T Consensus 236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred CHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 8999999999999999999999888887888877643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=274.97 Aligned_cols=244 Identities=24% Similarity=0.324 Sum_probs=194.0
Q ss_pred eeeeccCceEEEEEEEcCCCc--EEEEEEeecC--ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKKTEE--LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~--~~~iK~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||+|+||.||++.+..++. .+++|.+... ....+.+.+|+++++++ +|||++++++++...+..+++||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999987765 4678877642 23345788899999999 799999999999999999999999999
Q ss_pred CchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCC
Q 023058 102 GELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (288)
Q Consensus 102 ~~L~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~ 165 (288)
++|.+++.... .++..++..++.|++.|+++||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEECCCCC
Confidence 99999886532 3788999999999999999999999999999999999987776 99999998
Q ss_pred CcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCC
Q 023058 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244 (288)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (288)
+..............+..|+|||.+.+..++.+ +|+||||+++++|++ |..||...+....... +.. ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~~~-~~~~~~ 232 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----LPQ-GYRLEK 232 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCccccCHHHHHHH----HhC-CCCCCC
Confidence 863322222222233557999999877777666 999999999999996 9999976543222222 221 122222
Q ss_pred CCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 245 YVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 245 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
...++.++.+++.+|++.+|.+|||+.+++..+.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 266 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266 (270)
T ss_pred CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 3367899999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=271.20 Aligned_cols=245 Identities=33% Similarity=0.532 Sum_probs=203.0
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEc--CCeEEEEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVM 96 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 96 (288)
+|++.+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|++++++++|+|++++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999986543 333567789999999999999999998764 45689999
Q ss_pred eccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHh-----hcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 97 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 97 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH-----~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
||+++++|.+++.. ..+++...++.++.||+.||.+|| +.+++|+||+|+||+++.++. ++|+|||++.
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~ 158 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAK 158 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC--EEEecccccc
Confidence 99999999988865 357899999999999999999999 899999999999999987776 9999999987
Q ss_pred ccccCCC-CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-CCCCC
Q 023058 168 SSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDY 245 (288)
Q Consensus 168 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~ 245 (288)
....... .....+++.|++||.+.+...+.. +|+||||+++++|++|..||...+.. .....+..... ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~-- 231 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTARNQL----QLASKIKEGKFRRIP-- 231 (265)
T ss_pred cccCCcccccccccCCCccChhhhcCCCCCch-hHHHHHHHHHHHHHHCCCcccCcCHH----HHHHHHhcCCCCCCc--
Confidence 6544333 334467889999999988776665 99999999999999999999876522 22222222222 222
Q ss_pred CCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 246 VHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 246 ~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
...+..+.+++.+||+.+|.+|||+.++++
T Consensus 232 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 267899999999999999999999988876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=276.90 Aligned_cols=250 Identities=31% Similarity=0.446 Sum_probs=200.2
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
|++.+.||.|++|.||++.+..++..|++|++.... ...+.+.+|++.++.++|||++++++++..+...+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 678999999999999999999899999999987543 22356788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-CC
Q 023058 100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (288)
Q Consensus 100 ~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~~ 176 (288)
+ ++|..++.... .+++..+..++.|++.+|++||+.+++|+||+|+||+++.++. ++|+|||++........ ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc--EEEeecccccccCCCccccC
Confidence 5 58988887765 6899999999999999999999999999999999999988766 99999999875433222 22
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh--------------cccCC
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------------VQYSI 242 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~~~ 242 (288)
...+++.|+|||.+.+......++|+||||+++|+|++|..||...+......+....... ....+
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 3346788999998866543344499999999999999999999876543333332221000 00000
Q ss_pred C---------CCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 243 P---------DYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 243 ~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+ ....++.++.++|.+||+.+|.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 12356789999999999999999999988876
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=275.85 Aligned_cols=245 Identities=28% Similarity=0.432 Sum_probs=203.0
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+.|+..+.||.|++|.||.+.+..++..+++|.+.... ...+.+.+|+.++++++|+|++++++++..+...++|||+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 56888999999999999999999889999999887543 3345688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-CCC
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~~~ 177 (288)
+++++|.+++.. .+++..++..++.|++.++++||+.+++|+||+|+||+++.++. ++++|||++........ ...
T Consensus 84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCcccccc
Confidence 999999988864 56899999999999999999999999999999999999987776 99999999865433322 223
Q ss_pred CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-ccCCCCCCCCCHHHHHHH
Q 023058 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLI 256 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li 256 (288)
..++..|+|||.+.+..++.+ +|+||||+++|+|++|..||........... +... ....+ ..++..+.++|
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~li 233 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRVLFL----IPKNNPPTLT--GEFSKPFKEFI 233 (277)
T ss_pred ccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcChHhHhhh----hhcCCCCCCc--hhhhHHHHHHH
Confidence 456778999999887777666 9999999999999999999976543222211 1111 11222 25678999999
Q ss_pred HHhcccCcCCccccccccc
Q 023058 257 SRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 257 ~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+||+.+|.+||++.+++.
T Consensus 234 ~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 234 DACLNKDPSFRPTAKELLK 252 (277)
T ss_pred HHHcccCcccCcCHHHHHh
Confidence 9999999999999988866
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=276.28 Aligned_cols=254 Identities=26% Similarity=0.386 Sum_probs=200.0
Q ss_pred CCCeeeeeeeeccCceEEEEEEE----cCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcC--Ce
Q 023058 20 SDRYELVRDIGSGNFGVARLMRD----KKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP--TH 91 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~----~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 91 (288)
.+.|++++.||+|+||.||++.. ..++..|++|.+.... .....+.+|+.++++++|||++++.+++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 45689999999999999999984 3467889999986542 3335688999999999999999999998775 56
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.+++|||+++++|.+++.... .++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~ 160 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIE 160 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCccccccc
Confidence 899999999999999986653 5899999999999999999999999999999999999988776 9999999987554
Q ss_pred cCCCC----CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCC-----------chhHHHHHHHH
Q 023058 171 LHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-----------PKNFRKTIHRI 235 (288)
Q Consensus 171 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~-----------~~~~~~~~~~~ 235 (288)
..... ....++..|+|||.+.+..++.+ +|+||||+++|+|+++..|+..... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCcc-ccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 33221 22345667999999887777666 9999999999999998766532211 11111111111
Q ss_pred hhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.. ....+....++..+.+||.+||+.+|.+|||+.++++.+
T Consensus 240 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 240 EE-GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred Hc-CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 11 122333346889999999999999999999999987744
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=281.72 Aligned_cols=252 Identities=23% Similarity=0.402 Sum_probs=213.5
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccC
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (288)
+-|.++++||+|+||.||+|.++.+|..+|||.+..+ ...+++.+|+.++++++.|++|++++.+.....+|+|||||.
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4578999999999999999999999999999988764 456788999999999999999999999999999999999999
Q ss_pred CCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCCCCC
Q 023058 101 GGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 178 (288)
Q Consensus 101 ~~~L~~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~~~~ 178 (288)
.|++.+++. +++++.+.++..+++.-+.||+|||...-+|||||..||+++.++. .||.|||.+.+.... ......
T Consensus 112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTMAKRNTV 189 (502)
T KOG0574|consen 112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTMAKRNTV 189 (502)
T ss_pred CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhHHhhCcc
Confidence 999999885 4567999999999999999999999999999999999999987777 999999998754433 234567
Q ss_pred cCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 023058 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258 (288)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 258 (288)
.|||-|+|||++..-.|++. +||||||++..||..|.+||..-.....+.- -..+..+++..+-.++.++.+||++
T Consensus 190 IGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---IPT~PPPTF~KPE~WS~~F~DFi~~ 265 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---IPTKPPPTFKKPEEWSSEFNDFIRS 265 (502)
T ss_pred ccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccccceeEe---ccCCCCCCCCChHhhhhHHHHHHHH
Confidence 89999999999999999998 9999999999999999999986543221111 1112223333334678999999999
Q ss_pred hcccCcCCccccccccc-cchh
Q 023058 259 IFVADPAKVSMHFHATG-VYMH 279 (288)
Q Consensus 259 ~l~~~p~~Rpt~~~~l~-~~~~ 279 (288)
||..+|.+|-|+.++++ .|.+
T Consensus 266 CLiK~PE~R~TA~~L~~H~Fik 287 (502)
T KOG0574|consen 266 CLIKKPEERKTALRLCEHTFIK 287 (502)
T ss_pred HhcCCHHHHHHHHHHhhhhhhc
Confidence 99999999999988777 4443
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=271.38 Aligned_cols=250 Identities=22% Similarity=0.353 Sum_probs=202.2
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
...++|++.+.||+|+||.||++.+. .+..+++|.+.......+.+.+|+.++++++|+|++++++++.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 34589999999999999999999865 45669999887765556778899999999999999999999887 77899999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYT 158 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCCcceeeccCCCcc
Confidence 99999999998653 35788899999999999999999999999999999999987776 999999988644322211
Q ss_pred --CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 176 --KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 176 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
....++..|+|||.+....++.+ +|+||||+++|++++ |..||...+....... +. .....+.....+.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~ 232 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA----LE-RGYRMPRPENCPEEL 232 (260)
T ss_pred cccCCcccccccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH----Hh-CCCCCCCcccCCHHH
Confidence 12234567999999987777666 999999999999998 8999986544322221 11 222233334688999
Q ss_pred HHHHHHhcccCcCCccccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.+++.+|++.+|.+||++.++...+
T Consensus 233 ~~~i~~~l~~~p~~Rp~~~~l~~~L 257 (260)
T cd05073 233 YNIMMRCWKNRPEERPTFEYIQSVL 257 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHHHH
Confidence 9999999999999999998776543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=280.06 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=201.8
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEc-------CCCcEEEEEEeecCc--cchHHHHHHHHHHhhC-CCCceeeEeEEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVIL 87 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 87 (288)
...++|.+.+.||+|++|.||++++. .....+++|.+.... .....+.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34579999999999999999999863 234578999877532 2345678899999999 6999999999999
Q ss_pred cCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEec
Q 023058 88 TPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (288)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~ 151 (288)
..+.++++|||+++++|.+++... ..++..++..++.|++.||.|||+.|++|+||+|+||+++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 989999999999999999998653 2478889999999999999999999999999999999998
Q ss_pred CCCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchh
Q 023058 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (288)
Q Consensus 152 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~ 227 (288)
.++. ++|+|||.+........ .....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||........
T Consensus 169 ~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 169 EDNV--MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred CCCc--EEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc-chhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 7776 99999999875432211 112223457999999988777766 999999999999998 8889876543222
Q ss_pred HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 228 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
.... .... .......++.++.++|.+||+.+|.+|||+.++++.+..
T Consensus 246 ~~~~----~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~ 292 (314)
T cd05099 246 FKLL----REGH-RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292 (314)
T ss_pred HHHH----HcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 2221 2211 111223678899999999999999999999999886544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=276.30 Aligned_cols=249 Identities=22% Similarity=0.341 Sum_probs=199.3
Q ss_pred CeeeeeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
+|++.+.||+|+||.||++.+.. ....+++|.+..... ....+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58899999999999999998753 235688888765432 23568889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEe
Q 023058 95 VMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv 150 (288)
++||+.+++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999887542 247888999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCch
Q 023058 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (288)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~ 226 (288)
+.++. ++|+|||++........ .....++..|+|||.+.+..++.. +|+||||+++++|++ |..||.......
T Consensus 161 ~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 161 AEGRK--MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred cCCCc--EEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchH-hHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 87776 99999999875433221 122234568999999877777666 999999999999998 999997654322
Q ss_pred hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
... . .......+....++.++.+++.+||+.+|.+||++.++++.+.
T Consensus 238 ~~~-~----~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~ 284 (290)
T cd05045 238 LFN-L----LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284 (290)
T ss_pred HHH-H----HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 222 1 1122223333468899999999999999999999999977543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=272.27 Aligned_cols=247 Identities=25% Similarity=0.370 Sum_probs=199.5
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEE-cCCeEEEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVM 96 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~ 96 (288)
+..++|++.+.||+|++|.||++... +..+++|..... ...+.+.+|+.++++++|+|++++++++. .+...++++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 45578999999999999999999874 778999987643 34567889999999999999999999764 456789999
Q ss_pred eccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 97 EYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
|++++++|.+++.... .++...+..++.|++.+|++||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQ- 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceeccccC-
Confidence 9999999999887644 4789999999999999999999999999999999999988776 9999999887433222
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
.....+..|+|||.+.+..++.+ +|+||||+++|+|++ |..||....... ....+... ........+++.+.
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~ 229 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEKG-YKMDAPDGCPPVVY 229 (256)
T ss_pred -CCCccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHhcC-CCCCCCCCCCHHHH
Confidence 23334567999999887777666 999999999999997 999987543322 22222222 11122236899999
Q ss_pred HHHHHhcccCcCCccccccccccc
Q 023058 254 HLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
++|.+||+.+|.+|||+.++++.+
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~~~l 253 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLREQL 253 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHHHHH
Confidence 999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=270.39 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=203.6
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
...+|++.+.||.|++|.||++.+. ++..+++|.+.......+.+.+|++++++++|||++++++++......++++|+
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 3568999999999999999999886 367899999877666667889999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC--C
Q 023058 99 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P 175 (288)
Q Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~--~ 175 (288)
+.+++|.+++... +.++...++.++.|++.++++||+.|++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe--EEECCCcceeecccCccccc
Confidence 9999999888754 46899999999999999999999999999999999999987776 99999998764432211 1
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
.....+..|+|||.+.+..++.+ +|+||||+++|+|++ |..||......... ..+... .........++.+.+
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~ 232 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYENRSNSEVV----ETINAG-FRLYKPRLASQSVYE 232 (256)
T ss_pred CCCccchhhcCHhHhccCCcChH-HHHHHHHHHHHHHHcCCCCCCCcCCHHHHH----HHHhCC-CCCCCCCCCCHHHHH
Confidence 12234567999999987777665 999999999999998 89999764432222 222222 111122256899999
Q ss_pred HHHHhcccCcCCccccccccccc
Q 023058 255 LISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
++.+||+.+|.+|||+.++++.+
T Consensus 233 l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 233 LMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHcccChhhCCCHHHHHHhh
Confidence 99999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=271.47 Aligned_cols=251 Identities=31% Similarity=0.466 Sum_probs=198.6
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
.++......||+|+||.||++.+..++..+++|.+.... ...+.+.+|+.++++++|+||+++++++..++..++++|+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 345555678999999999999999889999999887653 3445788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-
Q 023058 99 ASGGELFERICNA-GRF--SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (288)
Q Consensus 99 ~~~~~L~~~~~~~-~~~--~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~- 174 (288)
+++++|.+.+... ..+ +...+..++.|++.|+++||+.|++|+||+|+||+++.+. ..++|+|||.+........
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccCCCc
Confidence 9999999988754 345 8888999999999999999999999999999999997532 2499999998865432222
Q ss_pred CCCCcCCCcccCCccccCcc--cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
.....+++.|+|||.+.+.. ++.+ +|+||+|+++++|++|..||........... ...........+. .+++++
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~-~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~ 241 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAP-ADIWSLGCTIVEMATGKPPFIELGEPQAAMF-KVGMFKIHPEIPE--SLSAEA 241 (268)
T ss_pred cccCCCCccccChhhhccccccCCch-hhhHHHHHHHHHHHhCCCCCccccChhhhHh-hhhhhccCCCCCc--ccCHHH
Confidence 22335788999999986543 4444 9999999999999999999975433221111 1111122223333 578999
Q ss_pred HHHHHHhcccCcCCccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+++.+||+.+|.+|||+.++++
T Consensus 242 ~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 242 KNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHHHHHcCCCchhCCCHHHHHh
Confidence 99999999999999999988765
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=277.35 Aligned_cols=246 Identities=33% Similarity=0.548 Sum_probs=207.4
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCC-CCceeeEeEEEEcCCeEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 95 (288)
++|.+.+.||.|++|.||++.+..++..+++|++... ....+.+.+|..++++++ |+||+++++++..++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 5799999999999999999999999999999998753 233356788999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~- 174 (288)
||++.+++|.+.+...+.++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCcccc
Confidence 999999999999988888999999999999999999999999999999999999987776 99999998864433221
Q ss_pred --------------------CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 023058 175 --------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (288)
Q Consensus 175 --------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (288)
.....++..|++||.+.+...+.. +|+||||++++++++|..||.......... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~ 233 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSNEYLTFQ----K 233 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChh-hhHHHHHHHHHHHHhCCCCCCCccHHHHHH----H
Confidence 122346788999999877776665 999999999999999999998766433322 2
Q ss_pred HhhcccCCCCCCCCCHHHHHHHHHhcccCcCCcccc----ccccc
Q 023058 235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMH----FHATG 275 (288)
Q Consensus 235 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~----~~~l~ 275 (288)
+......++. .+++.+.++|.+||+.+|.+|||+ .+++.
T Consensus 234 ~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 ILKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHhcCCCCCC--ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 2334444444 679999999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=273.41 Aligned_cols=251 Identities=20% Similarity=0.298 Sum_probs=198.8
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCc----EEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
..+.|++.+.||.|+||+||++.+..++. .+++|.+.... ....++.+|+..+++++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 45789999999999999999999877665 47777765332 223466778888899999999999998754 457
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
++++|++++++|.+++... +.++...+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~~ 161 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI--VQIADFGVADLLYP 161 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEEcCCccceeccC
Confidence 7899999999999998754 56899999999999999999999999999999999999987776 99999999875443
Q ss_pred CCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 172 HSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 172 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
... .....++..|++||.+.+..++.+ +|+||||+++|++++ |..||....... ..+. .......+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~----~~~~~~~~~~~~ 235 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDL----LEKGERLAQPQI 235 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHH----HHCCCcCCCCCC
Confidence 322 122345668999999988777766 999999999999998 999997654322 1121 122222222335
Q ss_pred CCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
++.++.+++.+|+..+|.+|||+.++++.+.
T Consensus 236 ~~~~~~~li~~c~~~~p~~Rps~~el~~~l~ 266 (279)
T cd05111 236 CTIDVYMVMVKCWMIDENVRPTFKELANEFT 266 (279)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 7889999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=278.05 Aligned_cols=252 Identities=28% Similarity=0.409 Sum_probs=205.9
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+.|+..+.||.|++|.||++.+..++..|++|.+.... ...+.+.+|+.++++++|||++++++.+..+...++|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 46788899999999999999999889999999886432 3345688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-CCC
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~~~ 177 (288)
+++++|.+.+.. ..++...+..++.|++.|+.+||+.|++|+||+|+||+++.++. ++|+|||++........ ...
T Consensus 84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhhc
Confidence 999999888754 56899999999999999999999999999999999999987776 99999998865443222 223
Q ss_pred CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-ccCCCCCCCCCHHHHHHH
Q 023058 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLI 256 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li 256 (288)
..++..|+|||.+.+..++.+ +|+||||+++++|++|..||........... +... ....+ ...+..+.++|
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~li 233 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLFL----IPKNSPPTLE--GQYSKPFKEFV 233 (277)
T ss_pred ccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccchhhHHhh----hhcCCCCCCC--cccCHHHHHHH
Confidence 356788999999988777666 9999999999999999999875543222211 1111 11222 25788999999
Q ss_pred HHhcccCcCCccccccccccchhhhhhhh
Q 023058 257 SRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 257 ~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
.+||+.+|.+||++.+++. ++|+..+
T Consensus 234 ~~~l~~~p~~Rp~~~~il~---~~~~~~~ 259 (277)
T cd06642 234 EACLNKDPRFRPTAKELLK---HKFITRY 259 (277)
T ss_pred HHHccCCcccCcCHHHHHH---hHHHHHH
Confidence 9999999999999988866 5555543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=278.08 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=199.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcC-------CCcEEEEEEeecCc--cchHHHHHHHHHHhhC-CCCceeeEeEEEEcC
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (288)
.++|.+.+.||+|+||.||.+.+.. +...+++|.+.... .....+.+|+++++++ +|||++++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4789999999999999999998643 23469999887542 2334677899999999 799999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCC
Q 023058 90 THLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~ 153 (288)
+..+++|||+++++|.+++.... .++..++..++.|++.||++||+.|++|+||+|+||+++.+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence 99999999999999999987532 47889999999999999999999999999999999999877
Q ss_pred CCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHH
Q 023058 154 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFR 229 (288)
Q Consensus 154 ~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~ 229 (288)
+. ++|+|||.+........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||..... ....
T Consensus 177 ~~--~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~~~g~~p~~~~~~-~~~~ 252 (307)
T cd05098 177 NV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPV-EELF 252 (307)
T ss_pred Cc--EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH-HHHHHHHHHHHHHHcCCCCCCCcCCH-HHHH
Confidence 76 99999998865432211 111223467999999988777666 999999999999998 8888865432 2222
Q ss_pred HHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 230 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
. .+.. ....+....++.++.++|.+||..+|.+|||+.++++.+.
T Consensus 253 ~---~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~ 297 (307)
T cd05098 253 K---LLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297 (307)
T ss_pred H---HHHc-CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 2 2122 2222223367899999999999999999999999987443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=273.72 Aligned_cols=250 Identities=28% Similarity=0.480 Sum_probs=205.3
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
..|...+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|+.+++.++|||++++++++......++++|++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 56777889999999999999998889999999886543 23345788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CCCCC
Q 023058 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 178 (288)
Q Consensus 100 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~~~~ 178 (288)
.+++|.+++.. .+++...+..++.|++.++++||+.|++|+||+|+||+++.++. ++|+|||.+....... .....
T Consensus 99 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 99 EGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCcccccc
Confidence 99999998877 67899999999999999999999999999999999999988776 9999999876433222 12234
Q ss_pred cCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc-cCCCCCCCCCHHHHHHHH
Q 023058 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHISPECRHLIS 257 (288)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 257 (288)
.+++.|+|||.+.+..++.+ +|+||+|+++++|++|..||...+....... +.... ........++..+.++|.
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~ 250 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR----IRDNLPPKLKNLHKVSPRLRSFLD 250 (285)
T ss_pred cCCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH----HHhcCCCCCcccccCCHHHHHHHH
Confidence 57889999999987777666 9999999999999999999976543222222 22221 122222347899999999
Q ss_pred HhcccCcCCccccccccc-cch
Q 023058 258 RIFVADPAKVSMHFHATG-VYM 278 (288)
Q Consensus 258 ~~l~~~p~~Rpt~~~~l~-~~~ 278 (288)
+||+.+|.+|||+.++++ .|+
T Consensus 251 ~~l~~~p~~Rpt~~~il~~~~~ 272 (285)
T cd06648 251 RMLVRDPAQRATAAELLNHPFL 272 (285)
T ss_pred HHcccChhhCcCHHHHccCccc
Confidence 999999999999998887 444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=271.68 Aligned_cols=246 Identities=28% Similarity=0.396 Sum_probs=202.2
Q ss_pred eeeeeeeeccCceEEEEEEEcCCC----cEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~----~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
+++.+.||.|+||.||++.+...+ ..+++|.+..... ..+.+.+|+..++.++|+|++++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 457889999999999999998766 8899999876543 4567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 97 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
|++++++|.+.+..... ++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDY 158 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceecccccc
Confidence 99999999999876554 899999999999999999999999999999999999988776 99999999875544322
Q ss_pred CC--CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 175 PK--STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 175 ~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
.. ...+++.|++||.+.+..++.+ +|+||||+++++|++ |..||........... +.... ..+.....+.+
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~ 232 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSK-SDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY----LKKGY-RLPKPENCPPE 232 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HhcCC-CCCCCCcCCHH
Confidence 22 1235678999999877666666 999999999999998 7888876443222222 22222 12222358999
Q ss_pred HHHHHHHhcccCcCCcccccccccc
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
+.+++.+||+.+|.+|||+.++++.
T Consensus 233 ~~~~i~~~l~~~p~~Rpt~~~ll~~ 257 (258)
T smart00219 233 IYKLMLQCWAEDPEDRPTFSELVEI 257 (258)
T ss_pred HHHHHHHHCcCChhhCcCHHHHHhh
Confidence 9999999999999999999988764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=274.28 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=195.5
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCc--EEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcC------Ce
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEE--LVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP------TH 91 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~--~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 91 (288)
|.+.+.||+|+||.||++++..++. .+++|.+... ....+.+.+|+..++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3577899999999999999877664 6899987654 23345678899999999999999999986432 25
Q ss_pred EEEEEeccCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCC
Q 023058 92 LAIVMEYASGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~ 165 (288)
.++++||+.+++|..++.. ...++...+..++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCc
Confidence 6899999999999887742 124789999999999999999999999999999999999987776 99999999
Q ss_pred CcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccC
Q 023058 166 SKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYS 241 (288)
Q Consensus 166 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
+........ ......++.|++||.+.+..++.+ +|+||||+++|+|++ |..||....... ....+.... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~----~~~~~~~~~-~ 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSE----IYDYLRQGN-R 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHcCC-C
Confidence 875543221 122345678999999988877776 999999999999999 788987644322 222222222 2
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 242 IPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.+....+++.+.++|.+||+.||.+|||+.++++.+.
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 269 (272)
T cd05075 233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269 (272)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 2233368899999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=281.69 Aligned_cols=247 Identities=29% Similarity=0.419 Sum_probs=223.5
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
.+.|+.-+.||.||||.|+-++...||+.||.|.+.+. .....-..+|-.++.+++.+.||.+-..|.+++.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 47789999999999999999999999999999988653 23334567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 96 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
+..|+||+|.-.+.+.+ .|++.....++.+|+.||++||+.+||.||+||+||++|+.++ ++|+|+|++.......
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEGK 341 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCCCC
Confidence 99999999988776655 6999999999999999999999999999999999999998888 9999999999888777
Q ss_pred CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
......||..|||||++.+..|+.. .|.|||||++|+|+.|+.||...........+.+.+......+++ ..+++.+
T Consensus 342 ~~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~--kFS~eak 418 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD--KFSEEAK 418 (591)
T ss_pred ccccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc--ccCHHHH
Confidence 7777799999999999999999888 999999999999999999999887777777777777777777776 7899999
Q ss_pred HHHHHhcccCcCCccccc
Q 023058 254 HLISRIFVADPAKVSMHF 271 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~ 271 (288)
++...+|+.||.+|....
T Consensus 419 slc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 419 SLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHHccCHHHhccCC
Confidence 999999999999999876
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=277.40 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=202.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
.++|++.+.||.|+||.||++.+.. ++..+++|.+.... .....+.+|+.++++++|||++++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4789999999999999999998753 57889999886543 2235688899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEe
Q 023058 93 AIVMEYASGGELFERICNAG----------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~----------------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv 150 (288)
++++|++++++|.+++.... .++...++.++.|++.||.+||+.|++|+||+|+||++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~ 163 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV 163 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence 99999999999999886432 36788899999999999999999999999999999999
Q ss_pred cCCCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCch
Q 023058 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (288)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~ 226 (288)
+.++. ++|+|||.+........ ......+..|+|||.+.+..++.+ +|+||||+++|+|++ |..||.......
T Consensus 164 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 164 GENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred cCCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 87776 99999998864433221 122234567999999888777776 999999999999997 888887554322
Q ss_pred hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
. ...+..... .+.....+..+.++|.+||+.+|.+|||+.|+++.|.
T Consensus 241 ~----~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 V----IYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred H----HHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 2 222222222 1222367899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=285.56 Aligned_cols=260 Identities=24% Similarity=0.340 Sum_probs=205.3
Q ss_pred CCCCCCCCCCCCeeeeeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCcc--chHHHHHHHHHHhhCC-CCceeeE
Q 023058 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRF 82 (288)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~ 82 (288)
..+....+..++|.+.+.||+|+||.||++.+. .++..||+|++..... ..+.+.+|+.++.++. ||||+++
T Consensus 27 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~ 106 (401)
T cd05107 27 PYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNL 106 (401)
T ss_pred CCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence 333445556688999999999999999999864 3456899999975432 2346788999999997 9999999
Q ss_pred eEEEEcCCeEEEEEeccCCCchHHHHHhcC--------------------------------------------------
Q 023058 83 KEVILTPTHLAIVMEYASGGELFERICNAG-------------------------------------------------- 112 (288)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------------------------------------------- 112 (288)
++.+...+..++|+||+.+++|.+++...+
T Consensus 107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 107 LGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred EEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 999999999999999999999998885431
Q ss_pred ------------------------------------------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCC
Q 023058 113 ------------------------------------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144 (288)
Q Consensus 113 ------------------------------------------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~ 144 (288)
.++...+..++.||+.||.|||+.|++|+||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlk 266 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLA 266 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCC
Confidence 25566788899999999999999999999999
Q ss_pred CCceEecCCCCCCEEEeecCCCcccccCC---CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCC
Q 023058 145 LENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFE 220 (288)
Q Consensus 145 p~nilv~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~ 220 (288)
|+||+++.++. ++|+|||++....... ......+++.|+|||.+.+..++.+ +|+||||+++++|++ |..||.
T Consensus 267 p~NiLl~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 267 ARNVLICEGKL--VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL-SDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred cceEEEeCCCE--EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH-hHHHHHHHHHHHHHHcCCCCCC
Confidence 99999987766 9999999987432221 1223345778999999988777666 999999999999998 889987
Q ss_pred CCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 221 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
............ . .....+....++.++.+++.+||..+|.+||++.++++.+
T Consensus 344 ~~~~~~~~~~~~---~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 344 ELPMNEQFYNAI---K-RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred CCCchHHHHHHH---H-cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 654333222221 1 1222223336789999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=275.05 Aligned_cols=252 Identities=19% Similarity=0.313 Sum_probs=200.0
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (288)
...++|++.+.||+|+||.||++.... .+..|++|.+..... ....+.+|+..+++++|||++++++++....
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 356899999999999999999987642 355799998764432 2235678999999999999999999999989
Q ss_pred eEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEE
Q 023058 91 HLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l 160 (288)
..+++|||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~L 160 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKI 160 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EEE
Confidence 999999999999999998642 23466788999999999999999999999999999999987776 999
Q ss_pred eecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHh
Q 023058 161 CDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRIL 236 (288)
Q Consensus 161 ~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 236 (288)
+|||++........ .....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||....... ....+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~DvwslG~~l~el~~~~~~p~~~~~~~~----~~~~~~ 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQ----VLKFVM 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChH-hHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHH
Confidence 99998864432221 122234567999999988777766 999999999999998 788987654322 222222
Q ss_pred hc-ccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 237 SV-QYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 237 ~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.. ....+. ..++.+.+++.+||+.+|.+|||+.++++.+.
T Consensus 236 ~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 276 (288)
T cd05061 236 DGGYLDQPD--NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276 (288)
T ss_pred cCCCCCCCC--CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 22 222232 56899999999999999999999999988544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=271.47 Aligned_cols=243 Identities=26% Similarity=0.364 Sum_probs=198.3
Q ss_pred eeeeccCceEEEEEEEcC-CC--cEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSGNFGVARLMRDKK-TE--ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~-~~--~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+.||.|++|.||++.+.. ++ ..+++|.+..... ..+.+.+|+..+++++||||+++++++.. ...++++|++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 33 3689998876544 44578899999999999999999999988 889999999999
Q ss_pred CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC----C
Q 023058 102 GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----P 175 (288)
Q Consensus 102 ~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~----~ 175 (288)
++|.+.+.... .++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE--EEeccccccccccccccceecc
Confidence 99999987654 6899999999999999999999999999999999999988876 99999999875543221 1
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
....++..|+|||.+.+..++.+ +|+||||+++++|++ |..||...+..+..... .......+.....|..+.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 232 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI----DKEGERLERPEACPQDIYN 232 (257)
T ss_pred cCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HhcCCcCCCCccCCHHHHH
Confidence 12345678999999887777776 999999999999998 99999765443332222 2222233333467899999
Q ss_pred HHHHhcccCcCCccccccccccc
Q 023058 255 LISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
++.+||+.+|.+|||+.++++.+
T Consensus 233 li~~~l~~~p~~Rps~~~~~~~l 255 (257)
T cd05040 233 VMLQCWAHNPADRPTFAALREFL 255 (257)
T ss_pred HHHHHCCCCcccCCCHHHHHHHh
Confidence 99999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=275.81 Aligned_cols=256 Identities=26% Similarity=0.390 Sum_probs=205.4
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcC----CCcEEEEEEeecCccc--hHHHHHHHHHHhhCCCCceeeEeEEEEc--CCe
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKK----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILT--PTH 91 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 91 (288)
.+.|++.+.||+|+||.||++.... ++..+++|.+...... .+.+.+|++.+++++|+|++++++++.. ...
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 4678899999999999999998653 4789999998876553 6678999999999999999999999877 557
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.+++|||+++++|.+++.... .++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~ 160 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLP 160 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccccccccc
Confidence 899999999999999987654 6899999999999999999999999999999999999988766 9999999987654
Q ss_pred cCCCC----CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCch----------hHHHHHHHHh
Q 023058 171 LHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK----------NFRKTIHRIL 236 (288)
Q Consensus 171 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~----------~~~~~~~~~~ 236 (288)
..... ........|++||.+.+..++.. +|+||||+++++|++|..|+....... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcc-cchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 32221 12234556999999877777666 999999999999999999986543211 0111112222
Q ss_pred hcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 237 SVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 237 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
......+....++..+.+++.+||+.+|.+|||+.++++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence 223333444467899999999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=273.85 Aligned_cols=250 Identities=32% Similarity=0.491 Sum_probs=200.4
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcC--CeEEEEEe
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVME 97 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e 97 (288)
|++.+.||.|++|.||++.+..++..+++|.+.... .....+.+|++++++++|+|++++++++... +..++|++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 788999999999999999999889999999998653 3345678899999999999999999999988 89999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC--
Q 023058 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (288)
Q Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-- 174 (288)
|+++ +|..++... ..++...++.++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSAD 157 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCccc
Confidence 9975 888887665 57999999999999999999999999999999999999998776 99999999875544331
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-CCCC---------
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPD--------- 244 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~--------- 244 (288)
.....++..|+|||.+.+......++|+||||+++++|++|..||...+................. .++.
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 223346778999998766443344499999999999999999999876654433333221110000 0000
Q ss_pred --------------CCC-CCHHHHHHHHHhcccCcCCccccccccc
Q 023058 245 --------------YVH-ISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 245 --------------~~~-~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
... +++.+.++|.+||+.+|.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 011 3889999999999999999999988866
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=283.18 Aligned_cols=253 Identities=28% Similarity=0.433 Sum_probs=195.8
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEcC-----Ce
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 91 (288)
..++|++.+.||+|++|.||++.+..++..|++|.+... ......+.+|+.++++++|+||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 357999999999999999999999999999999998642 23345678899999999999999999887654 35
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
.++++|++.+ +|...+. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 83 ~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~ 158 (336)
T cd07849 83 VYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADP 158 (336)
T ss_pred EEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeeccc
Confidence 7999999965 7776664 457899999999999999999999999999999999999987776 99999998865433
Q ss_pred CCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH-----------h
Q 023058 172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-----------L 236 (288)
Q Consensus 172 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~-----------~ 236 (288)
... .....+++.|+|||.+.+....+.++|+||+|+++|+|++|..||...+............ .
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 221 1224578889999987654433444999999999999999999997644322111111000 0
Q ss_pred --------hc---ccCCC---CCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 237 --------SV---QYSIP---DYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 237 --------~~---~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.. ....+ .....++++.++|.+||+.+|.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 00000 01245788999999999999999999988877
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=276.69 Aligned_cols=248 Identities=24% Similarity=0.354 Sum_probs=197.5
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCC-CCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++|...+.||+|+||.||++.+..++..+++|.+.... .....+.+|+..+.++. |+||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 56778899999999999999999999999999987543 33456788999999996 9999999999999999999999
Q ss_pred ccCCCchHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHhhc-CceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 98 YASGGELFERI---C--NAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 98 ~~~~~~L~~~~---~--~~~~~~~~~~~~i~~~i~~~l~~LH~~-~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
++.. ++.++. . ....+++..+..++.|++.||+|||+. |++|+||+|+||+++.++. ++|+|||++.....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhcc
Confidence 9864 554432 2 235799999999999999999999975 9999999999999987776 99999999875544
Q ss_pred CCCCCCCcCCCcccCCccccCc---ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-ccCCCC--C
Q 023058 172 HSQPKSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPD--Y 245 (288)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~--~ 245 (288)
........+++.|+|||.+.+. .++.+ +|+||+|+++++|++|..||.... ..... ....... ....+. .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~--~~~~~-~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVR-SDVWSLGITLYEVATGKFPYPKWN--SVFDQ-LTQVVKGDPPILSNSEE 236 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcch-hhhhHHHHHHHHHHhCCCCchhcc--hHHHH-HhhhcCCCCCcCCCcCC
Confidence 4433445678889999998766 45555 999999999999999999997654 11122 2222221 112221 1
Q ss_pred CCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 246 VHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 246 ~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
..++.++.+||.+||+.+|.+|||+.+++.
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 247899999999999999999999988877
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=273.90 Aligned_cols=254 Identities=22% Similarity=0.260 Sum_probs=204.2
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcC----CCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEc-CC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKK----TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-PT 90 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 90 (288)
+..++|++.+.||+|+||.||++.+.. ++..+++|.+.... ...+.+.+|+..+++++|+|++++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 457899999999999999999999875 35788999876432 334567889999999999999999998766 46
Q ss_pred eEEEEEeccCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEee
Q 023058 91 HLAIVMEYASGGELFERICNA--------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~d 162 (288)
..+++++++++++|..++... ..++..++..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kl~d 160 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITD 160 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc--EEECC
Confidence 789999999999999988653 35889999999999999999999999999999999999987776 99999
Q ss_pred cCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhc
Q 023058 163 FGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV 238 (288)
Q Consensus 163 f~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 238 (288)
||++........ .....++..|+|||.+.+..++.+ +|+||||++++++++ |..||...+.... ... ...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~----~~~-~~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEM----AAY-LKD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCCHHHH----HHH-HHc
Confidence 999875433221 122334567999999987777766 999999999999998 9999976543221 111 112
Q ss_pred ccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 239 QYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
....+....+|+.+.+++.+||+.+|.+|||+.++++.+..
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 235 GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 23333344678999999999999999999999999875543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=283.55 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=200.4
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeec---CccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCe
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~---~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 91 (288)
+...+..|+++++||.||.+.||++...+.+ .|++|.+.. +......+.+|+.+|.++ .|.+|+.++||-..++.
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 3455688999999999999999999987644 456665543 455566789999999999 58999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 92 LAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
+|+|||+- ..+|-.++..... .+...++.+.+||+.++.++|+.||||.||||.|+++-. |. +||+|||.+..+.
T Consensus 435 lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~--LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 435 LYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GR--LKLIDFGIANAIQ 510 (677)
T ss_pred EEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-ee--EEeeeechhcccC
Confidence 99999976 5699999977654 566799999999999999999999999999999999963 33 9999999998777
Q ss_pred cCCCC---CCCcCCCcccCCccccCcccC----------CCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 023058 171 LHSQP---KSTVGTPAYIAPEVLLKKEYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237 (288)
Q Consensus 171 ~~~~~---~~~~~~~~~~aPE~~~~~~~~----------~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (288)
..... ....||+.||+||++.....+ .+++|||||||++|+|+.|..||..-. .....+..+..
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---n~~aKl~aI~~ 587 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---NQIAKLHAITD 587 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---HHHHHHHhhcC
Confidence 66554 456799999999998644332 334999999999999999999997432 12222233333
Q ss_pred cc--cCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 238 VQ--YSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 238 ~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+ +.+|..... .++.+++..||+.||.+|||+-++|+
T Consensus 588 P~~~Iefp~~~~~-~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 588 PNHEIEFPDIPEN-DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred CCccccccCCCCc-hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 32 355553222 33999999999999999999988877
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=272.90 Aligned_cols=251 Identities=27% Similarity=0.444 Sum_probs=200.6
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
+|++.+.||.|++|.||++.+..++..|++|.+.... ...+.+.+|+.++++++|+|++++++++...+..++|||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 6899999999999999999999999999999987643 23456778999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-C
Q 023058 100 SGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P 175 (288)
Q Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~ 175 (288)
++ +|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........ .
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTF 157 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCcccc
Confidence 75 787777653 35899999999999999999999999999999999999987776 99999998864433222 2
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh--------------cccC
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------------VQYS 241 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~~ 241 (288)
....++..|++||.+.+......++|+||||+++++|++|..||...+.............. ....
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 23446788999998866544344599999999999999999999876654433333211100 0001
Q ss_pred CCC---------CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 242 IPD---------YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 242 ~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+. ....+..+.++|.+||+.||.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 110 0135788999999999999999999988865
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=276.69 Aligned_cols=258 Identities=22% Similarity=0.328 Sum_probs=204.6
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEc-------CCCcEEEEEEeecC--ccchHHHHHHHHHHhhC-CCCceeeEeEEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVI 86 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 86 (288)
.....+|.+.+.||+|+||.||.++.. .++..+++|.+... ......+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 345689999999999999999999752 23457999987653 23345788999999999 899999999999
Q ss_pred EcCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEe
Q 023058 87 LTPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (288)
Q Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv 150 (288)
......+++|||+++++|.+++... ..++...+..++.||+.||.|||+.|++|+||||+||++
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 9999999999999999999988653 246778899999999999999999999999999999999
Q ss_pred cCCCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCch
Q 023058 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (288)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~ 226 (288)
+.++. ++|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||.......
T Consensus 171 ~~~~~--~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 171 TENNV--MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred cCCCc--EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 87776 99999999875433221 122334567999999988777776 999999999999998 788886654322
Q ss_pred hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
... .+.. .........++..+.++|.+||+.+|.+|||+.++++.+ ++++.
T Consensus 248 ~~~----~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l-~~~~~ 298 (304)
T cd05101 248 LFK----LLKE-GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL-DRILT 298 (304)
T ss_pred HHH----HHHc-CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH-HHHHH
Confidence 222 2222 122222336889999999999999999999999998855 33443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=282.51 Aligned_cols=259 Identities=27% Similarity=0.418 Sum_probs=202.8
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEc----CCeE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHL 92 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 92 (288)
.++|++.+.||.|++|.||++.+..++..|++|.+.... .....+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 479999999999999999999999999999999987542 334567789999999999999999988763 3478
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
++||||+. ++|.+.+.....++...++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeeccc
Confidence 99999996 589888877778999999999999999999999999999999999999988776 999999998654332
Q ss_pred CCC-----CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH-------------
Q 023058 173 SQP-----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR------------- 234 (288)
Q Consensus 173 ~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~------------- 234 (288)
... ....++..|+|||.+.+......++|+||||+++|+|++|..||...+...........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 211 23357888999999866433344499999999999999999999765432222111110
Q ss_pred ------Hhhccc---CCC---CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 235 ------ILSVQY---SIP---DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 235 ------~~~~~~---~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
...... ..+ .....++++.++|.+||+.+|.+|||+.+++. ++|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~---~~~~~~ 299 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ---HPFLAQ 299 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh---Chhhhh
Confidence 000000 000 01246899999999999999999999987755 666543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=267.05 Aligned_cols=245 Identities=35% Similarity=0.552 Sum_probs=206.3
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+|.+.+.||.|++|.||++.+..++..+++|++.... ...+.+.+|++.+++++|+|++++.+.+..+...++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 6899999999999999999999889999999987653 3445688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-
Q 023058 99 ASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (288)
Q Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~- 173 (288)
+++++|.+.+... ..++...+..++.+++.|+.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVD 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcc
Confidence 9999999988764 67999999999999999999999999999999999999987766 9999999887544332
Q ss_pred CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc-cCCCCCCCCCHHH
Q 023058 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHISPEC 252 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 252 (288)
......+++.|+|||.+.+..++.+ +|+||+|+++++|++|..||...+....... ..... ...+. .++..+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~--~~~~~~ 231 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLELALK----ILKGQYPPIPS--QYSSEL 231 (258)
T ss_pred eecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH----HhcCCCCCCCC--CCCHHH
Confidence 2233457888999999887777666 9999999999999999999976553222222 22222 22222 678999
Q ss_pred HHHHHHhcccCcCCccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+++.+||..+|.+|||+.++++
T Consensus 232 ~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 232 RNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHHHHHcCCChhhCcCHHHHhc
Confidence 99999999999999999988866
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=280.49 Aligned_cols=258 Identities=22% Similarity=0.340 Sum_probs=204.3
Q ss_pred CCCeee-eeeeeccCceEEEEEEEcCCCcEEEEEEeecCccch---------------HHHHHHHHHHhhCCCCceeeEe
Q 023058 20 SDRYEL-VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---------------ENVQREIINHRSLRHPNIVRFK 83 (288)
Q Consensus 20 ~~~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---------------~~~~~e~~~l~~l~~~~i~~~~ 83 (288)
.++|.. .+.||.|++|+||++.+..+++.|++|.+....... ..+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 477865 577999999999999999899999999986543221 2467899999999999999999
Q ss_pred EEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeec
Q 023058 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (288)
Q Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df 163 (288)
+++..+...+++||++. ++|.+.+.....++......++.|++.||.+||+.|++|+||+|+||+++.++. ++|+||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~df 163 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADF 163 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECCc
Confidence 99999999999999996 589988888778999999999999999999999999999999999999988776 999999
Q ss_pred CCCcccccC---------------CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 023058 164 GYSKSSVLH---------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (288)
Q Consensus 164 ~~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~ 228 (288)
|.+...... .......+++.|+|||.+.+......++|+||||+++++|++|..||...+.....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 988644311 11122345778999999876554344599999999999999999999877654444
Q ss_pred HHHHHHHhhccc-CCCC---------------------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 229 RKTIHRILSVQY-SIPD---------------------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 229 ~~~~~~~~~~~~-~~~~---------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
............ .++. ....++++.++|.+||+.+|.+|||+.+++. ++|++
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~---~~~~~ 317 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK---HEYFK 317 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc---CcccC
Confidence 333322111100 0000 1245788999999999999999999988876 55543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=263.40 Aligned_cols=249 Identities=27% Similarity=0.377 Sum_probs=209.0
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCC-CCceeeEeEEEEcCCeEEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 96 (288)
.+..+.+..||.|+.|+||+++...+|..+|+|.+.+.. +..+++...+.++.+.. +|+||+.+++|..+..+++-|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 456778899999999999999999999999999998753 44467778888777774 999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
|.|.. -+..++.. .+++|+..+-.+...++.||.||.+ .||+|||+||+||++|+.++ +||||||.+.+......
T Consensus 171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeecccc
Confidence 98844 44444433 4578999999999999999999986 48999999999999998888 99999999998888888
Q ss_pred CCCCcCCCcccCCcccc---CcccCCCccchhhHHHHHHHHHhCCCCCCCCCC-chhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 175 PKSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
.....|.+.|||||.+. ...|+.. +|+||||++++||.||+.||...+- .+...++.. ...+.++.....++
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln---~ePP~L~~~~gFSp 323 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN---EEPPLLPGHMGFSP 323 (391)
T ss_pred cccccCCccccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---cCCCCCCcccCcCH
Confidence 88889999999999985 3456677 9999999999999999999987543 222333222 33356666666899
Q ss_pred HHHHHHHHhcccCcCCccccccccc
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++.+|+..||+.|+.+||...++++
T Consensus 324 ~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 324 DFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHHHHHHHHhhcCcccCcchHHHhc
Confidence 9999999999999999999999988
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=272.83 Aligned_cols=256 Identities=29% Similarity=0.486 Sum_probs=205.2
Q ss_pred CeeeeeeeeccCceEEEEEEEc---CCCcEEEEEEeecCc-----cchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeE
Q 023058 22 RYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (288)
+|++.+.||.|+||.||.+.+. .++..|++|++.... ...+.+.+|+.+++++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999975 468899999987532 2345678899999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
++|+|++++++|.+.+.....++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC--EEEeeCccceecccc
Confidence 999999999999999988888999999999999999999999999999999999999987766 999999988754332
Q ss_pred CC--CCCCcCCCcccCCccccCcc-cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 173 SQ--PKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 173 ~~--~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
.. .....++..|++||.+.+.. ....++|+||+|+++|+|++|..||...............+.......+. .++
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 236 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMS 236 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCc--cCC
Confidence 21 12345788899999986532 22334999999999999999999997654434444444444444444433 578
Q ss_pred HHHHHHHHHhcccCcCCcc-----ccccccccchhhhhhh
Q 023058 250 PECRHLISRIFVADPAKVS-----MHFHATGVYMHTKLQL 284 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rp-----t~~~~l~~~~~~~~~~ 284 (288)
+.+.+++.+||+.+|.+|| ++.+++. ++|++.
T Consensus 237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~---~~~~~~ 273 (290)
T cd05613 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKK---HPFFQK 273 (290)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc---Cccccc
Confidence 9999999999999999998 4444444 555443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=282.14 Aligned_cols=257 Identities=31% Similarity=0.448 Sum_probs=206.0
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC-----eEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 93 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 93 (288)
+|++.+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|+..++.++|+|++++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6899999999999999999999889999999887542 33457889999999999999999999988765 789
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
++|+++.+ +|.+.+.....++...+..++.|++.||++||+.|++|+||+|.||+++.++. ++|+|||++.......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~--~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccCceEeecccc
Confidence 99999974 88888887778999999999999999999999999999999999999988766 9999999987655443
Q ss_pred ----CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc----------
Q 023058 174 ----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---------- 239 (288)
Q Consensus 174 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 239 (288)
......+++.|+|||.+.+......++|+||||+++++|++|..||...+................
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 123345788899999998773334449999999999999999999987654333322222110000
Q ss_pred ----------c----CCC-CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 240 ----------Y----SIP-DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 240 ----------~----~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
. .+. .....+.++.++|.+||+.+|.+|||+.++++ |+|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~---~~~~~~ 294 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA---HPYLAQ 294 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh---CccHHh
Confidence 0 000 01246889999999999999999999988766 555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=271.53 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=202.8
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCc----EEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
..++|++.+.||+|+||+||++.+..+++ .+++|....... ....+.+|+..+++++|||++++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 45889999999999999999999876554 588998765532 33567889999999999999999999887 788
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
++++|++++++|.+.+... ..++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~ 161 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDV 161 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCcccccccC
Confidence 9999999999999988764 46899999999999999999999999999999999999987776 99999999875543
Q ss_pred CCCCCC---CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 172 HSQPKS---TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 172 ~~~~~~---~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
...... ...+..|+|||.+....++.. +|+||||++++++++ |..||......+... .+.. ....+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~ 235 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVEIPD----LLEK-GERLPQPPI 235 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH----HHhC-CCCCCCCCC
Confidence 222111 123457999999877777666 999999999999998 999997754432222 2222 222333335
Q ss_pred CCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.+.++.+++.+||..+|++|||+.++++.+.
T Consensus 236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~ 266 (279)
T cd05057 236 CTIDVYMVLVKCWMIDAESRPTFKELINEFS 266 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 7899999999999999999999999887443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=286.32 Aligned_cols=250 Identities=27% Similarity=0.367 Sum_probs=210.3
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCc---E-EEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEE---L-VAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~---~-~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
++-.+.++||+|.||.||++.....+. . ||+|..... .....++.+|++++++++|||||+++|+.....-+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 455567999999999999999875422 3 899987742 34456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
++|||+|.+|+|.++++..+ .++..+...++.+.+.||+|||+++++||||-..|++++.+.. +||+|||+++....
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGSQ 314 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccccCCcc
Confidence 99999999999999998877 4999999999999999999999999999999999999998776 89999999886553
Q ss_pred CCCCC-CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 172 HSQPK-STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 172 ~~~~~-~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
..... .......|+|||.+....++.+ +||||+|+++||+++ |..||...... .....+....+..+.....|
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~~~~~r~~~~~~~p 389 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIVKNGYRMPIPSKTP 389 (474)
T ss_pred eeeccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHHhcCccCCCCCCCH
Confidence 22222 2234568999999999988888 999999999999998 78899886653 44445545555555555789
Q ss_pred HHHHHHHHHhcccCcCCccccccccccc
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.++..++.+|+..+|++|||+.++.+.+
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm~~i~~~l 417 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTMSTIKKKL 417 (474)
T ss_pred HHHHHHHHHhccCChhhccCHHHHHHHH
Confidence 9999999999999999999999887644
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=277.60 Aligned_cols=258 Identities=25% Similarity=0.370 Sum_probs=197.8
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcC--
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP-- 89 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 89 (288)
++....++|++.+.||.|++|.||++.+..++..+++|.+.... .......+|++++++++||||+++++++...
T Consensus 2 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 2 YGCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred CCCcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 34455799999999999999999999999999999999986542 2234577899999999999999999987543
Q ss_pred ------CeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEee
Q 023058 90 ------THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (288)
Q Consensus 90 ------~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~d 162 (288)
..++++++|+.. ++...+.. ...++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~d 158 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIAD 158 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECc
Confidence 346999999966 66666554 457999999999999999999999999999999999999988777 99999
Q ss_pred cCCCcccccCCCC------------CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 023058 163 FGYSKSSVLHSQP------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (288)
Q Consensus 163 f~~~~~~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~ 230 (288)
||++......... ....+++.|+|||.+.+......++|+||+|+++|+|++|..||...+.......
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9988644322211 1123567899999886654334449999999999999999999987655443333
Q ss_pred HHHHHhhcc-------------------cCCC-----CCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 231 TIHRILSVQ-------------------YSIP-----DYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 231 ~~~~~~~~~-------------------~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
......... ...+ .....++.+.++|.+||+.||.+|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 222111000 0000 01234578999999999999999999977765
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=268.61 Aligned_cols=242 Identities=25% Similarity=0.358 Sum_probs=191.6
Q ss_pred eeeccCceEEEEEEEc--CCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCc
Q 023058 28 DIGSGNFGVARLMRDK--KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 103 (288)
Q Consensus 28 ~lg~g~~~~v~~~~~~--~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 103 (288)
.||+|+||.||++... .++..+++|...... ...+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999998765 345679999886543 22356889999999999999999999875 457899999999999
Q ss_pred hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC----CCC
Q 023058 104 LFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KST 178 (288)
Q Consensus 104 L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~----~~~ 178 (288)
|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCC
Confidence 9998865 456899999999999999999999999999999999999987776 999999988744332211 111
Q ss_pred cCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 023058 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257 (288)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (288)
..++.|+|||.+.+..++.+ +|+||||+++|++++ |..||........... +.... ..+.....++++.++|.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~l~~li~ 232 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF----IEQGK-RLDCPAECPPEMYALMK 232 (257)
T ss_pred CCCcccCCHHHHccCCCCch-hhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH----HHCCC-CCCCCCCCCHHHHHHHH
Confidence 23467999999877777666 999999999999996 9999987654332222 12211 12222367899999999
Q ss_pred HhcccCcCCccccccccccch
Q 023058 258 RIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 258 ~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
+||+.+|.+||++.++.+.+.
T Consensus 233 ~c~~~~~~~Rp~~~~i~~~l~ 253 (257)
T cd05115 233 DCWIYKWEDRPNFAKVEERMR 253 (257)
T ss_pred HHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=276.74 Aligned_cols=252 Identities=26% Similarity=0.373 Sum_probs=185.8
Q ss_pred eeeeeccCceEEEEEEEcC--CCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEc--CCeEEEEEeccCC
Q 023058 26 VRDIGSGNFGVARLMRDKK--TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG 101 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 101 (288)
..+||+|+||.||+|.+.. ++..||+|.+.... ....+.+|+.++++++|||++++++++.. +...++++||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 3689999999999999754 56789999886543 33567889999999999999999999854 4678999999865
Q ss_pred CchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCC--CCCCEEEeecCCCcccc
Q 023058 102 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV 170 (288)
Q Consensus 102 ~~L~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~--~~~~~~l~df~~~~~~~ 170 (288)
+|.+.+... ..+++..+..++.||+.||.+||+.|++|+||||+||++..+ ..++++|+|||++....
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 777766421 247899999999999999999999999999999999999432 22359999999987544
Q ss_pred cCCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCch---------hHHHHHH----
Q 023058 171 LHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK---------NFRKTIH---- 233 (288)
Q Consensus 171 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~---------~~~~~~~---- 233 (288)
.... .....+++.|+|||.+.+......++|+||||+++|+|++|..||....... .......
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCC
Confidence 3322 1234578899999998775543444999999999999999999997543210 0000000
Q ss_pred -------HH-------------hhcccC--------CCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 234 -------RI-------------LSVQYS--------IPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 234 -------~~-------------~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
.+ ...... .......+..+.++|.+||+.||.+|||+.|+++ |+|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~---hp~f 317 (317)
T cd07867 244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ---DPYF 317 (317)
T ss_pred CChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc---CCCC
Confidence 00 000000 0001124567889999999999999999988866 5553
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=266.81 Aligned_cols=247 Identities=32% Similarity=0.480 Sum_probs=202.1
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC------ccchHHHHHHHHHHhhCCCCceeeEeEEEEcC--CeE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTP--THL 92 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 92 (288)
.+|++.+.||+|++|.||++.+..++..+++|.+... ......+.+|++++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 6899999999999999999999999999999987542 12234678899999999999999999998764 468
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
++++|++++++|.+.+...+.++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECccccccccccc
Confidence 899999999999999988778999999999999999999999999999999999999987776 999999998754321
Q ss_pred C----CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCC
Q 023058 173 S----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 173 ~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
. ......++..|+|||.+.+..++.+ +|+||||+++++|++|..||..........+... ......++. .+
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~p~--~~ 234 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRK-ADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTKPMLPD--GV 234 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc--CCCCCCCCc--cc
Confidence 1 1123457888999999987776666 9999999999999999999986544333222211 111223333 68
Q ss_pred CHHHHHHHHHhcccCcCCccccccccc
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++.+.++|.+||. +|.+||++.+++.
T Consensus 235 ~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 235 SDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 8999999999997 6799999987766
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=295.24 Aligned_cols=257 Identities=21% Similarity=0.329 Sum_probs=188.3
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCC-cEEE------------------EEEeecCccchHHHHHHHHHHhhCCCCcee
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTE-ELVA------------------VKYIERGDKIDENVQREIINHRSLRHPNIV 80 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~------------------iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 80 (288)
.++|++++.||+|+||+||++...... ...+ .|.+.........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 368999999999999999998764322 1112 222222233345678999999999999999
Q ss_pred eEeEEEEcCCeEEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCC
Q 023058 81 RFKEVILTPTHLAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155 (288)
Q Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~ 155 (288)
++++++...+..+++++++.+ +|..++... .......+..++.||+.||.|||+.||+||||||+||+++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 999999999999999999855 666655432 22446678889999999999999999999999999999987776
Q ss_pred CCEEEeecCCCcccccCCC--CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchh---HHH
Q 023058 156 PRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN---FRK 230 (288)
Q Consensus 156 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~---~~~ 230 (288)
++|+|||++........ .....+++.|+|||.+.+..++.+ +|||||||++|+|++|..++........ ..+
T Consensus 306 --vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 306 --IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred --EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999875543322 223468999999999988888776 9999999999999998754433222111 111
Q ss_pred HHHHHhhcccCCC--------------------------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 231 TIHRILSVQYSIP--------------------------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 231 ~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
....+......++ ....++.++.++|.+||++||.+|||+.|+++ |+|++
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~---hp~f~ 458 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA---LPLFS 458 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh---Chhhh
Confidence 1111000000000 11246778889999999999999999988866 55554
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=296.21 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=211.9
Q ss_pred CCeeeeeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
.+-+..+.||+|.||+||+++-. .....||||.++.... ..+++++|++++..++|||||+++|++..++-++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 56678999999999999999864 2346799999886544 4568999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc----------C----CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEE
Q 023058 94 IVMEYASGGELFERICNA----------G----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~----------~----~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~ 159 (288)
+|+|||..|+|.+++... . +++..+.+.|+.||+.|+.||.+..+|||||-..|++|..+-. ||
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--VK 643 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--VK 643 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--EE
Confidence 999999999999988532 1 2789999999999999999999999999999999999987776 99
Q ss_pred EeecCCCcccccCCCCC---CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHH
Q 023058 160 ICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRI 235 (288)
Q Consensus 160 l~df~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~ 235 (288)
|+|||+++.....+... ......+|||||.+..+.++++ |||||+|+++||+++ |..||....+.+.+..+
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i---- 718 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI---- 718 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccchHHHHHHH----
Confidence 99999998665554443 3345678999999999999999 999999999999996 89999988775555443
Q ss_pred hhcccCCCCCCCCCHHHHHHHHHhcccCcCCcccccccccc
Q 023058 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
..+.. ++..-++|.++++|+..||+.+|.+||++.|+-..
T Consensus 719 ~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~ 758 (774)
T KOG1026|consen 719 RAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSR 758 (774)
T ss_pred HcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 33343 44444899999999999999999999999998443
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=276.80 Aligned_cols=251 Identities=26% Similarity=0.340 Sum_probs=194.7
Q ss_pred CeeeeeeeeccCceEEEEEEEcC--CCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcC--CeEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKK--TEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLA 93 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 93 (288)
+|.+.+.||+|++|.||++.+.. ++..||+|.+.... ...+...+|+.++++++|||++++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 78999999987632 3345678899999999999999999999988 7899
Q ss_pred EEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC----CCCCCEEEeecC
Q 023058 94 IVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG----SPAPRLKICDFG 164 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~----~~~~~~~l~df~ 164 (288)
+|||++++ ++.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++. ++|+|||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~--~kl~Dfg 157 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV--VKIGDLG 157 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccce--EEECCCc
Confidence 99999975 666655422 26899999999999999999999999999999999999987 554 9999999
Q ss_pred CCcccccCCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCch---------hHHHH
Q 023058 165 YSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK---------NFRKT 231 (288)
Q Consensus 165 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~---------~~~~~ 231 (288)
++........ .....+++.|+|||.+.+......++|+||||+++++|++|..||....... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 8875433322 2234567889999988765433444999999999999999999997654322 00000
Q ss_pred HHHHh----------------------hcccCCC---------CCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 232 IHRIL----------------------SVQYSIP---------DYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 232 ~~~~~----------------------~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
...+. ......+ .....+.++.++|.+||+.||.+|||+.++++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 0000011 01145678999999999999999999988866
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=270.51 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=200.5
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCC---CcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
..++|.+.+.||.|++|.||++.+... ...+++|...... ...+.+.+|+.++++++|||++++++++.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 457899999999999999999987543 3568999876543 334578899999999999999999998875 4567
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
++||++++++|.+++.... .++...+..++.|++.||++||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~ 160 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeecccc
Confidence 9999999999999997644 5899999999999999999999999999999999999988776 999999988654333
Q ss_pred CCC--CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 173 SQP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 173 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
... ....+...|+|||.+....++.+ +|+||||++++++++ |..||........... +... ...+....+|
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~~~~-~~~~~~~~~~ 234 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR----IENG-ERLPMPPNCP 234 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHcC-CcCCCCCCCC
Confidence 221 12223457999999877777666 999999999999886 9999976654332222 1111 1222334689
Q ss_pred HHHHHHHHHhcccCcCCccccccccccch
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
..+.++|.+|+..+|.+|||+.++++.+.
T Consensus 235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~l~ 263 (270)
T cd05056 235 PTLYSLMTKCWAYDPSKRPRFTELKAQLS 263 (270)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99999999999999999999998877443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=277.00 Aligned_cols=247 Identities=26% Similarity=0.449 Sum_probs=203.3
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
..|.....||+|+||.||++.+..++..|++|.+.... ...+.+.+|+..++.++|||++++++++..++..++++|++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 56667778999999999999999889999999986532 33456788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-CCCC
Q 023058 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKST 178 (288)
Q Consensus 100 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~~~~ 178 (288)
++++|...+.. ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........ ....
T Consensus 101 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 101 QGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccccce
Confidence 99999887644 56899999999999999999999999999999999999988776 99999998864433222 2334
Q ss_pred cCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc-cCCCCCCCCCHHHHHHHH
Q 023058 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHISPECRHLIS 257 (288)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 257 (288)
.++..|+|||.+.+..++.+ +|+||+|+++++|++|..||............ .... ........+++.+.++|.
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~i~ 252 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL----RDSPPPKLKNAHKISPVLRDFLE 252 (297)
T ss_pred ecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----hccCCCCccccCCCCHHHHHHHH
Confidence 57889999999987777666 99999999999999999999865433322221 1111 122223357889999999
Q ss_pred HhcccCcCCccccccccc
Q 023058 258 RIFVADPAKVSMHFHATG 275 (288)
Q Consensus 258 ~~l~~~p~~Rpt~~~~l~ 275 (288)
+||+.+|.+||++.++++
T Consensus 253 ~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 253 RMLTREPQERATAQELLD 270 (297)
T ss_pred HHhcCCcccCcCHHHHhh
Confidence 999999999999998877
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=273.12 Aligned_cols=245 Identities=27% Similarity=0.406 Sum_probs=197.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
.++|++.+.||+|++|.||++.+..+++.|++|.+.... ...+.+.+|+++++.++|||++++.+++..+...++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 377999999999999999999999889999999886432 2224678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
+||+.+ ++.+.+.. ...++...+..++.|++.+|.|||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSPA-- 168 (307)
T ss_pred HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecCCC--
Confidence 999975 66666643 456899999999999999999999999999999999999988776 999999988644322
Q ss_pred CCCCcCCCcccCCcccc---CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 175 PKSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
....+++.|+|||.+. ...++.+ +|+||||+++|+|++|..||...+........ ........+ ...++..
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~-sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~ 242 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNDSPTLS-SNDWSDY 242 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcc-cchHHHHHHHHHHHcCCCCCCCccHHHHHHHH---hcCCCCCCC-chhhCHH
Confidence 2345778899999874 2345455 99999999999999999999765432222111 111112221 1246889
Q ss_pred HHHHHHHhcccCcCCccccccccc
Q 023058 252 CRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+.++|.+||+.+|.+||++.+++.
T Consensus 243 ~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 243 FRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhc
Confidence 999999999999999999988876
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=274.62 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=204.0
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccC
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (288)
.|.-...||+|++|.||++....++..+++|.+.... .....+.+|+.+++.++|+|++++++.+...+..+++|||++
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 3444578999999999999999899999999886433 234567889999999999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CCCCCc
Q 023058 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 179 (288)
Q Consensus 101 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~~~~~ 179 (288)
+++|.+++.. ..++...+..++.|++.++++||+.|++|+||+|+||+++.++. ++|+|||++....... ......
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceecccccccccccc
Confidence 9999887644 46899999999999999999999999999999999999988776 9999999876543322 123345
Q ss_pred CCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 023058 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259 (288)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 259 (288)
+++.|++||.+.+..++.+ +|+||+|+++|+|++|..||.............. .....+.....+++.+.+++.+|
T Consensus 178 ~~~~y~~pE~~~~~~~~~~-~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~ 253 (292)
T cd06657 178 GTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPKLKNLHKVSPSLKGFLDRL 253 (292)
T ss_pred cCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---hCCcccCCcccCCHHHHHHHHHH
Confidence 7788999999877776665 9999999999999999999986544322222111 11122223335789999999999
Q ss_pred cccCcCCccccccccccchhhhhhh
Q 023058 260 FVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 260 l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
|+.+|.+||++.++++ |+|+..
T Consensus 254 l~~~P~~R~~~~~ll~---~~~~~~ 275 (292)
T cd06657 254 LVRDPAQRATAAELLK---HPFLAK 275 (292)
T ss_pred HhCCcccCcCHHHHhc---ChHHhc
Confidence 9999999999988876 555544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=274.61 Aligned_cols=254 Identities=30% Similarity=0.456 Sum_probs=200.5
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC-----
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 90 (288)
..++|++.+.||.|++|.||++.+..+++.|++|.+.... .....+.+|++++++++|||++++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3578999999999999999999999899999999987542 23346778999999999999999999987654
Q ss_pred -----eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecC
Q 023058 91 -----HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (288)
Q Consensus 91 -----~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~ 164 (288)
.+++++|++++ ++...+... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg 161 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFG 161 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCccc
Confidence 78999999976 666666543 46899999999999999999999999999999999999987776 9999999
Q ss_pred CCcccccCCC--CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-C
Q 023058 165 YSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-S 241 (288)
Q Consensus 165 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~ 241 (288)
++........ ......+..|++||.+.+......++|+||||+++++|++|..||...+................. .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 8875443322 122345678999998865543344499999999999999999999876554443333332111100 0
Q ss_pred C-----------------------CCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 242 I-----------------------PDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 242 ~-----------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+ .....+|..+.++|.+||+.||.+|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 012246899999999999999999999988766
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=269.48 Aligned_cols=247 Identities=32% Similarity=0.510 Sum_probs=203.3
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+|.+.+.||.|++|.||++.+..++..+++|.+.... ...+.+.+|+.++++++|+|++++++.+......++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 6899999999999999999999999999999987542 3345678999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC-
Q 023058 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (288)
Q Consensus 99 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~- 175 (288)
+++++|.+++.... .+++..+..++.|++.++.+||+.+++|+||+|+||+++.++. .++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccc
Confidence 99999999886643 4789999999999999999999999999999999999987654 3699999988755433222
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....+++.|+|||.+.+..++.+ +|+||||++++++++|..||...+....... ...... .+.....+.++.++
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~ 233 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLK----ICQGYF-APISPNFSRDLRSL 233 (257)
T ss_pred cccCCCccccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----HhcccC-CCCCCCCCHHHHHH
Confidence 23357888999999877777666 9999999999999999999976543232222 222211 11223578899999
Q ss_pred HHHhcccCcCCccccccccc
Q 023058 256 ISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~ 275 (288)
|.+||+.+|.+|||+.+++.
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHHHhccChhhCcCHHHHhh
Confidence 99999999999999988866
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=284.83 Aligned_cols=248 Identities=35% Similarity=0.564 Sum_probs=213.2
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCC
Q 023058 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (288)
.+.||+|-||+||-+++..+|+.||+|++.+- ......+.+|+.+|+++.||+||.+.-.|+..+.+|+|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 57899999999999999999999999998753 344467899999999999999999999999999999999999775
Q ss_pred chHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC-CCCCCEEEeecCCCcccccCCCCCCCcC
Q 023058 103 ELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (288)
Q Consensus 103 ~L~~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~-~~~~~~~l~df~~~~~~~~~~~~~~~~~ 180 (288)
-|.-++ .+.+++++...+.++.||+.||.|||.+||+|+||||+||++.+ +..+++||||||+++.+..........|
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG 728 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG 728 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence 554444 34568999999999999999999999999999999999999953 4556899999999998888777788899
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc--CCCCCCCCCHHHHHHHHH
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRHLISR 258 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~ 258 (288)
||.|+|||++.+..|+.. .|+||.|+++|.-+.|..||-..++ +-.++.+..+ .-..|.+++++..+||..
T Consensus 729 TPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEd------IndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 729 TPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDED------INDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred CccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccc------hhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 999999999999999888 9999999999999999999964432 2223333433 444578899999999999
Q ss_pred hcccCcCCccccccccccchhhhhh
Q 023058 259 IFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 259 ~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+|+..-.+|.|....+. |+|+|
T Consensus 802 LLqVkm~kRysvdk~ls---h~Wlq 823 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLS---HPWLQ 823 (888)
T ss_pred HHHHHHHHhcchHhhcc---chhhh
Confidence 99999999999987766 66665
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=265.70 Aligned_cols=242 Identities=25% Similarity=0.331 Sum_probs=196.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCch
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 104 (288)
+.||.|++|.||++.+.. ++.|++|.+..... ....+.+|++++++++|+||+++++++......+++||++.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 478999999999999987 89999998875433 345788999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC---CCCcC
Q 023058 105 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 180 (288)
Q Consensus 105 ~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~ 180 (288)
.+++... ..++...+..++.+++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+......... .....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc--EEEeeccccccccCCcceeccccCcc
Confidence 9988653 46889999999999999999999999999999999999987776 999999988744321111 11223
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 259 (288)
+..|+|||.+.+..++.. +|+||||+++|+|++ |..||............ . .....+.....+..+.+++.+|
T Consensus 158 ~~~y~~PE~~~~~~~~~~-~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~li~~~ 231 (251)
T cd05041 158 PIKWTAPEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQTRERI----E-SGYRMPAPQLCPEEIYRLMLQC 231 (251)
T ss_pred eeccCChHhhccCCCCcc-hhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH----h-cCCCCCCCccCCHHHHHHHHHH
Confidence 556999999887777666 999999999999998 88888765542222221 1 1122223336789999999999
Q ss_pred cccCcCCccccccccccc
Q 023058 260 FVADPAKVSMHFHATGVY 277 (288)
Q Consensus 260 l~~~p~~Rpt~~~~l~~~ 277 (288)
|+.+|.+|||+.++++.+
T Consensus 232 l~~~p~~Rp~~~ell~~l 249 (251)
T cd05041 232 WAYDPENRPSFSEIYNEL 249 (251)
T ss_pred hccChhhCcCHHHHHHHh
Confidence 999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=267.18 Aligned_cols=245 Identities=38% Similarity=0.608 Sum_probs=203.7
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCcc----chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCch
Q 023058 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (288)
Q Consensus 29 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 104 (288)
||.|++|.||.+.+..+++.+++|.+..... ....+.+|+.++++++|+|++++++.+..+...+++||++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999998899999999876532 344788899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCCCCCcCCCc
Q 023058 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 183 (288)
Q Consensus 105 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~ 183 (288)
.+++.....++...+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||.+...... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCcc
Confidence 999988878999999999999999999999999999999999999988776 999999988755443 22344557888
Q ss_pred ccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccC
Q 023058 184 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 263 (288)
Q Consensus 184 ~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 263 (288)
|++||...+...+.. +|+||||++++++++|..||...+. ......+......++. ..++.+.++|.+||..|
T Consensus 159 ~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~--~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 159 YLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILKDPLRFPE--FLSPEARDLISGLLQKD 231 (250)
T ss_pred ccChHHhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhcCCCCCCC--CCCHHHHHHHHHHhcCC
Confidence 999999877776665 9999999999999999999976543 2223333334444444 57899999999999999
Q ss_pred cCCccccccccccchhhhh
Q 023058 264 PAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 264 p~~Rpt~~~~l~~~~~~~~ 282 (288)
|.+||++.++.+...|+|+
T Consensus 232 p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhhCCCcccHHHHHhCCCC
Confidence 9999999543334445553
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=268.29 Aligned_cols=247 Identities=26% Similarity=0.343 Sum_probs=199.5
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
...++|++.+.||+|+||.||.+.. +++.+++|.+.... ..+.+.+|+.++++++|||++++.+++..+ ..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred ccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 3457899999999999999999874 67889999886533 346788999999999999999999998765 4789999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 98 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|+.+++|.+++.... .++...+..++.|++.||.+||+.|++||||+|+||+++.++. ++|+|||++...... .
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~~--~ 154 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSMG--V 154 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceecccc--C
Confidence 999999999987543 4789999999999999999999999999999999999987776 999999988643322 1
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
........|+|||.+.+..++.+ +|+||||+++++|++ |..||...+...... .+.. .........+++.+.+
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~ 228 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE----CVEK-GYRMEPPEGCPADVYV 228 (254)
T ss_pred CCCCCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCHHHHHH----HHhC-CCCCCCCCcCCHHHHH
Confidence 22334567999999887777766 999999999999997 999997654432222 2122 1222223367899999
Q ss_pred HHHHhcccCcCCccccccccccch
Q 023058 255 LISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
++.+||+.+|.+||++.++++.+.
T Consensus 229 li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 229 LMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHHcCCChhhCcCHHHHHHHHc
Confidence 999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=269.01 Aligned_cols=245 Identities=27% Similarity=0.424 Sum_probs=201.6
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+-|++.+.||.|+||.||++.+..++..+|+|.+.... ...+.+.+|+..+++++|||++++++.+..+...++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 34788999999999999999998889999999876433 2335678899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-CCC
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 177 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~~~ 177 (288)
+++++|..++.. ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++........ ...
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhcc
Confidence 999999988754 46899999999999999999999999999999999999987776 99999998764433221 223
Q ss_pred CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-ccCCCCCCCCCHHHHHHH
Q 023058 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLI 256 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li 256 (288)
..++..|+|||.+.+..++.. +|+||+|+++++|++|..||.......... .+... ....+ ..++.++.++|
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~~i 233 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKVLF----LIPKNNPPTLE--GNYSKPLKEFV 233 (277)
T ss_pred ccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCccchHHHHH----HHhcCCCCCCC--cccCHHHHHHH
Confidence 456788999999877776666 999999999999999999997654322221 11111 11222 25789999999
Q ss_pred HHhcccCcCCccccccccc
Q 023058 257 SRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 257 ~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+||+.+|.+||++.+++.
T Consensus 234 ~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 234 EACLNKEPSFRPTAKELLK 252 (277)
T ss_pred HHHccCChhhCcCHHHHHh
Confidence 9999999999999988877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=273.52 Aligned_cols=250 Identities=31% Similarity=0.466 Sum_probs=201.3
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
|++.+.||.|++|.||++.+..++..+++|.+..... ....+.+|+.++++++|+|++++++++..+...++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 6788999999999999999998999999999875432 3457888999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CCCC
Q 023058 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (288)
Q Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~~~ 177 (288)
++ ++.+.+.. ...++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~~~~~~ 157 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTH 157 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCcccccC
Confidence 76 78777765 357899999999999999999999999999999999999987776 9999999887554443 2233
Q ss_pred CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc---------------cCC
Q 023058 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---------------YSI 242 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~ 242 (288)
..++..|+|||.+.+......++|+||||+++|+|++|..||...+..+............. ..+
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 45778899999987763334449999999999999999999977655444333322211100 011
Q ss_pred CC---------CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 243 PD---------YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 243 ~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+. ...++.++.++|.+||++||.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 10 1246789999999999999999999987765
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=268.37 Aligned_cols=248 Identities=29% Similarity=0.461 Sum_probs=199.8
Q ss_pred CeeeeeeeeccCceEEEEEEEcC-CCcEEEEEEeecCc-----------cchHHHHHHHHHHhh-CCCCceeeEeEEEEc
Q 023058 22 RYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD-----------KIDENVQREIINHRS-LRHPNIVRFKEVILT 88 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~~-----------~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~ 88 (288)
.|++.+.||+|++|.||.+.+.. +++.+++|.+.... ....++.+|+.++.+ ++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 67899999875321 122346678887765 799999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCCCCEEEeec
Q 023058 89 PTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDF 163 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~~~~~l~df 163 (288)
++..+++|||+++++|.+++.. ...++...++.++.|++.+|.+||+ .|++|+||+|+||+++.++. ++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecc
Confidence 9999999999999999887743 3468999999999999999999996 78999999999999988776 999999
Q ss_pred CCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC
Q 023058 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243 (288)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
|.+.............++..|++||.+.+..++.+ +|+||||+++|+|++|..||.......... .+........
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~ 233 (269)
T cd08528 159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTNMLSLAT----KIVEAVYEPL 233 (269)
T ss_pred cceeecccccccccccCcccCcChhhhcCCCCchH-HHHHHHHHHHHHHHhCCCcccccCHHHHHH----HHhhccCCcC
Confidence 99876554443344567888999999988777666 999999999999999999997654322222 2222222211
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCcccccccccc
Q 023058 244 DYVHISPECRHLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
.....++.+.++|.+||+.||.+||++.++.+.
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 222568999999999999999999999888663
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=271.46 Aligned_cols=246 Identities=23% Similarity=0.354 Sum_probs=195.5
Q ss_pred eeeeccCceEEEEEEEcCCC------cEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 27 RDIGSGNFGVARLMRDKKTE------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~------~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+.||.|++|.||++++.... ..+++|.+.... .....+.+|+.+++.++||||+++++++...+..+++||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999986433 679999876543 3455788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC---CCCEEEeecCCCcc
Q 023058 99 ASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKS 168 (288)
Q Consensus 99 ~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~---~~~~~l~df~~~~~ 168 (288)
+++++|.+++... ..++..++..++.|++.++.|||+.+++|+||+|+||+++.++ ...++|+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999888642 2378899999999999999999999999999999999998766 11499999998865
Q ss_pred cccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCC
Q 023058 169 SVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244 (288)
Q Consensus 169 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (288)
...... ......+..|+|||.+.+..++.+ +|+||||+++|+|++ |..||...+...... .+.. ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~ellt~g~~p~~~~~~~~~~~----~~~~-~~~~~~ 234 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQ-SDVWSFGVLMWEILTLGQQPYPALNNQEVLQ----HVTA-GGRLQK 234 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccc-hhHHHHHHHHHHHHHcCCCCCcccCHHHHHH----HHhc-CCccCC
Confidence 433221 122345678999999988877666 999999999999998 999997654322221 1111 112222
Q ss_pred CCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 245 YVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 245 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
...+|..+.++|.+||+.+|.+||++.++++.+.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 3367899999999999999999999999877543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=268.11 Aligned_cols=238 Identities=20% Similarity=0.188 Sum_probs=190.5
Q ss_pred eeeeccCceEEEEEEEcCCC----------cEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 27 RDIGSGNFGVARLMRDKKTE----------ELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~----------~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
+.||+|+||.||++.+..++ ..+++|.+.........+.+|+.++++++|||++++++++.. ...+++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46899999999999998766 357888776655446788899999999999999999999888 7789999
Q ss_pred eccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCC-----CEEEeecCCCcccc
Q 023058 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-----RLKICDFGYSKSSV 170 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~-----~~~l~df~~~~~~~ 170 (288)
||+++++|.+++.... .++...+..++.||+.||.|||+.|++|+||+|+||+++.++.. .++|+|||++....
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~ 159 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence 9999999999997766 78999999999999999999999999999999999999876621 49999999887543
Q ss_pred cCCCCCCCcCCCcccCCccccCc--ccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
. .....+...|+|||.+.+. .++.+ +|+||||+++++|++ |..||....... ...... .....+. .
T Consensus 160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~-~Di~slG~~~~~l~~~~~~p~~~~~~~~-~~~~~~----~~~~~~~--~ 228 (259)
T cd05037 160 S---REERVERIPWIAPECIRNGQASLTIA-ADKWSFGTTLLEICSNGEEPLSTLSSSE-KERFYQ----DQHRLPM--P 228 (259)
T ss_pred c---ccccccCCCccChhhhcCCCCCcchh-hHHHHHHHHHHHHHhCCCCCcccCCchh-HHHHHh----cCCCCCC--C
Confidence 3 2334456779999998776 45455 999999999999998 577786654222 111111 1111122 2
Q ss_pred CCHHHHHHHHHhcccCcCCcccccccccc
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
....+.++|.+||..+|.+|||+.++++.
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 23789999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=267.86 Aligned_cols=244 Identities=32% Similarity=0.482 Sum_probs=204.8
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+|++.+.||+|++|.||++.+..++..+++|.+.... .....+.+|+.++++++|+||+++.+++......++++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5899999999999999999999899999999987643 3334677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 99 ASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
+++++|..++.. ...++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~~-~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL--VKIGDLGISKVLKKN-M 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc--EEEeeccchhhhccC-C
Confidence 999999988865 346899999999999999999999999999999999999987666 999999998765444 3
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-CCCCCCCCCHHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPECR 253 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 253 (288)
.....+++.|++||.+.+..++.+ +|+||||+++++|++|..||...+..... ..+..... ..+. ..+.++.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~ 230 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLR----YKVQRGKYPPIPP--IYSQDLQ 230 (256)
T ss_pred cccccCCccccCHHHHCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCCCCCch--hhCHHHH
Confidence 334557889999999988777666 99999999999999999999766532222 22222222 2222 6789999
Q ss_pred HHHHHhcccCcCCccccccccc
Q 023058 254 HLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++|.+||+.+|.+|||+.++++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 231 NFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHHHHcCCCcccCCCHHHHhc
Confidence 9999999999999999988876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=269.04 Aligned_cols=254 Identities=35% Similarity=0.564 Sum_probs=222.5
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc----chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
.++|..++.||+|.||.|-+++.+.+++.||+|++++.-- ..+....|-+.|+..+||.+..+...|...+++++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4789999999999999999999999999999999887532 233456788999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc-ccCCC
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQ 174 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~-~~~~~ 174 (288)
|||.+||.|...+.+...+++...+.+...|+.||.|||+++||.||+|.+|.+++.+++ +||.|||++... ..+..
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhcccccce
Confidence 999999999988888888999999999999999999999999999999999999999998 999999999754 44556
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
.+..+|||.|+|||++....|... .|.|.+|+++|||++|..||...+....+.-+ .-....+|. .++++.+.
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgra-VDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI----l~ed~kFPr--~ls~eAkt 397 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRA-VDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI----LMEDLKFPR--TLSPEAKT 397 (516)
T ss_pred eccccCChhhcCchhhccccccce-eehhhhhHHHHHHHhccCcccccchhHHHHHH----HhhhccCCc--cCCHHHHH
Confidence 788899999999999999999887 99999999999999999999987765555444 445667777 79999999
Q ss_pred HHHHhcccCcCCccc--cccccccchhhhh
Q 023058 255 LISRIFVADPAKVSM--HFHATGVYMHTKL 282 (288)
Q Consensus 255 li~~~l~~~p~~Rpt--~~~~l~~~~~~~~ 282 (288)
|++-+|..||.+|.. ..++.++..|+++
T Consensus 398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF 427 (516)
T KOG0690|consen 398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFF 427 (516)
T ss_pred HHHHHhhcChHhhcCCCchhHHHHHhhhhh
Confidence 999999999999974 4455555555554
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=291.83 Aligned_cols=246 Identities=31% Similarity=0.516 Sum_probs=203.0
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEee-cCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCchH
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 105 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (288)
-.||.|.||+||.+++.++...+|||.+. +++...+-+.+|+.+.++++|.|||+++|.+..++.+-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 36899999999999999999999999875 44555667899999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCC--CHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc-ccCCCCCCCcCC
Q 023058 106 ERICNA-GRF--SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTVGT 181 (288)
Q Consensus 106 ~~~~~~-~~~--~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~-~~~~~~~~~~~~ 181 (288)
+++... +++ .+..+-.+.+||++||.|||++.|||||||-+||+|+.- .+-+||.|||-+.+. ....-..+..||
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy-SGvlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY-SGVLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec-cceEEecccccchhhccCCccccccccc
Confidence 999664 355 788889999999999999999999999999999999743 335999999988753 334445667899
Q ss_pred CcccCCccccCccc-CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH--HHhhcccCCCCCCCCCHHHHHHHHH
Q 023058 182 PAYIAPEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH--RILSVQYSIPDYVHISPECRHLISR 258 (288)
Q Consensus 182 ~~~~aPE~~~~~~~-~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~ 258 (288)
..|||||++..++- -.+++|||||||++.||.||.+||....+.. ..+. ++.+.-+..|. .++++.+.||.+
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---AAMFkVGmyKvHP~iPe--elsaeak~Filr 814 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---AAMFKVGMYKVHPPIPE--ELSAEAKNFILR 814 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---HhhhhhcceecCCCCcH--HHHHHHHHHHHH
Confidence 99999999865432 2444999999999999999999998765422 2222 22222234444 788999999999
Q ss_pred hcccCcCCccccccccc-cch
Q 023058 259 IFVADPAKVSMHFHATG-VYM 278 (288)
Q Consensus 259 ~l~~~p~~Rpt~~~~l~-~~~ 278 (288)
|+.++|.+||++.++++ +|+
T Consensus 815 cFepd~~~R~sA~~LL~DpFl 835 (1226)
T KOG4279|consen 815 CFEPDPCDRPSAKDLLQDPFL 835 (1226)
T ss_pred HcCCCcccCccHHHhccCccc
Confidence 99999999999999988 443
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=270.49 Aligned_cols=253 Identities=28% Similarity=0.379 Sum_probs=199.5
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc--chHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 93 (288)
....++|++.+.||+|++|.||++.+..++..|++|.+..... ....+..|+..+.+. +||||+++++++..+...+
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 90 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF 90 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence 3356899999999999999999999998899999999876432 234456677666666 5999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
++||++.+ ++..++.. ...++...+..++.|++.++.|||+ .|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 91 ~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~--~kL~dfg~~~~~~~ 167 (296)
T cd06618 91 ICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN--VKLCDFGISGRLVD 167 (296)
T ss_pred EEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC--EEECccccchhccC
Confidence 99999855 67666654 4578999999999999999999997 59999999999999987776 99999999875543
Q ss_pred CCCCCCCcCCCcccCCccccCcc----cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 172 HSQPKSTVGTPAYIAPEVLLKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
........+++.|+|||.+.+.. ++.+ +|+||||+++|+|++|..||...... ...............+....
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06618 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIR-ADVWSLGISLVELATGQFPYKNCKTE--FEVLTKILQEEPPSLPPNEG 244 (296)
T ss_pred CCcccCCCCCccccCHhhcCCCCCccccccc-hhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHhcCCCCCCCCCCC
Confidence 33333445678899999986543 4445 99999999999999999999753321 11111122222233333335
Q ss_pred CCHHHHHHHHHhcccCcCCccccccccc
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++.++.+||.+||+.||.+||++.+++.
T Consensus 245 ~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 7899999999999999999999988877
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=276.67 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=199.9
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcC-------CCcEEEEEEeecC--ccchHHHHHHHHHHhhC-CCCceeeEeEEEEc
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILT 88 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (288)
...+|.+.+.||+|+||.||.|++.. .+..+++|.+... ....+.+.+|+++++++ +||||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 34689999999999999999998642 2236899987643 23345788999999999 79999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC
Q 023058 89 PTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~ 152 (288)
.+..++++||+++++|.+++.... .++..++..++.|++.||.+||+.|++|+||+|+||+++.
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~ 169 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence 999999999999999999886532 3677889999999999999999999999999999999987
Q ss_pred CCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhH
Q 023058 153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (288)
Q Consensus 153 ~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~ 228 (288)
++. ++|+|||++........ .....++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||.........
T Consensus 170 ~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 170 DNV--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred CCc--EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 776 99999998864433221 111223457999999988888777 999999999999998 88888765432222
Q ss_pred HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
. .+.. ....+....++..+.++|.+||+.+|.+|||+.++++.+
T Consensus 247 ~----~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 247 K----LLKE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred H----HHHc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 2 2222 122222336788999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=267.57 Aligned_cols=241 Identities=30% Similarity=0.451 Sum_probs=192.0
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeecCccc----hHHHHHHH---HHHhhCCCCceeeEeEEEEcCCeEEEEEeccC
Q 023058 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREI---INHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (288)
Q Consensus 28 ~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~---~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (288)
.||+|+||.||++.+..+++.||+|.+...... .....+|. ..++...||+++++.+.+...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 379999999999999989999999998754211 11233333 33445579999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCcC
Q 023058 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (288)
Q Consensus 101 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 180 (288)
+++|...+...+.++...+..++.|++.|+.|||+.+++|+||+|+||+++.++. ++|+|||++...... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~~-~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCcc-CCcCcCC
Confidence 9999998888788999999999999999999999999999999999999987776 999999988644322 2234468
Q ss_pred CCcccCCccccCc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 023058 181 TPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259 (288)
Q Consensus 181 ~~~~~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 259 (288)
+..|+|||.+.+. .++.+ +|+||+|+++|+|++|..||........ .............++. .+++++.++|.+|
T Consensus 158 ~~~y~aPE~~~~~~~~~~~-~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~--~~s~~~~~li~~~ 233 (278)
T cd05606 158 THGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPD--SFSPELRSLLEGL 233 (278)
T ss_pred CcCCcCcHHhcCCCCCCcc-cchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHHhhccCCCCCC--cCCHHHHHHHHHH
Confidence 8999999998755 45555 9999999999999999999986643221 1222222223333443 5689999999999
Q ss_pred cccCcCCcc-----ccccccc
Q 023058 260 FVADPAKVS-----MHFHATG 275 (288)
Q Consensus 260 l~~~p~~Rp-----t~~~~l~ 275 (288)
|..+|.+|| ++.++++
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHh
Confidence 999999999 7777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=264.74 Aligned_cols=242 Identities=23% Similarity=0.318 Sum_probs=194.2
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCch
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 104 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 104 (288)
+.||+|++|.||++... ++..+++|.+.... .....+.+|++++++++|||++++++++...+..+++|||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46899999999999865 57889999876543 2234678899999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC--CCCcCC
Q 023058 105 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGT 181 (288)
Q Consensus 105 ~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~ 181 (288)
.+++... ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||++......... .....+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCc
Confidence 9888653 45789999999999999999999999999999999999987776 999999988643322111 112335
Q ss_pred CcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhc
Q 023058 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (288)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (288)
..|+|||.+.+..++.+ +|+||||+++|++++ |..||.......... .+.. .........++.++.+++.+||
T Consensus 158 ~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~li~~~l 231 (250)
T cd05085 158 IKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQARE----QVEK-GYRMSCPQKCPDDVYKVMQRCW 231 (250)
T ss_pred ccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH----HHHc-CCCCCCCCCCCHHHHHHHHHHc
Confidence 67999999887777666 999999999999998 999997654332222 2221 1122222368899999999999
Q ss_pred ccCcCCccccccccccc
Q 023058 261 VADPAKVSMHFHATGVY 277 (288)
Q Consensus 261 ~~~p~~Rpt~~~~l~~~ 277 (288)
+.+|.+||++.++++.+
T Consensus 232 ~~~p~~Rp~~~~l~~~l 248 (250)
T cd05085 232 DYKPENRPKFSELQKEL 248 (250)
T ss_pred ccCcccCCCHHHHHHHh
Confidence 99999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=278.06 Aligned_cols=253 Identities=22% Similarity=0.357 Sum_probs=197.7
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEE-----cCCCcEEEEEEeecCc--cchHHHHHHHHHHhhC-CCCceeeEeEEEEcC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (288)
...++|++.+.||.|+||+||+|.+ ..+++.||+|.+.... .....+.+|+.++.++ +|||++++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3457899999999999999999984 3457889999987543 2334678899999999 689999999987654
Q ss_pred -CeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 023058 90 -THLAIVMEYASGGELFERICNA--------------------------------------------------------- 111 (288)
Q Consensus 90 -~~~~lv~e~~~~~~L~~~~~~~--------------------------------------------------------- 111 (288)
...+++|||+++++|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 5688999999999999887542
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC---CCCC
Q 023058 112 ----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 178 (288)
Q Consensus 112 ----------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~---~~~~ 178 (288)
..++...+..++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++........ ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcchhhcCCC
Confidence 13577788889999999999999999999999999999987776 99999998875432211 1122
Q ss_pred cCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 023058 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257 (288)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (288)
.++..|+|||.+.+..++.+ +|+||||+++++|++ |..||............ +... ...+.....++++.+++.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~ 316 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR---LKEG-TRMRAPDYTTPEMYQTML 316 (343)
T ss_pred CCCcceECcHHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH---Hhcc-CCCCCCCCCCHHHHHHHH
Confidence 34567999999888777776 999999999999996 99999765433222222 1111 112222256889999999
Q ss_pred HhcccCcCCccccccccccc
Q 023058 258 RIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 258 ~~l~~~p~~Rpt~~~~l~~~ 277 (288)
+||+.+|.+|||+.++++.+
T Consensus 317 ~cl~~~p~~Rps~~eil~~l 336 (343)
T cd05103 317 DCWHGEPSQRPTFSELVEHL 336 (343)
T ss_pred HHccCChhhCcCHHHHHHHH
Confidence 99999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=267.18 Aligned_cols=244 Identities=22% Similarity=0.300 Sum_probs=187.7
Q ss_pred eeeeccCceEEEEEEEcC--CCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCC
Q 023058 27 RDIGSGNFGVARLMRDKK--TEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (288)
+.||+|+||.||++.... ++..+++|.+..... ....+.+|+.++++++|||++++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998643 456789998765432 2346788999999999999999999999988999999999999
Q ss_pred chHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC---
Q 023058 103 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 174 (288)
Q Consensus 103 ~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~--- 174 (288)
+|.+++.... ..+...+..++.|++.|+.|||+.|++|+||||+||+++.++. ++|+|||++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEECCccccccccCcceeec
Confidence 9999886432 3566778889999999999999999999999999999987766 99999998864322211
Q ss_pred CCCCcCCCcccCCccccCcc-------cCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCC--
Q 023058 175 PKSTVGTPAYIAPEVLLKKE-------YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD-- 244 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~-------~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 244 (288)
.....++..|+|||.+.+.. ++. ++|+||||+++++|++ |..||............. .......+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~-~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~ 234 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTK-ESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV---REQQLKLPKPR 234 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCc-cchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh---hcccCCCCCCc
Confidence 12234567899999886432 234 4999999999999996 999997765433322211 112222221
Q ss_pred -CCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 245 -YVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 245 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
....++.+.+++..|+ .+|.+|||+.+++..|
T Consensus 235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l 267 (269)
T cd05087 235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267 (269)
T ss_pred cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHh
Confidence 1246788999999999 6899999999987644
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=278.87 Aligned_cols=260 Identities=29% Similarity=0.397 Sum_probs=199.5
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcC---------
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP--------- 89 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------- 89 (288)
.++|.+.+.||.|++|.||++.+..+++.|++|.+.... ...+.+.+|++++++++|||++++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 589999999999999999999999999999999986644 3345688899999999999999998776543
Q ss_pred -----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecC
Q 023058 90 -----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (288)
Q Consensus 90 -----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~ 164 (288)
...++++||+++ +|...+.. ..++...++.++.||+.||.+||+.|++|+||+|+||+++.++. .++|+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~dfg 160 (342)
T cd07854 84 SLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFG 160 (342)
T ss_pred cccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCcc
Confidence 357899999974 88777754 46899999999999999999999999999999999999974432 38999999
Q ss_pred CCcccccCCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh----
Q 023058 165 YSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL---- 236 (288)
Q Consensus 165 ~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~---- 236 (288)
.+........ .....++..|+|||.+.+......++|+||||+++|+|++|..||.................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9865432211 12234678899999876544344459999999999999999999976554333222211100
Q ss_pred --------------h--c-ccCCC---CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 237 --------------S--V-QYSIP---DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 237 --------------~--~-~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
. . ....+ ....++.++.+||.+||+.||.+|||+.+++. |+|++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~---h~~~~~~ 306 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM---HPYMSCY 306 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC---CCccccc
Confidence 0 0 00000 01246789999999999999999999988866 6666543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=285.87 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=209.2
Q ss_pred CCCCCCe-eeeeeeeccCceEEEEEEEcCCCcEEEEEEee-----cCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCC
Q 023058 17 MHDSDRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-----RGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (288)
Q Consensus 17 ~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~-----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (288)
....++| +....||+|.|-+||+|.|..+|..||-..++ ......+++..|+.+|+.|+||||++++++|.+..
T Consensus 35 ~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~ 114 (632)
T KOG0584|consen 35 KDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD 114 (632)
T ss_pred cCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence 3344566 56788999999999999999999888766543 33455588999999999999999999999998875
Q ss_pred e--EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC--ceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 91 H--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 91 ~--~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
. ..+|+|.+..|+|..++.+.++.....++.|++||+.||.|||++. |+|||||.+||||+. ..+.+||+|+|+|
T Consensus 115 n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG-~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 115 NKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG-NLGEVKIGDLGLA 193 (632)
T ss_pred CceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC-CcCceeecchhHH
Confidence 4 8899999999999999999999999999999999999999999987 999999999999984 4457999999999
Q ss_pred cccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCC
Q 023058 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (288)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
........ ...+|||.|||||.+. ..|+.. .||||||++++||+|+..||...... .++++.+..+...-.-..
T Consensus 194 tl~r~s~a-ksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~---AQIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 194 TLLRKSHA-KSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNP---AQIYKKVTSGIKPAALSK 267 (632)
T ss_pred HHhhcccc-ceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCH---HHHHHHHHcCCCHHHhhc
Confidence 86655443 3488999999999986 778777 99999999999999999999866543 344445555443222222
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
=-++++++||.+||.. ..+|||+.|+|.
T Consensus 268 V~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 VKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 2368999999999988 999999988877
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=277.57 Aligned_cols=259 Identities=29% Similarity=0.421 Sum_probs=202.0
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcC--CeEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTP--THLA 93 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~ 93 (288)
.++|++.+.||+|++|.||++.+..++..+++|.+... ........+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 47899999999999999999999988999999988542 23334567899999999 999999999998654 3689
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
+|||++++ +|...+... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.......
T Consensus 86 lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELE 161 (337)
T ss_pred EEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhcccccc
Confidence 99999975 888888665 7888999999999999999999999999999999999988877 9999999887544332
Q ss_pred C------CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh----------
Q 023058 174 Q------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------- 237 (288)
Q Consensus 174 ~------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------- 237 (288)
. .....++..|+|||.+.+......++|+||||+++|+|++|..||..................
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 1 122347888999998866554445599999999999999999999765543332222111100
Q ss_pred -------------ccc-CC-CCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 238 -------------VQY-SI-PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 238 -------------~~~-~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
... .. .....++.++.++|.+||+.||.+|||+.++++ ++|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~---~~~~~~~ 301 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE---HPYVAQF 301 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh---Chhhhhh
Confidence 000 00 011236889999999999999999999988876 5555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=268.39 Aligned_cols=249 Identities=30% Similarity=0.433 Sum_probs=197.8
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---chHHHHHHHHHHhhC---CCCceeeEeEEEEcCCe-----
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSL---RHPNIVRFKEVILTPTH----- 91 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~----- 91 (288)
|++.+.||.|++|.||++.+..++..|++|.+..... ....+.+|+.+++++ +|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7889999999999999999998899999999875322 223455677777666 59999999999988776
Q ss_pred EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 92 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
.+++||++++ +|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIY 157 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC--EEEeccCcceec
Confidence 9999999975 7888776643 5899999999999999999999999999999999999998866 999999988765
Q ss_pred ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc-cCCC-----
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIP----- 243 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~----- 243 (288)
..........++..|+|||.+.+..++.+ +|+||+|+++++|++|..||......+............. ..++
T Consensus 158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 158 SFEMALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred cCCcccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 44433334457788999999988877766 9999999999999999999987665444444433211100 0000
Q ss_pred ------C---------CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 244 ------D---------YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 244 ------~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
. ...+++.+.++|.+||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 0134678899999999999999999987765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=278.03 Aligned_cols=257 Identities=25% Similarity=0.377 Sum_probs=200.8
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC----
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT---- 90 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 90 (288)
...++|++.+.||+|++|.||++.+..++..||+|.+.... .....+.+|+.++++++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34688999999999999999999999999999999886432 22346778999999999999999999987653
Q ss_pred --eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcc
Q 023058 91 --HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (288)
Q Consensus 91 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~ 168 (288)
.+++||+++ +++|..++.. ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~~~~ 167 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQ 167 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccccc
Confidence 468999998 6688877754 57899999999999999999999999999999999999987776 99999998875
Q ss_pred cccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh-----------
Q 023058 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS----------- 237 (288)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------- 237 (288)
... ......+++.|++||.+.+....+.++|+||||++++++++|..||...+..............
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 168 TDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred ccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 432 2233456888999999876443344499999999999999999999865543322222111000
Q ss_pred --------cccCC------CCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 238 --------VQYSI------PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 238 --------~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
..... .....+++++.++|.+||+.||.+|||+.+++. |+|++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~---~~~~~ 302 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA---HPYFE 302 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc---CccHh
Confidence 00000 001357888999999999999999999988876 44444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=269.00 Aligned_cols=253 Identities=15% Similarity=0.125 Sum_probs=190.8
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCC---CcEEEEEEeecCccch------------HHHHHHHHHHhhCCCCceee
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKID------------ENVQREIINHRSLRHPNIVR 81 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~------------~~~~~e~~~l~~l~~~~i~~ 81 (288)
....++|++.+.||+|+||.||++.+..+ +..+++|+........ .....++..+..+.|+|+++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 34568999999999999999999998877 6677777644322211 01122334455678999999
Q ss_pred EeEEEEcCC----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCC
Q 023058 82 FKEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (288)
Q Consensus 82 ~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~ 157 (288)
+++++.... ..+++++.... ++.+.+......+...+..++.|++.||++||+.|++||||||+||+++.++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~-- 164 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR-- 164 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--
Confidence 998776543 44677887644 67777766656788899999999999999999999999999999999987766
Q ss_pred EEEeecCCCcccccCCC--------CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH-
Q 023058 158 LKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF- 228 (288)
Q Consensus 158 ~~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~- 228 (288)
++|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++++|++|..||.........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~-~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR-GDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 99999999875432211 122358999999999988888766 99999999999999999999876433221
Q ss_pred HH----HHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCcccccccccc
Q 023058 229 RK----TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 229 ~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
.. ....+....... ..+++.+.+++..|+..+|.+||+..++.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~ 292 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKI 292 (294)
T ss_pred HHhHHHHHHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHh
Confidence 11 112222222222 2468999999999999999999999888764
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=312.98 Aligned_cols=248 Identities=30% Similarity=0.431 Sum_probs=211.9
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
-+|+....||.|.||.||.+.+.++|+..|+|.+.-. ....+.+.+|+.++..++|||+|+++++=.+.+.+++.||
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 3678889999999999999999999999999987643 3444568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC---
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 174 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~--- 174 (288)
||.+|+|.+.++.++-.++.-...+..|++.|+.|||+.|||||||||.||+++.++. +|++|||.+.......+
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCC
Confidence 9999999999998888888888889999999999999999999999999999999997 99999999976555432
Q ss_pred --CCCCcCCCcccCCccccCccc--CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh-hcccCCCCCCCCC
Q 023058 175 --PKSTVGTPAYIAPEVLLKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-SVQYSIPDYVHIS 249 (288)
Q Consensus 175 --~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 249 (288)
.....||+.|||||++.+... ...++|||||||++.||+||..||...+.+- .++..+. .-.+.+|+ .++
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~V~~gh~Pq~P~--~ls 1467 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYHVAAGHKPQIPE--RLS 1467 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhHHhccCCCCCch--hhh
Confidence 234569999999999987552 2345899999999999999999998765432 3333322 23346666 599
Q ss_pred HHHHHHHHHhcccCcCCccccccccc
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++-++||.+||..||.+|+++.|+++
T Consensus 1468 ~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1468 SEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 99999999999999999999988876
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=283.34 Aligned_cols=240 Identities=30% Similarity=0.429 Sum_probs=210.6
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccC
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (288)
+...-++.||.|..|-||+++.. ++.||||++. +....+|.=|++|+||||+.+.++|...-.+++|||||.
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLH--NETVAVKKVR------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred HHhhhhhhhccCcccceeeeecc--CceehhHHHh------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 44556889999999999999985 6789999754 234467888999999999999999999889999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCcC
Q 023058 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (288)
Q Consensus 101 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 180 (288)
.|.|...+.....++......|..+|+.|++|||...|+|||||.-||+|+.+.. +||+|||-++....-.......|
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaG 273 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAG 273 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhh
Confidence 9999999999999999999999999999999999999999999999999998887 99999999886655555667789
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhc
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 260 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (288)
|..|||||++.+.+-+.+ .||||||+++|||+||..||...+.... +.++-.....+|-+..+|+.++=||++||
T Consensus 274 TVaWMAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVdssAI----IwGVGsNsL~LpvPstcP~GfklL~Kqcw 348 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDSSAI----IWGVGSNSLHLPVPSTCPDGFKLLLKQCW 348 (904)
T ss_pred hHhhhCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccchhee----EEeccCCcccccCcccCchHHHHHHHHHH
Confidence 999999999988777776 9999999999999999999998765333 33445555667777789999999999999
Q ss_pred ccCcCCccccccccc
Q 023058 261 VADPAKVSMHFHATG 275 (288)
Q Consensus 261 ~~~p~~Rpt~~~~l~ 275 (288)
+-.|..||++.+++.
T Consensus 349 ~sKpRNRPSFrqil~ 363 (904)
T KOG4721|consen 349 NSKPRNRPSFRQILL 363 (904)
T ss_pred hcCCCCCccHHHHHH
Confidence 999999999998875
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=267.55 Aligned_cols=245 Identities=20% Similarity=0.331 Sum_probs=187.1
Q ss_pred eeeeccCceEEEEEEEcC--CCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCC
Q 023058 27 RDIGSGNFGVARLMRDKK--TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (288)
+.||+|+||.||++.... ....+++|.+.... .....+.+|+..++.++|+||+++++.+.....++++||+++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999996533 34578888765432 22345778999999999999999999999999999999999999
Q ss_pred chHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC---C
Q 023058 103 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---Q 174 (288)
Q Consensus 103 ~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~---~ 174 (288)
+|.+++.... ..+...+..++.||+.||+|||+.|++|+||||+||+++.++. ++|+|||++....... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheec
Confidence 9999986643 2467788899999999999999999999999999999988776 9999999886432221 1
Q ss_pred CCCCcCCCcccCCccccCc------ccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCC---
Q 023058 175 PKSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD--- 244 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 244 (288)
.....+++.|+|||.+... .....++|+||||+++|+|++ |..||............. ......++.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~ 235 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV---REQDIKLPKPQL 235 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh---hccCccCCCCcc
Confidence 1223356679999987432 222445999999999999998 788887665433333322 222222221
Q ss_pred CCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 245 YVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 245 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
...++..+.+++..|+ .||.+|||+.++++.+
T Consensus 236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 2357888999999998 6999999999988754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=270.24 Aligned_cols=252 Identities=20% Similarity=0.333 Sum_probs=200.2
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCc----EEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
+..++|++.+.||+|+||.||++.+..++. .+++|.+..... ....+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 456889999999999999999999877665 468887765432 223577899999999999999999998654 4
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.+++++++++++|.+.+.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~ 160 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLE 160 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEcccccccccc
Confidence 678999999999999887644 5899999999999999999999999999999999999987776 9999999987543
Q ss_pred cCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCC
Q 023058 171 LHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (288)
Q Consensus 171 ~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
.... ......+..|++||.+.+..++.+ +|+||||+++|++++ |..||..... ..... ........+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~----~~~~~~~~~~~~ 234 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPT-REIPD----LLEKGERLPQPP 234 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHH----HHHCCCCCCCCC
Confidence 2221 112234568999999887777666 999999999999997 8899976432 11222 222233333344
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
..+.++.+++.+|+..+|.+||++.+++..+.
T Consensus 235 ~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~ 266 (303)
T cd05110 235 ICTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266 (303)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 67899999999999999999999999887443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=268.80 Aligned_cols=241 Identities=17% Similarity=0.186 Sum_probs=189.8
Q ss_pred eeeeccCceEEEEEEEcCCCc-------EEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 27 RDIGSGNFGVARLMRDKKTEE-------LVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~-------~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+.||.|+||.||++.+...+. .+++|.+.... ...+.+.+|..+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 468999999999999865443 48888775443 3345678899999999999999999999998999999999
Q ss_pred cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCC------CEEEeecCCCccccc
Q 023058 99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP------RLKICDFGYSKSSVL 171 (288)
Q Consensus 99 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~------~~~l~df~~~~~~~~ 171 (288)
+++++|..++...+ .++...+..++.||+.||+|||+.|++|+||||+||+++.++.. .++++|||.+.....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 99999999987644 58999999999999999999999999999999999999766542 379999998764432
Q ss_pred CCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCC-CCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
.....+++.|+|||.+.+......++|+||||+++|+|++|. .||...+... ... ........+. ..+.
T Consensus 161 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-~~~----~~~~~~~~~~--~~~~ 230 (258)
T cd05078 161 ---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-KLQ----FYEDRHQLPA--PKWT 230 (258)
T ss_pred ---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-HHH----HHHccccCCC--CCcH
Confidence 223456778999999876543334499999999999999985 5655433221 111 1222333443 4568
Q ss_pred HHHHHHHHhcccCcCCccccccccccc
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
++.++|.+||+.+|.+|||+.++++.+
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 899999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=268.32 Aligned_cols=250 Identities=31% Similarity=0.464 Sum_probs=199.6
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc--chHHHHHHHHHHhhCC-CCceeeEeEEEEcCCeEEEEEecc
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
|.+.+.||.|++|+||++....+++.+++|.+..... ......+|+..+++++ |+|++++++++..++..++|||++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 6789999999999999999998899999998865432 2234567899999998 999999999999999999999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCC
Q 023058 100 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (288)
Q Consensus 100 ~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (288)
+++|.+.+.... .++..++..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+...........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCC
Confidence 668888887654 7899999999999999999999999999999999999988776 99999999876555444444
Q ss_pred CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh---------------cccCC
Q 023058 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYSI 242 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~ 242 (288)
..++..|+|||.+.+......++|+||||+++++|++|..||......+...+....... .....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 567888999998865443344599999999999999999999766544433322211000 00000
Q ss_pred CC---------CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 243 PD---------YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 243 ~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+. ....+.++.++|.+||+.+|.+|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00 0123688999999999999999999988866
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=275.00 Aligned_cols=253 Identities=22% Similarity=0.317 Sum_probs=191.4
Q ss_pred eeeecc--CceEEEEEEEcCCCcEEEEEEeecCcc---chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 27 RDIGSG--NFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 27 ~~lg~g--~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
..||.| ++++||.+++..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++..++..++++|++.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 899999999999999999999875432 235678899999999999999999999999999999999999
Q ss_pred CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC----
Q 023058 102 GELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---- 175 (288)
Q Consensus 102 ~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~---- 175 (288)
+++..++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++. +++.||+.+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--VSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc--EEEechHHHhhhhccCcccccc
Confidence 9999888764 34899999999999999999999999999999999999987776 999999754322111111
Q ss_pred ----CCCcCCCcccCCccccCc--ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH--------------
Q 023058 176 ----KSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-------------- 235 (288)
Q Consensus 176 ----~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~-------------- 235 (288)
....++..|++||.+.+. .++.. +|+||+|+++++|++|..||................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVK-SDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 112245569999998764 34444 999999999999999999997654322211111000
Q ss_pred ---------------------------hhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc-cchhhhh
Q 023058 236 ---------------------------LSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG-VYMHTKL 282 (288)
Q Consensus 236 ---------------------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~~~~ 282 (288)
.......+.....++.+.+||.+||+.||.+|||+.++++ .|++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 0000011112235678999999999999999999988876 4444433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=296.89 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=211.4
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCc-----EEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (288)
...++-...+.||+|.||+||.++..+... .||+|.+.+. ......+.+|..+++.++|||||+++|++.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 445788999999999999999999865333 3899988875 444567999999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeec
Q 023058 91 HLAIVMEYASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df 163 (288)
..++++|||.+|+|..++.+. ..+...+++.++.+|++|.+||+++++|||||...|+|++.... +|++||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~--VKIaDF 846 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV--VKIADF 846 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc--EEEccc
Confidence 999999999999999999876 24899999999999999999999999999999999999987755 999999
Q ss_pred CCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcc
Q 023058 164 GYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQ 239 (288)
Q Consensus 164 ~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (288)
|+++....... .........|||||.+..+.++++ +||||||+++||+++ |..||...+..+..... ..+.
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~~~----~~gg 921 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV----LEGG 921 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH----HhCC
Confidence 99983332222 122234468999999999999998 999999999999998 88999987664444333 2223
Q ss_pred cCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 240 YSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.++.+..+|+.+.+++..||+.+|.+||+...+++
T Consensus 922 -RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 -RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 55555589999999999999999999999998887
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=264.03 Aligned_cols=241 Identities=20% Similarity=0.213 Sum_probs=185.8
Q ss_pred eeeeccCceEEEEEEEcCC------------CcEEEEEEeecCcc-chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 27 RDIGSGNFGVARLMRDKKT------------EELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~------------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
+.||.|++|.||++..... ...+++|.+..... ....+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999985422 23588888765432 3346778899999999999999999999988999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCC-----CCEEEeecCCCc
Q 023058 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-----PRLKICDFGYSK 167 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~-----~~~~l~df~~~~ 167 (288)
++|||+++++|..++.. ...++...++.++.||+.|+.|||+.|++|+||+|+||+++.++. ..++++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 99999999999888765 356899999999999999999999999999999999999975543 138999999876
Q ss_pred ccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHH-hCCCCCCCCCCchhHHHHHHHHhhcccCCCCCC
Q 023058 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (288)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
.... .....++..|+|||.+.+......++|+||||+++|+|+ .|..||........ .. ........ ..
T Consensus 161 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~----~~~~~~~~--~~ 230 (262)
T cd05077 161 TVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ER----FYEGQCML--VT 230 (262)
T ss_pred cccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HH----HHhcCccC--CC
Confidence 4322 123446778999998864443334499999999999997 58888865432211 11 11222222 12
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
..++++.++|.+||+.||.+||+..++++.+
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 3568899999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=278.77 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=199.2
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe---
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH--- 91 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--- 91 (288)
...++|++.+.||+|++|.||++.+..++..|++|++... ....+.+.+|+.++++++|+|++++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3468999999999999999999999999999999988653 2233567789999999999999999988766544
Q ss_pred ---EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcc
Q 023058 92 ---LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (288)
Q Consensus 92 ---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~ 168 (288)
.++|++++ +++|.+++.. ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~ 167 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARH 167 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEcccccccc
Confidence 89999999 5589888765 56899999999999999999999999999999999999987776 99999999875
Q ss_pred cccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc---------
Q 023058 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------- 239 (288)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------- 239 (288)
.... .....++..|+|||.+.+......++|+||||+++|++++|..||....................
T Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (343)
T cd07851 168 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245 (343)
T ss_pred cccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence 4322 33345678899999986543334449999999999999999999986654333332221110000
Q ss_pred ----------c-----CC-CCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 240 ----------Y-----SI-PDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 240 ----------~-----~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
. .+ ......++++.++|.+||+.+|.+|||+.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0 00 001235889999999999999999999988866
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=303.77 Aligned_cols=258 Identities=30% Similarity=0.465 Sum_probs=218.5
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeec----CccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER----GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
.+.|.+++.||.|+||.|.+++++.+++.||+|++.+ .....+-+..|-.++.--+.+=|+.++..|.++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 4789999999999999999999999999999999875 234445677888888888889999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~- 174 (288)
|+|++||+|..++....++|+...+.++..|+-||..||+.|+|||||||+||+++..|+ ++|.|||.+-.....+.
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCCcE
Confidence 999999999999999889999999999999999999999999999999999999998887 99999998876665444
Q ss_pred -CCCCcCCCcccCCcccc----C-cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCC
Q 023058 175 -PKSTVGTPAYIAPEVLL----K-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 175 -~~~~~~~~~~~aPE~~~----~-~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
+....|||.|.+||++. + +.|+.. .|.||+|+++|||+.|..||....-...+.+++.- ...+.||+...+
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~e-cDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h--k~~l~FP~~~~V 308 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRE-CDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH--KESLSFPDETDV 308 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCc-cchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch--hhhcCCCccccc
Confidence 45677999999999985 2 556666 89999999999999999999875554444444332 235688877789
Q ss_pred CHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
|.+.++||.+++ .+|..|..-.-+-++-.|+||.
T Consensus 309 SeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~ 342 (1317)
T KOG0612|consen 309 SEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFE 342 (1317)
T ss_pred CHHHHHHHHHHh-cChhhhcccccHHHHHhCcccc
Confidence 999999999999 7899999933333334455543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=272.00 Aligned_cols=257 Identities=27% Similarity=0.408 Sum_probs=197.5
Q ss_pred CeeeeeeeeccCceEEEEEEEcCC--CcEEEEEEeecC---ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcC----Ce
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKT--EELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTP----TH 91 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~--~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~----~~ 91 (288)
+|.+.+.||+|+||.||++.+..+ +..||+|.+... ....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999877 889999987643 22245677899999999 599999999875432 45
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
.+++++++. ++|...+.....++...++.++.||+.||++||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSE 157 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccc
Confidence 789999885 589988887788999999999999999999999999999999999999988776 99999999875433
Q ss_pred CCC-----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh----------
Q 023058 172 HSQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL---------- 236 (288)
Q Consensus 172 ~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~---------- 236 (288)
... .....+++.|+|||.+.+......++|+||+|++++++++|..||...+.............
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 221 12235788899999876643333449999999999999999999976553332222211100
Q ss_pred -------------hcc-cCCC-CCCCCCHHHHHHHHHhcccCcCCccccccccc-cchhhh
Q 023058 237 -------------SVQ-YSIP-DYVHISPECRHLISRIFVADPAKVSMHFHATG-VYMHTK 281 (288)
Q Consensus 237 -------------~~~-~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~~~ 281 (288)
... ..++ .....+..+.+++.+||+.||.+|||+.+++. .|+..|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 000 0000 11245789999999999999999999988876 444433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=267.66 Aligned_cols=244 Identities=27% Similarity=0.404 Sum_probs=197.3
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
+.|...+.||+|++|.||++.+..++..+++|.+.... .....+.+|+++++.++|||++++++++......+++|
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 45777889999999999999999899999999987532 22346778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
||+.+ ++.+.+.. ..+++..++..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++... ...
T Consensus 101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~---~~~ 174 (313)
T cd06633 101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKS---SPA 174 (313)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCccc---CCC
Confidence 99965 67666654 456899999999999999999999999999999999999987776 999999987632 222
Q ss_pred CCCcCCCcccCCcccc---CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 176 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
....++..|+|||.+. +..++.. +|+||||+++++|++|..||...+......... ...........++..+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~-sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l 249 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNDSPTLQSNEWTDSF 249 (313)
T ss_pred CCccccccccChhhccccCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----hcCCCCCCccccCHHH
Confidence 3456788899999974 2344444 999999999999999999997765433333221 1111111222567889
Q ss_pred HHHHHHhcccCcCCccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+++.+||+.+|.+||++.+++.
T Consensus 250 ~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 250 RGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999988876
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=266.49 Aligned_cols=239 Identities=21% Similarity=0.242 Sum_probs=186.3
Q ss_pred eeeccCceEEEEEEEcC------------------------CCcEEEEEEeecCcc-chHHHHHHHHHHhhCCCCceeeE
Q 023058 28 DIGSGNFGVARLMRDKK------------------------TEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRF 82 (288)
Q Consensus 28 ~lg~g~~~~v~~~~~~~------------------------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~ 82 (288)
.||+|+||.||++.... ....+++|.+..... ....+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 68999999999987532 124588888765432 23467788999999999999999
Q ss_pred eEEEEcCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCC-----C
Q 023058 83 KEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-----P 156 (288)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~-----~ 156 (288)
++++......++||||+++++|..++.. .+.++...+..++.|++.||+|||++|++|+||+|+||+++..+. .
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 9999999999999999999999888865 457899999999999999999999999999999999999975432 2
Q ss_pred CEEEeecCCCcccccCCCCCCCcCCCcccCCccccCcc-cCCCccchhhHHHHHHHHH-hCCCCCCCCCCchhHHHHHHH
Q 023058 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHR 234 (288)
Q Consensus 157 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~~~~l~-~g~~pf~~~~~~~~~~~~~~~ 234 (288)
.++++|||.+...... ....++..|+|||.+.+.. ++.+ +|+||||+++|+++ +|..||........ ...
T Consensus 162 ~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~--- 233 (274)
T cd05076 162 FIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTA-ADKWSFGTTLLEICFDGEVPLKERTPSEK-ERF--- 233 (274)
T ss_pred eeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcH-HHHHHHHHHHHHHHhCCCCCccccChHHH-HHH---
Confidence 3799999987533221 2234677899999886643 4444 99999999999984 78999976543222 111
Q ss_pred HhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 235 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.......+. ..++++.++|.+||+.+|.+|||+.++++.+
T Consensus 234 -~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 234 -YEKKHRLPE--PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -HHhccCCCC--CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 112222333 3567899999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=275.24 Aligned_cols=255 Identities=26% Similarity=0.419 Sum_probs=197.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcC------C
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 90 (288)
.++|.+.+.||+|++|.||+|.+..+++.||+|.+... ......+.+|+.++++++||||+++.+++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999999888999999998653 22335678899999999999999999998754 2
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.++++++++.. +|.... ...++...+..++.|++.||++||+.|++||||+|+||+++.++. ++|+|||++....
T Consensus 94 ~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~~ 168 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHAD 168 (342)
T ss_pred eEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCCC
Confidence 46999999864 666554 346899999999999999999999999999999999999988776 9999999987432
Q ss_pred cCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh--------------
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-------------- 236 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------- 236 (288)
. ......+++.|+|||.+.+......++|+||||+++++|++|..||...+.............
T Consensus 169 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 169 A--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred C--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 2 223345678899999987644334449999999999999999999986543333322221100
Q ss_pred -----hcccCCCC------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 237 -----SVQYSIPD------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 237 -----~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
......+. ....++++.++|.+||+.||.+||++.+++. |+|++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~---h~~f~~ 302 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE---HPYFDS 302 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc---Ccchhh
Confidence 00000000 1246788999999999999999999988876 555443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=267.75 Aligned_cols=245 Identities=27% Similarity=0.403 Sum_probs=199.5
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
.+.|...+.||+|+||.||++.+..++..+++|.+.... .....+.+|++.+++++|||++++++++..+...++|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 356899999999999999999999899999999987542 2234678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
|||+.+ ++.+.+.. ..+++..++..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~~--- 177 (317)
T cd06635 104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIASP--- 177 (317)
T ss_pred EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccCC---
Confidence 999976 67666644 456899999999999999999999999999999999999987776 99999998764322
Q ss_pred CCCCcCCCcccCCcccc---CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 175 PKSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
.....+++.|+|||.+. ...++.+ +|+||+|+++++|++|..||............ ............+++.
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 252 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPTLQSNEWSDY 252 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----HhccCCCCCCccccHH
Confidence 23446788899999974 3345455 99999999999999999999765433322222 2222222223357889
Q ss_pred HHHHHHHhcccCcCCccccccccc
Q 023058 252 CRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++++|.+||+.+|.+||++.+++.
T Consensus 253 l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 253 FRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred HHHHHHHHccCCcccCcCHHHHHh
Confidence 999999999999999999998887
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=273.42 Aligned_cols=255 Identities=25% Similarity=0.430 Sum_probs=198.5
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcC------
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------ 89 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 89 (288)
..++|.+.+.||+|+||.||++.+..++..||+|++.... ...+.+.+|+.++++++||||+++.+++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 4589999999999999999999998899999999987542 2235677899999999999999999988643
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
...+++++++ +++|.+.+.. ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~ 170 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT 170 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEecccccccc
Confidence 3467888887 6688877754 46899999999999999999999999999999999999988776 999999998743
Q ss_pred ccCCCCCCCcCCCcccCCccccCc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh------------
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL------------ 236 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~------------ 236 (288)
. .......++..|+|||.+.+. .++.+ +|+||||+++++|++|..||...+.............
T Consensus 171 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 171 D--DEMTGYVATRWYRAPEIMLNWMHYNQT-VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred c--ccccccccCCCccCHHHHhCccCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 2 223344678889999988664 34444 9999999999999999999976544333222211100
Q ss_pred -------hcccCCCC------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 237 -------SVQYSIPD------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 237 -------~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
......+. ....++++.++|.+||+.||.+||++.++++ |+|++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~---h~~f~ 304 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA---HAYFA 304 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc---Chhhh
Confidence 00000000 1245788999999999999999999988766 55554
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=262.84 Aligned_cols=246 Identities=22% Similarity=0.286 Sum_probs=189.9
Q ss_pred eeeeccCceEEEEEEEcC---CCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEE-cCCeEEEEEeccC
Q 023058 27 RDIGSGNFGVARLMRDKK---TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYAS 100 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~ 100 (288)
+.||+|+||.||++.+.. .+..+++|.+.... ...+.+.+|+.+++.++|||++++++++. .+...+++++|+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 34679999875432 23456778999999999999999999765 4556899999999
Q ss_pred CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-----C
Q 023058 101 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----Q 174 (288)
Q Consensus 101 ~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-----~ 174 (288)
+++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecc
Confidence 99999998654 35677888999999999999999999999999999999987776 9999999886443211 1
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhC-CCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
.....++..|+|||.+.+..++.+ +|+||||+++|+|++| ..||...+... ....+.... ..+.....|+.+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~ 232 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFD----ITVYLLQGR-RLLQPEYCPDPLY 232 (262)
T ss_pred cccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHhcCC-CCCCCCcCCHHHH
Confidence 112234568999999887777666 9999999999999995 55565433222 222222221 2222235789999
Q ss_pred HHHHHhcccCcCCccccccccccchhh
Q 023058 254 HLISRIFVADPAKVSMHFHATGVYMHT 280 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~~~~~~ 280 (288)
+++.+||+.+|.+||++.++++.+.+.
T Consensus 233 ~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 233 EVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 999999999999999999998865543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=269.63 Aligned_cols=256 Identities=28% Similarity=0.457 Sum_probs=198.2
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEc-CCeEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 93 (288)
...++|++.+.||.|+||.||++.+..+++.+++|.+... ....+.+.+|+.++++++|||++++.+++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 3568899999999999999999999999999999987542 2334567889999999999999999999876 45789
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
+++|++. ++|..++.. ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 87 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~~~-- 160 (328)
T cd07856 87 FVTELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQDP-- 160 (328)
T ss_pred EEeehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC--EEeCccccccccCC--
Confidence 9999984 588877754 46788899999999999999999999999999999999987766 99999998874322
Q ss_pred CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH------------------
Q 023058 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI------------------ 235 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~------------------ 235 (288)
......+++.|+|||.+.+......++|+||||+++|+|++|..||................
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 22234567789999987664433444999999999999999999997654322111111000
Q ss_pred --hhcc--cCCC---CCCCCCHHHHHHHHHhcccCcCCccccccccc-cchh
Q 023058 236 --LSVQ--YSIP---DYVHISPECRHLISRIFVADPAKVSMHFHATG-VYMH 279 (288)
Q Consensus 236 --~~~~--~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~ 279 (288)
.... ...+ ....+++.+.++|.+||+.+|.+|||+.+++. .++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~ 292 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccc
Confidence 0000 0001 01246789999999999999999999988877 4443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=267.36 Aligned_cols=249 Identities=33% Similarity=0.514 Sum_probs=200.7
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
|++.+.||+|++|.||++.+..+++.+++|.+... ....+.+.+|+.++++++|+|++++++++...+..++++|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 67889999999999999999999999999998764 333456788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CCCC
Q 023058 100 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (288)
Q Consensus 100 ~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~~~ 177 (288)
++ +|.+++... ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccccCc
Confidence 75 899988776 57999999999999999999999999999999999999988776 9999999887544332 2223
Q ss_pred CcCCCcccCCccccCc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh-----------c---ccCC
Q 023058 178 TVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-----------V---QYSI 242 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------~---~~~~ 242 (288)
...+..|+|||.+.+. .++.+ +|+||||++++++++|..||...+......+....... . ...+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred cccCcCcCChHHhcCCcCCCcc-ccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 4456789999998766 44444 99999999999999999999876544333332221100 0 0001
Q ss_pred CC---------CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 243 PD---------YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 243 ~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+. ....+..+.++|.+||+.||.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 10 1134788999999999999999999977755
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=263.77 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=194.1
Q ss_pred eeeeeeeeccCceEEEEEEEc---CCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC------
Q 023058 23 YELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 90 (288)
|.+.+.||+|++|.||++... .++..+++|.+.... ...+.+.+|++++++++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 356889999987542 33456788999999999999999999886542
Q ss_pred eEEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecC
Q 023058 91 HLAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~ 164 (288)
..+++++++.+++|..++... ..++...+..++.|++.|++|||+.|++|+||+|+||+++.++. ++|+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECccc
Confidence 247889999999998776432 14788999999999999999999999999999999999987766 9999999
Q ss_pred CCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhccc
Q 023058 165 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQY 240 (288)
Q Consensus 165 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (288)
++........ .....+.+.|++||.+.+..++.+ +|+||||+++|+|++ |..||...+.... ...+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~p~~~~~~~~~----~~~~~~~~- 232 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEI----YNYLIKGN- 232 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCCCCCCCCHHHH----HHHHHcCC-
Confidence 8875433221 122334567999999887777666 999999999999998 8888876543222 22222221
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 241 SIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 241 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
........+..+.+++.+||+.+|.+|||+.++++.+.
T Consensus 233 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~ 270 (273)
T cd05074 233 RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270 (273)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 12222357899999999999999999999999877553
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=260.25 Aligned_cols=247 Identities=21% Similarity=0.271 Sum_probs=185.8
Q ss_pred eeeeccCceEEEEEEEcCC--CcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCC
Q 023058 27 RDIGSGNFGVARLMRDKKT--EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 102 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~--~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (288)
+.||+|+||.||++....+ ...+++|.+.... ...+.+.+|+..++.++|||++++++.+......+++|||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3689999999999975432 3456677665433 33457889999999999999999999999999999999999999
Q ss_pred chHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC---CC
Q 023058 103 ELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QP 175 (288)
Q Consensus 103 ~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~---~~ 175 (288)
+|.+++... ..++...+..++.||+.||+|||+.+++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcc
Confidence 999988753 24667788899999999999999999999999999999987776 9999999875322211 12
Q ss_pred CCCcCCCcccCCccccCc-------ccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 176 KSTVGTPAYIAPEVLLKK-------EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
....++..|+|||.+... .++ .++|+||||+++|+|++ |..||...+........................
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQT-KPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP 237 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence 234567889999987532 223 34999999999999996 567886655433333332221111111111224
Q ss_pred CCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.++.+.+++..|+ .+|.+||++.++++.+
T Consensus 238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 238 YSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred CcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 7889999999999 7899999999987644
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=266.72 Aligned_cols=246 Identities=26% Similarity=0.398 Sum_probs=197.8
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
..+.|...+.||.|++|.||++.+..++..+++|.+.... ....++.+|+++++.++|+|++++.+++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 3466889999999999999999999899999999886432 223457789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 95 VMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 95 v~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
||||+.+ ++.+.+. ....++..++..++.|++.++.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 93 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~-- 167 (308)
T cd06634 93 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP-- 167 (308)
T ss_pred EEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc--EEECCcccceeecC--
Confidence 9999965 7766664 3456899999999999999999999999999999999999987766 99999998764432
Q ss_pred CCCCCcCCCcccCCccccC---cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 174 QPKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
.....+++.|+|||.+.+ ...+.+ +|+||||+++++|++|..||...+........ .............+.
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ 241 (308)
T cd06634 168 -ANXFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPALQSGHWSE 241 (308)
T ss_pred -cccccCCccccCHHHHhhcccCCCCcc-cchHHHHHHHHHHHcCCCCCccccHHHHHHHH----hhcCCCCcCcccccH
Confidence 233457788999999753 334444 99999999999999999998765432222221 122222222235788
Q ss_pred HHHHHHHHhcccCcCCccccccccc
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+.++|.+||+.+|.+||++.+++.
T Consensus 242 ~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 242 YFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred HHHHHHHHHhhCCcccCCCHHHHhh
Confidence 9999999999999999999988876
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=262.09 Aligned_cols=244 Identities=31% Similarity=0.475 Sum_probs=196.0
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC------ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
+|.+.+.||.|++|.||++.+..++..+++|..+.. .........|+.++++++|||++++++++......+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 689999999999999999999877766777765431 12223466788999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 96 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
+||+++++|.+.+.. ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++. +. ++|+|||.+.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~--~~l~d~g~~~~~~~ 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NL--LKIGDFGVSRLLMG 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CC--EeecccCceeecCC
Confidence 999999999887753 346899999999999999999999999999999999999974 33 99999998865433
Q ss_pred CCC-CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-ccCCCCCCCCC
Q 023058 172 HSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHIS 249 (288)
Q Consensus 172 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 249 (288)
... .....+++.|++||.+.+..++.+ +|+||+|+++++|++|..||....... ........ ....+ ..++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~~~--~~~~ 230 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLS----VVLRIVEGPTPSLP--ETYS 230 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHHcCCCCCCc--chhc
Confidence 222 234457888999999877777666 999999999999999999996543222 22222222 22233 2678
Q ss_pred HHHHHHHHHhcccCcCCccccccccc
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.++.++|.+||+.+|.+||++.++++
T Consensus 231 ~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 231 RQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 99999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=268.41 Aligned_cols=246 Identities=24% Similarity=0.392 Sum_probs=188.6
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCchHHHHH
Q 023058 33 NFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 109 (288)
Q Consensus 33 ~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 109 (288)
+++.||+++...+++.||+|++... ....+.+.+|++.+++++|+||+++++++...+..+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 5566777777778999999998754 3444678899999999999999999999999999999999999999999887
Q ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC--------CCCCc
Q 023058 110 NA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTV 179 (288)
Q Consensus 110 ~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~--------~~~~~ 179 (288)
.. ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++. +++.||+.+........ .....
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeecccccccccccccccccc
Confidence 53 45899999999999999999999999999999999999987776 99999998764332211 12234
Q ss_pred CCCcccCCccccCc--ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc------------------
Q 023058 180 GTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------------------ 239 (288)
Q Consensus 180 ~~~~~~aPE~~~~~--~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------ 239 (288)
++..|+|||.+.+. .++.+ +|+||+|+++++|++|..||....................
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~-~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEK-SDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRS 248 (314)
T ss_pred ccccccCHHHhcCCCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccc
Confidence 56789999998653 35555 9999999999999999999986543222111111000000
Q ss_pred ----------cCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 240 ----------YSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 240 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
.........+.++.+|+.+||+.||.+|||+.++++ |+|+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~---~p~~~~ 300 (314)
T cd08216 249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN---HSFFKQ 300 (314)
T ss_pred cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc---CchHhh
Confidence 000001123467899999999999999999998877 555443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=294.32 Aligned_cols=250 Identities=30% Similarity=0.445 Sum_probs=193.8
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEcC---------
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP--------- 89 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------- 89 (288)
..|+.++.||+||||.||+++++-+|+.||||++... .....++.+|+..+.+++|||+|+++..+...
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 5678899999999999999999999999999999765 55556799999999999999999986332100
Q ss_pred --------------------------------------------------------------------------------
Q 023058 90 -------------------------------------------------------------------------------- 89 (288)
Q Consensus 90 -------------------------------------------------------------------------------- 89 (288)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ------------------------------CeEEEEEeccCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHhhcCc
Q 023058 90 ------------------------------THLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQV 138 (288)
Q Consensus 90 ------------------------------~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~i~~~i~~~l~~LH~~~i 138 (288)
..+|+-||||+..++.+++..+... .....|+++++|+.||.|+|++||
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 1167889999887777766554433 578999999999999999999999
Q ss_pred eecCCCCCceEecCCCCCCEEEeecCCCcccc-------------------cCCCCCCCcCCCcccCCccccCcc---cC
Q 023058 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-------------------LHSQPKSTVGTPAYIAPEVLLKKE---YD 196 (288)
Q Consensus 139 ~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~~~---~~ 196 (288)
+||||||.|||++.+.. |||+|||+++... .........||-.|.|||.+.+.. |+
T Consensus 719 IHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred eeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999997777 9999999987411 001112345888999999997655 77
Q ss_pred CCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCC--CCCCHHHHHHHHHhcccCcCCcccccccc
Q 023058 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY--VHISPECRHLISRIFVADPAKVSMHFHAT 274 (288)
Q Consensus 197 ~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~~l 274 (288)
.+ .|+||||++++||+ .||... .........+..+..+.+.. .+-=+.-..+|.+|++.||++|||+.|+|
T Consensus 797 ~K-iDmYSLGIVlFEM~---yPF~Ts---MERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 797 SK-IDMYSLGIVLFEML---YPFGTS---MERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred ch-hhhHHHHHHHHHHh---ccCCch---HHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence 77 99999999999998 456544 33344444545555554411 01123466899999999999999999998
Q ss_pred c-cchh
Q 023058 275 G-VYMH 279 (288)
Q Consensus 275 ~-~~~~ 279 (288)
. .++.
T Consensus 870 ~s~llp 875 (1351)
T KOG1035|consen 870 NSELLP 875 (1351)
T ss_pred hccCCC
Confidence 8 5544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=274.38 Aligned_cols=245 Identities=32% Similarity=0.463 Sum_probs=205.3
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEEe
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
....|.+...+|.|+|+.|-.+.+..++..+++|++.... ....+|+.++... +|||++++.+.+.++...|+|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 4578999999999999999999999999999999988762 2445677555555 79999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEec-CCCCCCEEEeecCCCcccccCCCCC
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~-~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
.+.++-+.+.+-..+.+. .++..|+.+|+.++.|||+.|++||||+|+||+++ +.++ ++|+|||.++..... ..
T Consensus 397 ~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~--lrltyFG~a~~~~~~--~~ 471 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGH--LRLTYFGFWSELERS--CD 471 (612)
T ss_pred hccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCc--EEEEEechhhhCchh--hc
Confidence 999988877776655444 77788999999999999999999999999999995 5555 999999998865554 55
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (288)
...-|..|.|||+.....++.. +|+||||+++|+|++|..||...... ..+...+.....+ ..+|+..++||
T Consensus 472 tp~~t~~y~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s----~~vS~~AKdLl 543 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS----ECVSDEAKDLL 543 (612)
T ss_pred ccchhhcccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc----cccCHHHHHHH
Confidence 5677889999999998888887 99999999999999999999987664 2333333333333 37999999999
Q ss_pred HHhcccCcCCccccccccccchhhhh
Q 023058 257 SRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 257 ~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
++||+.||.+||++.+++. |+|+
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~---h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGA---HPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhcc---Ccch
Confidence 9999999999999988866 5655
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=254.39 Aligned_cols=232 Identities=22% Similarity=0.290 Sum_probs=185.6
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCchHHHHHhc
Q 023058 32 GNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 111 (288)
Q Consensus 32 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 111 (288)
|.++.||++.+..+++.|++|.+..... ..+|...+....|||++++++++......+++|||+++++|.+.+...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 8899999999999999999999876532 234445555667999999999999999999999999999999998887
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCcCCCcccCCcccc
Q 023058 112 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191 (288)
Q Consensus 112 ~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 191 (288)
..++...+..++.|++.||++||+.|++|+||+|+||+++.++. +++.|||.+...... .....++..|+|||.+.
T Consensus 80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG 155 (237)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhccccc--cccCCcCccccCCcccC
Confidence 78999999999999999999999999999999999999988776 999999976543322 22334566799999987
Q ss_pred CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccc
Q 023058 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHF 271 (288)
Q Consensus 192 ~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 271 (288)
+..++.+ +|+||+|+++|+|++|..|+....... . .......+. .+++.++++|.+||+.||.+||++.
T Consensus 156 ~~~~~~~-~DvwslG~il~el~~g~~~~~~~~~~~--~------~~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 156 ISEETEA-CDWWSLGAILFELLTGKTLVECHPSGI--N------THTTLNIPE--WVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CCCCCch-hhHHHHHHHHHHHHHCcchhhcCchhc--c------cccccCCcc--cCCHHHHHHHHHHccCCHHHhcCCC
Confidence 7777666 999999999999999998875432100 0 011122333 5789999999999999999999974
Q ss_pred cc--cccchhhhh
Q 023058 272 HA--TGVYMHTKL 282 (288)
Q Consensus 272 ~~--l~~~~~~~~ 282 (288)
+. -+.+.|+|+
T Consensus 225 ~~~~~~~~~h~~~ 237 (237)
T cd05576 225 VAGVEDIKSHPFF 237 (237)
T ss_pred ccchHHHHcCCCC
Confidence 33 224556653
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=232.77 Aligned_cols=252 Identities=27% Similarity=0.476 Sum_probs=204.1
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
.+|.-+++||+|.||+||++++..+++.||+|.+..++ .......+|+-+++.++|.|||+++++...++.+.+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 46778899999999999999999999999999997653 344678999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC-
Q 023058 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~- 175 (288)
+|+. +|..+... ++.++.+.++.++.|++.||.++|+.++.|||+||+|.+++.++. .||.|||+++....+..+
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrcy 158 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEee
Confidence 9966 78777754 567899999999999999999999999999999999999988887 999999999866555433
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhccc-CCC------CC--
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQY-SIP------DY-- 245 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~------~~-- 245 (288)
....-|.+|.+|.++.+...-+..-|+||.||++.|+.. |.+.|.+.+-.+...++......... .+| ++
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 344578999999999988766555899999999999986 55556655444444444332221110 122 21
Q ss_pred --------------CCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 246 --------------VHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 246 --------------~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
..++..-++++.++|.-+|.+|.+++++++
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 112345689999999999999999998877
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=276.08 Aligned_cols=248 Identities=31% Similarity=0.439 Sum_probs=198.5
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEcC------CeE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP------THL 92 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~ 92 (288)
..|...+.||+|+||.||+++++.+|+.||+|.+... ....++.-+|++++++++|||||++.++=... +.-
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 6778899999999999999999999999999998763 34456677899999999999999998875443 346
Q ss_pred EEEEeccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCC--CCCCEEEeecCCCc
Q 023058 93 AIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSK 167 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~--~~~~~~l~df~~~~ 167 (288)
.++||||.+|+|...+..- ..+++.+++.++..+..|+.|||+.||+||||||.||++-.. +..-.||+|||+|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 8999999999999999643 359999999999999999999999999999999999999433 33347999999999
Q ss_pred ccccCCCCCCCcCCCcccCCccccC-cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc-------
Q 023058 168 SSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------- 239 (288)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 239 (288)
....+.......||+.|.+||.+.. ..|+.. .|+||+|+++|+++||..||............+..+....
T Consensus 173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~t-VDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~ 251 (732)
T KOG4250|consen 173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTAT-VDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIG 251 (732)
T ss_pred cCCCCCeeeeecCchhhcChHHHhhccCcCce-eehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEe
Confidence 8888887778889999999999985 556555 9999999999999999999986655433222222211111
Q ss_pred ------------cCCCCCCCCCH----HHHHHHHHhcccCcCCccc
Q 023058 240 ------------YSIPDYVHISP----ECRHLISRIFVADPAKVSM 269 (288)
Q Consensus 240 ------------~~~~~~~~~~~----~l~~li~~~l~~~p~~Rpt 269 (288)
..+|.+...+. .+..++..+|..+|.+|..
T Consensus 252 ~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 252 AQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred eecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 12222223332 3567778899999999984
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=282.71 Aligned_cols=146 Identities=30% Similarity=0.475 Sum_probs=133.7
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
.++|.+.+.||.|+||.||++.+..+++.||+|++.... .....+.+|+.++..++||||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 479999999999999999999999999999999987543 2235678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
|||+.+++|..++...+.++...++.++.||+.||.|||..||+|+||||+||+++.++. ++|+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~--vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH--IKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC--EEEEeCCCCc
Confidence 999999999999988788999999999999999999999999999999999999987766 9999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=244.22 Aligned_cols=256 Identities=23% Similarity=0.438 Sum_probs=206.4
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC-CCceeeEeEEEEcCC--eEEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPT--HLAIV 95 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~--~~~lv 95 (288)
.+++|++++++|.|.+++||.+.+-.+++.++||++++-.. +.+.+|+.+|..+. +|||+++.++..++. ...++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk--kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK--KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH--HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 56899999999999999999999988999999999886543 67999999999996 999999999998764 57899
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
+|+++..+...+. +.++...+..++.+++.||.|+|++||+|||+||+|+|++... ..++|+|+|++....+..+.
T Consensus 114 FE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~-rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred hhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh-ceeeeeecchHhhcCCCcee
Confidence 9999887666554 4578899999999999999999999999999999999998443 36999999999999998888
Q ss_pred CCCcCCCcccCCccccCcc-cCCCccchhhHHHHHHHHHhCCCCCCCCCC-chhHHHHHHH---------HhhcccCCC-
Q 023058 176 KSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHR---------ILSVQYSIP- 243 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~~~~l~~g~~pf~~~~~-~~~~~~~~~~---------~~~~~~~~~- 243 (288)
.....+..|.-||.+...+ ++.. .|+|||||++..|+....||-...+ .+...++..- +..-...++
T Consensus 190 nVRVASRyfKGPELLVdy~~YDYS-LD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp 268 (338)
T KOG0668|consen 190 NVRVASRYFKGPELLVDYQMYDYS-LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP 268 (338)
T ss_pred eeeeehhhcCCchheeechhcccc-HHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence 8888898999999987654 4454 8999999999999999988864433 2222222100 000001111
Q ss_pred ---------------------CCCCCCHHHHHHHHHhcccCcCCccccccccc-cchhhh
Q 023058 244 ---------------------DYVHISPECRHLISRIFVADPAKVSMHFHATG-VYMHTK 281 (288)
Q Consensus 244 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~~~ 281 (288)
...-++++..+|+.++|.+|.++|+|+.|+.+ +++.+.
T Consensus 269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 11224689999999999999999999999988 444443
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=259.50 Aligned_cols=263 Identities=30% Similarity=0.405 Sum_probs=210.2
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC--CCc----eeeEeEEEEcC
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--HPN----IVRFKEVILTP 89 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~--~~~----i~~~~~~~~~~ 89 (288)
+....++|.++..+|+|.||.|-.+.+..++..||+|++..-..-.+...-|++.+.++. .|+ ++.+.++|...
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 344579999999999999999999999999999999998876666666777999999993 332 77888889999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-------------
Q 023058 90 THLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP------------- 154 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~------------- 154 (288)
++.++|+|.+ |-++.+++.+++ +++...++.+++|++.++++||+.+++|.||||+||++.+..
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999998 558999997654 799999999999999999999999999999999999994211
Q ss_pred -----CCCEEEeecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH
Q 023058 155 -----APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229 (288)
Q Consensus 155 -----~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~ 229 (288)
...|+++|||.+....... .....|..|.|||++.+-.++.+ .|+||+||++.|+.+|...|...++.+..
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL- 318 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL- 318 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH-
Confidence 1248999999987443332 45568899999999999999988 99999999999999999999987754432
Q ss_pred HHHHHHhhcc------------------cCCCCC-----------------------CCCCHHHHHHHHHhcccCcCCcc
Q 023058 230 KTIHRILSVQ------------------YSIPDY-----------------------VHISPECRHLISRIFVADPAKVS 268 (288)
Q Consensus 230 ~~~~~~~~~~------------------~~~~~~-----------------------~~~~~~l~~li~~~l~~~p~~Rp 268 (288)
.++..+.+.. ..+++. ..--..+.+||.+||.+||.+|+
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 3333332211 112210 00113588999999999999999
Q ss_pred ccccccccchhhhhhhhh
Q 023058 269 MHFHATGVYMHTKLQLLV 286 (288)
Q Consensus 269 t~~~~l~~~~~~~~~~~~ 286 (288)
|+.|++. |+||..+.
T Consensus 399 Tl~EAL~---HpFF~~~~ 413 (415)
T KOG0671|consen 399 TLREALS---HPFFARLT 413 (415)
T ss_pred cHHHHhc---CHHhhcCC
Confidence 9988866 77776654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=272.27 Aligned_cols=257 Identities=27% Similarity=0.441 Sum_probs=230.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
.++++++..||-||||.|=++........+|+|++++. ....+.+..|-+++..+++|.||+++..|.+.+++|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 47788999999999999999998876666899988753 34556788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
||-|-||.|+..+...+.|++...+.++.-+++|++|||+.||+.|||||+|.+++.++. +||.|||++.....+..+
T Consensus 499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~KT 576 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRKT 576 (732)
T ss_pred HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCce
Confidence 999999999999999999999999999999999999999999999999999999999988 999999999999999999
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
.+.+|||.|.|||.+.+...+.. .|.||||+++|||++|.+||.+.+....+..+.+++.. +.+|. .++....++
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~--i~~Pr--~I~k~a~~L 651 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK--IEFPR--RITKTATDL 651 (732)
T ss_pred eeecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh--hhccc--ccchhHHHH
Confidence 99999999999999999988887 99999999999999999999999887777777776544 34554 788999999
Q ss_pred HHHhcccCcCCccc--cccccccchhhhhh
Q 023058 256 ISRIFVADPAKVSM--HFHATGVYMHTKLQ 283 (288)
Q Consensus 256 i~~~l~~~p~~Rpt--~~~~l~~~~~~~~~ 283 (288)
|.++...+|.+|.. ...+-+.--|+||.
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 99999999999998 55555566677775
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=252.00 Aligned_cols=260 Identities=29% Similarity=0.395 Sum_probs=201.8
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCC----cEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEc-C
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT-P 89 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~ 89 (288)
.....|++...||+|+||.||+|....++ +.+|+|.++.. .......-+|+.+++.++|||++.+..++.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 34467999999999999999999554433 37899998754 2444678899999999999999999999987 7
Q ss_pred CeEEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCC--CCCCEEEee
Q 023058 90 THLAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICD 162 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~--~~~~~~l~d 162 (288)
..+++++||.+. +|++++.-. ..++...++.|+.||+.|+.|||++=++||||||.||+|..+ ..+++||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 899999999966 898888533 358999999999999999999999999999999999999655 335699999
Q ss_pred cCCCcccccCCCC----CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCch-----hHHHHHH
Q 023058 163 FGYSKSSVLHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-----NFRKTIH 233 (288)
Q Consensus 163 f~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~-----~~~~~~~ 233 (288)
+|+++.....-.. ....-|.+|.|||.+.+...-+++-|+|+.||++.||++..+.|.+.+... .....+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999866554332 334568899999999988777777999999999999999988887643211 1111111
Q ss_pred HHhhcc-----cCCCC------------------------------CCCCCHHHHHHHHHhcccCcCCccccccccc-cc
Q 023058 234 RILSVQ-----YSIPD------------------------------YVHISPECRHLISRIFVADPAKVSMHFHATG-VY 277 (288)
Q Consensus 234 ~~~~~~-----~~~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~ 277 (288)
.+.... ..+|. ...-++...+|+.+||.+||.+|.|++++++ ++
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 111111 01111 1224456889999999999999999999998 44
Q ss_pred h
Q 023058 278 M 278 (288)
Q Consensus 278 ~ 278 (288)
+
T Consensus 340 F 340 (438)
T KOG0666|consen 340 F 340 (438)
T ss_pred c
Confidence 4
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=271.77 Aligned_cols=270 Identities=25% Similarity=0.389 Sum_probs=223.0
Q ss_pred CCCccccCCCCCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCce
Q 023058 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNI 79 (288)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i 79 (288)
|++.++...+-..++- ..+.|++.+.||.|.+|.||++++..++...|+|+........++++.|+++++.. .|||+
T Consensus 1 ~~~~~~~~~~~~~lpd--p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv 78 (953)
T KOG0587|consen 1 MFAKSLMDIDLSSLPD--PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNV 78 (953)
T ss_pred CCcccccccchhhCCC--CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCc
Confidence 4444444444333332 24789999999999999999999999999999999999988889999999999988 69999
Q ss_pred eeEeEEEEc-----CCeEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC
Q 023058 80 VRFKEVILT-----PTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (288)
Q Consensus 80 ~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~ 152 (288)
+.++++|.. ++.+|+|||||.+|+..+++.+ ..++.+..+..|++.++.|+.+||...++|||||-.||+++.
T Consensus 79 ~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~ 158 (953)
T KOG0587|consen 79 ATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTE 158 (953)
T ss_pred ceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEec
Confidence 999999864 4689999999999999999876 357999999999999999999999999999999999999998
Q ss_pred CCCCCEEEeecCCCccccc-CCCCCCCcCCCcccCCccccC-----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 023058 153 SPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (288)
Q Consensus 153 ~~~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~ 226 (288)
++. +||+|||++.+... .....+..|||.|||||++.. ..|+.. +|+||||++..||..|.+|+.......
T Consensus 159 e~~--VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPmr 235 (953)
T KOG0587|consen 159 NAE--VKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPMR 235 (953)
T ss_pred cCc--EEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchhh
Confidence 887 99999999875443 345677889999999999854 345566 899999999999999999998764432
Q ss_pred hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc-cch
Q 023058 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG-VYM 278 (288)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~ 278 (288)
.... -..+..+.+..+..+++++.+||+.||..|..+||+..++++ .|+
T Consensus 236 aLF~---IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi 285 (953)
T KOG0587|consen 236 ALFL---IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFI 285 (953)
T ss_pred hhcc---CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcc
Confidence 2221 222223344456678999999999999999999999998887 443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=265.71 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=211.6
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc--hHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+...+.++||+|-||.|.+++... +..||+|.++..... ..++.+|+.+|.+++||||++++++|..++.+++++||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 678899999999999999999863 689999999876432 35799999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 99 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 99 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
++.|+|.+++..+. ........+++.||+.|++||.+.++||||+.+.|++++.+.+ +|++|||.++....+....
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCcee
Confidence 99999999998773 3466777889999999999999999999999999999988877 9999999998655544332
Q ss_pred ---CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHH--hCCCCCCCCCCchhHHHHHHHHhhcc--cCCCCCCCCC
Q 023058 177 ---STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML--VGAYPFEDPEEPKNFRKTIHRILSVQ--YSIPDYVHIS 249 (288)
Q Consensus 177 ---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 249 (288)
......+|+|+|.+..++++.. +|+|++|+++||++ +.+.||...+++........-..... .-++.+.-+|
T Consensus 695 vqgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp 773 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP 773 (807)
T ss_pred eecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence 2345678999999999999888 99999999999976 58899998877665555443322222 1333445789
Q ss_pred HHHHHHHHHhcccCcCCccccccccccc
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
..+.+++.+||..+..+||+.+++...|
T Consensus 774 ~~lyelml~Cw~~es~~RPsFe~lh~~l 801 (807)
T KOG1094|consen 774 QGLYELMLRCWRRESEQRPSFEQLHLFL 801 (807)
T ss_pred HHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence 9999999999999999999998874433
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=264.91 Aligned_cols=243 Identities=24% Similarity=0.352 Sum_probs=202.7
Q ss_pred eeeeeeccCceEEEEEEEcCC----CcEEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 25 LVRDIGSGNFGVARLMRDKKT----EELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 25 ~~~~lg~g~~~~v~~~~~~~~----~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
..+.||+|-||.||.+....- .-.||||.-+.+ ....+.+.+|.-+++.++||||++++|++.. .-.|+|||.
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL 471 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMEL 471 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEec
Confidence 356799999999999986432 235788877653 3445679999999999999999999999964 467999999
Q ss_pred cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCC
Q 023058 99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (288)
Q Consensus 99 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (288)
++.|.|..+++.++ +++...+..++.||..+|.|||+.++|||||-..||+|.++.. +||+|||+++..........
T Consensus 472 ~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~~yYka 549 (974)
T KOG4257|consen 472 APLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDDAYYKA 549 (974)
T ss_pred ccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhccccchhhc
Confidence 99999999997654 7999999999999999999999999999999999999998888 99999999987665544333
Q ss_pred Cc--CCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 178 TV--GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 178 ~~--~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
.. ...-|+|||.+.-..+++. +|+|.||+++||++. |..||....+.+.+-.+ .....+|-+.++|+.+..
T Consensus 550 S~~kLPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-----EnGeRlP~P~nCPp~LYs 623 (974)
T KOG4257|consen 550 SRGKLPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-----ENGERLPCPPNCPPALYS 623 (974)
T ss_pred cccccceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCccccccccceEEEe-----cCCCCCCCCCCCChHHHH
Confidence 22 3456999999977778777 999999999999875 99999998876655433 223344555589999999
Q ss_pred HHHHhcccCcCCcccccccccc
Q 023058 255 LISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
|+++||+++|.+||...++...
T Consensus 624 lmskcWayeP~kRPrftei~~~ 645 (974)
T KOG4257|consen 624 LMSKCWAYEPSKRPRFTEIKAI 645 (974)
T ss_pred HHHHHhccCcccCCcHHHHHHH
Confidence 9999999999999999988763
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=247.78 Aligned_cols=263 Identities=25% Similarity=0.354 Sum_probs=209.1
Q ss_pred CCCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeec---CccchHHHHHHHHHHhhCCCCceeeEeEEE
Q 023058 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVI 86 (288)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (288)
..+..|.+...+.|+-+.+||+|.||+||+|+...+++.|++|++-. .........+|+.++..++|+|++.++++|
T Consensus 6 ~s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic 85 (376)
T KOG0669|consen 6 DSMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC 85 (376)
T ss_pred hcccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHH
Confidence 45677888999999999999999999999999999999999987644 234456788999999999999999998887
Q ss_pred EcC--------CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCC
Q 023058 87 LTP--------THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (288)
Q Consensus 87 ~~~--------~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~ 157 (288)
... ..+|+||++|.. +|..++.+. .+++..++..++++++.||.|+|...|+|||+|+.|++++.++.
T Consensus 86 ~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi-- 162 (376)
T KOG0669|consen 86 RTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI-- 162 (376)
T ss_pred hhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--
Confidence 643 358999999965 888888665 57999999999999999999999999999999999999998888
Q ss_pred EEEeecCCCcccccCCCCCC-----CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 023058 158 LKICDFGYSKSSVLHSQPKS-----TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (288)
Q Consensus 158 ~~l~df~~~~~~~~~~~~~~-----~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~ 232 (288)
++|.|||+++..+....... ..-|.+|.+||.+.+.....+..|+|..||++.+|++|.+-+...++.....-+.
T Consensus 163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 99999999975554433221 2348899999998876554444999999999999999998888765543332222
Q ss_pred HHHhhccc-CCCC----------------------------CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 233 HRILSVQY-SIPD----------------------------YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 233 ~~~~~~~~-~~~~----------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.-+.+... .+|. .-.-+++..+|+.++|..||.+|+++.++++
T Consensus 243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11111100 1111 0112457889999999999999999999987
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=248.04 Aligned_cols=264 Identities=25% Similarity=0.353 Sum_probs=212.9
Q ss_pred CCCCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhC-CCCceeeEeEE
Q 023058 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEV 85 (288)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 85 (288)
.|+..........+.+-+..||.|.||+|++..++.+|+..|+|.+.... ...+++..|.+...+. ++||||++++.
T Consensus 52 ~p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 52 LPDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cCCcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 44555555566678888999999999999999999999999999998653 4556777888776655 79999999999
Q ss_pred EEcCCeEEEEEeccCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCCCCEE
Q 023058 86 ILTPTHLAIVMEYASGGELFERIC-----NAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLK 159 (288)
Q Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~~~~~ 159 (288)
.-.++..|+-||.|+ .++..+.. ....+++..+-.|..-.+.||+||.. ..|+|||+||+||+++..+. +|
T Consensus 132 ~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vK 208 (361)
T KOG1006|consen 132 LFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VK 208 (361)
T ss_pred hhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--Ee
Confidence 999999999999994 46654332 33468999999999999999999985 57999999999999998887 99
Q ss_pred EeecCCCcccccCCCCCCCcCCCcccCCccccC--cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 023058 160 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237 (288)
Q Consensus 160 l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (288)
|||||.+.....+-......|...|+|||.+.. ..++.+ ||+||||+++||+.||..|+...++ .......+..
T Consensus 209 LCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~ 284 (361)
T KOG1006|consen 209 LCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVI 284 (361)
T ss_pred eecccchHhHHHHHHhhhccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHc
Confidence 999999887666666666778999999999853 346777 9999999999999999999987653 3334444444
Q ss_pred cccC-CCC---CCCCCHHHHHHHHHhcccCcCCccccccccc-cchh
Q 023058 238 VQYS-IPD---YVHISPECRHLISRIFVADPAKVSMHFHATG-VYMH 279 (288)
Q Consensus 238 ~~~~-~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~ 279 (288)
+.+. +.. ..+.+..+..+|..||..|.+.||...+++. .|.+
T Consensus 285 gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr 331 (361)
T KOG1006|consen 285 GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYR 331 (361)
T ss_pred CCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhh
Confidence 4432 221 2357899999999999999999999999888 4433
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=267.20 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=216.4
Q ss_pred CCCCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCC-C--cEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEe
Q 023058 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKT-E--ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFK 83 (288)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-~--~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~ 83 (288)
.|.+.....+-.+...+.++||+|.||+|+++.+... | ..||||++..+.. ...++.+|+..+.+++|+|+++++
T Consensus 98 ~p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLy 177 (1039)
T KOG0199|consen 98 NPSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLY 177 (1039)
T ss_pred CcCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEe
Confidence 4456666677778889999999999999999988642 2 4689999886543 456899999999999999999999
Q ss_pred EEEEcCCeEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEe
Q 023058 84 EVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (288)
Q Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~ 161 (288)
++..+ ....+|||.++.|+|.+.+.. ...|....+-.++.||+.|+.||..++.|||||-..|+++-.... +||+
T Consensus 178 GvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt--VKI~ 254 (1039)
T KOG0199|consen 178 GVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT--VKIC 254 (1039)
T ss_pred eeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce--eeee
Confidence 99887 678999999999999999976 345889999999999999999999999999999999999987665 9999
Q ss_pred ecCCCcccccCCCCC----CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHh
Q 023058 162 DFGYSKSSVLHSQPK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRIL 236 (288)
Q Consensus 162 df~~~~~~~~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 236 (288)
|||+.+....+...- ...-...|+|||.+....++.. +|+|++|+++||||+ |+.||.+.......+ .+.
T Consensus 255 DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~qIL~----~iD 329 (1039)
T KOG0199|consen 255 DFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQILK----NID 329 (1039)
T ss_pred cccceeccCCCCcceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHHHHH----hcc
Confidence 999998655544432 1223446999999999999888 999999999999997 889999876633333 323
Q ss_pred hcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 237 SVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 237 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
....++....+++++++++..||..+|.+|||+.++.+
T Consensus 330 -~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 330 -AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred -ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 45566666689999999999999999999999998875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=273.55 Aligned_cols=252 Identities=23% Similarity=0.394 Sum_probs=215.3
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCC---cEEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
.++.+...|.+.||.|.||+|++++.+..+ ..||||.++.. .+...+++.|+.++-+.+||||+++.++....+-
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 344566789999999999999999987655 57999999865 3445679999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
+++|.|||+.|+|..++..+ +.|+..++..+++.|+.|++||.++|+|||||...||+|+.+-. +|+.|||+++...
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvle 782 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLE 782 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceeecc
Confidence 99999999999999998654 57999999999999999999999999999999999999987776 9999999998554
Q ss_pred cCCCCCC-Cc-C--CCcccCCccccCcccCCCccchhhHHHHHHHHH-hCCCCCCCCCCchhHHHHHHHHhhcccCCCCC
Q 023058 171 LHSQPKS-TV-G--TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245 (288)
Q Consensus 171 ~~~~~~~-~~-~--~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (288)
...+... .. | ..+|.|||.+...++++. ||+||+|+++||.+ .|..||+...+.+.+.. ....+.+|.+
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-----Ie~gyRLPpP 856 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-----IEQGYRLPPP 856 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHHHHH-----HHhccCCCCC
Confidence 4432211 11 1 357999999999999888 99999999999865 59999998877555444 3456778888
Q ss_pred CCCCHHHHHHHHHhcccCcCCcccccccccc
Q 023058 246 VHISPECRHLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 246 ~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
.++|..+.+|+..||++|-++||...|++..
T Consensus 857 mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 857 MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 8999999999999999999999999998663
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=242.41 Aligned_cols=237 Identities=42% Similarity=0.655 Sum_probs=199.4
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecCccc--hHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCchHHHHHh
Q 023058 33 NFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 110 (288)
Q Consensus 33 ~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 110 (288)
++|.||++.+..+++.+++|++...... .+.+.+|++.+++++|+|++++++++......++++|++++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 5899999999988999999998765433 47889999999999999999999999999999999999999999999887
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCcCCCcccCCccc
Q 023058 111 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190 (288)
Q Consensus 111 ~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~ 190 (288)
...++...+..++.+++.++.+||+.|++|+||+|.||+++.++. ++|+|||.+.............++..|++||.+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH--VKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc--EEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 766899999999999999999999999999999999999988765 999999998866655455566678899999999
Q ss_pred cCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC-CCHHHHHHHHHhcccCcCCccc
Q 023058 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHLISRIFVADPAKVSM 269 (288)
Q Consensus 191 ~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rpt 269 (288)
.+..++.+ +|+||+|++++++++|..||......... ................ ++.++.+++.+|+..+|++||+
T Consensus 159 ~~~~~~~~-~Di~slG~~l~~l~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 159 LGKGYGKA-VDVWSLGVILYELLTGKPPFPGDDQLLEL---FKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred ccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 87777775 99999999999999999999764332222 2222223332222112 7899999999999999999999
Q ss_pred cccccc
Q 023058 270 HFHATG 275 (288)
Q Consensus 270 ~~~~l~ 275 (288)
+.++++
T Consensus 235 ~~~~~~ 240 (244)
T smart00220 235 AEEALQ 240 (244)
T ss_pred HHHHhh
Confidence 988876
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=241.29 Aligned_cols=262 Identities=29% Similarity=0.465 Sum_probs=217.8
Q ss_pred cccCCCCCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhC-CCCce
Q 023058 5 AMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNI 79 (288)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l-~~~~i 79 (288)
||....|...........|.+++.||.|+|+.|-.++.+.+.+.||+|++++. ++..+=...|-....+. +||.+
T Consensus 234 a~~~m~g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pfl 313 (593)
T KOG0695|consen 234 AIDGMDGIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFL 313 (593)
T ss_pred hhhhccccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeE
Confidence 34445566666777779999999999999999999999999999999998753 33334455555555554 79999
Q ss_pred eeEeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEE
Q 023058 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (288)
Q Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~ 159 (288)
|.++.+|..+..+++|.||+++|+|--.+++..++|++..+.+...|..||+|||++||+.||||.+|++++..+. +|
T Consensus 314 vglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh--ik 391 (593)
T KOG0695|consen 314 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IK 391 (593)
T ss_pred EehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc--ee
Confidence 9999999999999999999999999888888899999999999999999999999999999999999999998887 99
Q ss_pred EeecCCCcc-cccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCC---CCCchhHHHHHH-H
Q 023058 160 ICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED---PEEPKNFRKTIH-R 234 (288)
Q Consensus 160 l~df~~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~---~~~~~~~~~~~~-~ 234 (288)
|+|+|.+.. ..+++...+.+|||.|.|||.+.+..|.-. .|.|+||++++||+.|..||.- .+...+-..... -
T Consensus 392 ltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv 470 (593)
T KOG0695|consen 392 LTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV 470 (593)
T ss_pred ecccchhhcCCCCCcccccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH
Confidence 999999875 455666788899999999999999999877 9999999999999999999963 222222222222 2
Q ss_pred HhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccc
Q 023058 235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHF 271 (288)
Q Consensus 235 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 271 (288)
+....+..|. .++-....+++..|+.||.+|....
T Consensus 471 ilekqiripr--slsvkas~vlkgflnkdp~erlgc~ 505 (593)
T KOG0695|consen 471 ILEKQIRIPR--SLSVKASHVLKGFLNKDPKERLGCR 505 (593)
T ss_pred Hhhhcccccc--eeehhhHHHHHHhhcCCcHHhcCCC
Confidence 3344456666 6777888899999999999998653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=249.49 Aligned_cols=247 Identities=31% Similarity=0.494 Sum_probs=212.0
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc----chHHHHHHHHHHhhC-CCCceeeEeEEEEcCCe
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 91 (288)
.+....|..+..||.|+||.|.++..+.+.+.||||+++++-- ..+-...|-++|... +.|.++.++.+|..-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4455788999999999999999999999999999999876522 112233455555555 56789999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
+|+||||+.+|+|-..++.-+++.+.....++..|+.||=+||++||+.||||.+|||++.++. +||.|||++.....
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeeccccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999998887 99999999986544
Q ss_pred C-CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 172 H-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 172 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
. ....+..|||.|+|||.+...+|... .|.||+|+++|||+.|+.||.+.++...++.+ ...+..+|. .++.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgks-vDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI----~ehnvsyPK--slSk 575 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI----MEHNVSYPK--SLSK 575 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----HHccCcCcc--cccH
Confidence 4 44577889999999999988888766 99999999999999999999998876666554 444556665 7899
Q ss_pred HHHHHHHHhcccCcCCcccccc
Q 023058 251 ECRHLISRIFVADPAKVSMHFH 272 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~ 272 (288)
+..++....|...|.+|....-
T Consensus 576 EAv~ickg~ltK~P~kRLGcg~ 597 (683)
T KOG0696|consen 576 EAVAICKGLLTKHPGKRLGCGP 597 (683)
T ss_pred HHHHHHHHHhhcCCccccCCCC
Confidence 9999999999999999987643
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=253.02 Aligned_cols=261 Identities=27% Similarity=0.381 Sum_probs=211.6
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchH--------HHHHHHHHHhhCCCCceeeEeEEEEcC-C
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHRSLRHPNIVRFKEVILTP-T 90 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--------~~~~e~~~l~~l~~~~i~~~~~~~~~~-~ 90 (288)
.++|.++..||.|||++||+|.+-...+.||+|+-+.+..+.+ ..-+|..+.+.++||.||++++++..+ +
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 5899999999999999999999999999999998766554443 245799999999999999999999754 6
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC--ceecCCCCCceEec-CCCCCCEEEeecCCCc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLD-GSPAPRLKICDFGYSK 167 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--i~H~dl~p~nilv~-~~~~~~~~l~df~~~~ 167 (288)
.++-|.|||+|++|.-++...+.+++.+.+.|+-||+.||.||.... |+|-||||.||++- .+..+.+||+|||++.
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 78999999999999999999999999999999999999999999765 99999999999985 3444579999999998
Q ss_pred ccccCCCC--------CCCcCCCcccCCccccCc---ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 023058 168 SSVLHSQP--------KSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 236 (288)
Q Consensus 168 ~~~~~~~~--------~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (288)
.+...... ....||-+|++||-+.-+ +..+.+.|+||.|+++|.++.|..||........+.+.-.-+.
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk 701 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK 701 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence 65443222 334588899999987533 2234458999999999999999999986543222222222222
Q ss_pred hcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc-cchhh
Q 023058 237 SVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG-VYMHT 280 (288)
Q Consensus 237 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~~ 280 (288)
.....||...-++.+.++||++||++.-..|....++.. +++.+
T Consensus 702 AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 702 ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 233467777778999999999999999999999988876 55544
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=256.79 Aligned_cols=258 Identities=31% Similarity=0.456 Sum_probs=215.2
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
..-|..++.||-|.||+|.++...++...||+|.+.+.+ .....++.|-.+|...+.+-+|+++..|.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 456888999999999999999999999999999987643 3345688899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|+|++||++-.++.+.+-|++...+.++..+..|+++.|.+|++||||||+||+||.++. |||+|||++.........
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceecccc
Confidence 999999999999999899999999999999999999999999999999999999999998 999999998522110000
Q ss_pred -------------------------------------------CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHH
Q 023058 176 -------------------------------------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 212 (288)
Q Consensus 176 -------------------------------------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l 212 (288)
....||+.|+|||++....++.- .|.||.|+++|+|
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em 864 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEM 864 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHH
Confidence 01137899999999999888777 8999999999999
Q ss_pred HhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 213 LVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 213 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+.|+.||...+......++.. +.....++...+++.+..++|.++. .++.+|..-.-.-++-.|+||.
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~n--w~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFk 932 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVIN--WRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFK 932 (1034)
T ss_pred hhCCCCccCCCCCcceeeeee--hhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCcccc
Confidence 999999988776554443322 2334566667789999999999876 7888998766555555566653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=264.18 Aligned_cols=258 Identities=17% Similarity=0.181 Sum_probs=170.3
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCC----CcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEE------E
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKT----EELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV------I 86 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~----~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~------~ 86 (288)
....++|++.+.||+|+||.||++.+..+ +..||+|.+...... +....+ .++...+.++..+... .
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 34568999999999999999999999988 899999987543221 111111 1122222222221111 2
Q ss_pred EcCCeEEEEEeccCCCchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHhhcCceecCCCCC
Q 023058 87 LTPTHLAIVMEYASGGELFERICNAGR--------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146 (288)
Q Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~ 146 (288)
..+..+++|++|+++++|.+++..... .....+..++.|++.||.|||+.||+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 345678999999999999988865421 123446679999999999999999999999999
Q ss_pred ceEecCCCCCCEEEeecCCCcccccCC--CCCCCcCCCcccCCccccCcccC---------------------CCccchh
Q 023058 147 NTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYD---------------------GKIADVW 203 (288)
Q Consensus 147 nilv~~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~---------------------~~~~Di~ 203 (288)
||+++.+. +.+||+|||++....... ......+++.|+|||.+...... ..++|||
T Consensus 285 NILl~~~~-~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 285 NIIFSEGS-GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HEEEeCCC-CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 99998532 249999999997543322 22445688999999976432221 1125999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCchhHHHHHHHH----------hhccc------CCCCCCCCCHHHHHHHHHhcccCcCCc
Q 023058 204 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI----------LSVQY------SIPDYVHISPECRHLISRIFVADPAKV 267 (288)
Q Consensus 204 slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~R 267 (288)
|+||++|+|+++..++.. ....+....... ..... .+......+...++||.+||+.||.+|
T Consensus 364 SlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 999999999987665432 111111111100 00000 000001123456799999999999999
Q ss_pred cccccccccchhhhhh
Q 023058 268 SMHFHATGVYMHTKLQ 283 (288)
Q Consensus 268 pt~~~~l~~~~~~~~~ 283 (288)
||+.++++ |+|++
T Consensus 442 ~ta~e~L~---Hpff~ 454 (566)
T PLN03225 442 ISAKAALA---HPYFD 454 (566)
T ss_pred CCHHHHhC---CcCcC
Confidence 99998877 55553
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=254.73 Aligned_cols=244 Identities=21% Similarity=0.314 Sum_probs=210.0
Q ss_pred eeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCc
Q 023058 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 103 (288)
Q Consensus 24 ~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 103 (288)
....+||.|-||.||.+.++...-.||+|.++-+....+++.+|..+++.++|||+|+++++|..+--+|+|.|||..|+
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN 349 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence 44678999999999999999888899999999988888999999999999999999999999999999999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCc--
Q 023058 104 LFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-- 179 (288)
Q Consensus 104 L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~-- 179 (288)
|.+++.+.. .++.-.++.++.||..|++||..++++||||-..|.+|..+.. +|+.|||+++.+.......+..
T Consensus 350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDTYTAHAGAK 427 (1157)
T KOG4278|consen 350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGDTYTAHAGAK 427 (1157)
T ss_pred HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCCceecccCcc
Confidence 999997654 4777788889999999999999999999999999999988877 9999999998766554443332
Q ss_pred CCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 023058 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258 (288)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 258 (288)
...-|.|||.+-...++.+ +|+|+||+++||+.| |-.||.+-+- ....++....+......+||+.+.+|+..
T Consensus 428 FPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidl-----SqVY~LLEkgyRM~~PeGCPpkVYeLMra 501 (1157)
T KOG4278|consen 428 FPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYGLLEKGYRMDGPEGCPPKVYELMRA 501 (1157)
T ss_pred CcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccH-----HHHHHHHhccccccCCCCCCHHHHHHHHH
Confidence 3457999999988899888 999999999999997 7778876543 22333444555555555899999999999
Q ss_pred hcccCcCCccccccccc
Q 023058 259 IFVADPAKVSMHFHATG 275 (288)
Q Consensus 259 ~l~~~p~~Rpt~~~~l~ 275 (288)
||+.+|.+||+..++-+
T Consensus 502 CW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 502 CWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HhcCCcccCccHHHHHH
Confidence 99999999999988765
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=279.94 Aligned_cols=245 Identities=21% Similarity=0.217 Sum_probs=186.0
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccC
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (288)
+.|...+.||+|+||.||++.+..++..||+|.+..... ...+|++.+++++||||+++++++..++..++||||++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 345667789999999999999988899999998865433 22456889999999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh---hcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCC
Q 023058 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCH---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (288)
Q Consensus 101 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH---~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (288)
+++|.+++.. ++...+..++.|++.|++||| +.+++|||+||+||+++.+.. .++. |+...... ....
T Consensus 767 ~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~---~~~~ 837 (968)
T PLN00113 767 GKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLC---TDTK 837 (968)
T ss_pred CCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-eccccccc---cCCC
Confidence 9999999853 788999999999999999999 679999999999999987776 4443 44332211 1122
Q ss_pred CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCc-hhHHHHHHHHhhc-------ccCCCCCC---
Q 023058 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV-------QYSIPDYV--- 246 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~-------~~~~~~~~--- 246 (288)
..+++.|+|||.+.+..++.+ +||||+|+++|||++|..||...... ............. ........
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred ccccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 357789999999988888777 99999999999999999998543221 1111111110000 00111100
Q ss_pred -CCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 247 -HISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 247 -~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
....++.+++.+||+.||.+|||+.++++.+.
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~ 949 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHH
Confidence 11235778999999999999999999988554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=252.50 Aligned_cols=260 Identities=18% Similarity=0.198 Sum_probs=185.7
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEc----------------CCCcEEEEEEeecCccc---------------hHHHHH
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDK----------------KTEELVAVKYIERGDKI---------------DENVQR 66 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~----------------~~~~~~~iK~~~~~~~~---------------~~~~~~ 66 (288)
...++|++.++||+|+||+||++... ..++.||+|.+...... .+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 35689999999999999999998642 23567999998653211 122334
Q ss_pred HHHHHhhCCCCce-----eeEeEEEEc--------CCeEEEEEeccCCCchHHHHHhcC---------------------
Q 023058 67 EIINHRSLRHPNI-----VRFKEVILT--------PTHLAIVMEYASGGELFERICNAG--------------------- 112 (288)
Q Consensus 67 e~~~l~~l~~~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~--------------------- 112 (288)
|+.++.+++|.++ +++++++.. ++..++|+||+++++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6666777766543 566666643 346899999999999988875421
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC--CCcCCCcccCC
Q 023058 113 ---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAP 187 (288)
Q Consensus 113 ---~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~aP 187 (288)
.++...++.++.|++.+|.|||+.+++|+||||+||+++.++. ++|+|||++.......... ....++.|++|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 2345678889999999999999999999999999999987776 9999999986543322222 22347899999
Q ss_pred ccccCccc--------------------C-CCccchhhHHHHHHHHHhCCC-CCCCCCCchh-------HHHHHHHHhhc
Q 023058 188 EVLLKKEY--------------------D-GKIADVWSCGVTLYVMLVGAY-PFEDPEEPKN-------FRKTIHRILSV 238 (288)
Q Consensus 188 E~~~~~~~--------------------~-~~~~Di~slG~~~~~l~~g~~-pf~~~~~~~~-------~~~~~~~~~~~ 238 (288)
|.+..... . ....|+||+||++++|+++.. ||........ ...........
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 98754321 1 112699999999999999875 6653221111 11111222334
Q ss_pred ccCCCCCCCCCHHHHHHHHHhcccCc---CCccccccccccchhhhh
Q 023058 239 QYSIPDYVHISPECRHLISRIFVADP---AKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~~p---~~Rpt~~~~l~~~~~~~~ 282 (288)
...++.....++..++|+.+||..+| .+|+|+.|+++ |+|+
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~---Hp~f 503 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS---HRFF 503 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC---CCCc
Confidence 45566566789999999999999866 68999998877 5554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=242.87 Aligned_cols=142 Identities=25% Similarity=0.400 Sum_probs=121.3
Q ss_pred CCCCCCCCCC----CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC-----C---
Q 023058 9 GPGMDMPIMH----DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----H--- 76 (288)
Q Consensus 9 ~~~~~~~~~~----~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-----~--- 76 (288)
.+|+.+|..+ ..++|-+.++||.|-|++||++.+..+.+.||+|+.+...--.+....||.+|++++ |
T Consensus 62 ~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~ 141 (590)
T KOG1290|consen 62 RKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGK 141 (590)
T ss_pred hcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 4566666543 338999999999999999999999999999999998877666678889999999983 3
Q ss_pred CceeeEeEEEEcC----CeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceE
Q 023058 77 PNIVRFKEVILTP----THLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTL 149 (288)
Q Consensus 77 ~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nil 149 (288)
.+||++++.|... .++++|+|+. |.+|..++... +-++...++.|++||+.||.|||. .||+|.||||+||+
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvL 220 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVL 220 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceee
Confidence 3699999999764 5899999999 55787777654 469999999999999999999995 69999999999999
Q ss_pred ec
Q 023058 150 LD 151 (288)
Q Consensus 150 v~ 151 (288)
+.
T Consensus 221 l~ 222 (590)
T KOG1290|consen 221 LC 222 (590)
T ss_pred ee
Confidence 95
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=235.53 Aligned_cols=262 Identities=26% Similarity=0.361 Sum_probs=200.5
Q ss_pred cCCCCCCCCCCC---CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC--CCCceee
Q 023058 7 TVGPGMDMPIMH---DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL--RHPNIVR 81 (288)
Q Consensus 7 ~~~~~~~~~~~~---~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~ 81 (288)
+.+-|+.+|..- ..++..+.+.||+|.||+||++.+. |+.||||+|...++ ....+|.++.+.+ +|+||+.
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccch--hhhhhHHHHHHHHHhccchhhh
Confidence 555666665442 2478899999999999999999996 78899999885443 5677788777665 9999999
Q ss_pred EeEEEEcC----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-----cC---ceecCCCCCceE
Q 023058 82 FKEVILTP----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-----MQ---VCHRDLKLENTL 149 (288)
Q Consensus 82 ~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-----~~---i~H~dl~p~nil 149 (288)
+++.=..+ ..+|+|.+|.+.|+|.+++.. ..++.+..++++..++.||++||. +| |+|||||..||+
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL 348 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 348 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence 98763322 378999999999999999987 678999999999999999999994 33 999999999999
Q ss_pred ecCCCCCCEEEeecCCCcccccCC-----CCCCCcCCCcccCCccccCccc-----CCCccchhhHHHHHHHHHhC----
Q 023058 150 LDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVG---- 215 (288)
Q Consensus 150 v~~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~~~~~l~~g---- 215 (288)
|..++. +.|+|+|++....... ......||.+|||||++..... +.+.+||||||+++||++-+
T Consensus 349 VKkn~~--C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g 426 (513)
T KOG2052|consen 349 VKKNGT--CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG 426 (513)
T ss_pred EccCCc--EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC
Confidence 999998 9999999997554442 2356679999999999864322 23348999999999998742
Q ss_pred ------CCCCCCCCCchhHHHHHHHHhhc---ccCCCC-CCCCC--HHHHHHHHHhcccCcCCccccccccc
Q 023058 216 ------AYPFEDPEEPKNFRKTIHRILSV---QYSIPD-YVHIS--PECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 216 ------~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~-~~~~~--~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+.||......+.....++.+.=. +++.|. |...+ ..+.++++.||..||.-|.|+--+..
T Consensus 427 gi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 427 GIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 47887765555544444443322 233333 21211 24778899999999999999965544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=234.24 Aligned_cols=261 Identities=25% Similarity=0.376 Sum_probs=209.2
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCC-
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPT- 90 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 90 (288)
..+....+|.-++.+|.|.- .|-.|-+...+.+|++|..... ....++..+|...+..+.|+|+++++.+|.-.+
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 44555689999999999988 7778889989999999987543 445577889999999999999999999997653
Q ss_pred -----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCC
Q 023058 91 -----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (288)
Q Consensus 91 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~ 165 (288)
.+|+|||+++. +|.+.++ ..++-..+..+++|++.|+.+||+.||+||||||+||++..+.. .|+.|||+
T Consensus 90 l~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ 164 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGL 164 (369)
T ss_pred HHHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchh
Confidence 57999999955 8888777 35788899999999999999999999999999999999987776 99999999
Q ss_pred CcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc------
Q 023058 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------ 239 (288)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------ 239 (288)
+......-.......+..|.|||++.+..+..+ .||||+||++.||++|...|.+.+.-+.+-+.........
T Consensus 165 ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 165 ARTEDTDFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred hcccCcccccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 986666645555667889999999999998888 9999999999999999999886554333333332211111
Q ss_pred -----------------c----CCCCC---------CCCCHHHHHHHHHhcccCcCCccccccccc-cchhhhh
Q 023058 240 -----------------Y----SIPDY---------VHISPECRHLISRIFVADPAKVSMHFHATG-VYMHTKL 282 (288)
Q Consensus 240 -----------------~----~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~~~~ 282 (288)
. .+|+. ..-...+++++.+||..||.+|.++.++|. ++++-|+
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~ 317 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWY 317 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeec
Confidence 0 11110 112356889999999999999999999988 6666554
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=247.36 Aligned_cols=197 Identities=29% Similarity=0.471 Sum_probs=176.7
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---------cchHHHHHHHHHHhhCC---CCceeeEeEEEEc
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------KIDENVQREIINHRSLR---HPNIVRFKEVILT 88 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~ 88 (288)
..|..++.+|+|.||.|+.|.++.+...|++|.+.+.. ...-.+-.|+.+|.+++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 56999999999999999999999999999999987643 22223567999999997 9999999999999
Q ss_pred CCeEEEEEecc-CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 89 PTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 89 ~~~~~lv~e~~-~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
++++|++||.. ++.+|.+++...+++.+.+...|++|++.|+++||++||+|||||-+|++++.++. +||+|||.+.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgsaa 718 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGSAA 718 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeeccchh
Confidence 99999999976 45689999999999999999999999999999999999999999999999998888 9999999876
Q ss_pred ccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCC
Q 023058 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (288)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~ 220 (288)
.. ..+.-....||..|.|||++.|..|-.+.-|||+||+++|-++....||.
T Consensus 719 ~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 719 YT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 43 34455677899999999999999999888999999999999999999885
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=246.38 Aligned_cols=248 Identities=26% Similarity=0.384 Sum_probs=203.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC------CCceeeEeEEEEcCCeEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR------HPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~ 93 (288)
-++|.|....|.|-|++|-.|.+..-|..||||++..+....+.-+.|+++|++|+ --|+++++..|.+..++|
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 37899999999999999999999998899999999998888888899999999995 348999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 94 IVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
+|+|.... +|..++...+. |....+..+++|+.-||..|...|++|.||||+||+|+...+ .+||||||.+....
T Consensus 511 lVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~ 588 (752)
T KOG0670|consen 511 LVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFAS 588 (752)
T ss_pred EEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCccccccc
Confidence 99998855 89999987653 778899999999999999999999999999999999985554 48999999987655
Q ss_pred cCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC------
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD------ 244 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 244 (288)
.+..+. ..-+.-|.|||++.|.+|+.. -|+||.||++|||.+|...|.+.+...-+.-.+ . ....+|.
T Consensus 589 eneitP-YLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m-e---~KGk~p~KmlRKg 662 (752)
T KOG0670|consen 589 ENEITP-YLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM-E---LKGKFPNKMLRKG 662 (752)
T ss_pred cccccH-HHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHH-H---hcCCCcHHHhhhc
Confidence 443322 223456999999999999999 999999999999999999998876533222211 1 1111110
Q ss_pred ---------------------------------------------CCCCC-------HHHHHHHHHhcccCcCCcccccc
Q 023058 245 ---------------------------------------------YVHIS-------PECRHLISRIFVADPAKVSMHFH 272 (288)
Q Consensus 245 ---------------------------------------------~~~~~-------~~l~~li~~~l~~~p~~Rpt~~~ 272 (288)
...+| ..+++|+..||..||.+|.|..+
T Consensus 663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 01122 35889999999999999999999
Q ss_pred ccc
Q 023058 273 ATG 275 (288)
Q Consensus 273 ~l~ 275 (288)
+|.
T Consensus 743 AL~ 745 (752)
T KOG0670|consen 743 ALK 745 (752)
T ss_pred Hhc
Confidence 977
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=250.65 Aligned_cols=256 Identities=24% Similarity=0.382 Sum_probs=206.1
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcC-------CCcEEEEEEeecCc--cchHHHHHHHHHHhhC-CCCceeeEeEEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVI 86 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 86 (288)
....++..+.+.||+|.||.|+++.-.. ....||+|...... ...+.+..|+++++.+ .|+|++.+++.+
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 3344566778899999999999997431 14578999887543 3456788999999999 599999999999
Q ss_pred EcCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEe
Q 023058 87 LTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (288)
Q Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv 150 (288)
...+.+++|+||+..|+|..++...+ .++...+..++.||+.|++||++..++||||-..||++
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI 451 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe
Confidence 99999999999999999999987655 38889999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeecCCCcccccCCCCC--CCc--CCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 023058 151 DGSPAPRLKICDFGYSKSSVLHSQPK--STV--GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (288)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~~~~--~~~--~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~ 225 (288)
+.+.. +|++|||+++......... ... ....|+|||.+....++.+ +|+||+|+++||+++ |..|+......
T Consensus 452 ~~~~~--~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 452 TKNKV--IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred cCCCE--EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 98877 9999999998544433322 111 2345999999999888888 999999999999997 78898764322
Q ss_pred hhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 226 KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
..+ ... .........+..+++++.+++..||+.+|.+||+..++.+.+..
T Consensus 529 ~~l---~~~-l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 529 EEL---LEF-LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHH---HHH-HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 222 222 23333334444789999999999999999999999999987666
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=249.16 Aligned_cols=254 Identities=30% Similarity=0.404 Sum_probs=214.0
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
.-...|+.++.+|.|+||.||++++..+++..|+|+++... ...+.+.+|+.+++.++||||+.+++.+.....+|+.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 44589999999999999999999999999999999998754 44467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (288)
|||.+++|.+.-+-.+++++.++...++..+++++|||+.|-+|||||-.||++++.+. +++.|||.+..+... ...
T Consensus 92 EycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~Kr 169 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKR 169 (829)
T ss_pred EecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999998888 999999988654433 445
Q ss_pred CCCcCCCcccCCcccc---CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 176 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
+...||+.|+|||+.. .+.|... +|+|++|++..|+-..+.|.-...... ...++..-.-..+.+.+...+++.+
T Consensus 170 ksfiGtpywmapEvaaverkggynql-cdiwa~gitAiel~eLqpplfdlhpmr-~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQL-CDIWALGITAIELGELQPPLFDLHPMR-ALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hcccCCccccchhHHHHHhccccccc-ccccccccchhhhhhcCCcccccchHH-HHHHhhccCCCCCcccCCccchHHH
Confidence 6788999999999863 5566666 999999999999998887765433211 1122211111223444556788999
Q ss_pred HHHHHHhcccCcCCccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+|++.+|..+|.+|||++.++.
T Consensus 248 h~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHHhcCCCccCCChhhhee
Confidence 99999999999999999987766
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=247.43 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=206.1
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCc----EEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
..+..++||+|.||+||++.+-..++ +||+|++.... +...++.+|+-.+.+++|||++++++++.... +.+|
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 34557899999999999998865554 67888876543 44578999999999999999999999998766 8899
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 96 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
.++++.|.|.++++.+ .++.....+.|+.||++|+.|||.+++|||||-..||+|..... +|+.|||++....+...
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCcccc
Confidence 9999999999998765 47999999999999999999999999999999999999998887 99999999986655544
Q ss_pred CCCCc---CCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 175 PKSTV---GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 175 ~~~~~---~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
.-... -.+-|+|-|.+....++.. +|+||+|+++||++| |..|+....-.+ +.+ ..+....++.+..++.
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~~e-I~d----lle~geRLsqPpiCti 927 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPAEE-IPD----LLEKGERLSQPPICTI 927 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCHHH-hhH----HHhccccCCCCCCccH
Confidence 33222 2456999999999999888 999999999999997 999988654322 222 2333334666668999
Q ss_pred HHHHHHHHhcccCcCCccccccccccchhh
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATGVYMHT 280 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~ 280 (288)
+++.++.+||-.|+..||+++++.+.|-+.
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 999999999999999999999987765543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=231.71 Aligned_cols=249 Identities=23% Similarity=0.251 Sum_probs=189.2
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC--CCCceeeEeEEEEcCC----eEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL--RHPNIVRFKEVILTPT----HLA 93 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~~----~~~ 93 (288)
..+.+..+.+|+|.||.||+|+.. ++.||||++...+. +.+.+|-++.+.. +|+||+++++.-.... .++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~k--qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEK--QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHH--HHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 478889999999999999999985 68999999876443 4566676666554 7999999988755544 799
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh---------cCceecCCCCCceEecCCCCCCEEEeecC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS---------MQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~---------~~i~H~dl~p~nilv~~~~~~~~~l~df~ 164 (288)
+|++|.+.|+|.+++..+ ..+..+..+++..+++||+|||+ -.|+|||||..||+|.++.+ +-|+|||
T Consensus 285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFG 361 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFG 361 (534)
T ss_pred EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeeccc
Confidence 999999999999999664 57899999999999999999995 35999999999999998888 9999999
Q ss_pred CCcccccCCCC---CCCcCCCcccCCccccCcccCC-----CccchhhHHHHHHHHHhCCCCC------------CCCCC
Q 023058 165 YSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDG-----KIADVWSCGVTLYVMLVGAYPF------------EDPEE 224 (288)
Q Consensus 165 ~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~-----~~~Di~slG~~~~~l~~g~~pf------------~~~~~ 224 (288)
++....+.... ....||.+|||||++.+..... ++.|+||+|.++||++++...+ ...-.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 99876654433 3356999999999997754433 3479999999999999865433 21101
Q ss_pred c-hhHHHHHHHH--hhcccCCCC-C--CCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 225 P-KNFRKTIHRI--LSVQYSIPD-Y--VHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 225 ~-~~~~~~~~~~--~~~~~~~~~-~--~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
. ..+.++..-+ .+.++.+++ + -.....+++.+..||+.||..|.|+.=+.+
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 1 1112222111 122233332 0 123457999999999999999999965544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=212.81 Aligned_cols=207 Identities=44% Similarity=0.682 Sum_probs=181.1
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCchHH
Q 023058 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 106 (288)
Q Consensus 29 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 106 (288)
||+|++|.||++....+++.+++|++..... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999988899999999887654 25789999999999999999999999999999999999999899999
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC-CCCCCEEEeecCCCcccccCC-CCCCCcCCCc
Q 023058 107 RICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPA 183 (288)
Q Consensus 107 ~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~-~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~ 183 (288)
++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++. ++|+||+.+....... ..........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc--EEEecCCceEEccCCcchhhcccCCCC
Confidence 98776 47899999999999999999999999999999999999987 555 9999999887544332 1333557788
Q ss_pred ccCCccccCc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhccc
Q 023058 184 YIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 262 (288)
Q Consensus 184 ~~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 262 (288)
|.+||..... ..+.. +|+|++|++++++ ..+.+++.+|++.
T Consensus 159 ~~~pe~~~~~~~~~~~-~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~ 200 (215)
T cd00180 159 YMAPEVLLGKGYYSEK-SDIWSLGVILYEL-------------------------------------PELKDLIRKMLQK 200 (215)
T ss_pred ccChhHhcccCCCCch-hhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhC
Confidence 9999998776 44444 9999999999999 5799999999999
Q ss_pred CcCCccccccccc
Q 023058 263 DPAKVSMHFHATG 275 (288)
Q Consensus 263 ~p~~Rpt~~~~l~ 275 (288)
+|.+||++.+++.
T Consensus 201 ~p~~R~~~~~l~~ 213 (215)
T cd00180 201 DPEKRPSAKEILE 213 (215)
T ss_pred CcccCcCHHHHhh
Confidence 9999999988865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=206.05 Aligned_cols=198 Identities=27% Similarity=0.411 Sum_probs=167.2
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeec--CccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEEec
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
.......||.|++|+|-+.++..+|...|+|.+.. ++...++..+|+.+..+. .+|.+|.+++....+..+++-||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 33457889999999999999999999999999864 455566788888877665 799999999999999999999999
Q ss_pred cCCCchHH----HHHhcCCCCHHHHHHHHHHHHHHHHHHhhc-CceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 99 ASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 99 ~~~~~L~~----~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
|+. +|.. .+..++..++..+-+|+-.++.||.+||++ .++|||+||+||+++.++. +|+||||.+.....+-
T Consensus 127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq--VKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ--VKICDFGISGYLVDSI 203 (282)
T ss_pred hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--EEEcccccceeehhhh
Confidence 944 7754 345667899999999999999999999964 7999999999999988777 9999999987665555
Q ss_pred CCCCCcCCCcccCCccccC----cccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 023058 174 QPKSTVGTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~ 223 (288)
......|+..|+|||.+.. ..|+.+ +|+||||+++.||.++..||....
T Consensus 204 Akt~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 204 AKTMDAGCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred HHHHhcCCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccC
Confidence 4455678889999998753 356666 999999999999999999998654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=217.98 Aligned_cols=275 Identities=22% Similarity=0.344 Sum_probs=210.9
Q ss_pred CCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEE-EEc
Q 023058 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEV-ILT 88 (288)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~-~~~ 88 (288)
-..++.+...+.|.+.+.||+|.||.+-++++..++..+++|.+.......+++.+|...---| .|.||+..+++ |..
T Consensus 14 ~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 14 MEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred cccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 3456667777999999999999999999999999999999999999988889999998876666 48999987765 666
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcc
Q 023058 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~ 168 (288)
.+.+++++||++.|+|..-+... .+.+...+.++.|+++|+.|+|+.++||||||.+||+|-....-++||||||.+..
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred CceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccc
Confidence 78999999999999998766443 47889999999999999999999999999999999999655555899999998863
Q ss_pred cccCCCCCCCcCCCcccCCccccCcc---c-CCCccchhhHHHHHHHHHhCCCCCCCCCCch-hHHHHHHHHhhcccCCC
Q 023058 169 SVLHSQPKSTVGTPAYIAPEVLLKKE---Y-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-NFRKTIHRILSVQYSIP 243 (288)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~---~-~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 243 (288)
.... -...-....|.+||...... + ..+.+|+|.||++++.+++|..||......+ ...+......+.....|
T Consensus 173 ~g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 173 VGTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred cCce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence 3221 12222455688998764321 1 2333899999999999999999998543322 22333333333333444
Q ss_pred C-CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhhhcC
Q 023058 244 D-YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLLVAS 288 (288)
Q Consensus 244 ~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~~~ 288 (288)
. -...++.+..+.++-|.++|++|=-..++...-...|.+..+++
T Consensus 251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t 296 (378)
T KOG1345|consen 251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKT 296 (378)
T ss_pred hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhcc
Confidence 3 23467888899999999999999555555665667777766653
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=246.69 Aligned_cols=241 Identities=29% Similarity=0.359 Sum_probs=187.8
Q ss_pred eeeeeeeeccCce-EEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEEeccC
Q 023058 23 YELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYAS 100 (288)
Q Consensus 23 y~~~~~lg~g~~~-~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (288)
|.-.+.+|.|+.| .||++.. .++.||||.+-.. ..+...+|+..++.. .||||++++..=.+....|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 3445677898887 6788887 4789999987643 334678999999988 69999999988888889999999995
Q ss_pred CCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC---CCCCCEEEeecCCCcccccCC
Q 023058 101 GGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 101 ~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~---~~~~~~~l~df~~~~~~~~~~ 173 (288)
. +|.+++.... .......+.++.|++.||++||+.+||||||||+||+|+. ++..+++|.|||++.....+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 5 9999997741 1222556788999999999999999999999999999976 465679999999998665544
Q ss_pred CC----CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhC-CCCCCCCCCchhHHHHHHHHhhcccCCCCCCC-
Q 023058 174 QP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH- 247 (288)
Q Consensus 174 ~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 247 (288)
.. ....|+-.|.|||++........ .|||||||++|..++| .+||...-. ....+..+.+.+.....
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~a-vDiFslGCvfyYvltgG~HpFGd~~~------R~~NIl~~~~~L~~L~~~ 738 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQA-VDIFSLGCVFYYVLTGGSHPFGDSLE------RQANILTGNYTLVHLEPL 738 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcc-cchhhcCceEEEEecCCccCCCchHH------hhhhhhcCccceeeeccC
Confidence 43 34468999999999987776665 9999999999988875 899986422 11233344443322111
Q ss_pred CCHHHHHHHHHhcccCcCCccccccccc
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+.+..+||.+|++++|..||++.+++.
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1128899999999999999999999988
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=223.42 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=191.6
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeec---CccchHHHHHHHHHHhhCCCCceeeEeEEEEcCC-----eEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 93 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 93 (288)
..+-.+.||.|.||+||.+.+..+|+.|++|++.. +-...+++.+|+.++.-.+|.|++..+++..-.. ..|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 34556899999999999999999999999998754 2344567889999999999999999998875442 356
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
++.|.+.. +|..++-.-..++...++-+++||++||+|||+.||.||||||.|.+|++|.. +||||||+++......
T Consensus 134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchhh
Confidence 77787744 67766666677999999999999999999999999999999999999977666 9999999998554433
Q ss_pred CC--CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH---------------HHHHH--
Q 023058 174 QP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR---------------KTIHR-- 234 (288)
Q Consensus 174 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~---------------~~~~~-- 234 (288)
.. ....-|-.|.|||.+.+...-+.+.||||.||++.||+.+...|.....-.... ..+.+
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 22 223356789999999887766666999999999999998888887644322211 11111
Q ss_pred --HhhcccCCC---------CCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 235 --ILSVQYSIP---------DYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 235 --~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+.+.....| .......+...++.++|.+||.+|.+..+++.
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 111111111 11223346778899999999999999988877
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=208.17 Aligned_cols=196 Identities=44% Similarity=0.718 Sum_probs=172.0
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccC
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (288)
|.+.+.||.|+++.||++.+..+++.+++|.+..... ..+.+.+|++.+++++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 6788999999999999999998889999999886543 46788899999999999999999999999899999999999
Q ss_pred CCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC--CCCC
Q 023058 101 GGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKS 177 (288)
Q Consensus 101 ~~~L~~~~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~--~~~~ 177 (288)
+++|.+.+..... ++...+..++.+++.++.+||+.+++|+|++|.||+++.++. ++|+|||.+....... ....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~--~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL--VKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeCceeeEecCcccccccc
Confidence 9899999987766 899999999999999999999999999999999999987765 9999999887654443 2344
Q ss_pred CcCCCcccCCccc-cCcccCCCccchhhHHHHHHHHHhCCCCCCC
Q 023058 178 TVGTPAYIAPEVL-LKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221 (288)
Q Consensus 178 ~~~~~~~~aPE~~-~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~ 221 (288)
..+...|++||.+ ....++. ++|+|+||+++++|++|..||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccc
Confidence 4577789999998 5555555 49999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=221.80 Aligned_cols=255 Identities=23% Similarity=0.356 Sum_probs=198.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcC---CCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 95 (288)
.+.|.++.+||+|+|++||++.+.. ..+.||+|.+.... ...++.+|++.+..+ .+.||+++.+++..++.+.+|
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 4789999999999999999999876 78899999987644 456799999999999 589999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc------
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS------ 169 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~------ 169 (288)
+||++.....++... ++..++..+++.++.||.++|.+|||||||||+|++.+.... +-.|+|||++...
T Consensus 114 lp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~~~~~ 189 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDGYQQT 189 (418)
T ss_pred ecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC-CceEEechhHHHHHhhhhh
Confidence 999998888777744 678999999999999999999999999999999999986554 6899999998510
Q ss_pred -----------cc-CCC----------------C-----------CCCcCCCcccCCccccCcccCCCccchhhHHHHHH
Q 023058 170 -----------VL-HSQ----------------P-----------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 210 (288)
Q Consensus 170 -----------~~-~~~----------------~-----------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~ 210 (288)
.+ .+. . -...||+.|.|||++.+.+.-+.+.|+||.|+++.
T Consensus 190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L 269 (418)
T KOG1167|consen 190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL 269 (418)
T ss_pred hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence 00 000 0 01137899999999987776666699999999999
Q ss_pred HHHhCCCCCCCCCC-chhHHHHH-----------------------------------------HHHhhccc---CCCC-
Q 023058 211 VMLVGAYPFEDPEE-PKNFRKTI-----------------------------------------HRILSVQY---SIPD- 244 (288)
Q Consensus 211 ~l~~g~~pf~~~~~-~~~~~~~~-----------------------------------------~~~~~~~~---~~~~- 244 (288)
.++++..||....+ ......+. ..+.+... ....
T Consensus 270 slls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~ 349 (418)
T KOG1167|consen 270 SLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG 349 (418)
T ss_pred hhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence 99999999864322 00000000 00000000 0001
Q ss_pred CCCCCHHHHHHHHHhcccCcCCccccccccc-cchh
Q 023058 245 YVHISPECRHLISRIFVADPAKVSMHFHATG-VYMH 279 (288)
Q Consensus 245 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~ 279 (288)
....|..+.+|+.+||..||.+|.|++++|. .|++
T Consensus 350 ~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 350 SDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred cccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 1234568999999999999999999999988 5554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=202.35 Aligned_cols=253 Identities=23% Similarity=0.181 Sum_probs=197.3
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCC-cEEEEEEeecCccc-hHHHHHHHHHHhhCC----CCceeeEeEEE-EcCCeEEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKI-DENVQREIINHRSLR----HPNIVRFKEVI-LTPTHLAI 94 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~iK~~~~~~~~-~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~~l 94 (288)
+|.+.++||+|+||.||.+.+..++ ..+|+|+....... ...+..|..++..+. .++++.+++.+ ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999998764 57888876654222 226788888888886 36899999999 57788999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-C--CCEEEeecCCCccc
Q 023058 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-A--PRLKICDFGYSKSS 169 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~-~--~~~~l~df~~~~~~ 169 (288)
||+.+ |.+|.++.... +.++..++..++.|++.+|++||+.|++||||||.|+.+.... . ..+.|.|||+++..
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99988 66999988554 4799999999999999999999999999999999999997553 1 35999999999822
Q ss_pred c--cCC--------C-CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 023058 170 V--LHS--------Q-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238 (288)
Q Consensus 170 ~--~~~--------~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (288)
. ... . .....||..|+++..+.+...+.. .|+|||++++.++..|..||..........+........
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~ 256 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL 256 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence 2 111 1 123348999999999999999888 999999999999999999998776544433332222222
Q ss_pred ccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 239 QYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.... .....+..+.++...+-..+...+|....+...+
T Consensus 257 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l 294 (322)
T KOG1164|consen 257 LTDR-FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELL 294 (322)
T ss_pred cccc-ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence 2111 1224567888888888888999999987776543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=202.43 Aligned_cols=248 Identities=17% Similarity=0.201 Sum_probs=196.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCC-----CcEEEEEEeecCccch--HHHHHHHHHHhhCCCCceeeEeEEEEcC-Ce
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVILTP-TH 91 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~iK~~~~~~~~~--~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~ 91 (288)
..+++....+.+|.||.||.+.+.+. .+.+.+|.++...+.. ..+..|.-.+..+.|||+.++.++...+ ..
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 35677788889999999999976532 2345666655443332 4577888888888999999999987654 57
Q ss_pred EEEEEeccCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeec
Q 023058 92 LAIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df 163 (288)
.++++.+.+.++|..++.. .+.++..++..++.|++.|++|||+.|++|.||-..|.++++.- ++||+|-
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L--qVkltDs 440 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL--QVKLTDS 440 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe--eEEeccc
Confidence 8899999999999999862 12477888899999999999999999999999999999998664 4999999
Q ss_pred CCCcccccCCCC---CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcc
Q 023058 164 GYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQ 239 (288)
Q Consensus 164 ~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (288)
.+++..-+.+.. ...-....|++||.+.+..+++. +|+||||+++|||++ |..|+..-+..+-. ......
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPfEm~-----~ylkdG 514 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPFEME-----HYLKDG 514 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHHHHH-----HHHhcc
Confidence 998755444332 11224557999999999999887 999999999999997 88998876543322 223445
Q ss_pred cCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 240 YSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+.+.++-++|+++..++.-||+..|++||+.+|+..
T Consensus 515 yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 556666699999999999999999999999998866
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=231.84 Aligned_cols=194 Identities=16% Similarity=0.186 Sum_probs=137.6
Q ss_pred hCCC-CceeeEeEEE-------EcCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCC
Q 023058 73 SLRH-PNIVRFKEVI-------LTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 143 (288)
Q Consensus 73 ~l~~-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl 143 (288)
.++| .||+.+.+++ ...+.++.++|++ +++|.+++.. ...++..+++.+++||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3444 4666777766 2234567788887 5599999965 346999999999999999999999999999999
Q ss_pred CCCceEecCCC-----------------CCCEEEeecCCCcccccCC-----------------CCCCCcCCCcccCCcc
Q 023058 144 KLENTLLDGSP-----------------APRLKICDFGYSKSSVLHS-----------------QPKSTVGTPAYIAPEV 189 (288)
Q Consensus 144 ~p~nilv~~~~-----------------~~~~~l~df~~~~~~~~~~-----------------~~~~~~~~~~~~aPE~ 189 (288)
||+||+++..+ ...++++|||+++...... ......+++.|+|||.
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999996422 2346677777765321100 0011246888999999
Q ss_pred ccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccc
Q 023058 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSM 269 (288)
Q Consensus 190 ~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt 269 (288)
+.+..++.+ +|||||||++|||++|..|+.... ........... .+......+...+++.+||+++|.+||+
T Consensus 187 ~~~~~~~~~-sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 187 DNGSSSNCA-SDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL-----PPQILLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred hccCCCCch-hhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc-----ChhhhhcCHHHHHHHHHhCCCChhhCcC
Confidence 988888766 999999999999999888765321 11111111111 1111122456778999999999999999
Q ss_pred cccccc
Q 023058 270 HFHATG 275 (288)
Q Consensus 270 ~~~~l~ 275 (288)
+.++++
T Consensus 259 ~~eil~ 264 (793)
T PLN00181 259 MSELLQ 264 (793)
T ss_pred hHHHhh
Confidence 998877
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=180.93 Aligned_cols=255 Identities=22% Similarity=0.245 Sum_probs=201.2
Q ss_pred CCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC-CCceeeEeEEEEcCCe
Q 023058 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTH 91 (288)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 91 (288)
..+-.+..++|.++++||.|+||.+|.+..-.+|+.||||+-. +...-..+.-|..+.+.++ ..+|+.+..++....+
T Consensus 7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es-~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLES-SKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeec-ccCCCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 3455667899999999999999999999999999999999543 3434456778888888886 4678888888888889
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCC-CEEEeecCCCccc
Q 023058 92 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSS 169 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~-~~~l~df~~~~~~ 169 (288)
-.+||+.. |.+|.++++- ...++..+++-++-|++.-++|+|..+++||||||+|++..-+..+ ++.|+|||++...
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999998 6699988864 4579999999999999999999999999999999999999654443 5899999999744
Q ss_pred ccC--------CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccC
Q 023058 170 VLH--------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241 (288)
Q Consensus 170 ~~~--------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
... .......||..|.+-.++.+...+.. .|+-|+|+++..+.-|..||.+.......++ ...+.....+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~tk~QK-yEkI~EkK~s 242 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAATKKQK-YEKISEKKMS 242 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhh-hhhhhhcceeeeeecCCCcccccchhhHHHH-HHHHHHhhcC
Confidence 332 33344568899999998888888777 9999999999999999999998766443332 2333333333
Q ss_pred CCC---CCCCCHHHHHHHHHhcccCcCCccccc
Q 023058 242 IPD---YVHISPECRHLISRIFVADPAKVSMHF 271 (288)
Q Consensus 242 ~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~ 271 (288)
.+. ..+.|.++...+.-|-..--.+-|...
T Consensus 243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 331 457888998888888777666666653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-27 Score=187.02 Aligned_cols=249 Identities=22% Similarity=0.258 Sum_probs=199.6
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
.-+-+|+|.++||+|+||+.+.+.+.-++++|||| +++....+..+..|....+.| ..++|+.++.++..+.+-.+|+
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIK-fEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIK-FEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEE-eccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 34568999999999999999999999999999999 666667778899999999999 5799999999998888899999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCC---CEEEeecCCCcccccC
Q 023058 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP---RLKICDFGYSKSSVLH 172 (288)
Q Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~---~~~l~df~~~~~~~~~ 172 (288)
|.. |-+|.+++.-- .+|+..++..++.|++.-++++|+..++.|||||+|++|...++. .+.++|||++.....+
T Consensus 104 dLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 998 66999998754 469999999999999999999999999999999999999654432 4889999999865554
Q ss_pred CC--------CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC-
Q 023058 173 SQ--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP- 243 (288)
Q Consensus 173 ~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 243 (288)
.. .+...||..||+--.+.+...+.. .|+-|||.++...+-|.+||.+......- ..+..+-.....-+
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA~tnK-~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKADTNK-EKYEKIGETKRSTPI 260 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccCcchH-HHHHHhccccccCCH
Confidence 44 344568999999999999998887 99999999999999999999987653332 22222222221111
Q ss_pred --CCCCCCHHHHHHHHHhcccCcCCcccc
Q 023058 244 --DYVHISPECRHLISRIFVADPAKVSMH 270 (288)
Q Consensus 244 --~~~~~~~~l~~li~~~l~~~p~~Rpt~ 270 (288)
-..+.|.++..-+.-.-+.+-.+-|+.
T Consensus 261 ~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 261 EVLCEGFPEEFATYLRYVRRLDFFETPDY 289 (449)
T ss_pred HHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence 123567777777766665666666655
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=181.34 Aligned_cols=159 Identities=20% Similarity=0.225 Sum_probs=120.6
Q ss_pred CchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCcC
Q 023058 102 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180 (288)
Q Consensus 102 ~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 180 (288)
|+|.+++.. ...+++.+++.++.|++.||.|||+.+ ||+||+++.++. +++ ||++...... ...+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc----cCCC
Confidence 578888876 446999999999999999999999998 999999987776 787 9987654332 2257
Q ss_pred CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchh-HHHHHHHHhhcccC-CCCCCCCCH--HHHHHH
Q 023058 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSVQYS-IPDYVHISP--ECRHLI 256 (288)
Q Consensus 181 ~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~--~l~~li 256 (288)
++.|+|||.+.+..++.+ +||||+|+++|+|++|..||........ .............. .+....+++ .+.++|
T Consensus 67 ~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred cccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 899999999988888776 9999999999999999999976543222 22222221111110 011112333 699999
Q ss_pred HHhcccCcCCccccccccc
Q 023058 257 SRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 257 ~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+||+.+|.+||++.++++
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~ 164 (176)
T smart00750 146 RVCASRLPQRREAANHYLA 164 (176)
T ss_pred HHHHhcccccccCHHHHHH
Confidence 9999999999999988877
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=189.29 Aligned_cols=167 Identities=17% Similarity=0.172 Sum_probs=127.9
Q ss_pred CCCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcC-CCcEEEEEEeecC------ccchHHHHHHHHHHhhCCCCceee-
Q 023058 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVR- 81 (288)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~- 81 (288)
||.+++.. .++|.+.+.||+|+||+||+|.+.. ++..+|+|+.... ....+.+.+|++++++++|+|+++
T Consensus 9 ~~~~~~~~--~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~ 86 (365)
T PRK09188 9 PGDQIPAL--SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ 86 (365)
T ss_pred cccccccc--cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence 44554443 5789999999999999999999876 6777899986532 122456889999999999999985
Q ss_pred EeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCC-CCCceEecCCCCCCEEE
Q 023058 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL-KLENTLLDGSPAPRLKI 160 (288)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl-~p~nilv~~~~~~~~~l 160 (288)
+++. +..++||||+++++|.. .. ... ...++.+++.+|.+||+.||+|||| ||+||+++.++. ++|
T Consensus 87 l~~~----~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikL 153 (365)
T PRK09188 87 LLAT----GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE--AAV 153 (365)
T ss_pred EEEc----CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC--EEE
Confidence 4432 45799999999988863 21 111 1467899999999999999999999 999999976665 999
Q ss_pred eecCCCcccccCCCC---------CCCcCCCcccCCcccc
Q 023058 161 CDFGYSKSSVLHSQP---------KSTVGTPAYIAPEVLL 191 (288)
Q Consensus 161 ~df~~~~~~~~~~~~---------~~~~~~~~~~aPE~~~ 191 (288)
+|||++......... ....+++.|.+||.+.
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 999999855443221 1224677789999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-27 Score=213.10 Aligned_cols=257 Identities=31% Similarity=0.487 Sum_probs=196.7
Q ss_pred CCe-eeeeeeeccCceEEEEEEEcCCCcEEEEEEee----cCccc---hHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 21 DRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIE----RGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 21 ~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~----~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
+.| .-...+|.|.+|.|+.+......+.+..|.+. ..... ...+..|+-+-..+.|+|++.....+......
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 345 45677899999988888877666666666543 21111 11255677777888999998887777666555
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
.-.||||++ +|..++...+.+...++--+++|++.|++|+|+.|+.|+|+|++|+++..++. +|++|||.+.....+
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYP 473 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccC
Confidence 555999999 99999988888999999999999999999999999999999999999998887 999999998765555
Q ss_pred CCC-----CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc---CCCC
Q 023058 173 SQP-----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY---SIPD 244 (288)
Q Consensus 173 ~~~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~ 244 (288)
.+. ....|+..|+|||.+.+..|++...||||.|+++..|.+|+.||......+.............. ...-
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL 553 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence 443 33458889999999999999999999999999999999999999876654432111100000000 1111
Q ss_pred CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 245 YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 245 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
...+|...+.+|.+||+.+|.+|.|++++++ .+|++
T Consensus 554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~---d~W~~ 589 (601)
T KOG0590|consen 554 LSLLPRETRIIIYRMLQLDPTKRITIEQILN---DEWIR 589 (601)
T ss_pred HHhchhhHHHHHHHHccCChhheecHHHHhh---ChHhh
Confidence 2357889999999999999999999988876 45544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-23 Score=178.11 Aligned_cols=249 Identities=36% Similarity=0.573 Sum_probs=195.7
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc----chHHHHHHHHHHhhCCCC-ceeeEeEEEEcCCeEEEEEe
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e 97 (288)
|.+.+.||.|+|+.||.+.+. ..+++|.+..... ....+.+|+..+..+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999997 6789998876432 356788999999999988 79999999988788899999
Q ss_pred ccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-
Q 023058 98 YASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~- 173 (288)
++.++++...+.... .++......++.|++.++.++|+.|++|+|+||+||+++.... .++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCc
Confidence 999999997776654 7999999999999999999999999999999999999987662 38999999887443332
Q ss_pred ------CCCCCcCCCcccCCccccCc--ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccC-CCC
Q 023058 174 ------QPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPD 244 (288)
Q Consensus 174 ------~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 244 (288)
......++..|.+||.+.+. .......|+|++|+++++++.|..||...............+...... ...
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 23566789999999999874 344444999999999999999999977665421112222222222211 111
Q ss_pred C--CCC----CHHHHHHHHHhcccCcCCccccccccc
Q 023058 245 Y--VHI----SPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 245 ~--~~~----~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
. ... ...+.+++..++..+|..|.+..+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 1 111 257999999999999999999977665
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=181.14 Aligned_cols=232 Identities=22% Similarity=0.268 Sum_probs=150.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc----chHHHHHHHHHHhhCC----------CCceeeEeEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLR----------HPNIVRFKEV 85 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~----------~~~i~~~~~~ 85 (288)
..++...+.||.|+++.||.+++..+++.+++|++..... ..+.+++|.-....+. |-.++..++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 3567889999999999999999999999999999865432 2234555554443332 2234444444
Q ss_pred EEcC------------C-----eEEEEEeccCCCchHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHhhcCceec
Q 023058 86 ILTP------------T-----HLAIVMEYASGGELFERIC---NAGR----FSEDEARFFFQQLISGVSYCHSMQVCHR 141 (288)
Q Consensus 86 ~~~~------------~-----~~~lv~e~~~~~~L~~~~~---~~~~----~~~~~~~~i~~~i~~~l~~LH~~~i~H~ 141 (288)
.... . ..+++|+-+ .++|..++. .... +.......+..|+++.+++||+.|++|+
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg 169 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG 169 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence 4321 1 236788877 448877653 2221 3344555677899999999999999999
Q ss_pred CCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCcCCCcccCCccccCc--------ccCCCccchhhHHHHHHHHH
Q 023058 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK--------EYDGKIADVWSCGVTLYVML 213 (288)
Q Consensus 142 dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Di~slG~~~~~l~ 213 (288)
||+|+|++++.++. +.|+||+........... ...+..|.+||..... .++. +.|.|+||+++|.|+
T Consensus 170 di~~~nfll~~~G~--v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~-~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGG--VFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTF-ATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS---EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-H-HHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCC--EEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeee-ccCHHHHHHHHHHHH
Confidence 99999999998887 999999876543332222 3344678888876432 2333 379999999999999
Q ss_pred hCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCc
Q 023058 214 VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKV 267 (288)
Q Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 267 (288)
++..||......... ...+....++|+.+++||..+|++||.+|
T Consensus 245 C~~lPf~~~~~~~~~----------~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADP----------EWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTS----------GGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccc----------cccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999999865432211 11445555799999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=208.49 Aligned_cols=238 Identities=23% Similarity=0.341 Sum_probs=181.5
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHH--HhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIIN--HRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~--l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
+|...+.||.+.|=.|.++++.. | .|++|++-+.. .....+.+.++- ....++||++++..+-..++..|+|.+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 78899999999999999999863 3 49999986543 222333333322 455589999999998888888999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC-
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 176 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~- 176 (288)
|... +|.+.+..++.+...+.+.|+.|++.||..+|..||+|||||.+||++++-+- +.|+||...+....+....
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW--~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW--LYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech--hhhhcccccCCccCCCCCcc
Confidence 9955 99999988888999999999999999999999999999999999999987665 8999998775433322221
Q ss_pred -------CCcCCCcccCCccccCcc---------c-CCCccchhhHHHHHHHHHh-CCCCCCCC------CC-chhHHHH
Q 023058 177 -------STVGTPAYIAPEVLLKKE---------Y-DGKIADVWSCGVTLYVMLV-GAYPFEDP------EE-PKNFRKT 231 (288)
Q Consensus 177 -------~~~~~~~~~aPE~~~~~~---------~-~~~~~Di~slG~~~~~l~~-g~~pf~~~------~~-~~~~~~~ 231 (288)
+.....+|.|||.+.... . -.++.||||+||++.||++ |++||... .. ....+..
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 223556899999986421 1 2344899999999999987 67777521 00 1222222
Q ss_pred HHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCcccccccccc
Q 023058 232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
+.++ -+..++.+|..|++.||.+|.++++.|+.
T Consensus 259 Le~I------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 259 LEKI------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhC------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 2221 13579999999999999999999999985
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=169.82 Aligned_cols=170 Identities=15% Similarity=0.176 Sum_probs=130.3
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHH----------HHHHHHHHhhCCCCceeeEeEEEEc
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----------VQREIINHRSLRHPNIVRFKEVILT 88 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~----------~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (288)
..++|++.+.||.|+||.||++.+ ++..+|+|++.......+. +.+|+..+.++.|++|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 468999999999999999999766 4668999999754332222 5789999999999999999988664
Q ss_pred C--------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEE
Q 023058 89 P--------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (288)
Q Consensus 89 ~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l 160 (288)
. +..+++|||++|.+|.+.. .++. ....+++.++..+|+.|++|+|++|+||+++.++ ++|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~l 175 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRI 175 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEE
Confidence 3 3578999999999997763 2232 2456999999999999999999999999998655 999
Q ss_pred eecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHH
Q 023058 161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213 (288)
Q Consensus 161 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~ 213 (288)
+|||............ .......++.+ +|+|+||+++..+.
T Consensus 176 iDfg~~~~~~e~~a~d-----------~~vler~y~~~-~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAKD-----------RIDLERHYGIK-NEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhHH-----------HHHHHhHhccc-ccccceeEeehHHH
Confidence 9999776442211110 02334445544 99999999987665
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=165.32 Aligned_cols=137 Identities=20% Similarity=0.201 Sum_probs=108.7
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc----------h-----------------HHHHHHHHHHhhCCCCc
Q 023058 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------D-----------------ENVQREIINHRSLRHPN 78 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----------~-----------------~~~~~e~~~l~~l~~~~ 78 (288)
...||+|++|.||+|.+. +|+.||+|++..+... . ....+|+..+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999997 8999999998764211 0 12234999999998877
Q ss_pred eeeEeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhcCceecCCCCCceEecCCCCCC
Q 023058 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLLDGSPAPR 157 (288)
Q Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~i~H~dl~p~nilv~~~~~~~ 157 (288)
+.....+... ..++||||++++++.........++...+..++.|++.+|.++ |+.|++|+||||+||+++. + +
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~--~ 155 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G--K 155 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C--c
Confidence 6544333222 2389999999877765544556789999999999999999999 6999999999999999983 3 4
Q ss_pred EEEeecCCCcc
Q 023058 158 LKICDFGYSKS 168 (288)
Q Consensus 158 ~~l~df~~~~~ 168 (288)
++|+|||++..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999998864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=175.23 Aligned_cols=195 Identities=29% Similarity=0.407 Sum_probs=144.2
Q ss_pred CCCceeeEeEEEEc---------------------------CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHH
Q 023058 75 RHPNIVRFKEVILT---------------------------PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127 (288)
Q Consensus 75 ~~~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~ 127 (288)
+|||||++...|.+ +..+|+||...+. +|..++.... .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence 59999999887653 2358999998855 8998886543 46677777889999
Q ss_pred HHHHHHhhcCceecCCCCCceEe--cCCCCCCEEEeecCCCccccc-------CCCCCCCcCCCcccCCccccCcc----
Q 023058 128 SGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVL-------HSQPKSTVGTPAYIAPEVLLKKE---- 194 (288)
Q Consensus 128 ~~l~~LH~~~i~H~dl~p~nilv--~~~~~~~~~l~df~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~---- 194 (288)
+|+.|||+.|+.|||+|.+||++ ++++.+...+.|||++-.... ....-...|.-..+|||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999999 567777899999998642111 11112234666789999876432
Q ss_pred -cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccc
Q 023058 195 -YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHA 273 (288)
Q Consensus 195 -~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 273 (288)
.+..++|.|+.|.+.||++....||....+...-...++ ....+..|+ .+|+.+++++..+|+.||++|++..=+
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq--e~qLPalp~--~vpp~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ--ESQLPALPS--RVPPVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh--hhhCCCCcc--cCChHHHHHHHHHhcCCccccCCccHH
Confidence 233348999999999999999999987433221111111 122334444 799999999999999999999998655
Q ss_pred cc
Q 023058 274 TG 275 (288)
Q Consensus 274 l~ 275 (288)
..
T Consensus 508 AN 509 (598)
T KOG4158|consen 508 AN 509 (598)
T ss_pred Hh
Confidence 44
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.8e-23 Score=159.65 Aligned_cols=139 Identities=18% Similarity=0.145 Sum_probs=110.4
Q ss_pred eeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc---------------------------hHHHHHHHHHHhhCCCC
Q 023058 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------------------------DENVQREIINHRSLRHP 77 (288)
Q Consensus 25 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---------------------------~~~~~~e~~~l~~l~~~ 77 (288)
+...||+|++|+||+|.+. +|+.||+|++...... ......|...+.++.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 8999999998764211 11235788999999999
Q ss_pred ceeeEeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCCC
Q 023058 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAP 156 (288)
Q Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~~ 156 (288)
++.....+.... .++||||++++++.........++......++.|++.++.++|+ .|++|+||||+||+++ ++.
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~- 155 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK- 155 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC-
Confidence 876554444332 48999999887554433344567889999999999999999999 9999999999999998 444
Q ss_pred CEEEeecCCCccc
Q 023058 157 RLKICDFGYSKSS 169 (288)
Q Consensus 157 ~~~l~df~~~~~~ 169 (288)
++|+|||++...
T Consensus 156 -~~liDFG~a~~~ 167 (190)
T cd05145 156 -PYIIDVSQAVEL 167 (190)
T ss_pred -EEEEEcccceec
Confidence 999999998744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-24 Score=167.06 Aligned_cols=248 Identities=21% Similarity=0.325 Sum_probs=194.2
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeec---CccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
++.+...+..+|.+...|+.|+++++.+ .++.|++.. ......++..|.-.++-..||||+++++.+..+-.+.+
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 3445667788899999999999999744 466666543 33444567788888899999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcC--ceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 95 VMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~LH~~~--i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
+..|++.++|...+++... .+..+..+++.++++|+.|||+.. |.---|+...++++.+-++++...|--++.
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--- 341 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--- 341 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---
Confidence 9999999999999987654 678899999999999999999876 445568889999999888777777654432
Q ss_pred cCCCCCCCcCCCcccCCccccCcccC--CCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCC
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~--~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
+..-..-.|.|++||.+...+.+ ..++|+|||+++++||.|+..||......+.=-++ .....+...|. ++
T Consensus 342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki--aleglrv~ipp--gi 414 (448)
T KOG0195|consen 342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI--ALEGLRVHIPP--GI 414 (448)
T ss_pred ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh--hhccccccCCC--Cc
Confidence 22234457889999999877654 44589999999999999999999877653322111 12233344555 78
Q ss_pred CHHHHHHHHHhcccCcCCccccccccccc
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
+..+..|+.-|.+.||.+||....+.-.+
T Consensus 415 s~hm~klm~icmnedpgkrpkfdmivpil 443 (448)
T KOG0195|consen 415 SRHMNKLMNICMNEDPGKRPKFDMIVPIL 443 (448)
T ss_pred cHHHHHHHHHHhcCCCCcCCCcceehhhH
Confidence 99999999999999999999998775443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-22 Score=154.85 Aligned_cols=186 Identities=17% Similarity=0.151 Sum_probs=138.3
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchH-----HHHHHHHHHhhCC-CCceeeEeEEEEcCCeEEEEE
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-----NVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~-----~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 96 (288)
.-+...|+.|+||+|+.+.. .+.+++.+.+........ .+.+|+++++++. +++++.++++ ...+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 45678899999999997776 577788777766554333 5789999999995 5889999886 3469999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCC-CCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl-~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
+|+.|.+|...... ....++.|++.+|.++|+.|++|+|| +|+||+++.++. ++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS--PAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC--EEEEECCCceecCCcchH
Confidence 99999888654321 12357789999999999999999999 799999987665 999999999754433211
Q ss_pred ----C----------CCcCCCcccCCccccCc-ccCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 023058 176 ----K----------STVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 223 (288)
Q Consensus 176 ----~----------~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~pf~~~~ 223 (288)
. ....++.+++|+...-- ..+-.+.+.++.|+-+|.++|+..+.....
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 01146667777654322 222233688899999999999998876543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-24 Score=184.37 Aligned_cols=236 Identities=28% Similarity=0.484 Sum_probs=192.1
Q ss_pred eeccCceEEEEEEE---cCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCC-CCceeeEeEEEEcCCeEEEEEeccCC
Q 023058 29 IGSGNFGVARLMRD---KKTEELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASG 101 (288)
Q Consensus 29 lg~g~~~~v~~~~~---~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (288)
+|+|.+|.|++++. .+.+..|++|+..+.. ........|..++..++ ||.+++++..+..+...+++.++..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 68999999987764 3457788999876532 11124556778888886 99999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCcCC
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 181 (288)
+.+...+.....+.......+...++-+++++|+.|++|+|+|++||+++.+|. +++.|||+++........ +|+
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~~---cgt 156 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKIA---CGT 156 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhhc---ccc
Confidence 999888888888899999999999999999999999999999999999998887 999999998855444333 889
Q ss_pred CcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcc
Q 023058 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 261 (288)
Q Consensus 182 ~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 261 (288)
..|+|||++. ..... .|.||+|+++++|++|..||.. .....+.......|. ..+...++++..++.
T Consensus 157 ~eymApEI~~--gh~~a-~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 157 YEYRAPEIIN--GHLSA-ADWWSFGVLAFELLTGTLPFGG--------DTMKRILKAELEMPR--ELSAEARSLFRQLFK 223 (612)
T ss_pred hhhhhhHhhh--ccCCc-ccchhhhhhHHHHhhCCCCCch--------HHHHHHhhhccCCch--hhhHHHHHHHHHHHh
Confidence 9999999987 23333 8999999999999999999987 334444444545555 788999999999999
Q ss_pred cCcCCcccc--ccccccchhhhh
Q 023058 262 ADPAKVSMH--FHATGVYMHTKL 282 (288)
Q Consensus 262 ~~p~~Rpt~--~~~l~~~~~~~~ 282 (288)
.+|..|... ..+.+...|+++
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~ 246 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFF 246 (612)
T ss_pred hCHHHHhccCcchhHHHhccchh
Confidence 999999887 344445555544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=183.32 Aligned_cols=228 Identities=31% Similarity=0.476 Sum_probs=172.6
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
........|..++.+..|.+|.||.++|+.+...+|+|+ .+..-.... ++.....|.+|
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~lilRn------ilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILRN------ILTFAGNPFVV-------------- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccchhhhc------cccccCCccee--------------
Confidence 334455889999999999999999999999999999964 322211110 22233333333
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
++=...+.+.++++... +.+++|||+.||+|+|+||+|.+|+.-+. +|++|||++........
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhcc
Confidence 23334455555555544 78899999999999999999999987776 99999999863222111
Q ss_pred ----------------CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 023058 175 ----------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238 (288)
Q Consensus 175 ----------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (288)
.+...+||.|.|||++....|.-+ .|.|++|+++|+.+.|..||.+.+.++.+...+...
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkp-vdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~--- 274 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD--- 274 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCC-ccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh---
Confidence 234468999999999999989777 999999999999999999999988777776665443
Q ss_pred ccCCCC-CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 239 QYSIPD-YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 239 ~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
..+++ .-..+++.+++|.++|+.+|..|.....+++.-.|.+++++
T Consensus 275 -i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 275 -IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred -ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 33333 22568999999999999999999888888888888887764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.4e-22 Score=181.13 Aligned_cols=194 Identities=24% Similarity=0.331 Sum_probs=155.3
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC---CCceeeEeEEEEcCCeEEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++.|.|-+.||+|+||.||+|.+.. |+.||+|+-.+...+.=-+-. +++.+|+ -+.|..+...+...+...+|+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~--q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICL--QVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehH--HHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 5789999999999999999999987 999999987665544321212 2233333 234555555566677889999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC-----CCCCCEEEeecCCCccccc
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~-----~~~~~~~l~df~~~~~~~~ 171 (288)
+|.+.|+|.++++..+.+++..+..+..|++..++.||..+|+||||||+|+++.. ....-++|+|||.+.-...
T Consensus 774 ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l 853 (974)
T KOG1166|consen 774 EYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL 853 (974)
T ss_pred eccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence 99999999999998888999999999999999999999999999999999999942 2223489999998864333
Q ss_pred CC---CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCC
Q 023058 172 HS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 217 (288)
Q Consensus 172 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~ 217 (288)
.. .-...+.+-.+-++|...|..++.. .|.|.|+.+++.|+.|..
T Consensus 854 fp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 854 FPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHHH
Confidence 22 2244567888999999999999888 999999999999998863
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-20 Score=147.88 Aligned_cols=135 Identities=19% Similarity=0.241 Sum_probs=106.4
Q ss_pred eeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC-ccchHHHHHHHHHHhhC-----CCCceeeEeEEEEcCC---e-EE
Q 023058 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSL-----RHPNIVRFKEVILTPT---H-LA 93 (288)
Q Consensus 24 ~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---~-~~ 93 (288)
.-.+.||+|+++.||. ++.++.. +||++... ....+.+.+|+.+++.+ .||||+++++++.++. . +.
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3457899999999995 6666655 69987754 23446789999999999 5799999999998874 4 33
Q ss_pred EEEec--cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHhhcCceecCCCCCceEecCC--CCCCEEEeecC
Q 023058 94 IVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFG 164 (288)
Q Consensus 94 lv~e~--~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~i~H~dl~p~nilv~~~--~~~~~~l~df~ 164 (288)
+|+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||+.+|+|+||||+||+++.. +..+++|+||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 4478999999664 45555 35677888777 99999999999999999999753 33469999954
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=151.28 Aligned_cols=140 Identities=17% Similarity=0.093 Sum_probs=111.1
Q ss_pred CCeeeeeeeeccCceEEEEEE-EcCCCcEEEEEEeecCccc-------------------------hHHHHHHHHHHhhC
Q 023058 21 DRYELVRDIGSGNFGVARLMR-DKKTEELVAVKYIERGDKI-------------------------DENVQREIINHRSL 74 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~-~~~~~~~~~iK~~~~~~~~-------------------------~~~~~~e~~~l~~l 74 (288)
.-|++.+.||+|++|.||+|. +..+|..||+|++...... ......|+..++++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999999 6678999999998754210 12356799999999
Q ss_pred CCCc--eeeEeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC-ceecCCCCCceEec
Q 023058 75 RHPN--IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-VCHRDLKLENTLLD 151 (288)
Q Consensus 75 ~~~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-i~H~dl~p~nilv~ 151 (288)
.+.+ ++++++. ...++|||++++.+|.........+...+...++.|++.++.+||+.| ++|+|++|+||+++
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 7533 4444443 234899999999887665544455677778899999999999999999 99999999999998
Q ss_pred CCCCCCEEEeecCCCc
Q 023058 152 GSPAPRLKICDFGYSK 167 (288)
Q Consensus 152 ~~~~~~~~l~df~~~~ 167 (288)
++. ++|+|||.+.
T Consensus 184 -~~~--i~LiDFg~a~ 196 (237)
T smart00090 184 -DGK--VVIIDVSQSV 196 (237)
T ss_pred -CCC--EEEEEChhhh
Confidence 444 9999999876
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-20 Score=159.19 Aligned_cols=203 Identities=23% Similarity=0.309 Sum_probs=157.8
Q ss_pred HhhCCCCceeeEeEEEEcCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCc-eecCCCCCce
Q 023058 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQV-CHRDLKLENT 148 (288)
Q Consensus 71 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i-~H~dl~p~ni 148 (288)
++.+.|.|+.++++.+.++...+.|.++|..|+|.+.+... -.++......+.++|+.|++|||...| .|+.++..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 45788999999999999999999999999999999999774 468888888999999999999998765 9999999999
Q ss_pred EecCCCCCCEEEeecCCCcccccC---CCCCCCcCCCcccCCccccCccc------CCCccchhhHHHHHHHHHhCCCCC
Q 023058 149 LLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEY------DGKIADVWSCGVTLYVMLVGAYPF 219 (288)
Q Consensus 149 lv~~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~------~~~~~Di~slG~~~~~l~~g~~pf 219 (288)
+++.... +||.|||+....... ...........|.|||.+..... .+++.|+||+|++++|+++...||
T Consensus 81 lvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 81 LVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred eeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9987777 999999987644321 11111224457999999876421 344589999999999999999999
Q ss_pred CCCCCchhHHHHHHHHhh-cc----cCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 220 EDPEEPKNFRKTIHRILS-VQ----YSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
...............+.. .. +........++++..++.+||..+|..||++.++-.
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 875544433444444444 11 122212256678999999999999999999988765
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-19 Score=142.21 Aligned_cols=134 Identities=22% Similarity=0.212 Sum_probs=111.7
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---------chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++.||+|++|.||++.. .+..+++|....... ...+..+|+.++..+.|++++....++...+..+++|
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36789999999999987 567799997654321 1134678999999999999887777777778889999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcc
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~ 168 (288)
||+++.+|.+.+..... ....++.+++.+|.++|+.|++|+|++|.||+++ ++. ++++|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~--~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGK--IYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCC--EEEEECCcccC
Confidence 99999999988865432 8889999999999999999999999999999998 444 99999998763
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-18 Score=136.71 Aligned_cols=129 Identities=21% Similarity=0.178 Sum_probs=104.2
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeecCcc---------chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 28 ~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
.||+|++|.||++.. ++..+++|....... ...++.+|+++++.+.++++.....++......+++||+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 379999999999995 567899998654221 124567899999999988766655555666777999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcc
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~ 168 (288)
+++++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ ++. ++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~--~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDK--LYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCc--EEEEECCCCcC
Confidence 999999887754321 7899999999999999999999999999998 444 99999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=136.00 Aligned_cols=133 Identities=22% Similarity=0.259 Sum_probs=105.0
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc-----------------------hHHHHHHHHHHhhCCCCc
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI-----------------------DENVQREIINHRSLRHPN 78 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----------------------~~~~~~e~~~l~~l~~~~ 78 (288)
.|.+.+.||+|++|.||++... +++.+++|++..+... ......|+..+..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888999999999999999875 7899999987643211 113567888888887774
Q ss_pred --eeeEeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCC
Q 023058 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (288)
Q Consensus 79 --i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~ 156 (288)
++..++. ...+++|||+++++|...... .....++.+++.++.++|+.|++|+||+|+||+++.++.
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~- 163 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK- 163 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc-
Confidence 4444432 345899999999888654321 345678899999999999999999999999999987665
Q ss_pred CEEEeecCCCc
Q 023058 157 RLKICDFGYSK 167 (288)
Q Consensus 157 ~~~l~df~~~~ 167 (288)
++|+|||.+.
T Consensus 164 -~~liDfg~~~ 173 (198)
T cd05144 164 -IYIIDWPQMV 173 (198)
T ss_pred -EEEEECCccc
Confidence 9999999885
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.8e-20 Score=154.76 Aligned_cols=175 Identities=26% Similarity=0.319 Sum_probs=130.4
Q ss_pred eEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 91 HLAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
++++.|++|...+|.+++.... ..+......++.|++.+++| +|.+|+|++|.||+...+.. ++|+|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhhee
Confidence 5889999999999999996543 46778888999999999999 99999999999999987776 9999999987
Q ss_pred ccccCC-------CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcc
Q 023058 168 SSVLHS-------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQ 239 (288)
Q Consensus 168 ~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (288)
...... ......++.+|++||.+.+..|+.+ .|||+||++++|++. =..++. .......+..+.
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~~f~T~~e-------r~~t~~d~r~g~ 476 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLIQFSTQFE-------RIATLTDIRDGI 476 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHHHhccHHH-------HHHhhhhhhcCC
Confidence 554444 2234468999999999999999888 999999999999985 112221 112222222222
Q ss_pred cCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 240 YSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
++.....+. ++-..|+.+||.+.|.+||++ .....+.|+
T Consensus 477 ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~---~~~~~~~~~ 515 (516)
T KOG1033|consen 477 IPPEFLQDY-PEEYTLLQQLLSPSPEERPSA---IEVALHEFL 515 (516)
T ss_pred CChHHhhcC-cHHHHHHHHhcCCCcccCchH---HHHhhhhhc
Confidence 221111122 345589999999999999944 555555554
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=7e-18 Score=152.02 Aligned_cols=134 Identities=20% Similarity=0.144 Sum_probs=107.9
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---------cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
.|...+.||+|+||+||++..... .+++|+..... ...+++.+|+++++.++|++++....+.......
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 345678999999999999987543 34444322110 1124578899999999999998887777777778
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcc
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~ 168 (288)
++||||+++++|.+.+. ....++.+++.+|.+||+.|++|||++|+||+++ ++. ++|+|||++..
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~~--~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DDR--LYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CCc--EEEEeCccccc
Confidence 99999999999988774 4567899999999999999999999999999994 444 99999998874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.6e-19 Score=159.59 Aligned_cols=254 Identities=31% Similarity=0.470 Sum_probs=200.7
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcC-CCcEEEEEEeecC---ccchHHHHHHHHHHhhCC-CCceeeEeEEEEcCCeEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERG---DKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 94 (288)
...|.+.+.||+|.++.|-.+.... ....++.|.+... ......+..|..+.+.+. |.|++..++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 5789999999999999998888754 3445666655433 333445666888888887 9999999999999999999
Q ss_pred EEeccCCCchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHh-hcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 95 VMEYASGGELFERI-CNAG-RFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 95 v~e~~~~~~L~~~~-~~~~-~~~~~~~~~i~~~i~~~l~~LH-~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
..++..++++...+ .... ..+....-.++.|+..++.|+| ..++.|+|++|+|.+++..+. .+++.||+++.....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRN 177 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhccccc
Confidence 99999898888777 4443 5778888899999999999999 999999999999999987772 389999999986555
Q ss_pred -CCC---CCCCcC-CCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCC
Q 023058 172 -HSQ---PKSTVG-TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (288)
Q Consensus 172 -~~~---~~~~~~-~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
.+. .....+ ++.|.|||...+..+..+..|+||.|+++..+++|..||................. .......+.
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 256 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-GRFTQLPWN 256 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-cccccCccc
Confidence 222 233457 99999999998877777769999999999999999999987665443222111111 222345566
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.++....+++.+++..+|..|.+..++..
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cCChhhhhcccccccCCchhccccccccc
Confidence 78899999999999999999999988765
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-16 Score=128.29 Aligned_cols=133 Identities=20% Similarity=0.222 Sum_probs=102.1
Q ss_pred eeee-ccCceEEEEEEEcCCCcEEEEEEeecCc--------------cchHHHHHHHHHHhhCCCCce--eeEeEEEEcC
Q 023058 27 RDIG-SGNFGVARLMRDKKTEELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNI--VRFKEVILTP 89 (288)
Q Consensus 27 ~~lg-~g~~~~v~~~~~~~~~~~~~iK~~~~~~--------------~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~ 89 (288)
..|| .||.|+||.+... +..+++|.+.... ....+..+|++++.++.|+++ +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 7999999999885 6779999885421 222467889999999998875 6666664332
Q ss_pred C----eEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecC
Q 023058 90 T----HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (288)
Q Consensus 90 ~----~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~ 164 (288)
. ..++|||++++ .+|.+++.. ..++.. .+.+++.++.+||+.||+|+||+|.||+++.++. ++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~--v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGK--FWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC--EEEEECC
Confidence 2 23599999987 688877754 345544 3578999999999999999999999999987665 9999999
Q ss_pred CCcc
Q 023058 165 YSKS 168 (288)
Q Consensus 165 ~~~~ 168 (288)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8763
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.5e-17 Score=125.65 Aligned_cols=134 Identities=21% Similarity=0.255 Sum_probs=95.8
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHH-------------------------HHHHHHHHhhCCCCc--
Q 023058 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-------------------------VQREIINHRSLRHPN-- 78 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~-------------------------~~~e~~~l~~l~~~~-- 78 (288)
.+.||+|++|.||.+.+. ++..||+|++......... ...|...+.++.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999987 7889999998754321111 134555555554433
Q ss_pred eeeEeEEEEcCCeEEEEEeccCCCchH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCCC
Q 023058 79 IVRFKEVILTPTHLAIVMEYASGGELF-ERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAP 156 (288)
Q Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~~L~-~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~~ 156 (288)
++++++. ...+++||+++++.+. ..+.... . ..+...++.+++.++.++|. .|++|+||+|+||+++ ++.
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~- 152 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK- 152 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc-
Confidence 4444443 2358999999884332 1121111 1 16778899999999999999 9999999999999998 554
Q ss_pred CEEEeecCCCccc
Q 023058 157 RLKICDFGYSKSS 169 (288)
Q Consensus 157 ~~~l~df~~~~~~ 169 (288)
++++|||.+...
T Consensus 153 -~~liDfg~a~~~ 164 (187)
T cd05119 153 -VYIIDVPQAVEI 164 (187)
T ss_pred -EEEEECcccccc
Confidence 999999988633
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=2e-16 Score=118.88 Aligned_cols=131 Identities=24% Similarity=0.276 Sum_probs=110.2
Q ss_pred eeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCC--CceeeEeEEEEcCCeEEEEEeccCCC
Q 023058 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGG 102 (288)
Q Consensus 25 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (288)
+++.||.|.++.||++.... ..+++|....... ...+.+|+..++.+++ .++++++.+....+..++++|++.+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 56789999999999999853 6799998766544 5678899999999976 58889988888778899999999887
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc---CceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 103 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 103 ~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~---~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
.+... +......++.+++.++..+|.. +++|+|++|.||+++..+. +++.||+.+.
T Consensus 79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~--~~l~Df~~~~ 137 (155)
T cd05120 79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI--LGIIDWEYAG 137 (155)
T ss_pred ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE--EEEEeccccc
Confidence 66543 5567778899999999999985 7999999999999987554 9999999876
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.3e-17 Score=131.29 Aligned_cols=229 Identities=17% Similarity=0.213 Sum_probs=151.6
Q ss_pred EEEEEEEcCCCcEEEEEEeecC----c-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC-----eEEEEEeccCCCchH
Q 023058 36 VARLMRDKKTEELVAVKYIERG----D-KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLAIVMEYASGGELF 105 (288)
Q Consensus 36 ~v~~~~~~~~~~~~~iK~~~~~----~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~ 105 (288)
.||++.+...|..|+-..++.. . ...+....-...+.++.|.||++++.|+.+.+ ...++.||+..+++.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 4555666555555444333221 1 11122233345566678999999999987754 478899999999999
Q ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC--ceecCCCCCceEecCCCCCCEEEeecCCCcccc-----cCCC
Q 023058 106 ERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-----LHSQ 174 (288)
Q Consensus 106 ~~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~--i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~-----~~~~ 174 (288)
+++++. ..+......+|+-||+.||.|||+.. |+|+++....|++..++. +|++--....... ....
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~E 238 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAE 238 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCce--EEecccCccccchhhhhhhHhh
Confidence 998654 35888899999999999999999986 999999999999986665 7765332211110 0111
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
.....+.+.|.+||.=.....+.. +|||++|....+|..+..--...+........... ..+.+. .+.-++
T Consensus 239 k~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~---~i~~le-----n~lqr~ 309 (458)
T KOG1266|consen 239 KSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN---VIIGLE-----NGLQRG 309 (458)
T ss_pred hhccccCCccccCCcCcccccccc-hhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh---heeecc-----CccccC
Confidence 223346788999997544445455 89999999999998776432222222222221111 111111 234567
Q ss_pred HHHHhcccCcCCccccccccc
Q 023058 255 LISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+|.+|++..|+.||++.+++-
T Consensus 310 ~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 310 SITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred cCcccccCCCCCCcchhhhhc
Confidence 899999999999999987765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1e-13 Score=121.82 Aligned_cols=167 Identities=19% Similarity=0.249 Sum_probs=127.2
Q ss_pred EEEEcCCCcEEEEEEeecCcc-chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHH
Q 023058 39 LMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 117 (288)
Q Consensus 39 ~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 117 (288)
.+..+.++.++.+.+...... ..+...+.+..++.++||||+++++.+..++..|+|+|.+. .|..++.+. ...
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~ 104 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKE 104 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHH
Confidence 355566788888888876554 33557889999999999999999999999999999999874 466666553 367
Q ss_pred HHHHHHHHHHHHHHHHh-hcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-CCCCcCCCcccCCccccCccc
Q 023058 118 EARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEY 195 (288)
Q Consensus 118 ~~~~i~~~i~~~l~~LH-~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~ 195 (288)
.+...++||+.||.+|| +.+++|++|....|+|+..+. ++|++|.+++....... ......--.|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcccChhhcCccc-
Confidence 78888899999999997 678999999999999988877 99999998764433322 11111222355565542222
Q ss_pred CCCccchhhHHHHHHHHHhC
Q 023058 196 DGKIADVWSCGVTLYVMLVG 215 (288)
Q Consensus 196 ~~~~~Di~slG~~~~~l~~g 215 (288)
-..|.|.|||++++++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 125999999999999998
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.1e-13 Score=107.26 Aligned_cols=135 Identities=15% Similarity=0.170 Sum_probs=98.0
Q ss_pred eeeeeccCceEEEEEEEcC------CCcEEEEEEeecC-------------c----------cchHHH----HHHHHHHh
Q 023058 26 VRDIGSGNFGVARLMRDKK------TEELVAVKYIERG-------------D----------KIDENV----QREIINHR 72 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~------~~~~~~iK~~~~~-------------~----------~~~~~~----~~e~~~l~ 72 (288)
...||.|..+.||.|.... .+..+|+|++.-+ + ...+.+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998654 3578999987421 0 111223 37999999
Q ss_pred hCCC--CceeeEeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhcCceecCCCCCceE
Q 023058 73 SLRH--PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTL 149 (288)
Q Consensus 73 ~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~i~H~dl~p~nil 149 (288)
++.. -+++.++++ ...++|||++.++.+..-.-....++..+...+..+++.++..+ |+.|++||||++.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9854 456666654 45689999997654422111222455667778889999999998 8999999999999999
Q ss_pred ecCCCCCCEEEeecCCCc
Q 023058 150 LDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 150 v~~~~~~~~~l~df~~~~ 167 (288)
++. +. +.|+||+.+.
T Consensus 158 ~~~-~~--v~iIDF~qav 172 (197)
T cd05146 158 WHD-GK--VWFIDVSQSV 172 (197)
T ss_pred EEC-Cc--EEEEECCCce
Confidence 974 33 9999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.8e-15 Score=129.18 Aligned_cols=247 Identities=20% Similarity=0.179 Sum_probs=187.5
Q ss_pred CCeeeeeeeec--cCceEEEEEEE--cCCCcEEEEEEeecC---ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeE
Q 023058 21 DRYELVRDIGS--GNFGVARLMRD--KKTEELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 21 ~~y~~~~~lg~--g~~~~v~~~~~--~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (288)
..+.+.+.+|. |.+|.||.+.- ..++..+++|.-+.. .....+-.+|+....++ .|++.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 56678889999 99999999988 778889999974322 23334566777777777 489999988888889999
Q ss_pred EEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHhhcCceecCCCCCceEecCC-CCCCEEEeecCCC
Q 023058 93 AIVMEYASGGELFERICNAGR-FSEDEARFFFQQLIS----GVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYS 166 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~~i~~----~l~~LH~~~i~H~dl~p~nilv~~~-~~~~~~l~df~~~ 166 (288)
++-.|.+. .+|..+-....+ ++...++..+.+... ||.++|..+++|-|++|.||+...+ .. ++++||++.
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s--~~~~df~~v 270 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTS--CKLTDFGLV 270 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccce--eecCCccee
Confidence 99999996 477666655444 899999999999999 9999999999999999999999877 44 899999998
Q ss_pred cccccCCCCC------CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCC--CCchhHHHHHHHHhhc
Q 023058 167 KSSVLHSQPK------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP--EEPKNFRKTIHRILSV 238 (288)
Q Consensus 167 ~~~~~~~~~~------~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~ 238 (288)
.....+.... ...+...|++||...+.. ...+|+|++|.++.+-.++..+.... ......+...
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~------ 342 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY------ 342 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc------
Confidence 7666555332 225777899999874443 33389999999999988887766544 2222221111
Q ss_pred ccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc-cchh
Q 023058 239 QYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG-VYMH 279 (288)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~ 279 (288)
.........+.++...+.+|++.+|-.|++++.+.+ .++|
T Consensus 343 -ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 343 -IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred -CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 111112245667777999999999999999998887 4443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.4e-14 Score=108.50 Aligned_cols=127 Identities=20% Similarity=0.251 Sum_probs=95.7
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCce-eeEeEEEEcCCeEEEEEeccCCCch
Q 023058 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL 104 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 104 (288)
++.|+.|.++.||+++.. ++.+++|.............+|+..++.+.+.++ ++++... ....++|||++++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 467888999999999975 7789999876554333456789999988865554 4455443 3345899999999877
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCc-----eecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQV-----CHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 105 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i-----~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
... ......++.+++.++..||+.++ +|+|++|.||+++ ++. ++++||+.+.
T Consensus 79 ~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~--~~liDf~~a~ 135 (170)
T cd05151 79 LTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGR--LWLIDWEYAG 135 (170)
T ss_pred ccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCe--EEEEeccccc
Confidence 543 01123456799999999999885 9999999999998 444 8999999765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.6e-13 Score=120.24 Aligned_cols=138 Identities=17% Similarity=0.173 Sum_probs=94.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCccch-----------------------------------H------HHH
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----------------------------------E------NVQ 65 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----------------------------------~------~~~ 65 (288)
+.||.|++|+||+|+.. +|+.||||+..++.... . ++.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999976 68999999986542000 0 133
Q ss_pred HHHHHHhhC----C-CCceeeEeEEEEcCCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHH-HHHHHhhcCc
Q 023058 66 REIINHRSL----R-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLIS-GVSYCHSMQV 138 (288)
Q Consensus 66 ~e~~~l~~l----~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~-~l~~LH~~~i 138 (288)
+|...+.++ + ++++.-..-+....+..++||||++|.+|.+...... .. ....++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 344444444 2 3443322222223445799999999999987664321 12 23445666665 4678999999
Q ss_pred eecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 139 ~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
+|+|++|.||+++.++. ++++|||++....
T Consensus 279 ~H~D~hPgNilv~~~g~--i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGK--IIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCc--EEEEeCCCeeECC
Confidence 99999999999987765 9999999987544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=7.3e-13 Score=99.38 Aligned_cols=129 Identities=23% Similarity=0.214 Sum_probs=102.2
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccch-----HHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKID-----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~-----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
..+.+|.-+.++.+... |.++++|.--+. +... .+..+|..++.++.-.++....-+..++....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35678999999988653 445777764332 1111 356689999999987787777777778888899999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
|+++..|.+.+... ...++..+-.-+..||..||+||||.++||+++.+. +.++|||++.
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCccc
Confidence 99998888888664 256778888888999999999999999999998554 8999999986
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.5e-14 Score=124.20 Aligned_cols=142 Identities=23% Similarity=0.333 Sum_probs=94.4
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc-----------------------------------chHH--
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-----------------------------------IDEN-- 63 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----------------------------------~~~~-- 63 (288)
..|.. +.||+|++|+||+|+..++|+.||||+..++-. ..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999998899999999875420 0111
Q ss_pred ----HHHHHHHHhhC----CCCceeeEeEEEE-cCCeEEEEEeccCCCchHHH--HHhcC----CCCHHHHHHHHHHHHH
Q 023058 64 ----VQREIINHRSL----RHPNIVRFKEVIL-TPTHLAIVMEYASGGELFER--ICNAG----RFSEDEARFFFQQLIS 128 (288)
Q Consensus 64 ----~~~e~~~l~~l----~~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~--~~~~~----~~~~~~~~~i~~~i~~ 128 (288)
+.+|...+.++ .+.+.+.+-.++. ..+..++||||+.|+++.+. +...+ .+....+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 22334334333 2333333333333 24567899999999998764 22222 133333444444444
Q ss_pred HHHHHhhcCceecCCCCCceEecCCC--CCCEEEeecCCCcccc
Q 023058 129 GVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSV 170 (288)
Q Consensus 129 ~l~~LH~~~i~H~dl~p~nilv~~~~--~~~~~l~df~~~~~~~ 170 (288)
..|++|+|++|.||+++.++ .++++++|||++....
T Consensus 278 ------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 ------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 68999999999999998765 2359999999986443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.6e-12 Score=97.25 Aligned_cols=143 Identities=17% Similarity=0.103 Sum_probs=110.8
Q ss_pred eeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---------ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 25 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
.+..+.+|..+.|+++..+ |+.++||.-... .-..++.++|++.+.++.--+|....-++.+...-.+.
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678889999999999884 778888864321 12235678899999999777777777777777788999
Q ss_pred EeccCC-CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCC-CEEEeecCCCccc
Q 023058 96 MEYASG-GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSS 169 (288)
Q Consensus 96 ~e~~~~-~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~-~~~l~df~~~~~~ 169 (288)
|||+++ .++.+++.... .....-...++++|-+.+..||..+++||||..+||++..++.. .+.++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999977 46677775543 23333447899999999999999999999999999999766553 3589999998744
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.3e-11 Score=105.76 Aligned_cols=219 Identities=16% Similarity=0.192 Sum_probs=154.1
Q ss_pred ceEEEEEEEcCCCcEEEEEEeecCcc-chHHHHHHHHHHhhCCCCceeeEeEEEEc----CCeEEEEEeccCC-CchHHH
Q 023058 34 FGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILT----PTHLAIVMEYASG-GELFER 107 (288)
Q Consensus 34 ~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~~-~~L~~~ 107 (288)
..+.|++....+|..|++|+++.... .......-++.++++.|+|+|++.+++.. +..+++|++|.++ .+|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 46889999999999999999954322 22234566889999999999999999873 3578999999875 456554
Q ss_pred HHh---------------cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 108 ICN---------------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 108 ~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
.-. +...+++.+|.++.|+..||.++|+.|+..+-|.|.+|+++.+. +++|...|........
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQED 446 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecCC
Confidence 321 12468899999999999999999999999999999999997554 4888776655533332
Q ss_pred CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCC-CCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
.. |-+.. ..+.|.-.||.++..|.+|..- +......+. ....+.. .++.+
T Consensus 447 ~~-------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s---~~~~I~~---------~yS~D 497 (655)
T KOG3741|consen 447 PT-------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS---HLTRITT---------TYSTD 497 (655)
T ss_pred CC-------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHH---HHHHhhh---------hhhHH
Confidence 20 11111 2237999999999999999633 222111111 1112111 46788
Q ss_pred HHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
++++|.-+...++.+ -++.+++.-...+++..
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~v 529 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTV 529 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHH
Confidence 999999999888886 66666666554444433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.1e-13 Score=123.86 Aligned_cols=257 Identities=27% Similarity=0.350 Sum_probs=188.0
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc----hHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
..+.+.+.+.+.++.++.++.+....++.....|+....... .+.+..+-.++....+|-++....-+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 557788899999999999999998888876666654432221 1222222233223334555544333444567899
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc---
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--- 171 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~--- 171 (288)
++++..+++|...+++.+....+-.+.....+..++++||...+.|+|++|.|.+...++. .++.||+.......
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccccC
Confidence 9999999999999998887777788888888999999999999999999999999987776 78888873210000
Q ss_pred -------------------------C----CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCC
Q 023058 172 -------------------------H----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222 (288)
Q Consensus 172 -------------------------~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~ 222 (288)
. .......+++.|.+||...+...... +|.|+.|+++++.++|..||...
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCCCc
Confidence 0 00112247889999999988888777 89999999999999999999987
Q ss_pred CCchhHHHHHHHHhhcccCCCCC-CCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 223 EEPKNFRKTIHRILSVQYSIPDY-VHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
.....++ .+.+....++.. ...+....+++..++..+|.+|..+....+.--++++
T Consensus 1039 tpq~~f~----ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~ 1095 (1205)
T KOG0606|consen 1039 TPQQIFE----NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFF 1095 (1205)
T ss_pred chhhhhh----ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCcc
Confidence 7655554 345555555542 3568899999999999999999999855554444433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.4e-12 Score=113.43 Aligned_cols=243 Identities=19% Similarity=0.160 Sum_probs=169.7
Q ss_pred CCCeeeeeeeeccCceEEEEEEEc-CCCcEEEEEEeecCccch-H--HHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGDKID-E--NVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~iK~~~~~~~~~-~--~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 94 (288)
..+|..+..||.|.|+.|+.+... .++..|++|.....-... . .-..|+.+...+ .|.+.+.....+......++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 467889999999999999887755 678889999765542211 1 223455555555 58888887777777777779
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
--|||.++++.....-...+.+..++.+..|++.++.++|+..++|+|++|+||++..++ ...+++||++.... ...
T Consensus 344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~--~~~ 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRL--AFS 420 (524)
T ss_pred chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhcccccccccc--cee
Confidence 999998888766654445688899999999999999999999999999999999998764 34789999977541 111
Q ss_pred CCCCcCCCccc--CCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 175 PKSTVGTPAYI--APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 175 ~~~~~~~~~~~--aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
........++. ++.......+..+ .|++|||..+.+..++...-...... .. +..+. .+...+.+..+
T Consensus 421 ~~~~~~~~r~~p~~~~~~e~~~~~~~-~~~~sl~~~~~e~~~~~~ls~~~~~~---~~----i~~~~--~p~~~~~~~~~ 490 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILLEDYPHLSK-ADIFSLGLSVDEAITGSPLSESGVQS---LT----IRSGD--TPNLPGLKLQL 490 (524)
T ss_pred cccccccccccccchhhccccccccc-cccccccccccccccCcccCcccccc---ee----eeccc--ccCCCchHHhh
Confidence 12222223333 4444445555555 99999999999998886433322211 11 11121 22222445778
Q ss_pred HHHHHHhcccCcCCccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
..+...+..+++..||.+.+...
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcc
Confidence 88888999999999999876654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.2e-11 Score=97.52 Aligned_cols=140 Identities=21% Similarity=0.273 Sum_probs=102.3
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCC--ceeeEeEEEEcC---CeEEEEEec
Q 023058 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHP--NIVRFKEVILTP---THLAIVMEY 98 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~---~~~~lv~e~ 98 (288)
.+.|+.|..+.||++.... |+.+++|....... ....+.+|.++++.+.+. .+++++.+.... +..+++||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3678899999999998753 57899998765443 456788999999999764 456677776553 266899999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------------
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS------------------------------------------- 135 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~------------------------------------------- 135 (288)
+++.++...+.. ..++..+...++.+++.+|..||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 998877654421 345566666666677777766663
Q ss_pred -------------cCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 136 -------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 136 -------------~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
..++|+|+.|.||+++.+....+.++||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 34799999999999987322237899999765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.2e-11 Score=99.09 Aligned_cols=246 Identities=13% Similarity=0.103 Sum_probs=158.0
Q ss_pred eeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHH-hhCCCCceee----EeEE--EEcC-CeEEEE
Q 023058 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVR----FKEV--ILTP-THLAIV 95 (288)
Q Consensus 24 ~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~----~~~~--~~~~-~~~~lv 95 (288)
...+.||+|+.+-+|..-.-.+ .+.|+++......+. +....+ ..-.||-+-. .... +-.. ....++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~a--qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQA--QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchhhc---hhheeecCCCchHHH--HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4567899999999996664332 467877654432221 112222 2224543222 1111 1122 247788
Q ss_pred EeccCCCchHHHH-------HhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcc
Q 023058 96 MEYASGGELFERI-------CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (288)
Q Consensus 96 ~e~~~~~~L~~~~-------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~ 168 (288)
|..+++..-...+ +...........+..+.++.+...||..|.+-||++++|++|++++. +.|.|-+....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi 166 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQI 166 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceee
Confidence 8888764222222 11223677888999999999999999999999999999999998887 99999876655
Q ss_pred cccCCCCCCCcCCCcccCCcccc-----CcccCCCccchhhHHHHHHHHHhC-CCCCCCCCC----chhHH-HHH-----
Q 023058 169 SVLHSQPKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEE----PKNFR-KTI----- 232 (288)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~~~~~l~~g-~~pf~~~~~----~~~~~-~~~----- 232 (288)
...+....+..+...|.+||... +..-+.+ .|.|.||+++++++.| .+||.+-.. ..... .+.
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ 245 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA 245 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence 55555566778999999999865 3333455 8999999999998876 899974211 00111 000
Q ss_pred --HHHhhcccC---CCCCCCCCHHHHHHHHHhcccC--cCCccccccccccc
Q 023058 233 --HRILSVQYS---IPDYVHISPECRHLISRIFVAD--PAKVSMHFHATGVY 277 (288)
Q Consensus 233 --~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~--p~~Rpt~~~~l~~~ 277 (288)
.+...+... ...+.-+++++..+..+|+... +.-|||++.|+.-+
T Consensus 246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl 297 (637)
T COG4248 246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAAL 297 (637)
T ss_pred echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Confidence 000011111 1123457899999999999654 45899998887643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.3e-10 Score=94.94 Aligned_cols=130 Identities=13% Similarity=0.037 Sum_probs=93.4
Q ss_pred EEEEEEEcCCCcEEEEEEeecCcc------------chHHHHHHHHHHhhCCCCcee--eEeEEEEc-----CCeEEEEE
Q 023058 36 VARLMRDKKTEELVAVKYIERGDK------------IDENVQREIINHRSLRHPNIV--RFKEVILT-----PTHLAIVM 96 (288)
Q Consensus 36 ~v~~~~~~~~~~~~~iK~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~--~~~~~~~~-----~~~~~lv~ 96 (288)
.|.++.. .|+.|.+|....... ......+|+..+.++...+|. .++.++.. ....++|+
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3545544 467899996643221 111367888888888544433 44555543 23578999
Q ss_pred eccCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC-----CCCCCEEEeecCCCc
Q 023058 97 EYASGG-ELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSK 167 (288)
Q Consensus 97 e~~~~~-~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~-----~~~~~~~l~df~~~~ 167 (288)
|++++. +|.+++.. ....+......++.+++..+..||+.|++|+|+++.||+++. ++...+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999875 78888753 334567778899999999999999999999999999999975 234569999999775
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.9e-12 Score=112.36 Aligned_cols=146 Identities=18% Similarity=0.221 Sum_probs=102.7
Q ss_pred HHHHHHHHHh-hcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC----------CCCcCCCcccCCccccCc
Q 023058 125 QLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----------KSTVGTPAYIAPEVLLKK 193 (288)
Q Consensus 125 ~i~~~l~~LH-~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~aPE~~~~~ 193 (288)
+.+.|+.++| +.++||++|.|++|+++.++. +||+.|+++.....+... ........|.+||++.+.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4449999999 568999999999999988887 999999987644332211 111246689999999885
Q ss_pred ccCCCccchhhHHHHHHHHHhCCCC-CCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCcccccc
Q 023058 194 EYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFH 272 (288)
Q Consensus 194 ~~~~~~~Di~slG~~~~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 272 (288)
..+.. +|++|+|+++|.+..|..+ +..... ...... .........+....++|.++++=+.+++..++..||++.+
T Consensus 185 ~~~~~-sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~-~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~ 261 (700)
T KOG2137|consen 185 TNTPA-SDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSF-SRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL 261 (700)
T ss_pred ccccc-ccceeeeeEEEEEecCCcchhhccCC-cchhhh-hhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence 55555 9999999999999854444 333222 111111 1111222233334589999999999999999999997776
Q ss_pred ccc
Q 023058 273 ATG 275 (288)
Q Consensus 273 ~l~ 275 (288)
.+.
T Consensus 262 l~~ 264 (700)
T KOG2137|consen 262 LLS 264 (700)
T ss_pred hhc
Confidence 665
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.3e-10 Score=89.82 Aligned_cols=122 Identities=26% Similarity=0.294 Sum_probs=80.0
Q ss_pred EEEEEEEcCCCcEEEEEEeecC--------------cc-------------chHHHHHHHHHHhhCCCC--ceeeEeEEE
Q 023058 36 VARLMRDKKTEELVAVKYIERG--------------DK-------------IDENVQREIINHRSLRHP--NIVRFKEVI 86 (288)
Q Consensus 36 ~v~~~~~~~~~~~~~iK~~~~~--------------~~-------------~~~~~~~e~~~l~~l~~~--~i~~~~~~~ 86 (288)
.||.|... ++..+|+|+.... .. ......+|.+.|.++... ++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 37888875 4778999986421 00 113467899999999766 466666553
Q ss_pred EcCCeEEEEEeccC--CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HhhcCceecCCCCCceEecCCCCCCEEEeec
Q 023058 87 LTPTHLAIVMEYAS--GGELFERICNAGRFSEDEARFFFQQLISGVSY-CHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (288)
Q Consensus 87 ~~~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~i~H~dl~p~nilv~~~~~~~~~l~df 163 (288)
...+||||++ +..+..+.... ++......++.+++..+.. +|..|++|||+++.||+++.+ . +.++||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~--~~iIDf 150 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K--VYIIDF 150 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C--EEE--G
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e--EEEEec
Confidence 3379999998 65555443322 1134566777788885555 689999999999999999866 4 999999
Q ss_pred CCCc
Q 023058 164 GYSK 167 (288)
Q Consensus 164 ~~~~ 167 (288)
+.+.
T Consensus 151 ~qav 154 (188)
T PF01163_consen 151 GQAV 154 (188)
T ss_dssp TTEE
T ss_pred Ccce
Confidence 9765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.2e-10 Score=92.79 Aligned_cols=131 Identities=21% Similarity=0.233 Sum_probs=100.7
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-----------------------cchHHHHHHHHHHhhCCCC--
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------------------KIDENVQREIINHRSLRHP-- 77 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----------------------~~~~~~~~e~~~l~~l~~~-- 77 (288)
+.+..+||.|.-|.||.+.++ .|.++++|.-..+. .......+|.+.|.++...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 356789999999999999998 58899999642110 1113467899999999765
Q ss_pred ceeeEeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCC
Q 023058 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (288)
Q Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~ 157 (288)
.+++.+++ +...+|||++++..|...- +.......++..|+.-+..+-..|++|||+++-||+++.++.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~-- 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD-- 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--
Confidence 77777665 4668999999886664322 235566667777888777777999999999999999998877
Q ss_pred EEEeecCC
Q 023058 158 LKICDFGY 165 (288)
Q Consensus 158 ~~l~df~~ 165 (288)
+.++||--
T Consensus 241 ~~vIDwPQ 248 (304)
T COG0478 241 IVVIDWPQ 248 (304)
T ss_pred EEEEeCcc
Confidence 99999953
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=7e-09 Score=80.73 Aligned_cols=139 Identities=10% Similarity=0.071 Sum_probs=101.9
Q ss_pred eeeeec--cCceEEEEEEEcCCCcEEEEEEeecC-------ccchHHHHHHHHHHhhCCCCc--eeeEeEEEE-c----C
Q 023058 26 VRDIGS--GNFGVARLMRDKKTEELVAVKYIERG-------DKIDENVQREIINHRSLRHPN--IVRFKEVIL-T----P 89 (288)
Q Consensus 26 ~~~lg~--g~~~~v~~~~~~~~~~~~~iK~~~~~-------~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~-~----~ 89 (288)
++.-+. ||.+-|+..... |..+-+|..+.. +.....+.+|+..+.++...+ ++++. ++. . .
T Consensus 21 ve~pN~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~ 97 (216)
T PRK09902 21 VEEPNYRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGE 97 (216)
T ss_pred ecCCCcCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCc
Confidence 344444 888899988764 446888876511 335568999999998885333 44444 322 1 1
Q ss_pred CeEEEEEeccC-CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 90 THLAIVMEYAS-GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 90 ~~~~lv~e~~~-~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
-..++|+|-++ ..+|.+++.+. .+.+......+..+++..+..||+.|+.|+|+.+.||+++.++...+.++||.-+
T Consensus 98 ~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 98 WRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred eEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 24689999665 35788777653 3467888889999999999999999999999999999998666556999999866
Q ss_pred c
Q 023058 167 K 167 (288)
Q Consensus 167 ~ 167 (288)
+
T Consensus 178 r 178 (216)
T PRK09902 178 R 178 (216)
T ss_pred c
Confidence 5
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.6e-09 Score=84.47 Aligned_cols=107 Identities=18% Similarity=0.193 Sum_probs=84.4
Q ss_pred hHHHHHHHHHHhhCCCCc--eeeEeEEEEcC----CeEEEEEeccCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 023058 61 DENVQREIINHRSLRHPN--IVRFKEVILTP----THLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYC 133 (288)
Q Consensus 61 ~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~L 133 (288)
..+..+|...+..+...+ .++++.+.... ...++|+|.+++. +|.+++......+......++.+++..+..|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 346778888887775333 44556665542 2468999999874 7888887755577888899999999999999
Q ss_pred hhcCceecCCCCCceEecCCC-CCCEEEeecCCCc
Q 023058 134 HSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK 167 (288)
Q Consensus 134 H~~~i~H~dl~p~nilv~~~~-~~~~~l~df~~~~ 167 (288)
|+.|++|+|+++.||+++.++ ..++.++||+-+.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 999999999999999998775 3459999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.5e-08 Score=79.20 Aligned_cols=136 Identities=17% Similarity=0.209 Sum_probs=90.2
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHH----------HHHHHHHHhhCC---CCceee----
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----------VQREIINHRSLR---HPNIVR---- 81 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~----------~~~e~~~l~~l~---~~~i~~---- 81 (288)
..++|.+.+.+......-|.+..- +|+.+++|.+.....-.++ ..+++....++. ......
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 457899999998877777776665 5788999987643221211 223333333332 222222
Q ss_pred -EeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEE
Q 023058 82 -FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (288)
Q Consensus 82 -~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l 160 (288)
..-.+.-....+++|||++|..|.+... +++ .+...+.+++..||+.|+.|||..|.|++++.++ +++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~i 175 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRI 175 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEE
Confidence 2222222346679999999987755432 222 2446788889999999999999999999998555 899
Q ss_pred eecCCCc
Q 023058 161 CDFGYSK 167 (288)
Q Consensus 161 ~df~~~~ 167 (288)
+||+...
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9997554
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.2e-08 Score=77.12 Aligned_cols=133 Identities=18% Similarity=0.173 Sum_probs=91.6
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--------------------cchHH-----HHHHHHHHhhCCCC--c
Q 023058 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------------------KIDEN-----VQREIINHRSLRHP--N 78 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--------------------~~~~~-----~~~e~~~l~~l~~~--~ 78 (288)
.-.|++|..+.||.|... ++..+|+|++.... ..... ..+|+..|+++.-. .
T Consensus 53 ~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 346778888999999874 57889999985321 11111 34677888887543 4
Q ss_pred eeeEeEEEEcCCeEEEEEeccCCCch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCCC
Q 023058 79 IVRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAP 156 (288)
Q Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~~L-~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~~ 156 (288)
+++.+.+. ...+|||+++.... .-.+.. -.+...+...+..++++.+..|-. .|+||+||+.-||++. ++.
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~- 204 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE- 204 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe-
Confidence 55555554 34899999965311 111111 123344677888899999888876 9999999999999998 444
Q ss_pred CEEEeecCCCc
Q 023058 157 RLKICDFGYSK 167 (288)
Q Consensus 157 ~~~l~df~~~~ 167 (288)
+.++|++-+.
T Consensus 205 -p~iID~~QaV 214 (268)
T COG1718 205 -PYIIDVSQAV 214 (268)
T ss_pred -EEEEECcccc
Confidence 8999998665
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.1e-07 Score=76.24 Aligned_cols=72 Identities=17% Similarity=0.173 Sum_probs=55.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCc--eeeEeEEEEcCCeEEEEEeccCCCc
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGGE 103 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~~~~ 103 (288)
..||.|..+.||+. .+..+++|..... .....+.+|.+.++.+...+ +++++++....+..+++|++++|.+
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 67899999999973 2446789977653 34456899999999986544 4678888877888899999998853
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.1e-07 Score=73.33 Aligned_cols=78 Identities=18% Similarity=0.210 Sum_probs=56.2
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCC--ceeeEeEEEEc---CCeEEEEEeccC
Q 023058 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP--NIVRFKEVILT---PTHLAIVMEYAS 100 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~---~~~~~lv~e~~~ 100 (288)
++.|+.|..+.||.+.... ..+++|..... .....+.+|..+++.+... .+++++..... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 5678999999999999864 58999986654 4556788888888887433 34566654332 345799999999
Q ss_pred CCchHH
Q 023058 101 GGELFE 106 (288)
Q Consensus 101 ~~~L~~ 106 (288)
+.++..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 877766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.3e-07 Score=83.85 Aligned_cols=138 Identities=20% Similarity=0.187 Sum_probs=90.6
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCc-----------------------------------cchHH------HH
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------------------------------KIDEN------VQ 65 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----------------------------------~~~~~------~~ 65 (288)
+.|+.++-|+||+|..++ |+.||||+..++- +..+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 577899999999999985 9999999875421 00011 23
Q ss_pred HHHHHHhhC-----CCCceeeEeEEEEcCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHH-HHHHhhcCc
Q 023058 66 REIINHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISG-VSYCHSMQV 138 (288)
Q Consensus 66 ~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~-l~~LH~~~i 138 (288)
+|...+.++ +.+++.-..-++...+.-.++|||++|..+.+..... ...+...+. ..++.+ +..+=.-|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia---~~~~~~f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELA---ELLVRAFLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHH---HHHHHHHHHHHHhcCc
Confidence 344444444 2455444444444556779999999998887764221 234433333 223322 233335899
Q ss_pred eecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 139 ~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.|+|..|.||+++.++. +.+.|||......
T Consensus 287 fHaDpHpGNi~v~~~g~--i~~lDfGi~g~l~ 316 (517)
T COG0661 287 FHADPHPGNILVRSDGR--IVLLDFGIVGRLD 316 (517)
T ss_pred cccCCCccceEEecCCc--EEEEcCcceecCC
Confidence 99999999999988866 9999999876443
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.5e-06 Score=82.64 Aligned_cols=79 Identities=19% Similarity=0.226 Sum_probs=57.8
Q ss_pred eeeeeeccCceEEEEEEEcCCC--cEEEEEEeecCc--cchHHHHHHHHHHhhCC-CCce--eeEeEEEEcC---CeEEE
Q 023058 25 LVRDIGSGNFGVARLMRDKKTE--ELVAVKYIERGD--KIDENVQREIINHRSLR-HPNI--VRFKEVILTP---THLAI 94 (288)
Q Consensus 25 ~~~~lg~g~~~~v~~~~~~~~~--~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~~l 94 (288)
.++.++.|.+..+|.+.....+ ..+++|+..... .....+.+|+.+++.+. |+++ ++++.++.+. +..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 4677888999999998875432 467888765433 23356889999999995 6665 6777777654 46789
Q ss_pred EEeccCCCc
Q 023058 95 VMEYASGGE 103 (288)
Q Consensus 95 v~e~~~~~~ 103 (288)
|||++++..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.57 E-value=7.4e-07 Score=84.00 Aligned_cols=197 Identities=20% Similarity=0.222 Sum_probs=138.1
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE----EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 023058 62 ENVQREIINHRSLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137 (288)
Q Consensus 62 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~----lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~ 137 (288)
....-|+..+.+..|+|+..+..+........ +..+++...++.+.++..+..+....+.+..+...|+.++|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 34556777788889999999998876653333 44567888889999999999999999999999999999999986
Q ss_pred ceecCCCCC---ceEecCCCCCCEEEe--ecCCCcccccCCCCCCCcCCCcccCCccccCcccCCC-ccchhhHHHHHHH
Q 023058 138 VCHRDLKLE---NTLLDGSPAPRLKIC--DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK-IADVWSCGVTLYV 211 (288)
Q Consensus 138 i~H~dl~p~---nilv~~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~~Di~slG~~~~~ 211 (288)
..|.-+..+ +.-++..+. +..+ ||+.+.................+.++|.......... ..|+|++|.....
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~--~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGV--VAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred cceeEEecccccccccCccce--eecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 555544444 222233333 4555 8887776655555555566677888887765554332 3799999999999
Q ss_pred HHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 212 MLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 212 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+..|..+-..... .. .+... .......+....|+.-++.+|+++.+++.
T Consensus 385 ~~~~~~i~~~~~~-------~~-------~~l~~-~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 385 LSQGEDISEKSAV-------PV-------SLLDV-LSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred hhhcCcccccccc-------hh-------hhhcc-ccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 9887654322111 00 01110 11126788899999999999999988877
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=8.5e-07 Score=66.60 Aligned_cols=130 Identities=18% Similarity=0.193 Sum_probs=93.8
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCcee-eEeEEEEcCCeEEEEEecc
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~e~~ 99 (288)
..-++.+.|+.|++|.||++... +..+++|+ .+.++....+..|.+++..+...++- +++.+..+ ++.|||+
T Consensus 22 ~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kv-rr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i 94 (201)
T COG2112 22 YELRVEKELAKGTTSVVYLGEWR--GGEVALKV-RRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI 94 (201)
T ss_pred hhhhhhhhhhcccccEEEEeecc--CceEEEEE-ecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence 34467889999999999999984 66889995 44556677899999999999877665 45444432 4559999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCC--CceEecCCCCCCEEEeecCCCc
Q 023058 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL--ENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 100 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p--~nilv~~~~~~~~~l~df~~~~ 167 (288)
.|.+|....... +..+ ...+++.--.|-..||-|+.++- .||++... . +.|+||+.+.
T Consensus 95 ~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~-~--~~iIDFd~At 154 (201)
T COG2112 95 DGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR-D--VYIIDFDSAT 154 (201)
T ss_pred cCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCC-c--EEEEEccchh
Confidence 988886655332 2223 33455555667789999999986 46666533 4 9999999776
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.6e-06 Score=70.49 Aligned_cols=75 Identities=12% Similarity=0.050 Sum_probs=53.5
Q ss_pred eeeccCc-eEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC-CCceeeEeEEEEcCCeEEEEEeccCCCchH
Q 023058 28 DIGSGNF-GVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELF 105 (288)
Q Consensus 28 ~lg~g~~-~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (288)
.|..|.+ +.||++... +..+++|...... .....+|+++++.+. +--+++++++....+..++||++++|.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 789999764 4678888765543 446778888888874 344667788777666789999999887765
Q ss_pred H
Q 023058 106 E 106 (288)
Q Consensus 106 ~ 106 (288)
.
T Consensus 81 ~ 81 (244)
T cd05150 81 A 81 (244)
T ss_pred H
Confidence 3
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.5e-08 Score=86.55 Aligned_cols=188 Identities=22% Similarity=0.259 Sum_probs=140.0
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCc-eeeEeEEEEcCCeEEEEEec
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~ 98 (288)
.+-+.....++++.++.+++.+...+.... .+++... ....-++++|.+++||| .+...+-+..+...++.+++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 345567788899999999999987655443 5555443 34556889999999999 66666666667789999999
Q ss_pred cCCC-ch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 99 ASGG-EL-FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 99 ~~~~-~L-~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
+..+ +- .......-.+...+...+++.-+.+++++|+.--+|+| ||+.+++. .+..+|+............
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~---~~~~~~~v~~~L~~~~~~~ 388 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE---VKLLDFAVPPQLTRTMKPR 388 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc---cccccccCCcccCcccccc
Confidence 9775 21 11111122356667777888889999999988778888 77776533 7899999877655555566
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCC
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~ 220 (288)
...+++.+++||+...+.+... -|.|+++.-..++..|..|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCC
Confidence 7789999999999988888887 899999987777777766643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.37 E-value=2e-05 Score=61.57 Aligned_cols=130 Identities=20% Similarity=0.179 Sum_probs=91.6
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-----------------cchHHHHHHHHHHhhCC------CCceeeE
Q 023058 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------------KIDENVQREIINHRSLR------HPNIVRF 82 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----------------~~~~~~~~e~~~l~~l~------~~~i~~~ 82 (288)
...||+|+.=.||.-- .....+||+..+.. .......+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 4568889888888433 34447899887654 23355667777766665 7889999
Q ss_pred eEEEEcCCeEEEEEeccCC------CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCC
Q 023058 83 KEVILTPTHLAIVMEYASG------GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (288)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~------~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~ 156 (288)
+|+..++....+|+|.+.+ -+|.+++... .++. ..... +-+-..+|-+.+|+.+|++|+||++..+..+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999997632 3577777443 3444 44443 4444567788889999999999999655543
Q ss_pred --CEEEeec
Q 023058 157 --RLKICDF 163 (288)
Q Consensus 157 --~~~l~df 163 (288)
++.|+|-
T Consensus 158 ~~~lvlIDG 166 (199)
T PF10707_consen 158 EFRLVLIDG 166 (199)
T ss_pred ceEEEEEeC
Confidence 3667764
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.5e-06 Score=74.13 Aligned_cols=137 Identities=19% Similarity=0.207 Sum_probs=85.9
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCc--------------------------------cchHHH------HHHH
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------------------------------KIDENV------QREI 68 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--------------------------------~~~~~~------~~e~ 68 (288)
+.|+..+.|+|++|+.+. |+.||+|+-+++- +..+.+ .+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 678999999999999986 9999999875421 111122 2222
Q ss_pred HHHhh----CCCCc------eeeEeEEEEcCCeEEEEEeccCCCchHHH--HHhcCCCCHHHHHHHHHHHHHHH-HHHhh
Q 023058 69 INHRS----LRHPN------IVRFKEVILTPTHLAIVMEYASGGELFER--ICNAGRFSEDEARFFFQQLISGV-SYCHS 135 (288)
Q Consensus 69 ~~l~~----l~~~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~--~~~~~~~~~~~~~~i~~~i~~~l-~~LH~ 135 (288)
+...+ +.|-+ |++++- ...+...++|||++|..+.+. +.+. .++...+ +..+.++. +-+=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i---~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDI---LNKLVEAYLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc-CCCHHHH---HHHHHHHHHHHHHh
Confidence 22222 23433 333322 223567999999999877544 3333 2444433 33333322 22336
Q ss_pred cCceecCCCCCceEecCC--CCCCEEEeecCCCcccc
Q 023058 136 MQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV 170 (288)
Q Consensus 136 ~~i~H~dl~p~nilv~~~--~~~~~~l~df~~~~~~~ 170 (288)
.|++|+|=.|.||+++.+ +..++.+.|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 789999999999999853 35579999999876443
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.34 E-value=4.2e-06 Score=67.72 Aligned_cols=72 Identities=11% Similarity=-0.011 Sum_probs=46.3
Q ss_pred eeeeccCce-EEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCC---ceeeEeEEEEcC---CeEEEEEecc
Q 023058 27 RDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVILTP---THLAIVMEYA 99 (288)
Q Consensus 27 ~~lg~g~~~-~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~---~~~~lv~e~~ 99 (288)
+.++.||.. .||.+. ..+++|.... ......+.+|.+.+..+... -++++++.+... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567766665 588763 2478886554 33445788999999887532 344555544332 2358899999
Q ss_pred CCCch
Q 023058 100 SGGEL 104 (288)
Q Consensus 100 ~~~~L 104 (288)
+|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 88665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.2e-05 Score=65.01 Aligned_cols=75 Identities=15% Similarity=0.257 Sum_probs=49.2
Q ss_pred eeeeeccCceEEEEEEEcC-CCcEEEEEEeecCccchHHHHHHHHHHhhCCCCce-eeEeEEEEcCCeEEEEEeccCCCc
Q 023058 26 VRDIGSGNFGVARLMRDKK-TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGE 103 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~~ 103 (288)
++.|..|-...+|++.... .++.|++|.........-...+|+.+++.+...++ ++++.... + +++|||+++.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence 4667778888999997653 35678999776543322344578888888854444 34443322 2 47999998866
Q ss_pred h
Q 023058 104 L 104 (288)
Q Consensus 104 L 104 (288)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.30 E-value=2.4e-05 Score=65.55 Aligned_cols=80 Identities=14% Similarity=0.085 Sum_probs=58.0
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCC---CceeeEeEEEEc---CCeEEEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH---PNIVRFKEVILT---PTHLAIV 95 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~---~~~~~lv 95 (288)
.-.-.+.||.|..+.||...... + .+++|.. +.......+.+|...++.+.. -.++++++++.. .+..++|
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~-~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQ-G-NPMPLMA-RSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCC-C-CEEEEEe-cccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 33456789999999999997643 3 4777764 332244578899999988853 357788887754 3668999
Q ss_pred EeccCCCch
Q 023058 96 MEYASGGEL 104 (288)
Q Consensus 96 ~e~~~~~~L 104 (288)
||++++.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999987654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.18 E-value=0.00017 Score=56.12 Aligned_cols=124 Identities=19% Similarity=0.279 Sum_probs=85.9
Q ss_pred CCeeeeeeeeccCc-eEEEEEEEcCCCcEEEEEEeec---Cc-------------------cchHHHHHHHHHHhhC---
Q 023058 21 DRYELVRDIGSGNF-GVARLMRDKKTEELVAVKYIER---GD-------------------KIDENVQREIINHRSL--- 74 (288)
Q Consensus 21 ~~y~~~~~lg~g~~-~~v~~~~~~~~~~~~~iK~~~~---~~-------------------~~~~~~~~e~~~l~~l--- 74 (288)
..++.++.||.|.. |.||+++- +|..||+|++.. .. .-..-+..|-+..-++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 99999998 477999999321 10 0011244555555555
Q ss_pred CCCce--eeEeEEEEcCC------------------eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh
Q 023058 75 RHPNI--VRFKEVILTPT------------------HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134 (288)
Q Consensus 75 ~~~~i--~~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH 134 (288)
++.++ ++++++..-.. ...+|.|+++... .+.... +.+|.+-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence 45566 89999874331 2467777765532 122223 456777778899
Q ss_pred hcCceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 135 ~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
..||+-+|+++.|.. + =+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~---~----G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR---G----GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc---C----CEEEecccC
Confidence 999999999999984 2 379999854
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.8e-05 Score=66.40 Aligned_cols=137 Identities=17% Similarity=0.112 Sum_probs=81.1
Q ss_pred eeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCc--eeeEeEE------EEcCCeEEEEE
Q 023058 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAIVM 96 (288)
Q Consensus 25 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~lv~ 96 (288)
-.+.|..|....+|.+... +..+++|+... ...+.+..|+.++..+...+ +++++.. ...++..++++
T Consensus 18 ~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 18 SFEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred heecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 3667777877899998763 45689998764 33456777888777774333 3444331 22345678999
Q ss_pred eccCCCchHH-----------H---HHhc-CCCC---------HHHH-----------HHHHHHHHHHHHHHhh------
Q 023058 97 EYASGGELFE-----------R---ICNA-GRFS---------EDEA-----------RFFFQQLISGVSYCHS------ 135 (288)
Q Consensus 97 e~~~~~~L~~-----------~---~~~~-~~~~---------~~~~-----------~~i~~~i~~~l~~LH~------ 135 (288)
++++|..+.. . ++.. ..+. .... ......+..++..+.+
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998865421 0 1110 0000 0000 0011112233334332
Q ss_pred -cCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 136 -~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
.+++|+|+.|.||+++.++. +.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDEL--SGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCce--EEEeehhhhc
Confidence 47999999999999987654 6899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.18 E-value=0.00013 Score=63.13 Aligned_cols=76 Identities=18% Similarity=0.110 Sum_probs=54.1
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeecC--------ccchHHHHHHHHHHhhCC---CCceeeEeEEEEcCCeEEE
Q 023058 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERG--------DKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~--------~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l 94 (288)
.+.||.|....||++....+++.+++|.-.+. ....++...|.+.|+.+. ..++++++.+ +++..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46789999999999999754468999974321 123456777888887763 3456677665 4566789
Q ss_pred EEeccCCCc
Q 023058 95 VMEYASGGE 103 (288)
Q Consensus 95 v~e~~~~~~ 103 (288)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999987643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.6e-05 Score=65.23 Aligned_cols=131 Identities=15% Similarity=0.100 Sum_probs=75.3
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeecCccch-HHHHHHHHHHhhCCCCce-eeEeEEEEcCCeEEEEEeccCCCchH
Q 023058 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGELF 105 (288)
Q Consensus 28 ~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (288)
.+..|-.+.+|++.. +++.+++|......... -+..+|..+++.+...++ ++++... . -++|+++++|..+.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccc
Confidence 455677778888873 46678899765433221 245788888888864433 3444433 2 36899999886543
Q ss_pred H-----------H------HHhcC----CCCHH-HHHHHHHHH---------HHHHHHHhh--------cCceecCCCCC
Q 023058 106 E-----------R------ICNAG----RFSED-EARFFFQQL---------ISGVSYCHS--------MQVCHRDLKLE 146 (288)
Q Consensus 106 ~-----------~------~~~~~----~~~~~-~~~~i~~~i---------~~~l~~LH~--------~~i~H~dl~p~ 146 (288)
. + ++... +++.. .+..+..++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 1 1 11111 11111 111111111 111222211 24899999999
Q ss_pred ceEecCCCCCCEEEeecCCCc
Q 023058 147 NTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 147 nilv~~~~~~~~~l~df~~~~ 167 (288)
||+++.++ +.++||..+.
T Consensus 157 Nil~~~~~---~~lIDwE~a~ 174 (256)
T TIGR02721 157 NLVVTPQG---LKLIDWEYAS 174 (256)
T ss_pred cEEEeCCC---CEEEeccccC
Confidence 99998655 6899998776
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.13 E-value=2e-06 Score=70.82 Aligned_cols=132 Identities=14% Similarity=0.156 Sum_probs=95.4
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-------------------cch----HHHHHHHHHHhhCCCC-
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-------------------KID----ENVQREIINHRSLRHP- 77 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-------------------~~~----~~~~~e~~~l~~l~~~- 77 (288)
-+.+..+||-|.-+-+|.+-+. .|.+.++|.-..+. .+. -...+|...++.+...
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4678999999999999999987 47888999532110 111 1244677888877432
Q ss_pred -ceeeEeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCC
Q 023058 78 -NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (288)
Q Consensus 78 -~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~ 156 (288)
-+++.+++ ...++||+++.+-+|.+.-+- .....+...+...+-.|...|++|||..--||+++.+..
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~- 240 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK- 240 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC-
Confidence 35555554 356899999988777654322 233446667777788899999999999999999997776
Q ss_pred CEEEeecCCC
Q 023058 157 RLKICDFGYS 166 (288)
Q Consensus 157 ~~~l~df~~~ 166 (288)
++++||=-+
T Consensus 241 -i~vIDFPQm 249 (465)
T KOG2268|consen 241 -IVVIDFPQM 249 (465)
T ss_pred -EEEeechHh
Confidence 999999543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.4e-05 Score=64.87 Aligned_cols=137 Identities=19% Similarity=0.204 Sum_probs=94.4
Q ss_pred eeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----------------------c-cchHH----HHHHHHHHhhCCCC
Q 023058 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----------------------D-KIDEN----VQREIINHRSLRHP 77 (288)
Q Consensus 25 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----------------------~-~~~~~----~~~e~~~l~~l~~~ 77 (288)
+..-|..|.-+.||.|... +|..+|||+++-+ . ...+- ...|++.|+++...
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4455778999999999876 5777999987421 0 11111 34688889999877
Q ss_pred ceeeEeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-hhcCceecCCCCCceEecCCCCC
Q 023058 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLLDGSPAP 156 (288)
Q Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~i~H~dl~p~nilv~~~~~~ 156 (288)
+|+...-+.. ....|||+++.....-.-.-..-.++...+..+-++++..+..| |.+++||.||+--|+++.. +.
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~- 302 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GK- 302 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CE-
Confidence 7665444433 24589999986433222112223466677777777888777776 5789999999999999974 44
Q ss_pred CEEEeecCCCc
Q 023058 157 RLKICDFGYSK 167 (288)
Q Consensus 157 ~~~l~df~~~~ 167 (288)
++++|.+-+.
T Consensus 303 -lyiIDVSQSV 312 (520)
T KOG2270|consen 303 -LYIIDVSQSV 312 (520)
T ss_pred -EEEEEccccc
Confidence 9999987654
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.05 E-value=7e-05 Score=63.51 Aligned_cols=74 Identities=9% Similarity=0.026 Sum_probs=45.0
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCc--eeeEeE------EEEcCCeEEEEEe
Q 023058 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKE------VILTPTHLAIVME 97 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~------~~~~~~~~~lv~e 97 (288)
.+.|+.|....+|.+... +..+++|+++ ....+.+..|+..+..+...+ +++++. +....+..+++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT--QGEYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeC--CCcEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 456777777899998864 3368999876 223344555666665553222 333332 1223456789999
Q ss_pred ccCCCc
Q 023058 98 YASGGE 103 (288)
Q Consensus 98 ~~~~~~ 103 (288)
+++|..
T Consensus 103 ~l~G~~ 108 (319)
T PRK05231 103 FLEGKW 108 (319)
T ss_pred ecCCCC
Confidence 998864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00011 Score=61.89 Aligned_cols=75 Identities=13% Similarity=0.165 Sum_probs=49.1
Q ss_pred eeeeeccCceEEEEEEEcC------CCcEEEEEEeecCccchHHHHHHHHHHhhCCCCce-eeEeEEEEcCCeEEEEEec
Q 023058 26 VRDIGSGNFGVARLMRDKK------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~ 98 (288)
++.|..|-...+|++.... .++.+++|+............+|..++..+...++ ++++..+. + ..|+++
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 3456666667888887643 25789999876654444567788888888854443 34555443 2 357888
Q ss_pred cCCCch
Q 023058 99 ASGGEL 104 (288)
Q Consensus 99 ~~~~~L 104 (288)
++|.++
T Consensus 79 i~G~~l 84 (302)
T cd05156 79 IPSRTL 84 (302)
T ss_pred eCCCcC
Confidence 877655
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00013 Score=61.49 Aligned_cols=140 Identities=17% Similarity=0.155 Sum_probs=80.4
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCc--eeeEeEE------EEcCCeEEE
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAI 94 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~l 94 (288)
....+.++.|....+|++... +..+++|...... ..+.+..|.+++..+...+ +++++.. ....+..++
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred ceeccccCCccccceEEEEeC--CCcEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 344666777777899998753 3468899765532 2345666777776664322 3343331 112456789
Q ss_pred EEeccCCCchH-----------HH---HHhc-CCC----------CHHH---HH----------HHHHHHHHHHHHHh--
Q 023058 95 VMEYASGGELF-----------ER---ICNA-GRF----------SEDE---AR----------FFFQQLISGVSYCH-- 134 (288)
Q Consensus 95 v~e~~~~~~L~-----------~~---~~~~-~~~----------~~~~---~~----------~i~~~i~~~l~~LH-- 134 (288)
++++++|..+. .. ++.. ..+ +... .. .....+...++++.
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 99999875431 11 1110 000 1000 00 00112233444443
Q ss_pred -----hcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 135 -----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 135 -----~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
..+++|+|+.+.|++++.++. ..++||+.+.
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~--~~vIDfd~~~ 216 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDSV--KGVIDFYFAC 216 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCce--EEEeeccccc
Confidence 368999999999999987654 6899999765
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.86 E-value=8.2e-05 Score=57.78 Aligned_cols=97 Identities=14% Similarity=0.064 Sum_probs=76.0
Q ss_pred HHHHHHHhhCCC-CceeeEeEEEEcCCeEEEEEeccCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHhh---cC
Q 023058 65 QREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFER---ICNAGRFSEDEARFFFQQLISGVSYCHS---MQ 137 (288)
Q Consensus 65 ~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~---~~~~~~~~~~~~~~i~~~i~~~l~~LH~---~~ 137 (288)
.+|.-+++.+.+ +++++++|.|- .+++.|+.+.+++... +..-...+...+..++.++++.+++++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357788888865 69999999983 3678899876655421 1122245889999999999999999987 34
Q ss_pred ceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 138 i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
+.-+|++++|+.+++++. ++++|.+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~--lk~iDld~v~ 110 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGR--LKLIDLDDVF 110 (188)
T ss_pred EEEeecchHHeEEeCCCc--EEEEechhcc
Confidence 888999999999997776 9999998764
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00029 Score=58.97 Aligned_cols=142 Identities=15% Similarity=0.113 Sum_probs=86.0
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEee--cCccchHHHHHHHHHHhhCCCCcee--eEeEEEEcCC--eEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKIDENVQREIINHRSLRHPNIV--RFKEVILTPT--HLAI 94 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~--~~~~~~~~~~~e~~~l~~l~~~~i~--~~~~~~~~~~--~~~l 94 (288)
....+++.+..|....+|...+. ++.+++.... .......+..+|+..++.+..--++ ..++++..+. ..|.
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CCCceeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 44556666655666677777664 7778888321 2234556778899998888653333 3344443333 5699
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHH-HHHHHHHHHHhh--------------------------------------
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFF-QQLISGVSYCHS-------------------------------------- 135 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~-~~i~~~l~~LH~-------------------------------------- 135 (288)
||+++.+..+...+... .....++ ..++..|..||+
T Consensus 103 v~~~veGe~~~~~~~~~-----~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 103 VMEWVEGEVVWSALPPE-----SLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred EEEEecceeccCcCCcc-----cchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 99999874332211000 0001111 244444444443
Q ss_pred --------------------cCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 136 --------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 136 --------------------~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
-.++|||+.+.|++++.+.. +-+.||+.+....+
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~--~gVlDwe~~~lGDP 231 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP--TGVLDWELATLGDP 231 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe--eEEEeccccccCCc
Confidence 34999999999999987666 89999998874444
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0023 Score=54.46 Aligned_cols=72 Identities=19% Similarity=0.197 Sum_probs=48.4
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeec-----C---ccchHHHHHHHHHHhhCC--CCc-eeeEeEEEEcCCeEEEEE
Q 023058 28 DIGSGNFGVARLMRDKKTEELVAVKYIER-----G---DKIDENVQREIINHRSLR--HPN-IVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 28 ~lg~g~~~~v~~~~~~~~~~~~~iK~~~~-----~---~~~~~~~~~e~~~l~~l~--~~~-i~~~~~~~~~~~~~~lv~ 96 (288)
.||.|....||++.+..+++.++||.-.+ + ....++..-|.+.|+... .|. +++++. .+++...++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 57889999999999865446899997431 1 233456667777776663 343 444433 3566778999
Q ss_pred eccCC
Q 023058 97 EYASG 101 (288)
Q Consensus 97 e~~~~ 101 (288)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 98854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0024 Score=55.38 Aligned_cols=73 Identities=16% Similarity=0.186 Sum_probs=51.1
Q ss_pred eeeeeeccCceEEEEEEEcCCCcEEEEEEeec-----Cc---cchHHHHHHHHHHhhCC---CCceeeEeEEEEcCCeEE
Q 023058 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GD---KIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 25 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~-----~~---~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~ 93 (288)
..+.||.|....||++.+. ++.++||.-.+ +. -...+...|.+.|+.+. ..++++++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4788899999999999974 45699997652 22 13345556667666653 347777877765 4568
Q ss_pred EEEeccCC
Q 023058 94 IVMEYASG 101 (288)
Q Consensus 94 lv~e~~~~ 101 (288)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999966
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0024 Score=53.96 Aligned_cols=29 Identities=21% Similarity=0.266 Sum_probs=25.8
Q ss_pred CceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 137 ~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
+++|+|+.++|++++.++. +.++||..++
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRG--GYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence 6999999999999987766 8999998766
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0014 Score=56.15 Aligned_cols=139 Identities=15% Similarity=0.179 Sum_probs=79.2
Q ss_pred eeeeeeeccCceEEEEEEEcC----CCcEEEEEEeecCccchHHHHHHHHHHhhCCCCcee-eEeEEEEcCCeEEEEEec
Q 023058 24 ELVRDIGSGNFGVARLMRDKK----TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 24 ~~~~~lg~g~~~~v~~~~~~~----~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~e~ 98 (288)
.-++.|..|-...+|++.... +++.|++|+........=+-.+|..+++.+...++- ++++.+... .|.+|
T Consensus 39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ef 114 (344)
T PLN02236 39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEF 114 (344)
T ss_pred EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEe
Confidence 334455557888999987532 246899998765433222336788888888654443 455555332 47888
Q ss_pred cCCCchHHH-----------------HHhcC----C-C-CHHHHHHHHHHH-----------------HHHHHHH-----
Q 023058 99 ASGGELFER-----------------ICNAG----R-F-SEDEARFFFQQL-----------------ISGVSYC----- 133 (288)
Q Consensus 99 ~~~~~L~~~-----------------~~~~~----~-~-~~~~~~~i~~~i-----------------~~~l~~L----- 133 (288)
+++.++... ++... . . ....+..+..++ ...+..|
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 876555311 11111 0 1 112222222111 1111111
Q ss_pred ---hhcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 134 ---HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 134 ---H~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
+...++|+|+++.||+++... ..+.++||..+.
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~ 230 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMIDEET-RAITIIDYEYAS 230 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence 123589999999999997532 249999998776
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.001 Score=55.15 Aligned_cols=30 Identities=23% Similarity=0.325 Sum_probs=23.8
Q ss_pred CceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 137 ~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
.++|+|+.|.||+++.++. -.-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC-EEEEECcHhcc
Confidence 4899999999999986432 14699999765
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0026 Score=54.15 Aligned_cols=76 Identities=16% Similarity=0.170 Sum_probs=46.8
Q ss_pred eeeeeeccCceEEEEEEEcCC---CcEEEEEEeecCccchHHHHHHHHHHhhCCCCce-eeEeEEEEcCCeEEEEEeccC
Q 023058 25 LVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYAS 100 (288)
Q Consensus 25 ~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~ 100 (288)
.++.|..|-...+|++..... +..|++|+........=+-.+|..+++.+...++ +++++++. .+ ++.+|++
T Consensus 18 ~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~ 93 (330)
T PLN02421 18 SVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFIN 93 (330)
T ss_pred EEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhhc
Confidence 344454477778998875432 3479999876544333234678888888865444 35555552 22 4788887
Q ss_pred CCch
Q 023058 101 GGEL 104 (288)
Q Consensus 101 ~~~L 104 (288)
+.++
T Consensus 94 g~~l 97 (330)
T PLN02421 94 ARTL 97 (330)
T ss_pred CCCC
Confidence 6554
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0031 Score=54.41 Aligned_cols=78 Identities=18% Similarity=0.150 Sum_probs=52.7
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeec----C---ccchHHHHHHHHHHhhCC--CC-ceeeEeEEEEcCC
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER----G---DKIDENVQREIINHRSLR--HP-NIVRFKEVILTPT 90 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~----~---~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~ 90 (288)
+.+. .+.||.|.-..||++.+...++.++||.-.+ + ....++..-|.+.|+... .| ++++++. .++.
T Consensus 30 ~~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e 106 (409)
T PRK12396 30 KGLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSV 106 (409)
T ss_pred ccce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcH
Confidence 3444 7888999999999999854456799997432 1 233456677888887763 45 4445533 3566
Q ss_pred eEEEEEeccCC
Q 023058 91 HLAIVMEYASG 101 (288)
Q Consensus 91 ~~~lv~e~~~~ 101 (288)
...+|||+++.
T Consensus 107 ~~~~vMEdL~~ 117 (409)
T PRK12396 107 MNCCVMEDLSD 117 (409)
T ss_pred HhhHHHHhCcc
Confidence 77888988854
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0047 Score=51.33 Aligned_cols=76 Identities=11% Similarity=0.073 Sum_probs=49.0
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC---CCCceeeEeEEEEcCCeEEEEEecc
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL---RHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
-+-.+.++.|....+|.+. .+++.+.+|+-. ......+..|..-|+.+ ..-.+++++.++...+..++++|++
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3456778888889999988 467889999766 33335677788877777 3456889999998887789999998
Q ss_pred CCC
Q 023058 100 SGG 102 (288)
Q Consensus 100 ~~~ 102 (288)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.018 Score=49.01 Aligned_cols=71 Identities=11% Similarity=0.007 Sum_probs=43.9
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCc--eeeEe---E--EEEcCCeEEEEEeccCCCc
Q 023058 32 GNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFK---E--VILTPTHLAIVMEYASGGE 103 (288)
Q Consensus 32 g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~---~--~~~~~~~~~lv~e~~~~~~ 103 (288)
+....||.+... ++..+++|+..........+..|.+.+..+.... ++... + +...++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~-~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDE-DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecC-CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 344678988864 3567999987655545667778888877663222 22211 1 1223456788999887653
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.034 Score=46.86 Aligned_cols=29 Identities=31% Similarity=0.615 Sum_probs=24.6
Q ss_pred cCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 136 ~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
.+++|||+.+.||+++. +. +.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~--i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NE--VYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-Cc--EEEEECcccc
Confidence 57899999999999986 33 8999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0061 Score=51.64 Aligned_cols=135 Identities=16% Similarity=0.171 Sum_probs=79.3
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCc------eeeEeEEE--EcCC--eEEEEEe
Q 023058 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKEVI--LTPT--HLAIVME 97 (288)
Q Consensus 28 ~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~--~~~~--~~~lv~e 97 (288)
.|.+ ....+|.++... | .+++|+..+. .....+..|+..+.-+.-.+ ++..-|-. ...+ +.+.+++
T Consensus 33 ~l~s-~eN~~f~~~~~~-g-~~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTED-G-RYILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecC-C-CeEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3443 456788888863 3 3499988887 67778888888888773222 22211111 1133 7889999
Q ss_pred ccCCCchHH-H--------------HHh-cCCC----------CHHH-----H---------HHHHHHHHHHHHHHh---
Q 023058 98 YASGGELFE-R--------------ICN-AGRF----------SEDE-----A---------RFFFQQLISGVSYCH--- 134 (288)
Q Consensus 98 ~~~~~~L~~-~--------------~~~-~~~~----------~~~~-----~---------~~i~~~i~~~l~~LH--- 134 (288)
+++|..+.. . ++. ...+ .... . .....++...+..+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 998876651 0 110 0000 0000 0 002223333333333
Q ss_pred -----hcC--ceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 135 -----SMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 135 -----~~~--i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
..+ ++|+|+.|.||+++.++. -+.++||+-++
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCC-eeeEEEccccc
Confidence 234 999999999999987763 26899999765
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0031 Score=50.05 Aligned_cols=55 Identities=16% Similarity=0.113 Sum_probs=33.2
Q ss_pred CcEEEEEEeecCccchHHHHHHHHHHhhCCCCce-eeEeEEEEcCCeEEEEEeccCCCch
Q 023058 46 EELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL 104 (288)
Q Consensus 46 ~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 104 (288)
++.|++++........-.-..|...++.+...++ +++++.+.. ..+.+|+++.+|
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTL 57 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE-
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEeccccc
Confidence 4678999888775555567778888888865444 455555432 245577765443
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.024 Score=49.26 Aligned_cols=77 Identities=9% Similarity=0.051 Sum_probs=45.3
Q ss_pred eeeeeeeccCceEEEEEEEcCCC-cE-----EEEEEeecCccchHHHHHHHHHHhhCCCCce-eeEeEEEEcCCeEEEEE
Q 023058 24 ELVRDIGSGNFGVARLMRDKKTE-EL-----VAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVM 96 (288)
Q Consensus 24 ~~~~~lg~g~~~~v~~~~~~~~~-~~-----~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~ 96 (288)
..++.|..|-...+|++...... .. |.++.........-+-.+|+++++.+...++ +++++.+.. +++.
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ 128 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQ 128 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEE
Confidence 34456656888899999754321 22 4444332222211233568888888865544 456665532 6888
Q ss_pred eccCCCch
Q 023058 97 EYASGGEL 104 (288)
Q Consensus 97 e~~~~~~L 104 (288)
||+++.++
T Consensus 129 efIeGr~l 136 (383)
T PTZ00384 129 EWVEGNTM 136 (383)
T ss_pred EEeccccC
Confidence 99887665
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.006 Score=53.93 Aligned_cols=159 Identities=14% Similarity=0.174 Sum_probs=94.2
Q ss_pred HHHHHHHHHHhhCCCCceeeEeEEEEcC-CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCcee
Q 023058 62 ENVQREIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140 (288)
Q Consensus 62 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H 140 (288)
..+.-...+++.+.|+|+...+++-... ....+|+|++ +.+|.+.+..+. +...... +|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~~ 86 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------AH 86 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------cc
Confidence 4566778899999999999999887653 4688999998 558988876543 2211111 22
Q ss_pred cCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCC
Q 023058 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (288)
Q Consensus 141 ~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~ 220 (288)
+ +-+.|+ ++.+| .+.... .... + + ++||||+|.++.++..|..-+.
T Consensus 87 ~-~~~~~~---------~~~td-~~~t~~------~~~~------------~----p-KsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 87 G-VLHLNI---------IYITD-HFLTKY------PSPI------------G----P-KSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred c-cceehh---------hhccc-cccccC------CCCC------------C----c-chhhhhHHHHHHHHHHhhHHHH
Confidence 2 122222 22333 000000 0000 0 2 4999999999999998887666
Q ss_pred CCCCchhHHHHHHHHhhcccCCC-------CCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 221 DPEEPKNFRKTIHRILSVQYSIP-------DYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.....+....+.+-.. ...... ....++..+..+..+|+...|..||...++.+
T Consensus 133 ~~~~s~~l~~i~k~~~-~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYT-DDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHHHHHHHHHHHhcc-CchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 5443222222211110 000000 01146778889999999999999997766655
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.036 Score=54.44 Aligned_cols=138 Identities=15% Similarity=0.194 Sum_probs=75.5
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-------CCCceeeEe-----EEEEc-CC--e
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-------RHPNIVRFK-----EVILT-PT--H 91 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-------~~~~i~~~~-----~~~~~-~~--~ 91 (288)
+.|+ |..-.+|++... ++..+++|+..... .......|...+.-+ ..|.+++.. ..... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~-~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTD-DGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeC-CCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 456788888764 46679999887643 333444555555433 233333321 11111 22 5
Q ss_pred EEEEEeccCCCchHHH-----------------HHh----cC------CC-----------------CHHHHHHHHHHHH
Q 023058 92 LAIVMEYASGGELFER-----------------ICN----AG------RF-----------------SEDEARFFFQQLI 127 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~-----------------~~~----~~------~~-----------------~~~~~~~i~~~i~ 127 (288)
.+.+++|.+|..+.+. ++. .. .+ .....+.++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 6788999988666431 000 00 00 0111222333333
Q ss_pred HHHHH-----Hh--hcCceecCCCCCceEecCCCCCCEE-EeecCCCc
Q 023058 128 SGVSY-----CH--SMQVCHRDLKLENTLLDGSPAPRLK-ICDFGYSK 167 (288)
Q Consensus 128 ~~l~~-----LH--~~~i~H~dl~p~nilv~~~~~~~~~-l~df~~~~ 167 (288)
..... +. ..+++|+|+.+.||+++.++..++. |+|||.+.
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 33321 21 2569999999999999876522355 99999876
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.00028 Score=69.31 Aligned_cols=200 Identities=13% Similarity=0.066 Sum_probs=125.4
Q ss_pred HHHHHHhhCCCCceeeEeEEEEc--CCeEEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC--
Q 023058 66 REIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQ-- 137 (288)
Q Consensus 66 ~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~-- 137 (288)
.|....+...|+++.....=... ....+..++++.+|.+.+.+-++- .+...-+....++.+....-+|+..
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 34444555678887764443322 234577888888888888875532 2333344444444466666666432
Q ss_pred ---ceecCCCCCceEecCCCCCCEEEeecCCCc-ccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHH
Q 023058 138 ---VCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 213 (288)
Q Consensus 138 ---i~H~dl~p~nilv~~~~~~~~~l~df~~~~-~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~ 213 (288)
-+|.++++-|.++..+.. ++++++|+.+ ........+...+++.|+.++....-.++.+ +|+|..++.+|...
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~--v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYN--VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLRS 1434 (2724)
T ss_pred CccchhhhhhhhccceecCCc--ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHHh
Confidence 789999999999987776 9999999988 3333333455567778888888877777776 99999999999998
Q ss_pred hCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccc
Q 023058 214 VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHA 273 (288)
Q Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 273 (288)
.|..+|. ...+...+........+.-..-.|.+.......+|-..-..||.-...
T Consensus 1435 ~~n~~fi-----~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~is 1489 (2724)
T KOG1826|consen 1435 DGNAYFI-----FFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYIS 1489 (2724)
T ss_pred cccHHHH-----HHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhh
Confidence 8877664 222333333333332222222334455555555555666666655443
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.018 Score=48.92 Aligned_cols=93 Identities=24% Similarity=0.224 Sum_probs=63.8
Q ss_pred HhhCCCCceeeEeEEEEc-CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCce
Q 023058 71 HRSLRHPNIVRFKEVILT-PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENT 148 (288)
Q Consensus 71 l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~ni 148 (288)
++....+++.+..-+-.+ ..+.|++|++. ++++.-.- ....+++..++.+++..+.-+.. ...-|+|+.-.||
T Consensus 279 w~~~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~ik----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~ni 353 (488)
T COG5072 279 WRECGSVFLETLKVVSLDETLYLYLHFKDH-GTPISIIK----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNI 353 (488)
T ss_pred hhhccchhhhcceEEecCCceEEEEEEecC-Cceeeeee----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccce
Confidence 334444444444333322 34678888876 44553221 23567888999999988888774 4689999999999
Q ss_pred EecCCCCCCEEEeecCCCccccc
Q 023058 149 LLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 149 lv~~~~~~~~~l~df~~~~~~~~ 171 (288)
+++ +|+ +.|+||-+++....
T Consensus 354 LId-~Gn--vtLIDfklsRl~~~ 373 (488)
T COG5072 354 LID-EGN--VTLIDFKLSRLSYS 373 (488)
T ss_pred eee-cCc--eEEEEeeeeecccC
Confidence 999 666 99999999884433
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.082 Score=46.88 Aligned_cols=76 Identities=16% Similarity=0.039 Sum_probs=47.6
Q ss_pred eeeeeeccCceEEEEEEEcCC--------CcEEEEEEeecCccchHHHHHHHHHHhhCCCCcee-eEeEEEEcCCeEEEE
Q 023058 25 LVRDIGSGNFGVARLMRDKKT--------EELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIV 95 (288)
Q Consensus 25 ~~~~lg~g~~~~v~~~~~~~~--------~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv 95 (288)
-++.|..|-...+|++..... ++.|++++...+....-.-.+|..+++.+...++- ++++.+. -+.+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 566776777788999875421 46799998766543332445677777777544443 4445442 2457
Q ss_pred EeccCCCch
Q 023058 96 MEYASGGEL 104 (288)
Q Consensus 96 ~e~~~~~~L 104 (288)
.+|+++.+|
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 888877544
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.044 Score=43.42 Aligned_cols=100 Identities=17% Similarity=0.082 Sum_probs=62.4
Q ss_pred EEEEEEeecCc-c-chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHH
Q 023058 48 LVAVKYIERGD-K-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 125 (288)
Q Consensus 48 ~~~iK~~~~~~-~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~ 125 (288)
+.++|++...+ . ..+-+.++..++.++. +|+++..- ..-.+.++.|.|-.... .+... ..-
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------~~~N~----i~a 149 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------NFSNF----ITA 149 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------chhHH----HHH
Confidence 34555554322 2 3445667777777764 56666532 44568899998843211 01111 111
Q ss_pred HHHHHHHHhh--cCceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 126 LISGVSYCHS--MQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 126 i~~~l~~LH~--~~i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
=+.+|.-.|+ .+..|||..|+|||.+..+. +||.|-++.
T Consensus 150 gi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~--lKlVDP~~L 190 (308)
T PF07387_consen 150 GIKDLMDFHSENQHCLHGDCNPDNIMCDKFGY--LKLVDPVCL 190 (308)
T ss_pred hHHHHHHhhccCCCeecCCCChhheeecCCCC--EEecChhhh
Confidence 1455667783 46999999999999999998 999987643
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.21 Score=39.91 Aligned_cols=78 Identities=21% Similarity=0.201 Sum_probs=52.6
Q ss_pred eeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC---CCCceeeEeEEEEcCCeEEEEEeccC
Q 023058 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL---RHPNIVRFKEVILTPTHLAIVMEYAS 100 (288)
Q Consensus 24 ~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (288)
+..+.+..|.--+.|.+.+ ...++.+|+-.... ...+.+|+.-|+.+ +.-.+++++.++....+.|+|++|.+
T Consensus 19 ~er~~v~gG~inea~~v~d--g~~~~FvK~n~~~~--~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~ 94 (286)
T COG3001 19 KEREEVSGGDINEAWRLRD--GTDPFFVKCNQREQ--LSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP 94 (286)
T ss_pred hcccccCCccccceeEeec--CCcceEEEecchhh--HHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence 3445555565566776665 35678899754432 23455565555544 55678889999999999999999998
Q ss_pred CCchH
Q 023058 101 GGELF 105 (288)
Q Consensus 101 ~~~L~ 105 (288)
.+.+.
T Consensus 95 ~~~~d 99 (286)
T COG3001 95 TGPLD 99 (286)
T ss_pred CCCCC
Confidence 76553
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 288 | ||||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-148 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-148 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-148 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-148 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-146 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-143 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-49 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-47 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-47 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-47 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-47 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-47 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-47 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-47 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-47 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-46 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-44 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-44 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-44 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-43 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-43 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-43 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-43 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-43 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-38 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-38 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-38 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-37 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-37 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-37 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-37 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-37 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-37 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-37 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-37 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-37 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-37 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-37 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-37 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-37 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-37 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-37 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-37 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-37 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-36 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-36 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-36 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-36 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-36 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-36 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-35 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-35 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-35 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-35 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-35 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-35 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-35 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-35 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-35 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-35 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-35 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-35 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-34 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-34 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-34 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-34 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-34 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-34 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-34 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-34 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-34 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-34 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-34 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-34 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-34 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-34 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-34 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-34 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-34 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-34 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-34 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-34 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-34 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-34 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-34 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-34 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-34 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-34 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-34 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-34 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-34 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-34 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-34 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-34 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-34 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-34 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-34 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-34 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-34 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-34 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-34 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-34 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-34 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-34 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-34 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-34 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-34 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-34 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-34 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-34 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-34 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-34 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-34 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-34 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-34 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-34 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-34 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-34 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-33 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-33 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-33 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-33 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-33 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-33 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-32 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-32 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-32 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-32 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-32 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-32 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-32 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-32 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-32 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-32 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-32 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-32 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-32 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-32 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-32 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-32 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-31 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-31 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-31 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-31 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-31 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-31 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-31 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-31 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-31 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-31 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-30 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-30 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-30 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-30 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-30 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-30 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-30 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-30 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-29 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-29 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-29 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-29 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-29 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-29 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-29 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-29 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-29 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-29 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-29 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-29 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-29 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-29 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-29 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-29 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-29 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-29 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-29 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-29 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-29 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-29 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-29 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-29 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-28 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-28 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-28 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-28 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-28 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-28 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-28 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-28 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-28 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-28 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-28 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-28 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-28 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-28 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-28 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-28 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-28 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-28 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-28 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-28 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-28 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-28 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-28 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-28 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-28 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-28 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-28 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-28 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-28 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-28 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-28 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-28 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-28 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-28 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-28 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-28 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-28 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-28 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-28 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-28 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-28 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-28 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-27 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-27 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-27 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-27 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-27 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-27 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-27 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-27 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-27 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-27 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-27 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-27 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-27 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-27 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-27 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-27 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-27 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-27 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-27 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-27 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-27 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-27 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-27 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-27 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-27 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-27 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-27 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-27 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-26 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-26 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-26 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-25 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-25 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-25 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-25 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-25 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-25 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-25 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-25 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-25 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-25 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-25 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-25 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-25 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-25 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-25 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-25 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-25 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-25 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-25 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-25 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-25 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-25 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-25 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-24 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-24 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-24 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-24 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-24 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-24 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-24 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-24 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-24 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-24 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-24 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-24 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-24 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-24 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-24 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-24 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-24 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-24 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-23 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-22 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-21 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-21 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-21 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-21 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-21 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-20 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-20 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-20 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-20 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-20 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-20 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-20 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-20 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-20 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-20 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-20 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-20 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-20 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-20 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-19 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-19 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-19 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-19 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-19 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-19 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-19 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-19 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-19 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-19 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-19 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-19 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-19 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-19 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-19 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-19 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-19 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-19 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-19 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-19 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-19 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-19 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-19 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-19 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-19 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-19 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-19 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-19 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-19 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-19 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-19 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-19 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-19 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-19 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-19 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-19 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-19 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-19 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-19 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-19 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-19 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-19 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-19 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-19 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-19 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-19 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-19 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-19 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-19 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-19 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-19 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-19 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-19 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-19 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-19 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-19 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-19 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-19 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-19 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-19 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-18 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-18 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-18 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-18 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-18 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-18 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-18 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-18 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-18 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-18 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-18 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-18 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-18 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-18 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-17 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-17 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-17 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-17 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-17 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-17 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-17 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-17 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-17 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-17 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-17 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-17 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-17 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-17 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-17 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-17 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-17 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-17 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-17 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-16 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-15 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-15 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-15 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-15 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-15 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-15 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-15 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-15 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-15 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-15 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-15 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-15 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-15 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-15 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-15 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-15 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-15 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-15 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-15 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-15 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-15 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-14 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-14 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-13 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-13 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-13 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-13 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-13 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-13 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-12 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-12 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-12 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 7e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-11 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 5e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-08 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-08 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-08 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-08 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-08 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-08 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 6e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 6e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 8e-08 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 9e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-08 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 9e-08 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 9e-08 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-07 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-07 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 3e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-07 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-07 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 9e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-06 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 3e-06 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 3e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-06 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 4e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 6e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-05 |
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 482 bits (1242), Expect = e-173
Identities = 237/266 (89%), Positives = 254/266 (95%), Gaps = 1/266 (0%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
MDR+ +T GP +DMPIMHDSDRY+ V+DIGSGNFGVARLMRDK T+ELVAVKYIERG I
Sbjct: 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI 59
Query: 61 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180
FFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
TPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI RILSV+Y
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 241 SIPDYVHISPECRHLISRIFVADPAK 266
SIPD + ISPEC HLISRIFVADPA
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPAT 265
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 385 bits (991), Expect = e-135
Identities = 85/261 (32%), Positives = 139/261 (53%), Gaps = 15/261 (5%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
M +P + + ++LV+ +G G +G +L ++ TEE VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 186
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPDY 245
PE+L ++E+ + DVWSCG+ L ML G P++ P + + + + + +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKKTYLNPW 231
Query: 246 VHISPECRHLISRIFVADPAK 266
I L+ +I V +P+
Sbjct: 232 KKIDSAPLALLHKILVENPSA 252
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 381 bits (982), Expect = e-135
Identities = 85/261 (32%), Positives = 139/261 (53%), Gaps = 15/261 (5%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREII 69
M +P + + ++LV+ +G G +G +L ++ TEE VAVK ++ +D EN+++EI
Sbjct: 1 MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
++ L H N+V+F + +EY SGGELF+RI E +A+ FF QL++G
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 186
V Y H + + HRD+K EN LLD LKI DFG + +++ GT Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPDY 245
PE+L ++E+ + DVWSCG+ L ML G P++ P + + + + + +
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKKTYLNPW 231
Query: 246 VHISPECRHLISRIFVADPAK 266
I L+ +I V +P+
Sbjct: 232 KKIDSAPLALLHKILVENPSA 252
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 305 bits (783), Expect = e-104
Identities = 102/250 (40%), Positives = 135/250 (54%), Gaps = 14/250 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y L +G G FG ++ + T VAVK + R KI ++REI N + RH
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TPT +VMEY SGGELF+ IC GR E EAR FQQ++S V YCH
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ + Y
Sbjct: 131 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
G D+WSCGV LY +L G PF+D P F+K I + IP+ +++ L+
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPE--YLNRSVATLL 242
Query: 257 SRIFVADPAK 266
+ DP K
Sbjct: 243 MHMLQVDPLK 252
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = e-103
Identities = 98/249 (39%), Positives = 142/249 (57%), Gaps = 13/249 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
Y L++ IG GNF +L R T VA+K I++ +++ + + RE+ + L HP
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHP 74
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV+ EVI T L ++MEYASGGE+F+ + GR E EAR F+Q++S V YCH +
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRDLK EN LLD +KI DFG+S + + + G P Y APE+ K+YDG
Sbjct: 135 IVHRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
DVWS GV LY ++ G+ PF+ + + +L +Y IP Y+ S +C +L+
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRER----VLRGKYRIPFYM--STDCENLLK 246
Query: 258 RIFVADPAK 266
R V +P K
Sbjct: 247 RFLVLNPIK 255
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = e-102
Identities = 86/251 (34%), Positives = 120/251 (47%), Gaps = 14/251 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
RY R +G G F + D T+E+ A K + + E + EI HRSL H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEY 195
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL KK +
Sbjct: 135 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
+ DVWS G +Y +LVG PFE ++T RI +YSIP HI+P L
Sbjct: 193 SFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAASL 245
Query: 256 ISRIFVADPAK 266
I ++ DP
Sbjct: 246 IQKMLQTDPTA 256
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 304 bits (779), Expect = e-101
Identities = 100/250 (40%), Positives = 136/250 (54%), Gaps = 14/250 (5%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y L +G G FG ++ + + T VAVK + R KI ++REI N + RH
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLFRH 75
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TP+ + +VMEY SGGELF+ IC GR E E+R FQQ++SGV YCH
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN LLD KI DFG S +++ G+P Y APEV+ + Y
Sbjct: 136 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
G D+WS GV LY +L G PF+D P F+K I + P +++P L+
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----ICDGIFYTPQ--YLNPSVISLL 247
Query: 257 SRIFVADPAK 266
+ DP K
Sbjct: 248 KHMLQVDPMK 257
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = e-101
Identities = 86/251 (34%), Positives = 120/251 (47%), Gaps = 14/251 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
RY R +G G F + D T+E+ A K + + E + EI HRSL H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
++V F + +V+E L E +E EAR++ +Q++ G Y H
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKEY 195
+V HRDLKL N L+ +KI DFG + + K + GTP YIAPEVL KK +
Sbjct: 161 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
+ DVWS G +Y +LVG PFE ++T RI +YSIP HI+P L
Sbjct: 219 SFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAASL 271
Query: 256 ISRIFVADPAK 266
I ++ DP
Sbjct: 272 IQKMLQTDPTA 282
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = e-100
Identities = 109/250 (43%), Positives = 149/250 (59%), Gaps = 15/250 (6%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRH 76
Y + +G G+FG +L KT++ VA+K+I R + V+REI + LRH
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISR-QLLKKSDMHMRVEREISYLKLLRH 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P+I++ +VI TPT + +V+EYA GGELF+ I R +EDE R FFQQ+I + YCH
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
++ HRDLK EN LLD + +KI DFG S + K++ G+P Y APEV+ K Y
Sbjct: 128 KIVHRDLKPENLLLDDN--LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
G DVWSCG+ LYVMLVG PF+D P F+K + S Y +PD +SP + LI
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPD--FLSPGAQSLI 239
Query: 257 SRIFVADPAK 266
R+ VADP +
Sbjct: 240 RRMIVADPMQ 249
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 292 bits (750), Expect = 2e-99
Identities = 77/259 (29%), Positives = 125/259 (48%), Gaps = 24/259 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI------DENVQREIINHRSLR 75
+Y + +G G++G + + D +T AVK +++ K+ + NV++EI R LR
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKK-KKLRRIPNGEANVKKEIQLLRRLR 64
Query: 76 HPNIVRFKEVIL--TPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVS 131
H N+++ +V+ + +VMEY G E+ + + RF +A +F QLI G+
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLE 123
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPE 188
Y HS + H+D+K N LL LKI G +++ + +++ G+PA+ PE
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTG--GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 189 VLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
+ + G D+WS GVTLY + G YPFE N K I Y+IP
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD----NIYKLFENIGKGSYAIPGD-- 235
Query: 248 ISPECRHLISRIFVADPAK 266
P L+ + +PAK
Sbjct: 236 CGPPLSDLLKGMLEYEPAK 254
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 1e-98
Identities = 74/252 (29%), Positives = 127/252 (50%), Gaps = 15/252 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH 76
+ +++ +G G+F T VA+K I++ + + VQ E+ H L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHS 135
P+I+ ++ +V+E GE+ + N FSE+EAR F Q+I+G+ Y HS
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 194
+ HRDL L N LL + +KI DFG + + + T+ GTP YI+PE+ +
Sbjct: 131 HGILHRDLTLSNLLLTRN--MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
+ + +DVWS G Y +L+G PF+ + T+++++ Y +P +S E +
Sbjct: 189 HGLE-SDVWSLGCMFYTLLIGRPPFDT----DTVKNTLNKVVLADYEMPS--FLSIEAKD 241
Query: 255 LISRIFVADPAK 266
LI ++ +PA
Sbjct: 242 LIHQLLRRNPAD 253
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 6e-98
Identities = 89/281 (31%), Positives = 131/281 (46%), Gaps = 47/281 (16%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER------------------------- 56
+Y L +IG G++GV +L ++ A+K + +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 57 --GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAG 112
E V +EI + L HPN+V+ EV+ P HL +V E + G + E +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-----K 167
SED+ARF+FQ LI G+ Y H ++ HRD+K N L+ +KI DFG S
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED--GHIKIADFGVSNEFKGS 190
Query: 168 SSVLHSQPKSTVGTPAYIAPEVL--LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
++L +TVGTPA++APE L +K + GK DVW+ GVTLY + G PF D
Sbjct: 191 DALLS----NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
Query: 226 KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
K I S PD I+ + + LI+R+ +P
Sbjct: 247 CLHSK----IKSQALEFPDQPDIAEDLKDLITRMLDKNPES 283
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 9e-97
Identities = 78/250 (31%), Positives = 131/250 (52%), Gaps = 14/250 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH 76
D +++ R +G G FG L R+K+ + ++A+K + + ++ ++REI LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R + +++E+A GEL++ + GRF E + F ++L + YCH
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN L+ LKI DFG+S + + ++ GT Y+ PE++ K +D
Sbjct: 134 KVIHRDIKPENLLMGYK--GELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTHD 190
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
K D+W GV Y LVG PF+ P + R+ I++V P ++ S + LI
Sbjct: 191 EK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRR----IVNVDLKFPPFL--SDGSKDLI 243
Query: 257 SRIFVADPAK 266
S++ P +
Sbjct: 244 SKLLRYHPPQ 253
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 5e-96
Identities = 81/250 (32%), Positives = 135/250 (54%), Gaps = 14/250 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRH 76
+ +E+ R +G G FG L R+K+++ ++A+K + + ++ ++RE+ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R T + +++EYA G ++ + +F E + +L + +SYCHS
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN LL + LKI DFG+S S+ GT Y+ PE++ + +D
Sbjct: 129 RVIHRDIKPENLLLGSA--GELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
K D+WS GV Y LVG PFE +++T RI V+++ PD ++ R LI
Sbjct: 186 EK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPD--FVTEGARDLI 238
Query: 257 SRIFVADPAK 266
SR+ +P++
Sbjct: 239 SRLLKHNPSQ 248
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 4e-95
Identities = 75/260 (28%), Positives = 115/260 (44%), Gaps = 32/260 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--------VQREIINHR 72
+Y++ +GSG FG VA+K++E+ D+I + V E++ +
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLK 101
Query: 73 SLRH--PNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISG 129
+ ++R + P +++E +LF+ I G E+ AR FF Q++
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 161
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIA 186
V +CH+ V HRD+K EN L+D + LK+ DFG K +V GT Y
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT----DFDGTRVYSP 216
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
PE + Y G+ A VWS G+ LY M+ G PFE E I+ Q
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFRQ-- 264
Query: 247 HISPECRHLISRIFVADPAK 266
+S EC+HLI P+
Sbjct: 265 RVSSECQHLIRWCLALRPSD 284
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 281 bits (722), Expect = 9e-95
Identities = 74/255 (29%), Positives = 111/255 (43%), Gaps = 24/255 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIINHR 72
+Y + +GSG FG DK+ + V VK+I++ D V EI
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 73 SLRHPNIVRFKEVILTPTHLAIVME-YASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ H NI++ ++ +VME + SG +LF I R E A + F+QL+S V
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y + HRD+K EN ++ +K+ DFG + + GT Y APEVL+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAED--FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
Y G ++WS GVTLY ++ PF + EE + P V S E
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAAIHPPYLV--SKE 250
Query: 252 CRHLISRIFVADPAK 266
L+S + P +
Sbjct: 251 LMSLVSGLLQPVPER 265
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 1e-94
Identities = 72/262 (27%), Positives = 104/262 (39%), Gaps = 34/262 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE--------NVQREIINHR 72
Y L +G G FG VA+K I R +++ E+
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR-NRVLGWSPLSDSVTCPLEVALLW 89
Query: 73 SLR----HPNIVRFKEVILTPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLI 127
+ HP ++R + T +V+E +LF+ I G E +R FF Q++
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAY 184
+ + +CHS V HRD+K EN L+D K+ DFG GT Y
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT----DFDGTRVY 204
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
PE + + +Y A VWS G+ LY M+ G PFE IL + P
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER----------DQEILEAELHFPA 254
Query: 245 YVHISPECRHLISRIFVADPAK 266
H+SP+C LI R P+
Sbjct: 255 --HVSPDCCALIRRCLAPKPSS 274
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 7e-88
Identities = 87/252 (34%), Positives = 132/252 (52%), Gaps = 12/252 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHP 77
+ Y L IG G++G ++ K T A K I + ++ + ++EI +SL HP
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQEIEIMKSLDHP 66
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NI+R E T + +VME +GGELFER+ + F E +A + ++S V+YCH +
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 138 VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V HRDLK EN L SP LK+ DFG + ++ VGTP Y++P+V L+ Y
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV-LEGLY- 184
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRH 254
G D WS GV +YV+L G PF P + + K I ++ D++++SP+
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAES 240
Query: 255 LISRIFVADPAK 266
LI R+ P +
Sbjct: 241 LIRRLLTKSPKQ 252
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 2e-87
Identities = 53/294 (18%), Positives = 103/294 (35%), Gaps = 59/294 (20%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER------------------GDKIDE 62
+ Y ++R + G F L K + A+K E+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 63 NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--------RF 114
+ + E+ +++ + + +I + I+ EY + +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 115 SEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 170
+ + +++ SY H+ +CHRD+K N L+D + R+K+ DFG S+
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN--GRVKLSDFGESEYMVDKK 206
Query: 171 LHSQPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
+ + GT ++ PE + Y+G D+WS G+ LYVM PF +
Sbjct: 207 IK----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI---SLV 259
Query: 230 KTIHRILSVQYSIPDYV-----------------HISPECRHLISRIFVADPAK 266
+ + I + P +S E + +PA+
Sbjct: 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 9e-87
Identities = 86/253 (33%), Positives = 131/253 (51%), Gaps = 11/253 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
SD Y++ ++G G F V R K T A K I + + ++RE R L+H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCHS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL K Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
K D+W+CGV LY++LVG PF D ++ + + + I + Y P++ ++PE +
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAK 239
Query: 254 HLISRIFVADPAK 266
LI + +P K
Sbjct: 240 SLIDSMLTVNPKK 252
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 4e-86
Identities = 82/262 (31%), Positives = 124/262 (47%), Gaps = 20/262 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIIN 70
D Y + + +GSG G +L ++KT + VA+K I + NV+ EI
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 131 SYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
Query: 190 LLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSVQYSIPDYV 246
L+ + D WS GV L++ L G PF + + + I S +Y+ V
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----ITSGKYNFIPEV 243
Query: 247 --HISPECRHLISRIFVADPAK 266
+S + L+ ++ V DP
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKA 265
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 3e-85
Identities = 77/255 (30%), Positives = 122/255 (47%), Gaps = 14/255 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKID-ENVQREIINHRSLRHP 77
D + R +GSG FG L+ ++ + +K I ++ E ++ EI +SL HP
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYC 133
NI++ EV ++ IVME GGEL ERI SE +Q+++ ++Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 134 HSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
HS V H+DLK EN L SP +KI DFG ++ + GT Y+APEV K
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV-FK 199
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPE 251
++ K D+WS GV +Y +L G PF + +K + + + ++P+
Sbjct: 200 RDVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLTPQ 254
Query: 252 CRHLISRIFVADPAK 266
L+ ++ DP +
Sbjct: 255 AVDLLKQMLTKDPER 269
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 4e-85
Identities = 64/287 (22%), Positives = 115/287 (40%), Gaps = 41/287 (14%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ + L +G G R KKT +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 78 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 132
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 191 --------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS- 241
+K+Y D+WS GVT Y G+ PF E P+ ++ +++I++ + S
Sbjct: 188 ERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 242 ------------------IPDYVHISPECR----HLISRIFVADPAK 266
+P +S + +++ I AD K
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 260 bits (665), Expect = 4e-85
Identities = 80/261 (30%), Positives = 125/261 (47%), Gaps = 18/261 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREIIN 70
D Y + + +GSG G +L ++KT + VA++ I + NV+ EI
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ L HP I++ K + IV+E GGELF+++ R E + +F Q++ V
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 131 SYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
Y H + HRDLK EN LL +KI DFG+SK S ++ GTP Y+APEV
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312
Query: 190 LLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDY 245
L+ + D WS GV L++ L G PF + + + +I S +Y+ +
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD---QITSGKYNFIPEVW 369
Query: 246 VHISPECRHLISRIFVADPAK 266
+S + L+ ++ V DP
Sbjct: 370 AEVSEKALDLVKKLLVVDPKA 390
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 1e-84
Identities = 85/252 (33%), Positives = 129/252 (51%), Gaps = 12/252 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE-NVQREIINHRSLRHPN 78
+ + +GSG F L++ + T +L A+K I++ + +++ EI + ++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV +++ + TH +VM+ SGGELF+RI G ++E +A QQ++S V Y H +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 139 CHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYD 196
HRDLK EN L ++ I DFG SK + + + GTP Y+APEVL +K Y
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPY- 184
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRH 254
K D WS GV Y++L G PF + E K F K I Y P + IS +
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAKD 240
Query: 255 LISRIFVADPAK 266
I + DP +
Sbjct: 241 FICHLLEKDPNE 252
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 252 bits (647), Expect = 5e-84
Identities = 86/258 (33%), Positives = 135/258 (52%), Gaps = 16/258 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D YE+ ++GSG F + R R K T + A K+I R E ++RE+ R
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+RHPNI+ ++ T + +++E SGGELF+ + +EDEA F +Q++ GV Y
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS ++ H DLK EN +L P PR+K+ DFG + ++ K+ GTP ++APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248
+ G AD+WS GV Y++L GA PF + + I +V Y + + +
Sbjct: 184 NYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTN----ISAVNYDFDEEYFSNT 238
Query: 249 SPECRHLISRIFVADPAK 266
S + I R+ V DP +
Sbjct: 239 SELAKDFIRRLLVKDPKR 256
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 5e-84
Identities = 64/287 (22%), Positives = 114/287 (39%), Gaps = 41/287 (14%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ + L +G G R KKT +L A+K + + RE + L H
Sbjct: 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67
Query: 78 NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 132
NIV+ + T H ++ME+ G L+ + NA E E + ++ G+++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HR++K N + + K+ DFG ++ Q S GT Y+ P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 191 --------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS- 241
+K+Y D+WS GVT Y G+ PF E P+ ++ +++I++ + S
Sbjct: 188 ERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 242 ------------------IPDYVHISP----ECRHLISRIFVADPAK 266
+P +S +++ I AD K
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 1e-83
Identities = 87/253 (34%), Positives = 132/253 (52%), Gaps = 11/253 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGDKID-ENVQREIINHRSLRH 76
SD Y++ ++G G F V R K T A K I + D + ++RE R L+H
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I + +V + +GGELFE I +SE +A QQ++ ++YCHS
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HR+LK EN LL + +K+ DFG + GTP Y++PEVL K Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
K D+W+CGV LY++LVG PF D ++ + + + I + Y P++ ++PE +
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAK 262
Query: 254 HLISRIFVADPAK 266
LI + +P K
Sbjct: 263 SLIDSMLTVNPKK 275
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 2e-83
Identities = 89/253 (35%), Positives = 138/253 (54%), Gaps = 12/253 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
++RY +V +G G+FG +D+ T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEV L+ Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
D K DVWS GV LY++L G PF E ++ + + +Y+ +P + IS + +
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAK 254
Query: 254 HLISRIFVADPAK 266
LI ++ P+
Sbjct: 255 DLIRKMLTFHPSL 267
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 4e-83
Identities = 81/265 (30%), Positives = 121/265 (45%), Gaps = 24/265 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDENVQREI- 68
+ YE +G G V R K T + AVK I E ++ E +E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 69 INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
I + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 189 VLLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI- 242
++ D GK D+WS GV +Y +L G+ PF ++ R I+S Y
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQFG 249
Query: 243 -PDYVHISPECRHLISRIFVADPAK 266
P++ S + L+SR V P K
Sbjct: 250 SPEWDDYSDTVKDLVSRFLVVQPQK 274
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 5e-83
Identities = 85/253 (33%), Positives = 122/253 (48%), Gaps = 11/253 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPN 78
+D YE+ DIG G++ V + K T AVK I DK + EI I R +HPN
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPTEEIEILLRYGQHPN 77
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
I+ K+V ++ +V E GGEL ++I FSE EA + V Y H+ V
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 139 CHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
HRDLK N L ++ICDFG++K + T T ++APEVL ++ Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--HISPECR 253
D D+WS GV LY ML G PF + + RI S ++S+ +S +
Sbjct: 198 D-AACDIWSLGVLLYTMLTGYTPF-ANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK 255
Query: 254 HLISRIFVADPAK 266
L+S++ DP +
Sbjct: 256 DLVSKMLHVDPHQ 268
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 9e-83
Identities = 76/264 (28%), Positives = 119/264 (45%), Gaps = 23/264 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---------GDKIDENVQREI-I 69
+Y+ IG G V R + T AVK +E +++ E +RE I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
+ HP+I+ + + + + +V + GELF+ + SE E R + L+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
VS+ H+ + HRDLK EN LLD + +++ DFG+S + + GTP Y+APE+
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 190 LLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
L + GK D+W+CGV L+ +L G+ PF + R I+ QY
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSS 326
Query: 245 YV--HISPECRHLISRIFVADPAK 266
S + LISR+ DP
Sbjct: 327 PEWDDRSSTVKDLISRLLQVDPEA 350
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 1e-82
Identities = 85/258 (32%), Positives = 137/258 (53%), Gaps = 16/258 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y+ ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 133 CHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS+Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248
+ G AD+WS GV Y++L GA PF + + + +V Y D + +
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----VSAVNYEFEDEYFSNT 244
Query: 249 SPECRHLISRIFVADPAK 266
S + I R+ V DP K
Sbjct: 245 SALAKDFIRRLLVKDPKK 262
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 3e-82
Identities = 90/253 (35%), Positives = 137/253 (54%), Gaps = 12/253 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
++RY +V +G G+FG +D+ T++ AVK I + +K + RE+ + L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ E++ + IV E +GGELF+ I RFSE +A +Q+ SG++Y H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 137 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL+ +KI DFG S +++ K +GT YIAPEV L+ Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECR 253
D K DVWS GV LY++L G PF KN + R+ + + +P + IS + +
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYG----KNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 254 HLISRIFVADPAK 266
LI ++ P+
Sbjct: 255 DLIRKMLTFHPSL 267
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 4e-82
Identities = 80/258 (31%), Positives = 131/258 (50%), Gaps = 16/258 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y++ ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ HPNI+ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
H+ ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248
+ G AD+WS GV Y++L GA PF + + I +V Y + +
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITAVSYDFDEEFFSQT 245
Query: 249 SPECRHLISRIFVADPAK 266
S + I ++ V + K
Sbjct: 246 SELAKDFIRKLLVKETRK 263
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 5e-82
Identities = 57/263 (21%), Positives = 104/263 (39%), Gaps = 26/263 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++K + + A+KY+ + + ++ + EI L+ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 147 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
+DVWS G LY M G PF+ N +H I+ + I
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---IINQISKLHAIIDPNHEIE 260
Query: 244 DYVHISPECRHLISRIFVADPAK 266
+ + ++ DP +
Sbjct: 261 FPDIPEKDLQDVLKCCLKRDPKQ 283
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 6e-82
Identities = 80/258 (31%), Positives = 131/258 (50%), Gaps = 16/258 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y++ ++GSG F + + R+K T A K+I R E ++RE+ R
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ H N++ +V T + +++E SGGELF+ + SE+EA F +Q++ GV+Y
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
H+ ++ H DLK EN +L P P +K+ DFG + + K+ GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248
+ G AD+WS GV Y++L GA PF + + I SV Y + + H
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITSVSYDFDEEFFSHT 245
Query: 249 SPECRHLISRIFVADPAK 266
S + I ++ V + K
Sbjct: 246 SELAKDFIRKLLVKETRK 263
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 7e-82
Identities = 95/273 (34%), Positives = 139/273 (50%), Gaps = 15/273 (5%)
Query: 3 RSAMTVGPGM--DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---G 57
+ PGM SDRY+ R +G G+FG L +DK T + AVK I +
Sbjct: 6 MDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK 65
Query: 58 DKID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 116
K D E++ RE+ + L HPNI++ E + +V E +GGELF+ I + RFSE
Sbjct: 66 QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE 125
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP 175
+A +Q++SG++Y H ++ HRDLK EN LL+ S ++I DFG S +
Sbjct: 126 VDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
K +GT YIAPEV L YD K DVWS GV LY++L G PF N + ++
Sbjct: 186 KDKIGTAYYIAPEV-LHGTYDEK-CDVWSTGVILYILLSGCPPFNG----ANEYDILKKV 239
Query: 236 LS--VQYSIPDYVHISPECRHLISRIFVADPAK 266
+ +P + +S + LI ++ P+
Sbjct: 240 EKGKYTFELPQWKKVSESAKDLIRKMLTYVPSM 272
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 1e-81
Identities = 85/253 (33%), Positives = 135/253 (53%), Gaps = 12/253 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRH 76
S+ Y+ V+ +GSG +G L RDK T A+K I + + + E+ + L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI++ + + +VME GGELF+ I + +F+E +A +Q++SGV+Y H
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 137 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ HRDLK EN LL +KI DFG S + K +GT YIAPEV L+K+Y
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-LRKKY 214
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
D K DVWS GV L+++L G PF + ++ + ++ +Y+ P++ ++S +
Sbjct: 215 DEK-CDVWSIGVILFILLAGYPPFGG----QTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269
Query: 254 HLISRIFVADPAK 266
LI ++ D +
Sbjct: 270 DLIKQMLQFDSQR 282
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 2e-81
Identities = 59/250 (23%), Positives = 109/250 (43%), Gaps = 8/250 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
++Y + D+G G FG+ + +++ K+++ V++EI RH NI
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQV 138
+ E + L ++ E+ SG ++FERI + +E E + Q+ + + HS +
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-ST 182
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLI 256
D+WS G +YV+L G PF + I++ +Y+ + + IS E +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNAEYTFDEEAFKEISIEAMDFV 238
Query: 257 SRIFVADPAK 266
R+ V +
Sbjct: 239 DRLLVKERKS 248
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 3e-81
Identities = 75/301 (24%), Positives = 125/301 (41%), Gaps = 58/301 (19%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDKID-ENVQREIINHRS 73
+Y L IG G++GV R+ + +T + A+K + + + D E ++ E+ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 113
L HPNI R EV ++ +VME GG L +++
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 114 --------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153
E +Q+ S + Y H+ +CHRD+K EN L +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204
Query: 154 PAPRLKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYD-GKIADVWSCGV 207
+ +K+ DFG SK + + GTP ++APEVL G D WS GV
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 208 TLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRIFVADPA 265
L+++L+GA PF + + +L+ + P+Y +SP R L+S + +
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQ----VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320
Query: 266 K 266
+
Sbjct: 321 E 321
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 3e-81
Identities = 71/278 (25%), Positives = 112/278 (40%), Gaps = 39/278 (14%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ +E + +G G FG R+ A+K I ++ + E++ SL H +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 80 VRFKEVIL-------------TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQ 125
VR+ L + L I MEY G L++ I + DE F+Q
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---------------SV 170
++ +SY HS + HRDLK N +D S +KI DFG +K+
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
S +GT Y+A EVL + + D++S G+ + M+ YPF E N K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILK 239
Query: 231 TIHRILSVQYSIPDYV--HISPECRHLISRIFVADPAK 266
++ SV P + + +I + DP K
Sbjct: 240 ---KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNK 274
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 4e-81
Identities = 88/250 (35%), Positives = 135/250 (54%), Gaps = 8/250 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
SD +E+ ++G G + + K T++ A+K +++ + V+ EI L HPNI
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRLSHPNI 110
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
++ KE+ TPT +++V+E +GGELF+RI G +SE +A +Q++ V+Y H +
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170
Query: 140 HRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
HRDLK EN L +P LKI DFG SK K+ GTP Y APE+L Y G
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GP 229
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLI 256
D+WS G+ Y++L G PF D + + RIL+ +Y P + +S + L+
Sbjct: 230 EVDMWSVGIITYILLCGFEPFYD---ERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV 286
Query: 257 SRIFVADPAK 266
++ V DP K
Sbjct: 287 RKLIVLDPKK 296
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 256 bits (656), Expect = 4e-81
Identities = 72/276 (26%), Positives = 107/276 (38%), Gaps = 31/276 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKIDENVQREIINHRSLRHPN 78
+E+ +G+G FG + T E VA+K + K E EI + L HPN
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 79 IVRFKEVILTPTHLA------IVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISG 129
+V +EV LA + MEY GG+L + + N E R + S
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 130 VSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 188
+ Y H ++ HRDLK EN +L G KI D GY+K VGT Y+APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-------------- 234
+L +K+Y D WS G + + G PF +P + +
Sbjct: 194 LLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252
Query: 235 ILSVQYSIPDYVHISPECRHLISRIF----VADPAK 266
+ +P H+S + R + +
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQ 288
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 4e-81
Identities = 90/264 (34%), Positives = 136/264 (51%), Gaps = 23/264 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--------------GDKIDENVQ 65
+ Y VR +GSG +G L ++K A+K I++ +K E +
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 125
EI +SL HPNI++ +V + +V E+ GGELFE+I N +F E +A +Q
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 126 LISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
++SG+ Y H + HRD+K EN LL + + +KI DFG S + + +GT Y
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSI 242
IAPEV LKK+Y+ K DVWSCGV +Y++L G PF +N + I ++ +
Sbjct: 215 IAPEV-LKKKYNEK-CDVWSCGVIMYILLCGYPPFGG----QNDQDIIKKVEKGKYYFDF 268
Query: 243 PDYVHISPECRHLISRIFVADPAK 266
D+ +IS E + LI + D K
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNK 292
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 4e-81
Identities = 56/263 (21%), Positives = 104/263 (39%), Gaps = 26/263 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++K + + A+KY+ + + ++ + EI L+ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQ-IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + S VGT Y+ PE +
Sbjct: 128 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
+DVWS G LY M G PF+ + +H I+ + I
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIE 241
Query: 244 DYVHISPECRHLISRIFVADPAK 266
+ + ++ DP +
Sbjct: 242 FPDIPEKDLQDVLKCCLKRDPKQ 264
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 5e-81
Identities = 87/257 (33%), Positives = 135/257 (52%), Gaps = 18/257 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
++ Y+L ++G G F V R + A I D + ++RE R L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNIVR + I H ++ + +GGELFE I +SE +A QQ++ V +CH M
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 137 QVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 191
V HR+LK EN LL G+ +K+ DFG + Q GTP Y++PEVL
Sbjct: 130 GVVHRNLKPENLLLASKLKGAA---VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHIS 249
K Y GK D+W+CGV LY++LVG PF D ++ + +++ I + Y P++ ++
Sbjct: 187 KDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVT 241
Query: 250 PECRHLISRIFVADPAK 266
PE + LI+++ +P+K
Sbjct: 242 PEAKDLINKMLTINPSK 258
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 9e-81
Identities = 92/258 (35%), Positives = 133/258 (51%), Gaps = 14/258 (5%)
Query: 20 SDRYEL---VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLR 75
Y+L + +G G+F + R KK+ + AVK I + +++ N Q+EI
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEG 64
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HPNIV+ EV H +VME +GGELFERI FSE EA + ++L+S VS+ H
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 136 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKK 193
+ V HRDLK EN L D + +KI DFG+++ +QP T T Y APE+L +
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI---HRILSVQYS--IPDYVHI 248
YD + D+WS GV LY ML G PF+ + + +I +S + ++
Sbjct: 185 GYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243
Query: 249 SPECRHLISRIFVADPAK 266
S E + LI + DP K
Sbjct: 244 SQEAKDLIQGLLTVDPNK 261
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 3e-80
Identities = 69/251 (27%), Positives = 118/251 (47%), Gaps = 9/251 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D Y+++ ++GSG FGV +K T + K+I +D V+ EI L HP
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQ 137
++ + + +++E+ SGGELF+RI + SE E + +Q G+ + H
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ H D+K EN + + A +KI DFG + K T T + APE++ ++ G
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-G 228
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHL 255
D+W+ GV YV+L G PF ++ +T+ + + + +SPE +
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAG----EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284
Query: 256 ISRIFVADPAK 266
I + +P K
Sbjct: 285 IKNLLQKEPRK 295
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 1e-79
Identities = 54/263 (20%), Positives = 104/263 (39%), Gaps = 26/263 (9%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPN 78
Y +++ IGSG + ++ +++ A+KY+ + + ++ + EI L+ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 79 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+R + +T ++ +VME +L + E + +++ ++ V H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKK 193
+ H DLK N L+ LK+ DFG + + S VG Y+ PE +
Sbjct: 175 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 194 EYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243
+DVWS G LY M G PF+ + +H I+ + I
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIE 288
Query: 244 DYVHISPECRHLISRIFVADPAK 266
+ + ++ DP +
Sbjct: 289 FPDIPEKDLQDVLKCCLKRDPKQ 311
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 3e-79
Identities = 69/257 (26%), Positives = 117/257 (45%), Gaps = 15/257 (5%)
Query: 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREI-INHRSL 74
++ Y L +++G G F V R K T + A K+++ RG + EI + +
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSY 132
P ++ EV + + +++EYA+GGE+F A SE++ +Q++ GV Y
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 133 CHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
H + H DLK +N LL P +KI DFG S+ + + +GTP Y+APE+L
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHIS 249
D+W+ G+ Y++L PF + + + I V + + +S
Sbjct: 207 YDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN----ISQVNVDYSEETFSSVS 261
Query: 250 PECRHLISRIFVADPAK 266
I + V +P K
Sbjct: 262 QLATDFIQSLLVKNPEK 278
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 7e-79
Identities = 77/251 (30%), Positives = 126/251 (50%), Gaps = 9/251 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D Y++ ++G+G FGV + ++ T A K++ + D E V++EI LRHP
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQ 137
+V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G+ + H
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
H DLK EN + + LK+ DFG + K T GT + APEV K G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 334
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHL 255
D+WS GV Y++L G PF +N +T+ + S +++ D + IS + +
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 256 ISRIFVADPAK 266
I ++ +ADP
Sbjct: 391 IRKLLLADPNT 401
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 2e-78
Identities = 78/261 (29%), Positives = 123/261 (47%), Gaps = 20/261 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE------RGDKIDENVQREIINHRS 73
D YEL IG G F V R +++T + AVK ++ E+++RE
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISG 129
L+HP+IV E + L +V E+ G +L I +SE A + +Q++
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 130 VSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAP 187
+ YCH + HRD+K LL + +K+ FG + VGTP ++AP
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDY 245
EV+ ++ Y GK DVW CGV L+++L G PF +E + I+ +Y +
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQW 256
Query: 246 VHISPECRHLISRIFVADPAK 266
HIS + L+ R+ + DPA+
Sbjct: 257 SHISESAKDLVRRMLMLDPAE 277
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 3e-78
Identities = 74/253 (29%), Positives = 124/253 (49%), Gaps = 11/253 (4%)
Query: 20 SDRYELVR--DIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRH 76
+ Y + + +G G FG + T +A K I+ RG K E V+ EI L H
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHS 135
N+++ + + + +VMEY GGELF+RI + +E + F +Q+ G+ + H
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
M + H DLK EN L A ++KI DFG ++ + K GTP ++APEV + ++
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV-VNYDF 264
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 253
D+WS GV Y++L G PF + + IL+ ++ ++ IS E +
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN----ILACRWDLEDEEFQDISEEAK 320
Query: 254 HLISRIFVADPAK 266
IS++ + + +
Sbjct: 321 EFISKLLIKEKSW 333
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 1e-77
Identities = 86/275 (31%), Positives = 134/275 (48%), Gaps = 16/275 (5%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID 61
V G+ + D Y++ + +G G G + +K+T+E A+K ++
Sbjct: 43 FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----C 98
Query: 62 ENVQREI-INHRSLRHPNIVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RF 114
+RE+ ++ R+ + P+IVR +V L IVME GGELF RI + G F
Sbjct: 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS 173
+E EA + + + Y HS+ + HRD+K EN L P LK+ DFG++K + H+
Sbjct: 159 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+ TP Y+APEVL ++YD K D+WS GV +Y++L G PF
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277
Query: 234 RILSVQYSIPDYV--HISPECRHLISRIFVADPAK 266
RI QY P+ +S E + LI + +P +
Sbjct: 278 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 312
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 2e-76
Identities = 76/259 (29%), Positives = 120/259 (46%), Gaps = 19/259 (7%)
Query: 20 SDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHP 77
+D Y+L + +G G G ++T + A+K + ++E+ + ++ P
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGP 82
Query: 78 NIVRFKEVILTPTHLA----IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVS 131
+IV +V H I+ME GGELF RI G F+E EA + + + +
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 132 YCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV 189
+ HS + HRD+K EN L LK+ DFG++K ++ TP Y+APEV
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEV 200
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--H 247
L ++YD K D+WS GV +Y++L G PF RI QY P+
Sbjct: 201 LGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259
Query: 248 ISPECRHLISRIFVADPAK 266
+S + + LI + DP +
Sbjct: 260 VSEDAKQLIRLLLKTDPTE 278
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 7e-76
Identities = 76/277 (27%), Positives = 115/277 (41%), Gaps = 31/277 (11%)
Query: 20 SDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREI-INHRSLRH 76
D Y+L D +G G + + T + AVK IE + I V RE+ + ++ H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
N++ E +V E GG + I F+E EA Q + S + + H+
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130
Query: 137 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIA 186
+ HRDLK EN L + +P +KICDF S + + + G+ Y+A
Sbjct: 131 GIAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 187 PEVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPF-----------EDPEEPKNFRKT 231
PEV+ + K D+WS GV LY++L G PF P
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 232 IHRILSVQYS--IPDYVHISPECRHLISRIFVADPAK 266
I +Y D+ HIS + LIS++ V D +
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQ 286
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 4e-75
Identities = 70/253 (27%), Positives = 129/253 (50%), Gaps = 16/253 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHP 77
++Y ++ IG G+FG A L++ + +K I E +RE+ +++HP
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHS 135
NIV+++E L IVM+Y GG+LF+RI F ED+ +F Q+ + + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ HRD+K +N L +++ DFG ++ + ++ +GTP Y++PE+ K
Sbjct: 144 RKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECR 253
Y+ K +D+W+ G LY + + FE + + + +I+S + + H S + R
Sbjct: 202 YNNK-SDIWALGCVLYELCTLKHAFEA----GSMKNLVLKIISGSFPPVSL--HYSYDLR 254
Query: 254 HLISRIFVADPAK 266
L+S++F +P
Sbjct: 255 SLVSQLFKRNPRD 267
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-74
Identities = 63/269 (23%), Positives = 105/269 (39%), Gaps = 26/269 (9%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHP 77
D+ Y ++ +G G F L+ A+K I ++ D E QRE HR HP
Sbjct: 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP 86
Query: 78 NIVRFKEVILTPT----HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISG 129
NI+R L +++ + G L+ I +ED+ + + G
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----------V 179
+ H+ HRDLK N LL + + D G + +H +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDE--GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 180 GTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237
T +Y APE+ + + + DVWS G LY M+ G P++ + + ++ +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVALAVQ 261
Query: 238 VQYSIPDYVHISPECRHLISRIFVADPAK 266
Q SIP S L++ + DP +
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQ 290
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 4e-74
Identities = 76/262 (29%), Positives = 124/262 (47%), Gaps = 25/262 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHP 77
+ YE++ IG+G++G + +R K +++ K ++ G + + + E+ R L+HP
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 78 NIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
NIVR+ + I+ T L IVMEY GG+L I + E+ QL +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 132 YCHSM-----QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYI 185
CH V HRDLK N LDG +K+ DFG ++ + S K+ VGTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPD 244
+PE + + Y+ K +D+WS G LY + PF + ++ +I ++ IP
Sbjct: 184 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIPY 238
Query: 245 YVHISPECRHLISRIFVADPAK 266
S E +I+R+
Sbjct: 239 --RYSDELNEIITRMLNLKDYH 258
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 2e-72
Identities = 58/264 (21%), Positives = 102/264 (38%), Gaps = 34/264 (12%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++ + IGSG FG + + + +K + +E +RE+ L H NIV
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIV 67
Query: 81 RFKEVILTPTH----------------LAIVMEYASGGELFERI--CNAGRFSEDEARFF 122
+ + L I ME+ G L + I + + A
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182
F+Q+ GV Y HS ++ +RDLK N L + ++KI DFG S + + GT
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDT--KQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242
Y++PE + ++Y + D+++ G+ L +L E F + I
Sbjct: 186 RYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDT---AFETSKFFTDLRDG-----II 236
Query: 243 PDYVHISPECRHLISRIFVADPAK 266
D + + L+ ++ P
Sbjct: 237 SD--IFDKKEKTLLQKLLSKKPED 258
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 2e-70
Identities = 71/256 (27%), Positives = 113/256 (44%), Gaps = 16/256 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
+ + + IG G F VA+K ++ D +D + +EI + L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 132
PN++++ + L IV+E A G+L I + + E +F QL S + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL 191
HS +V HRD+K N + + +K+ D G + S + S VGTP Y++PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISP 250
+ Y+ K +D+WS G LY M PF + N +I Y +P H S
Sbjct: 210 ENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPS-DHYSE 265
Query: 251 ECRHLISRIFVADPAK 266
E R L++ DP K
Sbjct: 266 ELRQLVNMCINPDPEK 281
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 6e-70
Identities = 67/274 (24%), Positives = 109/274 (39%), Gaps = 39/274 (14%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSLR-HPNI 79
R + R + G F +D + A+K + ++ + +E+ + L HPNI
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 80 VRF-------KEVILTPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISG 129
V+F KE T +++ G+L E + G S D F Q
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 130 VSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------- 178
V + H + + HRDLK+EN LL +K+CDFG + + + +
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 179 ----VGTPAYIAPEV--LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232
TP Y PE+ L G+ D+W+ G LY++ +PFED
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG--------AK 258
Query: 233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
RI++ +YSIP + LI + +P +
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEE 292
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-68
Identities = 75/257 (29%), Positives = 113/257 (43%), Gaps = 36/257 (14%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPN 78
D + +G G G + +K+T+E A+K ++ +RE+ ++ R+ + P+
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPH 72
Query: 79 IVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSY 132
IVR +V L IVME GGELF RI + G F+E EA + + + Y
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 133 CHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
HS+ + HRD+K EN L P LK+ DFG A E
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKET-T 171
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--HIS 249
++YD K D+WS GV +Y++L G PF RI QY P+ +S
Sbjct: 172 GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 230
Query: 250 PECRHLISRIFVADPAK 266
E + LI + +P +
Sbjct: 231 EEVKMLIRNLLKTEPTQ 247
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 6e-68
Identities = 58/251 (23%), Positives = 101/251 (40%), Gaps = 17/251 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSL-RH 76
++ + +G G++G +R K+ L AVK RG K E+ +H + +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHS 135
P VR ++ L + E G L + G E + + + + +++ HS
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
+ H D+K N L P R K+ DFG + G P Y+APE+ L+ Y
Sbjct: 176 QGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-LQGSY 232
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
ADV+S G+T+ + P + +++ L + +S E R +
Sbjct: 233 GTA-ADVFSLGLTILEVACNMEL---PHGGEGWQQLRQGYLPPE--FTA--GLSSELRSV 284
Query: 256 ISRIFVADPAK 266
+ + DP
Sbjct: 285 LVMMLEPDPKL 295
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-65
Identities = 73/253 (28%), Positives = 122/253 (48%), Gaps = 20/253 (7%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 76
++ + +G G+F L R+ T A+K +I + +K+ +R++++ L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS--RLDH 89
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 193
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L +K
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
K +D+W+ G +Y ++ G PF E F+K I+ ++Y P+ P+ R
Sbjct: 208 SA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 260
Query: 254 HLISRIFVADPAK 266
L+ ++ V D K
Sbjct: 261 DLVEKLLVLDATK 273
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 3e-65
Identities = 62/276 (22%), Positives = 105/276 (38%), Gaps = 40/276 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+E ++ +G G FGV ++K + A+K I + E V RE+ L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 79 IVRFKEVILT------------PTHLAIVMEYASGGELFERI---CNAGRFSEDEARFFF 123
IVR+ L +L I M+ L + + C F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------------SSV 170
Q+ V + HS + HRDLK N +K+ DFG
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+++ VGT Y++PE + Y K D++S G+ L+ +L YPF E +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMERV---R 235
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
T+ + ++++ P + P ++ + P +
Sbjct: 236 TLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPME 270
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 1e-64
Identities = 64/282 (22%), Positives = 106/282 (37%), Gaps = 46/282 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNI 79
+ + +G G+ G + VAVK + + EI + S HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV 71
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED-------EARFFFQQLISGVSY 132
+R+ T L I +E L + + + E+ +Q+ SGV++
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 133 CHSMQVCHRDLKLENTLLDGSPAP-----------RLKICDFGYSK-----SSVLHSQPK 176
HS+++ HRDLK +N L+ S R+ I DFG K S +
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 177 STVGTPAYIAPEVLLKKEYD------GKIADVWSCGVTLYVMLVGAY-PFEDPEEPKNFR 229
+ GT + APE+L + + D++S G Y +L PF D
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS----- 245
Query: 230 KTIHRILSVQYSIPDYV-----HISPECRHLISRIFVADPAK 266
I+ +S+ + + E LIS++ DP K
Sbjct: 246 -RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLK 286
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 6e-62
Identities = 62/259 (23%), Positives = 94/259 (36%), Gaps = 23/259 (8%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-INHRSLRHPNIV 80
+ +G G G R VAVK I + RE+ + S HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVI 81
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVC 139
R+ I +E L E + E QQ SG+++ HS+ +
Sbjct: 82 RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140
Query: 140 HRDLKLENTLL---DGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL-- 190
HRDLK N L+ + + I DFG K S+ GT +IAPE+L
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 191 -LKKEYDGKIADVWSCGVTLYVMLVGAY-PFEDPEEPKNFRKTIHRILSVQYSIPDY-VH 247
K+ D++S G Y ++ PF + R+ + + H
Sbjct: 201 DCKENPTYT-VDIFSAGCVFYYVISEGSHPFGKSLQ----RQANILLGACSLDCLHPEKH 255
Query: 248 ISPECRHLISRIFVADPAK 266
R LI ++ DP K
Sbjct: 256 EDVIARELIEKMIAMDPQK 274
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-60
Identities = 49/279 (17%), Positives = 94/279 (33%), Gaps = 40/279 (14%)
Query: 19 DSDRYELVRDIGSGNFGVARL-----MRDKKTEELVAVKYIERGDKIDENVQREIIN-HR 72
S + +G G F + D K ++ +K + + + + +++ +
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-----NAGRFSEDEARFFFQQLI 127
++F L +V E S G L I + F +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPR---------LKICDFGYSKSSVLHSQPKST 178
+ H ++ H D+K +N +L + L + D G S + PK T
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGT 240
Query: 179 V-----GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPKNFRKTI 232
+ T + E+L K ++ +I D + T+Y ML G Y ++
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 233 HR---------ILSVQYSIPDYVHIS--PECRHLISRIF 260
R V +IPD H+ R + ++F
Sbjct: 300 RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-60
Identities = 75/256 (29%), Positives = 136/256 (53%), Gaps = 22/256 (8%)
Query: 21 DRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----S 73
++EL++ +G G+FG + + + +L A+K + + + + R
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVE 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
+ HP IV+ T L +++++ GG+LF R+ F+E++ +F+ +L + +
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 134 HSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVL 190
HS+ + +RDLK EN LLD G +K+ DFG SK S+ H + + GT Y+APEV+
Sbjct: 143 HSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
++ + + AD WS GV ++ ML G PF+ K+ ++T+ IL + +P + +SP
Sbjct: 199 NRRGH-TQSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSP 251
Query: 251 ECRHLISRIFVADPAK 266
E + L+ +F +PA
Sbjct: 252 EAQSLLRMLFKRNPAN 267
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-59
Identities = 78/254 (30%), Positives = 126/254 (49%), Gaps = 27/254 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
++++R +G+G+FG L+R + A+K + K + V+ + + H +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHTNDERLMLSIV 63
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
HP I+R + ++M+Y GGELF + + RF A+F+ ++ + Y H
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 135 SMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
S + +RDLK EN LLD G +KI DFG++K + + GTP YIAPEV+
Sbjct: 124 SKDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVST 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252
K Y K D WS G+ +Y ML G PF D K + K IL+ + P + +
Sbjct: 178 KPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK----ILNAELRFPP--FFNEDV 230
Query: 253 RHLISRIFVADPAK 266
+ L+SR+ D ++
Sbjct: 231 KDLLSRLITRDLSQ 244
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-59
Identities = 62/251 (24%), Positives = 115/251 (45%), Gaps = 15/251 (5%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRHPNI 79
E++R IG G+FG +++ T+++ A+KY+ + ++ N R + L HP +
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
V + +V++ GG+L + F E+ + F +L+ + Y + ++
Sbjct: 78 VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137
Query: 140 HRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
HRD+K +N LLD G + I DF + +Q + GT Y+APE+ ++ G
Sbjct: 138 HRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 198 --KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
D WS GVT Y +L G P+ + ++ +H + + P S E L
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTFETTVVTYPSA--WSQEMVSL 250
Query: 256 ISRIFVADPAK 266
+ ++ +P +
Sbjct: 251 LKKLLEPNPDQ 261
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-59
Identities = 74/252 (29%), Positives = 133/252 (52%), Gaps = 19/252 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
D+++ ++ +G+G+FG L++ K++ A+K +++ + +N + ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ +RDLK EN L+D G +++ DFG++K + + + GTP +APE++L K
Sbjct: 161 DLIYRDLKPENLLIDQQG----YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKG 214
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
Y K D W+ GV +Y M G PF + + + K I+S + P H S + +
Sbjct: 215 Y-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSSDLKD 267
Query: 255 LISRIFVADPAK 266
L+ + D K
Sbjct: 268 LLRNLLQVDLTK 279
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-59
Identities = 64/274 (23%), Positives = 105/274 (38%), Gaps = 40/274 (14%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE---RGDKIDENVQREIINHRSL-R 75
+ + + IGSG FG + + A+K + G ++N RE+ H L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
H ++VR+ H+ I EY +GG L + I R F E E + Q+ G+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 132 YCHSMQVCHRDLKLENTLLD-----------------GSPAPRLKICDFGYSKSSVLHSQ 174
Y HSM + H D+K N + S KI D G+ S
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISS 186
Query: 175 PKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
P+ G ++A EVL + K AD+++ +T+ + ++ H
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQ-------WH 238
Query: 234 RILSVQYS-IPDYVHISPECRHLISRIFVADPAK 266
I + IP +S E L+ + DP +
Sbjct: 239 EIRQGRLPRIPQ--VLSQEFTELLKVMIHPDPER 270
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-58
Identities = 77/257 (29%), Positives = 128/257 (49%), Gaps = 22/257 (8%)
Query: 21 DRYELVRDIGSGNFG---VARLMRDKKTEELVAVKYIERGDKIDENVQRE-IINHR---- 72
+ +EL+R +G G +G R + T ++ A+K +++ + R
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HP IV T L +++EY SGGELF ++ G F ED A F+ ++ + +
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 189
H + +RDLK EN +L+ G +K+ DFG K S+ T GT Y+APE+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
L++ + + D WS G +Y ML GA PF +N +KTI +IL + ++P Y ++
Sbjct: 193 LMRSGH-NRAVDWWSLGALMYDMLTGAPPFTG----ENRKKTIDKILKCKLNLPPY--LT 245
Query: 250 PECRHLISRIFVADPAK 266
E R L+ ++ + A
Sbjct: 246 QEARDLLKKLLKRNAAS 262
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 8e-58
Identities = 83/256 (32%), Positives = 123/256 (48%), Gaps = 23/256 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
D +E +R +G G+FG L R K+T +L AVK + + D I +Q + +
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL-KKDVI---LQDDDVECTMTEKRILS 78
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ HP + + TP L VME+ +GG+L I + RF E ARF+ ++IS +
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
+ H + +RDLKL+N LLD K+ DFG K + + +T GTP YIAPE+L
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
+ Y G D W+ GV LY ML G PFE E F IL+ + P +
Sbjct: 197 QEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPT--WLHE 249
Query: 251 ECRHLISRIFVADPAK 266
+ ++ +P
Sbjct: 250 DATGILKSFMTKNPTM 265
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 8e-58
Identities = 85/257 (33%), Positives = 132/257 (51%), Gaps = 26/257 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------R 72
+ ++ ++ +G G FG L+R+K T A+K + R + I + ++ + H +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL-RKEVI---IAKDEVAHTVTESRVLQ 60
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
+ RHP + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 189
HS V +RD+KLEN +LD G +KI DFG K + T GTP Y+APEV
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDG----HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
L +Y G+ D W GV +Y M+ G PF + + + F IL + P +S
Sbjct: 177 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPRT--LS 229
Query: 250 PECRHLISRIFVADPAK 266
PE + L++ + DP +
Sbjct: 230 PEAKSLLAGLLKKDPKQ 246
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-57
Identities = 83/258 (32%), Positives = 126/258 (48%), Gaps = 27/258 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ + L + +G G+FG L KKT + A+K + K D + + +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVECTMVEKRVLS 72
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ HP + T +L VMEY +GG+L I + +F A F+ ++I G+
Sbjct: 73 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
+ HS + +RDLKL+N LLD G +KI DFG K ++L +T GTP YIAPE
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
+LL ++Y D WS GV LY ML+G PF +E + F I P + +
Sbjct: 189 ILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMDNPFYPRW--L 241
Query: 249 SPECRHLISRIFVADPAK 266
E + L+ ++FV +P K
Sbjct: 242 EKEAKDLLVKLFVREPEK 259
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-57
Identities = 82/258 (31%), Positives = 124/258 (48%), Gaps = 27/258 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ ++ IG G+FG L R K E AVK + + I ++++ H
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL-QKKAI---LKKKEEKHIMSERNVLL 93
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++++HP +V T L V++Y +GGELF + F E ARF+ ++ S +
Sbjct: 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y HS+ + +RDLK EN LLD G + + DFG K ++ H+ ST GTP Y+APE
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
VL K+ Y + D W G LY ML G PF +N + IL+ + +I
Sbjct: 210 VLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYS----RNTAEMYDNILNKPLQLKP--NI 262
Query: 249 SPECRHLISRIFVADPAK 266
+ RHL+ + D K
Sbjct: 263 TNSARHLLEGLLQKDRTK 280
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 5e-57
Identities = 76/261 (29%), Positives = 125/261 (47%), Gaps = 28/261 (10%)
Query: 24 ELVRDIGSGNFG---VARLMRDKKTEELVAVK-----YIERGDKIDENVQRE-----IIN 70
EL++ +G+G +G + R + T +L A+K I + K E+ + E I
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 117 Q----SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 131 SYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 186
+ H + + +RD+KLEN LLD G + + DFG SK V ++ GT Y+A
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 187 PEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245
P+++ + K D WS GV +Y +L GA PF E + + RIL + P
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288
Query: 246 VHISPECRHLISRIFVADPAK 266
+S + LI R+ + DP K
Sbjct: 289 --MSALAKDLIQRLLMKDPKK 307
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 5e-57
Identities = 81/258 (31%), Positives = 119/258 (46%), Gaps = 27/258 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
+ + +G G+FG L K T+EL AVK + K D +Q + +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL----KKDVVIQDDDVECTMVEKRVLA 75
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+
Sbjct: 76 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
+ S + +RDLKL+N +LD G +KI DFG K ++ T GTP YIAPE
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248
++ + Y GK D W+ GV LY ML G PFE +E + F+ I+ + P +
Sbjct: 192 IIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPKS--M 244
Query: 249 SPECRHLISRIFVADPAK 266
S E + + P K
Sbjct: 245 SKEAVAICKGLMTKHPGK 262
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 9e-57
Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 28/263 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
++L+R IG G++ L+R KKT+ + A+K + + + + E I+
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV-KKELV---NDDEDIDWVQTEKHVFE 64
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----KNFRKTIHRILSVQYSIP 243
+L ++Y G D W+ GV ++ M+ G PF+ IL Q IP
Sbjct: 181 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239
Query: 244 DYVHISPECRHLISRIFVADPAK 266
+S + ++ DP +
Sbjct: 240 RS--LSVKAASVLKSFLNKDPKE 260
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-56
Identities = 33/292 (11%), Positives = 69/292 (23%), Gaps = 62/292 (21%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR-- 75
+G + D++T E V ++ + ++ E++ R LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 76 -----------------------HPNIVRFKEVILTPTHLAIVMEY--------ASGGEL 104
++R + L+ Y G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
Q+I ++ H + H L+ + +LD + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR--GGVFLTGFE 251
Query: 165 YSKSSVLHSQPKSTVGTPAYIAPEVL----------LKKEYDGKIADVWSCGVTLYVMLV 214
V + + + PE+ ++ D W+ G+ +Y +
Sbjct: 252 ---HLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 215 GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
P +I R L+
Sbjct: 309 ADLPITKDAALGGSEWIFRSCK----------NIPQPVRALLEGFLRYPKED 350
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 7e-56
Identities = 74/263 (28%), Positives = 124/263 (47%), Gaps = 28/263 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------- 71
++L+R IG G++ L+R KKT+ + A++ + + + + E I+
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV-KKELV---NDDEDIDWVQTEKHVFE 107
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 132 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 188
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR-----KTIHRILSVQYSIP 243
+L ++Y G D W+ GV ++ M+ G PF+ N IL Q IP
Sbjct: 224 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 282
Query: 244 DYVHISPECRHLISRIFVADPAK 266
+S + ++ DP +
Sbjct: 283 R--SLSVKAASVLKSFLNKDPKE 303
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 8e-56
Identities = 85/252 (33%), Positives = 128/252 (50%), Gaps = 15/252 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
+ +E ++ +G G FG L+++K T A+K +++ + ++ + + RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + K T L VMEYA+GGELF + FSED ARF+ +++S + Y HS
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 137 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKKE 194
+ V +RDLKLEN +LD +KI DFG K + T GTP Y+APEVL +
Sbjct: 268 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
Y G+ D W GV +Y M+ G PF + + K F IL + P + PE +
Sbjct: 326 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILMEEIRFPRT--LGPEAKS 378
Query: 255 LISRIFVADPAK 266
L+S + DP +
Sbjct: 379 LLSGLLKKDPKQ 390
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-55
Identities = 65/254 (25%), Positives = 100/254 (39%), Gaps = 15/254 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +G G+FG M+DK+T AVK + ++ E++ L P
Sbjct: 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPR 111
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + I ME GG L + I G ED A ++ Q + G+ Y H+ ++
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLK 192
H D+K +N LL R +CDFG++ GT ++APEV++
Sbjct: 172 LHGDVKADNVLLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252
K D K D+WS + ML G +P+ K I IP +P
Sbjct: 231 KPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK-IASEPPPIREIPP--SCAPLT 286
Query: 253 RHLISRIFVADPAK 266
I +P
Sbjct: 287 AQAIQEGLRKEPVH 300
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 5e-55
Identities = 83/259 (32%), Positives = 120/259 (46%), Gaps = 27/259 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
YE+V+ IG G FG +L+R K T ++ A+K + E ++R
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAFFWEERDIMAFA 126
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
P +V+ +L +VMEY GG+L + + E ARF+ +++ + H
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK 192
SM HRD+K +N LLD S LK+ DFG + VGTP YI+PEVL
Sbjct: 186 SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 193 KEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVH 247
+ D G+ D WS GV LY MLVG PF + T +I++ + PD
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA----DSLVGTYSKIMNHKNSLTFPDDND 299
Query: 248 ISPECRHLISRIFVADPAK 266
IS E ++LI F+ D
Sbjct: 300 ISKEAKNLICA-FLTDREV 317
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 8e-55
Identities = 41/286 (14%), Positives = 74/286 (25%), Gaps = 46/286 (16%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRHP 77
+ +LV + G+ V L+RD + E A+K G + E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 78 NIVRFKEVI--------------------------LTPTHLAIVMEYASG------GELF 105
+ ++ + ++M AS L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 106 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165
G QLI + S + H +N + RL + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD--GRLMLGDVS- 239
Query: 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPE 223
+ P AP L + W G+++Y + PF
Sbjct: 240 --ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 224 EPKNF---RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
R ++ + + + + LI R D +
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRR 343
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 187 bits (475), Expect = 1e-54
Identities = 72/250 (28%), Positives = 117/250 (46%), Gaps = 13/250 (5%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-------SLRH 76
+ R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ + H+
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL K
Sbjct: 312 FVVYRDLKPANILLDEH--GHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
AD +S G L+ +L G PF + K+ + L++ +PD SPE R L+
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRSLL 425
Query: 257 SRIFVADPAK 266
+ D +
Sbjct: 426 EGLLQRDVNR 435
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 8e-54
Identities = 79/253 (31%), Positives = 122/253 (48%), Gaps = 17/253 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN------VQREIINHRSL 74
+ + +G G+FG L K T+EL AVK +++ I ++ V++ ++
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-LPG 399
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+ +
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLKK 193
S + +RDLKL+N +LD +KI DFG K ++ T GTP YIAPE++ +
Sbjct: 460 SKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
Y GK D W+ GV LY ML G PFE +E + F+ I+ + P +S E
Sbjct: 518 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPKS--MSKEAV 570
Query: 254 HLISRIFVADPAK 266
+ + P K
Sbjct: 571 AICKGLMTKHPGK 583
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-53
Identities = 65/252 (25%), Positives = 110/252 (43%), Gaps = 11/252 (4%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS----LRH 76
+ + R +G G FG + + T ++ A K +E+ + +N + +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH 134
+V T L +V+ +GG+L I + G+ F E A F+ ++ G+ H
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ +RDLK EN LLD ++I D G + K VGT Y+APEV+ +
Sbjct: 304 RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
Y D W+ G LY M+ G PF+ ++ + + V + SP+ R
Sbjct: 362 Y-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQARS 418
Query: 255 LISRIFVADPAK 266
L S++ DPA+
Sbjct: 419 LCSQLLCKDPAE 430
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 7e-53
Identities = 72/257 (28%), Positives = 109/257 (42%), Gaps = 18/257 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR----SLRH 76
D + R +G G FG + K T +L A K + + + + + +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSY 132
IV T T L +VM +GG++ I N F E A F+ Q++SG+ +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 189
H + +RDLK EN LLD G ++I D G + GTP ++APE+
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDG----NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
LL +EY D ++ GVTLY M+ PF E ++ R+L + PD S
Sbjct: 361 LLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FS 417
Query: 250 PECRHLISRIFVADPAK 266
P + + DP K
Sbjct: 418 PASKDFCEALLQKDPEK 434
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 8e-53
Identities = 65/266 (24%), Positives = 112/266 (42%), Gaps = 31/266 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------R 72
D +E+++ IG G F +++ K+T ++ A+K + + ++R ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM----NKWDMLKRGEVSCFREERDVLV 116
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVS 131
+ I + +L +VMEY GG+L + G R + ARF+ +++ +
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 189
H + HRD+K +N LLD +++ DFG +S VGTP Y++PE+
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 190 LLKKEYD------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYS 241
L G D W+ GV Y M G PF + +T +I+ S
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA----DSTAETYGKIVHYKEHLS 290
Query: 242 IPDY-VHISPECRHLISRIFVADPAK 266
+P + E R I R + P
Sbjct: 291 LPLVDEGVPEEARDFIQR-LLCPPET 315
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 9e-53
Identities = 66/260 (25%), Positives = 118/260 (45%), Gaps = 28/260 (10%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH--------RSL 74
+E+++ IG G FG +++ K +++ A+K + E ++R +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKIL----NKWEMLKRAETACFREERDVLVNG 131
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYC 133
I +L +VM+Y GG+L + R E+ ARF+ +++ +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 191
H + HRD+K +N L+D + +++ DFG + +S+ VGTP YI+PE+L
Sbjct: 192 HQLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 192 KKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDY 245
E G D WS GV +Y ML G PF ++ +T +I++ ++ P
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA----ESLVETYGKIMNHKERFQFPTQ 305
Query: 246 V-HISPECRHLISRIFVADP 264
V +S + LI R+ +
Sbjct: 306 VTDVSENAKDLIRRLICSRE 325
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-52
Identities = 73/247 (29%), Positives = 120/247 (48%), Gaps = 16/247 (6%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVIL 87
+G G +G+ RD + +A+K I D + + EI H+ L+H NIV++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 88 TPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144
+ I ME GG L + +E F+ +Q++ G+ Y H Q+ HRD+K
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 145 LENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKE--YDGKIAD 201
+N L++ + + LKI DFG SK + ++ ++ GT Y+APE++ K Y AD
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-AD 207
Query: 202 VWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRI 259
+WS G T+ M G PF + EP+ + ++ + IP+ +S E + I +
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEPQ---AAMFKVGMFKVHPEIPE--SMSAEAKAFILKC 262
Query: 260 FVADPAK 266
F DP K
Sbjct: 263 FEPDPDK 269
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-48
Identities = 35/288 (12%), Positives = 72/288 (25%), Gaps = 55/288 (19%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR-- 75
+G + D++T E V ++ + ++ E++ R LR
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 76 --------------------HPNIVRFKEVILTPTHLAIVMEYAS-----------GGEL 104
P + V L + ++ + G L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 105 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
Q+I ++ H + H L+ + +LD + + F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFE 256
Query: 165 YSKS--SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI----ADVWSCGVTLYVMLVGAYP 218
+ + S P A +L ++ + D W+ G+ +Y + P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 219 FEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
D +I R L+
Sbjct: 317 NTDDAALGGSEWIFRSC----------KNIPQPVRALLEGFLRYPKED 354
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 9e-47
Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 7/223 (3%)
Query: 2 DRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDK 59
+ PGM + + + IG G+FG D +T+++VA+K I E +
Sbjct: 3 HSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED 62
Query: 60 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
E++Q+EI P + ++ L T L I+MEY GG + + G E +
Sbjct: 63 EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQI 121
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 178
++++ G+ Y HS + HRD+K N LL +K+ DFG + ++T
Sbjct: 122 ATILREILKGLDYLHSEKKIHRDIKAANVLLSEH--GEVKLADFGVAGQLTDTQIKRNTF 179
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
VGTP ++APEV+ + YD K AD+WS G+T + G P +
Sbjct: 180 VGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSE 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-46
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 10/206 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ ++++ +G G++G K+T ++VA+K + + E + +EI + P++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHV 86
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
V++ T L IVMEY G + + I +EDE Q + G+ Y H M+
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K N LL +G K+ DFG + + + ++ + +GTP ++APEV+ + Y
Sbjct: 147 IHRDIKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFED 221
+ AD+WS G+T M G P+ D
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYAD 227
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-46
Identities = 66/230 (28%), Positives = 107/230 (46%), Gaps = 9/230 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREI-INHRSLR 75
D +E + ++G+GN GV + K + ++A K I K + RE+ + H
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-N 89
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
++ HRD+K N L++ +K+CDFG S + S S VGT +Y++PE L
Sbjct: 150 KHKIMHRDVKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 206
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
Y + +D+WS G++L M VG YP P+ + ++ P
Sbjct: 207 YSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-45
Identities = 73/260 (28%), Positives = 119/260 (45%), Gaps = 31/260 (11%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHP 77
+Y IG G G D T + VA++ + ++ K + + EI+ R ++P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV + + L L +VMEY +GG L + + E + ++ + + + HS Q
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 138 VCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
V HRD+K +N LL DG +K+ DFG+ + + S+ + VGTP ++APEV+ +K
Sbjct: 137 VIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--------DYV 246
Y K D+WS G+ M+ G P+ + E P L Y I +
Sbjct: 193 YGPK-VDIWSLGIMAIEMIEGEPPYLN-ENP----------LRALYLIATNGTPELQNPE 240
Query: 247 HISPECRHLISRIFVADPAK 266
+S R ++R D K
Sbjct: 241 KLSAIFRDFLNRCLEMDVEK 260
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-45
Identities = 73/263 (27%), Positives = 112/263 (42%), Gaps = 36/263 (13%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D E+ +G G FGV + + K + VA+K I + + E+ + HPN
Sbjct: 6 DYKEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQI-ESESERKAFIVELRQLSRVNHPN 62
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI---SGVSYCHS 135
IV+ L P + +VMEYA GG L+ + A A + GV+Y HS
Sbjct: 63 IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 136 MQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 192
MQ + HRDLK N LL LKICDFG + + + + G+ A++APEV
Sbjct: 121 MQPKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKTIHRILSVQYSIP 243
Y K DV+S G+ L+ ++ PF++ P R +
Sbjct: 178 SNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP----------LI 226
Query: 244 DYVHISPECRHLISRIFVADPAK 266
+ L++R + DP++
Sbjct: 227 KNLP--KPIESLMTRCWSKDPSQ 247
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-45
Identities = 64/258 (24%), Positives = 115/258 (44%), Gaps = 16/258 (6%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREI-INHRSLR 75
+ + E + ++GSG G MR +KT ++AVK + + ++ + ++ + +S
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
P IV+ +T T + I ME + G E ++ + Y
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 136 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL---- 190
V HRD+K N LLD ++K+CDFG S V + G AY+APE +
Sbjct: 143 KHGVIHRDVKPSNILLDER--GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 191 -LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHI 248
K +YD + ADVWS G++L + G +P+++ K + + ++L + +P ++
Sbjct: 201 PTKPDYDIR-ADVWSLGISLVELATGQFPYKN---CKTDFEVLTKVLQEEPPLLPGHMGF 256
Query: 249 SPECRHLISRIFVADPAK 266
S + + + D K
Sbjct: 257 SGDFQSFVKDCLTKDHRK 274
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-44
Identities = 71/259 (27%), Positives = 125/259 (48%), Gaps = 29/259 (11%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIE-RGDKIDENVQREIINHRSLRHPN 78
+ IG G+ G+ L R+K + VAVK ++ R + E + E++ R +H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V + L L ++ME+ GG L + I + R +E++ + ++ ++Y H+ V
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 139 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K ++ LL DG R+K+ DFG+ + S + KS VGTP ++APEV+ + Y
Sbjct: 163 IHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--------DYVH 247
+ D+WS G+ + M+ G P+ + P + + +
Sbjct: 219 ATE-VDIWSLGIMVIEMVDGEPPYFS-DSP----------VQAMKRLRDSPPPKLKNSHK 266
Query: 248 ISPECRHLISRIFVADPAK 266
+SP R + R+ V DP +
Sbjct: 267 VSPVLRDFLERMLVRDPQE 285
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-44
Identities = 60/248 (24%), Positives = 106/248 (42%), Gaps = 18/248 (7%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR---EIINHRSLRHPNIVRF--- 82
IG G+F D +T VA ++ QR E + L+HPNIVRF
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 83 -KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VC 139
+ + + +V E + G L + R + +Q++ G+ + H+ +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
HRDLK +N + G P +KI D G + S K+ +GTP ++APE+ +++YD
Sbjct: 154 HRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEM-YEEKYDES- 209
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSVQYSIPDYVHISPECRHLISR 258
DV++ G+ + M YP+ + + +R+ + S PE + +I
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA--SFDK--VAIPEVKEIIEG 265
Query: 259 IFVADPAK 266
+ +
Sbjct: 266 CIRQNKDE 273
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 8e-44
Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN--VQREI-INHRSLR 75
+D E + ++G G +GV MR + +++AVK I E + ++ I+ R++
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICN-AGRFSEDEARFFFQQLISGVSY 132
P V F + + I ME + ++++ + ED ++ + +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 133 CHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 190
HS + V HRD+K N L++ ++K+CDFG S V K G Y+APE +
Sbjct: 125 LHSKLSVIHRDVKPSNVLINAL--GQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERI 181
Query: 191 L----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
+K Y K +D+WS G+T+ + + +P++ P
Sbjct: 182 NPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP 219
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-43
Identities = 60/213 (28%), Positives = 108/213 (50%), Gaps = 17/213 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHP 77
++ +E+V ++G G FG ++K+T L A K I + +++++ EI + HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSM 136
IV+ L I++E+ GG + + +E + + +Q++ +++ HS
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 137 QVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLL-- 191
++ HRDLK N L+ +G +++ DFG S K+ + S +GTP ++APEV++
Sbjct: 137 RIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 192 ---KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
YD K AD+WS G+TL M P +
Sbjct: 193 TMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHE 224
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 8e-43
Identities = 74/272 (27%), Positives = 116/272 (42%), Gaps = 30/272 (11%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRH 76
+ D YEL IGSG V + +E VA+K I E+ + + +EI H
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELF--------ERICNAGRFSEDEARFFFQQLIS 128
PNIV + + L +VM+ SGG + + +G E ++++
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTP 182
G+ Y H HRD+K N LL + ++I DFG S + K+ VGTP
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHR 234
++APEV+ + + YD K AD+WS G+T + GA P+ +N ++
Sbjct: 191 CWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 235 ILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
+ + + Y R +IS DP K
Sbjct: 250 GVQDKEMLKKY---GKSFRKMISLCLQKDPEK 278
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 9e-43
Identities = 76/256 (29%), Positives = 120/256 (46%), Gaps = 26/256 (10%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIV 80
+ IG+G+FG + R + VAVK + D E V RE+ + LRHPNIV
Sbjct: 40 NIKEKIGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSM- 136
F + P +L+IV EY S G L+ + +G E + G++Y H+
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 137 -QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLK 192
+ HR+LK N L+D +K+CDFG S+ + S KS GTP ++APEVL
Sbjct: 158 PPIVHRNLKSPNLLVDKK--YTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISP 250
+ + K +DV+S GV L+ + P+ + N + + + IP ++ P
Sbjct: 214 EPSNEK-SDVYSFGVILWELATLQQPWGN----LNPAQVVAAVGFKCKRLEIPRNLN--P 266
Query: 251 ECRHLISRIFVADPAK 266
+ +I + +P K
Sbjct: 267 QVAAIIEGCWTNEPWK 282
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-42
Identities = 42/225 (18%), Positives = 79/225 (35%), Gaps = 26/225 (11%)
Query: 58 DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---CNAGRF 114
+ +I N V + +L I M+ L + + C+
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
F Q+ V + HS + HRDLK N +K+ DFG + +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEE 219
Query: 175 PKST-------------VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
++ VGT Y++PE + Y K D++S G+ L+ +L Y F
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFST 275
Query: 222 PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
E + I + ++++ + P+ ++ + P +
Sbjct: 276 QMERV---RIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTE 316
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-09
Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 2/66 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLRHPN 78
+E ++ +G G FGV ++K + A+K I ++ E V RE+ L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 79 IVRFKE 84
IVR+
Sbjct: 66 IVRYFN 71
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-42
Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 17/232 (7%)
Query: 6 MTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDEN 63
+ + P ++ + + +IG G +G M K + +++AVK I +K +
Sbjct: 9 LKISPEQHWDF--TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ 66
Query: 64 VQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICNA--GRFSEDE 118
+ ++ + RS P IV+F + I ME S + ++ + + E+
Sbjct: 67 LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI 126
Query: 119 ARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ +++ +++ HRD+K N LLD S +K+CDFG S V
Sbjct: 127 LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS--GNIKLCDFGISGQLVDSIAKTR 184
Query: 178 TVGTPAYIAPEVL----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
G Y+APE + ++ YD + +DVWS G+TLY + G +P+
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSV 235
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-42
Identities = 73/259 (28%), Positives = 107/259 (41%), Gaps = 27/259 (10%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-----ENVQREIINHRSLRHPN 78
L IG G FG ++ R + VAVK D ENV++E L+HPN
Sbjct: 10 TLEEIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-- 136
I+ + V L +L +VME+A GG L + R D + Q+ G++Y H
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 137 -QVCHRDLKLENTLLDGSPAPR------LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ HRDLK N L+ LKI DFG ++ + S G A++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEV 185
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVH 247
+ + +DVWS GV L+ +L G PF + + + + IP
Sbjct: 186 IRASMFSKG-SDVWSYGVLLWELLTGEVPFRG----IDGLAVAYGVAMNKLALPIPSTCP 240
Query: 248 ISPECRHLISRIFVADPAK 266
L+ + DP
Sbjct: 241 --EPFAKLMEDCWNPDPHS 257
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-42
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 20/220 (9%)
Query: 19 DSDRYELVRDIGSG--NFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRS 73
+ YEL+ IG G + L R K T E V V+ I +++ +Q E+ +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVS 131
HPNIV ++ + L +V + + G + IC +E + Q ++ +
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPA 183
Y H M HR +K + L+ + + + + V+H PK +V
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 184 YIAPEVL--LKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+++PEVL + YD K +D++S G+T + G PF+D
Sbjct: 201 WLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 239
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-41
Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 22/219 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPN 78
+ +ELV +G+G +G R KT +L A+K ++ +E +++EI + H N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 79 IVRF------KEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGV 130
I + K L +VME+ G + + + E+ + ++++ G+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 131 SYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAP 187
S+ H +V HRD+K +N LL + +K+ DFG S ++T +GTP ++AP
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 188 EVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 221
EV+ E YD K +D+WS G+T M GA P D
Sbjct: 199 EVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-----ERGDKIDENVQREIINHRSL 74
+ +R+IG G+FG RD + E+VA+K + + +K + + +E+ + L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKL 111
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
RHPN ++++ L +VMEY G + E E + G++Y H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 135 SMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL- 191
S + HRD+K N LL G +K+ DFG + + S VGTP ++APEV+L
Sbjct: 172 SHNMIHRDVKAGNILLSEPG----LVKLGDFGSASI---MAPANSFVGTPYWMAPEVILA 224
Query: 192 --KKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
+ +YDGK DVWS G+T + P +
Sbjct: 225 MDEGQYDGK-VDVWSLGITCIELAERKPPLFN 255
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-41
Identities = 69/264 (26%), Positives = 112/264 (42%), Gaps = 33/264 (12%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV--------QREIINHRSLR 75
E + IG G FG+ R K + +VA+K + GD E QRE+ +L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 134
HPNIV+ ++ P +VME+ G+L+ R+ + + G+ Y
Sbjct: 82 HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 135 SM--QVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + HRDL+ N L + K+ DFG S+ +G ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPET 197
Query: 190 LL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-----SI 242
+ ++ Y K AD +S + LY +L G PF++ K I I ++ +I
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGLRPTI 251
Query: 243 PDYVHISPECRHLISRIFVADPAK 266
P+ P R++I + DP K
Sbjct: 252 PEDCP--PRLRNVIELCWSGDPKK 273
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 6e-41
Identities = 52/256 (20%), Positives = 98/256 (38%), Gaps = 27/256 (10%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIV 80
+ + + G R + + + VK ++ D + + E R HPN++
Sbjct: 13 NFLTKLNENHSGELWKGRWQGND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 81 RFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHSM 136
+P H ++ + G L+ + F D+++ F + G+++ H++
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 137 Q--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ + L + ++D +I S Q + PA++APE L KK
Sbjct: 131 EPLIPRHALNSRSVMIDEDM--TARISMADVKFSF----QSPGRMYAPAWVAPEALQKKP 184
Query: 195 YDGKI--ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISP 250
D AD+WS V L+ ++ PF D + + ++ +IP ISP
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFAD----LSNMEIGMKVALEGLRPTIPP--GISP 238
Query: 251 ECRHLISRIFVADPAK 266
L+ DPAK
Sbjct: 239 HVSKLMKICMNEDPAK 254
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-39
Identities = 52/220 (23%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
E+ IG G FG R + VA++ I+ ++ ++ RE++ +R RH
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSM 136
N+V F ++P HLAI+ G L+ + +A ++ R Q+++ G+ Y H+
Sbjct: 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL 190
+ H+DLK +N D ++ I DFG + + + G ++APE++
Sbjct: 150 GILHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 191 ---------LKKEYDGKIADVWSCGVTLYVMLVGAYPFED 221
K + +DV++ G Y + +PF+
Sbjct: 207 RQLSPDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKT 245
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-39
Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 12/204 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
DRY + +G G +G D T E VA+K I R + +E V RE+ + L+H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQH 92
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
NI+ K VI L ++ EYA +L + + S + F QLI+GV++CHS
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 137 QVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 191
+ HRDLK +N LL S A LKI DFG +++ + + + + T Y PE+LL
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 192 KKEYDGKIADVWSCGVTLYVMLVG 215
+ Y + D+WS ML+
Sbjct: 212 SRHYSTSV-DIWSIACIWAEMLMK 234
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-39
Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 29/259 (11%)
Query: 24 ELVRDIGSGNFG-VAR-LMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHPN 78
+ + IGSG+FG V + VAVK + + +Q E+ R RH N
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
I+ F T LAIV ++ G L+ + + +F + +Q G+ Y H+
Sbjct: 82 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
+ HRDLK N L +KI DFG + Q + G+ ++APEV+ ++
Sbjct: 141 IIHRDLKSNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 195 ---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251
Y + +DV++ G+ LY ++ G P+ + N R I ++ PD +
Sbjct: 199 SNPYSFQ-SDVYAFGIVLYELMTGQLPYSN----INNRDQIIEMVGRGSLSPDLSKVRSN 253
Query: 252 C----RHLISRIFVADPAK 266
C + L++ +
Sbjct: 254 CPKRMKRLMAECLKKKRDE 272
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 80/297 (26%), Positives = 120/297 (40%), Gaps = 49/297 (16%)
Query: 7 TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
T G G D P Y + IG+G+FGV + + ELVA+K + DK +N R
Sbjct: 43 TPGQGPDRPQ---EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--R 96
Query: 67 EIINHRSLRHPNIVRFKEVILTPT------HLAIVMEYASG---GELFERICNAGRFSED 117
E+ R L H NIVR + + +L +V++Y
Sbjct: 97 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ + QL ++Y HS +CHRD+K +N LLD A LK+CDFG +K L +
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLVRGEPN 213
Query: 178 T--VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEE-------- 224
+ + Y APE++ +Y I DVWS G L +L+G +P + +
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
Query: 225 ---PKNFRKTIHRILS--VQYSIPDYV----------HISPECRHLISRIFVADPAK 266
P R+ I + ++ P PE L SR+ P
Sbjct: 273 LGTPT--REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-38
Identities = 67/287 (23%), Positives = 116/287 (40%), Gaps = 40/287 (13%)
Query: 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSL 74
M S +++ + +G+G + +K T VA+K + + + REI + L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 75 RHPNIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISG 129
+H NIVR +VI T L +V E+ + + ++F QL+ G
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 188
+++CH ++ HRDLK +N L++ +LK+ DFG +++ + S+ V T Y AP+
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 189 VLL-KKEYDGKIADVWSCGVTLYVMLVGA--------------------YPFED------ 221
VL+ + Y I D+WSCG L M+ G P E
Sbjct: 179 VLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237
Query: 222 --PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
P+ N ++ R L + + + +P
Sbjct: 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDM 284
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-37
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 14/212 (6%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE 62
+ V G + ++YE + +G G++G+ R+K T +VA+K D+
Sbjct: 7 HHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDK 65
Query: 63 NV----QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSE 116
V REI + LRH N+V EV +V E+ + E N
Sbjct: 66 MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDY 123
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176
+ + Q+I+G+ +CHS + HRD+K EN L+ S +K+CDFG++++ +
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS--GVVKLCDFGFARTLAAPGEVY 181
Query: 177 ST-VGTPAYIAPEVLL-KKEYDGKIADVWSCG 206
V T Y APE+L+ +Y + DVW+ G
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAV-DVWAIG 212
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-37
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 14/207 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
+YE + IG G +G ++++T E+VA+K + R D DE V REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
NIVR +V+ + L +V E+ + F+ G + + F QL+ G+ +CH
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-K 192
S V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPF 219
K Y I D+WS G + P
Sbjct: 177 KLYSTSI-DMWSAGCIFAELANAGRPL 202
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-37
Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 18/196 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
++YE + IG G++GV R++ T ++VA+K + D ++ REI + L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
PN+V EV L +V EY +R E + Q + V++CH
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-T--VGTPAYIAPEVLL 191
HRD+K EN L+ +K+CDFG+++ L V T Y +PE+L+
Sbjct: 120 KHNCIHRDVKPENILITKH--SVIKLCDFGFARL--LTGPSDYYDDEVATRWYRSPELLV 175
Query: 192 K-KEYDGKIADVWSCG 206
+Y + DVW+ G
Sbjct: 176 GDTQYGPPV-DVWAIG 190
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-36
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 21/217 (9%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------ 65
M + + + RYE + +G G F RDK T ++VA+K I + E
Sbjct: 1 MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTA 59
Query: 66 -REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFF 122
REI + L HPNI+ + +++++V ++ + + N+ + + +
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAY 117
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-V 179
+ G+ Y H + HRDLK N LLD G LK+ DFG +KS ++ + V
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQV 173
Query: 180 GTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
T Y APE+L + Y + D+W+ G L +L+
Sbjct: 174 VTRWYRAPELLFGARMYGVGV-DMWAVGCILAELLLR 209
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
Y + IG+G+FGV + +++E VA+K + DK +N RE+ R ++HPN+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV-LQDKRFKN--RELQIMRIVKHPNV 94
Query: 80 VRFKEVILTPTH------LAIVMEYASG---GELFERICNAGRFSEDEARFFFQQLISGV 130
V K + L +V+EY + + QL+ +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
+Y HS+ +CHRD+K +N LLD LK+ DFG +K +L + + + + Y APE
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILIAGEPNVSYICSRYYRAPE 211
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVG 215
++ Y I D+WS G + ++ G
Sbjct: 212 LIFGATNYTTNI-DIWSTGCVMAELMQG 238
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 3e-36
Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 15/203 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ----REIINHRSLRH 76
++Y + IG G +GV ++ E A+K I R +K DE + REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 77 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
NIV+ +VI T L +V E+ +L + G A+ F QL++G++YCH
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-K 192
+V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 193 KEYDGKIADVWSCGVTLYVMLVG 215
K+Y I D+WS G M+ G
Sbjct: 176 KKYSTTI-DIWSVGCIFAEMVNG 197
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-36
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ Y + +G G + + K T+ LVA+K I E + RE+ + L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 79 IVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
IV ++I T L +V EY + + + + F QL+ G++YCH
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-KKE 194
+V HRDLK +N L++ LK+ DFG +++ + ++ V T Y P++LL +
Sbjct: 120 KVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 195 YDGKIADVWSCGVTLYVMLVG 215
Y +I D+W G Y M G
Sbjct: 178 YSTQI-DMWGVGCIFYEMATG 197
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-36
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 15/206 (7%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPN 78
D Y+LVR +G G + + E V VK ++ K + ++REI +LR PN
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPN 92
Query: 79 IVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
I+ +++ P A+V E+ + + + ++ + RF+ +++ + YCHSM
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 149
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK-K 193
+ HRD+K N ++D +L++ D+G ++ H + V + + PE+L+ +
Sbjct: 150 GIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPF 219
YD + D+WS G L M+ PF
Sbjct: 207 MYDYSL-DMWSLGCMLASMIFRKEPF 231
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 63/223 (28%), Positives = 108/223 (48%), Gaps = 15/223 (6%)
Query: 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI 60
M ++ ++Y+ + +G G +GV +D +VA+K I R D
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAE 58
Query: 61 DENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRF 114
DE + REI + L HPNIV +VI + L +V E+ ++ + N
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGL 116
Query: 115 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
+ + + + QL+ GV++CH ++ HRDLK +N L++ LK+ DFG +++ + +
Sbjct: 117 QDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVR 174
Query: 175 PKST-VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 215
+ V T Y AP+VL+ K+Y + D+WS G M+ G
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITG 216
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-35
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 29 IGSGNFGVARLMRDKKTEELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVIL 87
+G G FG A + ++T E++ +K + R ++ +E+ R L HPN+++F V+
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 88 TPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146
L + EY GG L I + + + F + + SG++Y HSM + HRDL
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 147 NTLLDGSPAPRLKICDFGYSK---------------SSVLHSQPKSTVGTPAYIAPEVLL 191
N L+ + + + DFG ++ + + VG P ++APE++
Sbjct: 138 NCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 222
+ YD K DV+S G+ L ++ D
Sbjct: 196 GRSYDEK-VDVFSFGIVLCEIIGRVNADPDY 225
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-35
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----Q 65
++ P + +YE + IG G FG R +KT + VA+K + + E
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITAL 64
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLA--------IVMEYASG--GELFERICNAGRFS 115
REI + L+H N+V E+ T +V ++ L + +F+
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFT 122
Query: 116 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVL 171
E + Q L++G+ Y H ++ HRD+K N L+ LK+ DFG +S +
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNS 180
Query: 172 HSQP-KSTVGTPAYIAPEVLL-KKEYDGKIADVWSCG 206
+ V T Y PE+LL +++Y I D+W G
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPI-DLWGAG 216
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-35
Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 29/226 (12%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF- 82
L+ +G G +G + R E VAVK D+ + E+ N LRH NI+ F
Sbjct: 11 TLLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 83 ---KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-- 137
+ T L ++ Y G L++ + + SG+++ H
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 138 ------VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIA 186
+ HRDLK +N L+ + + I D G + ++ L VGT Y+A
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 187 PEVL------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
PEVL + + D+W+ G+ L+ + E+ K
Sbjct: 186 PEVLDETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-35
Identities = 56/207 (27%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 21 DRYELVRD-IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH 76
D +E +G G +G A+ +D K ++ A+K IE I + REI R L+H
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAK-RKDGKDDKDYALKQIEG-TGISMSACREIALLRELKH 77
Query: 77 PNIVRFKEVILTPTHLAI--VMEYAS--------GGELFERICNAGRFSEDEARFFFQQL 126
PN++ ++V L+ + + +YA + + + Q+
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPR--LKICDFG----YSKSSVLHSQPKSTVG 180
+ G+ Y H+ V HRDLK N L+ G R +KI D G ++ + V
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 181 TPAYIAPEVLL-KKEYDGKIADVWSCG 206
T Y APE+LL + Y I D+W+ G
Sbjct: 198 TFWYRAPELLLGARHYTKAI-DIWAIG 223
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-34
Identities = 71/207 (34%), Positives = 100/207 (48%), Gaps = 9/207 (4%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLR 75
++RY++V +G G L D VA+K I + E +RE+ N L
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
H NIV +V +VMEY G L E I + G S D A F Q++ G+ + H
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKK 193
M++ HRD+K +N L+D LKI DFG +K S +Q +GT Y +PE +
Sbjct: 130 MRIVHRDIKPQNILID--SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFE 220
D D++S G+ LY MLVG PF
Sbjct: 188 ATDEC-TDIYSIGIVLYEMLVGEPPFN 213
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-34
Identities = 55/246 (22%), Positives = 101/246 (41%), Gaps = 32/246 (13%)
Query: 7 TVGPGMDMPIMH---DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
+ G G +P++ + + ++V+ IG G +G + K E VAVK ++
Sbjct: 20 SSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEASWF 77
Query: 64 VQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
+ EI +RH NI+ F + + T L ++ +Y G L++ + +
Sbjct: 78 RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSM 136
Query: 120 RFFFQQLISGVSYCHSMQ--------VCHRDLKLENTLLDGSPAPRLKICDFGYSK---- 167
+SG+ + H+ + HRDLK +N L+ + I D G +
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVKFIS 194
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVL------LKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220
++ + P + VGT Y+ PEVL + AD++S G+ L+ +
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM-ADMYSFGLILWEVARRCVSGG 253
Query: 221 DPEEPK 226
EE +
Sbjct: 254 IVEEYQ 259
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-34
Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 19/228 (8%)
Query: 3 RSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDE 62
++ D + DR+++ R G G FG +L ++K T VA+K + D
Sbjct: 5 MMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFR 63
Query: 63 N-VQREIINHRSLRHPNIVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGR- 113
N + + + L HPNIV+ + T L +VMEY L N R
Sbjct: 64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRR 122
Query: 114 ---FSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168
+ F QLI + H S+ VCHRD+K N L++ + LK+CDFG +K
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKK 181
Query: 169 SVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
+ + + Y APE++ + Y + D+WS G M++G
Sbjct: 182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLG 228
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-34
Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 28/206 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ-------REIINHRS 73
RYE V +IG G +G RD + VA+K + R RE+ R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRR 67
Query: 74 LR---HPNIVRFKEVILTPTH-----LAIVMEYASG--GELFERICNAGRFSEDEARFFF 123
L HPN+VR +V T + +V E+ ++ + +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLM 126
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVG 180
+Q + G+ + H+ + HRDLK EN L+ +K+ DFG ++ +S V
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSG--GTVKLADFGLARI---YSYQMALTPVVV 181
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCG 206
T Y APEVLL+ Y + D+WS G
Sbjct: 182 TLWYRAPEVLLQSTYATPV-DMWSVG 206
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 62/246 (25%), Positives = 98/246 (39%), Gaps = 32/246 (13%)
Query: 7 TVGPGMDMPIMH---DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN 63
T G G +P++ + L IG G FG + R K E VAVK ++
Sbjct: 25 TSGSGSGLPLLVQRTIARTIVLQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWF 82
Query: 64 VQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 119
+ EI LRH NI+ F + T T L +V +Y G LF+ + N + +
Sbjct: 83 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGM 141
Query: 120 RFFFQQLISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---- 167
SG+++ H + HRDLK +N L+ + I D G +
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDS 199
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVLLK------KEYDGKIADVWSCGVTLYVMLVGAYPFE 220
+ + P VGT Y+APEVL E + AD+++ G+ + +
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGG 258
Query: 221 DPEEPK 226
E+ +
Sbjct: 259 IHEDYQ 264
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 62/214 (28%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
RY ++ +G G G+ D ++ VA+K I D ++ REI R L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGG--------ELFE----RICNAGRFSEDEARFFFQQL 126
IV+ E++ + E E + G E+ AR F QL
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL 129
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 182
+ G+ Y HS V HRDLK N ++ + LKI DFG ++ H K + T
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
Y +P +LL Y I D+W+ G ML G
Sbjct: 189 WYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTG 221
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-32
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 9/205 (4%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLRHP 77
Y L R +G G G D E +VA+K + D QRE L+ P
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
++V + L + M +G +L + G + A +Q+ S + H+
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRD+K EN L+ S + DFG + + +Q +TVGT Y+APE +
Sbjct: 155 ATHRDVKPENILV--SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFE 220
+ AD+++ LY L G+ P++
Sbjct: 213 TYR-ADIYALTCVLYECLTGSPPYQ 236
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-32
Identities = 68/250 (27%), Positives = 99/250 (39%), Gaps = 30/250 (12%)
Query: 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV---- 64
G M P DRYEL +G G L RD + VAVK + D +
Sbjct: 1 GSHMTTPSHLS-DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF 59
Query: 65 QREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120
+RE N +L HP IV + IVMEY G L + + G + A
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPK 176
+++ H + HRD+K N ++ S +K+ DFG + S +Q
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--------------EDP 222
+ +GT Y++PE D + +DV+S G LY +L G PF EDP
Sbjct: 178 AVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236
Query: 223 EEPKNFRKTI 232
P + +
Sbjct: 237 IPPSARHEGL 246
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 8e-32
Identities = 51/226 (22%), Positives = 84/226 (37%), Gaps = 28/226 (12%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEE-LVAVKYIERGDKIDENVQ----REIINHRSL 74
+ +YE+ I G G L D+ V +K + D Q E +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEV 136
Query: 75 RHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
HP+IV+ + IVMEY G L + EA + +++
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPA 194
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+SY HS+ + + DLK EN +L +LK+ D G + GTP + APE+
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAPEI 248
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFED------PEEPKNFR 229
+ D+++ G TL + + PE+ +
Sbjct: 249 VRTGPTVA--TDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK 292
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRD-KKTEELVAVKYIERGDKIDENVQ----REI---INHR 72
+YE V +IG G +G RD K VA+K + R +E + RE+ +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 73 SLRHPNIVRFKEVILTP-----THLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQ 125
+ HPN+VR +V T L +V E+ ++ + + Q
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQ 128
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 183
L+ G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ Q T V T
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARI--YSFQMALTSVVVTLW 184
Query: 184 YIAPEVLLKKEYDGKIADVWSCG 206
Y APEVLL+ Y + D+WS G
Sbjct: 185 YRAPEVLLQSSYATPV-DLWSVG 206
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
+RY+ + +GSG +G D KT VAVK + R I + RE+ + ++H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V L +V G +L I + ++D +F Q++ G+
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y HS + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNED--CELKILDFGLARH----TADEMTGYVATRWYRAPE 199
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVG 215
++L Y+ + D+WS G + +L G
Sbjct: 200 IMLNWMHYNQTV-DIWSVGCIMAELLTG 226
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 59/251 (23%), Positives = 100/251 (39%), Gaps = 21/251 (8%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
RY+ ++ IGSG G+ D E VA+K + R ++ + RE++ + + H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
NI+ V L IVME L ++ + + Q++ G+
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYLLYQMLCGI 140
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+ HS + HRDLK N ++ LKI DFG ++++ V T Y APEV+
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--QYSIPDYVHI 248
L Y + D+WS G + M+ G F + ++++ +
Sbjct: 199 LGMGYKENV-DIWSVGCIMGEMIKGGVLFPG----TDHIDQWNKVIEQLGTPCPEFMKKL 253
Query: 249 SPECRHLISRI 259
P R +
Sbjct: 254 QPTVRTYVENR 264
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 67/288 (23%), Positives = 118/288 (40%), Gaps = 54/288 (18%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
Y ++ +GSG +G D +T VA+K + R ++ + RE+ + +RH
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V L +VM + G +L ++ + ED +F Q++ G+
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y H+ + HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ----ADSEMTGYVVTRWYRAPE 195
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------- 238
V+L Y + D+WS G + M+ G F+ + + I+ V
Sbjct: 196 VILNWMRYTQTV-DIWSVGCIMAEMITGKTLFKG----SDHLDQLKEIMKVTGTPPAEFV 250
Query: 239 ---------QY--SIPD---------YVHISPECRHLISRIFVADPAK 266
Y +P+ + SP +L+ ++ V D +
Sbjct: 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 298
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 55/288 (19%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
Y +GSG +G DK++ E VA+K + R +I + RE++ + ++H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
N++ +V + L +VM + +L + + +FSE++ ++ Q++ G+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGL 139
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
Y HS V HRDLK N ++ LKI DFG ++ + + T V T Y APE
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNED--CELKILDFGLARH----ADAEMTGYVVTRWYRAPE 193
Query: 189 VLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------- 238
V+L Y+ + D+WS G + ML G F+ K++ + +IL V
Sbjct: 194 VILSWMHYNQTV-DIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKVTGVPGTEFV 248
Query: 239 ---------QY--SIPD---------YVHISPECRHLISRIFVADPAK 266
Y S+P + SP+ L+ ++ D K
Sbjct: 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDK 296
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-30
Identities = 53/238 (22%), Positives = 93/238 (39%), Gaps = 47/238 (19%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
S +Y L + +G+G+FG+ + D ++ + A+K + + D +N RE+ + L H NI
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-DPRYKN--RELDIMKVLDHVNI 62
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG--------------------------- 112
++ + T N G
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 113 --------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158
+ + QL V + HS+ +CHRD+K +N L++ L
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-TL 181
Query: 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
K+CDFG +K + + + + Y APE++L EY I D+WS G +++G
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILG 238
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-30
Identities = 58/253 (22%), Positives = 103/253 (40%), Gaps = 25/253 (9%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
RY+ ++ IGSG G+ D + VA+K + R ++ + RE++ + + H
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 77 PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
NI+ V L +VME L + I + + Q++ G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGI 177
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 188
+ HS + HRDLK N ++ LKI DFG +++ + T V T Y APE
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 233
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--QYSIPDYV 246
V+L Y + D+WS G + M+ F +++ ++++
Sbjct: 234 VILGMGYKENV-DIWSVGCIMGEMVRHKILFPG----RDYIDQWNKVIEQLGTPCPEFMK 288
Query: 247 HISPECRHLISRI 259
+ P R+ +
Sbjct: 289 KLQPTVRNYVENR 301
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 36/223 (16%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQ------REII 69
+ S ++L +G G +GV K T E+VA+K KI+ + REI
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIK 61
Query: 70 NHRSLRHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQ 124
+ +H NI+ + + I+ E +L R+ + S+D ++F
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIY 119
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKST-- 178
Q + V H V HRDLK N L++ + LK+CDFG +S+ +S+P
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSN--CDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 179 -----VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
V T Y APEV+L +Y + DVWSCG L + +
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLR 219
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 67/214 (31%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID--ENVQ------REIINH 71
RY + IG G +G+ D + VA+K KI E+ REI
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKIL 79
Query: 72 RSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 126
RH NI+ ++I PT + IV + +L ++ S D +F Q+
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQI 137
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 182
+ G+ Y HS V HRDLK N LL+ + LKICDFG ++ + V T
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 183 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
Y APE++L K Y I D+WS G L ML
Sbjct: 196 WYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSN 228
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-30
Identities = 53/240 (22%), Positives = 95/240 (39%), Gaps = 29/240 (12%)
Query: 9 GPGMDMP-IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQRE 67
G + + S +L+ G FG + + + E VAVK DK + E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGC--VWKAQLLNEYVAVKIFPIQDKQSWQNEYE 68
Query: 68 IINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 123
+ + ++H NI++F K L ++ + G L + + A S +E
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIA 127
Query: 124 QQLISGVSYCHSMQ----------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
+ + G++Y H + HRD+K +N LL + I DFG +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGK 185
Query: 174 QPKST---VGTPAYIAPEVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225
T VGT Y+APEVL +++ + D+++ G+ L+ + + P +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDE 244
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 61/294 (20%), Positives = 102/294 (34%), Gaps = 50/294 (17%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ------------ 65
Y + R I SG++G D + VA+K + V
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 66 REIINHRSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERI-CNAGRFSEDEA 119
REI HPNI+ +++ + L +V E +L + I S
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHI 136
Query: 120 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
++F ++ G+ H V HRDL N LL + + ICDF ++ + V
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN--NDITICDFNLAREDTADANKTHYV 194
Query: 180 GTPAYIAPEVLLK-KEYDGKIADVWSCG---------------------VTLYVMLVGAY 217
Y APE++++ K + + D+WS G + V +VG
Sbjct: 195 THRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 218 PFEDPEEPKNF--RKTIHRILSVQYSIP---DYVHISPECRHLISRIFVADPAK 266
ED + R + LS + P LI+++ +P +
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-29
Identities = 55/238 (23%), Positives = 87/238 (36%), Gaps = 37/238 (15%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D D +L+ IG G +G + + E VAVK ++ + ++ I + H N
Sbjct: 11 DLDNLKLLELIGRGRYG--AVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDN 68
Query: 79 IVRF-----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
I RF + +VMEY G L + + + + + G++Y
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 134 HSM---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVLHSQP 175
H+ + HRDL N L+ I DFG S +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKND--GTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 176 KSTVGTPAYIAPEVL------LKKEYDGKIADVWSCGVTLYVML---VGAYPFEDPEE 224
S VGT Y+APEVL E K D+++ G+ + + +P E E
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-29
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 41/226 (18%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSL 74
DRYE+ IG+G++G DK + +VA+K I R D ID + + REI L
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 75 RHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
H ++V+ ++++ L +V+E A + + +E + L+ G
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 183
V Y HS + HRDLK N L++ +K+CDFG +++ S +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQD--CSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 184 ----------------------YIAPEVLL-KKEYDGKIADVWSCG 206
Y APE++L ++ Y I DVWS G
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIG 271
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 54/238 (22%), Positives = 92/238 (38%), Gaps = 26/238 (10%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHR 72
+ RY LVR +G G+F L +D VA+K + E + EI +N
Sbjct: 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDA 75
Query: 73 SLRHP------NIVRFKEV----ILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEAR 120
+I++ + H+ +V E G L + +
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK 134
Query: 121 FFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPR----LKICDFGYSKSSVLHSQP 175
+QL+ G+ Y H + H D+K EN L++ +P +KI D G +
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHY 192
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
+++ T Y +PEVLL + D+WS ++ ++ G + FE E + H
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-28
Identities = 60/239 (25%), Positives = 96/239 (40%), Gaps = 36/239 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLRH 76
D Y + IG G++G L DK TE+ VA+K + R D ID + + REI L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 77 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
I+R ++I+ L IV+E A +L + +E+ + L+ G +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-------- 183
+ H + HRDLK N LL+ +K+CDFG +++
Sbjct: 144 FIHESGIIHRDLKPANCLLNQD--CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 184 ---------------YIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
Y APE++L + Y I D+WS G +L + +
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTNR 259
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 66/225 (29%), Positives = 98/225 (43%), Gaps = 34/225 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER--GDKID-ENVQREIINHRSLR- 75
+YELV+ +G G +G+ D++T E+VAVK I + D + REI+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 76 HPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
H NIV V+ + +V +Y +L + A ++ QLI + Y
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------------- 178
HS + HRD+K N LL+ +K+ DFG S+S V + +
Sbjct: 126 HSGGLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 179 -------VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 215
V T Y APE+LL +Y I D+WS G L +L G
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCG 227
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 64/211 (30%), Positives = 91/211 (43%), Gaps = 22/211 (10%)
Query: 18 HDSDRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH 76
H + RYE+++ IG G+FG V + D K + VA+K + + EI R L H
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEI---RILEH 149
Query: 77 ---------PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQ 125
N++ E H+ + E S L+E I FS R F
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAY 184
++ + H ++ H DLK EN LL +K+ DFG SS Q T + + Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFY 265
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
APEV+L Y I D+WS G L +L G
Sbjct: 266 RAPEVILGARYGMPI-DMWSLGCILAELLTG 295
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 64/206 (31%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP--- 77
DRYE+ IG G+FG D+ +E VA+K I+ Q E+ +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 78 ---NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 132
IV K + HL +V E S L++ + N S + R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 133 CHS--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 189
+ + + H DLK EN LL +KI DFG SS Q + + Y +PEV
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEV 229
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVG 215
LL YD I D+WS G L M G
Sbjct: 230 LLGMPYDLAI-DMWSLGCILVEMHTG 254
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-26
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + ++ +G GNFG + T E+VAVK + ++ + +REI +S
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 67
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L+H NIV++K V + L ++MEY G L + + + R + + Q+ G+
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
Y + + HRDL N L+ + R+KI DFG +K + + V P
Sbjct: 128 EYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWY 184
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY 210
APE L + ++ +DVWS GV LY
Sbjct: 185 APESLTESKFSVA-SDVWSFGVVLY 208
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + ++ +G GNFG + T E+VAVK + ++ + +REI +S
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKS 98
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L+H NIV++K V + L ++MEY G L + + + R + + Q+ G+
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
Y + + HRDL N L+ + R+KI DFG +K + + V P
Sbjct: 159 EYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWY 215
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY 210
APE L + ++ +DVWS GV LY
Sbjct: 216 APESLTESKFSVA-SDVWSFGVVLY 239
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 60/207 (28%), Positives = 80/207 (38%), Gaps = 14/207 (6%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 81
L IG GNFG R + LVAVK D + +E + HPNIVR
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 82 FKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 140
V + IVME GG+ + R +G+ Y S H
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH 236
Query: 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEY 195
RDL N L+ LKI DFG S+ + G + APE L Y
Sbjct: 237 RDLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 196 DGKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVWS G+ L+ +GA P+ +
Sbjct: 293 SSE-SDVWSFGILLWETFSLGASPYPN 318
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 63/235 (26%), Positives = 94/235 (40%), Gaps = 18/235 (7%)
Query: 19 DSDRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI-ERGDKIDENVQREIINHRS 73
+ + + +G GNFG L T LVAVK + G + QREI ++
Sbjct: 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKA 80
Query: 74 LRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 130
L IV+++ V P L +VMEY G L + + + R + Q+ G+
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 185
Y S + HRDL N L+ S A +KI DFG +K + + V P
Sbjct: 141 EYLGSRRCVHRDLAARNILV-ESEA-HVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWY 197
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239
APE L + + +DVWS GV LY + E + ++
Sbjct: 198 APESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-25
Identities = 39/251 (15%), Positives = 70/251 (27%), Gaps = 38/251 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRH 76
RY L+ G D + VA+ +++ + ++ + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + R +V+ T +V E+ GG L E S A Q L + H
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
V + S + + PA +
Sbjct: 149 GVALSIDHPSRVRV--SIDGDVV-------------------LAYPATMPDA-------- 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH--ISPECRH 254
D+ G +LY +LV +P + R + Q P + I +
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-PAERDTAGQPIEPADIDRDIPFQISA 238
Query: 255 LISRIFVADPA 265
+ +R D
Sbjct: 239 VAARSVQGDGG 249
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-25
Identities = 57/213 (26%), Positives = 84/213 (39%), Gaps = 21/213 (9%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRH 76
L+ +G G+FGV VAVK ++ + I SL H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHS 135
N++R V+LTP + +V E A G L +R+ + G F + Q+ G+ Y S
Sbjct: 81 RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEV 189
+ HRDL N LL + +KI DFG + L APE
Sbjct: 140 KRFIHRDLAARNLLL-ATRD-LVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWCAPES 195
Query: 190 LLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
L + + +D W GVTL+ + G P+
Sbjct: 196 LKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-24
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 19 DSDRYELVRDIGSGNFGV---ARL-MRDKKTEELVAVKYI--ERGDKIDENVQREIINHR 72
+ + +RD+G G+FG R T E VAVK + E G ++++EI R
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78
Query: 73 SLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISG 129
+L H NIV++K + + ++ME+ G L E + N + + + + Q+ G
Sbjct: 79 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYI--- 185
+ Y S Q HRDL N L+ S ++KI DFG +K + + + TV
Sbjct: 139 MDYLGSRQYVHRDLAARNVLV-ESEH-QVKIGDFGLTK--AIETDKEYYTVKDDRDSPVF 194
Query: 186 --APEVLLKKEYDGKIADVWSCGVTLY 210
APE L++ ++ +DVWS GVTL+
Sbjct: 195 WYAPECLMQSKFYIA-SDVWSFGVTLH 220
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 50/208 (24%), Positives = 83/208 (39%), Gaps = 8/208 (3%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + R CN S + Q+ S + Y
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
HR+L N L+ + +K+ DFG S+ + APE L +
Sbjct: 338 NFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVW+ GV L+ + G P+
Sbjct: 396 FSIK-SDVWAFGVLLWEIATYGMSPYPG 422
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-23
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 10/209 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + R CN S + Q+ S + Y
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLLKK 193
HRDL N L+ + +K+ DFG S+ + + G P + APE L
Sbjct: 131 NFIHRDLAARNCLVGENHL--VKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 187
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
++ K +DVW+ GV L+ + G P+
Sbjct: 188 KFSIK-SDVWAFGVLLWEIATYGMSPYPG 215
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-23
Identities = 50/211 (23%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERGDKIDENVQREIINH----RSLR 75
+ ++ +GSG FG + + + ++ VA+K + +EI++ S+
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD 75
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 134
+P++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 76 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLL 191
++ HRDL N L+ +P +KI DFG +K + G P ++A E +L
Sbjct: 135 DRRLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 192 KKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ Y + +DVWS GVT++ +M G+ P++
Sbjct: 193 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-23
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 21 DRYELVRDIGSGNFGVARL----MRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSL 74
+ +RD+G G+FG L + T E+VAVK + + G + ++EI R+L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 75 RHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
H +I+++K L +VMEY G L + + + F QQ+ G++Y
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAY 149
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----AP 187
H+ HRDL N LL + +KI DFG +K +V V AP
Sbjct: 150 LHAQHYIHRDLAARNVLL-DNDR-LVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAP 206
Query: 188 EVLLKKEYDGKIADVWSCGVTLY 210
E L + ++ +DVWS GVTLY
Sbjct: 207 ECLKEYKFYYA-SDVWSFGVTLY 228
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-23
Identities = 56/222 (25%), Positives = 85/222 (38%), Gaps = 32/222 (14%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP-- 77
+RYE+V ++G G FG V + + + VA+K I K E + EI + ++
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78
Query: 78 ----NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVS 131
V + H+ I E G FE + + R QL +
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 132 YCHSMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHSQ 174
+ H Q+ H DLK EN L S +++ DFG S+ +
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHE 194
Query: 175 PKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+T V T Y PEV+L+ + DVWS G L+ G
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 9e-23
Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 38/227 (16%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSL 74
+ + ++R +G G FG V + ++ AVK + K + + E I + +
Sbjct: 35 NAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI 93
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 132
+ NIV++ + H+ ++ E G L+E I F ++ + + +++ ++Y
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 133 CHSMQVCHRDLKLENTLLDGSPA-----------------------PRLKICDFGYSKSS 169
M + H DLK EN LLD +K+ DFG +
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CA 209
Query: 170 VLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
S + + T Y APEV+L +D D+WS G L + G
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTG 255
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-22
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 10/208 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 241 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
HRDL+ N L+ + K+ DFG ++ + APE L
Sbjct: 300 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L + G P+
Sbjct: 358 FTIK-SDVWSFGILLTELTTKGRVPYPG 384
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 6e-22
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D V++IGSG FG+ L ++ VA+K I G +E+ E L HP
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPK 64
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V L + +V E+ G L + R G F+ + + G++Y
Sbjct: 65 LVQLYGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
V HRDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV
Sbjct: 124 CVIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 180
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
Y K +DVWS GV ++ V G P+E+
Sbjct: 181 RYSSK-SDVWSFGVLMWEVFSEGKIPYEN 208
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 7e-22
Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 10/208 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L F + + Q+ SG++Y M
Sbjct: 324 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLKKE 194
HRDL+ N L+ + K+ DFG ++ + APE L
Sbjct: 383 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440
Query: 195 YDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L + G P+
Sbjct: 441 FTIK-SDVWSFGILLTELTTKGRVPYPG 467
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 7e-22
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 16/215 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
++ R + + IGSG+ G RL + + VA+K ++ G ++ + E
Sbjct: 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HPNI+R + V+ IV EY G L F R + G+F+ + + + +G+
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMR 165
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---AP 187
Y + HRDL N L+D + K+ DFG S+ +T G I AP
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223
Query: 188 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
E + + + +DVWS GV ++ V+ G P+ +
Sbjct: 224 EAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWN 257
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 1e-21
Identities = 57/275 (20%), Positives = 98/275 (35%), Gaps = 66/275 (24%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHRSLR 75
RY ++R +G G+F L D + ++ VA+K ++ + E EI + +
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 76 HPN---IVR----FKEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQL 126
PN +V+ FK + TH+ +V E + + N + QQ+
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK-SNYQGLPLPCVKKIIQQV 155
Query: 127 ISGVSYCHS-MQVCHRDLKLENTLLD---------------------------------- 151
+ G+ Y H+ ++ H D+K EN LL
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 152 -------------GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
+ ++KI D G + +H + T Y + EVL+ Y+
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233
AD+WS + + G Y FE + R H
Sbjct: 274 -ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-21
Identities = 61/222 (27%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 21 DRYELVRD--------IGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQRE 67
+ L RD +G GNFG KK + VA+K +++G E + RE
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMRE 60
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
L +P IVR V + +VME A GG L + + Q+
Sbjct: 61 AQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT-- 181
G+ Y HRDL N LL + KI DFG SK L + +
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKW 175
Query: 182 P-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
P + APE + +++ + +DVWS GVT++ + G P++
Sbjct: 176 PLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 216
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-21
Identities = 50/209 (23%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERG--DKIDENVQREIINHRSLRHP 77
+ ++ +GSG FG + + + ++ VA+K + K ++ + E S+ +P
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSM 136
++ R + LT T + ++ + G L + + + + Q+ G++Y
Sbjct: 78 HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLLKK 193
++ HRDL N L+ +P +KI DFG +K + G P ++A E +L +
Sbjct: 137 RLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
Y + +DVWS GVT++ +M G+ P++
Sbjct: 195 IYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 20/217 (9%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D+ + + +G+G FG RL K E VA+K ++ G +K + E
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HPNI+R + V+ + IV EY G L F R + +F+ + + + SG+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMK 161
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI--- 185
Y M HRDL N L++ + K+ DFG + VL P +T G I
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWT 217
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+PE + +++ +DVWS G+ L+ VM G P+ +
Sbjct: 218 SPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 66/223 (29%), Positives = 91/223 (40%), Gaps = 34/223 (15%)
Query: 21 DRYELVRDIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREI-----INHR-- 72
RYE+V +G G FG V + K VAVK ++ D+ E + EI +N
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGV 130
+ V+ E H+ IV E G ++ I G F D R Q+ V
Sbjct: 74 NSTF-RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHS 173
++ HS ++ H DLK EN L S P +K+ DFG S+
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188
Query: 174 QPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215
+ ST V T Y APEV+L + DVWS G L +G
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLG 230
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-21
Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 19/216 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYI--ERGDKIDENVQREIINHR 72
++ +GSG FG + + ++ ++ V +K I + G + + V ++
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 131
SL H +IVR + + L +V +Y G L + + + G + Q+ G+
Sbjct: 71 SLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMY 129
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----A 186
Y + HR+L N LL SP+ ++++ DFG + +L K + + A A
Sbjct: 130 YLEEHGMVHRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMA 185
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
E + +Y + +DVWS GVT++ +M GA P+
Sbjct: 186 LESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAG 220
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-21
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 21 DRYELV---RDIGSGNFGVAR--LMRDKKTEELVAVKYIERGDKIDENVQREIINH---- 71
DR L +++GSGNFG + + KK + VAVK + + + D ++ E++
Sbjct: 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVM 72
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+ L +P IVR + + + +VME A G L + + + Q+ G+
Sbjct: 73 QQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 131
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYI 185
Y HRDL N LL + KI DFG SK L + K+ P +
Sbjct: 132 YLEESNFVHRDLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWY 187
Query: 186 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
APE + ++ K +DVWS GV ++ G P+
Sbjct: 188 APECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 223
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-21
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 12/209 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L + +G+G FG + K + VAVK ++ G E E ++L+H
Sbjct: 186 PRESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDK 244
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ T + I+ E+ + G L F + + + F Q+ G+++
Sbjct: 245 LVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
HRDL+ N L+ S KI DFG ++ + ++ + G I APE +
Sbjct: 304 NYIHRDLRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFG 360
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L ++ G P+
Sbjct: 361 SFTIK-SDVWSFGILLMEIVTYGRIPYPG 388
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-20
Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 18/212 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
+ L++++GSG FGV + K + VAVK I+ G ++ +E L
Sbjct: 6 KREEITLLKELGSGQFGVVKLGKW----KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS 61
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
HP +V+F V + IV EY S G L + R + + + G+++
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVL 190
S Q HRDL N L+D +K+ DFG ++ VL Q S+VGT + APEV
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVF 177
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+Y K +DVW+ G+ ++ V +G P++
Sbjct: 178 HYFKYSSK-SDVWAFGILMWEVFSLGKMPYDL 208
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-20
Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 12/209 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +LV +G+G FG + + VAVK +++G + E + L+H
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR V+ T + I+ EY G L F + + + + ++ Q+ G+++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLKK 193
HRDL+ N L+ + + KI DFG ++ + ++ + G I APE +
Sbjct: 129 NYIHRDLRAANILVSDTLS--CKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ K +DVWS G+ L ++ G P+
Sbjct: 186 TFTIK-SDVWSFGILLTEIVTHGRIPYPG 213
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-20
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR 75
D ++++G+G FGV + + + VA+K I+ G ++ E +L
Sbjct: 22 DPKDLTFLKELGTGQFGVVKYGKW----RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS 77
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H +V+ V + I+ EY + G L + R RF + + + + Y
Sbjct: 78 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVL 190
S Q HRDL N L++ +K+ DFG S+ VL + S+VG+ + PEVL
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVL 193
Query: 191 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ ++ K +D+W+ GV ++ + +G P+E
Sbjct: 194 MYSKFSSK-SDIWAFGVLMWEIYSLGKMPYER 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-20
Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 18/210 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 75
Query: 79 IVRFKEVILTPT-HLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + R D F + + Y
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLK 192
HRDL N L+ S K+ DFG +K + + + APE L +
Sbjct: 136 NNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALRE 188
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
K++ K +DVWS G+ L+ + G P+
Sbjct: 189 KKFSTK-SDVWSFGILLWEIYSFGRVPYPR 217
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 56/206 (27%), Positives = 86/206 (41%), Gaps = 20/206 (9%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 83
+G GNFG KK + VA+K +++G E + RE L +P IVR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 84 EVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRD 142
V + +VME A GG L + + Q+ G+ Y HR+
Sbjct: 403 GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 143 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLLKKEYD 196
L N LL + KI DFG SK L + + + APE + +++
Sbjct: 462 LAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 197 GKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVWS GVT++ + G P++
Sbjct: 518 SR-SDVWSYGVTMWEALSYGQKPYKK 542
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-20
Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 18/210 (8%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 247
Query: 79 IVRFKEVILT-PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + R D F + + Y
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLK 192
HRDL N L+ K+ DFG +K + + + APE L +
Sbjct: 308 NNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALRE 360
Query: 193 KEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
K++ K +DVWS G+ L+ + G P+
Sbjct: 361 KKFSTK-SDVWSFGILLWEIYSFGRVPYPR 389
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 6e-20
Identities = 51/219 (23%), Positives = 85/219 (38%), Gaps = 22/219 (10%)
Query: 20 SDRYE-------LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQRE 67
+Y L R +G G FG K + VAVK ++ E E
Sbjct: 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 126
+ ++L HP+IV+ +I I+ME GEL + N + Q+
Sbjct: 64 AVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 122
Query: 127 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI- 185
++Y S+ HRD+ + N L+ +K+ DFG S+ + T I
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSR-YIEDEDYYKASVTRLPIK 179
Query: 186 --APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+PE + + + +DVW V ++ ++ G PF
Sbjct: 180 WMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFW 217
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 8e-20
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 17/214 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+R EL R IG G FG M + VA+K + D + E +E + R
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 72
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 131
HP+IV+ VI I+ME + GEL F + + QL + ++
Sbjct: 73 FDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALA 130
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPE 188
Y S + HRD+ N L+ + +K+ DFG S+ + S P ++APE
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPE 187
Query: 189 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ + + +DVW GV ++ +++ G PF+
Sbjct: 188 SINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 220
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 17/216 (7%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEEL-VAVKYIERG--DKIDENVQREIINHR 72
+ IG+G FG L +E+ VA+K ++ G +K + E
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 101
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGV 130
H NI+R + VI + I+ EY G L F R G FS + + + +G+
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGM 160
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---A 186
Y +M HRDL N L++ + K+ DFG S+ + +T G I A
Sbjct: 161 KYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 218
Query: 187 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 221
PE + +++ +DVWS G+ ++ VM G P+ +
Sbjct: 219 PEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 52/228 (22%), Positives = 90/228 (39%), Gaps = 35/228 (15%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHR 72
++ L R +G G FG A+L ++ + VAVK ++ +++ RE +
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 73 SLRHPNIVRF------KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
HP++ + +++ + G+L F A R E+ Q
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQ 137
Query: 125 QLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
L+ G+ Y S HRDL N +L + + DFG S+ ++S
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYY 193
Query: 178 TVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
G + + A E L Y +DVW+ GVT++ +M G P+
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPY 240
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 53/220 (24%), Positives = 81/220 (36%), Gaps = 24/220 (10%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
L+R +G G FG M + + VAVK + + + E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI------ 127
H NIVR V L I+ME +GG+L + + L+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 128 -SGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI 185
G Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAML 207
Query: 186 -----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
PE ++ + K D WS GV L+ + +G P+
Sbjct: 208 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-19
Identities = 53/250 (21%), Positives = 90/250 (36%), Gaps = 43/250 (17%)
Query: 10 PGMDMPIMHDSDRYE-------LVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDK 59
P + + + L + +G G FG L ++ T VAVK ++ +
Sbjct: 16 PRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS 75
Query: 60 IDENVQ---REIINHRSLRHPNIVR-----FKEVILTPTHLAIVMEYASGGEL--FERIC 109
++ E + HPN++R + +++ + G+L +
Sbjct: 76 SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135
Query: 110 NAGRFSEDEARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162
R Q L+ G+ Y + HRDL N +L + + D
Sbjct: 136 ---RLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVAD 190
Query: 163 FGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA 216
FG SK ++S G A + A E L + Y K +DVW+ GVT++ + G
Sbjct: 191 FGLSK--KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGM 247
Query: 217 --YPFEDPEE 224
YP E
Sbjct: 248 TPYPGVQNHE 257
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 3e-19
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 24 ELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPN 78
EL R IG G FG M + VA+K + D + E +E + R HP+
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
IV+ VI I+ME + GEL + + QL + ++Y S +
Sbjct: 453 IVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVG-TPA-YIAPEVLLKK 193
HRD+ N L+ + +K+ DFG S+ + K++ G P ++APE + +
Sbjct: 512 FVHRDIAARNVLVSSNDC--VKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 194 EYDGKIADVWSCGVTLY-VMLVGAYPFED 221
+ +DVW GV ++ +++ G PF+
Sbjct: 568 RFTSA-SDVWMFGVCMWEILMHGVKPFQG 595
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 5e-19
Identities = 52/220 (23%), Positives = 81/220 (36%), Gaps = 24/220 (10%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
L+R +G G FG M + + VAVK + + + E +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI------ 127
H NIVR V L I++E +GG+L + + L+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 128 -SGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI 185
G Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAML 248
Query: 186 -----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
PE ++ + K D WS GV L+ + +G P+
Sbjct: 249 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 287
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-19
Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 20/222 (9%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
+ I S IG G+FG L+ + + AVK + R I E Q E
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76
Query: 68 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 135
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 183
Q+ G+ Y S + HRDL N +LD +K+ DFG ++ + + S
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR-DMYDKEYYSVHNKTGA 192
Query: 184 -----YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++A E L +++ K +DVWS GV L+ +M GA P+
Sbjct: 193 KLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 233
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-18
Identities = 58/217 (26%), Positives = 91/217 (41%), Gaps = 32/217 (14%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSL 74
L R++G G FG + K + LVAVK ++ QRE +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE---------RICNAGRFSEDEARFFFQQ 125
+H +IV+F V L +V EY G+L + I G+ + + Q
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 126 LI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
++ SG+ Y S HRDL N L+ +KI DFG S+ ++S
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYR 190
Query: 179 VGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
VG + PE ++ +++ + +DVWS GV L+
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILW 226
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 5e-18
Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 18/221 (8%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
+ I S IG G+FG L+ + + AVK + R I E Q E
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 68 IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 124
I + HPN++ + L +V+ Y G+L F R + + F
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 199
Query: 125 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 184
Q+ G+ + S + HRDL N +LD +K+ DFG ++ T A
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 185 I-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ A E L +++ K +DVWS GV L+ +M GA P+
Sbjct: 258 LPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 297
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-18
Identities = 37/219 (16%), Positives = 72/219 (32%), Gaps = 29/219 (13%)
Query: 24 ELVRDIGSGNFGV-------ARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR 75
+G G F + E V +K +++ E+ L
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 133
H ++V V + +V E+ G L + + N + +QL + + +
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL 129
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRL------KICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
+ H ++ +N LL + K+ D G S + + + + ++ P
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI---PWVPP 186
Query: 188 EVLLKKEYDGKI----ADVWSCGVTLY-VMLVGAYPFED 221
E + + K D WS G TL+ + G P
Sbjct: 187 ECIE----NPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 32/226 (14%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDEN-VQREIINHRSL 74
L ++G G FG + ++ + LVAVK ++ + QRE L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------RICNAGRFSEDEARFFFQQL 126
+H +IVRF V L +V EY G+L AG QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 127 I-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179
+ +G+ Y + HRDL N L+ +KI DFG S+ ++S V
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSR--DIYSTDYYRV 216
Query: 180 GTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
G + PE +L +++ + +DVWS GV L+ + G P+
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 22/229 (9%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQ--RE 67
D+ I H+ R IG G+FGV + + A+K + R ++ + RE
Sbjct: 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE 72
Query: 68 IINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFF 123
+ R L HPN++ ++L +++ Y G+L F R + + F
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIR-SPQRNPTVKDLISFG 130
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVG 180
Q+ G+ Y + HRDL N +LD S +K+ DFG ++ +S +
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHA 188
Query: 181 T-PA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEE 224
P + A E L + K +DVWS GV L+ ++ GA Y DP +
Sbjct: 189 RLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFD 236
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-17
Identities = 45/222 (20%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERGDKIDENV--QREIINHRS 73
++ + R++G G+FG VA+ + + E VA+K + + E + E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEAR--------FFF 123
++VR V+ ++ME + G+L + R +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 124 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
++ G++Y ++ + HRDL N ++ + +KI DFG ++ ++ G
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKG 200
Query: 184 YI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ +PE L + +DVWS GV L+ + + P+
Sbjct: 201 LLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY 241
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-17
Identities = 44/230 (19%), Positives = 87/230 (37%), Gaps = 34/230 (14%)
Query: 19 DSDRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINH 71
+ ++G FG + + VA+K ++ + E + E +
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLR 66
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFF 122
L+HPN+V V+ L+++ Y S G+L + + ++
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 123 FQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175
+ +G+ Y S V H+DL N L+ +KI D G + +++
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR--EVYAAD 182
Query: 176 KSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
+ + + APE ++ ++ +D+WS GV L+ V G P+
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 55/235 (23%), Positives = 86/235 (36%), Gaps = 47/235 (20%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
+R + +G+G FG A + VAVK + ER + E V
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------FERICNAGRFSE 116
+ H NIV ++ EY G+L + +
Sbjct: 83 L-----GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
DE + L+S G+++ S HRDL N LL KICDFG ++
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLAR-- 193
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
+ + V A + APE + Y + +DVWS G+ L+ + +G+ P
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 8e-16
Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 79
+++ L R IGSG+FG L + +T E VA+K E + E +R L+ I
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ + + +VM+ S +LF C+ + S Q+I+ V + HS
Sbjct: 66 PNVRWFGVEGDYNVLVMDLLGPSLEDLF-NFCS-RKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 138 VCHRDLKLENTLLD-GSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 188
HRD+K +N L+ G A ++ I DFG +K S+ H + K+ GT Y +
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183
Query: 189 VLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
L E D D+ S G L L G+ P
Sbjct: 184 THLGIEQSRRD----DLESLGYVLMYFLRGSLP 212
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 55/236 (23%), Positives = 90/236 (38%), Gaps = 42/236 (17%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+ E VRDIG G FG A + + +VAVK ++ + + QRE
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSE 116
+PNIV+ V + ++ EY + G+L + A S
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 117 DEARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
+ + +G++Y + HRDL N L+ +KI DFG S++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVVKIADFGLSRN- 223
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++S I PE + Y + +DVW+ GV L+ + G P+
Sbjct: 224 -IYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-15
Identities = 58/233 (24%), Positives = 87/233 (37%), Gaps = 47/233 (20%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
D + + IG GNFG AR+ +D + A+K + + D E V +
Sbjct: 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCK 81
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDE 118
+ HPNI+ +L + +EYA G L E +
Sbjct: 82 L-----GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 119 ARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171
+ QQL+ G+ Y Q HRDL N L+ + KI DFG S+ +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEV 194
Query: 172 HSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
+ T + A E L Y +DVWS GV L+ ++ +G P
Sbjct: 195 Y-----VKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 48/215 (22%), Positives = 86/215 (40%), Gaps = 24/215 (11%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
Y++ R IG G+FGV + + VA+K+ E ++ E ++ L I
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
H +V++ S +L +C +FS +Q+++ V H
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGPSLEDLL-DLCG-RKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 138 VCHRDLKLENTLL---DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIA 186
+ +RD+K +N L+ + A + + DFG K + H + K+ GT Y++
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 187 PEVLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
L +E D D+ + G L G+ P
Sbjct: 187 INTHLGREQSRRD----DLEALGHVFMYFLRGSLP 217
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-15
Identities = 53/236 (22%), Positives = 90/236 (38%), Gaps = 42/236 (17%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
L + +G G FG A ++ + VAVK ++ ++ E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSE 116
+ HP++++ L +++EYA G L ++
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
DE LIS G+ Y M++ HRDL N L+ +KI DFG S+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRD- 199
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
++ + + I A E L Y + +DVWS GV L+ ++ +G P+
Sbjct: 200 -VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-15
Identities = 46/222 (20%), Positives = 82/222 (36%), Gaps = 42/222 (18%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVK-------YIERGDKIDE-NVQRE 67
+ + + +G+G FG A + + VAVK E+ + E +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEAR 120
+ +H NIV + ++ EY G+L + F+ +
Sbjct: 106 L-----GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 121 FFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173
+ L+ G+++ S HRD+ N LL + KI DFG ++ + +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLARD--IMN 216
Query: 174 QPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
V A + APE + Y + +DVWS G+ L+
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLW 257
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-15
Identities = 57/249 (22%), Positives = 92/249 (36%), Gaps = 53/249 (21%)
Query: 14 MPIMHDSDRYE-------LVRDIGSGNFG-----VARLMRDKKTEELVAVKYI------- 54
+ +D+ ++E L + +G G FG A + T VAVK +
Sbjct: 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 55 ERGDKIDE-NVQREIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGEL-------- 104
E + E + I H N+V P L +++E+ G L
Sbjct: 73 EHRALMSELKILIHI-----GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 127
Query: 105 -FERICNAGRFSEDEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAP 156
+ + LI G+ + S + HRDL N LL
Sbjct: 128 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV- 186
Query: 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY- 210
+KICDFG ++ ++ P A + APE + + Y + +DVWS GV L+
Sbjct: 187 -VKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWE 242
Query: 211 VMLVGAYPF 219
+ +GA P+
Sbjct: 243 IFSLGASPY 251
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-15
Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIV 80
+ + + IG GNFG RL ++ T E VA+K +E + E ++ L I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 81 RFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+ + A+V+E S +LF +C+ FS QLIS + Y HS +
Sbjct: 69 QVYYFGPCGKYNAMVLELLGPSLEDLF-DLCD-RTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 139 CHRDLKLENTLLDGSPAPRLKIC---DFGYSK-----SSVLH---SQPKSTVGTPAYIAP 187
+RD+K EN L+ ++ DF +K + H + KS GT Y++
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186
Query: 188 EVLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
L KE D D+ + G L G+ P
Sbjct: 187 NTHLGKEQSRRD----DLEALGHMFMYFLRGSLP 216
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-14
Identities = 60/213 (28%), Positives = 88/213 (41%), Gaps = 22/213 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
+RY L R IGSG+FG L D E VA+K E + E ++ ++ I
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67
Query: 80 VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ + +VME S +LF C+ +FS Q+IS + Y HS
Sbjct: 68 PTIRWCGAEGDYNVMVMELLGPSLEDLF-NFCS-RKFSLKTVLLLADQMISRIEYIHSKN 125
Query: 138 VCHRDLKLENTLL-DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 188
HRD+K +N L+ G + I DFG +K + H + K+ GT Y +
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185
Query: 189 VLLKKEY---DGKIADVWSCGVTLYVMLVGAYP 218
L E D D+ S G L +G+ P
Sbjct: 186 THLGIEQSRRD----DLESLGYVLMYFNLGSLP 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-14
Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 37/230 (16%)
Query: 21 DRYELVRDIGSGNFG------VARLMRDKKTEEL-VAVKYIERGDKIDENV--QREIINH 71
D+ L + +G G FG + +DK E + VAVK ++ + E+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARF 121
+ + +H NI+ L +++EYAS G L + E +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 122 FFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
F+ L+S G+ Y S + HRDL N L+ + +KI DFG ++ +++
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR--DINNI 210
Query: 175 PKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 218
T + APE L + Y + +DVWS GV ++ + +G P
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSP 259
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-14
Identities = 54/231 (23%), Positives = 81/231 (35%), Gaps = 51/231 (22%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEELVAVKYI-------ERGDKIDE-NVQRE 67
+ E + +GSG FG A + VAVK + ER + E + +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL----------------FERICNA 111
+ H NIV + ++ EY G+L
Sbjct: 105 L-----GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 112 GRFSEDEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164
ED F+ L+ G+ + HRDL N L+ +KICDFG
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFG 217
Query: 165 YSKSSVLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
++ + S V A + APE L + Y K +DVWS G+ L+
Sbjct: 218 LARD--IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLW 265
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-14
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 37/231 (16%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEE--LVAVKYIERGDKIDENV--QREIINH 71
D+ L + +G G FG A + K +E VAVK ++ + E+
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARF 121
+ + +H NI+ L +++EYAS G L + E +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 122 FFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174
F+ L+S G+ Y S + HRDL N L+ + +KI DFG ++ +++
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNI 256
Query: 175 PKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 219
T + APE L + Y + +DVWS GV ++ + +G P+
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 306
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-14
Identities = 58/226 (25%), Positives = 87/226 (38%), Gaps = 46/226 (20%)
Query: 21 DRYELVRDIGSGNFG-----VARLMRDKKTEE--LVAVKYI-------ERGDKIDE-NVQ 65
DR L + +G G FG A + K VAVK + + D I E +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 66 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSE 116
+ I +H NI+ L +++EYAS G L +
Sbjct: 129 KMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 117 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169
E + + L+S G+ Y S + HRDL N L+ + +KI DFG ++
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLAR-- 239
Query: 170 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 210
+H T + APE L + Y + +DVWS GV L+
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLW 284
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 9e-12
Identities = 39/196 (19%), Positives = 59/196 (30%), Gaps = 52/196 (26%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN---------VQREIIN 70
+++ + IG G FG T VA+K I N + EII
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 71 HRSL---------RHPNIVRFKEVIL------------------------------TPTH 91
+ L R + V
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLL 150
L IV+E+ GG E++ S A+ QL + ++ S++ HRDL N LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 151 DGSPAPRLKICDFGYS 166
+ +L G S
Sbjct: 196 KKTSLKKLHYTLNGKS 211
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 3e-09
Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 15/106 (14%)
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST--VGTPAYI 185
G+++ H HRD+K N LLD + KI DFG ++ S ++ VGT AY+
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYM 202
Query: 186 APEVLLKKEY-DGKI---ADVWSCGVTLYVMLVGAYPFEDPEEPKN 227
AP E G+I +D++S GV L ++ G ++ EP+
Sbjct: 203 AP------EALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-09
Identities = 63/215 (29%), Positives = 88/215 (40%), Gaps = 52/215 (24%)
Query: 29 IGSGNFG-VAR-LMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRF-- 82
IG G FG V + ++RD VA+K I+E + EI RHP++V
Sbjct: 47 IGHGVFGKVYKGVLRDGAK---VALKRRTPESSQGIEE-FETEIETLSFCRHPHLVSLIG 102
Query: 83 --KEVILTPTHLAIVMEYASGGELFERICNAGRFSE------------DEARFFFQQLIS 128
E + ++ +Y G L + + + AR
Sbjct: 103 FCDE----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR-------- 150
Query: 129 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STV--GTPAYI 185
G+ Y H+ + HRD+K N LLD + P KI DFG SK Q STV GT YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYI 208
Query: 186 APE-----VLLKKEYDGKIADVWSCGVTLYVMLVG 215
PE L +K +DV+S GV L+ +L
Sbjct: 209 DPEYFIKGRLTEK------SDVYSFGVVLFEVLCA 237
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-09
Identities = 30/167 (17%), Positives = 60/167 (35%), Gaps = 24/167 (14%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 81
++ L + IGSG FG+ L E A ++ + + + E+ ++ + + ++
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 82 FKEVILTPTHLAI-------------------VMEY--ASGGELFERICNAGRFSEDEAR 120
+L I VME ++ N G F +
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG--QN-GTFKKSTVL 154
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+++ + Y H + H D+K N LL ++ + D+G S
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 22/171 (12%), Positives = 57/171 (33%), Gaps = 29/171 (16%)
Query: 22 RYELVRDIGSGNFGV--------ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS 73
+++L N G+ ++ ++K ++ D N Q R+
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQN--FFQRA 99
Query: 74 LRHPNIVRFKEVILTPT---------------HLAIVMEY--ASGGELFERICNAGRFSE 116
+ + ++K++ TP + +V+ S + SE
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV-SPKHVLSE 158
Query: 117 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+L+ + + H + H ++ EN +D ++ + +G++
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 7e-08
Identities = 27/169 (15%), Positives = 54/169 (31%), Gaps = 25/169 (14%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEEL-----VAVK---------------YIERGDKID 61
+++ IG G FG L +E + VK Y
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 62 ENVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE 118
+ L P ++ ++M+ + +++E RFS
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA-NA-KRFSRKT 153
Query: 119 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+++ + Y H + H D+K N LL+ ++ + D+G +
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 1e-07
Identities = 56/215 (26%), Positives = 82/215 (38%), Gaps = 61/215 (28%)
Query: 29 IGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDENVQRE------IINHRSLRHPNI 79
+G G FG RL D LVAVK ++ + + + +I+ H N+
Sbjct: 38 LGRGGFGKVYKGRL-ADGT---LVAVKRLKEERT--QGGELQFQTEVEMISM--AVHRNL 89
Query: 80 VRFKEVILTPTHLAIVMEYASGG----ELFERICNAGRFS--------EDEARFFFQQLI 127
+R + +TPT +V Y + G L ER + AR
Sbjct: 90 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR------- 142
Query: 128 SGVSYCH---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----- 179
G++Y H ++ HRD+K N LLD + DFG +K L + V
Sbjct: 143 -GLAYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVR 196
Query: 180 GTPAYIAPE-----VLLKKEYDGKIADVWSCGVTL 209
GT +IAPE +K DV+ GV L
Sbjct: 197 GTIGHIAPEYLSTGKSSEK------TDVFGYGVML 225
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 11/119 (9%)
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
+ Q+ G+ + S + HRDL N LL +KICDFG ++ ++ P
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKG 253
Query: 182 PAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHR 234
A + APE + + Y + +DVWS GV L+ + +GA P+ + + F + +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 4e-04
Identities = 31/153 (20%), Positives = 55/153 (35%), Gaps = 22/153 (14%)
Query: 18 HDSDRYE-------LVRDIGSGNFG-----VARLMRDKKTEELVAVKYIERG----DKID 61
+D+ ++E L + +G G FG A + T VAVK ++ G +
Sbjct: 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 71
Query: 62 ENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFERICNAGRFSEDEAR 120
+ +I+ H H N+V P L +++E+ G L + + R +
Sbjct: 72 LMSELKILIHIG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPYK 129
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 153
+ G Y + DLK + S
Sbjct: 130 TKGARFRQGKDYVGA---IPVDLKRRLDSITSS 159
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 9e-06
Identities = 36/288 (12%), Positives = 95/288 (32%), Gaps = 76/288 (26%)
Query: 23 YELVRDIGSGNFG--VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
+ V ++ N+ ++ + +++ ++ YIE+ D++ + Q + S R +
Sbjct: 80 QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQPYL 138
Query: 81 RFKEVI--LTPTHLAIV--MEYASGGE----LFERICNAGRFSEDEARFFFQQL-ISGVS 131
+ ++ + L P ++ + G + +C + + + + F+ ++ +
Sbjct: 139 KLRQALLELRPAKNVLIDGV----LGSGKTWVALDVCLSYKV---QCKMDFKIFWLN-LK 190
Query: 132 YCHS-------MQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 183
C+S +Q + ++ + D S +L+I +L S+P
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP-------- 242
Query: 184 YIAPEVLLKKEYDGKI-ADVWS----------C---------GVTLYVMLVGAYPFEDPE 223
Y LL + +V + C VT ++
Sbjct: 243 Y--ENCLL-------VLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDH 293
Query: 224 EPKNFRKT-IHRILSVQYSIPDYVHISPEC-RHLISRIFVADPAKVSM 269
+ +L Y+ P+ + +P ++S+
Sbjct: 294 HSMTLTPDEVKSLLL------KYLDCRPQDLPREVLTT---NPRRLSI 332
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 288 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.53 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.3 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.09 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.98 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.93 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.84 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.67 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.54 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.53 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.39 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.31 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.18 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.17 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.02 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.93 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.8 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.76 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.75 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.73 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.71 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.65 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.61 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.41 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.33 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.01 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.89 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.97 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.3 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.77 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-62 Score=406.65 Aligned_cols=258 Identities=29% Similarity=0.489 Sum_probs=228.4
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
...++|++.+.||+|+||+||+|++..+++.||+|++.+. ....+.+.+|++++++++||||+++++++.+++.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 4457899999999999999999999999999999999753 344567899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
+||||+++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|.......
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPES 186 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTT
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCC
Confidence 99999999999999999899999999999999999999999999999999999999988877 9999999998654332
Q ss_pred ---CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 174 ---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 174 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
......||+.|+|||++.+..++.+ +|+|||||++|+|++|..||...+. ......+....+.+|. .+++
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~----~~~~~~i~~~~~~~p~--~~s~ 259 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNE----GLIFAKIIKLEYDFPE--KFFP 259 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCT--TCCH
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCc--ccCH
Confidence 2345679999999999998888776 9999999999999999999987543 3444455666777776 7899
Q ss_pred HHHHHHHHhcccCcCCccccccccc---cchhhhhhh
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATG---VYMHTKLQL 284 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~---~~~~~~~~~ 284 (288)
++++||.+||+.||.+|||+.|+++ ...|+||+-
T Consensus 260 ~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp HHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 9999999999999999999999876 567888864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-62 Score=399.59 Aligned_cols=253 Identities=39% Similarity=0.662 Sum_probs=208.4
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
.++|++.+.||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+++|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 479999999999999999999999999999999997542 3345788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|||+ +++|.+.+...+++++.+++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+|.........
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~~~~ 168 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDGNFL 168 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC---------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCCCcc
Confidence 9999 5699999998899999999999999999999999999999999999999988776 999999999876665556
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....||+.|+|||++.+..+...++|||||||++|+|++|..||...+. ......+....+.++. .+|+++++|
T Consensus 169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~l 242 (275)
T 3hyh_A 169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI----PVLFKNISNGVYTLPK--FLSPGAAGL 242 (275)
T ss_dssp ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCT--TSCHHHHHH
T ss_pred CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHcCCCCCCC--CCCHHHHHH
Confidence 6678999999999999888876669999999999999999999976443 3444455566666665 689999999
Q ss_pred HHHhcccCcCCccccccccccchhhhhhh
Q 023058 256 ISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
|.+||+.||.+|||+.|+++ |+|++.
T Consensus 243 i~~~L~~dP~~R~s~~eil~---hpw~k~ 268 (275)
T 3hyh_A 243 IKRMLIVNPLNRISIHEIMQ---DDWFKV 268 (275)
T ss_dssp HHHHSCSSGGGSCCHHHHHH---CHHHHT
T ss_pred HHHHccCChhHCcCHHHHHc---Cccccc
Confidence 99999999999999988765 777753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-60 Score=398.75 Aligned_cols=252 Identities=26% Similarity=0.441 Sum_probs=218.3
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
+.|+++++||+|+||+||+|++..+|+.||||++.... ...+.+.+|+.++++++|||||++++++.+++.+|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 67999999999999999999999999999999997543 34456889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CCCCC
Q 023058 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 178 (288)
Q Consensus 100 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~~~~ 178 (288)
++++|.+++.. +++++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++....... .....
T Consensus 154 ~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~ 230 (346)
T 4fih_A 154 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL 230 (346)
T ss_dssp TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCC
T ss_pred CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCccccc
Confidence 99999998876 57999999999999999999999999999999999999988877 9999999998654443 34566
Q ss_pred cCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-ccCCCCCCCCCHHHHHHHH
Q 023058 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLIS 257 (288)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~ 257 (288)
.||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....... +... ...++.+..+++++++||.
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~----i~~~~~~~~~~~~~~s~~~~dli~ 305 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM----IRDNLPPRLKNLHKVSPSLKGFLD 305 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred ccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH----HHcCCCCCCCccccCCHHHHHHHH
Confidence 89999999999998889777 9999999999999999999987654333332 2222 2234444578999999999
Q ss_pred HhcccCcCCccccccccccchhhhhh
Q 023058 258 RIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 258 ~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+||+.||.+|||+.|+++ |+|++
T Consensus 306 ~~L~~dP~~R~ta~e~l~---Hp~~~ 328 (346)
T 4fih_A 306 RLLVRDPAQRATAAELLK---HPFLA 328 (346)
T ss_dssp HHSCSSTTTSCCHHHHTT---CGGGG
T ss_pred HHcCCChhHCcCHHHHhc---CHhhc
Confidence 999999999999988876 66654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-60 Score=400.33 Aligned_cols=256 Identities=28% Similarity=0.497 Sum_probs=211.8
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
....++|++++.||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.++++++|||||++++++.+++.+|
T Consensus 20 f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y 99 (350)
T 4b9d_A 20 FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLY 99 (350)
T ss_dssp CSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 344589999999999999999999999999999999997653 33457889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
+|||||++++|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNS 177 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecC
Confidence 9999999999999996543 5799999999999999999999999999999999999988877 99999999986543
Q ss_pred CCC-CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 172 HSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 172 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
... .....||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+..... ..+...... +....+|+
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~----~~i~~~~~~-~~~~~~s~ 251 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLV----LKIISGSFP-PVSLHYSY 251 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCCC-CCCTTSCH
T ss_pred CcccccccCCCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHH----HHHHcCCCC-CCCccCCH
Confidence 322 234469999999999999888776 99999999999999999999876543333 333443332 22347899
Q ss_pred HHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
++++||.+||+.||.+|||+.|+++ |+|++
T Consensus 252 ~~~~li~~~L~~dP~~R~s~~e~l~---hp~~~ 281 (350)
T 4b9d_A 252 DLRSLVSQLFKRNPRDRPSVNSILE---KGFIA 281 (350)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHT---SHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHhc---CHHhh
Confidence 9999999999999999999988876 55553
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-60 Score=392.78 Aligned_cols=256 Identities=30% Similarity=0.535 Sum_probs=213.7
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEc---CCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
..++|++++.||+|+||+||+|++. .+++.||+|++.... ....++.+|++++++++|||||++++++.+++.+
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 3578999999999999999999974 467899999987532 2334688899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
|+||||+++++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||+++.++. +||+|||+|+.....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC----
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCC
Confidence 999999999999999999899999999999999999999999999999999999999988877 999999999754433
Q ss_pred -CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 173 -SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 173 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
.......||+.|+|||++.+..++.+ +|+|||||++|+|++|..||...+.. .....+......+|. .+|++
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i~~~~~~~p~--~~s~~ 252 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRK----ETMTMILKAKLGMPQ--FLSPE 252 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCT--TSCHH
T ss_pred CccccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcCHH----HHHHHHHcCCCCCCC--cCCHH
Confidence 33456679999999999999888877 99999999999999999999875543 344445556666665 78999
Q ss_pred HHHHHHHhcccCcCCcccccc--ccccchhhhhh
Q 023058 252 CRHLISRIFVADPAKVSMHFH--ATGVYMHTKLQ 283 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~--~l~~~~~~~~~ 283 (288)
+++||.+||+.||.+|||+.. +-+.+.|+|++
T Consensus 253 ~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~ 286 (304)
T 3ubd_A 253 AQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286 (304)
T ss_dssp HHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGT
T ss_pred HHHHHHHHcccCHHHCCCCCcCCHHHHHcCcccc
Confidence 999999999999999999742 22355677775
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-59 Score=399.61 Aligned_cols=252 Identities=26% Similarity=0.441 Sum_probs=218.7
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
+.|+++++||+|+||+||+|++..+|+.||||++.... ...+.+.+|+.++++++|||||++++++.+++.+|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 67999999999999999999999999999999997643 34457889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CCCCC
Q 023058 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 178 (288)
Q Consensus 100 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~~~~ 178 (288)
++|+|.+++.. +.+++.++..++.||+.||+|||++||+||||||+|||++.++. +||+|||++....... .....
T Consensus 231 ~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 231 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCCC
T ss_pred CCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCcccccc
Confidence 99999998865 56999999999999999999999999999999999999988877 9999999998654433 34556
Q ss_pred cCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-ccCCCCCCCCCHHHHHHHH
Q 023058 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLIS 257 (288)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~ 257 (288)
.||+.|+|||++.+..|+.+ +|||||||++|+|++|..||...+....... +... ...++....+++++++||.
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~----i~~~~~~~~~~~~~~s~~~~dli~ 382 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM----IRDNLPPRLKNLHKVSPSLKGFLD 382 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred ccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH----HHcCCCCCCcccccCCHHHHHHHH
Confidence 79999999999999999877 9999999999999999999987654333332 2222 2344445578999999999
Q ss_pred HhcccCcCCccccccccccchhhhhh
Q 023058 258 RIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 258 ~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+||+.||.+|||+.|+++ |+|++
T Consensus 383 ~~L~~dP~~R~ta~ell~---Hp~~~ 405 (423)
T 4fie_A 383 RLLVRDPAQRATAAELLK---HPFLA 405 (423)
T ss_dssp HHSCSSTTTSCCHHHHTT---CGGGG
T ss_pred HHcCCChhHCcCHHHHhc---CHHhc
Confidence 999999999999988876 66664
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=381.56 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=209.9
Q ss_pred CCe-eeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEc----CCeE
Q 023058 21 DRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHL 92 (288)
Q Consensus 21 ~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 92 (288)
++| ++.++||+|+||+||+|.+..++..||+|++.... ...+.+.+|++++++++|||||++++++.+ +..+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 555 78889999999999999999999999999997543 334568899999999999999999999865 3568
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC--ceecCCCCCceEecC-CCCCCEEEeecCCCccc
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 169 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--i~H~dl~p~nilv~~-~~~~~~~l~df~~~~~~ 169 (288)
++||||+++++|.+++...+.+++..+..++.||+.||+|||++| |+||||||+|||++. ++. +||+|||+|...
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~--vKl~DFGla~~~ 182 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLK 182 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC--EEECCTTGGGGC
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC--EEEEeCcCCEeC
Confidence 999999999999999999889999999999999999999999999 999999999999974 455 999999999743
Q ss_pred ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
. ........||+.|+|||++.+ .++.+ +|||||||++|+|++|..||........ ....+............++
T Consensus 183 ~-~~~~~~~~GTp~YmAPE~~~~-~y~~~-~DiwSlGvilyelltg~~Pf~~~~~~~~---~~~~i~~~~~~~~~~~~~~ 256 (290)
T 3fpq_A 183 R-ASFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQ---IYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp C-TTSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHH---HHHHHTTTCCCGGGGGCCC
T ss_pred C-CCccCCcccCccccCHHHcCC-CCCcH-HHHHHHHHHHHHHHHCCCCCCCCCcHHH---HHHHHHcCCCCCCCCccCC
Confidence 2 233445679999999998865 57766 9999999999999999999976544332 2333333322222233678
Q ss_pred HHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
+++++||.+||+.||.+|||+.|+++ |+|++.
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~---Hp~~~~ 288 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLN---HAFFQE 288 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHT---SGGGC-
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc---CccccC
Confidence 99999999999999999999988755 888764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-58 Score=387.34 Aligned_cols=248 Identities=26% Similarity=0.368 Sum_probs=212.3
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
..+.|++.++||+|+||+||+|++..+|+.||+|++..... ..+|+.++++++|||||++++++.+++.+|+||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 34678999999999999999999999999999999986543 24799999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC----
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---- 174 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~---- 174 (288)
+++++|.+++...+.+++.++..++.||+.||+|||++||+||||||+|||++.++. ++||+|||++........
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC---------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccce
Confidence 999999999998889999999999999999999999999999999999999987653 399999999986544322
Q ss_pred --CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 175 --PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 175 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+.......+...... ...++ ..+|+++
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~--~~~s~~~ 286 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP-IREIP--PSCAPLT 286 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG-GGGSC--TTSCHHH
T ss_pred ecCCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC-chhcC--ccCCHHH
Confidence 223469999999999999888877 99999999999999999999887766655554432111 11233 3789999
Q ss_pred HHHHHHhcccCcCCccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+||.+||+.||.+|||+.|+++
T Consensus 287 ~~li~~~L~~dP~~R~sa~el~~ 309 (336)
T 4g3f_A 287 AQAIQEGLRKEPVHRASAMELRR 309 (336)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHH
Confidence 99999999999999999999865
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-57 Score=375.53 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=208.5
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
+..++|.+.+.||+|+||+||+|++. .++..||||++.... ...+.+.+|++++++++|||||++++++.+++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 34578999999999999999999864 357889999997643 334678999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCE
Q 023058 92 LAIVMEYASGGELFERICNA-------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~ 158 (288)
+++||||+++|+|.+++... ..+++.++..++.||+.||+|||+.+|+||||||+||+++.++. +
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~ 167 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--V 167 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--E
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--E
Confidence 99999999999999999753 35999999999999999999999999999999999999988877 9
Q ss_pred EEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 023058 159 KICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHR 234 (288)
Q Consensus 159 ~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~ 234 (288)
||+|||+++....... .....+|+.|+|||.+.+..++.+ +||||||+++|||+| |..||...+..... ..
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~----~~ 242 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVI----EC 242 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----HH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HH
Confidence 9999999975433322 233458999999999999888877 999999999999998 89999876543333 33
Q ss_pred Hhhcc-cCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 235 ILSVQ-YSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 235 ~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+..+. ...| ..+|+++.+||.+||+.||.+|||+.++.+
T Consensus 243 i~~~~~~~~p--~~~~~~~~~li~~cl~~dP~~RPs~~~i~~ 282 (299)
T 4asz_A 243 ITQGRVLQRP--RTCPQEVYELMLGCWQREPHMRKNIKGIHT 282 (299)
T ss_dssp HHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCCC--ccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 33332 2333 379999999999999999999999998854
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=380.44 Aligned_cols=259 Identities=27% Similarity=0.398 Sum_probs=213.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEc------CC
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT------PT 90 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~ 90 (288)
.++|++++.||+|+||+||+|++..+|+.||||++.... ...+.+.+|++++++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999999999999999997543 233567899999999999999999999764 35
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.+|+||||++ ++|.+++...+.+++.+++.+++||+.||+|||++||+||||||+||+++.++. +||+|||+++...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC-
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecc
Confidence 7899999996 589999988889999999999999999999999999999999999999988777 9999999997543
Q ss_pred cC-----CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-----
Q 023058 171 LH-----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY----- 240 (288)
Q Consensus 171 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----- 240 (288)
.. .......||+.|+|||++.+..+...++||||+||++|+|++|..||.+.+..+....+.........
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 32 22345679999999999888766555599999999999999999999887665555444332211110
Q ss_pred -----------CCCC---------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 241 -----------SIPD---------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 241 -----------~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
.++. ...+++++.+||.+||+.||.+|||+.|+++ |+|++.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~---Hp~f~~ 350 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR---HPFLAK 350 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT---SGGGTT
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc---CHhhCc
Confidence 0111 1247899999999999999999999988876 666653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-56 Score=372.13 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=204.3
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
..++|.+.++||+|+||+||+|+.. .++..||||++.... ...+++.+|++++++++|||||++++++.+++.+
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4467899999999999999999864 367899999997543 3346789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCC
Q 023058 93 AIVMEYASGGELFERICNA---------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~ 157 (288)
++||||+++|+|.+++... +++++.++..++.||+.||+|||+.+|+||||||+||+++.+..
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~-- 196 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV-- 196 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--
Confidence 9999999999999998653 35899999999999999999999999999999999999998776
Q ss_pred EEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 023058 158 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (288)
Q Consensus 158 ~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (288)
+||+|||+++....... .....+|+.|+|||.+.+..++.+ +||||||+++|||++ |..||...+.......
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~--- 272 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC--- 272 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH---
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCcc-ccccchHHHHHHHHcCCCCCCCCCCHHHHHHH---
Confidence 99999999975543322 234568999999999999888777 999999999999998 8999987654333332
Q ss_pred HHhhc-ccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 234 RILSV-QYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 234 ~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
+... ....| ..+|+++.+||.+||+.||.+|||+.|+++.+
T Consensus 273 -i~~g~~~~~p--~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L 314 (329)
T 4aoj_A 273 -ITQGRELERP--RACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314 (329)
T ss_dssp -HHHTCCCCCC--TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHH
T ss_pred -HHcCCCCCCc--ccccHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 2322 23334 37999999999999999999999999987643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-56 Score=368.98 Aligned_cols=252 Identities=20% Similarity=0.317 Sum_probs=210.7
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEc-----CCCcEEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (288)
+..+++++.++||+|+||+||+|... .+++.||||++... ....+.+.+|+.++++++|||||++++++..++
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 44578999999999999999999853 46788999998654 234467999999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC
Q 023058 91 HLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~ 154 (288)
.+++|||||++|+|.+++... ..+++.++..++.||+.||+|||+.+|+||||||+||+++.++
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC
Confidence 999999999999999999643 3589999999999999999999999999999999999999887
Q ss_pred CCCEEEeecCCCcccccCC---CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHH
Q 023058 155 APRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (288)
Q Consensus 155 ~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~ 230 (288)
. +||+|||+++...... ......+|+.|+|||.+.+..++.+ +||||||+++|||++ |..||...+..+.
T Consensus 183 ~--~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t~g~~Pf~~~~~~~~--- 256 (308)
T 4gt4_A 183 N--VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDV--- 256 (308)
T ss_dssp C--EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTCCHHHH---
T ss_pred C--EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCCHHHH---
Confidence 7 9999999997554332 2344568999999999999888877 999999999999998 8999987654333
Q ss_pred HHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
...+.... ..+.+..+|+++.+|+.+||+.||.+|||+.++++.|
T Consensus 257 -~~~i~~~~-~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 257 -VEMIRNRQ-VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp -HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -HHHHHcCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 23333322 2333447999999999999999999999999987744
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=366.93 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=201.6
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
-+..+++++.++||+|+||+||+++... .||||+++... ...+.+.+|+.++++++|||||++++++.. +.++
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~ 107 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA 107 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence 3456789999999999999999998753 58999987543 334578899999999999999999998754 5689
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
+|||||++++|.+++... .++++.++..++.||+.||+|||+.||+||||||+|||++.++. +||+|||+|+.....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRW 185 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC----
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceecccC
Confidence 999999999999999764 57999999999999999999999999999999999999998776 999999999754332
Q ss_pred C---CCCCCcCCCcccCCccccCc---ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCC-CCC
Q 023058 173 S---QPKSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI-PDY 245 (288)
Q Consensus 173 ~---~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~ 245 (288)
. ......||+.|+|||++.+. .++.+ +||||||+++|||++|..||...+...........-.. .+.. ...
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~k-sDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~-~p~~~~~~ 263 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ-SDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA-SPDLSKLY 263 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC-CCCSTTSC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcH-HHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC-CCCccccc
Confidence 2 23445799999999998643 35555 99999999999999999999876654443333222111 1111 123
Q ss_pred CCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 246 VHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 246 ~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
..+|+++.+||.+||+.||.+|||+.++++
T Consensus 264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 264 KNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp TTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 468999999999999999999999999876
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=371.19 Aligned_cols=278 Identities=86% Similarity=1.361 Sum_probs=230.9
Q ss_pred CCCccccCCCCCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCcee
Q 023058 1 MDRSAMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80 (288)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 80 (288)
|++..++..| ..++.....++|++.+.||+|+||+||++++..+++.||+|++.......+.+.+|+.++++++||||+
T Consensus 1 m~~~~~~~~p-~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv 79 (361)
T 3uc3_A 1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79 (361)
T ss_dssp -----------CCCCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCCCCC-CCccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCC
Confidence 6776666665 566788889999999999999999999999999999999999988777778899999999999999999
Q ss_pred eEeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEE
Q 023058 81 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (288)
Q Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l 160 (288)
++++++...+.+++||||+++++|.+++...++++...++.++.|++.||.|||+.||+||||||+||+++.++.++++|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl 159 (361)
T 3uc3_A 80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKI 159 (361)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred cEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEE
Confidence 99999999999999999999999999998888999999999999999999999999999999999999998777767999
Q ss_pred eecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc
Q 023058 161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240 (288)
Q Consensus 161 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (288)
+|||++.............+++.|+|||.+.+..+..+++||||||+++|+|++|..||...............+.....
T Consensus 160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 239 (361)
T 3uc3_A 160 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239 (361)
T ss_dssp CCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC
T ss_pred eecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC
Confidence 99999876555555566679999999999988888777689999999999999999999988777777777778777788
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 241 SIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 241 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
.++....+++++.+||.+||+.||.+|||+.++++ |+|+
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~---hp~f 278 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKT---HSWF 278 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT---SHHH
T ss_pred CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh---Ccch
Confidence 88877789999999999999999999999988866 5555
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-55 Score=363.89 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=193.8
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCC--------
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT-------- 90 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 90 (288)
++|++++.||+|+||+||+|++..+++.||+|++..... ..+.+.+|+.++++++|||||++++++...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 469999999999999999999999999999999876432 3356889999999999999999999987543
Q ss_pred ----eEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeec
Q 023058 91 ----HLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (288)
Q Consensus 91 ----~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df 163 (288)
.+|+||||+++++|.+++..... .+...++.++.||+.||+|||++||+||||||+||+++.++. +||+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DF 162 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDF 162 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccC
Confidence 47999999999999999987654 455678899999999999999999999999999999988877 999999
Q ss_pred CCCcccccCCCC-------------CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 023058 164 GYSKSSVLHSQP-------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (288)
Q Consensus 164 ~~~~~~~~~~~~-------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~ 230 (288)
|+++........ ....||+.|+|||++.+..++.+ +|||||||++|+|++ ||.... ....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyell~---Pf~~~~---~~~~ 235 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELLY---PFSTQM---ERVR 235 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHS---CCSSHH---HHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH-HHHHHHHHHHHHHcc---CCCCcc---HHHH
Confidence 999755433221 22469999999999999888777 999999999999995 775321 1122
Q ss_pred HHHHHhhcccCCCC-CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 231 TIHRILSVQYSIPD-YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 231 ~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
....+.... +|. ....++.+.+||.+||+.||.+|||+.|+++ |+|++
T Consensus 236 ~~~~~~~~~--~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~---h~~~~ 284 (299)
T 4g31_A 236 TLTDVRNLK--FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE---NAVFE 284 (299)
T ss_dssp HHHHHHTTC--CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT---SGGGC
T ss_pred HHHHHhcCC--CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc---CHhhC
Confidence 222222222 221 1234567889999999999999999988876 66654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-54 Score=365.94 Aligned_cols=257 Identities=23% Similarity=0.356 Sum_probs=203.8
Q ss_pred CCCeeeeeeeeccCceEEEEEEEc---CCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 95 (288)
.++|++.+.||+|+||+||+|+++ .+++.||+|.+.... ...++.+|+++++.+ +||||+++++++.+++.+++|
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 478999999999999999999875 357889999887643 345788999999998 699999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC--
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-- 173 (288)
|||+++++|.+++ +.+++.+++.+++||+.||+|||++||+||||||+||+++.+. +++||+|||+|+......
T Consensus 99 mE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 99 MPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp EECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSCG
T ss_pred EeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCcccc
Confidence 9999999999988 3589999999999999999999999999999999999998652 249999999996433221
Q ss_pred ---------------------------CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 023058 174 ---------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (288)
Q Consensus 174 ---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~ 226 (288)
......||+.|+|||++.+......++||||+||++|+|++|..||....+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~ 254 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL 254 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHH
Confidence 11234699999999999876543444999999999999999999997654322
Q ss_pred hHHHHHHH-----------------------------------Hhhcc--------------cCCCCCCCCCHHHHHHHH
Q 023058 227 NFRKTIHR-----------------------------------ILSVQ--------------YSIPDYVHISPECRHLIS 257 (288)
Q Consensus 227 ~~~~~~~~-----------------------------------~~~~~--------------~~~~~~~~~~~~l~~li~ 257 (288)
.....+.. +.... .....+..+|+++.+||.
T Consensus 255 ~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~ 334 (361)
T 4f9c_A 255 TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLD 334 (361)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHH
T ss_pred HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHH
Confidence 11111100 00000 111224568899999999
Q ss_pred HhcccCcCCccccccccccchhhhhhh
Q 023058 258 RIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 258 ~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
+||+.||.+|||+.|+++ |+||+.
T Consensus 335 ~lL~~dP~~R~ta~eaL~---Hp~f~~ 358 (361)
T 4f9c_A 335 KLLDLNPASRITAEEALL---HPFFKD 358 (361)
T ss_dssp HHTCSCTTTSCCHHHHHT---SGGGTT
T ss_pred HHCcCChhHCcCHHHHhc---CcccCC
Confidence 999999999999988866 888764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-54 Score=384.76 Aligned_cols=258 Identities=28% Similarity=0.434 Sum_probs=217.0
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHH---HHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENV---QREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~---~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
..++|++++.||+|+||+||+|++..+|+.||+|++.+.. ...... .+++.+++.++|||||+++++|.+++.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 4578999999999999999999999999999999997532 222223 344667778899999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
+|+||||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|.....
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK 344 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeecCC
Confidence 9999999999999999999999999999999999999999999999999999999999998887 99999999976543
Q ss_pred CCCCCCCcCCCcccCCccccCc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 172 HSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
.......||+.|+|||++.++ .++.. +|+|||||++|+|++|..||...+... .......+......+|. .+|+
T Consensus 345 -~~~~t~~GTp~YmAPEvl~~~~~y~~~-vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~~~~~p~--~~S~ 419 (689)
T 3v5w_A 345 -KKPHASVGTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPD--SFSP 419 (689)
T ss_dssp -CCCCSCCSCGGGCCHHHHSTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHCCCCCCT--TSCH
T ss_pred -CCCCCccCCcCccCHHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCCCCCc--cCCH
Confidence 334567899999999999754 56666 999999999999999999998654433 23444555566666666 7999
Q ss_pred HHHHHHHHhcccCcCCccccc--cccccchhhhhh
Q 023058 251 ECRHLISRIFVADPAKVSMHF--HATGVYMHTKLQ 283 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~--~~l~~~~~~~~~ 283 (288)
++++||.+||+.||.+|++.. .+.+...|+|++
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~ 454 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGT
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcccc
Confidence 999999999999999999952 233455677775
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=388.49 Aligned_cols=256 Identities=30% Similarity=0.533 Sum_probs=222.3
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 478999999999999999999999999999999987654 3345688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCC
Q 023058 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177 (288)
Q Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~ 177 (288)
+++++|.+++.. .+.+++.++..++.||+.||+|||++||+||||||+||+++.+..+.+||+|||++...........
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~ 315 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 315 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceee
Confidence 999999998864 4579999999999999999999999999999999999999876555699999999987766555556
Q ss_pred CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC--CCCCCHHHHHH
Q 023058 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHL 255 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~l 255 (288)
..||+.|+|||++.+..++.. +|||||||++|+|++|..||...+... ....+....+.++. +..+++++++|
T Consensus 316 ~~GT~~y~APEv~~~~~y~~~-~DiWSlGvilyeml~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~dl 390 (573)
T 3uto_A 316 TTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDE----TLRNVKSCDWNMDDSAFSGISEDGKDF 390 (573)
T ss_dssp ECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred eEECccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHhCCCCCCcccccCCCHHHHHH
Confidence 679999999999999888766 999999999999999999998765433 33344455444432 35789999999
Q ss_pred HHHhcccCcCCccccccccccchhhhhh
Q 023058 256 ISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
|.+||+.||.+|||+.|+++ |+|++
T Consensus 391 i~~~L~~dp~~R~t~~e~l~---Hpw~~ 415 (573)
T 3uto_A 391 IRKLLLADPNTRMTIHQALE---HPWLT 415 (573)
T ss_dssp HHTTSCSSGGGSCCHHHHHH---STTTS
T ss_pred HHHHccCChhHCcCHHHHhc---CcCcC
Confidence 99999999999999988865 66664
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-54 Score=362.90 Aligned_cols=252 Identities=23% Similarity=0.376 Sum_probs=209.1
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCC-----CcEEEEEEeecCc--cchHHHHHHHHHHhhCCC-CceeeEeEEEEcC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGD--KIDENVQREIINHRSLRH-PNIVRFKEVILTP 89 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~ 89 (288)
+..++|++.+.||+|+||+||+|.+..+ ++.||+|.+.... ...+.+.+|+.++++++| ||||++++++..+
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 3457899999999999999999997643 3679999987643 233568899999999965 8999999998764
Q ss_pred -CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC
Q 023058 90 -THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (288)
Q Consensus 90 -~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~ 152 (288)
+.+++|||||++|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+||+++.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 5789999999999999999653 24889999999999999999999999999999999999988
Q ss_pred CCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhH
Q 023058 153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (288)
Q Consensus 153 ~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~ 228 (288)
++. +||+|||+|+....... .....+|+.|+|||.+.+..++.+ +|||||||++|||++ |..||........+
T Consensus 221 ~~~--vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 221 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp GGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred CCC--EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 877 99999999985543332 233458899999999999888777 999999999999998 89999876654444
Q ss_pred HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCcccccccccc
Q 023058 229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
...... ......|. .+++++.++|.+||+.||.+|||+.++++.
T Consensus 298 ~~~i~~--g~~~~~p~--~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 298 CRRLKE--GTRMRAPD--YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHH--TCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHc--CCCCCCCc--cCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 433322 12233443 789999999999999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=350.85 Aligned_cols=248 Identities=40% Similarity=0.679 Sum_probs=220.8
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+++.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 479999999999999999999999999999999997643 33456789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
||+++++|.+++...+++++.+++.++.|++.||+|||+.|++||||||+||+++.++. ++|+|||++..........
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~ 171 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLD 171 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGGG
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCccc
Confidence 99999999999988889999999999999999999999999999999999999987776 9999999998666555556
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 256 (288)
...+++.|+|||.+.+..+...++|+||||+++|+|++|..||...+. ......+.......|. .+++++.+||
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~li 245 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL----KELRERVLRGKYRIPF--YMSTDCENLL 245 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHHHHHH
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCCC--CCCHHHHHHH
Confidence 677999999999999888876669999999999999999999987543 3344445555666665 6899999999
Q ss_pred HHhcccCcCCccccccccc
Q 023058 257 SRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 257 ~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+||+.||.+|||+.++++
T Consensus 246 ~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 246 KRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHCCSSTTTSCCHHHHTT
T ss_pred HHHCCCChhHCcCHHHHhc
Confidence 9999999999999999877
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=347.04 Aligned_cols=252 Identities=22% Similarity=0.261 Sum_probs=193.8
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCC----eEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~ 96 (288)
++|.+.+.||+|+||+||+|++ +|+.||||++............|+..+.+++||||+++++++..++ .+++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 6799999999999999999987 5889999998765443334445666677889999999999997653 689999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--------CceecCCCCCceEecCCCCCCEEEeecCCCcc
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~ 168 (288)
||+++++|.+++... +++...+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++.
T Consensus 81 Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCcc
Confidence 999999999999764 689999999999999999999987 9999999999999988877 99999999875
Q ss_pred cccCCC-----CCCCcCCCcccCCccccCcc------cCCCccchhhHHHHHHHHHhCCCCCCCCCC----------c-h
Q 023058 169 SVLHSQ-----PKSTVGTPAYIAPEVLLKKE------YDGKIADVWSCGVTLYVMLVGAYPFEDPEE----------P-K 226 (288)
Q Consensus 169 ~~~~~~-----~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~~~~~l~~g~~pf~~~~~----------~-~ 226 (288)
...... .....||+.|+|||.+.+.. ++.+ +|||||||++|||++|..||..... . .
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k-~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHH-HHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChh-HhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 443322 22346999999999986542 3344 9999999999999999776643221 1 1
Q ss_pred hHHHHHHHHhhccc--CCCCC---CCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 227 NFRKTIHRILSVQY--SIPDY---VHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 227 ~~~~~~~~~~~~~~--~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
........+..... .+|.. ...++.+.+|+.+||+.||.+|||+.++++.+.
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 293 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 12223333322222 22221 123357899999999999999999999987553
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-51 Score=347.48 Aligned_cols=258 Identities=31% Similarity=0.548 Sum_probs=221.7
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc-------chHHHHHHHHHHhhCCCCceeeEeEEEEcCC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (288)
...++|++.+.||+|+||.||++.+..++..||+|++..... ..+.+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 88 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT 88 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence 345789999999999999999999999999999999976432 2467899999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCC--CCEEEeecCCCcc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKS 168 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~--~~~~l~df~~~~~ 168 (288)
.+++|||++++++|.+++...+.+++..+..++.||+.||.|||+.||+|+||||+||+++.++. ..++|+|||++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999999999999988888999999999999999999999999999999999999976652 2599999999987
Q ss_pred cccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC--CC
Q 023058 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YV 246 (288)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 246 (288)
...........+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+... ....+....+.++. +.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~~ll~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQE----TLANITAVSYDFDEEFFS 243 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHTTCCCCCHHHHT
T ss_pred cCCCCccccCCCCccEECchHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCCCCchhcc
Confidence 666555566779999999999988888766 999999999999999999998755433 33344444444432 24
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.+++.+.+||.+||..||.+|||+.++++ |+|+.
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~---hp~~~ 277 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALR---HPWIT 277 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHT---STTTS
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhc---CcCcC
Confidence 68999999999999999999999988877 55543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=348.44 Aligned_cols=272 Identities=26% Similarity=0.422 Sum_probs=221.5
Q ss_pred cCCCCCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhC-CCCceee
Q 023058 7 TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVR 81 (288)
Q Consensus 7 ~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~ 81 (288)
..............++|++++.||+|+||.||+|++..+++.||+|++.... ...+.+.+|..++.++ +||||++
T Consensus 38 ~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~ 117 (396)
T 4dc2_A 38 NTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117 (396)
T ss_dssp -----------CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCC
T ss_pred ccccccccccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCe
Confidence 3333334444556689999999999999999999999999999999998642 2334578899999877 8999999
Q ss_pred EeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEe
Q 023058 82 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (288)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~ 161 (288)
+++++.+++.+++||||+++++|...+...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++|+
T Consensus 118 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~ 195 (396)
T 4dc2_A 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLT 195 (396)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEEC
T ss_pred eEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEe
Confidence 99999999999999999999999999998889999999999999999999999999999999999999988877 9999
Q ss_pred ecCCCccc-ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCc-----hhHHHHHHHH
Q 023058 162 DFGYSKSS-VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----KNFRKTIHRI 235 (288)
Q Consensus 162 df~~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~-----~~~~~~~~~~ 235 (288)
|||++... ..........+|+.|+|||.+.+..++.. +|+||||+++|+|++|..||...... .........+
T Consensus 196 DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~-~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i 274 (396)
T 4dc2_A 196 DYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274 (396)
T ss_dssp CCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH
T ss_pred ecceeeecccCCCccccccCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH
Confidence 99999753 33344556679999999999998888776 99999999999999999999754321 1223344455
Q ss_pred hhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccc---cccccchhhhhh
Q 023058 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHF---HATGVYMHTKLQ 283 (288)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~---~~l~~~~~~~~~ 283 (288)
......+|. .+++++.+||.+||+.||.+||++. .+.+.+.|+|++
T Consensus 275 ~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~ 323 (396)
T 4dc2_A 275 LEKQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323 (396)
T ss_dssp HHCCCCCCT--TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred hccccCCCC--cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence 556666666 6899999999999999999999974 344566677765
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-50 Score=338.42 Aligned_cols=252 Identities=32% Similarity=0.556 Sum_probs=218.0
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
..++|++.+.||+|+||.||++++..+++.||+|++... ....+.+.+|+.+++.++||||+++++++...+.+++
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 357999999999999999999999999999999999753 3345678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc-CC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS 173 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~-~~ 173 (288)
||||+++++|...+...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++..... ..
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccCCC
Confidence 9999999999999988889999999999999999999999999999999999999988776 99999999875333 23
Q ss_pred CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
......+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+.. .....+......++. .+++++.
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~ 233 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILMEEIRFPR--TLSPEAK 233 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCT--TSCHHHH
T ss_pred cccccccChhhCChhhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCCC--CCCHHHH
Confidence 3445678999999999988888776 99999999999999999999865432 333344445555665 6899999
Q ss_pred HHHHHhcccCcCCcc-----ccccccccchhhhh
Q 023058 254 HLISRIFVADPAKVS-----MHFHATGVYMHTKL 282 (288)
Q Consensus 254 ~li~~~l~~~p~~Rp-----t~~~~l~~~~~~~~ 282 (288)
+||.+||+.||.+|| ++.++++ |+|+
T Consensus 234 ~li~~lL~~dP~~R~g~~~~~~~ei~~---h~~f 264 (337)
T 1o6l_A 234 SLLAGLLKKDPKQRLGGGPSDAKEVME---HRFF 264 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHT---SGGG
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHHc---CCCc
Confidence 999999999999999 6766655 5554
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=344.83 Aligned_cols=256 Identities=25% Similarity=0.445 Sum_probs=220.3
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
.++|++.+.||+|+||.||++.+..+++.+|+|.+.........+.+|+.+++.++||||+++++++.+.+..++|||++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 58999999999999999999999999999999999877666677889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCC
Q 023058 100 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (288)
Q Consensus 100 ~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~ 178 (288)
++++|.+.+.... .+++.+++.++.||+.||.|||+.|++|+||||+||+++.+..+.++|+|||++............
T Consensus 84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 163 (321)
T 1tki_A 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence 9999999997654 799999999999999999999999999999999999998744456999999999866554444455
Q ss_pred cCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC--CCCCCHHHHHHH
Q 023058 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLI 256 (288)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li 256 (288)
.+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||....... ....+......++. +..+++++.+||
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T 1tki_A 164 FTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQ----IIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp ESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred cCChhhcCcHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcCCCHHH----HHHHHHcCCCCCChhhhccCCHHHHHHH
Confidence 68999999999988777666 999999999999999999998765433 33333444443332 346899999999
Q ss_pred HHhcccCcCCccccccccccchhhhhh
Q 023058 257 SRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 257 ~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.+||+.||.+|||+.|+++ |+|++
T Consensus 239 ~~~L~~dp~~Rpt~~e~l~---hp~~~ 262 (321)
T 1tki_A 239 DRLLVKERKSRMTASEALQ---HPWLK 262 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHH---SHHHH
T ss_pred HHHcCCChhHCcCHHHHhc---Chhhc
Confidence 9999999999999988866 66664
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=342.58 Aligned_cols=252 Identities=43% Similarity=0.737 Sum_probs=217.8
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++||||+++++++..++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 48999999999999999999999999999999998753 23345788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|||+ +++|.+.+...+.+++.+++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++.........
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~~ 164 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFL 164 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBTT
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCccc
Confidence 9999 6799999888889999999999999999999999999999999999999987776 999999999876666666
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....+++.|+|||.+.+..+...++|+||||+++|+|++|..||.......... .+.......+. .+++++.+|
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----~i~~~~~~~p~--~~s~~~~~l 238 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----KVNSCVYVMPD--FLSPGAQSL 238 (336)
T ss_dssp CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----CCCSSCCCCCT--TSCHHHHHH
T ss_pred ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----HHHcCCCCCcc--cCCHHHHHH
Confidence 677899999999999888876666999999999999999999998654433221 11222333343 689999999
Q ss_pred HHHhcccCcCCccccccccccchhhhhh
Q 023058 256 ISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
|.+||+.||.+|||+.|+++ |+|+.
T Consensus 239 i~~~L~~dP~~Rpt~~eil~---hp~~~ 263 (336)
T 3h4j_B 239 IRRMIVADPMQRITIQEIRR---DPWFN 263 (336)
T ss_dssp HHTTSCSSGGGSCCHHHHTT---CHHHH
T ss_pred HHHHcCCChhHCcCHHHHHh---Chhhc
Confidence 99999999999999988876 55554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=332.90 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=217.9
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
.....++|++.+.||+|+||+||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++..++..++
T Consensus 15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 3445689999999999999999999999999999999987543 344568899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
||||+.+++|.+++... .+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++........
T Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTC
T ss_pred EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCccc
Confidence 99999999999998764 6899999999999999999999999999999999999987776 99999999875544333
Q ss_pred -CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
.....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+........ .............+++.+.
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 247 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFR 247 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHHCSCCCSCGGGSCHHHH
T ss_pred ccCCccCCcCccChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhCCCCCCCCccccCHHHH
Confidence 344568999999999988888776 99999999999999999999876543332222 2223333333447899999
Q ss_pred HHHHHhcccCcCCccccccccccchhhhhh
Q 023058 254 HLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+||.+||+.||.+|||+.++++ |+|++
T Consensus 248 ~li~~~l~~dp~~Rps~~ell~---h~~~~ 274 (297)
T 3fxz_A 248 DFLNRCLEMDVEKRGSAKELLQ---HQFLK 274 (297)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTT---CGGGG
T ss_pred HHHHHHccCChhHCcCHHHHhh---Chhhc
Confidence 9999999999999999988877 44443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=343.06 Aligned_cols=259 Identities=31% Similarity=0.504 Sum_probs=214.8
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCC
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 90 (288)
.....++|++.+.||+|+||.||+|++..+++.||+|++... ....+...+|..+++.+ +||||+++++++.+.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 334568999999999999999999999999999999999753 23445678899999988 7999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.+++||||+++++|..++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++....
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~ 175 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeecc
Confidence 99999999999999999998889999999999999999999999999999999999999988876 9999999987533
Q ss_pred cC-CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 171 LH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 171 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
.. .......+|+.|+|||.+.+..++.. +|+||||+++|+|++|..||...+.. .....+......++. .++
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~~ 248 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENED----DLFEAILNDEVVYPT--WLH 248 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTH-HHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCT--TSC
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCc-cCCCcchHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCCC--CCC
Confidence 32 33445679999999999988888776 99999999999999999999876543 344445556666665 689
Q ss_pred HHHHHHHHHhcccCcCCcccccc---ccccchhhhhh
Q 023058 250 PECRHLISRIFVADPAKVSMHFH---ATGVYMHTKLQ 283 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~---~l~~~~~~~~~ 283 (288)
+++.++|.+||+.||.+||++.+ +.+.+.|+|++
T Consensus 249 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~ 285 (353)
T 3txo_A 249 EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285 (353)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred HHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence 99999999999999999999922 12345566664
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=341.90 Aligned_cols=258 Identities=32% Similarity=0.566 Sum_probs=219.6
Q ss_pred CCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc-------chHHHHHHHHHHhhCCCCceeeEeEE
Q 023058 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEV 85 (288)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~ 85 (288)
.+......++|++.+.||+|+||.||++.+..++..||+|++..... ..+.+.+|+.++++++||||++++++
T Consensus 3 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 82 (326)
T 2y0a_A 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV 82 (326)
T ss_dssp CCBCSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 33444456789999999999999999999999999999999876432 34678899999999999999999999
Q ss_pred EEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC--CCCEEEeec
Q 023058 86 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDF 163 (288)
Q Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~--~~~~~l~df 163 (288)
+......++|||++++++|.+++...+.+++..++.++.||+.||.|||+.|++|+||||+||+++.++ ..+++|+||
T Consensus 83 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 83 YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999999999998888899999999999999999999999999999999999998765 224999999
Q ss_pred CCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC
Q 023058 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243 (288)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
|++.............+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||......... ..+......++
T Consensus 163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~~~~~~~~~~ 237 (326)
T 2y0a_A 163 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETL----ANVSAVNYEFE 237 (326)
T ss_dssp TTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHHTCCCCC
T ss_pred CCCeECCCCCccccccCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHH----HHHHhcCCCcC
Confidence 99987665555566679999999999988887766 99999999999999999999875443322 22333333332
Q ss_pred C--CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 244 D--YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 244 ~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
. ...+++.+.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 2367899999999999999999999988876
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=340.53 Aligned_cols=258 Identities=24% Similarity=0.429 Sum_probs=220.6
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
....++|++.+.||+|+||.||++++..+++.||+|++... ......+.+|+.+++.++||||+++++++.+.+.+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34568999999999999999999999999999999998753 23446788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
++||||+.+++|..++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeeccCC
Confidence 999999999999999998889999999999999999999999999999999999999988776 999999999876665
Q ss_pred CCCCCCcCCCcccCCccccC---cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 173 SQPKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
.......+|+.|+|||.+.+ ..++.. +|+||||+++|+|++|..||....... .......+......++. .++
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~-~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~p~--~~s 244 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHTFETTVVTYPS--AWS 244 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTT-HHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHHHHHHCCCCCCT--TSC
T ss_pred CceeccCCCccccCCeeeccCCCCCCCcc-ceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhhcccCCCC--cCC
Confidence 55667789999999999864 345555 999999999999999999998654432 33444444555555555 689
Q ss_pred HHHHHHHHHhcccCcCCccc-cccccccchhhhhh
Q 023058 250 PECRHLISRIFVADPAKVSM-HFHATGVYMHTKLQ 283 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt-~~~~l~~~~~~~~~ 283 (288)
+++.+||.+||+.||.+||+ +.++++ |+|+.
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~---hp~f~ 276 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQN---FPYMN 276 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHT---SGGGT
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHc---Chhhh
Confidence 99999999999999999999 444444 45543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=335.78 Aligned_cols=255 Identities=33% Similarity=0.520 Sum_probs=217.4
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCe
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTH 91 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 91 (288)
....++|++.+.||+|+||.||+|++..+++.||+|++... ....+....|..+++.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34568999999999999999999999999999999999764 33455678899998876 99999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
+++||||+++++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++.....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENML 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhccc
Confidence 9999999999999999988889999999999999999999999999999999999999988776 99999999875433
Q ss_pred C-CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 172 H-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 172 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
. .......+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+... ....+......++. .+++
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~ 243 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEE----LFHSIRMDNPFYPR--WLEK 243 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCH
T ss_pred CCCcccCCCCCcccCChhhhcCCCCCCh-hhhHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHHhCCCCCCc--ccCH
Confidence 2 33445678999999999988888766 999999999999999999998755433 33344445555555 6899
Q ss_pred HHHHHHHHhcccCcCCccccc-cccccchhhhhh
Q 023058 251 ECRHLISRIFVADPAKVSMHF-HATGVYMHTKLQ 283 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~-~~l~~~~~~~~~ 283 (288)
++.+||.+||+.||.+||++. ++++ |+|+.
T Consensus 244 ~~~~li~~lL~~dp~~R~~~~~~i~~---hp~f~ 274 (345)
T 1xjd_A 244 EAKDLLVKLFVREPEKRLGVRGDIRQ---HPLFR 274 (345)
T ss_dssp HHHHHHHHHSCSSGGGSBTTBSCGGG---SGGGT
T ss_pred HHHHHHHHHhcCCHhHcCCChHHHHc---Ccccc
Confidence 999999999999999999997 5544 55553
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=340.84 Aligned_cols=255 Identities=33% Similarity=0.566 Sum_probs=218.8
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++|++.+.||+|+||.||++.+..++..||+|++..... ..+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 689999999999999999999999999999999976532 33568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCC-CCEEEeecCCCcccccCCCCC
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~-~~~~l~df~~~~~~~~~~~~~ 176 (288)
++.+++|.+.+.....+++..+..++.||+.||.|||+.||+|+||||+||+++.++. ..++|+|||++..........
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~ 188 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccc
Confidence 9999999999988888999999999999999999999999999999999999976432 459999999998666555455
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC--CCCCCCHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRH 254 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 254 (288)
...+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+... ....+......++ .+..+++++.+
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~ 263 (362)
T 2bdw_A 189 GFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHR----LYAQIKAGAYDYPSPEWDTVTPEAKS 263 (362)
T ss_dssp CSCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred cCCCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhCCCCCCcccccCCCHHHHH
Confidence 6679999999999988888776 999999999999999999998755433 3333344444333 33468999999
Q ss_pred HHHHhcccCcCCccccccccccchhhhhh
Q 023058 255 LISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
||.+||+.||.+|||+.++++ |+|+.
T Consensus 264 li~~~L~~dP~~R~t~~e~l~---hp~~~ 289 (362)
T 2bdw_A 264 LIDSMLTVNPKKRITADQALK---VPWIC 289 (362)
T ss_dssp HHHHHSCSSGGGSCCHHHHTT---SHHHH
T ss_pred HHHHHcCCChhhCcCHHHHhc---CcccC
Confidence 999999999999999988876 55553
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=335.38 Aligned_cols=260 Identities=28% Similarity=0.459 Sum_probs=218.4
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 93 (288)
..++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|..+++++ +||||+++++++.+.+.++
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 4589999999999999999999999999999999998643 2334577899999888 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc-cC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LH 172 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~-~~ 172 (288)
+||||+++++|..++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++.... ..
T Consensus 87 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCTT
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCCC
Confidence 99999999999999988889999999999999999999999999999999999999987776 9999999987533 23
Q ss_pred CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCc-----hhHHHHHHHHhhcccCCCCCCC
Q 023058 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----KNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
.......+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...... .........+......++. .
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~ 241 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--S 241 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--T
T ss_pred CcccccCCCccccCccccCCCCCChH-HhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--C
Confidence 33455679999999999988888666 99999999999999999999753221 1223334444555556665 6
Q ss_pred CCHHHHHHHHHhcccCcCCccccc---cccccchhhhhh
Q 023058 248 ISPECRHLISRIFVADPAKVSMHF---HATGVYMHTKLQ 283 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~---~~l~~~~~~~~~ 283 (288)
+++++.++|.+||+.||.+||++. .+.+.+.|+|+.
T Consensus 242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~ 280 (345)
T 3a8x_A 242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280 (345)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence 899999999999999999999973 233455577664
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=330.83 Aligned_cols=251 Identities=31% Similarity=0.539 Sum_probs=217.3
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
..++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|..+++.++||||+++++++.+.+.+++
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 4589999999999999999999999999999999987642 344677889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++..... .
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~~--~ 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--V 159 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--C
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceecCC--c
Confidence 9999999999999998889999999999999999999999999999999999999987776 99999999875432 2
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
.....+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+... ....+......++. .+++++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~ 232 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMK----TYEKILNAELRFPP--FFNEDVKD 232 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHCCCCCCT--TSCHHHHH
T ss_pred cccccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCC--CCCHHHHH
Confidence 345678999999999988888776 999999999999999999998754433 33344455555655 68999999
Q ss_pred HHHHhcccCcCCcc-----ccccccccchhhhhh
Q 023058 255 LISRIFVADPAKVS-----MHFHATGVYMHTKLQ 283 (288)
Q Consensus 255 li~~~l~~~p~~Rp-----t~~~~l~~~~~~~~~ 283 (288)
+|.+||+.||.+|| ++.++++ |+|+.
T Consensus 233 li~~lL~~dp~~R~~~~~~~~~~i~~---hp~f~ 263 (318)
T 1fot_A 233 LLSRLITRDLSQRLGNLQNGTEDVKN---HPWFK 263 (318)
T ss_dssp HHHHHTCSCTTTCTTSSTTTTHHHHT---SGGGS
T ss_pred HHHHHhccCHHHcCCCcCCCHHHHhc---Ccccc
Confidence 99999999999999 6655554 66654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=346.21 Aligned_cols=257 Identities=33% Similarity=0.581 Sum_probs=216.9
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
..++|++.+.||+|+||+||++.+..++..+|+|++.... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3578999999999999999999999999999999987654 2335688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCC-CCCCEEEeecCCCcccccCCC
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~-~~~~~~l~df~~~~~~~~~~~ 174 (288)
||++.+++|.+.+...+.+++..+..++.||+.||.|||+.||+||||||+||+++.+ ..+.++|+|||++........
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 9999999999999988899999999999999999999999999999999999999853 234599999999975544332
Q ss_pred -CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCC--CCCCCCCHH
Q 023058 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPE 251 (288)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 251 (288)
.....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+..... ..+......+ +.+..++++
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyell~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~ 243 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLY----QQIKAGAYDFPSPEWDTVTPE 243 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCCCCCTTTTTTSCHH
T ss_pred eeecccCCcccCCHHHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCccHHHHH----HHHHhCCCCCCccccccCCHH
Confidence 244578999999999988888776 99999999999999999999876543333 3334444433 344578999
Q ss_pred HHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+.+||.+||+.||.+|||+.|+++ |+|+.
T Consensus 244 ~~~li~~~L~~dP~~Rpta~e~L~---hp~~~ 272 (444)
T 3soa_A 244 AKDLINKMLTINPSKRITAAEALK---HPWIS 272 (444)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHH---SCTTH
T ss_pred HHHHHHHHcCCChhHCCCHHHHhc---Ccccc
Confidence 999999999999999999988876 55543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=348.11 Aligned_cols=257 Identities=38% Similarity=0.659 Sum_probs=223.2
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
.....++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3445689999999999999999999999999999999997542 334678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
.++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++.....
T Consensus 91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSD 168 (476)
T ss_dssp EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhccc
Confidence 9999999999999999988888999999999999999999999999999999999999987776 99999999986655
Q ss_pred CCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
........+++.|+|||.+.+..+...++|+||||+++|+|++|..||......... ..+.......+. .++++
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~s~~ 242 (476)
T 2y94_A 169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF----KKICDGIFYTPQ--YLNPS 242 (476)
T ss_dssp TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH----HHHHTTCCCCCT--TCCHH
T ss_pred cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH----HHHhcCCcCCCc--cCCHH
Confidence 555556679999999999988877666699999999999999999999876543333 334444444444 68999
Q ss_pred HHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+.+||.+||+.||.+|||+.++++ |+|+.
T Consensus 243 ~~~Li~~~L~~dP~~Rpt~~eil~---hp~~~ 271 (476)
T 2y94_A 243 VISLLKHMLQVDPMKRATIKDIRE---HEWFK 271 (476)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHT---CHHHH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHh---CHHhh
Confidence 999999999999999999988876 55553
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=342.30 Aligned_cols=256 Identities=26% Similarity=0.463 Sum_probs=217.2
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
......++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++++++||||+++++++......+
T Consensus 45 ~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 45 KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp BCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred cCCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence 33444589999999999999999999999999999999987653 23456889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 94 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
+||||+.+++|.+.+.... .+++..++.++.||+.||.|||+.||+||||||+||+++.+..+.++|+|||++......
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999999999887554 699999999999999999999999999999999999998655556999999999866554
Q ss_pred CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC--CCCCCCH
Q 023058 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISP 250 (288)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 250 (288)
.......+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+..... ..+....+.++ ....+++
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~ 279 (387)
T 1kob_A 205 EIVKVTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETL----QNVKRCDWEFDEDAFSSVSP 279 (387)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHHCCCCCCSSTTTTSCH
T ss_pred cceeeeccCCCccCchhccCCCCCCc-ccEeeHhHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCCccccccCCH
Confidence 44445578999999999988877666 99999999999999999999876543333 23333333322 2346899
Q ss_pred HHHHHHHHhcccCcCCccccccccc
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++.+||.+||+.||.+|||+.++++
T Consensus 280 ~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 280 EAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhh
Confidence 9999999999999999999998877
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=333.42 Aligned_cols=252 Identities=29% Similarity=0.510 Sum_probs=218.4
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
...++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 117 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 45689999999999999999999999999999999987542 34467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
+||||+++++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceeccC--
Confidence 99999999999999988889999999999999999999999999999999999999988776 99999999875433
Q ss_pred CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
......+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+. ......+......++. .+++++.
T Consensus 194 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~~~~~~ 266 (350)
T 1rdq_E 194 RTWTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQP----IQIYEKIVSGKVRFPS--HFSSDLK 266 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TCCHHHH
T ss_pred CcccccCCccccCHHHhcCCCCCCc-CCEecccHhHhHHhhCCCCCCCCCH----HHHHHHHHcCCCCCCC--CCCHHHH
Confidence 2345578999999999988888766 9999999999999999999987543 3333444555556665 6899999
Q ss_pred HHHHHhcccCcCCccc-----cccccccchhhhhh
Q 023058 254 HLISRIFVADPAKVSM-----HFHATGVYMHTKLQ 283 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt-----~~~~l~~~~~~~~~ 283 (288)
++|.+||+.||.+||+ +.+++ .|+|+.
T Consensus 267 ~li~~lL~~dp~~R~~~~~~~~~ei~---~h~~f~ 298 (350)
T 1rdq_E 267 DLLRNLLQVDLTKRFGNLKNGVNDIK---NHKWFA 298 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHH---TSGGGT
T ss_pred HHHHHHhhcCHHhccCCccCCHHHHH---hCcCcC
Confidence 9999999999999999 55554 466654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=325.37 Aligned_cols=258 Identities=26% Similarity=0.441 Sum_probs=207.4
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++|++.+.||+|+||+||+|.+..+++.||+|++..... ....+.+|+.++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 689999999999999999999999999999999976432 33678899999999999999999999999999999999
Q ss_pred ccCCCchHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCC
Q 023058 98 YASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (288)
Q Consensus 98 ~~~~~~L~~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (288)
++++ ++...+ ...+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++. ++|+|||++...... ...
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSCC
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCccccc
Confidence 9977 555444 44678999999999999999999999999999999999999988776 999999999755433 233
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc--C------------
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--S------------ 241 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~------------ 241 (288)
....+++.|+|||.+.+....+.++|+||||+++|+|++|..||..................... .
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 45568999999999987764344499999999999999988886554433322222221111100 0
Q ss_pred ----------CCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 242 ----------IPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 242 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
......+++++++||.+||+.||.+|||+.|+++ |+|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~---hp~f~~ 288 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ---HPYFSD 288 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT---SGGGTT
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc---Cccccc
Confidence 0011247899999999999999999999988866 777654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=334.15 Aligned_cols=257 Identities=30% Similarity=0.484 Sum_probs=217.7
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (288)
...++|++.+.||+|+||.||++++..+++.||+|++... ....+.+.+|..++..+ +||||+++++++.+.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 4568999999999999999999999999999999998764 23446678899999888 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc-
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 171 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~- 171 (288)
++||||+++++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++.....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCcccccccC
Confidence 999999999999999988889999999999999999999999999999999999999988776 99999999875332
Q ss_pred CCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
........+++.|+|||.+.+..++.. +|+||||+++|+|++|..||...+.. .....+......++. .++++
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~ 247 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIMEHNVAYPK--SMSKE 247 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCT--TSCHH
T ss_pred CcccccccCCccccChhhhcCCCcCCc-ccccchHHHHHHHHcCCCCCCCCCHH----HHHHHHHhCCCCCCC--CCCHH
Confidence 233455679999999999988888766 99999999999999999999875443 333444555666665 78999
Q ss_pred HHHHHHHhcccCcCCccccc--cccccchhhhhh
Q 023058 252 CRHLISRIFVADPAKVSMHF--HATGVYMHTKLQ 283 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~--~~l~~~~~~~~~ 283 (288)
+.+||.+||+.||.+||++. .+.+.+.|+|+.
T Consensus 248 ~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~ 281 (353)
T 2i0e_A 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281 (353)
T ss_dssp HHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGT
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcccc
Confidence 99999999999999999652 223344466654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=323.41 Aligned_cols=257 Identities=33% Similarity=0.563 Sum_probs=220.0
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
..++|++.+.||+|+||.||++.+..++..||+|++..... ..+.+.+|+.++++++||||+++++++..++..+++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 46899999999999999999999999999999999876432 335678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCC-CCEEEeecCCCcccccCCC
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~-~~~~l~df~~~~~~~~~~~ 174 (288)
||++.+++|.+.+.....++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ..++|+|||++........
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999999999988888999999999999999999999999999999999999975543 3599999999976665555
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc--CCCCCCCCCHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPEC 252 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 252 (288)
.....+++.|+|||.+.+..++.+ +|+||||+++++|++|..||........... +..... ..+....+++++
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEA 238 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCCCTTTTTTSCHHH
T ss_pred ccCCCCCcCCcCchhhcCCCCCcc-cchHHHHHHHHHHHHCCCCCCCCchhHHHHH----HHhccccCCchhhcccCHHH
Confidence 556678999999999988888766 9999999999999999999987654333332 233333 333345789999
Q ss_pred HHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 253 RHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.++|.+||+.||.+|||+.++++ |+|+.
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~---h~~~~ 266 (284)
T 3kk8_A 239 KSLIDSMLTVNPKKRITADQALK---VPWIC 266 (284)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTT---SHHHH
T ss_pred HHHHHHHcccChhhCCCHHHHhc---Ccccc
Confidence 99999999999999999988877 55554
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=336.32 Aligned_cols=256 Identities=35% Similarity=0.575 Sum_probs=200.6
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ..+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 130 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence 467999999999999999999999999999999987643 3456788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC-CCCCCEEEeecCCCcccccCCCCCCC
Q 023058 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKST 178 (288)
Q Consensus 100 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~-~~~~~~~l~df~~~~~~~~~~~~~~~ 178 (288)
++++|.+.+...+.++..+++.++.|++.||.|||+.|++|+||||+||+++. +..+.++|+|||++............
T Consensus 131 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 210 (349)
T 2w4o_A 131 TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210 (349)
T ss_dssp CSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccc
Confidence 99999999988888999999999999999999999999999999999999975 22345999999998865554444556
Q ss_pred cCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCC--CCCCCCCHHHHHHH
Q 023058 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLI 256 (288)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li 256 (288)
.+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||........ ....+....... +.+..++.++.+||
T Consensus 211 ~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~li 286 (349)
T 2w4o_A 211 CGTPGYCAPEILRGCAYGPE-VDMWSVGIITYILLCGFEPFYDERGDQF---MFRRILNCEYYFISPWWDEVSLNAKDLV 286 (349)
T ss_dssp --CGGGSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCTTCHHH---HHHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred cCCCCccCHHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCcccHH---HHHHHHhCCCccCCchhhhCCHHHHHHH
Confidence 78999999999988887776 9999999999999999999986654332 222333333322 22357899999999
Q ss_pred HHhcccCcCCccccccccccchhhhhh
Q 023058 257 SRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 257 ~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.+||+.||.+|||+.++++ |+|+.
T Consensus 287 ~~~L~~dP~~Rpt~~e~l~---hp~~~ 310 (349)
T 2w4o_A 287 RKLIVLDPKKRLTTFQALQ---HPWVT 310 (349)
T ss_dssp HTTSCSSGGGSCCHHHHHH---STTTT
T ss_pred HHHccCChhhCcCHHHHhc---CcccC
Confidence 9999999999999988866 55543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=333.86 Aligned_cols=257 Identities=32% Similarity=0.530 Sum_probs=215.2
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
..++|++.+.||+|+||+||++.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++..++..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 3589999999999999999999999999999999987543 23356889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC---
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 173 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~--- 173 (288)
||+++++|.+++.....+++..++.++.||+.||+|||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRER 162 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEEC
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCccc
Confidence 99999999999988778999999999999999999999999999999999999987776 9999999997543222
Q ss_pred CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
......+++.|+|||.+.+..+...++|+||||+++|+|++|..||............ ........+....+++.+.
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 239 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPL 239 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH---HHTTCTTSTTGGGSCHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---HhcccccCCccccCCHHHH
Confidence 2235568999999999988777555699999999999999999999876554332222 2222333344456899999
Q ss_pred HHHHHhcccCcCCccccccccccchhhhhh
Q 023058 254 HLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+||.+||+.||.+|||+.|+++ |+|+.
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~---h~~~~ 266 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKK---DRWYN 266 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTT---CTTTT
T ss_pred HHHHHHccCChhhCcCHHHHhh---Chhhc
Confidence 9999999999999999988877 44443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=328.72 Aligned_cols=261 Identities=27% Similarity=0.415 Sum_probs=210.5
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
...++|++++.||+|+||+||++.+. +++.||+|++.... .....+.+|+.++++++||||+++++++..++..++
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34699999999999999999999996 48899999987543 223568899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-
Q 023058 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~- 172 (288)
|||++++ +|.+.+... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPV 173 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETTSCC
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecCCCc
Confidence 9999976 777777654 45999999999999999999999999999999999999988776 999999999765433
Q ss_pred CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-CCC--------
Q 023058 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIP-------- 243 (288)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~-------- 243 (288)
.......+++.|+|||.+.+......++|+||||+++|+|++|..||..................... .++
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence 22344568999999999877543344499999999999999999999987776666555443222111 000
Q ss_pred ---------------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 244 ---------------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 244 ---------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
....+++++.+||.+||+.||.+|||+.|+++ |+|++.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~---hp~f~~~ 307 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN---HPYFKDL 307 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT---SGGGTTS
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc---CcccccC
Confidence 01246789999999999999999999988866 7777643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=329.73 Aligned_cols=257 Identities=30% Similarity=0.391 Sum_probs=207.9
Q ss_pred CCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEE
Q 023058 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVI 86 (288)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (288)
|+.+.+....++|++.+.||+|+||.||++.+..++..||+|.+.... ...+.+.+|+.++++++||||+++++++
T Consensus 1 Gs~~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 1 GSHMIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp ---CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred CCcchhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 445556666799999999999999999999999999999999986543 2335688999999999999999999999
Q ss_pred EcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
..++..++||||+++++|.+++...++++...++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~ 158 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIA 158 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSS
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCc
Confidence 999999999999999999999998889999999999999999999999999999999999999987776 999999998
Q ss_pred cccccCCC--CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCC--
Q 023058 167 KSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI-- 242 (288)
Q Consensus 167 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 242 (288)
........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||............ +.......
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~~~~ 234 (294)
T 4eqm_A 159 KALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH---IQDSVPNVTT 234 (294)
T ss_dssp TTC-------------CCSSCCHHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH---HSSCCCCHHH
T ss_pred cccccccccccCccccCccccCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hhccCCCcch
Confidence 75543322 234568999999999988887766 99999999999999999999876543322222 12211111
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCccccccc
Q 023058 243 PDYVHISPECRHLISRIFVADPAKVSMHFHA 273 (288)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 273 (288)
.....+|+.+.++|.+||+.||.+||+..+.
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~ 265 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQE 265 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHH
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHH
Confidence 1123689999999999999999999955433
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=330.06 Aligned_cols=260 Identities=30% Similarity=0.486 Sum_probs=209.4
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEc---CCCcEEEEEEeecCc-----cchHHHHHHHHHHhhCCCCceeeEeEEE
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVI 86 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (288)
+.....++|++.+.||+|+||.||++++. .+++.||+|++.... .....+.+|+.++++++||||+++++++
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 34456789999999999999999999985 578999999987542 2345677899999999999999999999
Q ss_pred EcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
...+.+++||||+++++|.+.+...+.+++..+..++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~ 168 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLC 168 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCcc
Confidence 999999999999999999999988888999999999999999999999999999999999999987776 999999998
Q ss_pred cccccC-CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCC
Q 023058 167 KSSVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245 (288)
Q Consensus 167 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (288)
...... .......+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+... ....+......++.
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~p~- 242 (327)
T 3a62_A 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKK----TIDKILKCKLNLPP- 242 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHTCCCCCT-
T ss_pred cccccCCccccccCCCcCccCHhhCcCCCCCCc-ccchhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhCCCCCCC-
Confidence 754332 22345568999999999988877666 999999999999999999998755433 33344445555555
Q ss_pred CCCCHHHHHHHHHhcccCcCCccccc--cccccchhhhhh
Q 023058 246 VHISPECRHLISRIFVADPAKVSMHF--HATGVYMHTKLQ 283 (288)
Q Consensus 246 ~~~~~~l~~li~~~l~~~p~~Rpt~~--~~l~~~~~~~~~ 283 (288)
.+++++.++|.+||+.||.+||++. .+.+.+.|+|+.
T Consensus 243 -~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~ 281 (327)
T 3a62_A 243 -YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281 (327)
T ss_dssp -TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGS
T ss_pred -CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCccc
Confidence 6899999999999999999999554 334455677764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=322.77 Aligned_cols=256 Identities=33% Similarity=0.574 Sum_probs=218.5
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC-ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
..++|++.+.||+|+||.||++.+..++..+++|++... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 357899999999999999999999999999999998764 3445678999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEe---cCCCCCCEEEeecCCCcccccCCC
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv---~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
++++++|.+.+...+.++...++.++.|++.||.+||+.|++|+||+|+||++ +.++. ++|+|||++........
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~--~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP--LKLIDFGLAARFKPGKM 164 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCC--EEECCCTTCEECCTTSC
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCc--EEEEecccceeccCccc
Confidence 99999999999888889999999999999999999999999999999999999 44444 99999999987666665
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC--CCCCCHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPEC 252 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l 252 (288)
.....+++.|+|||.+.+. ++.+ +|+||||+++++|++|..||......... ..+.......+. ...+++.+
T Consensus 165 ~~~~~~t~~y~aPE~~~~~-~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEGL-YGPE-CDEWSAGVMMYVLLCGYPPFSAPTDSEVM----LKIREGTFTFPEKDWLNVSPQA 238 (277)
T ss_dssp BCCCCSCTTTCCHHHHTTC-BCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCHHHHTTSCHHH
T ss_pred hhccCCCCCccChHHhccc-CCch-hhehhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhCCCCCCchhhhcCCHHH
Confidence 6667799999999998654 6555 99999999999999999999876543332 233333433332 23678999
Q ss_pred HHHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 253 RHLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
.++|.+||+.||.+|||+.++++ |+|++..
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~---h~~~~~~ 268 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALE---HEWFEKQ 268 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTT---SHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHhc---CHHHhcc
Confidence 99999999999999999988866 6666543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=334.58 Aligned_cols=258 Identities=31% Similarity=0.505 Sum_probs=212.4
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc----chHHHHHHHHH-HhhCCCCceeeEeEEEEcCCe
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIIN-HRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~ 91 (288)
....++|++.+.||+|+||.||++++..+++.||+|++..... ....+.+|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 3456899999999999999999999999999999999976532 23345566665 467899999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc-
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV- 170 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~- 170 (288)
+++||||+++++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCcccccccc
Confidence 9999999999999999988888999999999999999999999999999999999999988776 9999999987533
Q ss_pred cCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
.........+|+.|+|||.+.+..++.. +|+||||+++|+|++|..||...+.. .....+......++. .+++
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~~~~~~~--~~~~ 264 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTA----EMYDNILNKPLQLKP--NITN 264 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSBHH----HHHHHHHHSCCCCCS--SSCH
T ss_pred CCCccccccCCccccCHHHhCCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHhcccCCCC--CCCH
Confidence 2334456679999999999988888776 99999999999999999999875443 333344444555554 6899
Q ss_pred HHHHHHHHhcccCcCCcccccccc-ccchhhhhh
Q 023058 251 ECRHLISRIFVADPAKVSMHFHAT-GVYMHTKLQ 283 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l-~~~~~~~~~ 283 (288)
++.+||.+||+.||.+||++.+.. +...|+|++
T Consensus 265 ~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~ 298 (373)
T 2r5t_A 265 SARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298 (373)
T ss_dssp HHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGT
T ss_pred HHHHHHHHHcccCHHhCCCCCCCHHHHhCCcccc
Confidence 999999999999999999996433 366677764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=321.56 Aligned_cols=259 Identities=38% Similarity=0.632 Sum_probs=211.1
Q ss_pred CCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcC
Q 023058 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (288)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (288)
.......++|++.+.||+|++|.||++.+..+++.|++|++.... ...+.+.+|+..+++++||||+++++++...
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 344455689999999999999999999999899999999987542 3345788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
+..++|||++++++|.+++...+.++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~ 161 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMM 161 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeeccccccc
Confidence 999999999999999999988888999999999999999999999999999999999999987776 999999998766
Q ss_pred ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
..........+++.|+|||.+.+..+...++|+||||+++++|++|..||..... ......+.......+. .++
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~--~~~ 235 (276)
T 2h6d_A 162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV----PTLFKKIRGGVFYIPE--YLN 235 (276)
T ss_dssp CC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSC
T ss_pred CCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHhhcCcccCch--hcC
Confidence 5544445567899999999998777655569999999999999999999976543 2233333444444444 689
Q ss_pred HHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
..+.++|.+||+.||.+|||+.++++ |+|+.
T Consensus 236 ~~l~~li~~~l~~~p~~Rps~~~~l~---h~~~~ 266 (276)
T 2h6d_A 236 RSVATLLMHMLQVDPLKRATIKDIRE---HEWFK 266 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH---SHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHh---Chhhc
Confidence 99999999999999999999988876 55554
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=324.89 Aligned_cols=255 Identities=34% Similarity=0.539 Sum_probs=209.5
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---------------------------chHHHHHHHHHH
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------------------------IDENVQREIINH 71 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------------------------~~~~~~~e~~~l 71 (288)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 35899999999999999999999999999999999875431 124688999999
Q ss_pred hhCCCCceeeEeEEEEc--CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceE
Q 023058 72 RSLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (288)
Q Consensus 72 ~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nil 149 (288)
++++||||+++++++.. .+..++|||++++++|.++. ....++...++.++.||+.||.|||+.|++|+||||+||+
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 99999999999999987 56899999999999987754 3457999999999999999999999999999999999999
Q ss_pred ecCCCCCCEEEeecCCCcccccCCC-CCCCcCCCcccCCccccCccc--CCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 023058 150 LDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (288)
Q Consensus 150 v~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~ 226 (288)
++.++. ++|+|||++........ .....+++.|+|||.+.+... ...++|+||||+++|+|++|..||.....
T Consensus 170 ~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-- 245 (298)
T 2zv2_A 170 VGEDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI-- 245 (298)
T ss_dssp ECTTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred ECCCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH--
Confidence 987776 99999999875543322 234568999999999876543 34458999999999999999999976543
Q ss_pred hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
......+......++....+++++.++|.+||+.||.+|||+.++++ |+|+.
T Consensus 246 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~---hp~~~ 297 (298)
T 2zv2_A 246 --MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL---HPWVT 297 (298)
T ss_dssp --HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT---CHHHH
T ss_pred --HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc---Ccccc
Confidence 22333344445555655678999999999999999999999988765 77764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=332.22 Aligned_cols=256 Identities=31% Similarity=0.546 Sum_probs=218.5
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc-------chHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
..++|++.+.||+|+||.||++.+..++..||+|++..... ..+.+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 35789999999999999999999999999999999876432 34678999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCC--CEEEeecCCCccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP--RLKICDFGYSKSS 169 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~--~~~l~df~~~~~~ 169 (288)
.++|||++++++|.+++.....++...++.++.|++.||.+||+.|++|+||+|+||+++.++.. +++|+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 99999999999999999888889999999999999999999999999999999999999876621 4999999999866
Q ss_pred ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC--CCC
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVH 247 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 247 (288)
..........+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||....... ....+......++. ...
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~ 244 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQE----TLANITSVSYDFDEEFFSH 244 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHTTCCCCCHHHHTT
T ss_pred CccccccccCCCCCccCcccccCCCCCCc-cccHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhcccccChhhhcc
Confidence 65555556678999999999988877666 999999999999999999998754432 22333333333331 136
Q ss_pred CCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
+++.+.++|.+||+.||.+|||+.++++ |+|+
T Consensus 245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~---hp~~ 276 (321)
T 2a2a_A 245 TSELAKDFIRKLLVKETRKRLTIQEALR---HPWI 276 (321)
T ss_dssp CCHHHHHHHHTTSCSSTTTSCCHHHHHH---STTT
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhc---Cccc
Confidence 8899999999999999999999988876 4554
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=345.67 Aligned_cols=271 Identities=33% Similarity=0.547 Sum_probs=221.5
Q ss_pred cccCCCCCCCCCCC--CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCce
Q 023058 5 AMTVGPGMDMPIMH--DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNI 79 (288)
Q Consensus 5 ~~~~~~~~~~~~~~--~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i 79 (288)
.+.+.||+.+.... ..++|++++.||+|+||+||+|++..++..||+|++... ......+.+|+.++++++||||
T Consensus 19 ~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni 98 (494)
T 3lij_A 19 DLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98 (494)
T ss_dssp GCCCCGGGGCCCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTB
T ss_pred eeccchhheeecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCC
Confidence 34555555443322 225799999999999999999999999999999998754 3345678899999999999999
Q ss_pred eeEeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-CCCE
Q 023058 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRL 158 (288)
Q Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~-~~~~ 158 (288)
+++++++.....+++||||+.+++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+||+++..+ ...+
T Consensus 99 v~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 178 (494)
T 3lij_A 99 MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALI 178 (494)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCE
T ss_pred CeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcE
Confidence 999999999999999999999999999998888999999999999999999999999999999999999997533 3459
Q ss_pred EEeecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 023058 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238 (288)
Q Consensus 159 ~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (288)
+|+|||++.............+++.|+|||.+. ..++.+ +||||||+++|+|++|..||......... ..+...
T Consensus 179 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~ 252 (494)
T 3lij_A 179 KIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEK-CDVWSIGVILFILLAGYPPFGGQTDQEIL----RKVEKG 252 (494)
T ss_dssp EECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHT
T ss_pred EEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCc-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhC
Confidence 999999998766655556677999999999885 456665 99999999999999999999876543333 333334
Q ss_pred ccC--CCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 239 QYS--IPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 239 ~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
... .+.+..+++.+.+||.+||+.||.+|||+.++++ |+|+..
T Consensus 253 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~---hp~~~~ 297 (494)
T 3lij_A 253 KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE---HPWIKE 297 (494)
T ss_dssp CCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT---CHHHHH
T ss_pred CCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc---Cccccc
Confidence 333 3334578999999999999999999999988876 666543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=347.89 Aligned_cols=270 Identities=34% Similarity=0.576 Sum_probs=222.5
Q ss_pred ccCCCCCCCCCC--CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--------------cchHHHHHHHH
Q 023058 6 MTVGPGMDMPIM--HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------------KIDENVQREII 69 (288)
Q Consensus 6 ~~~~~~~~~~~~--~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--------------~~~~~~~~e~~ 69 (288)
+++.||+..... ...++|++++.||+|+||+||+|.+..++..||+|++.... ...+.+.+|+.
T Consensus 19 ~~~~~~~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 98 (504)
T 3q5i_A 19 IAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98 (504)
T ss_dssp CCCCGGGGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHH
T ss_pred eeechhheeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHH
Confidence 344444443322 33589999999999999999999999999999999987543 33467889999
Q ss_pred HHhhCCCCceeeEeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceE
Q 023058 70 NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 149 (288)
Q Consensus 70 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nil 149 (288)
++++++||||+++++++.....+++||||+++++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+||+
T Consensus 99 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil 178 (504)
T 3q5i_A 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENIL 178 (504)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEE
Confidence 99999999999999999999999999999999999999988889999999999999999999999999999999999999
Q ss_pred ecCCCC-CCEEEeecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH
Q 023058 150 LDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 228 (288)
Q Consensus 150 v~~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~ 228 (288)
++.++. ..++|+|||++.............+++.|+|||.+.+ .++.+ +||||||+++|+|++|..||...+...
T Consensus 179 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~-- 254 (504)
T 3q5i_A 179 LENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEK-CDVWSCGVIMYILLCGYPPFGGQNDQD-- 254 (504)
T ss_dssp ESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred EecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 986653 3599999999987666555566779999999999864 56665 999999999999999999998765433
Q ss_pred HHHHHHHhhcccCCC--CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 229 RKTIHRILSVQYSIP--DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 229 ~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
....+......++ .+..+++++.+||.+||+.||.+|||+.++++ |+|++.
T Consensus 255 --~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~---h~~~~~ 307 (504)
T 3q5i_A 255 --IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN---SRWIKK 307 (504)
T ss_dssp --HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT---SHHHHH
T ss_pred --HHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc---CHhhhh
Confidence 3333344443332 23578999999999999999999999988876 566543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=326.59 Aligned_cols=260 Identities=24% Similarity=0.382 Sum_probs=197.0
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
..++|++++.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 4579999999999999999999999999999999987543 34467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 97 EYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 97 e~~~~~~L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
|++++ +|.+++... ..++...+..++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++....
T Consensus 83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFG 159 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETT
T ss_pred EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecC
Confidence 99975 898888653 35899999999999999999999999999999999999988776 9999999987554
Q ss_pred cC-CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc---------
Q 023058 171 LH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------- 240 (288)
Q Consensus 171 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 240 (288)
.. .......+++.|+|||.+.+......++|+||||+++|+|++|..||...+.................
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 33 22344568999999999876543344499999999999999999999876654444443332111000
Q ss_pred -----CC--------------CCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 241 -----SI--------------PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 241 -----~~--------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
.. .....+++++.+||.+||+.||.+|||+.++++ |+|+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~---hp~f~~ 299 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH---HPWFAE 299 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT---SGGGGG
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC---Chhhhc
Confidence 00 011257889999999999999999999988876 555543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=344.22 Aligned_cols=262 Identities=29% Similarity=0.410 Sum_probs=224.0
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
...++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++...+.++
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 34589999999999999999999999999999999997542 33467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 94 IVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
+||||+++++|...+... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++...
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~ 339 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVEL 339 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEEC
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeec
Confidence 999999999999988764 36999999999999999999999999999999999999988776 999999999865
Q ss_pred ccCCCC-CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCC
Q 023058 170 VLHSQP-KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 170 ~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
...... ....+|+.|+|||.+.+..++.. +|+||||+++|+|++|..||...............+......++. .+
T Consensus 340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~--~~ 416 (543)
T 3c4z_A 340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KF 416 (543)
T ss_dssp CTTCCCBCCCCSCTTTSCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT--TS
T ss_pred cCCCcccccccCCccccChhhhcCCCCChH-HhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc--cc
Confidence 444332 33479999999999988888776 999999999999999999998765544455555566666666665 78
Q ss_pred CHHHHHHHHHhcccCcCCcccccc--ccccchhhhhhh
Q 023058 249 SPECRHLISRIFVADPAKVSMHFH--ATGVYMHTKLQL 284 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~--~l~~~~~~~~~~ 284 (288)
++++.+||.+||+.||.+||++.+ +.+.+.|+|++-
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 999999999999999999998754 233566777653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=347.11 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=222.0
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
...++|++.+.||+|+||.||++++..+++.||+|++... ......+.+|+.++++++||||+++++++.+.+.++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4568899999999999999999999999999999998753 234456889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 94 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
+||||+++++|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++.....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~ 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPE 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceeccc
Confidence 9999999999999987654 3999999999999999999999999999999999999988776 99999999986655
Q ss_pred CCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
........+|+.|+|||.+.+..++.. +|+||||+++|+|++|..||...............+......++. .++++
T Consensus 339 ~~~~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~--~~s~~ 415 (576)
T 2acx_A 339 GQTIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE--RFSPQ 415 (576)
T ss_dssp TCCEECCCSCGGGCCHHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCT--TSCHH
T ss_pred CccccccCCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCc--cCCHH
Confidence 444455679999999999988888766 999999999999999999998766544445555555555555654 78999
Q ss_pred HHHHHHHhcccCcCCcc-----ccccccccchhhhhh
Q 023058 252 CRHLISRIFVADPAKVS-----MHFHATGVYMHTKLQ 283 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rp-----t~~~~l~~~~~~~~~ 283 (288)
+.+||.+||+.||.+|| ++.++++ |+|++
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~---HpfF~ 449 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREVKE---HPLFK 449 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHHHT---SGGGT
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHHHh---Chhhc
Confidence 99999999999999999 5555554 66654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=334.96 Aligned_cols=266 Identities=23% Similarity=0.388 Sum_probs=212.8
Q ss_pred CCCCCCCCCCCeeeeeeeecc--CceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEE
Q 023058 12 MDMPIMHDSDRYELVRDIGSG--NFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVI 86 (288)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~g--~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (288)
..-+.....++|++.+.||+| +||.||++++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++
T Consensus 16 ~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp --CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 344556678999999999999 99999999999999999999998653 2335677899999999999999999999
Q ss_pred EcCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecC
Q 023058 87 LTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (288)
Q Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~ 164 (288)
..++.+++|||++++++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++|+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~--~kl~dfg 173 (389)
T 3gni_B 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLR 173 (389)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCGG
T ss_pred EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccc
Confidence 9999999999999999999999775 67999999999999999999999999999999999999987776 9999999
Q ss_pred CCcccccC--------CCCCCCcCCCcccCCccccC--cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 023058 165 YSKSSVLH--------SQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (288)
Q Consensus 165 ~~~~~~~~--------~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (288)
.+...... .......+++.|+|||.+.+ ..++.+ +|||||||++|+|++|..||...............
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 252 (389)
T 3gni_B 174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252 (389)
T ss_dssp GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred cceeeccccccccccccccccccccccccCHHHHhccCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 87533221 22233468889999999987 456665 99999999999999999999876554443332211
Q ss_pred Hhhc----------------------------------------ccCCCCCCCCCHHHHHHHHHhcccCcCCcccccccc
Q 023058 235 ILSV----------------------------------------QYSIPDYVHISPECRHLISRIFVADPAKVSMHFHAT 274 (288)
Q Consensus 235 ~~~~----------------------------------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l 274 (288)
.... ....+....+++++.+||.+||+.||.+|||+.+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 1100 001112235789999999999999999999999887
Q ss_pred ccchhhhhh
Q 023058 275 GVYMHTKLQ 283 (288)
Q Consensus 275 ~~~~~~~~~ 283 (288)
+ |+|++
T Consensus 333 ~---hp~f~ 338 (389)
T 3gni_B 333 N---HSFFK 338 (389)
T ss_dssp T---SGGGG
T ss_pred c---CHHHH
Confidence 6 55544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=338.25 Aligned_cols=257 Identities=31% Similarity=0.450 Sum_probs=216.6
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
...++|++.+.||+|+||.||++++..+++.||+|++... ....+.+.+|..+++.++||||+++++++.+++.++
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 3468999999999999999999999999999999998752 233446889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
+||||+++++|.+++.. ..+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++.......
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCC
Confidence 99999999999998865 46899999999999999999999999999999999999988877 9999999997554432
Q ss_pred --CCCCCcCCCcccCCccccCcc----cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 174 --QPKSTVGTPAYIAPEVLLKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 174 --~~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
......+|+.|+|||++.+.. ++.+ +|+||||+++|+|++|..||...+.......+.... ....++....
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~ 299 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRE-CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--NSLTFPDDND 299 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCCTTCC
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCc-ceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc--ccccCCCccc
Confidence 234567999999999987654 4455 999999999999999999998765544444443221 1245565567
Q ss_pred CCHHHHHHHHHhcccCcCC--ccccccccccchhhhhh
Q 023058 248 ISPECRHLISRIFVADPAK--VSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~--Rpt~~~~l~~~~~~~~~ 283 (288)
+++++++||.+||+.+|.+ ||++.++++ |+|++
T Consensus 300 ~s~~~~~li~~lL~~~~~rlgR~~~~ei~~---Hp~f~ 334 (410)
T 3v8s_A 300 ISKEAKNLICAFLTDREVRLGRNGVEEIKR---HLFFK 334 (410)
T ss_dssp CCHHHHHHHHHHSSCGGGCTTSSCHHHHHT---SGGGC
T ss_pred ccHHHHHHHHHHccChhhhCCCCCHHHHhc---Ccccc
Confidence 9999999999999988988 999988876 55553
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=321.99 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=205.5
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++|++.+.||+|+||+||+|++ .+++.||+|++.... ...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 6899999999999999999999 578899999986543 233678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCC
Q 023058 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (288)
++++ +|.+.+... +.++...++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++...... ...
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCcccccc
Confidence 9976 888888764 57999999999999999999999999999999999999987776 999999998754332 223
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc--------------C
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------------S 241 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------~ 241 (288)
....+++.|+|||.+.+......++|+||||+++|+|++|..||..................... .
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 34568999999999876553344499999999999999999999876654444443332211100 0
Q ss_pred CC---------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 242 IP---------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 242 ~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+. ....+++++.+||.+||+.||.+|||+.++++ |+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~---hp~f~ 285 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE---HAYFK 285 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT---SGGGG
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc---Ccchh
Confidence 00 01357899999999999999999999988866 77765
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=319.48 Aligned_cols=253 Identities=32% Similarity=0.589 Sum_probs=214.7
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
..++|++.+.||+|+||.||++.+..++..||+|++.... .....+.+|+.++++++||||+++++++...+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4589999999999999999999999999999999986532 334568899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
|||++++++|.+.+.....++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... .
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~~-~ 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSS-R 163 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC-----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCCcc-c
Confidence 9999999999999988888999999999999999999999999999999999999987776 999999987543322 2
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
.....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||..... ......+......++. .+++++.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~--~~~~~~~~ 236 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTY----QETYKRISRVEFTFPD--FVTEGARD 236 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHHTCCCCCT--TSCHHHHH
T ss_pred ccccCCCCCccCHhHhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCcH----HHHHHHHHhCCCCCCC--cCCHHHHH
Confidence 344568999999999988777666 9999999999999999999986543 2333334444555555 68999999
Q ss_pred HHHHhcccCcCCccccccccccchhhhhhh
Q 023058 255 LISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
||.+||+.||.+|||+.++++ |+|+..
T Consensus 237 li~~~l~~~p~~Rps~~e~l~---h~~~~~ 263 (279)
T 3fdn_A 237 LISRLLKHNPSQRPMLREVLE---HPWITA 263 (279)
T ss_dssp HHHHHCCSSGGGSCCHHHHHH---CHHHHH
T ss_pred HHHHHhccChhhCCCHHHHhh---CccccC
Confidence 999999999999999988866 777654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=324.50 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=210.4
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc------cchHHHHHHHHHHhhC---CCCceeeEeEEEEcC
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSL---RHPNIVRFKEVILTP 89 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~------~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~ 89 (288)
..++|++.+.||+|+||+||++++..+++.||+|++.... .......+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4689999999999999999999999999999999987432 2234677788777776 499999999999875
Q ss_pred C-----eEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEee
Q 023058 90 T-----HLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (288)
Q Consensus 90 ~-----~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~d 162 (288)
. ..+++||++.+ +|.+++..... +++..++.++.||+.||+|||+.|++|+||||+||+++.++. ++|+|
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~D 163 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLAD 163 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECS
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEee
Confidence 4 58999999975 99999877654 999999999999999999999999999999999999987776 99999
Q ss_pred cCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-C
Q 023058 163 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-S 241 (288)
Q Consensus 163 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~ 241 (288)
||++.............+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||..................... .
T Consensus 164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (308)
T 3g33_A 164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242 (308)
T ss_dssp CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CccccccCCCcccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 999986665555566678999999999988888777 99999999999999999999877655554444333211110 1
Q ss_pred CCC--------------------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 242 IPD--------------------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 242 ~~~--------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
++. ...+++.+.+||.+||+.||.+|||+.++++ |+|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~---h~~~~~ 302 (308)
T 3g33_A 243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ---HSYLHK 302 (308)
T ss_dssp SCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT---STTC--
T ss_pred ccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc---CccccC
Confidence 110 1257899999999999999999999988866 666654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=350.16 Aligned_cols=258 Identities=36% Similarity=0.562 Sum_probs=218.9
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
...++|++.+.||+|+||.||++.+..+++.||+|++... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3457899999999999999999999999999999998754 344567899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCC-CCCCEEEeecCCCcccccC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~-~~~~~~l~df~~~~~~~~~ 172 (288)
+|||++.+++|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+||+++.. ..+.++|+|||++......
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999999999999888899999999999999999999999999999999999999532 2335999999998765554
Q ss_pred CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc--CCCCCCCCCH
Q 023058 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISP 250 (288)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 250 (288)
.......+++.|+|||.+.+ .++.+ +||||||+++|+|++|..||...+..... ..+..... ..+.+..+++
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 183 KKMKDKIGTAYYIAPEVLHG-TYDEK-CDVWSTGVILYILLSGCPPFNGANEYDIL----KKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp CSHHHHTTGGGTCCHHHHHT-CCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCSGGGGGSCH
T ss_pred cccccCCCCccccCceeecC-CCCCc-ceeHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHcCCCCCCCcccccCCH
Confidence 44445568999999999866 56555 99999999999999999999876543333 33334433 3344457899
Q ss_pred HHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
++++||.+||+.||.+|||+.++++ |+|++.
T Consensus 257 ~~~~li~~~L~~dp~~R~s~~e~l~---h~~~~~ 287 (484)
T 3nyv_A 257 SAKDLIRKMLTYVPSMRISARDALD---HEWIQT 287 (484)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHT---SHHHHH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhh---Chhhcc
Confidence 9999999999999999999988866 666654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=322.56 Aligned_cols=260 Identities=29% Similarity=0.480 Sum_probs=208.1
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
..+...++|++.+.||+|+||.||++.+..++..+|+|++.... ...+.+.+|++++++++||||+++++++...+..
T Consensus 16 ~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp ESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence 33445589999999999999999999999999999999987653 3447789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCC-CCCCEEEeecCCCc
Q 023058 93 AIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSK 167 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~-~~~~~~l~df~~~~ 167 (288)
++|||++++++|.+.+.. ...++...++.++.|++.||++||+.|++|+||+|+||+++.+ ..+.++|+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999999888754 3679999999999999999999999999999999999999542 23459999999998
Q ss_pred ccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC-CCC
Q 023058 168 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP-DYV 246 (288)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 246 (288)
............+++.|+|||.+. ..++.+ +|+||||+++|+|++|..||.......... .......... ...
T Consensus 176 ~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~-~Di~slG~il~~ll~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~ 249 (285)
T 3is5_A 176 LFKSDEHSTNAAGTALYMAPEVFK-RDVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ----KATYKEPNYAVECR 249 (285)
T ss_dssp C----------CTTGGGCCHHHHT-TCCCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCCC--C
T ss_pred ecCCcccCcCcccccCcCChHHhc-cCCCcc-cCeehHHHHHHHHHhCCCCCCCCCHHHHHh----hhccCCcccccccC
Confidence 665555556667899999999875 345444 999999999999999999998754322222 2222222222 223
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.+++++.+||.+||+.||.+|||+.|+++ |+|++
T Consensus 250 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~---hp~f~ 283 (285)
T 3is5_A 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLH---HEWFK 283 (285)
T ss_dssp CCCHHHHHHHHHHTCSCTTTSCCHHHHHT---SGGGG
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhc---CHHhh
Confidence 57899999999999999999999988866 66664
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=330.37 Aligned_cols=255 Identities=31% Similarity=0.554 Sum_probs=212.6
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc------cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
.++|++.+.||+|+||+||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++..++.++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 478999999999999999999999999999999986431 23567899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-CCCEEEeecCCCcc
Q 023058 94 IVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKS 168 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~-~~~~~l~df~~~~~ 168 (288)
+||||+++++|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++ ...++|+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998777542 3589999999999999999999999999999999999997543 24599999999976
Q ss_pred cccCCC-CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC--CC
Q 023058 169 SVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DY 245 (288)
Q Consensus 169 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~ 245 (288)
...... .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||.... ......+.......+ .+
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~-----~~~~~~i~~~~~~~~~~~~ 256 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTK-----ERLFEGIIKGKYKMNPRQW 256 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCSSH-----HHHHHHHHHTCCCCCHHHH
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCch-HhhHHHHHHHHHHHHCCCCCCCcH-----HHHHHHHHcCCCCCCcccc
Confidence 544332 344578999999999988888766 999999999999999999998642 223333333333332 12
Q ss_pred CCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 246 VHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 246 ~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
..+++++.+||.+||+.||.+|||+.++++ |+|++
T Consensus 257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~---hp~~~ 291 (351)
T 3c0i_A 257 SHISESAKDLVRRMLMLDPAERITVYEALN---HPWLK 291 (351)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT---SHHHH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhc---Chhhc
Confidence 468999999999999999999999988876 55554
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=330.69 Aligned_cols=256 Identities=32% Similarity=0.509 Sum_probs=215.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEEec
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ...+|++++.++ +||||+++++++.+++..++||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 4789999999999999999999999999999999976543 245788888877 799999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCC--CCEEEeecCCCcccccCC-CC
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLHS-QP 175 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~--~~~~l~df~~~~~~~~~~-~~ 175 (288)
+++++|.+.+...+.+++..+..++.||+.||.|||+.||+||||||+||++..+.. ..++|+|||++....... ..
T Consensus 98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 177 (342)
T 2qr7_A 98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177 (342)
T ss_dssp CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence 999999999988888999999999999999999999999999999999999854321 349999999997554332 23
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC--CCCCCHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECR 253 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~ 253 (288)
....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||..... .........+......++. +..+++++.
T Consensus 178 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 255 (342)
T 2qr7_A 178 MTPCYTANFVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTAK 255 (342)
T ss_dssp CCSSCCSSCCCHHHHHHHHHHHH-HHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHHCCCCCCSTTTTTSCHHHH
T ss_pred eccCCCccccCHHHhcCCCCCCc-cCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHccCCcccCccccccCCHHHH
Confidence 45678999999999987777666 9999999999999999999986433 2334444555555554442 356899999
Q ss_pred HHHHHhcccCcCCccccccccccchhhhhh
Q 023058 254 HLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+||.+||+.||.+|||+.++++ |+|+.
T Consensus 256 ~li~~~L~~dP~~R~t~~~il~---hp~~~ 282 (342)
T 2qr7_A 256 DLVSKMLHVDPHQRLTAALVLR---HPWIV 282 (342)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTT---SHHHH
T ss_pred HHHHHHCCCChhHCcCHHHHhc---CCeec
Confidence 9999999999999999988876 55553
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=345.63 Aligned_cols=258 Identities=36% Similarity=0.588 Sum_probs=217.7
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
...++|++.+.||+|+||+||++.+..+++.||+|++... ......+.+|+.++++++||||+++++++.....+++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 3458999999999999999999999999999999998643 3445678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-CCCEEEeecCCCcccccCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~-~~~~~l~df~~~~~~~~~~ 173 (288)
|||++.+++|.+.+...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+.++|+|||++.......
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 999999999999998888999999999999999999999999999999999999996432 3459999999998766655
Q ss_pred CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc--CCCCCCCCCHH
Q 023058 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPE 251 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 251 (288)
......+++.|+|||.+.+ .++.+ +||||||+++|+|++|..||.......... .+..... ..+.+..++++
T Consensus 179 ~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~ 252 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRG-TYDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILK----RVETGKYAFDLPQWRTISDD 252 (486)
T ss_dssp ---CCTTGGGGCCGGGGGS-CCCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCSCSGGGGGSCHH
T ss_pred ccCCCcCCCCCCCHHHhCC-CCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCCCcccCCCCHH
Confidence 5566779999999999875 46555 999999999999999999998765433333 3333333 33445578999
Q ss_pred HHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
+.+||.+||+.||.+|||+.++++ |+|++.
T Consensus 253 ~~~li~~~L~~dp~~R~t~~~~l~---hp~~~~ 282 (486)
T 3mwu_A 253 AKDLIRKMLTFHPSLRITATQCLE---HPWIQK 282 (486)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH---CHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHhc---CHhhcc
Confidence 999999999999999999988866 666654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=341.24 Aligned_cols=253 Identities=34% Similarity=0.554 Sum_probs=208.7
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
..++|++.+.||+|+||.||++.+..+++.||+|++... ......+.+|+.++++++||||+++++++...+.+++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 457899999999999999999999999999999998753 2334567789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCCCCEEEeecCCCccccc-C
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-H 172 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~-~ 172 (288)
||||+++++|...+...+.++...+..++.||+.||+|||+ .||+||||||+||+++.++. ++|+|||++..... .
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDG 303 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC--
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCCC
Confidence 99999999999999888899999999999999999999998 99999999999999988776 99999999875333 2
Q ss_pred CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
.......+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.. .....+......++. .+++++
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~~~~~ 376 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEEIRFPR--TLGPEA 376 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCT--TSCHHH
T ss_pred cccccccCCccccCHhhcCCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHHHhCCCCCCc--cCCHHH
Confidence 33455679999999999988888776 99999999999999999999875543 333344445555555 689999
Q ss_pred HHHHHHhcccCcCCcc-----ccccccccchhhhhh
Q 023058 253 RHLISRIFVADPAKVS-----MHFHATGVYMHTKLQ 283 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rp-----t~~~~l~~~~~~~~~ 283 (288)
.+||.+||+.||.+|| |+.++++ |+|+.
T Consensus 377 ~~li~~~L~~dP~~R~~~~~~t~~ell~---hp~f~ 409 (446)
T 4ejn_A 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQ---HRFFA 409 (446)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHT---SGGGT
T ss_pred HHHHHHHcccCHHHhCCCCCCCHHHHHh---Ccccc
Confidence 9999999999999999 8877766 55543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=321.78 Aligned_cols=257 Identities=33% Similarity=0.598 Sum_probs=213.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc-------chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3689999999999999999999999999999999876421 356789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC--CCCEEEeecCCCcccc
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSV 170 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~--~~~~~l~df~~~~~~~ 170 (288)
++|||++++++|.+++.....++...++.++.|++.||.+||+.|++|+||+|+||+++.++ ..+++|+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999998888899999999999999999999999999999999999998665 2259999999998665
Q ss_pred cCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC--CCCC
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 248 (288)
.........+++.|+|||.+.+..++.+ +|+||||+++++|++|..||......... ..+.......+. ...+
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 164 AGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQETL----TNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp --------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTTCCCCCHHHHTTC
T ss_pred CCCcccccCCCcCccCcceecCCCCCcc-hhhhhHHHHHHHHHHCCCCCCCcchHHHH----HHhHhcccCCcchhcccC
Confidence 5554555678999999999988777666 99999999999999999999875543222 222333332221 2367
Q ss_pred CHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
++.+.++|.+||+.||.+|||+.++++ |+|++.
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~---h~~~~~ 271 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLE---HSWIKA 271 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH---CHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHh---CHHHHH
Confidence 899999999999999999999988765 666654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=322.46 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=207.6
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc---hHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
.++|++.+.||+|+||.||++.+..+++.||+|++...... .+.+.+|+.++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 37899999999999999999999999999999998665432 345778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (288)
|++++++|..++...+.++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...... ...
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCccccc
Confidence 99999999988888888999999999999999999999999999999999999987776 999999998755432 223
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc---------------cc
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QY 240 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~ 240 (288)
....+++.|+|||.+.+......++|+||||+++|+|++|..||......+............ ..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 445688999999998764443444999999999999999999998766544433332221110 00
Q ss_pred CCCC----------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 241 SIPD----------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 241 ~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
..+. ...+++++.+||.+||+.||.+|||+.++++ |+|++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~---hp~f~~ 290 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH---HPYFEN 290 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT---SGGGTT
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc---ChHHHh
Confidence 1111 1357889999999999999999999988876 555543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=326.67 Aligned_cols=257 Identities=36% Similarity=0.570 Sum_probs=196.8
Q ss_pred CCeeee---eeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC-CCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELV---RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~---~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++. +.||+|+||.||++.+..+++.||+|++... ......+|+.+++++. ||||+++++++.++...++||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 567775 7899999999999999999999999998753 3467789999999997 999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-CCCEEEeecCCCcccccCCC-
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ- 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~-~~~~~l~df~~~~~~~~~~~- 174 (288)
|++++++|.+++...+.+++.+++.++.||+.||.|||+.|++||||||+||+++.++ ...++|+|||++........
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 9999999999999988999999999999999999999999999999999999997654 22499999999975443322
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCc---hhHHHHHHHHhhcccCCCC--CCCCC
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQYSIPD--YVHIS 249 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~~ 249 (288)
.....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...... .........+......++. +..++
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244 (325)
T ss_dssp ------------------CCCCHH-HHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred ccccCCCcCccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence 344567999999999988888766 99999999999999999999865432 2233444555555544432 23589
Q ss_pred HHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+++.+||.+||+.||.+|||+.++++ |+|++
T Consensus 245 ~~~~~li~~~L~~dP~~Rpt~~ell~---h~w~~ 275 (325)
T 3kn6_A 245 QEAKDLIQGLLTVDPNKRLKMSGLRY---NEWLQ 275 (325)
T ss_dssp HHHHHHHHHHHCCCTTTCCCTTTSTT---CGGGC
T ss_pred HHHHHHHHHHCCCChhHCCCHHHHhc---Chhhc
Confidence 99999999999999999999988765 66664
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=334.19 Aligned_cols=255 Identities=29% Similarity=0.490 Sum_probs=209.0
Q ss_pred CCeee--eeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYEL--VRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~--~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
+.|.+ .+.||+|+||.||++.+..++..||+|++.... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34544 678999999999999999999999999988654 345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
|+++++|.+.+... ..+++..++.++.||+.||.|||+.||+|+||||+||++..+..++++|+|||++..........
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 99999998888654 46999999999999999999999999999999999999964444469999999998766555555
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC--CCCCCCHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRH 254 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 254 (288)
...+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+........ ....+.++ ....+++++.+
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~~~~~~~ 321 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFP-TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI----LACRWDLEDEEFQDISEEAKE 321 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HHTCCCSCSGGGTTSCHHHHH
T ss_pred cccCCCcEeChhhccCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhccCCCChhhhccCCHHHHH
Confidence 6679999999999987777666 99999999999999999999876544333333 33333332 23468999999
Q ss_pred HHHHhcccCcCCccccccccccchhhhhh
Q 023058 255 LISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
||.+||+.||.+|||+.++++ |+|++
T Consensus 322 li~~~L~~dp~~Rps~~e~l~---hp~~~ 347 (373)
T 2x4f_A 322 FISKLLIKEKSWRISASEALK---HPWLS 347 (373)
T ss_dssp HHHTTSCSSGGGSCCHHHHHH---SHHHH
T ss_pred HHHHHcCCChhhCCCHHHHhc---CcCcC
Confidence 999999999999999988866 66654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=327.43 Aligned_cols=255 Identities=24% Similarity=0.368 Sum_probs=211.4
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC--eEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~ 93 (288)
...++|++.+.||+|+||+||++.+..+++.||+|++.... ...+.+.+|++++++++||||+++++++.... ..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 44689999999999999999999999999999999987543 33467789999999999999999999998765 789
Q ss_pred EEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEe----cCCCCCCEEEeecCCC
Q 023058 94 IVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL----DGSPAPRLKICDFGYS 166 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv----~~~~~~~~~l~df~~~ 166 (288)
+||||+++++|.+++..... ++...++.++.||+.||.|||+.|++|+||||+||++ +.++ .++|+|||++
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~Dfg~a 163 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAA 163 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE--EEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc--eEEEccCCCc
Confidence 99999999999999976543 9999999999999999999999999999999999998 4444 4999999999
Q ss_pred cccccCCCCCCCcCCCcccCCcccc--------CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 023058 167 KSSVLHSQPKSTVGTPAYIAPEVLL--------KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238 (288)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (288)
.............+++.|+|||.+. +..++.+ +||||||+++|+|++|..||...............+...
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTT-HHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 8766655555667899999999886 3555555 999999999999999999998766555545555444443
Q ss_pred cc-------------------CCCCC----CCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 239 QY-------------------SIPDY----VHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 239 ~~-------------------~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+ ..+.. ..+++.+.++|.+||+.||.+|||+.|+++
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~ 302 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence 32 11111 123467899999999999999999999876
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=334.15 Aligned_cols=262 Identities=32% Similarity=0.504 Sum_probs=205.4
Q ss_pred CCCCCCCCCeeee-eeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHH-hhCCCCceeeEeEEEEc---
Q 023058 14 MPIMHDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILT--- 88 (288)
Q Consensus 14 ~~~~~~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~--- 88 (288)
.......++|.+. +.||.|+||+||++.+..+++.||+|++... ....+|+.++ +..+||||+++++++..
T Consensus 54 ~~~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 54 IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cCCCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 3334445788887 7899999999999999999999999998642 4567888887 45589999999999875
Q ss_pred -CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-CCCEEEeecC
Q 023058 89 -PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFG 164 (288)
Q Consensus 89 -~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~-~~~~~l~df~ 164 (288)
...+++||||+++++|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||+++.+. .+.+||+|||
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecc
Confidence 567899999999999999997654 599999999999999999999999999999999999998632 3459999999
Q ss_pred CCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC-
Q 023058 165 YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP- 243 (288)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 243 (288)
++.............+++.|+|||++.+..++.. +||||||+++|+|++|..||...............+....+.++
T Consensus 210 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 210 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp TCEECC-----------CTTCCGGGSCCCCSSSH-HHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred cccccCCCCccccCCCCCCccCHhhcCCCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 9986655444556678999999999988888766 99999999999999999999876543322112222333333333
Q ss_pred -CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 244 -DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 244 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.+..+++++.+||.+||+.||.+|||+.++++ |+|+.
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~---hp~~~ 326 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN---HPWIM 326 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH---SHHHH
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc---Ccccc
Confidence 34578999999999999999999999988765 66654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=330.62 Aligned_cols=242 Identities=29% Similarity=0.438 Sum_probs=210.5
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---------chHHHHHHHHHHhhCCCCceeeEeEEEEcCC
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (288)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4789999999999999999999999999999999876532 2345778999999999999999999999999
Q ss_pred eEEEEEeccCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 91 HLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 91 ~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
..++|||++..+ +|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++. ++|+|||++...
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~ 180 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEEC
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceEC
Confidence 999999998666 99999998889999999999999999999999999999999999999987776 999999999866
Q ss_pred ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
..........+++.|+|||.+.+..+...++|+||||+++|+|++|..||..... ....... ....++
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~~~~--~~~~~~ 248 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAAIH--PPYLVS 248 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTTCCC--CSSCCC
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHhhccC--CCcccC
Confidence 5555555567899999999998888756559999999999999999999975321 1112222 233689
Q ss_pred HHHHHHHHHhcccCcCCccccccccc
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+++.+||.+||+.||.+|||+.++++
T Consensus 249 ~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 249 KELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999999999999999999988877
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=325.18 Aligned_cols=249 Identities=26% Similarity=0.396 Sum_probs=209.5
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC-ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
...++|++.+.||+|+||+||++.+..+++.||+|.+... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 4568999999999999999999999999999999988653 344567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
||+++++|.+++.. ...++..++..++.|++.||+|||+.|++|+||||+||+++.++. ++|+|||++.........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC-----
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceeccccccc
Confidence 99999999999987 567999999999999999999999999999999999999987776 999999998754333221
Q ss_pred ---------------CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchh-----HHHHHHHH
Q 023058 176 ---------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-----FRKTIHRI 235 (288)
Q Consensus 176 ---------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~-----~~~~~~~~ 235 (288)
....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||........ .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~- 242 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR- 242 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence 14468999999999988888776 9999999999999999999875432211 1111111
Q ss_pred hhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
..+ ..+|+.+.++|.+||+.||.+|||+.++++.+
T Consensus 243 -----~~~--~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L 277 (310)
T 3s95_A 243 -----YCP--PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277 (310)
T ss_dssp -----TCC--TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -----cCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 112 26889999999999999999999999998743
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=327.76 Aligned_cols=261 Identities=23% Similarity=0.385 Sum_probs=212.1
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC-----CCceeeEeEEEEcCC
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFKEVILTPT 90 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~ 90 (288)
+....++|++.+.||+|+||+||++++..+++.||+|++............|+.+++.+. ||||+++++++...+
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 334468999999999999999999999999999999999876666677888999999996 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCC---------------
Q 023058 91 HLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--------------- 153 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~--------------- 153 (288)
..++|||++ +++|.+++.... .++...++.++.||+.||.|||+.||+||||||+||+++.+
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 999999999 889999997654 59999999999999999999999999999999999999751
Q ss_pred --------CCCCEEEeecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 023058 154 --------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 225 (288)
Q Consensus 154 --------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~ 225 (288)
....++|+|||++.... .......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+..
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~ 265 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHM 265 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHHHHHCCCCCCCCcHH
Confidence 13359999999987433 23345678999999999998888777 99999999999999999999876543
Q ss_pred hhHHHHHHHHhhcc----------------------cCCCCC------------------CCCCHHHHHHHHHhcccCcC
Q 023058 226 KNFRKTIHRILSVQ----------------------YSIPDY------------------VHISPECRHLISRIFVADPA 265 (288)
Q Consensus 226 ~~~~~~~~~~~~~~----------------------~~~~~~------------------~~~~~~l~~li~~~l~~~p~ 265 (288)
.............. ..++.. ...++.+.+||.+||+.||.
T Consensus 266 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 345 (360)
T 3llt_A 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPT 345 (360)
T ss_dssp HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChh
Confidence 33332221110000 001110 01237788999999999999
Q ss_pred Cccccccccccchhhhhh
Q 023058 266 KVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 266 ~Rpt~~~~l~~~~~~~~~ 283 (288)
+|||+.|+++ |+|++
T Consensus 346 ~Rpta~elL~---hp~f~ 360 (360)
T 3llt_A 346 LRPSPAELLK---HKFLE 360 (360)
T ss_dssp GSCCHHHHTT---SGGGC
T ss_pred hCCCHHHHhc---CcccC
Confidence 9999988866 77764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=315.59 Aligned_cols=254 Identities=31% Similarity=0.582 Sum_probs=218.0
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
...++|++.+.||+|++|.||++.+..++..||+|++... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 3458999999999999999999999999999999998753 233467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
+|||++++++|.+.+...+.++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..... .
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~-~ 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPS-L 167 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSS-S
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCcc-c
Confidence 99999999999999988888999999999999999999999999999999999999987776 99999998864433 2
Q ss_pred CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
......+++.|+|||.+.+..++.. +|+||||+++|+|++|..||....... ....+......++. .+++++.
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~ 240 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTE----THRRIVNVDLKFPP--FLSDGSK 240 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTTCCCCCT--TSCHHHH
T ss_pred ccccccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCCHhH----HHHHHhccccCCCC--cCCHHHH
Confidence 2344568999999999988888776 999999999999999999998754332 22333444445554 6899999
Q ss_pred HHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 254 HLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
++|.+||+.||.+|||+.++++ |+|+..
T Consensus 241 ~li~~~l~~~p~~Rps~~~ll~---h~~~~~ 268 (284)
T 2vgo_A 241 DLISKLLRYHPPQRLPLKGVME---HPWVKA 268 (284)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHT---CHHHHH
T ss_pred HHHHHHhhcCHhhCCCHHHHhh---CHHHHh
Confidence 9999999999999999988866 666653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=322.10 Aligned_cols=254 Identities=34% Similarity=0.507 Sum_probs=217.6
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
...++|.+.+.||+|+||.||++.+..+++.|++|++.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34579999999999999999999999999999999987642 33456888999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
+|||++.+++|.+++.....++..+++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDG 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTT
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCc
Confidence 99999999999999988888999999999999999999999999999999999999987776 9999999987654332
Q ss_pred -CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
......+++.|+|||.+.+..++.. +|+||||+++|+|++|..||....... ....+......++. .+++.+
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~--~~~~~~ 268 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKE----TYLRIKKNEYSIPK--HINPVA 268 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHTCCCCCT--TSCHHH
T ss_pred ccccccCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHHHCcCCCCCCCHHH----HHHHHhcCCCCCCc--cCCHHH
Confidence 2344568999999999988777666 999999999999999999998654322 23333444445554 689999
Q ss_pred HHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 253 RHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.++|.+||+.||.+|||+.++++ |+|+.
T Consensus 269 ~~li~~~l~~dp~~Rps~~ell~---~~~~~ 296 (335)
T 2owb_A 269 ASLIQKMLQTDPTARPTINELLN---DEFFT 296 (335)
T ss_dssp HHHHHHHTCSSGGGSCCGGGGGG---SHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHhc---Ccccc
Confidence 99999999999999999988876 55543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=315.71 Aligned_cols=253 Identities=34% Similarity=0.509 Sum_probs=216.9
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
...++|.+.+.||+|+||.||++.+..+++.+++|++.... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45689999999999999999999999999999999987643 23456788999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
+|||++++++|.+++.....++..+++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTT
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCc
Confidence 99999999999999988888999999999999999999999999999999999999987776 9999999987554332
Q ss_pred -CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
......+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||....... ....+.......+. .+++.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~--~~~~~~ 242 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKE----TYLRIKKNEYSIPK--HINPVA 242 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTTCCCCCT--TSCHHH
T ss_pred cccccccCCCCcCCcchhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhhccCCCcc--ccCHHH
Confidence 2344568999999999988777666 999999999999999999998754322 22333444444444 689999
Q ss_pred HHHHHHhcccCcCCccccccccccchhhhh
Q 023058 253 RHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
.++|.+||+.||.+|||+.++++ |+|+
T Consensus 243 ~~li~~~l~~~p~~Rps~~~ll~---~~~~ 269 (294)
T 2rku_A 243 ASLIQKMLQTDPTARPTINELLN---DEFF 269 (294)
T ss_dssp HHHHHHHTCSSGGGSCCGGGGGG---SHHH
T ss_pred HHHHHHHcccChhhCcCHHHHhh---Chhe
Confidence 99999999999999999988877 4554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=336.30 Aligned_cols=258 Identities=24% Similarity=0.450 Sum_probs=215.1
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
...++|++.+.||+|+||+||++++..+++.||+|++... ....+.+.+|..++..++||||+++++++.+++.++
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 3458999999999999999999999999999999998753 222344889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
+||||+++++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+|||++......
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMED 228 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccC
Confidence 99999999999999987 568999999999999999999999999999999999999988876 999999999755443
Q ss_pred CC--CCCCcCCCcccCCcccc-----CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCC
Q 023058 173 SQ--PKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245 (288)
Q Consensus 173 ~~--~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (288)
.. .....||+.|+|||.+. ...++.+ +|+||||+++|+|++|..||...+.......+..... ...+|..
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~-~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~ 305 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--RFQFPTQ 305 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--HCCCCSS
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCc-CeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc--cccCCcc
Confidence 32 23457999999999986 4456565 9999999999999999999987665444444432211 2333432
Q ss_pred -CCCCHHHHHHHHHhcccCcCC--ccccccccccchhhhhh
Q 023058 246 -VHISPECRHLISRIFVADPAK--VSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 246 -~~~~~~l~~li~~~l~~~p~~--Rpt~~~~l~~~~~~~~~ 283 (288)
..+++++++||.+||+.+|.+ |+++.++++ |+|++
T Consensus 306 ~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~---Hpff~ 343 (437)
T 4aw2_A 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK---HPFFS 343 (437)
T ss_dssp CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT---SGGGT
T ss_pred cccCCHHHHHHHHHHhcccccccCCCCHHHHhC---CCccC
Confidence 358999999999999988888 999988766 66654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=320.68 Aligned_cols=253 Identities=27% Similarity=0.407 Sum_probs=203.4
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc---hHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
.....++|++.+.||+|+||+||++++ ++..||+|++...... .+.+.+|+.++++++||||+++++++......
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 345568999999999999999999987 5788999998765432 34678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhcC--ceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 93 AIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~LH~~~--i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
++||||+++++|.+++...+. ++...++.++.|++.||+|||+.| ++||||||+||+++.++. ++|+|||++.
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~ 187 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSR 187 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC---
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCCCc
Confidence 999999999999999977553 999999999999999999999999 999999999999987776 9999999987
Q ss_pred ccccCC-CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCC
Q 023058 168 SSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (288)
Q Consensus 168 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
...... ......+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+...... .+...........
T Consensus 188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~~----~~~~~~~~~~~~~ 262 (309)
T 3p86_A 188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVA----AVGFKCKRLEIPR 262 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHH----HHHHSCCCCCCCT
T ss_pred cccccccccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcCCCCCCCc
Confidence 443332 2344568999999999988888776 999999999999999999998765433222 2221222223333
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.+++.+.++|.+||+.||.+|||+.++++.+
T Consensus 263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L 293 (309)
T 3p86_A 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 7899999999999999999999999998744
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=322.37 Aligned_cols=255 Identities=34% Similarity=0.573 Sum_probs=212.1
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc-chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
...++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 345899999999999999999999999999999999986532 3456889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEe---cCCCCCCEEEeecCCCcccccCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv---~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
|++++++|.+.+...+.++...++.++.|++.||.+||+.|++|+||+|+||++ +.++ .++|+|||++..... .
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~-~ 162 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS--KIMITDFGLSKMEQN-G 162 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC--CEEBCSCSTTCCCCC-B
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC--CEEEccCCcceecCC-C
Confidence 999999999999888889999999999999999999999999999999999999 4444 499999998864332 2
Q ss_pred CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCC--CCCCCCCHH
Q 023058 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPE 251 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 251 (288)
......+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||......... ..+......+ +....++++
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~~~~ 237 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKPYSKA-VDCWSIGVITYILLCGYPPFYEETESKLF----EKIKEGYYEFESPFWDDISES 237 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCSCCHH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHHHCCCCCCTTTTTTSCHH
T ss_pred ccccccCCCCccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHcCCCCCCccccccCCHH
Confidence 2233458999999999988777666 99999999999999999999875543332 2333333322 223468999
Q ss_pred HHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+.++|.+||+.||.+|||+.++++ |+|++
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~---h~~~~ 266 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALS---HPWID 266 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHT---SHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHhc---Ccccc
Confidence 999999999999999999988876 55554
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=326.95 Aligned_cols=265 Identities=29% Similarity=0.394 Sum_probs=205.2
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---chHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
+.....++|++.+.||+|+||+||++.+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++..++.
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 344556899999999999999999999999999999999875432 23456789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC---CCCEEEeecCCCcc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKS 168 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~---~~~~~l~df~~~~~ 168 (288)
.++||||+++ +|.+++...+.++...++.++.||+.||.|||+.||+|+||||+||+++.++ ...++|+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999975 9999999888899999999999999999999999999999999999995322 23499999999875
Q ss_pred cccC-CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-CCC---
Q 023058 169 SVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIP--- 243 (288)
Q Consensus 169 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~--- 243 (288)
.... .......+++.|+|||.+.+......++||||||+++|+|++|..||..................... .++
T Consensus 187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 4332 22344567999999999987654344499999999999999999999876654444444332211100 000
Q ss_pred ----------C----------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 244 ----------D----------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 244 ----------~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
. ...+++++.+||.+||+.||.+|||+.|+++ |+|++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~---hp~f~ 323 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE---HPYFS 323 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT---SGGGS
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC---CcccC
Confidence 0 0116789999999999999999999988866 67665
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=333.46 Aligned_cols=271 Identities=29% Similarity=0.480 Sum_probs=214.4
Q ss_pred cccCCCCCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC------ccchHHHHHHHHHHhhCCCCc
Q 023058 5 AMTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHPN 78 (288)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~------~~~~~~~~~e~~~l~~l~~~~ 78 (288)
+-+..+|+.+. ...++|++.+.||+|+||+||++.+..++..||+|++... ....+.+.+|+.++++++|||
T Consensus 12 ~~~~~q~~~~~--~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn 89 (345)
T 3hko_A 12 ENLYFQGGSLL--ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89 (345)
T ss_dssp --CCCCCBCHH--HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTT
T ss_pred ccccccCchhh--hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCC
Confidence 33444444443 3358999999999999999999999999999999998653 344567889999999999999
Q ss_pred eeeEeEEEEcCCeEEEEEeccCCCchHHHHHh----------------------------------------cCCCCHHH
Q 023058 79 IVRFKEVILTPTHLAIVMEYASGGELFERICN----------------------------------------AGRFSEDE 118 (288)
Q Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----------------------------------------~~~~~~~~ 118 (288)
|+++++++...+..++||||+++++|.+++.. ...+++..
T Consensus 90 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (345)
T 3hko_A 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKL 169 (345)
T ss_dssp BCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHH
T ss_pred cceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHH
Confidence 99999999999999999999999999988742 11236778
Q ss_pred HHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-----CCCCcCCCcccCCccccC-
Q 023058 119 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLK- 192 (288)
Q Consensus 119 ~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~- 192 (288)
++.++.||+.||+|||+.|++|+||+|+||+++.++...++|+|||++........ .....+++.|+|||.+.+
T Consensus 170 ~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 249 (345)
T 3hko_A 170 ISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249 (345)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCS
T ss_pred HHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccC
Confidence 88999999999999999999999999999999877755699999999875433222 234568999999999865
Q ss_pred -cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccC--CCCCCCCCHHHHHHHHHhcccCcCCccc
Q 023058 193 -KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRIFVADPAKVSM 269 (288)
Q Consensus 193 -~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt 269 (288)
..++.+ +||||||+++|+|++|..||............ ...... .+....+++++.+||.+||+.||.+|||
T Consensus 250 ~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 250 NESYGPK-CDAWSAGVLLHLLLMGAVPFPGVNDADTISQV----LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp SSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred CCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHH----HhcccccCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 445555 99999999999999999999876654443333 223322 2233357899999999999999999999
Q ss_pred cccccccchhhhhhhh
Q 023058 270 HFHATGVYMHTKLQLL 285 (288)
Q Consensus 270 ~~~~l~~~~~~~~~~~ 285 (288)
+.++++ |+|++.+
T Consensus 325 ~~~~l~---hp~~~~~ 337 (345)
T 3hko_A 325 AMRALQ---HPWISQF 337 (345)
T ss_dssp HHHHHH---SHHHHTT
T ss_pred HHHHhc---ChhhccC
Confidence 988866 6666543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=320.41 Aligned_cols=262 Identities=29% Similarity=0.446 Sum_probs=211.2
Q ss_pred CCCCCeeee-eeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEE
Q 023058 18 HDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 18 ~~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 94 (288)
...++|++. +.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.+++++ +||||+++++++..++.+++
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 345889996 78999999999999999999999999997654 3456788999999885 79999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCC-CCEEEeecCCCcccccCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~-~~~~l~df~~~~~~~~~~ 173 (288)
|||++++++|.+++.....+++..++.++.||+.||.+||+.|++|+||||+||+++.++. ..++|+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 9999999999999988888999999999999999999999999999999999999986553 348999999987543221
Q ss_pred C--------CCCCcCCCcccCCccccC-----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCch-----------hHH
Q 023058 174 Q--------PKSTVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-----------NFR 229 (288)
Q Consensus 174 ~--------~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~-----------~~~ 229 (288)
. .....+++.|+|||.+.+ ..++.+ +||||||+++|+|++|..||......+ ...
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTT-HHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcc-cccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 1 123458999999999865 445555 999999999999999999998754321 112
Q ss_pred HHHHHHhhcccCCCC--CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 230 KTIHRILSVQYSIPD--YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 230 ~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.....+......++. ...+++++.+||.+||+.||.+|||+.++++ |+|++
T Consensus 248 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~---hp~~~ 300 (316)
T 2ac3_A 248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ---HPWVQ 300 (316)
T ss_dssp HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH---STTCC
T ss_pred HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc---Chhhc
Confidence 233344444444442 2368899999999999999999999988866 55554
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=316.13 Aligned_cols=248 Identities=29% Similarity=0.501 Sum_probs=191.0
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
..++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 4578999999999999999999999899999999987542 234678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
|||++++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPH 166 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC---
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCCC
Confidence 99999999999998765 57999999999999999999999999999999999999987776 9999999987554332
Q ss_pred -CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
......+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||.......... .+.......+ ..++.++
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~--~~~~~~~ 239 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----KVVLADYEMP--SFLSIEA 239 (278)
T ss_dssp -------------------------C-THHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCCCC--TTSCHHH
T ss_pred CcceeccCCCCcCCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCChhHHHHHH----HHhhcccCCc--cccCHHH
Confidence 2234568899999999988777666 999999999999999999998765433222 2222223333 3689999
Q ss_pred HHHHHHhcccCcCCccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.++|.+||+.||.+|||+.++++
T Consensus 240 ~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 240 KDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHcccCHhhCCCHHHHhc
Confidence 99999999999999999988877
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=333.94 Aligned_cols=268 Identities=27% Similarity=0.350 Sum_probs=207.3
Q ss_pred CCCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEE
Q 023058 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVI 86 (288)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (288)
.+|.+......++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+++.+|+.++++++||||+++++++
T Consensus 15 ~~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 94 (432)
T 3n9x_A 15 YFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLI 94 (432)
T ss_dssp CTTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred hhcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEE
Confidence 3566677777899999999999999999999999999999999997532 3346788999999999999999999999
Q ss_pred EcC-----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEe
Q 023058 87 LTP-----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (288)
Q Consensus 87 ~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~ 161 (288)
... ..+++|||++++ +|.+++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~ 171 (432)
T 3n9x_A 95 IPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVC 171 (432)
T ss_dssp CCSCTTTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEEC
T ss_pred ecCCCCcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEc
Confidence 776 579999999964 99999988888999999999999999999999999999999999999987776 9999
Q ss_pred ecCCCcccccCCC-----------------------CCCCcCCCcccCCccccCc-ccCCCccchhhHHHHHHHHHhCCC
Q 023058 162 DFGYSKSSVLHSQ-----------------------PKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAY 217 (288)
Q Consensus 162 df~~~~~~~~~~~-----------------------~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~ 217 (288)
|||++........ .....+|+.|+|||.+... .++.. +|+|||||++|+|++|..
T Consensus 172 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~-~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS-IDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTH-HHHHHHHHHHHHHHTTCT
T ss_pred cCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcc-cccchHHHHHHHHHhccc
Confidence 9999975543321 2445689999999986544 45544 999999999999998544
Q ss_pred CCC-----------CCCCc-----------------hhHHHH--------------------HHHHhhcccCCC-----C
Q 023058 218 PFE-----------DPEEP-----------------KNFRKT--------------------IHRILSVQYSIP-----D 244 (288)
Q Consensus 218 pf~-----------~~~~~-----------------~~~~~~--------------------~~~~~~~~~~~~-----~ 244 (288)
||. +.... +....+ ...+.......+ .
T Consensus 251 p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (432)
T 3n9x_A 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK 330 (432)
T ss_dssp TTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHH
T ss_pred ccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHH
Confidence 443 22100 000000 000000000001 0
Q ss_pred CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 245 YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 245 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
...+++++.+||.+||+.||.+|||+.|+++ |+|++.
T Consensus 331 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~---Hp~f~~ 367 (432)
T 3n9x_A 331 YPSISDDGINLLESMLKFNPNKRITIDQALD---HPYLKD 367 (432)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHT---CGGGTT
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc---Chhhhh
Confidence 1357999999999999999999999988877 555543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=331.87 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=211.3
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
...++|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|..++..++||||+++++++.+.+.++
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 34689999999999999999999999999999999997532 23345789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 94 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+||+++.++. +||+|||++......
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRAD 215 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCC
Confidence 999999999999999775 47999999999999999999999999999999999999988776 999999999765443
Q ss_pred CC--CCCCcCCCcccCCccccC-------cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC
Q 023058 173 SQ--PKSTVGTPAYIAPEVLLK-------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243 (288)
Q Consensus 173 ~~--~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
.. .....+|+.|+|||.+.. ..++.+ +|+||||+++|+|++|..||...+.......+.... ....++
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p 292 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE-CDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK--EHLSLP 292 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCC
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChH-HhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCcCCC
Confidence 32 234579999999999873 455555 999999999999999999998765544444333221 112233
Q ss_pred C-CCCCCHHHHHHHHHhcccCcCCcc---ccccccccchhhhhh
Q 023058 244 D-YVHISPECRHLISRIFVADPAKVS---MHFHATGVYMHTKLQ 283 (288)
Q Consensus 244 ~-~~~~~~~l~~li~~~l~~~p~~Rp---t~~~~l~~~~~~~~~ 283 (288)
. ...+|+++++||.+||+ +|.+|+ ++.+++ .|+|+.
T Consensus 293 ~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~---~Hpff~ 332 (412)
T 2vd5_A 293 LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFR---THPFFF 332 (412)
T ss_dssp ----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHH---TSGGGT
T ss_pred ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh---cCCCcC
Confidence 2 23689999999999998 999985 666554 466664
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=340.51 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=202.4
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcC------C
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 90 (288)
.++|++++.||+|+||+||+|.+..+++.||+|++... ....+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 48899999999999999999999999999999999753 33446788999999999999999999999754 3
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.+++||||+++ +|.+.+.. .++...+..++.||+.||+|||+.||+||||||+||+++.++. +||+|||++....
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 215 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC----
T ss_pred eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecC
Confidence 67999999976 56665533 5899999999999999999999999999999999999988776 9999999998766
Q ss_pred cCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc-----------
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ----------- 239 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 239 (288)
.........+++.|+|||.+.+..++.+ +|||||||++|+|++|..||.+.+..+....+........
T Consensus 216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 216 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp -CCCC----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred CCcccCCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 5555566779999999999998888776 9999999999999999999987665444444333211100
Q ss_pred ----cCCCCCCC---------------------CCHHHHHHHHHhcccCcCCccccccccc-cchhhh
Q 023058 240 ----YSIPDYVH---------------------ISPECRHLISRIFVADPAKVSMHFHATG-VYMHTK 281 (288)
Q Consensus 240 ----~~~~~~~~---------------------~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~~~ 281 (288)
...+.... .++++.+||.+||+.||.+|||+.|+++ +|+..|
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 00000000 1467999999999999999999999887 444433
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=315.52 Aligned_cols=256 Identities=32% Similarity=0.538 Sum_probs=215.0
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
.++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 378999999999999999999999999999999987543 334678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC---C
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---Q 174 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~---~ 174 (288)
++++++|.+++.....++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... .
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchhc
Confidence 9999999999887778999999999999999999999999999999999999987776 9999999987543221 2
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
.....+++.|+|||.+.+..+...++|+||||+++|+|++|..||............ ........+....+++.+.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 240 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLA 240 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH---HHTTCTTSTTGGGSCHHHHH
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---hhhcccccCchhhcCHHHHH
Confidence 334568899999999988776555599999999999999999999876543322221 12222233334468999999
Q ss_pred HHHHhcccCcCCccccccccccchhhhhh
Q 023058 255 LISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+|.+||+.||.+|||+.++++ |+|++
T Consensus 241 li~~~l~~~p~~Rps~~~il~---~~~~~ 266 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIKK---DRWYN 266 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT---CTTTT
T ss_pred HHHHHCCCCchhCCCHHHHhc---Ccccc
Confidence 999999999999999988877 45543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=326.59 Aligned_cols=256 Identities=24% Similarity=0.344 Sum_probs=205.0
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc----chHHHHHHHHHHhhCCCCceeeEeEEEEcCC----
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPT---- 90 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 90 (288)
..++|++.+.||+|+||.||++++..+++.||+|++..... ....+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 45899999999999999999999999999999999976432 2346789999999999999999999987654
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
..++||||+++++|.+++...+.++..+++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++....
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC----
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCccccc
Confidence 35999999999999999988889999999999999999999999999999999999999988776 9999999987544
Q ss_pred cCCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCC--CC
Q 023058 171 LHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PD 244 (288)
Q Consensus 171 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~ 244 (288)
.... .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||............. ...... ..
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~----~~~~~~~~~~ 242 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----REDPIPPSAR 242 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----HCCCCCHHHH
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh----cCCCCCcccc
Confidence 3322 223458999999999988877766 999999999999999999998755433322222 211111 11
Q ss_pred CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 245 YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 245 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
...+++++.++|.+||+.||.+||++.+++. ++|++.
T Consensus 243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~---~~l~~~ 279 (311)
T 3ork_A 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMR---ADLVRV 279 (311)
T ss_dssp STTCCHHHHHHHHHHTCSSGGGSCSSHHHHH---HHHHHH
T ss_pred cCCCCHHHHHHHHHHHhcCHhhChhhHHHHH---HHHHHH
Confidence 2368999999999999999999999976654 555543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=320.57 Aligned_cols=263 Identities=26% Similarity=0.424 Sum_probs=211.0
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc---hHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
....++|++.+.||+|+||.||++.+..+++.||+|++...... .+.+.+|+.++++++||||+++++++...+..+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 34568999999999999999999999999999999998654332 345778999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~- 172 (288)
+|||++++++|..+....+.++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++......
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCTTC-------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc--EEEEeCCCceeecCCc
Confidence 99999999888888877788999999999999999999999999999999999999987776 999999998754433
Q ss_pred CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc--------------
Q 023058 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------------- 238 (288)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------- 238 (288)
.......+++.|+|||.+.+......++|+||||+++|+|++|..||...................
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 223455689999999999776443444999999999999999999998776544443333211100
Q ss_pred -ccCCCC----------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 239 -QYSIPD----------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 239 -~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
....+. ...+++.+.+||.+||+.||.+|||+.|+++ |+|++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~---hp~f~~ 312 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH---HDFFQM 312 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG---SHHHHG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc---Cchhcc
Confidence 001111 1257899999999999999999999988866 666653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=328.88 Aligned_cols=257 Identities=23% Similarity=0.416 Sum_probs=206.2
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEc---------
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--------- 88 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--------- 88 (288)
...++|++.+.||+|+||+||+|.+..+++.||+|++..+.. ...+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 346899999999999999999999999999999999876543 23479999999999999999999844
Q ss_pred -----------------------------CCeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhh
Q 023058 89 -----------------------------PTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHS 135 (288)
Q Consensus 89 -----------------------------~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~ 135 (288)
...+++||||+++ +|.+.+. ....++...++.++.||+.||.|||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3348999999975 7665553 45679999999999999999999999
Q ss_pred cCceecCCCCCceEec-CCCCCCEEEeecCCCcccccCCCCCCCcCCCcccCCccccCcc-cCCCccchhhHHHHHHHHH
Q 023058 136 MQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVML 213 (288)
Q Consensus 136 ~~i~H~dl~p~nilv~-~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~~~~l~ 213 (288)
.||+||||||+||+++ .++. ++|+|||++.............+++.|+|||.+.+.. ++.+ +|+||+|+++|+|+
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~ell 236 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNT--LKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPS-IDLWSIGCVFGELI 236 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTE--EEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTH-HHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCc--EEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcc-hhhhhHHHHHHHHH
Confidence 9999999999999997 3454 9999999998766666666778899999999987765 5554 99999999999999
Q ss_pred hCCCCCCCCCCchhHHHHHHHHhhc-------------ccCCCC----------CCCCCHHHHHHHHHhcccCcCCcccc
Q 023058 214 VGAYPFEDPEEPKNFRKTIHRILSV-------------QYSIPD----------YVHISPECRHLISRIFVADPAKVSMH 270 (288)
Q Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~-------------~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~ 270 (288)
+|..||......+............ ...++. ...+++++.+||.+||+.||.+|||+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 9999998876555444443221110 001111 12578999999999999999999999
Q ss_pred ccccccchhhhhhh
Q 023058 271 FHATGVYMHTKLQL 284 (288)
Q Consensus 271 ~~~l~~~~~~~~~~ 284 (288)
.|+++ |+|++.
T Consensus 317 ~e~l~---hp~f~~ 327 (383)
T 3eb0_A 317 YEAMA---HPFFDH 327 (383)
T ss_dssp HHHHT---SGGGHH
T ss_pred HHHhc---CHHHHH
Confidence 88877 555544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=316.92 Aligned_cols=257 Identities=31% Similarity=0.485 Sum_probs=215.2
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----------cchHHHHHHHHHHhhCC-CCceeeEeEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----------KIDENVQREIINHRSLR-HPNIVRFKEV 85 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----------~~~~~~~~e~~~l~~l~-~~~i~~~~~~ 85 (288)
....++|++.+.||+|++|.||++.+..+++.||+|++.... ...+.+.+|+.+++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 345699999999999999999999999999999999987643 12345778999999995 9999999999
Q ss_pred EEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCC
Q 023058 86 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (288)
Q Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~ 165 (288)
+...+..++|||++++++|.+++.....++...++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~ 170 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGF 170 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTT
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccc
Confidence 9999999999999999999999988888999999999999999999999999999999999999987776 99999999
Q ss_pred CcccccCCCCCCCcCCCcccCCcccc------CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc
Q 023058 166 SKSSVLHSQPKSTVGTPAYIAPEVLL------KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239 (288)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (288)
+.............+++.|+|||.+. ...++.+ +|+||||+++++|++|..||......... ..+....
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~ 245 (298)
T 1phk_A 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE-VDMWSTGVIMYTLLAGSPPFWHRKQMLML----RMIMSGN 245 (298)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTC
T ss_pred hhhcCCCcccccccCCccccCHHHhccccccccccCCcc-cccHhHHHHHHHHHHCCCCCcCccHHHHH----HHHhcCC
Confidence 98666555555667899999999885 2344444 99999999999999999999875443322 2233333
Q ss_pred cCC--CCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 240 YSI--PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 240 ~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
... +....+++.+.++|.+||+.||.+|||+.++++ |+|++
T Consensus 246 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~---h~~~~ 288 (298)
T 1phk_A 246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA---HPFFQ 288 (298)
T ss_dssp CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT---SGGGC
T ss_pred cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh---ChHhh
Confidence 332 333468999999999999999999999988876 55544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=318.33 Aligned_cols=246 Identities=26% Similarity=0.455 Sum_probs=209.1
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEeccC
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 100 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (288)
.|...+.||+|+||.||+|.+..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 125 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ 125 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence 4888899999999999999999899999999987654 334668899999999999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CCCCCc
Q 023058 101 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV 179 (288)
Q Consensus 101 ~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~~~~~ 179 (288)
+++|.+++.. ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....... ......
T Consensus 126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~ 202 (321)
T 2c30_A 126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLV 202 (321)
T ss_dssp SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCC
T ss_pred CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCcccccccc
Confidence 9999998754 46999999999999999999999999999999999999987776 9999999987554432 234456
Q ss_pred CCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc-cCCCCCCCCCHHHHHHHHH
Q 023058 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHISPECRHLISR 258 (288)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~ 258 (288)
+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||........... +.... ........+++.+.++|.+
T Consensus 203 gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~ 277 (321)
T 2c30_A 203 GTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR----LRDSPPPKLKNSHKVSPVLRDFLER 277 (321)
T ss_dssp SCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSSCCCCTTGGGSCHHHHHHHHH
T ss_pred CCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HhcCCCCCcCccccCCHHHHHHHHH
Confidence 8999999999988888776 9999999999999999999986544332222 22222 2233334678999999999
Q ss_pred hcccCcCCccccccccc
Q 023058 259 IFVADPAKVSMHFHATG 275 (288)
Q Consensus 259 ~l~~~p~~Rpt~~~~l~ 275 (288)
||+.||.+|||+.++++
T Consensus 278 ~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 278 MLVRDPQERATAQELLD 294 (321)
T ss_dssp HSCSSTTTSCCHHHHHT
T ss_pred HccCChhhCcCHHHHhc
Confidence 99999999999998877
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=314.60 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=213.2
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
....++|++.+.||+|+||.||++.+. ++..||+|++.......+.+.+|+.++++++||||+++++++..++..++||
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 456789999999999999999999987 4778999999987777788999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC--
Q 023058 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (288)
Q Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-- 173 (288)
|++++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHHH
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEeccccccccccccccc
Confidence 999999999999654 46899999999999999999999999999999999999987776 9999999987543322
Q ss_pred CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
......+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||.......... .+... .........++.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~ 236 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTG-FRLYKPRLASTHV 236 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHTT-CCCCCCTTSCHHH
T ss_pred cccCcccccccCCHHHhcCCCCCch-hhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH----HHhcC-ccCCCCCcCCHHH
Confidence 2233446778999999987777666 999999999999999 999998755433222 22222 2222333679999
Q ss_pred HHHHHHhcccCcCCccccccccccch
Q 023058 253 RHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.++|.+||+.||.+|||+.++++.+.
T Consensus 237 ~~li~~~l~~~p~~Rps~~~ll~~l~ 262 (269)
T 4hcu_A 237 YQIMNHCWRERPEDRPAFSRLLRQLA 262 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHccCCcccCcCHHHHHHHHH
Confidence 99999999999999999999887443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=324.35 Aligned_cols=257 Identities=23% Similarity=0.337 Sum_probs=210.7
Q ss_pred CCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCc---EEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEc
Q 023058 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT 88 (288)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (288)
+......++|++.+.||+|+||.||++.+..++. .||+|++... ....+.+.+|+.++++++||||+++++++..
T Consensus 42 ~~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp -CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred hccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 4445567899999999999999999999975554 5999998764 2334568899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 89 PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
++..++||||+++++|.+++... ..++..+++.++.|++.||.+||+.||+||||||+||+++.++. ++|+|||++.
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~ 199 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSR 199 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCE
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCccc
Confidence 99999999999999999999654 57999999999999999999999999999999999999987776 9999999997
Q ss_pred ccccCCCC----CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCC
Q 023058 168 SSVLHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSI 242 (288)
Q Consensus 168 ~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
........ ....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||............ .. ....
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----~~-~~~~ 273 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV----EE-GYRL 273 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH----HT-TCCC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH----Hc-CCCC
Confidence 55433221 12235678999999988887776 999999999999998 99999876543333222 22 2333
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 243 PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
+....+++.+.++|.+||+.||.+|||+.++++.+.
T Consensus 274 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~ 309 (325)
T 3kul_A 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309 (325)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 444478999999999999999999999999988543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=324.26 Aligned_cols=258 Identities=24% Similarity=0.398 Sum_probs=202.1
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc--hHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
++|++++.||+|+||+||++.+..+++.||+|++...... ...+.+|+.++++++||||+++++++..++..++|||+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 6899999999999999999999999999999998754322 12455799999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CCC
Q 023058 99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (288)
Q Consensus 99 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (288)
+++ +|.+++...+ .++...++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++....... ...
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC--------
T ss_pred ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCccccc
Confidence 975 8888876644 5999999999999999999999999999999999999987776 9999999987544332 223
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-CCC------------
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIP------------ 243 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~------------ 243 (288)
...+++.|+|||.+.+......++|+||||+++|+|++|..||...+................. .++
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN 238 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence 4467999999999877544344499999999999999999999876654444433332111100 000
Q ss_pred -----------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 244 -----------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 244 -----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
....+++++.+||.+||+.||.+|||+.|+++ |+|+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~---hp~f~~ 287 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK---HPFFLS 287 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT---SGGGGG
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc---Chhhhh
Confidence 01247889999999999999999999988877 555543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=326.98 Aligned_cols=253 Identities=30% Similarity=0.515 Sum_probs=214.0
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---------chHHHHHHHHHHhhC-CCCceeeEeEEEEcCC
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 90 (288)
++|++.+.||.|++|.||+|.+..+|+.||+|++..... ..+.+.+|+.+++++ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 579999999999999999999998999999999876532 134577899999999 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
..++||||+++++|.+++.....++...+..++.||+.||.|||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccC
Confidence 99999999999999999988888999999999999999999999999999999999999987776 9999999998766
Q ss_pred cCCCCCCCcCCCcccCCccccCc------ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCC--
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI-- 242 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 242 (288)
.........+++.|+|||.+.+. .++.+ +|+||||+++|+|++|..||........ ...+......+
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~Di~slG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKE-VDLWACGVILFTLLAGSPPFWHRRQILM----LRMIMEGQYQFSS 326 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCCCH
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCch-hhHHhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhCCCCCCC
Confidence 65555667799999999988632 34455 9999999999999999999986543222 22233333322
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 243 PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+.+..+++.+.++|.+||+.||.+|||+.++++ |+|++
T Consensus 327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~---hp~f~ 364 (365)
T 2y7j_A 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ---HPFFE 364 (365)
T ss_dssp HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH---SGGGC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc---CcccC
Confidence 223467899999999999999999999988765 77764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=326.23 Aligned_cols=261 Identities=26% Similarity=0.400 Sum_probs=214.5
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
....++|++.+.||+|+||.||++.+..++..||+|++.... ...+.+.+|+.++++++||||+++++++..++..++
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 344689999999999999999999999999999999987653 334578899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc-CceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
||||+++++|.+++...+.++...+..++.|++.||.|||+. |++|+||+|+||+++.++. ++|+|||++......
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS- 185 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH-
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCcccccc-
Confidence 999999999999998888899999999999999999999996 9999999999999988776 999999998644322
Q ss_pred CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhH-------------------------
Q 023058 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF------------------------- 228 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~------------------------- 228 (288)
......+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||.........
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHH-HHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 2334568999999999988877766 99999999999999999999765432111
Q ss_pred -------------HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 229 -------------RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 229 -------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
......+............+++++.+||.+||+.||.+|||+.++++ |+|++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~---hp~~~~ 330 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV---HAFIKR 330 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT---SHHHHH
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh---ChHhhc
Confidence 11112222222222223357899999999999999999999988876 666553
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=335.63 Aligned_cols=256 Identities=33% Similarity=0.542 Sum_probs=203.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---------cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (288)
.++|.+.+.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.++++++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 478999999999999999999999999999999987532 112347899999999999999999999864 4
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-CCCEEEeecCCCccc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS 169 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~-~~~~~l~df~~~~~~ 169 (288)
..++|||++++++|.+.+...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++ ...++|+|||++...
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5799999999999999988888899999999999999999999999999999999999997543 235999999999876
Q ss_pred ccCCCCCCCcCCCcccCCccccC---cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC--C
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--D 244 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~ 244 (288)
..........+++.|+|||.+.+ ..++.+ +|+||||+++|+|++|..||............. ......+. .
T Consensus 293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i---~~~~~~~~~~~ 368 (419)
T 3i6u_A 293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI---TSGKYNFIPEV 368 (419)
T ss_dssp C-----------CTTCCTTTTC----CTTHHH-HHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH---HTTCCCCCHHH
T ss_pred CCCccccccCCCCCccCceeeecCCCCCCCch-hhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH---hcCCCCCCchh
Confidence 65555556678999999999864 334344 999999999999999999998765544443332 22222222 1
Q ss_pred CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 245 YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 245 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+..+++.+.+||.+||+.||.+|||+.++++ |+|++
T Consensus 369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~---hp~~~ 404 (419)
T 3i6u_A 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALR---HPWLQ 404 (419)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH---SGGGC
T ss_pred hcccCHHHHHHHHHHccCChhHCcCHHHHhC---CcccC
Confidence 2368999999999999999999999988866 56654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=312.58 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=211.9
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
...++|++.+.||+|+||.||++.+. ++..||+|++.......+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 45689999999999999999999886 56789999998877777889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC--
Q 023058 98 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-- 174 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-- 174 (288)
++++++|.+++...+ .++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEEE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhhc
Confidence 999999999987654 5999999999999999999999999999999999999987776 99999999875433322
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
.....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||........... +.... ........++.+.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~l~ 235 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----VSQGH-RLYRPHLASDTIY 235 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHTTC-CCCCCTTSCHHHH
T ss_pred ccCCCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHHHHHH----HHcCC-CCCCCCcChHHHH
Confidence 223345678999999988788777 999999999999998 9999986654333222 22222 2222236789999
Q ss_pred HHHHHhcccCcCCccccccccccc
Q 023058 254 HLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
++|.+||+.||.+|||+.++++.+
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~L 259 (268)
T 3sxs_A 236 QIMYSCWHELPEKRPTFQQLLSSI 259 (268)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHH
Confidence 999999999999999999998743
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=329.49 Aligned_cols=257 Identities=29% Similarity=0.376 Sum_probs=197.4
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCC-CCceeeEeEEEEcCC--eEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLR-HPNIVRFKEVILTPT--HLA 93 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~--~~~ 93 (288)
.++|++.+.||+|+||.||+|.+..+++.||+|++... .....+..+|+.+++++. ||||+++++++..++ .++
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 47899999999999999999999999999999998643 334456788999999997 999999999997654 789
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 172 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~- 172 (288)
+||||+++ +|...+.. ..++...+..++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 88 lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 88 LVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCC
T ss_pred EEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCcccccccccc
Confidence 99999974 88888865 57899999999999999999999999999999999999987776 999999998754321
Q ss_pred ---------------------CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 023058 173 ---------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (288)
Q Consensus 173 ---------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~ 231 (288)
.......+|+.|+|||.+.+....+.++|||||||++|+|++|..||...+.......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 11223468999999999987443344499999999999999999999876654444433
Q ss_pred HHHHhhcc-----------------------------------------cCCCCCCCCCHHHHHHHHHhcccCcCCcccc
Q 023058 232 IHRILSVQ-----------------------------------------YSIPDYVHISPECRHLISRIFVADPAKVSMH 270 (288)
Q Consensus 232 ~~~~~~~~-----------------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 270 (288)
...+.... ........+++++.+||.+||+.||.+|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 32111000 0001122678999999999999999999999
Q ss_pred ccccccchhhhhh
Q 023058 271 FHATGVYMHTKLQ 283 (288)
Q Consensus 271 ~~~l~~~~~~~~~ 283 (288)
.|+++ |+|+.
T Consensus 324 ~e~l~---Hp~~~ 333 (388)
T 3oz6_A 324 NDALK---HPFVS 333 (388)
T ss_dssp HHHTT---STTTT
T ss_pred HHHhC---CHHHH
Confidence 98877 55543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=323.66 Aligned_cols=264 Identities=26% Similarity=0.372 Sum_probs=208.2
Q ss_pred CCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEc--
Q 023058 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-- 88 (288)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 88 (288)
.+.+...++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++++++||||+++++++..
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 10 CPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp CTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred ccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 344455699999999999999999999999999999999986543 334567899999999999999999999877
Q ss_pred ------CCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEe
Q 023058 89 ------PTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (288)
Q Consensus 89 ------~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~ 161 (288)
.+..++|||++++ +|...+.. ...++..+++.++.||+.||.+||+.||+||||||+||+++.++. ++|+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~ 166 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLA 166 (351)
T ss_dssp -------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEEC
T ss_pred cccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEc
Confidence 3468999999976 67666654 357999999999999999999999999999999999999987776 9999
Q ss_pred ecCCCcccccC-----CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 023058 162 DFGYSKSSVLH-----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 236 (288)
Q Consensus 162 df~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (288)
|||++...... .......+++.|+|||.+.+......++||||||+++|+|++|..||.................
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 99998754322 2223456799999999987655434449999999999999999999987665444433332222
Q ss_pred hcccC-CCCCC-------------------------CCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 237 SVQYS-IPDYV-------------------------HISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 237 ~~~~~-~~~~~-------------------------~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
..... ++... ..++.+.+||.+||+.||.+|||+.|+++ |+|+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~---hp~f~ 316 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN---HDFFW 316 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT---SGGGG
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC---CCCcC
Confidence 11111 11100 02678999999999999999999988876 56653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=315.64 Aligned_cols=257 Identities=36% Similarity=0.596 Sum_probs=216.5
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
.++|++.+.||+|++|.||++.+..+++.|++|++.... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 478999999999999999999999999999999987542 34567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-CCCEEEeecCCCcccccCCCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~-~~~~~l~df~~~~~~~~~~~~ 175 (288)
|++.+++|.+.+.....++...++.++.||+.||.+||+.|++|+||+|+||+++.++ ...++|+|||++.........
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 9999999999988888899999999999999999999999999999999999997643 345999999998766554444
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc--CCCCCCCCCHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECR 253 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~ 253 (288)
....+++.|+|||.+.+. ++.+ +|+||||+++++|++|..||....... ....+..... ..+....+++++.
T Consensus 181 ~~~~~~~~y~aPE~~~~~-~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRGT-YDEK-CDVWSAGVILYILLSGTPPFYGKNEYD----ILKRVETGKYAFDLPQWRTISDDAK 254 (287)
T ss_dssp SCHHHHHTTCCHHHHTTC-CCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred ccccCcccccChHHhcCC-CCCc-hhhHhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCchhhhhcCHHHH
Confidence 555678899999988654 5555 999999999999999999998755432 2233333333 3333457899999
Q ss_pred HHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 254 HLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
++|.+||+.||.+|||+.++++ ++|++..
T Consensus 255 ~li~~~l~~dp~~Rps~~ell~---hp~~~~~ 283 (287)
T 2wei_A 255 DLIRKMLTFHPSLRITATQCLE---HPWIQKY 283 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH---SHHHHHH
T ss_pred HHHHHHcccChhhCcCHHHHhc---CHHHhcc
Confidence 9999999999999999988865 6666544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=323.66 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=204.5
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc------chHHHHHHHHHHhhCCCCceeeEeEEEEcC
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (288)
.....++|++.+.||+|+||.||++.+..+++.||+|++..... ....+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 34456899999999999999999999999999999999875321 234678999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcc
Q 023058 90 THLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~ 168 (288)
+..++|||++++ +|...+.... .++...++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++..
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~ 161 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKS 161 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGST
T ss_pred CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEeccccee
Confidence 999999999976 8888776543 6899999999999999999999999999999999999987776 99999999876
Q ss_pred cccC-CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-CCCC--
Q 023058 169 SVLH-SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPD-- 244 (288)
Q Consensus 169 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~-- 244 (288)
.... .......+++.|+|||.+.+......++|+||||+++|+|++|..||..................... .++.
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence 5433 23345568999999999876554444599999999999999999999877655544444433211110 1110
Q ss_pred -------------------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 245 -------------------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 245 -------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
...+++++.+||.+||+.||.+|||+.|+++ |+|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~---h~~f 295 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK---MKYF 295 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT---SGGG
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc---Chhh
Confidence 1356789999999999999999999988877 5554
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=345.53 Aligned_cols=253 Identities=31% Similarity=0.499 Sum_probs=218.9
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 93 (288)
..++|++++.||+|+||.||++++..+++.||+|++... ....+....|..++..+ +||+|+.+++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 457899999999999999999999999999999998753 34456678899999887 7999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc-C
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-H 172 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~-~ 172 (288)
+||||+++++|..++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++. ++|+|||++..... .
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccCC
Confidence 99999999999999998889999999999999999999999999999999999999988877 99999999975332 3
Q ss_pred CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 173 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 173 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
.......+|+.|+|||++.+..++.. +|+||||+++|+|++|..||...+. ......+......++. .+++++
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~ 569 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAYPK--SMSKEA 569 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHSSCCCCCT--TSCHHH
T ss_pred cccccccCCCcccCHhhhcCCCCCcc-ceEechHHHHHHHHcCCCCCCCCCH----HHHHHHHHhCCCCCCc--cCCHHH
Confidence 33455679999999999988888776 9999999999999999999987544 3344455566666666 789999
Q ss_pred HHHHHHhcccCcCCcccc-----ccccccchhhhhh
Q 023058 253 RHLISRIFVADPAKVSMH-----FHATGVYMHTKLQ 283 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~-----~~~l~~~~~~~~~ 283 (288)
.+||.+||+.||.+||++ .++++ |+|++
T Consensus 570 ~~li~~lL~~dP~~R~~~~~~~~~ei~~---h~ff~ 602 (674)
T 3pfq_A 570 VAICKGLMTKHPGKRLGCGPEGERDIKE---HAFFR 602 (674)
T ss_dssp HHHHHHHSCSSSTTCTTCSTTHHHHHHS---SGGGS
T ss_pred HHHHHHHccCCHHHCCCCCCCcHHHHhc---Ccccc
Confidence 999999999999999998 45544 55554
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=316.30 Aligned_cols=255 Identities=20% Similarity=0.324 Sum_probs=211.9
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
...+..++|++.+.||+|+||.||++.+. ++..||+|++.......+.+.+|+.++++++||||+++++++...+..++
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 96 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence 34456789999999999999999999887 57789999999877777889999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 95 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
|||++++++|.+++.. ...++...++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCHH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEccccccccccccc
Confidence 9999999999999976 457999999999999999999999999999999999999987776 9999999987543321
Q ss_pred --CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 174 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 174 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
......+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||............ ... .........++
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~----~~~-~~~~~~~~~~~ 248 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----AQG-LRLYRPHLASE 248 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HTT-CCCCCCTTCCH
T ss_pred cccccCCccCcccCCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccChhHHHHHH----hcc-cCCCCCCcCCH
Confidence 1233446778999999987777666 999999999999998 99999876543333222 222 22222336789
Q ss_pred HHHHHHHHhcccCcCCccccccccccch
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.+.++|.+||+.||.+|||+.++++.+.
T Consensus 249 ~l~~li~~~l~~~p~~Rps~~~ll~~L~ 276 (283)
T 3gen_A 249 KVYTIMYSCWHEKADERPTFKILLSNIL 276 (283)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 9999999999999999999999988554
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=315.20 Aligned_cols=259 Identities=26% Similarity=0.400 Sum_probs=208.6
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEEEEc-----
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT----- 88 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----- 88 (288)
......++|++.+.||+|+||.||++.+..+++.||+|++.......+.+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 344456899999999999999999999999999999999988777778899999999999 89999999999976
Q ss_pred -CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCC
Q 023058 89 -PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (288)
Q Consensus 89 -~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~ 165 (288)
....++|||++++++|.+++... ..++...++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~ 175 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGV 175 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTT
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcC
Confidence 46899999999999999999764 46999999999999999999999999999999999999987776 99999999
Q ss_pred CcccccC-CCCCCCcCCCcccCCcccc-----CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc
Q 023058 166 SKSSVLH-SQPKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239 (288)
Q Consensus 166 ~~~~~~~-~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (288)
+...... .......+++.|+|||.+. +..++.+ +|+||||+++|+|++|..||.......... .+....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~ 250 (326)
T 2x7f_A 176 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALF----LIPRNP 250 (326)
T ss_dssp TC-------------CCGGGCCHHHHC--------CCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSC
T ss_pred ceecCcCccccccccCCccccChhhhccccccCcCCCcc-chHHHHHHHHHHHHhCCCCCCCCcHHHHHH----HhhcCc
Confidence 8754332 2233456899999999986 3445555 999999999999999999997654322222 222222
Q ss_pred cCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 240 YSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
........+++.+.++|.+||+.||.+|||+.++++ |+|+.
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~---hp~~~ 291 (326)
T 2x7f_A 251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK---HPFIR 291 (326)
T ss_dssp CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT---SHHHH
T ss_pred cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh---ChHHh
Confidence 222223468999999999999999999999988876 55554
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=314.28 Aligned_cols=257 Identities=20% Similarity=0.293 Sum_probs=217.8
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
.....++|++.+.||+|+||.||++.+..++..||+|.+.......+.+.+|+.++++++||||+++++++..++..++|
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 34567899999999999999999999999999999999988777778899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 96 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
||++++++|.+++.... .++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDT 165 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCCc
Confidence 99999999999997643 5899999999999999999999999999999999999987776 9999999987544332
Q ss_pred CC--CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 174 QP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 174 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
.. ....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||...+........ ......+....+|+
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 239 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-----EKDYRMERPEGCPE 239 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-----HTTCCCCCCTTCCH
T ss_pred cccccCCccccCcCChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----hccCCCCCCCCCCH
Confidence 21 22345778999999987777666 999999999999999 99999876554333222 11222333347899
Q ss_pred HHHHHHHHhcccCcCCccccccccccchhh
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATGVYMHT 280 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~ 280 (288)
.+.++|.+||+.||.+|||+.++++.+..-
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999998855443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=316.23 Aligned_cols=261 Identities=24% Similarity=0.360 Sum_probs=206.5
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEE----EcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcC
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (288)
+.....++|++.+.||+|+||+||+++ +..+++.||+|++.... ...+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345567999999999999999999998 56688999999987643 3345788999999999999999999998654
Q ss_pred --CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 90 --THLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 90 --~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
..+++|||++++++|.+++...+ .++...++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~ 161 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLT 161 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCccc
Confidence 46899999999999999997754 5999999999999999999999999999999999999988776 999999999
Q ss_pred cccccCCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCC-----------chhHHHH
Q 023058 167 KSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-----------PKNFRKT 231 (288)
Q Consensus 167 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~-----------~~~~~~~ 231 (288)
........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||..... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChH-HHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 75543322 122345667999999988887666 9999999999999999999864321 0111111
Q ss_pred HHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
...........+....+|+++.++|.+||+.||.+|||+.++++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~ 287 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 11122223334444578999999999999999999999999987553
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=321.37 Aligned_cols=258 Identities=27% Similarity=0.474 Sum_probs=209.2
Q ss_pred CCCeeee-eeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEE
Q 023058 20 SDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 20 ~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 94 (288)
.++|.+. +.||+|+||.||++.+..+++.||+|++... ......+.+|+.+++++ +||||+++++++...+..++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 4678887 8999999999999999999999999998753 23346788999999999 56999999999999999999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-CCCEEEeecCCCccccc
Q 023058 95 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVL 171 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~-~~~~~l~df~~~~~~~~ 171 (288)
||||+.+++|.+++... ..+++.+++.++.|++.||++||+.|++||||+|+||+++... .+.++|+|||++.....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99999999999888543 5799999999999999999999999999999999999998621 23499999999986665
Q ss_pred CCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
........+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+........... ......+....+++.
T Consensus 187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~ 263 (327)
T 3lm5_A 187 ACELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV--NVDYSEETFSSVSQL 263 (327)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTTTTSCHH
T ss_pred ccccccccCCcCccCCeeecCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc--ccccCchhhcccCHH
Confidence 555556679999999999988887766 99999999999999999999876543333332221 122233334578999
Q ss_pred HHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+.++|.+||+.||.+|||+.++++ |+|++
T Consensus 264 ~~~li~~~L~~dP~~Rpt~~~ll~---h~~~~ 292 (327)
T 3lm5_A 264 ATDFIQSLLVKNPEKRPTAEICLS---HSWLQ 292 (327)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTT---CGGGC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhC---CHhhc
Confidence 999999999999999999988876 55543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=323.75 Aligned_cols=252 Identities=29% Similarity=0.506 Sum_probs=212.2
Q ss_pred CCCeeeeeeeeccCceEEEEEEEc---CCCcEEEEEEeecCc-----cchHHHHHHHHHHhhC-CCCceeeEeEEEEcCC
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPT 90 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 90 (288)
.++|++.+.||+|+||.||++++. .+++.||+|++.... ...+.+.+|+.+++++ +||||+++++++..+.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 479999999999999999999984 478999999986432 3345677899999999 6999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
..++||||+++++|.+++.....++...++.++.||+.||.|||+.||+|+||||+||+++.++. ++|+|||++....
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeecc
Confidence 99999999999999999988888999999999999999999999999999999999999987776 9999999987543
Q ss_pred cCC--CCCCCcCCCcccCCccccCcc-cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 171 LHS--QPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 171 ~~~--~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
... ......+++.|+|||.+.+.. ....++||||||+++|+|++|..||...............+......++. .
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~ 288 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--E 288 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--T
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCc--c
Confidence 222 223346899999999997633 22344999999999999999999998766555555555555555555554 7
Q ss_pred CCHHHHHHHHHhcccCcCCcc-----ccccccc
Q 023058 248 ISPECRHLISRIFVADPAKVS-----MHFHATG 275 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rp-----t~~~~l~ 275 (288)
+++.+.+||.+||+.||.+|| |+.++++
T Consensus 289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 899999999999999999999 7777766
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=327.48 Aligned_cols=262 Identities=26% Similarity=0.327 Sum_probs=213.7
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC------CCCceeeEeEEEEc
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL------RHPNIVRFKEVILT 88 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~ 88 (288)
+.....++|++.+.||+|+||+||+|.+..+++.||+|++...........+|+.+++.+ +|+||+++++++..
T Consensus 91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 344456789999999999999999999999999999999987666666778888888777 57799999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 89 PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
....++|||++. ++|.+++.... .++...++.++.||+.||.|||+.||+||||||+||+++.++...++|+|||++
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999999996 58988887654 489999999999999999999999999999999999998877656999999998
Q ss_pred cccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc------
Q 023058 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY------ 240 (288)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------ 240 (288)
.... .......+++.|+|||.+.+..++.+ +|||||||++|+|++|..||...+.................
T Consensus 250 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~ 326 (429)
T 3kvw_A 250 CYEH--QRVYTYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326 (429)
T ss_dssp EETT--CCCCSSCSCGGGCCHHHHHTBCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTB
T ss_pred eecC--CcccccCCCCCccChHHHhCCCCCch-HHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 6433 23345678999999999998888776 99999999999999999999877654444433322110000
Q ss_pred ----------CC-----------------------------CC--------CCCCCHHHHHHHHHhcccCcCCccccccc
Q 023058 241 ----------SI-----------------------------PD--------YVHISPECRHLISRIFVADPAKVSMHFHA 273 (288)
Q Consensus 241 ----------~~-----------------------------~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 273 (288)
.. +. ....++++.+||.+||+.||.+|||+.|+
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~ 406 (429)
T 3kvw_A 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA 406 (429)
T ss_dssp TTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHH
Confidence 00 00 01347889999999999999999999998
Q ss_pred cccchhhhhh
Q 023058 274 TGVYMHTKLQ 283 (288)
Q Consensus 274 l~~~~~~~~~ 283 (288)
++ |+|+.
T Consensus 407 L~---Hpw~~ 413 (429)
T 3kvw_A 407 LR---HPWLR 413 (429)
T ss_dssp HT---STTTC
T ss_pred hC---Chhhc
Confidence 77 55543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=316.17 Aligned_cols=256 Identities=22% Similarity=0.258 Sum_probs=200.7
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc----chHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
.....++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++..++.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ 108 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence 34445899999999999999999999999999999999875432 23568899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
.+++||++++++|.+++...+.++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.....
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTD 186 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSCCC------
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC--EEEecCccCccccc
Confidence 9999999999999999988888999999999999999999999999999999999999987776 99999999875443
Q ss_pred CCC--CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-CCCCCCCC
Q 023058 172 HSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHI 248 (288)
Q Consensus 172 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 248 (288)
... .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...... .....+..... .......+
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~ 261 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLS----VMGAHINQAIPRPSTVRPGI 261 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHHH----HHHHHHHSCCCCGGGTSTTC
T ss_pred cccccccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchHH----HHHHHhccCCCCccccCCCC
Confidence 322 234568899999999988877776 99999999999999999999864321 11111111111 11123368
Q ss_pred CHHHHHHHHHhcccCcCCcc-ccccccccch
Q 023058 249 SPECRHLISRIFVADPAKVS-MHFHATGVYM 278 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rp-t~~~~l~~~~ 278 (288)
|+++.++|.+||+.||.+|| ++.++++.+.
T Consensus 262 ~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~ 292 (309)
T 2h34_A 262 PVAFDAVIARGMAKNPEDRYVTCGDLSAAAH 292 (309)
T ss_dssp CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CHHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence 99999999999999999999 7777766443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=312.15 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=215.1
Q ss_pred CCCCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEE
Q 023058 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVI 86 (288)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (288)
.|+.........+.|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++
T Consensus 10 ~p~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 89 (303)
T 3a7i_A 10 LPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89 (303)
T ss_dssp ---CTTCEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCchhcCCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 34555555566688999999999999999999999999999999987653 3456789999999999999999999999
Q ss_pred EcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 87 LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
......++|||++++++|.+++.. +.++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~ 166 (303)
T 3a7i_A 90 LKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVA 166 (303)
T ss_dssp EETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTC
T ss_pred ecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeecccc
Confidence 999999999999999999998864 57899999999999999999999999999999999999987776 999999998
Q ss_pred cccccCC-CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc-cCCCC
Q 023058 167 KSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPD 244 (288)
Q Consensus 167 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~ 244 (288)
....... ......+++.|+|||.+.+..++.+ +|+||||+++++|++|..||.......... .+.... ...+
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~- 240 (303)
T 3a7i_A 167 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLF----LIPKNNPPTLE- 240 (303)
T ss_dssp EECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSCCCCCC-
T ss_pred eecCccccccCccCCCcCccCHHHHhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcCHHHHHH----HhhcCCCCCCc-
Confidence 7554332 2344568899999999988888776 999999999999999999997654322222 222222 2222
Q ss_pred CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 245 YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 245 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
..++..+.++|.+||+.||.+|||+.++++
T Consensus 241 -~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 241 -GNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp -SSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -cccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 368999999999999999999999988877
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=321.50 Aligned_cols=258 Identities=28% Similarity=0.414 Sum_probs=209.1
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcC-----Ce
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 91 (288)
..++|++++.||+|+||.||++.+..++..||+|++.... ...+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3479999999999999999999999999999999987543 2336788999999999999999999999765 47
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
.++|||++.+ +|.+++.. ..++...++.++.||+.||.|||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADP 180 (364)
T ss_dssp EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCG
T ss_pred EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCC
Confidence 8999999975 89888865 46999999999999999999999999999999999999987776 99999999975543
Q ss_pred CCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-------
Q 023058 172 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY------- 240 (288)
Q Consensus 172 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------- 240 (288)
... .....+++.|+|||.+.+......++|+||||+++|+|++|..||......+..............
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 322 234478999999998766553344499999999999999999999887765555444322111100
Q ss_pred ---------CCCC---------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 241 ---------SIPD---------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 241 ---------~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
..+. ...+++++.+||.+||+.||.+|||+.++++ |+|++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~---hp~~~ 318 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA---HPYLE 318 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT---SGGGT
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc---Ccchh
Confidence 0000 1357899999999999999999999988877 55544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=311.29 Aligned_cols=257 Identities=23% Similarity=0.322 Sum_probs=194.8
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccch---HHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
...++|++.+.||+|+||.||++.+..+++.||+|++....... +...++...++.++||||+++++++..++..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 45689999999999999999999999999999999987643222 223445555788899999999999999999999
Q ss_pred EEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhc-CceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 95 VMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 95 v~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~-~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
|||++++ +|.+++. ....+++..++.++.|++.||.+||+. |++|+||||+||+++.++. ++|+|||++...
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~ 160 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDFGISGYL 160 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC--EEBCCC------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecCCcccc
Confidence 9999975 7766654 356799999999999999999999998 9999999999999987776 999999999866
Q ss_pred ccCCCCCCCcCCCcccCCccc----cCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCC
Q 023058 170 VLHSQPKSTVGTPAYIAPEVL----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (288)
..........+++.|+|||.+ .+..++.+ +|+||||+++|+|++|..||....... .............. ..
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~-~~ 236 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTPF--QQLKQVVEEPSPQL-PA 236 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHH-HHHHHHHHHHHHHHHTSCSSCCCSCHH--HHHHHHHHSCCCCC-CT
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcH-HHHHHHHHHHHHHHHCCCCccccCchH--HHHHHHhccCCCCc-cc
Confidence 555555556789999999996 34445444 999999999999999999997643322 22222222222222 23
Q ss_pred CCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 246 VHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 246 ~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
..+++++.++|.+||+.||.+|||+.++++ |+|++.
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~---hp~f~~ 272 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTYPELMQ---HPFFTL 272 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT---SHHHHH
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCHHHHHh---Cccccc
Confidence 368999999999999999999999988866 677654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=317.30 Aligned_cols=261 Identities=23% Similarity=0.377 Sum_probs=210.6
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC-CCceeeEeEEEEc--CCeEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILT--PTHLA 93 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~~ 93 (288)
....++|++.+.||+|+||.||++.+..+++.||+|++... ..+.+.+|+.++++++ ||||+++++++.. ....+
T Consensus 32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 34458999999999999999999999999999999998743 3467899999999997 9999999999988 56889
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
+|||++++++|.+++. .++...++.++.||+.||.|||+.|++|+||||+||+++.++. .++|+|||++.......
T Consensus 110 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTC
T ss_pred EEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCC
Confidence 9999999999988874 4899999999999999999999999999999999999986652 49999999998766666
Q ss_pred CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH----------HhhcccC--
Q 023058 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR----------ILSVQYS-- 241 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~----------~~~~~~~-- 241 (288)
......+++.|+|||.+.+......++||||||+++|+|++|..||............... +......
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 6666788999999999877443344499999999999999999999654432211111111 0000000
Q ss_pred --------------------CCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhhh
Q 023058 242 --------------------IPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLLV 286 (288)
Q Consensus 242 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~ 286 (288)
......+++++.+||.+||+.||.+|||+.++++ |+|+.-+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~---hp~f~~~~ 327 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME---HPYFYTVV 327 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT---SGGGTTCC
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc---CccHhhhc
Confidence 0111237899999999999999999999988866 77776543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=318.01 Aligned_cols=244 Identities=28% Similarity=0.416 Sum_probs=204.3
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc----chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 569999999999999999999999999999999876432 2246789999999999999999999999999999999
Q ss_pred eccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 97 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
||+.+ +|.+.+. ....++...++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++..... .
T Consensus 134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~---~ 207 (348)
T 1u5q_A 134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---A 207 (348)
T ss_dssp ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---B
T ss_pred ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEeeccCceecCC---C
Confidence 99974 7777774 4567999999999999999999999999999999999999987776 99999999875433 2
Q ss_pred CCCcCCCcccCCcccc---CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 176 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
....+++.|+|||.+. +..++.+ +||||||+++|+|++|..||...+....... +............+++.+
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~~~-~DiwslG~il~ell~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l 282 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQSGHWSEYF 282 (348)
T ss_dssp CCCCSCGGGCCHHHHHTTSSCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCCCTTSCHHH
T ss_pred CcccCCcceeCHhhhccccCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhcCCCCCCCCCCCHHH
Confidence 3456899999999985 4556555 9999999999999999999987654333222 222222222234689999
Q ss_pred HHHHHHhcccCcCCccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+||.+||+.||.+|||+.++++
T Consensus 283 ~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 283 RNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHcccChhhCcCHHHHhh
Confidence 99999999999999999988877
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=322.17 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=209.1
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEc-------CCCcEEEEEEeecCc--cchHHHHHHHHHHhhC-CCCceeeEeEEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVIL 87 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 87 (288)
...++|++.+.||+|+||.||+|.+. .++..||+|++.... ...+.+.+|+.+++++ +||||+++++++.
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 44589999999999999999999974 345679999987643 2345688999999999 8999999999999
Q ss_pred cCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEec
Q 023058 88 TPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 151 (288)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~ 151 (288)
..+.+++||||+++++|.+++.... .++..+++.++.||+.||+|||+.||+||||||+||+++
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 9999999999999999999997643 478999999999999999999999999999999999998
Q ss_pred CCCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchh
Q 023058 152 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (288)
Q Consensus 152 ~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~ 227 (288)
.++. +||+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||........
T Consensus 238 ~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 238 ENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp TTCC--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred CCCC--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 7776 99999999875443322 223346778999999988877766 999999999999999 9999987654443
Q ss_pred HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 228 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.... ... ........+++++.++|.+||+.||.+|||+.++++.+.
T Consensus 315 ~~~~----~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 360 (370)
T 2psq_A 315 FKLL----KEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360 (370)
T ss_dssp HHHH----HTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH----hcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 3322 111 122223378999999999999999999999999988543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=308.82 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=206.1
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc--------hHHHHHHHHHHhhCCCCceeeEeEEEEc
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI--------DENVQREIINHRSLRHPNIVRFKEVILT 88 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (288)
....++|++.+.||+|+||.||++.+..+++.||+|++...... .+.+.+|+.++++++||||+++++++..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 34569999999999999999999999999999999998654321 1578899999999999999999999876
Q ss_pred CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcC--ceecCCCCCceEecCCCC---CCEEEee
Q 023058 89 PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPA---PRLKICD 162 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~--i~H~dl~p~nilv~~~~~---~~~~l~d 162 (288)
.. ++|||++++++|.+.+... ..++...++.++.|++.||.+||+.| ++|+||||+||+++.++. ..++|+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 65 6999999999998877654 47999999999999999999999999 999999999999975442 2389999
Q ss_pred cCCCcccccCCCCCCCcCCCcccCCcccc--CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc
Q 023058 163 FGYSKSSVLHSQPKSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240 (288)
Q Consensus 163 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (288)
||++..... ......+++.|+|||.+. ...++.+ +|+||||+++|+|++|..||........... ........
T Consensus 173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~ 247 (287)
T 4f0f_A 173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFI--NMIREEGL 247 (287)
T ss_dssp CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHH-HHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH--HHHHHSCC
T ss_pred CCccccccc--cccccCCCccccCchhhccCCCCcCch-hhHHHHHHHHHHHHcCCCCCccccccHHHHH--HHHhccCC
Confidence 999874332 234456899999999984 3344444 9999999999999999999987655443222 22222233
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 241 SIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 241 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.......+++.+.++|.+||+.||.+|||+.++++.+
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 2233347899999999999999999999999988754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=315.49 Aligned_cols=248 Identities=21% Similarity=0.251 Sum_probs=196.8
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc---hHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---DENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
++|++.+.||+|+||+||+|.+..+++.||+|++...... ......|+..+.++ +||||+++++++..++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 7899999999999999999999999999999988654322 22344555555444 8999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|++ +++|.+.+... ..+++..++.++.|++.||+|||+.||+|+||||+||+++.++. ++|+|||++.........
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC-----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCC
Confidence 999 55888777554 46999999999999999999999999999999999999988776 999999998866655555
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....+++.|+|||.+.+ .++.+ +||||||+++++|++|..|+... .... .+............+++++.++
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~el~~g~~~~~~~---~~~~----~~~~~~~~~~~~~~~~~~l~~l 284 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SYGTA-ADVFSLGLTILEVACNMELPHGG---EGWQ----QLRQGYLPPEFTAGLSSELRSV 284 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CCSTH-HHHHHHHHHHHHHHHTCCCCSSH---HHHH----HHTTTCCCHHHHTTSCHHHHHH
T ss_pred cccCCCccccCHhHhcC-CCCch-hhHHHHHHHHHHHHhCCCCCCCc---cHHH----HHhccCCCcccccCCCHHHHHH
Confidence 66678999999998876 56555 99999999999999997666542 1111 1122211111123688999999
Q ss_pred HHHhcccCcCCccccccccccchhhhhh
Q 023058 256 ISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
|.+||+.||.+|||+.++++ |+|++
T Consensus 285 i~~~L~~dP~~Rpt~~ell~---hp~~~ 309 (311)
T 3p1a_A 285 LVMMLEPDPKLRATAEALLA---LPVLR 309 (311)
T ss_dssp HHHHSCSSTTTSCCHHHHHT---SGGGS
T ss_pred HHHHcCCChhhCcCHHHHHh---Ccccc
Confidence 99999999999999988876 66654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=309.60 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=209.6
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEc----C
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----P 89 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~ 89 (288)
....+.|++.+.||+|+||.||++.+..++..|++|.+.... ...+.+.+|+.++++++||||+++++++.. .
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 344567999999999999999999999999999999987543 334568899999999999999999999865 3
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC--ceecCCCCCceEec-CCCCCCEEEeecCCC
Q 023058 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLD-GSPAPRLKICDFGYS 166 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--i~H~dl~p~nilv~-~~~~~~~~l~df~~~ 166 (288)
...++|||++++++|.+++...+.++...++.++.||+.||.|||+.| ++|+||+|+||+++ .++. ++|+|||++
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~--~kl~Dfg~~ 179 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLA 179 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGG
T ss_pred ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC--EEEeeCCCc
Confidence 568999999999999999988888999999999999999999999999 99999999999997 4555 999999998
Q ss_pred cccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCC
Q 023058 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (288)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
..... .......+++.|+|||.+.+ .++.+ +|+||||+++|+|++|..||.......... ..+...........
T Consensus 180 ~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~ 253 (290)
T 1t4h_A 180 TLKRA-SFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIY---RRVTSGVKPASFDK 253 (290)
T ss_dssp GGCCT-TSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHH---HHHTTTCCCGGGGG
T ss_pred ccccc-cccccccCCcCcCCHHHHhc-cCCCc-chHHHHHHHHHHHHhCCCCCCCcCcHHHHH---HHHhccCCccccCC
Confidence 64332 22334568999999998864 45555 999999999999999999998755433322 22233222222233
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
..++++.++|.+||+.||.+|||+.++++ |+|++.
T Consensus 254 ~~~~~l~~li~~~l~~dp~~Rps~~ell~---h~~f~~ 288 (290)
T 1t4h_A 254 VAIPEVKEIIEGCIRQNKDERYSIKDLLN---HAFFQE 288 (290)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHT---SGGGC-
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhh---Cccccc
Confidence 57789999999999999999999988866 777653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=317.57 Aligned_cols=263 Identities=22% Similarity=0.305 Sum_probs=211.8
Q ss_pred CCCCCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEE--EEEEeecC--ccchHHHHHHHHHHhhC-CCCceeeE
Q 023058 8 VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELV--AVKYIERG--DKIDENVQREIINHRSL-RHPNIVRF 82 (288)
Q Consensus 8 ~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~--~iK~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~ 82 (288)
.+++...-.....++|++.+.||+|+||.||++++..++..+ ++|.+... ....+.+.+|+.+++++ +||||+++
T Consensus 12 ~~~~~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 91 (327)
T 1fvr_A 12 NNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91 (327)
T ss_dssp ----CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCE
T ss_pred CCCCCcccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhh
Confidence 344444444556699999999999999999999998888765 99988753 33445788999999999 89999999
Q ss_pred eEEEEcCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCC
Q 023058 83 KEVILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146 (288)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~ 146 (288)
++++...+..++|||++++++|.+++.... .++...++.++.||+.||.+||+.|++|+||+|+
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~ 171 (327)
T 1fvr_A 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 171 (327)
T ss_dssp EEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred ceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccc
Confidence 999999999999999999999999997654 6999999999999999999999999999999999
Q ss_pred ceEecCCCCCCEEEeecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 023058 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEP 225 (288)
Q Consensus 147 nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~ 225 (288)
||+++.++. ++|+|||++.............+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||......
T Consensus 172 NIl~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~ 248 (327)
T 1fvr_A 172 NILVGENYV--AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCA 248 (327)
T ss_dssp GEEECGGGC--EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred eEEEcCCCe--EEEcccCcCccccccccccCCCCCccccChhhhccccCCch-hcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence 999987776 99999999875544444445567889999999987777666 999999999999998 99999875432
Q ss_pred hhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 226 KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
. ....+.. .........+++.+.++|.+||+.||.+|||+.++++.+.
T Consensus 249 ~----~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 296 (327)
T 1fvr_A 249 E----LYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296 (327)
T ss_dssp H----HHHHGGG-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H----HHHHhhc-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 2 2222222 2223333478999999999999999999999999988544
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=311.17 Aligned_cols=256 Identities=24% Similarity=0.392 Sum_probs=208.6
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
...++|++.+.||+|+||.||++.+..+++.||+|.+.... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 34588999999999999999999999999999999987643 45678999999999999999999999999999999999
Q ss_pred ccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CC
Q 023058 98 YASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 175 (288)
Q Consensus 98 ~~~~~~L~~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~ 175 (288)
++++++|.+++. ....++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~ 182 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAKR 182 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSCB
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhcccc
Confidence 999999999986 4567999999999999999999999999999999999999987776 9999999987544332 23
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||............ .......+.....+++.+.++
T Consensus 183 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~l 258 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---PTNPPPTFRKPELWSDNFTDF 258 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCCCCCSSGGGSCHHHHHH
T ss_pred CccCCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hcCCCcccCCcccCCHHHHHH
Confidence 34568899999999988888777 99999999999999999999865432222211 111222233333578999999
Q ss_pred HHHhcccCcCCccccccccccchhhhhh
Q 023058 256 ISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
|.+||+.||.+|||+.++++ |+|+.
T Consensus 259 i~~~l~~dp~~Rpt~~~ll~---~~~~~ 283 (314)
T 3com_A 259 VKQCLVKSPEQRATATQLLQ---HPFVR 283 (314)
T ss_dssp HHHHTCSCTTTSCCHHHHTT---SHHHH
T ss_pred HHHHccCChhhCcCHHHHHh---CHHHh
Confidence 99999999999999988877 55543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=321.20 Aligned_cols=250 Identities=22% Similarity=0.350 Sum_probs=200.1
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC--------
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT-------- 90 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-------- 90 (288)
++|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 68999999999999999999999999999999987543 34467889999999999999999999985532
Q ss_pred -------------------------------------------------eEEEEEeccCCCchHHHHHhcCC---CCHHH
Q 023058 91 -------------------------------------------------HLAIVMEYASGGELFERICNAGR---FSEDE 118 (288)
Q Consensus 91 -------------------------------------------------~~~lv~e~~~~~~L~~~~~~~~~---~~~~~ 118 (288)
..++|||++++++|.+++..... .+...
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 38999999999999999987653 56667
Q ss_pred HHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-------------CCCCCcCCCccc
Q 023058 119 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------------QPKSTVGTPAYI 185 (288)
Q Consensus 119 ~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-------------~~~~~~~~~~~~ 185 (288)
++.++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++....... ......+++.|+
T Consensus 166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 8999999999999999999999999999999987776 9999999987554432 223346899999
Q ss_pred CCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcC
Q 023058 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 265 (288)
Q Consensus 186 aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 265 (288)
|||.+.+..++.+ +|+||||+++|+|++|..|+. ................ .....++++.++|.+||+.||.
T Consensus 244 aPE~~~~~~~~~~-~Di~slG~il~el~~~~~~~~------~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~ 315 (332)
T 3qd2_B 244 SPEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQM------ERVRIITDVRNLKFPL-LFTQKYPQEHMMVQDMLSPSPT 315 (332)
T ss_dssp CHHHHHCCCCCTH-HHHHHHHHHHHHHHSCCCCHH------HHHHHHHHHHTTCCCH-HHHHHCHHHHHHHHHHHCSSGG
T ss_pred ChHHhcCCCCcch-hhHHHHHHHHHHHHHcCCChh------HHHHHHHHhhccCCCc-ccccCChhHHHHHHHHccCCCC
Confidence 9999988888766 999999999999999876542 2222222222221110 1123567889999999999999
Q ss_pred Cccccccccccchhhhhh
Q 023058 266 KVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 266 ~Rpt~~~~l~~~~~~~~~ 283 (288)
+|||+.++++ |+|++
T Consensus 316 ~Rps~~~~l~---~~~f~ 330 (332)
T 3qd2_B 316 ERPEATDIIE---NAIFE 330 (332)
T ss_dssp GSCCHHHHHH---STTCC
T ss_pred cCCCHHHHhh---chhhh
Confidence 9999988865 66654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=325.23 Aligned_cols=256 Identities=26% Similarity=0.382 Sum_probs=197.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC------
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------ 90 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 90 (288)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 489999999999999999999999999999999987642 33356789999999999999999999997764
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
..++|||++++ +|.+.+. ..++...+..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++....
T Consensus 104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG 178 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC-----
T ss_pred ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeecccccc
Confidence 78999999975 7877775 35899999999999999999999999999999999999987776 9999999998655
Q ss_pred cCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh--------------
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-------------- 236 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------- 236 (288)
.........+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.............
T Consensus 179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 179 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp -----------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred cccccCCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 5444455678999999999988888776 9999999999999999999987654333333221100
Q ss_pred ----hcccCCC--------------CC----CCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 237 ----SVQYSIP--------------DY----VHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 237 ----~~~~~~~--------------~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
.....+. .. ...++++.+||.+||+.||.+|||+.++++ |+|++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~---hp~~~~ 324 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ---HPYINV 324 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH---SHHHHT
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC---Ccchhh
Confidence 0000000 00 001567999999999999999999988866 555543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=317.47 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=202.9
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---chHHHHHHHHHHhhCCC--CceeeEeEEEEcCCeE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRH--PNIVRFKEVILTPTHL 92 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~ 92 (288)
...++|++.+.||+|+||.||++.+. ++..||+|++..... ..+.+.+|+.++++++| |||+++++++..+...
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 45688999999999999999999985 588999999876533 23567899999999976 9999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
++|||+ .+++|.+++...+.++..++..++.||+.||.|||+.||+||||||+||+++ ++. ++|+|||++......
T Consensus 85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~--~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM--LKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTE--EEECCCSSSCCC---
T ss_pred EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCc--EEEeecccccccCcc
Confidence 999995 5779999999988999999999999999999999999999999999999997 444 999999999765443
Q ss_pred CC---CCCCcCCCcccCCccccC-----------cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 023058 173 SQ---PKSTVGTPAYIAPEVLLK-----------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238 (288)
Q Consensus 173 ~~---~~~~~~~~~~~aPE~~~~-----------~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (288)
.. .....+++.|+|||.+.+ ..++.+ +||||||+++|+|++|..||....... .. ...+...
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~--~~-~~~~~~~ 236 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK-SDVWSLGCILYYMTYGKTPFQQIINQI--SK-LHAIIDP 236 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHH-HHHHHHHHHHHHHHHSSCTTTTCCSHH--HH-HHHHHCT
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCch-hhHHHHHHHHHHHHhCCCcchhhhhHH--HH-HHHHhcC
Confidence 32 234568999999999864 344444 999999999999999999997654321 11 2222222
Q ss_pred ccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 239 QYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
..........++++.+||.+||+.||.+|||+.++++ |+|++
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~---hp~~~ 278 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA---HPYVQ 278 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT---SHHHH
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh---Ccccc
Confidence 2222223367889999999999999999999988866 66665
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=321.78 Aligned_cols=252 Identities=33% Similarity=0.534 Sum_probs=204.7
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---------cchHHHHHHHHHHhhCCCCceeeEeEEEEcC
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---------KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (288)
..++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3478999999999999999999999999999999986532 1223578999999999999999999998766
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-CCCEEEeecCCCcc
Q 023058 90 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKS 168 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~-~~~~~l~df~~~~~ 168 (288)
. .++|||++++++|.+.+.....++...++.++.||+.||.+||+.|++|+||+|+||+++.++ ...++|+|||++..
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 5 899999999999999998888899999999999999999999999999999999999997644 23599999999875
Q ss_pred cccCCCCCCCcCCCcccCCcccc---CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC--
Q 023058 169 SVLHSQPKSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP-- 243 (288)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 243 (288)
...........+++.|+|||.+. +..++.+ +|+||||+++|+|++|..||.............. .....+.
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~ 242 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---SGKYNFIPE 242 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTH-HHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH---HTCCCCCHH
T ss_pred cccccccccccCCcCccCchhhccCCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH---hCccccCch
Confidence 54332223345899999999974 3445444 9999999999999999999987655444333322 2222221
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 244 DYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
....+++++.++|.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 12367899999999999999999999988876
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=323.30 Aligned_cols=256 Identities=25% Similarity=0.391 Sum_probs=202.2
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC----
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT---- 90 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 90 (288)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+++.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 34589999999999999999999999999999999986532 23456789999999999999999999998763
Q ss_pred --eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcc
Q 023058 91 --HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (288)
Q Consensus 91 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~ 168 (288)
.+++|||++ +++|.+++.. ..++...+..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++..
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~ 177 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQ 177 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEE
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeecccc
Confidence 469999999 7799988876 57999999999999999999999999999999999999987776 99999999975
Q ss_pred cccCCCCCCCcCCCcccCCccccC-cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc---------
Q 023058 169 SVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------- 238 (288)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 238 (288)
... ......+++.|+|||.+.+ ..++.. +|+|||||++++|++|..||...+..+....+.......
T Consensus 178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQT-VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp CCS--SCCSSCSCGGGCCTHHHHTTTCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccc--ccCcCcCCCCcCCHHHHhCCCCCChh-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 432 2344568999999999877 455555 999999999999999999998766544443332211100
Q ss_pred ----------cc-----CCC-CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 239 ----------QY-----SIP-DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 239 ----------~~-----~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.. .+. ....+++++.+||.+||+.||.+|||+.++++ |+|++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~---hp~f~ 312 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA---HPYFE 312 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH---SGGGT
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc---ChHHH
Confidence 00 000 11357899999999999999999999988866 55554
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=310.97 Aligned_cols=258 Identities=21% Similarity=0.225 Sum_probs=211.3
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
...++|++.+.||+|+||.||++.+..+++.||+|++.... ..+.+.+|+..++++ +|+|++.+++++......++||
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 44689999999999999999999999999999999886543 345688999999999 7999999999999999999999
Q ss_pred eccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCC---CCEEEeecCCCcccccC
Q 023058 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLH 172 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~---~~~~l~df~~~~~~~~~ 172 (288)
|++ +++|.+++...+ +++...++.++.||+.||.+||+.|++|+||||+||+++.++. ..++|+|||++......
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 999 889999998654 5999999999999999999999999999999999999975432 24999999999755443
Q ss_pred CC--------CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC-
Q 023058 173 SQ--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP- 243 (288)
Q Consensus 173 ~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 243 (288)
.. .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||............ ..+.......+
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~ 242 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQSTPL 242 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-HHHHHHHHHSCH
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHcCCCCcchhhccccHHHH-HHHHhhccCccH
Confidence 22 234568999999999988877666 99999999999999999999876543322211 11111111111
Q ss_pred --CCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 244 --DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 244 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
....+|+++.++|.+||+.||.+|||+.++++.+..
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~ 280 (298)
T 1csn_A 243 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 280 (298)
T ss_dssp HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHH
Confidence 122689999999999999999999999999885544
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=317.51 Aligned_cols=255 Identities=21% Similarity=0.328 Sum_probs=194.8
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEcCCCc---EEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcC
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (288)
.....++|++.+.||+|+||.||++.+..++. .||+|++... ....+.+.+|+.++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 44556899999999999999999999887664 8999998754 34456788999999999999999999999887
Q ss_pred CeE------EEEEeccCCCchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCC
Q 023058 90 THL------AIVMEYASGGELFERICNAG------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (288)
Q Consensus 90 ~~~------~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~ 157 (288)
... +++||++.+++|.+++.... .++...++.++.|++.||.|||+.|++|+||||+||+++.++.
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~-- 175 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT-- 175 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC--
Confidence 654 99999999999999886432 5899999999999999999999999999999999999987776
Q ss_pred EEEeecCCCcccccCCCC---CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 023058 158 LKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIH 233 (288)
Q Consensus 158 ~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~ 233 (288)
++|+|||++......... ....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||.............
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~- 253 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI- 253 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCc-cchhhHHHHHHHHHhCCCCCccccChHHHHHHHh-
Confidence 999999998754433222 23345678999999988777666 999999999999999 999998776544433322
Q ss_pred HHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.. ...+....+++++.++|.+||+.||.+|||+.++++.+.
T Consensus 254 ---~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 294 (323)
T 3qup_A 254 ---GG-NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294 (323)
T ss_dssp ---TT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ---cC-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11 122333478999999999999999999999888877443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=318.24 Aligned_cols=256 Identities=22% Similarity=0.231 Sum_probs=209.6
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
...++|++.+.||+|+||.||++.+..+++.||+|++.... ..+.+.+|+.+++++ +||||+++++++..++..++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 34589999999999999999999999999999999887643 345688999999999 9999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCC---CCEEEeecCCCcccccC
Q 023058 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLH 172 (288)
Q Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~---~~~~l~df~~~~~~~~~ 172 (288)
|++ +++|.+++.. ...++...++.++.|++.||+|||+.||+||||||+||+++.++. ..++|+|||++......
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 999 8899999976 467999999999999999999999999999999999999976553 23999999999754333
Q ss_pred CC--------CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC
Q 023058 173 SQ--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244 (288)
Q Consensus 173 ~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (288)
.. .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||........ ......+.......+.
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRR-DDLEALGHMFMYFLRGSLPWQGLKADTL-KERYQKIGDTKRATPI 241 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHHHHHHHHHHHSCH
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCch-hHHHHHHHHHHHHhcCCCCccccccccH-HHHHHHHHhhhccCCH
Confidence 22 235568999999999988887666 9999999999999999999987654332 2222222222211111
Q ss_pred ---CCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 245 ---YVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 245 ---~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
....| ++.++|.+||+.||.+||++.++.+.+.
T Consensus 242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 11345 9999999999999999999999888554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=331.13 Aligned_cols=259 Identities=27% Similarity=0.391 Sum_probs=190.1
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcC-----C
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP-----T 90 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 90 (288)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+++.+|+.++++++||||+++++++... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3589999999999999999999999999999999986532 3345788999999999999999999998543 5
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.+++|||++. ++|..++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++. +||+|||++....
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTT
T ss_pred eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--Eeecccccchhcc
Confidence 7999999985 589999988888999999999999999999999999999999999999988776 9999999997554
Q ss_pred cCCC----------------------------CCCCcCCCcccCCcccc-CcccCCCccchhhHHHHHHHHHh-------
Q 023058 171 LHSQ----------------------------PKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLV------- 214 (288)
Q Consensus 171 ~~~~----------------------------~~~~~~~~~~~aPE~~~-~~~~~~~~~Di~slG~~~~~l~~------- 214 (288)
.... .....+|+.|+|||++. +..++.. +|||||||++|+|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~-~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA-IDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTH-HHHHHHHHHHHHHHTTSTTTCS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcH-hHHHHHHHHHHHHHHhcccccc
Confidence 3221 12335799999999865 4445555 999999999999998
Q ss_pred ----CCCCCCCCCCch----------------hHHHHHHHHhh-----------------------cccC------CCCC
Q 023058 215 ----GAYPFEDPEEPK----------------NFRKTIHRILS-----------------------VQYS------IPDY 245 (288)
Q Consensus 215 ----g~~pf~~~~~~~----------------~~~~~~~~~~~-----------------------~~~~------~~~~ 245 (288)
|..+|.+..... ........+.. .... ....
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence 566664432100 00000000000 0000 0012
Q ss_pred CCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 246 VHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 246 ~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
..+++++.+||.+||+.||.+|||+.|+++ |+|++.
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~---Hp~f~~ 402 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITINECLA---HPFFKE 402 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH---SGGGTT
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhc---CHhhhh
Confidence 356899999999999999999999988866 666543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=314.16 Aligned_cols=256 Identities=21% Similarity=0.306 Sum_probs=211.7
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEc
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT 88 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (288)
.....++|.+.+.||+|+||.||++.+. .++..||+|++.... ...+.+.+|+.++++++||||+++++++..
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 3455789999999999999999999983 455889999987543 333568899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHhhcCceecCCC
Q 023058 89 PTHLAIVMEYASGGELFERICNAGR------------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLK 144 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~~------------------------~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~ 144 (288)
.+..++|||++++++|.+++..... ++..+++.++.||+.||.|||+.|++|+|||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 9999999999999999999976543 8999999999999999999999999999999
Q ss_pred CCceEecCCCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCC
Q 023058 145 LENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFE 220 (288)
Q Consensus 145 p~nilv~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~ 220 (288)
|+||+++.++. ++|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||.
T Consensus 178 p~NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 178 ARNILVAEGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp GGGEEEETTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSST
T ss_pred hheEEEcCCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCcCch-hhHHHHHHHHHHHHhCCCCCCC
Confidence 99999987776 99999999875433222 233446778999999988777666 999999999999999 999998
Q ss_pred CCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 221 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
........... .. ....+....+++++.++|.+||+.||.+|||+.++++.+..
T Consensus 255 ~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 255 GIPPERLFNLL----KT-GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp TCCGGGHHHHH----HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHHHHHHh----hc-CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 76654433222 11 12222334789999999999999999999999999875543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=320.23 Aligned_cols=262 Identities=25% Similarity=0.392 Sum_probs=200.6
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCC-------
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT------- 90 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------- 90 (288)
...++|++.+.||+|+||.||++.+..++..||+|++...........+++..++.++||||+++++++....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 3348999999999999999999999999999999999877666677888999999999999999999986533
Q ss_pred eEEEEEeccCCCchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHh--hcCceecCCCCCceEecC-CCCCCEEEeec
Q 023058 91 HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDG-SPAPRLKICDF 163 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~~i~~~i~~~l~~LH--~~~i~H~dl~p~nilv~~-~~~~~~~l~df 163 (288)
..++||||+++ +|...+ .....++...++.++.|++.||.+|| +.||+|+||||+||+++. ++. ++|+||
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~--~kl~Df 176 (360)
T 3e3p_A 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT--LKLCDF 176 (360)
T ss_dssp EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE--EEECCC
T ss_pred eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc--EEEeeC
Confidence 38899999977 554433 34567899999999999999999999 999999999999999985 555 999999
Q ss_pred CCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc----
Q 023058 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---- 239 (288)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 239 (288)
|++.............+++.|+|||.+.+......++||||||+++|+|++|..||...+................
T Consensus 177 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 177 GSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp TTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 9998776666666677899999999987666434449999999999999999999988665444444433211100
Q ss_pred ---------cCC-------------CCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 240 ---------YSI-------------PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 240 ---------~~~-------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
... ......++++.+||.+||+.||.+|||+.++++ |+|++.+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~---hp~f~~~ 321 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC---HPYFDEL 321 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT---SGGGGGG
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc---Ccccccc
Confidence 000 001125688999999999999999999988876 6666543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=310.02 Aligned_cols=258 Identities=25% Similarity=0.376 Sum_probs=208.7
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEE----EcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcC-
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP- 89 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 89 (288)
....++|++.+.||+|+||.||++. +..+++.||+|++.... ...+.+.+|+.++++++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 3445789999999999999999999 56789999999987543 3446789999999999999999999999877
Q ss_pred -CeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 90 -THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 90 -~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
...++|||++++++|.+++.. ...++...++.++.|++.||++||+.|++|+||||+||+++.++. ++|+|||++.
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~ 174 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTK 174 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCE
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC--EEECcccccc
Confidence 678999999999999999954 457999999999999999999999999999999999999988776 9999999987
Q ss_pred ccccCCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCC-----------CCchhHHHHH
Q 023058 168 SSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-----------EEPKNFRKTI 232 (288)
Q Consensus 168 ~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~-----------~~~~~~~~~~ 232 (288)
....... .....++..|+|||.+.+..++.+ +|+||||+++|+|++|..|+... ..........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcc-hhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 5544332 234457778999999988877766 99999999999999999886432 1111222222
Q ss_pred HHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 233 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.. .......+....+++.+.++|.+||+.||.+|||+.++++.+.
T Consensus 254 ~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 298 (302)
T 4e5w_A 254 NT-LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298 (302)
T ss_dssp HH-HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HH-HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 22 2222333444478999999999999999999999999988553
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=318.74 Aligned_cols=254 Identities=23% Similarity=0.318 Sum_probs=209.8
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcC-------CCcEEEEEEeecCcc--chHHHHHHHHHHhhC-CCCceeeEeEEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI 86 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 86 (288)
....++|++.+.||+|+||.||+|.+.. .+..||+|++..... ..+.+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 4456899999999999999999999753 335799999876532 335688999999999 999999999999
Q ss_pred EcCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEe
Q 023058 87 LTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (288)
Q Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv 150 (288)
..++..++|||++++++|.+++.... .++...++.++.||+.||.+||+.|++||||||+||++
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 99999999999999999999997653 48999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeecCCCcccccCC---CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCch
Q 023058 151 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (288)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~ 226 (288)
+.++. ++|+|||++....... ......+++.|+|||.+.+..++.+ +||||||+++++|++ |..||.......
T Consensus 225 ~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 225 TEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp CTTCC--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred cCCCc--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 87776 9999999987554332 2233446778999999988877766 999999999999999 999998765332
Q ss_pred hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.. ..+... ........+++++.++|.+||+.||.+|||+.++++.+.
T Consensus 302 ~~----~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 348 (382)
T 3tt0_A 302 LF----KLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348 (382)
T ss_dssp HH----HHHHTT-CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH----HHHHcC-CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 22 222222 222233478999999999999999999999999988543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=307.81 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=204.5
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 95 (288)
.++|++.+.||+|+||.||++.+..+++.||+|++... ......+.+|+..+.++ +||||+++++++..++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 47899999999999999999999999999999998864 33445678899999999 999999999999999999999
Q ss_pred EeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-----------------
Q 023058 96 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP----------------- 154 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~----------------- 154 (288)
||++++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999998764 6799999999999999999999999999999999999997543
Q ss_pred CCCEEEeecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 023058 155 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (288)
Q Consensus 155 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (288)
...++|+|||.+...... ....+++.|+|||.+.+......++||||||+++++|++|..++... .......
T Consensus 170 ~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~-- 241 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWHEIR-- 241 (289)
T ss_dssp CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHHHHHH--
T ss_pred ceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHHHHHH--
Confidence 225999999998754432 33458999999999977644444599999999999999998776432 2222211
Q ss_pred HhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 235 ILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 235 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.......+. .+++++.++|.+||+.||.+|||+.++++ |+|+.
T Consensus 242 -~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~---h~~~~ 284 (289)
T 1x8b_A 242 -QGRLPRIPQ--VLSQEFTELLKVMIHPDPERRPSAMALVK---HSVLL 284 (289)
T ss_dssp -TTCCCCCSS--CCCHHHHHHHHHHTCSSGGGSCCHHHHHT---CTTC-
T ss_pred -cCCCCCCCc--ccCHHHHHHHHHHhCCCcccCCCHHHHhh---ChHhh
Confidence 111223333 68999999999999999999999988866 55554
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=324.69 Aligned_cols=256 Identities=28% Similarity=0.459 Sum_probs=204.2
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcC------CeEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP------THLA 93 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~~ 93 (288)
..+|++.+.||+|+||.||++.+..+++.||+|++..... ...+|++++++++||||+++++++... ..++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 3579999999999999999999999999999999876433 234799999999999999999998542 2477
Q ss_pred EEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 94 IVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
+||||+++ ++...+. ....++...++.++.||+.||.|||+.||+||||||+||+++.++. .+||+|||++...
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQL 207 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEEC
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhhc
Confidence 99999976 6655543 3467999999999999999999999999999999999999985533 3899999999866
Q ss_pred ccCCCCCCCcCCCcccCCccccCc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh--------c--
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------V-- 238 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------~-- 238 (288)
..........+++.|+|||.+.+. .++.+ +|||||||++|+|++|..||...+..+........... .
T Consensus 208 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~ 286 (420)
T 1j1b_A 208 VRGEPNVSYICSRYYRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286 (420)
T ss_dssp CTTCCCCSCCSCTTSCCHHHHTTCSSCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred ccCCCceeeeeCCCcCCHHHHcCCCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 555555566789999999998765 45555 99999999999999999999886654444444332110 0
Q ss_pred ---ccCCCC----------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 239 ---QYSIPD----------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 239 ---~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
...++. ...+++++.+||.+||+.||.+|||+.|+++ |+|++.
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~---hp~f~~ 342 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA---HSFFDE 342 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT---SGGGGG
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC---CHhhcc
Confidence 011111 1246899999999999999999999988876 555543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=321.03 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=203.0
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCC--CCceeeEeEEEEcCCeEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLR--HPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~l 94 (288)
.++|++.+.||+|+||.||++.+.. +..||+|++.... ...+.+.+|+.++++++ ||||+++++++..++.+++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 4569999999999999999999875 8899999987643 23456889999999996 5999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
||| +.+++|.+++.....++..+++.++.||+.||.|||+.||+||||||+||+++ ++. +||+|||++........
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~--~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM--LKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSC--EEECCCSSSCCC-----
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCe--EEEEecCccccccCCCc
Confidence 999 55779999999888999999999999999999999999999999999999996 444 99999999986543322
Q ss_pred ---CCCCcCCCcccCCccccC-----------cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc
Q 023058 175 ---PKSTVGTPAYIAPEVLLK-----------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240 (288)
Q Consensus 175 ---~~~~~~~~~~~aPE~~~~-----------~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (288)
.....+++.|+|||.+.+ ..++.+ +||||||+++|+|++|..||....... .....+.....
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~~~~~~~~ 285 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPK-SDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNH 285 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHH-HHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHCTTS
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCCh-hhHHHHHHHHHHHHHCCCcchhhhHHH---HHHHHHhCccc
Confidence 234568999999999865 234444 999999999999999999997654321 12223333333
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 241 SIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 241 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
..+.....++++.+||.+||+.||.+|||+.++++ |+|++
T Consensus 286 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~---hp~~~ 325 (390)
T 2zmd_A 286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA---HPYVQ 325 (390)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT---SHHHH
T ss_pred cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh---CcCcc
Confidence 33333356889999999999999999999988866 55554
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=310.00 Aligned_cols=262 Identities=22% Similarity=0.263 Sum_probs=207.5
Q ss_pred CCCCCCCCCCCCCCeeeee-eeeccCceEEEEEEE--cCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeE
Q 023058 9 GPGMDMPIMHDSDRYELVR-DIGSGNFGVARLMRD--KKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRF 82 (288)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~-~lg~g~~~~v~~~~~--~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~ 82 (288)
....+-......++|.+.+ .||+|+||.||++.+ ..+++.|++|++.... ...+.+.+|+.++++++||||+++
T Consensus 4 ~~i~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 83 (291)
T 1xbb_A 4 EEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83 (291)
T ss_dssp -------CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cccCcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 3333445556678999999 999999999999954 5567899999987643 224678899999999999999999
Q ss_pred eEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEee
Q 023058 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (288)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~d 162 (288)
++++ ..+..++|||++.+++|.+++...+.++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|
T Consensus 84 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~D 160 (291)
T 1xbb_A 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISD 160 (291)
T ss_dssp EEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECC
T ss_pred EEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc--EEEcc
Confidence 9999 55678999999999999999998888999999999999999999999999999999999999988776 99999
Q ss_pred cCCCcccccCCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhh
Q 023058 163 FGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILS 237 (288)
Q Consensus 163 f~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 237 (288)
||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||.......... .+..
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~~~ 235 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA----MLEK 235 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHHT
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHHc
Confidence 999875443322 122335678999999987777665 999999999999999 999998765432222 2222
Q ss_pred cccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 238 VQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 238 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
.. ..+....+++.+.++|.+||+.||.+|||+.++++.+.+
T Consensus 236 ~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 236 GE-RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp TC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 21 122233789999999999999999999999999885543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=326.18 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=210.0
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
.+..++|++.+.||+|+||.||++.+..++..||+|.+.... ...+.+.+|+.++++++||||+++++++..++..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 455689999999999999999999999899999999987542 223467789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 95 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
|||++++++|.+++...+ .++...+..++.|++.||+|||+.|++||||+|+||+++.++. +||+|||++.......
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGV 267 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECTTSE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecCCCc
Confidence 999999999999987654 6999999999999999999999999999999999999987776 9999999987433221
Q ss_pred C---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 174 Q---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 174 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
. .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||.......... .+ ......+....+|
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~t~g~~p~~~~~~~~~~~----~~-~~~~~~~~~~~~~ 341 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTRE----FV-EKGGRLPCPELCP 341 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH----HH-HTTCCCCCCTTCC
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HH-HcCCCCCCCCCCC
Confidence 1 112234567999999988777666 999999999999998 999998765422221 11 2222333334789
Q ss_pred HHHHHHHHHhcccCcCCccccccccccch
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
+.+.++|.+||+.||.+|||+.++++.+.
T Consensus 342 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 370 (377)
T 3cbl_A 342 DAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370 (377)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 99999999999999999999999987554
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=306.90 Aligned_cols=251 Identities=28% Similarity=0.383 Sum_probs=198.7
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
...++|++.+.||+|+||.||++.+. +..+|+|++.... ...+.+.+|+++++.++||||+++++++..++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 45689999999999999999999984 7889999986542 2346788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---ceecCCCCCceEecCC------CCCCEEEeec
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ---VCHRDLKLENTLLDGS------PAPRLKICDF 163 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---i~H~dl~p~nilv~~~------~~~~~~l~df 163 (288)
++|||++++++|.+++. ...++...++.++.|++.||.+||+.| ++|+||+|+||+++.+ ..+.++|+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999988885 457999999999999999999999999 8999999999999752 1335999999
Q ss_pred CCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC
Q 023058 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243 (288)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
|++....... .....+++.|+|||.+.+..++.+ +|+||||+++++|++|..||........ ...........+
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~ 234 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAV----AYGVAMNKLALP 234 (271)
T ss_dssp CC--------------CCGGGSCHHHHHHCCCSHH-HHHHHHHHHHHHHHHCCCTTTTSCHHHH----HHHHHTSCCCCC
T ss_pred Cccccccccc-ccCCCCccceeCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHhhhcCCCCCC
Confidence 9987544332 234568999999999987777665 9999999999999999999987553222 222233333344
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 244 DYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
....+++.+.++|.+||+.||.+|||+.++++.+
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L 268 (271)
T 3dtc_A 235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 4457899999999999999999999999988754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=316.32 Aligned_cols=261 Identities=29% Similarity=0.352 Sum_probs=210.5
Q ss_pred CCCCeeeeeeeeccCceEEEEEEE-cCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCC------ceeeEeEEEEcCCe
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRD-KKTEELVAVKYIERGDKIDENVQREIINHRSLRHP------NIVRFKEVILTPTH 91 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~~~~~ 91 (288)
..++|++.+.||+|+||.||++.+ ..+++.||+|++.......+.+.+|+.+++.++|+ +++++++++...+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 368999999999999999999998 55789999999987666667888999999888654 59999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC---------------
Q 023058 92 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--------------- 154 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~--------------- 154 (288)
.++|||++ +++|.+++...+ .++...++.++.||+.||.|||+.|++|+||||+||+++.++
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99999999 779999887765 689999999999999999999999999999999999998643
Q ss_pred --CCCEEEeecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 023058 155 --APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 232 (288)
Q Consensus 155 --~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~ 232 (288)
.+.++|+|||++.... .......+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...+.........
T Consensus 171 ~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 247 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247 (339)
T ss_dssp ESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHH
T ss_pred ccCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 3459999999987433 23345578999999999988888776 999999999999999999998765433322221
Q ss_pred HHHhhccc------------------CC---------------------CCCCCCCHHHHHHHHHhcccCcCCccccccc
Q 023058 233 HRILSVQY------------------SI---------------------PDYVHISPECRHLISRIFVADPAKVSMHFHA 273 (288)
Q Consensus 233 ~~~~~~~~------------------~~---------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~ 273 (288)
.. ..... .+ ......++++.+||.+||+.||.+|||+.|+
T Consensus 248 ~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 326 (339)
T 1z57_A 248 RI-LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREA 326 (339)
T ss_dssp HH-HCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HH-hCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHH
Confidence 11 11000 00 0011235679999999999999999999888
Q ss_pred cccchhhhhhhhhc
Q 023058 274 TGVYMHTKLQLLVA 287 (288)
Q Consensus 274 l~~~~~~~~~~~~~ 287 (288)
++ |+|++.+-+
T Consensus 327 l~---hp~f~~~~~ 337 (339)
T 1z57_A 327 LK---HPFFDLLKK 337 (339)
T ss_dssp TT---SGGGGGGGC
T ss_pred hc---CHHHHHHhc
Confidence 66 777766543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=313.71 Aligned_cols=257 Identities=23% Similarity=0.343 Sum_probs=214.2
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEE-----cCCCcEEEEEEeecCcc--chHHHHHHHHHHhhC-CCCceeeEeEEEEc
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT 88 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (288)
....++|++.+.||+|+||.||++.+ ..++..||+|.+..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34568999999999999999999985 45678999999876542 346788999999999 99999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEe
Q 023058 89 PTHLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv 150 (288)
++..++|||++++++|.+++.... .++...++.++.|++.||.+||+.|++|+||||+||++
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 999999999999999999987654 48999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCch
Q 023058 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (288)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~ 226 (288)
+.++. ++|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||.......
T Consensus 179 ~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 179 THGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp ETTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cCCCC--EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 87776 99999999875544332 223446778999999987777666 999999999999998 999998776555
Q ss_pred hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhh
Q 023058 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHT 280 (288)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~ 280 (288)
........ .........+++.+.++|.+||+.||.+|||+.++++.+...
T Consensus 256 ~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 256 KFYKMIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp HHHHHHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhcc----CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 44443332 222233346899999999999999999999999998865443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=321.87 Aligned_cols=253 Identities=22% Similarity=0.363 Sum_probs=209.0
Q ss_pred CCCCCeeeeeeeeccCceEEEEEE-----EcCCCcEEEEEEeecCcc--chHHHHHHHHHHhhC-CCCceeeEeEEEEcC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (288)
...++|++.+.||+|+||.||++. +..+++.||+|++..... ..+.+.+|+.+++++ +||||+++++++...
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 456899999999999999999999 556678999999976432 335688999999999 789999999999876
Q ss_pred C-eEEEEEeccCCCchHHHHHhcCC-------------------------------------------------------
Q 023058 90 T-HLAIVMEYASGGELFERICNAGR------------------------------------------------------- 113 (288)
Q Consensus 90 ~-~~~lv~e~~~~~~L~~~~~~~~~------------------------------------------------------- 113 (288)
+ ..++||||+++++|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 5 48999999999999999976543
Q ss_pred -----------CCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC---CCCCc
Q 023058 114 -----------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTV 179 (288)
Q Consensus 114 -----------~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~---~~~~~ 179 (288)
++...++.++.||+.||.|||+.||+|+||||+||+++.++. ++|+|||++........ .....
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC--CE
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhccccC
Confidence 899999999999999999999999999999999999987776 99999999875433322 23345
Q ss_pred CCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHH
Q 023058 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 258 (288)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 258 (288)
+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||............... ....+....+++++.++|.+
T Consensus 257 ~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~ 331 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTMLD 331 (359)
T ss_dssp ECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHH
T ss_pred CCceeEChhhhcCCCCCch-hhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc----CCCCCCCCCCCHHHHHHHHH
Confidence 7888999999988777766 999999999999998 99999877655544433322 22222233689999999999
Q ss_pred hcccCcCCccccccccccc
Q 023058 259 IFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 259 ~l~~~p~~Rpt~~~~l~~~ 277 (288)
||+.||.+|||+.++++.+
T Consensus 332 ~l~~dP~~Rps~~ell~~L 350 (359)
T 3vhe_A 332 CWHGEPSQRPTFSELVEHL 350 (359)
T ss_dssp HTCSSGGGSCCHHHHHHHH
T ss_pred HccCChhhCCCHHHHHHHH
Confidence 9999999999999998744
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=319.30 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=210.1
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccch------------------HHHHHHHHHHhhCCCCcee
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID------------------ENVQREIINHRSLRHPNIV 80 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------------------~~~~~e~~~l~~l~~~~i~ 80 (288)
..++|++.+.||+|+||.||++.+ +++.||+|++....... +.+.+|+.++++++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 358999999999999999999999 79999999987542111 7889999999999999999
Q ss_pred eEeEEEEcCCeEEEEEeccCCCchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEec
Q 023058 81 RFKEVILTPTHLAIVMEYASGGELFER------ICN--AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLD 151 (288)
Q Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~--~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~ 151 (288)
++++++...+..++|||++++++|.++ +.. ...++...++.++.|++.||.+||+ .|++|+||+|+||+++
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 999999999999999999999999887 655 5679999999999999999999999 9999999999999998
Q ss_pred CCCCCCEEEeecCCCcccccCCCCCCCcCCCcccCCccccCc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 023058 152 GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (288)
Q Consensus 152 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~ 230 (288)
.++. ++|+|||++...... ......+++.|+|||.+.+. .++..++|+||||+++++|++|..||....... .
T Consensus 187 ~~~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~ 260 (348)
T 2pml_X 187 KNGR--VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV---E 260 (348)
T ss_dssp TTSC--EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH---H
T ss_pred CCCc--EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH---H
Confidence 7776 999999998754333 33455689999999999877 555535999999999999999999998765532 2
Q ss_pred HHHHHhhcccCCCCC-----------------CCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 231 TIHRILSVQYSIPDY-----------------VHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 231 ~~~~~~~~~~~~~~~-----------------~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
....+......++.. ..+++++.+||.+||+.||.+|||+.++++
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 233334444444421 468999999999999999999999988877
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=306.15 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=212.3
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
....++|++.+.||+|+||.||++.+. ++..|++|.+.......+.+.+|+.++++++||||+++++++..++..+++|
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 345689999999999999999999987 5778999999887777788999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC--
Q 023058 97 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 173 (288)
Q Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-- 173 (288)
|++++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHH
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEccccccccccccccc
Confidence 999999999998765 46899999999999999999999999999999999999987776 9999999987543221
Q ss_pred CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
......+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||......... ..+.... ........++.+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~----~~i~~~~-~~~~~~~~~~~l 234 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVV----EDISTGF-RLYKPRLASTHV 234 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHTTC-CCCCCTTSCHHH
T ss_pred ccccccccccccChhhhcCCCccch-hchhhhHHHHHHHhccCCCCCCCCCHHHHH----HHHhcCC-cCCCCccCcHHH
Confidence 1233456778999999987777655 999999999999999 89999875443322 2222221 222233679999
Q ss_pred HHHHHHhcccCcCCccccccccccch
Q 023058 253 RHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.++|.+||+.||.+|||+.++++.+.
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~L~ 260 (267)
T 3t9t_A 235 YQIMNHCWRERPEDRPAFSRLLRQLA 260 (267)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHH
Confidence 99999999999999999999987543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=317.62 Aligned_cols=256 Identities=21% Similarity=0.223 Sum_probs=203.1
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCC----eE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HL 92 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~ 92 (288)
....++|++.+.||+|+||.||++++. ++.||+|++...........+|+.++++++||||+++++++.... .+
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 356689999999999999999999885 789999999876666666777999999999999999999998743 47
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc----------CceecCCCCCceEecCCCCCCEEEee
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM----------QVCHRDLKLENTLLDGSPAPRLKICD 162 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~----------~i~H~dl~p~nilv~~~~~~~~~l~d 162 (288)
++||||+++++|.+++... .++...++.++.|++.||.|||+. |++|+||||+||+++.++. +||+|
T Consensus 98 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~--~kL~D 174 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIAD 174 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC--EEECC
T ss_pred EEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe--EEEcc
Confidence 9999999999999999664 589999999999999999999999 9999999999999987776 99999
Q ss_pred cCCCcccccCCC---CCCCcCCCcccCCccccCc-----ccCCCccchhhHHHHHHHHHhCCCCCCCCCCch--------
Q 023058 163 FGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-------- 226 (288)
Q Consensus 163 f~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~-------- 226 (288)
||++........ .....+++.|+|||.+.+. .++. ++||||||+++|+|++|..||.......
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL-RIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHH-HHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCc-cchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 999975443332 2335689999999998763 2323 3799999999999999999997653311
Q ss_pred ----hHHHHHHHHhhcccCC--CC---CCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 227 ----NFRKTIHRILSVQYSI--PD---YVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 227 ----~~~~~~~~~~~~~~~~--~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
................ +. ....++++.+||.+||+.||.+|||+.++++.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 314 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1112222221111111 11 0112345999999999999999999999988554
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=322.65 Aligned_cols=269 Identities=17% Similarity=0.171 Sum_probs=207.0
Q ss_pred CCCCCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcC---CCcEEEEEEeecCccc------------hHHHHHHHHHHh
Q 023058 8 VGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGDKI------------DENVQREIINHR 72 (288)
Q Consensus 8 ~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~------------~~~~~~e~~~l~ 72 (288)
+.+|..+ .....++|++.+.||+|+||.||+|.+.. ++..+|+|+....... ...+.+|+..++
T Consensus 25 l~~g~~~-~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~ 103 (345)
T 2v62_A 25 FPEGKVL-DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103 (345)
T ss_dssp CCTTCEE-ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred CCCCCee-ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhc
Confidence 3444444 33445899999999999999999999987 7889999998765321 123567888889
Q ss_pred hCCCCceeeEeEEEEc----CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCce
Q 023058 73 SLRHPNIVRFKEVILT----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148 (288)
Q Consensus 73 ~l~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~ni 148 (288)
.++||||+++++++.. ....++|||++ +++|.+++...+.++..+++.++.||+.||+|||+.||+||||||+||
T Consensus 104 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 182 (345)
T 2v62_A 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANL 182 (345)
T ss_dssp TCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred cccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHE
Confidence 9999999999999988 67899999999 889999998777899999999999999999999999999999999999
Q ss_pred EecCCCCCCEEEeecCCCcccccCCCC--------CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCC
Q 023058 149 LLDGSPAPRLKICDFGYSKSSVLHSQP--------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 220 (288)
Q Consensus 149 lv~~~~~~~~~l~df~~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~ 220 (288)
+++.++.+.++|+|||++......... ....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||.
T Consensus 183 ll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 183 LLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR-SDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp EEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCTTG
T ss_pred EEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCcc
Confidence 998877445999999999755433221 33468999999999988877666 999999999999999999996
Q ss_pred CCCCch-hHHHHHHHHhhccc----CCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 221 DPEEPK-NFRKTIHRILSVQY----SIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 221 ~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
...... .............. .......+++++.++|.+||+.||.+|||+.++++.+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 325 (345)
T 2v62_A 262 QNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP 325 (345)
T ss_dssp GGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred ccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 532222 22222222111111 111122688999999999999999999999999886654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=309.44 Aligned_cols=255 Identities=27% Similarity=0.380 Sum_probs=200.0
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
...++|++.+.||+|+||.||++.+..++..||+|++.... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 34578999999999999999999999899999999987532 33456889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 94 IVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
+|||++.+++|.+++.. ...++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFF 186 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCC------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC--EEEEeccceeee
Confidence 99999999999988864 456899999999999999999999999999999999999987776 999999998754
Q ss_pred ccCCC-CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCC
Q 023058 170 VLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 170 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
..... .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...... .......+............+
T Consensus 187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 263 (310)
T 2wqm_A 187 SSKTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHY 263 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTC---CC--HHHHHHHHHTTCSCCCCTTTS
T ss_pred cCCCccccccCCCeeEeChHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccchh--HHHHHHHhhcccCCCCccccc
Confidence 43322 234468899999999988777666 99999999999999999999764322 222333333333322223468
Q ss_pred CHHHHHHHHHhcccCcCCccccccccccc
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
++++.++|.+||+.||.+|||+.++++.+
T Consensus 264 ~~~l~~li~~~l~~dp~~Rps~~~il~~l 292 (310)
T 2wqm_A 264 SEELRQLVNMCINPDPEKRPDVTYVYDVA 292 (310)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 99999999999999999999999998744
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=305.40 Aligned_cols=251 Identities=20% Similarity=0.273 Sum_probs=207.5
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcC--C
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--T 90 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 90 (288)
.....++|++.+.||+|+||.||++.+. +..+|+|++.... ...+.+.+|+.++++++||||+++++++... .
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 3456689999999999999999999985 7889999987653 3335688999999999999999999999887 7
Q ss_pred eEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC--ceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 91 HLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~--i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
..++|||++++++|.+++.... .++...++.++.|++.||.|||+.| ++|+||+|+||+++.++. +++.||++.
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~ 160 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVK 160 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSC
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccce
Confidence 8899999999999999998765 4899999999999999999999999 999999999999988777 888887765
Q ss_pred cccccCCCCCCCcCCCcccCCccccCcccCCC--ccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC
Q 023058 167 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK--IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244 (288)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~--~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (288)
... ......+++.|+|||.+.+...... ++|+||||+++|+|++|..||........... ..........
T Consensus 161 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~ 232 (271)
T 3kmu_A 161 FSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK----VALEGLRPTI 232 (271)
T ss_dssp CTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH----HHHSCCCCCC
T ss_pred eee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH----HHhcCCCCCC
Confidence 432 2234567899999999987665542 49999999999999999999987654333222 2222322333
Q ss_pred CCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 245 YVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 245 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
...+++++.++|.+||+.||.+|||+.++++.+.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~ 266 (271)
T 3kmu_A 233 PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 3478999999999999999999999999987543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=319.61 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=210.0
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcC
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (288)
....++|++.+.||+|+||.||++.+. .++..||+|++.... ...+.+.+|+.++++++||||+++++++...
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 445689999999999999999999997 345889999987643 2345688999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCC
Q 023058 90 THLAIVMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p 145 (288)
+..++||||+++++|.+++... ..++..+++.++.||+.||.|||+.|++|+||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 9999999999999999998763 5689999999999999999999999999999999
Q ss_pred CceEecCCCCCCEEEeecCCCcccccCC---CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCC
Q 023058 146 ENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFED 221 (288)
Q Consensus 146 ~nilv~~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~ 221 (288)
+||+++.++. ++|+|||++....... ......+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||..
T Consensus 203 ~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 203 RNCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp GGEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ceEEECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcc-cccHHHHHHHHHHHhcCCCcCCC
Confidence 9999987776 9999999987543322 2234457889999999987777666 999999999999998 9999987
Q ss_pred CCCchhHHHHHHHHhhccc-CCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 222 PEEPKNFRKTIHRILSVQY-SIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
....... ..+..... ..+ ..+++.+.++|.+||+.||.+|||+.++++.+..
T Consensus 280 ~~~~~~~----~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~ 332 (343)
T 1luf_A 280 MAHEEVI----YYVRDGNILACP--ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 332 (343)
T ss_dssp SCHHHHH----HHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CChHHHH----HHHhCCCcCCCC--CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHH
Confidence 5543222 22222222 233 3789999999999999999999999998875543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=325.01 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=208.8
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCC-eEEEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIV 95 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv 95 (288)
.+..++|++.+.||+|+||.||++.+. +..||+|++.... ..+.+.+|+.++++++||||+++++++.... ..++|
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 456689999999999999999999985 7799999987654 5678999999999999999999999987665 79999
Q ss_pred EeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 96 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
|||+++++|.+++...+. ++...++.++.||+.||+|||+.|++||||+|+||+++.++. +||+|||++......
T Consensus 266 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST- 342 (450)
T ss_dssp EECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC---
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCccccccc-
Confidence 999999999999977553 799999999999999999999999999999999999987776 999999998744322
Q ss_pred CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
.....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||............. . ....+....+|+.+
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~----~-~~~~~~p~~~~~~l 415 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----K-GYKMDAPDGCPPAV 415 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH----T-TCCCCCCTTCCHHH
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----c-CCCCCCCCcCCHHH
Confidence 223356788999999988888776 999999999999998 999998776554443322 1 22233334789999
Q ss_pred HHHHHHhcccCcCCccccccccccch
Q 023058 253 RHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.++|.+||+.||.+|||+.++++.+.
T Consensus 416 ~~li~~cl~~dp~~Rpt~~~l~~~L~ 441 (450)
T 1k9a_A 416 YDVMKNCWHLDAATRPTFLQLREQLE 441 (450)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 99999999999999999999987554
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=316.81 Aligned_cols=270 Identities=24% Similarity=0.357 Sum_probs=214.7
Q ss_pred CCCCCCCCCCCCCCeeeeeeeeccCceEEEEEE----EcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEe
Q 023058 9 GPGMDMPIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFK 83 (288)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~ 83 (288)
.++..+......++|++.+.||+|+||.||+++ +..++..||+|++.... ...+.+.+|++++++++||||++++
T Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 90 (327)
T 3lxl_A 11 LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90 (327)
T ss_dssp ------CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred HhhcChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEE
Confidence 345666777888999999999999999999999 56688999999987653 3345688999999999999999999
Q ss_pred EEEEc--CCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEE
Q 023058 84 EVILT--PTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (288)
Q Consensus 84 ~~~~~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l 160 (288)
+++.. ....++|||++++++|.+++.. ...++...++.++.|++.||.+||+.|++|+||||+||+++.++. ++|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl 168 (327)
T 3lxl_A 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKI 168 (327)
T ss_dssp EEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEE
T ss_pred EEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEE
Confidence 99874 4678999999999999999976 456999999999999999999999999999999999999988776 999
Q ss_pred eecCCCcccccCCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCc-----------
Q 023058 161 CDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----------- 225 (288)
Q Consensus 161 ~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~----------- 225 (288)
+|||++........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||......
T Consensus 169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~ 247 (327)
T 3lxl_A 169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247 (327)
T ss_dssp CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----C
T ss_pred cccccceecccCCccceeeccCCccccccCHHHhccCCCChH-HhHHHHHHHHHHHHhCCCCCccccchhhhhccccccc
Confidence 99999875543322 233457778999999988777666 99999999999999999998643211
Q ss_pred hhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 226 KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
......... .......+....+++.+.++|.+||+.||.+|||+.++++.+...|.
T Consensus 248 ~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 248 PALSRLLEL-LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp CHHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred ccHHHHHHH-hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111222222 22233334445789999999999999999999999999886655443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=314.40 Aligned_cols=261 Identities=19% Similarity=0.307 Sum_probs=206.0
Q ss_pred CCCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEE----EEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEe
Q 023058 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELV----AVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 83 (288)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~----~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~ 83 (288)
|.+.+......++|++.+.||+|+||.||++.+..+++.+ ++|.+... ....+.+.+|+.++++++||||++++
T Consensus 4 ~~~~~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 83 (327)
T 3lzb_A 4 PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp ----CCEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCC
T ss_pred CchhhhcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEE
Confidence 4455666677899999999999999999999998777655 66655432 34557789999999999999999999
Q ss_pred EEEEcCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEee
Q 023058 84 EVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (288)
Q Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~d 162 (288)
+++..+. .+++++++.+++|.+++.. ...++...++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|
T Consensus 84 ~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~D 160 (327)
T 3lzb_A 84 GICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITD 160 (327)
T ss_dssp EEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECC
T ss_pred EEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEcc
Confidence 9998765 7889999999999998876 457999999999999999999999999999999999999988776 99999
Q ss_pred cCCCcccccCCCC---CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhc
Q 023058 163 FGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV 238 (288)
Q Consensus 163 f~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 238 (288)
||++......... ....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||............ ..
T Consensus 161 fG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-----~~ 234 (327)
T 3lzb_A 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-----EK 234 (327)
T ss_dssp TTC----------------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-----HT
T ss_pred CcceeEccCccccccccCCCccccccCHHHHcCCCCChH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-----Hc
Confidence 9999755433222 22335678999999988887766 999999999999999 99999876554332222 12
Q ss_pred ccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 239 QYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
....+....+++++.++|.+||+.||.+|||+.++++.+..
T Consensus 235 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 275 (327)
T 3lzb_A 235 GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 22333344689999999999999999999999999885543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=315.63 Aligned_cols=260 Identities=19% Similarity=0.314 Sum_probs=205.5
Q ss_pred CCCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcE----EEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEe
Q 023058 10 PGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEEL----VAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 83 (288)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~----~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~ 83 (288)
|.+.+......++|++.+.||+|+||+||++.+..+++. |++|.+... ....+.+.+|+.++++++||||++++
T Consensus 4 p~~~~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 83 (327)
T 3poz_A 4 PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83 (327)
T ss_dssp --CCSSEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEE
T ss_pred hhHHHHhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEE
Confidence 344555666779999999999999999999998877665 477776533 24456789999999999999999999
Q ss_pred EEEEcCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEee
Q 023058 84 EVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (288)
Q Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~d 162 (288)
+++.... .+++++++.+++|.+++.. ...++...++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|
T Consensus 84 ~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~D 160 (327)
T 3poz_A 84 GICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITD 160 (327)
T ss_dssp EEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECC
T ss_pred EEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEcc
Confidence 9998765 7789999999999998876 457999999999999999999999999999999999999988776 99999
Q ss_pred cCCCcccccCCCC---CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhc
Q 023058 163 FGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV 238 (288)
Q Consensus 163 f~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 238 (288)
||++......... ....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||......... ... ..
T Consensus 161 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~----~~ 234 (327)
T 3poz_A 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL----EK 234 (327)
T ss_dssp TTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHH----HT
T ss_pred CcceeEccCCcccccccCCCccccccChHHhccCCCCch-hhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HHH----Hc
Confidence 9998754433322 22345778999999988888766 999999999999999 99999876543332 221 12
Q ss_pred ccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 239 QYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
....+....++.++.+++.+||+.||.+|||+.++++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 274 (327)
T 3poz_A 235 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 274 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 2223333468999999999999999999999999987543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=322.49 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=202.1
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCC------eE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT------HL 92 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~ 92 (288)
...+|++.+.||+|+||+||+|.+..++. +|+|++...... ..+|+.+++.++||||+++++++...+ .+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 34689999999999999999999987665 788877654332 247999999999999999999986533 48
Q ss_pred EEEEeccCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEec-CCCCCCEEEeecCCCcc
Q 023058 93 AIVMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKS 168 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~-~~~~~~~~l~df~~~~~ 168 (288)
++||||++++.+.... .....++...++.++.||+.||+|||+.||+||||||+||+++ .++. ++|+|||++..
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~--~kL~DFG~a~~ 191 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV--LKLIDFGSAKI 191 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE--EEECCCTTCEE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc--EEEeeCCCccc
Confidence 8999999774333222 2356799999999999999999999999999999999999998 5555 99999999987
Q ss_pred cccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc----------
Q 023058 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------- 238 (288)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 238 (288)
...........+++.|+|||.+.+......++|+|||||++|+|++|..||...+..+............
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 192 LIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp CCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred ccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 6666666667789999999998776533444999999999999999999998876544444443321100
Q ss_pred ---ccCCCC----------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 239 ---QYSIPD----------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 239 ---~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
...++. ...+++++.+||.+||+.||.+|||+.++++ |+|++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~---hp~f~~ 327 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC---HPFFDE 327 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT---SGGGST
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc---Chhhhh
Confidence 001111 1247899999999999999999999988866 666653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=321.81 Aligned_cols=254 Identities=25% Similarity=0.437 Sum_probs=190.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcC------C
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T 90 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 90 (288)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+++.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 489999999999999999999999999999999986532 3345678999999999999999999999764 5
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
..+++++++ +++|.+++.. ..++...+..++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++....
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~ 183 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTA 183 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC--------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeecccccccc
Confidence 679999999 6699888865 57999999999999999999999999999999999999987776 9999999987543
Q ss_pred cCCCCCCCcCCCcccCCccccC-cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-----------
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV----------- 238 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 238 (288)
. ......+++.|+|||.+.+ ..++.+ +|+|||||++|+|++|..||...+.......+.......
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 184 D--EMTGYVATRWYRAPEIMLNWMHYNQT-VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTT-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred c--cCCCcCcCcCccChHHHcCCcCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 2 2334568999999999877 445555 999999999999999999998766544444333221110
Q ss_pred --------ccCCCC------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 239 --------QYSIPD------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 239 --------~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
....+. ....++.+.+||.+||+.||.+|||+.++++ |+|++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~---hp~~~ 316 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA---HAYFA 316 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT---SGGGT
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc---Chhhh
Confidence 000010 1246889999999999999999999988876 55554
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=317.26 Aligned_cols=256 Identities=23% Similarity=0.343 Sum_probs=210.8
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEc-----CCCcEEEEEEeecC--ccchHHHHHHHHHHhhC-CCCceeeEeEEEEc
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILT 88 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (288)
....++|++.+.||+|+||.||++.+. .++..||+|++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 345689999999999999999999973 35678999998753 33456789999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCC
Q 023058 89 PTHLAIVMEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 145 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p 145 (288)
.+..++|||++++++|.+++.... .++...++.++.||+.||.+||+.|++|+||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 999999999999999999997643 278999999999999999999999999999999
Q ss_pred CceEecCCCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCC
Q 023058 146 ENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFED 221 (288)
Q Consensus 146 ~nilv~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~ 221 (288)
+||+++.++. ++|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||..
T Consensus 201 ~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 201 RNVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp GGEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hhEEEcCCCc--EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChh-HhHHHHHHHHHHHHcCCCCCccc
Confidence 9999987776 99999999875543322 123346778999999988777666 999999999999998 9999988
Q ss_pred CCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 222 PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
............. ....+....+++++.++|.+||+.||.+|||+.++++.+..
T Consensus 278 ~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 331 (344)
T 1rjb_A 278 IPVDANFYKLIQN----GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 331 (344)
T ss_dssp CCCSHHHHHHHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcHHHHHHHHhc----CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 7655544443322 22333334689999999999999999999999999885543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=315.82 Aligned_cols=258 Identities=29% Similarity=0.415 Sum_probs=189.4
Q ss_pred CCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEcC
Q 023058 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (288)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (288)
...|.....++|++.+.||+|++|.||++.+..+++.||+|.+... ....+.+.+|+.++++++||||+++++++...
T Consensus 6 ~~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 6 SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp -------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS
T ss_pred cccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 3456677789999999999999999999999888999999988654 23445678999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEe
Q 023058 90 THLAIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~ 161 (288)
+..++|||++++++|.+++.. ...++...++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~ 163 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIA 163 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEEC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEE
Confidence 999999999999999998864 346899999999999999999999999999999999999987776 9999
Q ss_pred ecCCCcccccCC------CCCCCcCCCcccCCccccCc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 023058 162 DFGYSKSSVLHS------QPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (288)
Q Consensus 162 df~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (288)
|||++....... ......+++.|+|||.+.+. .++.+ +|+||||+++|+|++|..||.............
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-- 240 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTL-- 240 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTH-HHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH--
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCch-hhHHHHHHHHHHHHhCCCCCccCchhhHHHHHh--
Confidence 999876443321 12334688999999998763 44444 999999999999999999998765544332221
Q ss_pred HhhcccCC-------CCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 235 ILSVQYSI-------PDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 235 ~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
....... .....+++++.++|.+||+.||.+|||+.++++
T Consensus 241 -~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 -QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -TSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -ccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1111111 112367899999999999999999999998877
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=321.25 Aligned_cols=254 Identities=19% Similarity=0.281 Sum_probs=206.8
Q ss_pred CCCCCeeeeeeeeccCceEEEEEE-----EcCCCcEEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (288)
...++|++.+.||+|+||.||+|. +..++..||+|++... ......+.+|+.++++++||||+++++++....
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 345889999999999999999999 4456789999998653 233346888999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-CCCEEEee
Q 023058 91 HLAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICD 162 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~-~~~~~l~d 162 (288)
..++|||++++++|.+++.... .++..+++.++.||+.||.|||+.||+||||||+||+++.++ ...++|+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999999997643 489999999999999999999999999999999999998543 22499999
Q ss_pred cCCCcccccC---CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhc
Q 023058 163 FGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV 238 (288)
Q Consensus 163 f~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 238 (288)
||++...... .......+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||......... ..+...
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~pf~~~~~~~~~----~~i~~~ 302 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVL----EFVTSG 302 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH----HHHHTT
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcC
Confidence 9998643222 22334557889999999988887766 999999999999998 99999876543322 222222
Q ss_pred ccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 239 QYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
. .......+++.+.+||.+||+.||.+|||+.++++.+
T Consensus 303 ~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l 340 (367)
T 3l9p_A 303 G-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340 (367)
T ss_dssp C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred C-CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 2 2222337899999999999999999999999998844
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=315.14 Aligned_cols=269 Identities=29% Similarity=0.435 Sum_probs=185.8
Q ss_pred cCCCCCCCCCCCCCCCeeeee-eeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEE
Q 023058 7 TVGPGMDMPIMHDSDRYELVR-DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 85 (288)
Q Consensus 7 ~~~~~~~~~~~~~~~~y~~~~-~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 85 (288)
+..+|-........++|++.+ .||+|+||.||++.+..+++.||+|++..... ...+....++.++||||++++++
T Consensus 14 ~~~~~p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~e~~~~~~~~~h~~i~~~~~~ 90 (336)
T 3fhr_A 14 VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---ARQEVDHHWQASGGPHIVCILDV 90 (336)
T ss_dssp ------CCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH---HHHHHHHHHHHTTSTTBCCEEEE
T ss_pred ccccCCCCCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH---HHHHHHHHHHhcCCCChHHHHHH
Confidence 444555555566679999966 59999999999999999999999999876432 22333344677799999999999
Q ss_pred EEc----CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-CCCE
Q 023058 86 ILT----PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRL 158 (288)
Q Consensus 86 ~~~----~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~-~~~~ 158 (288)
+.. ....++||||+++++|.+++.... .+++.+++.++.||+.||.|||+.|++|+||+|+||+++.++ .+.+
T Consensus 91 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~ 170 (336)
T 3fhr_A 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL 170 (336)
T ss_dssp EEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCE
T ss_pred HhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceE
Confidence 876 456899999999999999997754 699999999999999999999999999999999999997533 3459
Q ss_pred EEeecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 023058 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238 (288)
Q Consensus 159 ~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (288)
+|+|||++..... .......+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||...............+...
T Consensus 171 kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (336)
T 3fhr_A 171 KLTDFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG 248 (336)
T ss_dssp EECCCTTCEEC-----------------------CHHHHH-HHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred EEeccccceeccc-cccccCCCCcCccChhhhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc
Confidence 9999999875432 22344567999999999987777666 999999999999999999998765433322222222222
Q ss_pred cc--CCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 239 QY--SIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 239 ~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.. ..+.+..+++++.+||.+||+.||.+|||+.++++ |+|+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~---hp~~~ 292 (336)
T 3fhr_A 249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN---HPWIN 292 (336)
T ss_dssp --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH---SHHHH
T ss_pred ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc---Ccccc
Confidence 22 23334578999999999999999999999988866 66664
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=307.96 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=202.0
Q ss_pred CCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcC-Ce
Q 023058 13 DMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP-TH 91 (288)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~ 91 (288)
........++|++.+.||+|++|.||++.+. ++.||+|++.... ..+.+.+|+.++++++||||+++++++... +.
T Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 13 RSGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp --CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred hccccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 3334456799999999999999999999884 7899999987543 556789999999999999999999997654 47
Q ss_pred EEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 92 LAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
.++|||++++++|.+++...+. ++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~ 167 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEA 167 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC----
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--EEEeeccccccc
Confidence 8999999999999999876543 899999999999999999999999999999999999987776 999999998744
Q ss_pred ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCC
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
... .....+++.|+|||.+.+..++.+ +|+||||+++++|++ |..||........... +... ........+
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~ 239 (278)
T 1byg_A 168 SST--QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----VEKG-YKMDAPDGC 239 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----HTTT-CCCCCCTTC
T ss_pred ccc--ccCCCccccccCHHHhCCCCCCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HhcC-CCCCCcccC
Confidence 332 233456788999999987777666 999999999999998 9999987654333322 2221 222333478
Q ss_pred CHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
++.+.++|.+||+.||.+|||+.++++.+.+
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 9999999999999999999999999885543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=307.81 Aligned_cols=260 Identities=22% Similarity=0.316 Sum_probs=197.4
Q ss_pred CCCCCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEE
Q 023058 11 GMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVIL 87 (288)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (288)
...-+..+..++|++.+.||+|+||+||++.+.. .+++|++.... ...+.+.+|+.++++++||||++++++.
T Consensus 14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp ----CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred CCCCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 3344556667999999999999999999998753 49999987543 2335688999999999999999999965
Q ss_pred cCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 88 TPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
.....++|||++.+++|.+.+... ..++...++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~ 167 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLA 167 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC--
T ss_pred cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEEccceec
Confidence 456689999999999999988543 46999999999999999999999999999999999999988776 999999998
Q ss_pred cccccC---CCCCCCcCCCcccCCcccc---CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc
Q 023058 167 KSSVLH---SQPKSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240 (288)
Q Consensus 167 ~~~~~~---~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (288)
...... .......+++.|+|||.+. +..++.+ +||||||+++++|++|..||................. ...
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~ 245 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ-SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS-LSP 245 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHH-HHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS-CCC
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcc-cchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc-cCc
Confidence 744332 2223446899999999986 3444444 9999999999999999999987766544444332211 111
Q ss_pred CCC-CCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 241 SIP-DYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 241 ~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
... ....+|+.+.++|.+||+.||.+|||+.++++.+.
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 284 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 111 12368899999999999999999999999987553
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=307.29 Aligned_cols=254 Identities=23% Similarity=0.343 Sum_probs=198.8
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCC---CcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
....++|++.+.||+|+||.||++.+..+ +..|++|...... ...+.+.+|+..+++++||||+++++++. ++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 34568999999999999999999998653 4569999876532 33456889999999999999999999984 567
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.++|||++++++|.+++.... .++...++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYME 167 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC--------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC--EEECccccccccC
Confidence 899999999999999997654 6999999999999999999999999999999999999987776 9999999987554
Q ss_pred cCCC--CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 171 LHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 171 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
.... .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||............ .... ..+....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i----~~~~-~~~~~~~ 241 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENGE-RLPMPPN 241 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTTC-CCCCCTT
T ss_pred cccccccccCCCcccccChhhcccCCCCCc-cCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH----HcCC-CCCCCCC
Confidence 3322 223345678999999987777666 999999999999996 99999876654443332 2211 2223347
Q ss_pred CCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
+|+.+.++|.+||+.||.+|||+.++++.+..
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 273 (281)
T 1mp8_A 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 273 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 89999999999999999999999999885543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=327.22 Aligned_cols=257 Identities=25% Similarity=0.363 Sum_probs=209.9
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC--eEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLA 93 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~ 93 (288)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|++++++++||||+++++++.... ..+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 34689999999999999999999999999999999987543 33467789999999999999999999998765 789
Q ss_pred EEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEe----cCCCCCCEEEeecCCC
Q 023058 94 IVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL----DGSPAPRLKICDFGYS 166 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv----~~~~~~~~~l~df~~~ 166 (288)
+||||+++++|.+++.... .++...++.++.||+.||+|||+.||+||||||+||++ +.++ .++|+|||++
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~DFG~a 163 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAA 163 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE--EEEECCGGGC
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce--eEEEecCCCc
Confidence 9999999999999986543 39999999999999999999999999999999999998 4443 4999999999
Q ss_pred cccccCCCCCCCcCCCcccCCccccC--------cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 023058 167 KSSVLHSQPKSTVGTPAYIAPEVLLK--------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238 (288)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (288)
.............+++.|+|||.+.+ ..++.+ +|+||||+++|+|++|..||...............+...
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHH-HHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred eEccCCCccccccCCccccCHHHhhccccccccccCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 86655555556678999999999865 334444 999999999999999999998655444444444444443
Q ss_pred ccC-------------------CCCC----CCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 239 QYS-------------------IPDY----VHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 239 ~~~-------------------~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
... .+.. ..+++.+.++|.+||+.||.+|||+.++++.+
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l 304 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHH
Confidence 321 1111 12446789999999999999999999987743
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=316.56 Aligned_cols=260 Identities=15% Similarity=0.186 Sum_probs=201.4
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCC-----CcEEEEEEeecCccch------------HHHHHHHHHHhhCCCCcee
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKT-----EELVAVKYIERGDKID------------ENVQREIINHRSLRHPNIV 80 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~iK~~~~~~~~~------------~~~~~e~~~l~~l~~~~i~ 80 (288)
...++|++.+.||+|+||.||++.+..+ ++.||+|++....... .....|+..++.++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3457999999999999999999998764 5789999987653211 1233455666778899999
Q ss_pred eEeEEEEcC----CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCC
Q 023058 81 RFKEVILTP----THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA 155 (288)
Q Consensus 81 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~ 155 (288)
++++++... ...++|||++ +++|.+++... ..++...++.++.||+.||.|||+.||+||||||+||+++.+..
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998764 4689999999 88999999775 57999999999999999999999999999999999999984344
Q ss_pred CCEEEeecCCCcccccCCCC--------CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 023058 156 PRLKICDFGYSKSSVLHSQP--------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (288)
Q Consensus 156 ~~~~l~df~~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~ 227 (288)
+.++|+|||++......... ....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||........
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR-GDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 45999999999754433221 23348999999999988887666 9999999999999999999986443332
Q ss_pred HHHHHHHHhhccc-C----CCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 228 FRKTIHRILSVQY-S----IPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 228 ~~~~~~~~~~~~~-~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
............. . ......+|+++.++|..||+.||.+||++.++++.+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 2222111111110 0 00113679999999999999999999999998875543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=309.49 Aligned_cols=260 Identities=28% Similarity=0.396 Sum_probs=209.8
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEc-CCCcEEEEEEeecCc---cchHHHHHHHHHHhhC---CCCceeeEeEEEE---
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDK-KTEELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVIL--- 87 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~--- 87 (288)
...++|++.+.||+|+||.||++.+. .+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34589999999999999999999995 678899999987532 2233566777777666 8999999999987
Q ss_pred --cCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeec
Q 023058 88 --TPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (288)
Q Consensus 88 --~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df 163 (288)
.....++|||+++ ++|.+++.... .++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+||
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Df 164 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADF 164 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecC
Confidence 5568999999997 59999887654 4899999999999999999999999999999999999987776 999999
Q ss_pred CCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc-cCC
Q 023058 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSI 242 (288)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~ 242 (288)
|++.............+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||.................... ..+
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred cccccccCCCCccccccccceeCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence 99876655444455678999999999988887766 9999999999999999999987765444444433221100 000
Q ss_pred C--------------------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 243 P--------------------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 243 ~--------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
+ ....+++.+.+||.+||+.||.+|||+.++++ |+|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~---hp~~~~ 302 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS---HPYFQD 302 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT---SGGGTT
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc---Cccccc
Confidence 0 11357899999999999999999999988866 666653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=308.29 Aligned_cols=252 Identities=30% Similarity=0.480 Sum_probs=206.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC-----ccchHHHHHHHHHHhhCCCCceeeEeEEEEc--CCeE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----DKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHL 92 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 92 (288)
.++|++.+.||+|+||.||++.+..++..+++|++... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47999999999999999999999999999999998754 2345678899999999999999999999853 4588
Q ss_pred EEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 93 AIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
++|||++.++ |.+.+.. ...++...++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccC
Confidence 9999999775 7666655 346999999999999999999999999999999999999987776 9999999987543
Q ss_pred cCC---CCCCCcCCCcccCCccccCccc-CCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCC
Q 023058 171 LHS---QPKSTVGTPAYIAPEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (288)
Q Consensus 171 ~~~---~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
... ......+++.|+|||.+.+... ...++|+||||+++|+|++|..||..... ......+......++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~i~~~~~~~~~-- 234 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI----YKLFENIGKGSYAIPG-- 234 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHCCCCCCS--
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH----HHHHHHHhcCCCCCCC--
Confidence 321 1234568999999999876432 24459999999999999999999986543 2333344444444444
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.+++.+.++|.+||+.||.+|||+.++++ |+|+.
T Consensus 235 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~---~~~~~ 268 (305)
T 2wtk_C 235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQ---HSWFR 268 (305)
T ss_dssp SSCHHHHHHHHHHTCSSTTTSCCHHHHHH---SHHHH
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhc---Ccccc
Confidence 68999999999999999999999988865 66654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=330.65 Aligned_cols=252 Identities=20% Similarity=0.301 Sum_probs=214.4
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
+..++|++.+.||+|+||.||++.+..++..||+|.+.......+.+.+|+.++++++||||+++++++......++|||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34578999999999999999999999889999999998877777889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-
Q 023058 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (288)
Q Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~- 174 (288)
++++++|.+++... ..++...++.++.||+.||+|||+.||+||||||+||+++.++. +||+|||++........
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCCEE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCcee
Confidence 99999999999764 35899999999999999999999999999999999999987776 99999999875433221
Q ss_pred -CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
.....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...+........ ......+....+|+.+
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l 448 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-----EKDYRMERPEGCPEKV 448 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-----HTTCCCCCCTTCCHHH
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcH-HhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----HcCCCCCCCCCCCHHH
Confidence 122335678999999988887766 999999999999998 99999876544333222 2223333344789999
Q ss_pred HHHHHHhcccCcCCccccccccccc
Q 023058 253 RHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.+||.+||+.||.+|||+.++++.+
T Consensus 449 ~~li~~cl~~dP~~RPs~~el~~~L 473 (495)
T 1opk_A 449 YELMRACWQWNPSDRPSFAEIHQAF 473 (495)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCcChhHCcCHHHHHHHH
Confidence 9999999999999999999998744
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=305.10 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=209.6
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
.....++|++.+.||+|+||.||++.+. ++..||+|.+.......+.+.+|++++++++||||+++++++.. +..++|
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 85 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence 3445689999999999999999999976 56789999998877777889999999999999999999999864 568999
Q ss_pred EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 96 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
||++++++|.+++.... .++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNE 163 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSC
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccccCcc
Confidence 99999999999986543 6999999999999999999999999999999999999987776 9999999987554322
Q ss_pred C--CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 174 Q--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 174 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
. .....+++.|+|||.+.+..++.+ +|+||||+++++|++ |..||........... +... ........+++
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~ 237 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN----LERG-YRMVRPDNCPE 237 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHTT-CCCCCCTTCCH
T ss_pred cccccCCCCccCccChhhhccCCCCch-hhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH----Hhcc-cCCCCcccccH
Confidence 1 223446778999999987777666 999999999999999 9999987654332222 2222 22233347899
Q ss_pred HHHHHHHHhcccCcCCccccccccccch
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.+.++|.+||+.||.+|||+.++++.+.
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l~~~l~ 265 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 9999999999999999999999887543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=319.60 Aligned_cols=255 Identities=11% Similarity=0.125 Sum_probs=207.3
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcC--------CCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceee---------
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKK--------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR--------- 81 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~--------- 81 (288)
..++|++.+.||+|+||.||++.+.. .++.||+|++... +.+.+|+.++++++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 35899999999999999999999987 3789999998754 46789999999999998887
Q ss_pred ------EeEEEEc-CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC
Q 023058 82 ------FKEVILT-PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (288)
Q Consensus 82 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~ 152 (288)
+++++.. ++..++|||++ +++|.+++... ..++...++.++.||+.||.|||+.|++|+||||+||+++.
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence 6777776 67899999999 88999999876 67999999999999999999999999999999999999997
Q ss_pred CCCCCEEEeecCCCcccccCCC--------CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCC-
Q 023058 153 SPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE- 223 (288)
Q Consensus 153 ~~~~~~~l~df~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~- 223 (288)
++..+++|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||....
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR-SDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCcccCCc
Confidence 7633499999999975443322 123468999999999988777666 999999999999999999998765
Q ss_pred CchhHHHHHHHHhhcccCCCC----CCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 224 EPKNFRKTIHRILSVQYSIPD----YVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
..................+.. +..+++.+.++|.+||+.||.+|||+.++++.+..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp CHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred CHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 333333333333332222222 23578999999999999999999999999885544
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=308.83 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=206.5
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
...++|++.+.||+|+||.||++.+..++..+++|++.... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 44589999999999999999999999999999999987543 44567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc-CCC
Q 023058 97 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~-~~~ 174 (288)
|++++++|.+++.. ...++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCccccccccc
Confidence 99999999988865 457999999999999999999999999999999999999987776 99999998653221 122
Q ss_pred CCCCcCCCcccCCcccc-----CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 175 PKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
.....+++.|+|||.+. +..++.+ +|+||||+++|+|++|..||............. ............++
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 249 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSDPPTLLTPSKWS 249 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HSCCCCCSSGGGSC
T ss_pred cccccCChhhcCCeeeccccCCCCCCchh-hhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHh---ccCCcccCCccccC
Confidence 33456889999999984 4445544 999999999999999999998765433322221 11222222334678
Q ss_pred HHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
..+.++|.+||+.||.+|||+.++++ |+|++
T Consensus 250 ~~l~~li~~~l~~dp~~Rps~~~ll~---h~~~~ 280 (302)
T 2j7t_A 250 VEFRDFLKIALDKNPETRPSAAQLLE---HPFVS 280 (302)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHTT---STTTT
T ss_pred HHHHHHHHHHcccChhhCCCHHHHhc---ChHHh
Confidence 99999999999999999999988876 55544
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=319.64 Aligned_cols=255 Identities=22% Similarity=0.347 Sum_probs=200.8
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEc---CCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDK---KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (288)
.....++|++.+.||+|+||.||++++. .++..||+|.+.... ...+.+.+|+.++++++||||+++++++...+
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 3455679999999999999999999986 456789999987643 33456889999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 91 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
..++||||+++++|.+++...+ .++..+++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++...
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~ 197 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVL 197 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC------
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCcccccc
Confidence 9999999999999999997654 6999999999999999999999999999999999999987776 999999998755
Q ss_pred ccCCCC----CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCC
Q 023058 170 VLHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244 (288)
Q Consensus 170 ~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (288)
...... ....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||.......... .+. .....+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~----~i~-~~~~~~~ 271 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIK----AVD-EGYRLPP 271 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTC-CTTTTCCHHHHHH----HHH-TTEECCC
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHH-cCCCCCC
Confidence 433221 11234678999999988777766 999999999999997 999998765433222 222 2233344
Q ss_pred CCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 245 YVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 245 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
...++..+.++|.+||+.||.+||++.++++.+.
T Consensus 272 ~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~ 305 (373)
T 2qol_A 272 PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305 (373)
T ss_dssp CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHH
Confidence 4478999999999999999999999999987543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=305.13 Aligned_cols=260 Identities=26% Similarity=0.369 Sum_probs=212.2
Q ss_pred CCCCCCCeeeee-eeeccCceEEEEEEEc--CCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC
Q 023058 16 IMHDSDRYELVR-DIGSGNFGVARLMRDK--KTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (288)
Q Consensus 16 ~~~~~~~y~~~~-~lg~g~~~~v~~~~~~--~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (288)
.....++|.+.+ .||+|+||.||++.+. .++..||+|++.... ...+.+.+|+.++++++||||+++++++ ..+
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 345568898888 9999999999999864 467889999987643 3446788999999999999999999999 455
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 91 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
..++|||++++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~ 160 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKAL 160 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC--EEECcccceeee
Confidence 689999999999999998654 46999999999999999999999999999999999999987776 999999998755
Q ss_pred ccCCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhc-ccCCC
Q 023058 170 VLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV-QYSIP 243 (288)
Q Consensus 170 ~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~ 243 (288)
..... .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||........... +... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----i~~~~~~~~~ 235 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IEQGKRMECP 235 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH----HHTTCCCCCC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----HhcCCcCCCC
Confidence 43322 223345788999999987777666 999999999999998 9999987665333322 2222 22333
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 244 DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
..+|+++.++|.+||+.||.+|||+.++++.+..-+.+.-
T Consensus 236 --~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 236 --PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp --TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 3789999999999999999999999999987766655543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=329.20 Aligned_cols=246 Identities=13% Similarity=0.101 Sum_probs=194.9
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHH---HHHhhCCCCceeeEe-------E
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREI---INHRSLRHPNIVRFK-------E 84 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~---~~l~~l~~~~i~~~~-------~ 84 (288)
..++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+.+|+ ..+++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 458899999999999999999999889999999998743 23446788999 555566899999988 7
Q ss_pred EEEcCC-----------------eEEEEEeccCCCchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHhhcCcee
Q 023058 85 VILTPT-----------------HLAIVMEYASGGELFERICNAGRFSE-------DEARFFFQQLISGVSYCHSMQVCH 140 (288)
Q Consensus 85 ~~~~~~-----------------~~~lv~e~~~~~~L~~~~~~~~~~~~-------~~~~~i~~~i~~~l~~LH~~~i~H 140 (288)
++...+ ..+++||++ +++|.+++...+.+++ ..++.++.||+.||+|||+.||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 776653 289999999 5699999976555555 788889999999999999999999
Q ss_pred cCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCcCCCcccCCccccCc-----------ccCCCccchhhHHHHH
Q 023058 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-----------EYDGKIADVWSCGVTL 209 (288)
Q Consensus 141 ~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~~Di~slG~~~ 209 (288)
|||||+||+++.++. +||+|||++..... ......+ +.|+|||.+.+. .++.+ +|+||||+++
T Consensus 230 rDikp~NIll~~~~~--~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~-~DvwSlG~il 303 (377)
T 3byv_A 230 TYLRPVDIVLDQRGG--VFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS-FDAWALGLVI 303 (377)
T ss_dssp SCCCGGGEEECTTCC--EEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH-HHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCC--EEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChh-hhHHHHHHHH
Confidence 999999999987776 99999999874322 2233456 999999999877 66655 9999999999
Q ss_pred HHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 210 YVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 210 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
|+|++|..||........... .......+++++.+||.+||+.||.+|||+.++++ |+|++.
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~---hp~f~~ 365 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEW----------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME---TPEYEQ 365 (377)
T ss_dssp HHHHHSSCCC------CCSGG----------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT---SHHHHH
T ss_pred HHHHHCCCCCcccccccchhh----------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh---ChHHHH
Confidence 999999999976543222111 11222468999999999999999999999988877 555543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=324.67 Aligned_cols=252 Identities=22% Similarity=0.342 Sum_probs=210.9
Q ss_pred CCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 16 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
..+..++|++.+.||+|+||.||++.+. ++..||+|++.......+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 3455689999999999999999999986 4678999999887777788999999999999999999999986 5678999
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 96 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
||++.+++|.+++... ..++...++.++.||+.||+|||+.|++||||||+||+++.++. +||+|||++.......
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNE 338 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBCCHH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcCCCc
Confidence 9999999999999754 36899999999999999999999999999999999999987776 9999999987543221
Q ss_pred --CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 174 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 174 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
......+++.|+|||.+....++.+ +||||||+++|+|++ |..||............ .. ....+....+|+
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i----~~-~~~~~~~~~~~~ 412 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL----ER-GYRMPRPENCPE 412 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----HH-TCCCCCCTTSCH
T ss_pred eeccCCCcccccccCHHHhccCCCCcH-HHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH----Hc-CCCCCCCCCCCH
Confidence 1223345678999999987777666 999999999999999 99999876543333222 22 233344457899
Q ss_pred HHHHHHHHhcccCcCCccccccccccc
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
++.++|.+||+.||.+|||+.++++.+
T Consensus 413 ~l~~li~~cl~~dp~~RPt~~~i~~~L 439 (454)
T 1qcf_A 413 ELYNIMMRCWKNRPEERPTFEYIQSVL 439 (454)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 999999999999999999999887644
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=318.29 Aligned_cols=258 Identities=23% Similarity=0.343 Sum_probs=196.9
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc------------chHHHHHHHHHHhhCCCCceeeEeEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------------IDENVQREIINHRSLRHPNIVRFKEVI 86 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------------~~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (288)
..++|++.+.||+|+||.||++.+.. +..||+|++..... ..+.+.+|+.++++++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 46899999999999999999999875 89999999864321 126788999999999999999999998
Q ss_pred Ec-----CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEE
Q 023058 87 LT-----PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 160 (288)
Q Consensus 87 ~~-----~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l 160 (288)
.. ....++|||++.+ +|.+.+... ..++...++.++.||+.||.|||+.|++|+||||+||+++.++. ++|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl 175 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITI 175 (362)
T ss_dssp EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEE
T ss_pred EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEE
Confidence 54 3478999999975 777777654 36999999999999999999999999999999999999987776 999
Q ss_pred eecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc--
Q 023058 161 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-- 238 (288)
Q Consensus 161 ~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-- 238 (288)
+|||++.............+++.|+|||.+.+......++|+||||+++|+|++|..||...................
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 999999865555555666789999999998774433444999999999999999999998765444433333211110
Q ss_pred ------------------ccCCCC------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 239 ------------------QYSIPD------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 239 ------------------~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
....+. ....++.+.+||.+||+.||.+|||+.++++ |+|++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~---hp~f~ 321 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR---HPYFE 321 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT---SGGGT
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc---Cchhh
Confidence 001110 1246889999999999999999999988877 55544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=317.06 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=201.4
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE----
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL---- 92 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~---- 92 (288)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 479999999999999999999999999999999987643 2345788999999999999999999999877654
Q ss_pred --EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 93 --AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 93 --~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
++|||++. ++|...+. ..++...++.++.|++.||.|||+.||+|+||||+||+++.++. ++|+|||++....
T Consensus 121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD 195 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC----
T ss_pred eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCcccccc
Confidence 99999997 47877663 35999999999999999999999999999999999999987776 9999999987443
Q ss_pred cCCCCCCCcCCCcccCCccccC-cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-----------
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV----------- 238 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 238 (288)
. ......+++.|+|||.+.+ ..++.+ +|+||||+++|+|++|..||...+...............
T Consensus 196 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 196 A--EMTGYVVTRWYRAPEVILSWMHYNQT-VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTT-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred c--CcCCcccCccccCHHHhcCCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 2 2344567999999999887 455555 999999999999999999998765444433332211100
Q ss_pred --------ccCCCC------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 239 --------QYSIPD------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 239 --------~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
....+. ...+++++.+||.+||+.||.+|||+.++++ |+|++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~---hp~f~ 328 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT---HPFFE 328 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT---SGGGT
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc---Ccccc
Confidence 000000 1256899999999999999999999988876 55554
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=321.20 Aligned_cols=257 Identities=23% Similarity=0.346 Sum_probs=203.7
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC--------CCceeeEeEEEE----
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR--------HPNIVRFKEVIL---- 87 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~~---- 87 (288)
.++|++.+.||+|+||+||+|++..+++.||+|++.......+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 48999999999999999999999999999999999877666678889999999985 788999999987
Q ss_pred cCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhc-CceecCCCCCceEecCCC----------
Q 023058 88 TPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSP---------- 154 (288)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~-~i~H~dl~p~nilv~~~~---------- 154 (288)
.....++|||++.+ ++.+.+... ..++...++.++.||+.||.|||+. ||+||||||+||+++.++
T Consensus 116 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 116 NGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 55689999999954 666655443 4699999999999999999999998 999999999999998664
Q ss_pred -------------------------------------CCCEEEeecCCCcccccCCCCCCCcCCCcccCCccccCcccCC
Q 023058 155 -------------------------------------APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197 (288)
Q Consensus 155 -------------------------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 197 (288)
...++|+|||++..... ......+++.|+|||.+.+..++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~ 272 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYNT 272 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCCT
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCCCCc
Confidence 12499999999875443 234456899999999998888877
Q ss_pred CccchhhHHHHHHHHHhCCCCCCCCCCchhH--HHHHHHHhhcccCC---------------------------------
Q 023058 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNF--RKTIHRILSVQYSI--------------------------------- 242 (288)
Q Consensus 198 ~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~--------------------------------- 242 (288)
+ +||||||+++|+|++|..||......... ......+.......
T Consensus 273 ~-~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (397)
T 1wak_A 273 P-ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 351 (397)
T ss_dssp H-HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH
T ss_pred H-HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh
Confidence 6 99999999999999999999865543211 11111111000000
Q ss_pred -------CCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 243 -------PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 243 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
......++.+.+||.+||+.||.+|||+.|+++ |+|+.
T Consensus 352 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~---hp~~~ 396 (397)
T 1wak_A 352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR---HPWLN 396 (397)
T ss_dssp HHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT---SGGGG
T ss_pred HhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh---Ccccc
Confidence 001123467899999999999999999988876 66653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=303.77 Aligned_cols=242 Identities=23% Similarity=0.330 Sum_probs=205.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEc-----------
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----------- 88 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------- 88 (288)
.++|++.+.||+|+||.||++.+..+++.||+|.+.... +.+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 478999999999999999999999899999999987654 357789999999999999999998854
Q ss_pred -----CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEe
Q 023058 89 -----PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 161 (288)
Q Consensus 89 -----~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~ 161 (288)
...+++|||++++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~ 164 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIG 164 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEEC
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEEC
Confidence 34589999999999999999654 57999999999999999999999999999999999999987776 9999
Q ss_pred ecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccC
Q 023058 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241 (288)
Q Consensus 162 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
|||++.............+++.|+|||.+.+..++.+ +|+||||+++|+|++|..|+... .......... .
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~~~--~ 235 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFET------SKFFTDLRDG--I 235 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTH-HHHHHHHHHHHHHHSCCSSHHHH------HHHHHHHHTT--C
T ss_pred cchhheeccccccccccCCcccccChhhhccCCCcch-hhhHHHHHHHHHHHhcCCcchhH------HHHHHHhhcc--c
Confidence 9999887666555556678999999999988777666 99999999999999999887421 1222222221 1
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 242 IPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.+ ..+++.+.++|.+||+.||.+|||+.++++.+
T Consensus 236 ~~--~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l 269 (284)
T 2a19_B 236 IS--DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269 (284)
T ss_dssp CC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cc--ccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 22 25789999999999999999999999998743
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=312.62 Aligned_cols=259 Identities=23% Similarity=0.329 Sum_probs=186.1
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc--chHHHHHHHH-HHhhCCCCceeeEeEEEEcCCe
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK--IDENVQREII-NHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
......++|++.+.||+|+||.||++.+..+++.||+|++..... .......|+. +++.++||||+++++++..++.
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 334567999999999999999999999999999999999976532 2234555555 6777899999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhc-CceecCCCCCceEecCCCCCCEEEeecCC
Q 023058 92 LAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~-~i~H~dl~p~nilv~~~~~~~~~l~df~~ 165 (288)
.++|||++.+ +|.+++.. ...++...+..++.|++.||.+||+. |++|+||+|+||+++.++. ++|+|||+
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~ 172 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGI 172 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCSS
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCCC
Confidence 9999999976 88777653 56799999999999999999999998 9999999999999987776 99999999
Q ss_pred CcccccCCCCCCCcCCCcccCCcccc----CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc-c
Q 023058 166 SKSSVLHSQPKSTVGTPAYIAPEVLL----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-Y 240 (288)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~ 240 (288)
+.............+++.|+|||.+. +..++.+ +|+||||+++|+|++|..||....... .....+.... .
T Consensus 173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~ 248 (327)
T 3aln_A 173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVF---DQLTQVVKGDPP 248 (327)
T ss_dssp SCC------------------------------CCSH-HHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCC
T ss_pred ceecccccccccCCCCccccCceeeccccCcCCCCch-hhHHHHHHHHHHHHHCCCCCCCcchHH---HHHHHHhcCCCC
Confidence 97665544444557899999999983 4455555 999999999999999999997643211 1111111111 1
Q ss_pred CCC--CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 241 SIP--DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 241 ~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.++ ....+++.+.+||.+||+.||.+|||+.++++ |+|+.
T Consensus 249 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~---hp~~~ 290 (327)
T 3aln_A 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK---HPFIL 290 (327)
T ss_dssp CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT---SHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh---ChHHH
Confidence 111 12358999999999999999999999988877 45543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=311.37 Aligned_cols=258 Identities=29% Similarity=0.402 Sum_probs=204.0
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcC-----Ce
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 91 (288)
..++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4689999999999999999999999999999999987543 2335677999999999999999999998754 67
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
.+++||++. ++|.+.+.. +.++...++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDE 164 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC-
T ss_pred EEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEeccccccccc
Confidence 899999997 489888866 57999999999999999999999999999999999999987776 99999999875433
Q ss_pred CCC-----------CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh---
Q 023058 172 HSQ-----------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--- 237 (288)
Q Consensus 172 ~~~-----------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~--- 237 (288)
... .....+++.|+|||.+.+......++|+||||+++|+|++|..||...+..............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence 221 122457899999998766443444599999999999999999999876543322222111100
Q ss_pred -----------------cccCCCC------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 238 -----------------VQYSIPD------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 238 -----------------~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.....+. ...+++++.+||.+||+.||.+|||+.++++ |+|++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~---hp~~~ 310 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE---HPYLQ 310 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT---SGGGT
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc---Ccccc
Confidence 0000010 1357899999999999999999999988876 55554
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=311.36 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=207.8
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEc-------CCCcEEEEEEeecCc--cchHHHHHHHHHHhhC-CCCceeeEeEEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDK-------KTEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVI 86 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 86 (288)
....++|++.+.||+|+||.||++.+. .++..||+|++.... ...+.+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 345689999999999999999999975 356789999987643 3345688999999999 899999999999
Q ss_pred EcCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEe
Q 023058 87 LTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (288)
Q Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv 150 (288)
...+..++|||++++++|.+++.... .++...++.++.||+.||.+||+.|++|+||||+||++
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 99999999999999999999997653 38999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCch
Q 023058 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (288)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~ 226 (288)
+.++. ++|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||.......
T Consensus 191 ~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 191 TENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp CTTCC--EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred cCCCC--EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChH-HHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 87776 99999999875443321 233346778999999987777666 999999999999999 999998764433
Q ss_pred hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.... +.... ..+....+++.+.++|.+||+.||.+|||+.++++.+.
T Consensus 268 ~~~~----~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 314 (334)
T 2pvf_A 268 LFKL----LKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314 (334)
T ss_dssp HHHH----HHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH----HhcCC-CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 2222 22221 22223478999999999999999999999999987543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=311.19 Aligned_cols=265 Identities=28% Similarity=0.378 Sum_probs=202.1
Q ss_pred CCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEE-----
Q 023058 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVIL----- 87 (288)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 87 (288)
+++....++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 4 IHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp --CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred cccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 345556799999999999999999999999999999999987654 33467889999999999999999999874
Q ss_pred ---------cCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCE
Q 023058 88 ---------TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 158 (288)
Q Consensus 88 ---------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~ 158 (288)
.....++|||+++ ++|.+++.. ++++...++.++.|++.||++||+.|++|+||+|+||+++.++ ..+
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~ 160 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVL 160 (320)
T ss_dssp CCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEE
T ss_pred cccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeE
Confidence 3467899999997 599888854 5789999999999999999999999999999999999997433 249
Q ss_pred EEeecCCCcccccC----CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 023058 159 KICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 234 (288)
Q Consensus 159 ~l~df~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (288)
+|+|||++...... .......+++.|+|||.+.+......++|+||||+++|+|++|..||...............
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999998755332 12233456889999998876443344599999999999999999999876654433333221
Q ss_pred Hhh------------------cccCCC------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 235 ILS------------------VQYSIP------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 235 ~~~------------------~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
... .....+ ....+++++.+||.+||+.||.+|||+.++++ |+|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~---hp~~~~ 311 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS---HPYMSI 311 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT---SHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC---Cccccc
Confidence 100 000000 01357999999999999999999999988866 777654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=312.21 Aligned_cols=255 Identities=19% Similarity=0.268 Sum_probs=206.5
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcE----EEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEc
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEEL----VAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT 88 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~----~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (288)
......++|++.+.||+|+||.||++.+..++.. +++|.+... ......+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred HhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 3455678999999999999999999999877765 677776543 233356778999999999999999999986
Q ss_pred CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 89 PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
++..++|||++.+++|.+.+... +.++...++.++.||+.||.|||+.|++||||||+||+++.++. ++|+|||++.
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~ 163 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVAD 163 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCccc
Confidence 45689999999999999988764 47899999999999999999999999999999999999987776 9999999998
Q ss_pred ccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCC
Q 023058 168 SSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIP 243 (288)
Q Consensus 168 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
....... .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||............ ... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~~-~~~~ 237 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL----EKG-ERLA 237 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH----HTT-CBCC
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChh-hHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH----HcC-CCCC
Confidence 6544332 233446778999999988877766 999999999999999 99999876654333222 121 1222
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 244 DYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
....++.++.++|.+||+.||.+|||+.++++.+.
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~ 272 (325)
T 3kex_A 238 QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFT 272 (325)
T ss_dssp CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 23367889999999999999999999999988543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=308.06 Aligned_cols=252 Identities=15% Similarity=0.136 Sum_probs=204.3
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCC-------cEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTE-------ELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-------~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (288)
...++|++.+.||+|+||.||++.+..++ ..|++|++.... ...+.+.+|+.++++++||||+++++++..+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 45689999999999999999999998776 469999986543 4456788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCC------CEEEee
Q 023058 90 THLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP------RLKICD 162 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~------~~~l~d 162 (288)
+..++|||++++++|.+++...+. ++...++.++.||+.||.|||+.|++||||||+||+++.++.. .++|+|
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999999999999977654 9999999999999999999999999999999999999866642 289999
Q ss_pred cCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCC
Q 023058 163 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 242 (288)
Q Consensus 163 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
||++...... ....+++.|+|||.+.+......++|+||||+++|+|++|..|+............ .......
T Consensus 165 fg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~----~~~~~~~ 237 (289)
T 4fvq_A 165 PGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF----YEDRHQL 237 (289)
T ss_dssp CCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHTTCCC
T ss_pred CcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH----hhccCCC
Confidence 9988643222 23346788999999987443344599999999999999965555443332222222 2223333
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 243 PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
+. ..++++.++|.+||+.||.+|||+.++++.+.
T Consensus 238 ~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 271 (289)
T 4fvq_A 238 PA--PKAAELANLINNCMDYEPDHRPSFRAIIRDLN 271 (289)
T ss_dssp CC--CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CC--CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 33 56889999999999999999999999987443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=312.09 Aligned_cols=257 Identities=20% Similarity=0.324 Sum_probs=212.7
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCc-----EEEEEEeecCc--cchHHHHHHHHHHhhC-CCCceeeEeEEEEc
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILT 88 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (288)
....++|++.+.||+|+||.||++.+..++. .|++|.+.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 4456899999999999999999999876554 79999987653 2345688999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC
Q 023058 89 PTHLAIVMEYASGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 154 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~ 154 (288)
.+..++|||++++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 99999999999999999988642 3579999999999999999999999999999999999998777
Q ss_pred CCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHH
Q 023058 155 APRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRK 230 (288)
Q Consensus 155 ~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~ 230 (288)
. ++|+|||++........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...........
T Consensus 202 ~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 278 (333)
T 2i1m_A 202 V--AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278 (333)
T ss_dssp E--EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred e--EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChH-HHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence 6 99999999875443322 223346778999999988777666 999999999999998 9999987765554444
Q ss_pred HHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhh
Q 023058 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHT 280 (288)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~ 280 (288)
.... ....+....+++.+.++|.+||+.||.+|||+.++++.+...
T Consensus 279 ~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 279 LVKD----GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhc----CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 3322 223333346799999999999999999999999998855443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=310.19 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=197.2
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhh--CCCCceeeEeEEEEc----CCeE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILT----PTHL 92 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~----~~~~ 92 (288)
..++|++.+.||+|+||+||++.+ +++.||+|++.... .....+|.+++.. ++||||+++++++.. ....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 468999999999999999999988 58899999987543 3445566666655 799999999998654 3468
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------hcCceecCCCCCceEecCCCCCCEEEeecC
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFG 164 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~i~H~dl~p~nilv~~~~~~~~~l~df~ 164 (288)
++||||+++++|.+++.. ..++...++.++.|++.||.||| +.|++||||||+||+++.++. ++|+|||
T Consensus 82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg 158 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLG 158 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCT
T ss_pred EEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeCC
Confidence 999999999999999954 57999999999999999999999 999999999999999987776 9999999
Q ss_pred CCcccccCCC-----CCCCcCCCcccCCccccCcccCC-----CccchhhHHHHHHHHHhC----------CCCCCCCCC
Q 023058 165 YSKSSVLHSQ-----PKSTVGTPAYIAPEVLLKKEYDG-----KIADVWSCGVTLYVMLVG----------AYPFEDPEE 224 (288)
Q Consensus 165 ~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~-----~~~Di~slG~~~~~l~~g----------~~pf~~~~~ 224 (288)
++........ .....+++.|+|||.+.+..... .++|+||||+++|+|++| ..||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 9864433222 23346899999999987763221 349999999999999999 888876543
Q ss_pred chhHHHHHHHHhhcccCCCCC------CCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 225 PKNFRKTIHRILSVQYSIPDY------VHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
..................+.. ...++.+.++|.+||+.||.+|||+.++++.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 298 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298 (301)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred CCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence 333222222222222211111 124578999999999999999999999987553
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=311.65 Aligned_cols=244 Identities=29% Similarity=0.450 Sum_probs=206.7
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc-------chHHHHHHHHHHhhCC--CCceeeEeEEEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLR--HPNIVRFKEVIL 87 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~--~~~i~~~~~~~~ 87 (288)
....++|++.+.||+|+||.||++.+..+++.||+|++..... ..+.+.+|+.++++++ |+|++++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3446899999999999999999999999999999999976532 2245678999999996 599999999999
Q ss_pred cCCeEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEec-CCCCCCEEEeecCC
Q 023058 88 TPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGY 165 (288)
Q Consensus 88 ~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~-~~~~~~~~l~df~~ 165 (288)
.++..++++|++.+ ++|.+++...+.++...++.++.||+.||.+||+.|++|+||+|+||+++ .++. ++|+|||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~--~kL~Dfg~ 196 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGS 196 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE--EEECCCTT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCC--EEEeeCcc
Confidence 99999999999975 79999998888999999999999999999999999999999999999998 4555 99999999
Q ss_pred CcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCC
Q 023058 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245 (288)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (288)
+...... ......+++.|+|||.+.+..+...++|+||||+++|+|++|..||.... ........++.
T Consensus 197 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------~~~~~~~~~~~- 264 (320)
T 3a99_A 197 GALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFRQ- 264 (320)
T ss_dssp CEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCCCCCSS-
T ss_pred ccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------hhhcccccccc-
Confidence 8755432 23345689999999999877775565899999999999999999996421 11222333333
Q ss_pred CCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 246 VHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 246 ~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+++++.++|.+||+.||.+|||+.++++
T Consensus 265 -~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 265 -RVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 68999999999999999999999988877
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=315.50 Aligned_cols=257 Identities=29% Similarity=0.367 Sum_probs=207.7
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC-CC-----ceeeEeEEEEcCCeEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HP-----NIVRFKEVILTPTHLA 93 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~~~~~~~~~~ 93 (288)
.++|++.+.||+|+||+||+|.+..+++.||+|++............|+.+++.++ |+ +++++.+++...+..+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 58999999999999999999999999999999999876666667788888888874 44 4999999999999999
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh--hcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 94 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH--~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
+|||++++ +|.+++... ..++...++.++.|++.||.+|| +.||+||||||+||+++.+..+.++|+|||++...
T Consensus 133 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 99999965 999988765 35899999999999999999999 57999999999999997655556999999999754
Q ss_pred ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc---------
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------- 240 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------- 240 (288)
.. ......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+.................
T Consensus 212 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (382)
T 2vx3_A 212 GQ--RIYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288 (382)
T ss_dssp TC--CCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred cc--ccccccCCccccChHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHH
Confidence 32 3345678999999999988888766 99999999999999999999977654444444332110000
Q ss_pred -----CCCC-------------------CC---------------------C----CCHHHHHHHHHhcccCcCCccccc
Q 023058 241 -----SIPD-------------------YV---------------------H----ISPECRHLISRIFVADPAKVSMHF 271 (288)
Q Consensus 241 -----~~~~-------------------~~---------------------~----~~~~l~~li~~~l~~~p~~Rpt~~ 271 (288)
..+. .. . .++++.+||.+||+.||.+|||+.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~ 368 (382)
T 2vx3_A 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY 368 (382)
T ss_dssp HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHH
T ss_pred HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHH
Confidence 0000 00 0 013789999999999999999998
Q ss_pred cccccchhhhhh
Q 023058 272 HATGVYMHTKLQ 283 (288)
Q Consensus 272 ~~l~~~~~~~~~ 283 (288)
|+++ |+|++
T Consensus 369 e~L~---hp~f~ 377 (382)
T 2vx3_A 369 YALQ---HSFFK 377 (382)
T ss_dssp HHTT---SGGGC
T ss_pred HHhc---Ccccc
Confidence 8877 55554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=310.32 Aligned_cols=254 Identities=22% Similarity=0.373 Sum_probs=208.6
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEE-----cCCCcEEEEEEeecCcc--chHHHHHHHHHHhhC-CCCceeeEeEEEEcC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRD-----KKTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (288)
...++|++.+.||+|+||.||++.+ ..+++.||+|++..... ..+.+.+|+.+++++ +||||+++++++...
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 4568999999999999999999985 35678999999876533 334688999999999 799999999998775
Q ss_pred C-eEEEEEeccCCCchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC
Q 023058 90 T-HLAIVMEYASGGELFERICNAGR----------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (288)
Q Consensus 90 ~-~~~lv~e~~~~~~L~~~~~~~~~----------------~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~ 152 (288)
+ .++++||++++++|.+++..... ++...++.++.|++.||.+||+.|++|+||||+||+++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 4 58999999999999999977553 889999999999999999999999999999999999987
Q ss_pred CCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhH
Q 023058 153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNF 228 (288)
Q Consensus 153 ~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~ 228 (288)
++. ++|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||.........
T Consensus 184 ~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 184 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp GGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCC--EEECCCccccccccCccceeccCCCcceeecCchhhccccccch-hHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 776 99999999875443322 123346788999999988777666 999999999999998 99999876654443
Q ss_pred HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
...... ......+ ..+++.+.++|.+||+.||.+|||+.++++.+.
T Consensus 261 ~~~~~~--~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 306 (316)
T 2xir_A 261 CRRLKE--GTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306 (316)
T ss_dssp HHHHHH--TCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhcc--CccCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 333222 1122223 368999999999999999999999999988443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=302.61 Aligned_cols=254 Identities=22% Similarity=0.231 Sum_probs=205.0
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEE-EEcCCeEEEEEec
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV-ILTPTHLAIVMEY 98 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~lv~e~ 98 (288)
.++|++.+.||+|+||.||++++..+++.||+|++..... .+.+.+|+.++++++|++++..+.. +......++|||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 5899999999999999999999999999999998876443 3568899999999998876655444 4667788999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEec---CCCCCCEEEeecCCCcccccCCC
Q 023058 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~---~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
+ +++|.+++.. ...++...++.++.|++.||.|||+.|++|+||||+||+++ .++. ++|+|||++........
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCe--EEEeeCCCccccccccc
Confidence 9 8899999874 45799999999999999999999999999999999999994 5555 99999999875544322
Q ss_pred --------CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCc---hhHHHHHHHHhhccc-CC
Q 023058 175 --------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQY-SI 242 (288)
Q Consensus 175 --------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~-~~ 242 (288)
.....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||...... ............... ..
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred ccccccccccccccccccCChhhhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 234568999999999988887666 99999999999999999999875432 222222222111111 11
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCccccccccccchhh
Q 023058 243 PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHT 280 (288)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~ 280 (288)
...+|+++.++|.+||+.||.+|||+.++++.+.+-
T Consensus 243 --~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 243 --CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp --TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred --HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 126899999999999999999999999998865543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=303.28 Aligned_cols=255 Identities=30% Similarity=0.453 Sum_probs=203.3
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
.++|.....||+|+||.||++.+..++..||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++|||+
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 344555559999999999999999999999999987653 3456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC-CCCCCEEEeecCCCcccccCC-
Q 023058 99 ASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS- 173 (288)
Q Consensus 99 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~-~~~~~~~l~df~~~~~~~~~~- 173 (288)
+++++|.+++.... .++...++.++.|++.||.+||+.|++|+||+|+||+++. ++. ++|+|||++.......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~--~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAGINP 178 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC--EEECCTTTCEESCC---
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC--EEEeecccccccCCCCC
Confidence 99999999987652 4678999999999999999999999999999999999986 555 9999999987544322
Q ss_pred CCCCCcCCCcccCCccccCcc--cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 174 QPKSTVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
......+++.|+|||.+.+.. ++. ++|+||||+++|+|++|..||.......... ............+. .++++
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~ 254 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGK-AADIWSLGCTIIEMATGKPPFYELGEPQAAM-FKVGMFKVHPEIPE--SMSAE 254 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSH-HHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH-HHHHHHCCCCCCCT--TSCHH
T ss_pred cccccCCCccccChhhhcCCCCCCCc-HHHHHHHHHHHHHHHHCCCCccCCCchhHHH-Hhhccccccccccc--cCCHH
Confidence 233456889999999987653 444 4999999999999999999997644322211 11111222233333 68999
Q ss_pred HHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+.++|.+||+.||.+|||+.++++ |+|+.
T Consensus 255 ~~~li~~~l~~dp~~Rps~~~ll~---~~~~~ 283 (295)
T 2clq_A 255 AKAFILKCFEPDPDKRACANDLLV---DEFLK 283 (295)
T ss_dssp HHHHHHHTTCSSTTTSCCHHHHHT---SGGGC
T ss_pred HHHHHHHHccCChhhCCCHHHHhc---Chhhh
Confidence 999999999999999999988866 55543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=323.04 Aligned_cols=256 Identities=16% Similarity=0.158 Sum_probs=188.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc----chHHHHHHH---HHHhhCCCCceeeEe-------EE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREI---INHRSLRHPNIVRFK-------EV 85 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~---~~l~~l~~~~i~~~~-------~~ 85 (288)
..+|++.+.||+|+||+||++.+..+++.||+|++..... ..+.+.+|+ ..++. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 4569999999999999999999999999999999987542 334566774 45555 799977754 55
Q ss_pred EEcC-----------------CeEEEEEeccCCCchHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHhhcCceec
Q 023058 86 ILTP-----------------THLAIVMEYASGGELFERICNA-GRFSEDEA------RFFFQQLISGVSYCHSMQVCHR 141 (288)
Q Consensus 86 ~~~~-----------------~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~------~~i~~~i~~~l~~LH~~~i~H~ 141 (288)
+..+ ..+++||||++ ++|.+++... ..++...+ ..++.||+.||+|||+.||+||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 5433 34899999998 7999999763 34455555 6778999999999999999999
Q ss_pred CCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCcCCCcccCCccccC--cccCCCccchhhHHHHHHHHHhCCCCC
Q 023058 142 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPF 219 (288)
Q Consensus 142 dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~~~~l~~g~~pf 219 (288)
||||+||+++.++. +||+|||++...... .....+++.|+|||.+.+ ..++.+ +|+||||+++|+|++|..||
T Consensus 219 Dikp~NIll~~~~~--~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~-~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 219 HFTPDNLFIMPDGR--LMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHA-LNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TCSGGGEEECTTSC--EEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHH-HHHHHHHHHHHHHHHSSCST
T ss_pred cCCHHHEEECCCCC--EEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCcc-ccHHHHHHHHHHHHhCCCCC
Confidence 99999999988776 999999998754322 124556799999999976 556555 99999999999999999999
Q ss_pred CCCCCchhH--HH-HHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 220 EDPEEPKNF--RK-TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 220 ~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
......... .. ...........++....+++.+.+||.+||+.||.+|||+.++++ |+|++.+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~---hp~f~~~ 359 (371)
T 3q60_A 294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME---TPEFLQL 359 (371)
T ss_dssp TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT---SHHHHHH
T ss_pred CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc---CHHHHHH
Confidence 876332110 00 000011123344444578999999999999999999999988876 6666543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=309.28 Aligned_cols=267 Identities=26% Similarity=0.378 Sum_probs=206.0
Q ss_pred ccCCCCCCCCCCCCCCCeeeeeeeeccCceEEEEEEE----cCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCce
Q 023058 6 MTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRD----KKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 79 (288)
Q Consensus 6 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~----~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i 79 (288)
+...||..- ....+.|++++.||+|+||.||++.. ..+++.||+|++.... ...+.+.+|+.++++++||||
T Consensus 18 ~~~~pg~~~--~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 95 (318)
T 3lxp_A 18 LFQGPGDPT--VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95 (318)
T ss_dssp ------CCC--BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred eecCCCCCc--eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcch
Confidence 445566642 33334449999999999999987753 4578899999997653 334568899999999999999
Q ss_pred eeEeEEEEcC--CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCC
Q 023058 80 VRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 157 (288)
Q Consensus 80 ~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~ 157 (288)
+++++++... ..+++|||++++++|.+++... .++...++.++.|++.||.+||+.|++|+||+|+||+++.++.
T Consensus 96 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~-- 172 (318)
T 3lxp_A 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL-- 172 (318)
T ss_dssp CCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--
T ss_pred hhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--
Confidence 9999999874 6789999999999999998664 4899999999999999999999999999999999999987776
Q ss_pred EEEeecCCCcccccCCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCc--------
Q 023058 158 LKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------- 225 (288)
Q Consensus 158 ~~l~df~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~-------- 225 (288)
++|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||......
T Consensus 173 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~ 251 (318)
T 3lxp_A 173 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251 (318)
T ss_dssp EEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC
T ss_pred EEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCcccccchhhhhhhccc
Confidence 99999999875544322 233457778999999988777765 99999999999999999998753211
Q ss_pred --hhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 226 --KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 226 --~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.................+....+++++.+||.+||+.||.+|||+.++++.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 306 (318)
T 3lxp_A 252 QGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306 (318)
T ss_dssp CHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 01111112222223334444578999999999999999999999999987543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=309.40 Aligned_cols=257 Identities=21% Similarity=0.319 Sum_probs=204.5
Q ss_pred CCCCCCCCCeeeeeeeeccCceEEEEEEEcCCC----cEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEE
Q 023058 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVIL 87 (288)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (288)
+...+..++|.+.+.||+|+||.||++.+..++ ..||+|.+.... .....+.+|+.++++++||||+++++++.
T Consensus 37 ~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 37 FTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp -CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 334556789999999999999999999987543 459999987643 23346789999999999999999999999
Q ss_pred cCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 88 TPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
..+..++|||++++++|.+++... ..++...++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~ 194 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLS 194 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc--EEECCCCcc
Confidence 999999999999999999998764 57999999999999999999999999999999999999987776 999999998
Q ss_pred cccccCCCC----CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccC
Q 023058 167 KSSVLHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYS 241 (288)
Q Consensus 167 ~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
......... ....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||......... ..+.. ...
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~~----~~~~~-~~~ 268 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVM----KAIND-GFR 268 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHT-TCC
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCch-hhhHHHHHHHHHHHcCCCCCcccCCHHHHH----HHHHC-CCc
Confidence 755433221 12235678999999988777666 999999999999998 99999765543222 22222 223
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 242 IPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.+....+++.+.++|.+||+.||.+||++.++++.+.
T Consensus 269 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 305 (333)
T 1mqb_A 269 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 305 (333)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 3334478999999999999999999999999987543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=312.58 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=203.6
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEE----cCCe
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVIL----TPTH 91 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~ 91 (288)
....++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++. ....
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 455689999999999999999999999999999999886543 34467889999999999999999999987 3457
Q ss_pred EEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 92 LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
.++|||++.+++|.+++.. ...++...++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||++.
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~ 182 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMN 182 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCE
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcch
Confidence 8999999999999988875 467999999999999999999999999999999999999987776 9999999876
Q ss_pred ccccCCCC----------CCCcCCCcccCCccccCcc---cCCCccchhhHHHHHHHHHhCCCCCCCCCC-chhHHHHHH
Q 023058 168 SSVLHSQP----------KSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIH 233 (288)
Q Consensus 168 ~~~~~~~~----------~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~~~~l~~g~~pf~~~~~-~~~~~~~~~ 233 (288)
........ ....+++.|+|||.+.+.. ++.+ +|+||||+++|+|++|..||..... .......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-- 259 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDER-TDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-- 259 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTH-HHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH--
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCch-hhHHHHHHHHHHHHhCCCChhhhhcccchhhHH--
Confidence 44322111 1223688999999987543 4444 9999999999999999999953211 0111111
Q ss_pred HHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 234 RILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.......+....+++.+.++|.+||+.||.+|||+.++++.+
T Consensus 260 --~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 260 --VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp --HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 122334444557899999999999999999999999998744
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=306.61 Aligned_cols=248 Identities=30% Similarity=0.491 Sum_probs=204.4
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEc--CCeEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLA 93 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 93 (288)
..++|++.+.||+|+||.||++.+..+++.|++|.+.... ...+.+.+|+.++++++||||+++++++.. ....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4589999999999999999999999999999999997643 334568899999999999999999998754 56899
Q ss_pred EEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC-----ceecCCCCCceEecCCCCCCEEEeecC
Q 023058 94 IVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFG 164 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~-----i~H~dl~p~nilv~~~~~~~~~l~df~ 164 (288)
+|||++++++|.+++... ..++...++.++.|++.||++||+.| ++|+||+|+||+++.++. ++|+|||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg 161 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFG 161 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecCc
Confidence 999999999999988653 34999999999999999999999999 999999999999987776 9999999
Q ss_pred CCcccccCCC-CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-CC
Q 023058 165 YSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SI 242 (288)
Q Consensus 165 ~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~ 242 (288)
++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||........ ...+..... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~i~~~~~~~~ 236 (279)
T 2w5a_A 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKEL----AGKIREGKFRRI 236 (279)
T ss_dssp HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCCC
T ss_pred hheeeccccccccccCCCccccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCcccCHHHH----HHHHhhcccccC
Confidence 8864432211 122357899999999988777665 9999999999999999999987653222 222233322 23
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 243 PDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
+. .+++++.++|.+||+.||.+|||+.++++
T Consensus 237 ~~--~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 237 PY--RYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp CT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Cc--ccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 33 68999999999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=306.44 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=197.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEc-----------
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT----------- 88 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----------- 88 (288)
.++|++.+.||+|+||.||++.+..+++.||+|++.......+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 368999999999999999999999999999999998766666788999999999999999999998764
Q ss_pred --CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCC
Q 023058 89 --PTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (288)
Q Consensus 89 --~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~ 165 (288)
....++|||++++++|.+++.... .++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~ 162 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGL 162 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcc
Confidence 357899999999999999997644 5788999999999999999999999999999999999987776 99999999
Q ss_pred CcccccC---------------CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH
Q 023058 166 SKSSVLH---------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230 (288)
Q Consensus 166 ~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~ 230 (288)
+...... .......+++.|+|||.+.+......++|+||||+++|+|++ ||.... ....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---~~~~ 236 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---ERVN 236 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---HHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---hHHH
Confidence 8754322 112344588999999998765433444999999999999997 554321 2222
Q ss_pred HHHHHhhcccCCCC--CCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 231 TIHRILSVQYSIPD--YVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 231 ~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
....+......++. ....++.+.++|.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 33333333333332 2356788999999999999999999988877
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=303.03 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=187.6
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccch---HHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
..++|++.+.||+|+||.||++.+..+++.||+|++....... +.+.++..+++.++||||+++++++..++..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 4578999999999999999999999999999999997654322 2233455567888999999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhc-CceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 96 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~-~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
||++ ++.+..+... ...++...++.++.|++.||.+||+. |++|+||+|+||+++.++. ++|+|||++.......
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC-------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhccCCc
Confidence 9999 5456555543 56799999999999999999999996 9999999999999987776 9999999987655544
Q ss_pred CCCCCcCCCcccCCcccc-----CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCC
Q 023058 174 QPKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
......+++.|+|||.+. +..++.+ +|+||||+++|+|++|..||......... ............+....+
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 256 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIR-ADVWSLGISLVELATGQFPYKNCKTDFEV--LTKVLQEEPPLLPGHMGF 256 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTH-HHHHHHHHHHHHHHHSSCTTTTCCSHHHH--HHHHHHSCCCCCCSSSCC
T ss_pred cccccCCCccccChhhcccccccccCCccc-cchhhHHHHHHHHHhCCCCCCCCCccHHH--HHHHhccCCCCCCccCCC
Confidence 445567899999999985 3344444 99999999999999999999864432221 111222223344544568
Q ss_pred CHHHHHHHHHhcccCcCCccccccccc
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++++.++|.+||+.||.+|||+.++++
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 257 SGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 999999999999999999999998887
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=303.24 Aligned_cols=254 Identities=22% Similarity=0.215 Sum_probs=200.5
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEE-EEcCCeEEEEEec
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV-ILTPTHLAIVMEY 98 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~lv~e~ 98 (288)
.++|++.+.||+|+||.||++.+..+++.||+|++.... ..+.+.+|+.++++++|++++..+.. +......++|||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 489999999999999999999999999999999866543 23468899999999988776655554 4667889999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEe---cCCCCCCEEEeecCCCcccccCCC
Q 023058 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv---~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
+ +++|.+++.. ...++...++.++.||+.||.|||+.|++|+||||+||++ +.++. ++|+|||++........
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~--~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDART 163 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC--EEECCCTTCEECBCTTT
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe--EEEecCccceeccCccc
Confidence 9 8899999875 4579999999999999999999999999999999999999 55665 99999999975544322
Q ss_pred --------CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCch---hHHHHHHHHhhcccCCC
Q 023058 175 --------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK---NFRKTIHRILSVQYSIP 243 (288)
Q Consensus 175 --------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~ 243 (288)
.....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||....... ............... .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~ 241 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-V 241 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-H
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCch-hHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh-h
Confidence 234568999999999988887666 999999999999999999998754432 222222221111110 0
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 244 DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
....+|+++.++|.+||+.||.+|||+.++++.+..
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 112578999999999999999999999999885543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=306.57 Aligned_cols=262 Identities=24% Similarity=0.359 Sum_probs=208.4
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEE----EcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcC
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMR----DKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP 89 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (288)
+.....++|++.+.||+|+||.||++. +..+++.||+|++.... ...+.+.+|+.++++++||||+++++++...
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 344556889999999999999999998 45678999999987643 3345788999999999999999999998765
Q ss_pred C--eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 90 T--HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 90 ~--~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
+ ..++|||++++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~ 192 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLT 192 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTC
T ss_pred CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcch
Confidence 4 789999999999999999775 46999999999999999999999999999999999999987776 999999998
Q ss_pred cccccCCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCC-----------chhHHHH
Q 023058 167 KSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-----------PKNFRKT 231 (288)
Q Consensus 167 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~-----------~~~~~~~ 231 (288)
........ .....++..|+|||.+.+..++.+ +|+||||+++++|++|..||..... .......
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhccccccccccccCCCCceeEECchhhcCCCCCch-hhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 75544322 223346677999999987777665 9999999999999999998864210 0111111
Q ss_pred HHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
...........+....+++++.++|.+||+.||.+|||+.++++.+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~ 319 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 112222222333445789999999999999999999999999885543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=313.58 Aligned_cols=257 Identities=21% Similarity=0.229 Sum_probs=206.1
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
...++|++.+.||+|+||.||++.+. +++.||+|.+.... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 35689999999999999999999975 68899999887653 34467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 97 EYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
||+++++|.+++.... .++...++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++......
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV--PKITDFGISKKGTEL 192 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC--EEECCCTTCEECSSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence 9999999998886543 5899999999999999999999999999999999999987776 999999998754332
Q ss_pred CC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHH---HHHHHhhccc------
Q 023058 173 SQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK---TIHRILSVQY------ 240 (288)
Q Consensus 173 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~------ 240 (288)
.. .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||........... ..........
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP 271 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCCTH-HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCCcc-cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence 22 223347899999999988887766 9999999999999999999976543222111 1111111111
Q ss_pred CCC--CCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 241 SIP--DYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 241 ~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
... .....+..+.+++.+||+.||.+|||+.++++.+.
T Consensus 272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 000 01123567999999999999999999999987543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=301.92 Aligned_cols=253 Identities=22% Similarity=0.258 Sum_probs=205.1
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcC---CCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
....++|++.+.||+|+||.||++.+.. ++..||+|.+.... ...+.+.+|+.++++++||||+++++++..+ .
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~ 86 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-P 86 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-S
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C
Confidence 4567899999999999999999998653 33469999987642 3446788999999999999999999998654 5
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.++|||++++++|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIE 164 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC-
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc--EEeCccCCCcccc
Confidence 68999999999999999765 45999999999999999999999999999999999999988776 9999999987554
Q ss_pred cCCC--CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 171 LHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 171 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
.... .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||.............. ....+....
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~ 238 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK-----GDRLPKPDL 238 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH-----TCCCCCCTT
T ss_pred cccccccccCCCCcceeCchhhccCCCCch-hccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc-----CCCCCCCCC
Confidence 3322 233446778999999987777665 999999999999998 9999987665443332221 112233346
Q ss_pred CCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
+++.+.++|.+||+.||.+|||+.++++.+.
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 269 (281)
T 3cc6_A 239 CPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence 8999999999999999999999999988543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=305.56 Aligned_cols=255 Identities=21% Similarity=0.294 Sum_probs=199.1
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcC---CCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKK---TEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (288)
....++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ...+.+.+|+.++++++||||+++++++...+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 4456899999999999999999998765 45589999987543 23356889999999999999999999998754
Q ss_pred -----eEEEEEeccCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEE
Q 023058 91 -----HLAIVMEYASGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (288)
Q Consensus 91 -----~~~lv~e~~~~~~L~~~~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~ 159 (288)
..+++||++.+++|.+++.. ...++...++.++.||+.||.+||+.|++|+||||+||+++.++. ++
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~k 187 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VC 187 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--EE
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EE
Confidence 45999999999999998843 346999999999999999999999999999999999999987776 99
Q ss_pred EeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHH
Q 023058 160 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRI 235 (288)
Q Consensus 160 l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~ 235 (288)
|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||..............
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-- 264 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH-- 264 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT--
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc--
Confidence 999999875443321 223346778999999988777666 999999999999999 8899987665443333221
Q ss_pred hhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
...... ...+++.+.++|.+||+.||.+|||+.++++.+..
T Consensus 265 -~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 305 (313)
T 3brb_A 265 -GHRLKQ--PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305 (313)
T ss_dssp -TCCCCC--BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred -CCCCCC--CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 112222 33789999999999999999999999999885443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=310.23 Aligned_cols=257 Identities=25% Similarity=0.334 Sum_probs=203.8
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCC-cEEEEEEeecCccchHHHHHHHHHHhhCCCCc------eeeEeEEEEcCCeE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTE-ELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKEVILTPTHL 92 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~~~~~~~ 92 (288)
.++|++.+.||+|+||.||++.+..++ ..||+|++.......+.+.+|+.++++++|++ ++.+.+++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 589999999999999999999998776 68999999876666677888999999987655 89999999999999
Q ss_pred EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCC-----------------
Q 023058 93 AIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS----------------- 153 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~----------------- 153 (288)
++|||++ ++++.+.+... ..++...++.++.||+.||.|||+.||+|+||||+||+++.+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~ 176 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccccc
Confidence 9999999 45666666554 369999999999999999999999999999999999999432
Q ss_pred CCCCEEEeecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 023058 154 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 233 (288)
Q Consensus 154 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 233 (288)
....++|+|||++.... .......+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||..............
T Consensus 177 ~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 253 (355)
T 2eu9_A 177 KNTSIRVADFGSATFDH--EHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253 (355)
T ss_dssp SCCCEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCcEEEeecCcccccc--ccccCCcCCCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 23349999999987433 23345578999999999988888776 9999999999999999999987654333322221
Q ss_pred HHhhcc--------------------------------------cCCCCCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 234 RILSVQ--------------------------------------YSIPDYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 234 ~~~~~~--------------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
...... .........++++.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 110000 000011122457999999999999999999988876
Q ss_pred cchhhhhh
Q 023058 276 VYMHTKLQ 283 (288)
Q Consensus 276 ~~~~~~~~ 283 (288)
|+|+.
T Consensus 334 ---hp~f~ 338 (355)
T 2eu9_A 334 ---HPFFA 338 (355)
T ss_dssp ---SGGGG
T ss_pred ---Chhhc
Confidence 55554
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=300.86 Aligned_cols=255 Identities=24% Similarity=0.332 Sum_probs=204.7
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCc---EEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE-
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL- 92 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~- 92 (288)
..-.|.+.+.||+|+||+||++.+..++. .+|+|.+..... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 34567788999999999999999765444 799998875432 345688999999999999999999999876654
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 93 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
+++|+++.+++|.+++.. ...++...++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.....
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILD 176 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTSSCTTTT
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCCcccccC
Confidence 999999999999999876 456899999999999999999999999999999999999987776 99999999874432
Q ss_pred C-----CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCC
Q 023058 172 H-----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (288)
Q Consensus 172 ~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
. .......+++.|+|||.+.+..++.+ +|+||||+++|+|++|..|+............... ....+...
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 251 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ----GRRLPQPE 251 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT----TCCCCCCT
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChh-hchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc----CCCCCCCc
Confidence 2 22234456788999999988877766 99999999999999966665544443333332222 22233334
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccccchhh
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATGVYMHT 280 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~ 280 (288)
.+++.+.++|.+||+.||.+|||+.++++.+..-
T Consensus 252 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 252 YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 7899999999999999999999999998865443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=321.06 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=205.3
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
.+..++|++.+.||+|+||.||++.+.. +..||+|++.......+.+.+|+.++++++||||+++++++.. +..++||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 3556889999999999999999999875 4679999998777667789999999999999999999999876 6789999
Q ss_pred eccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 97 EYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
|++++++|.+++.. ...++...+..++.|++.||+|||+.|++||||+|+||+++.++. +||+|||++........
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEY 335 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC-------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCCCce
Confidence 99999999999964 346899999999999999999999999999999999999987776 99999999975443221
Q ss_pred --CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 175 --PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 175 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
.....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||.......... .+.. ....+....+|+.
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~----~i~~-~~~~~~~~~~~~~ 409 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVER-GYRMPCPPECPES 409 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHHT-TCCCCCCTTSCHH
T ss_pred ecccCCcccccccCHhHHhcCCCCcc-ccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHc-CCCCCCCCCCCHH
Confidence 122345678999999988777666 999999999999999 999998765433222 2222 2233334478999
Q ss_pred HHHHHHHhcccCcCCccccccccccc
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
+.++|.+||+.||.+|||+.++++.+
T Consensus 410 l~~li~~cl~~dP~~Rpt~~~l~~~L 435 (452)
T 1fmk_A 410 LHDLMCQCWRKEPEERPTFEYLQAFL 435 (452)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHH
Confidence 99999999999999999999887743
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=307.89 Aligned_cols=253 Identities=22% Similarity=0.366 Sum_probs=197.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhh--CCCCceeeEeEEEEcC----CeEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTP----THLA 93 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~----~~~~ 93 (288)
.++|++.+.||+|+||.||++.+. ++.||+|++..... ....+|.+++.. ++||||+++++++... ...+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 478999999999999999999985 88999999875443 334445555544 4999999999999877 6899
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--------CceecCCCCCceEecCCCCCCEEEeecCC
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------~i~H~dl~p~nilv~~~~~~~~~l~df~~ 165 (288)
+||||+++++|.+++... .++...++.++.|++.||.|||+. |++|+||||+||+++.++. ++|+|||+
T Consensus 112 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~ 188 (337)
T 3mdy_A 112 LITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGL 188 (337)
T ss_dssp EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTT
T ss_pred EEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCC
Confidence 999999999999999654 689999999999999999999998 9999999999999987776 99999999
Q ss_pred CcccccCCCC-----CCCcCCCcccCCccccCcccCCC-----ccchhhHHHHHHHHHhC----------CCCCCCCCCc
Q 023058 166 SKSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYDGK-----IADVWSCGVTLYVMLVG----------AYPFEDPEEP 225 (288)
Q Consensus 166 ~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~~~-----~~Di~slG~~~~~l~~g----------~~pf~~~~~~ 225 (288)
+......... ....+++.|+|||.+.+...... ++||||||+++|+|++| ..||......
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 268 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence 8654333222 24568999999999977665543 38999999999999999 7777654433
Q ss_pred hhHHHHHHHHhhcc---cCCCC---CCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 226 KNFRKTIHRILSVQ---YSIPD---YVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 226 ~~~~~~~~~~~~~~---~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
.............. ..++. ...+++++.++|.+||+.||.+|||+.++++.+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 32222222222221 12221 12456779999999999999999999999885543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=304.73 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=203.7
Q ss_pred CCCCCCCCCCCeeeeeeeeccCceEEEEEEEcC-CC--cEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeE
Q 023058 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKK-TE--ELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKE 84 (288)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~--~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~ 84 (288)
+........++|++.+.||+|+||+||++.+.. ++ ..|++|++... ....+.+.+|+.++++++||||+++++
T Consensus 9 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 88 (291)
T 1u46_A 9 QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88 (291)
T ss_dssp --CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence 344556677999999999999999999998643 33 36899988753 234467889999999999999999999
Q ss_pred EEEcCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeec
Q 023058 85 VILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (288)
Q Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df 163 (288)
++..+. .++|+|++.+++|.+.+... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+||
T Consensus 89 ~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Df 165 (291)
T 1u46_A 89 VVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDF 165 (291)
T ss_dssp EECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCC
T ss_pred EEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC--EEEccc
Confidence 998765 78999999999999988764 56999999999999999999999999999999999999987776 999999
Q ss_pred CCCcccccCCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhc
Q 023058 164 GYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV 238 (288)
Q Consensus 164 ~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 238 (288)
|++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||....... ....+...
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~~ 240 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKE 240 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTS
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcccCCHHH----HHHHHHcc
Confidence 99875543322 223346778999999987777665 999999999999999 999998765432 33333444
Q ss_pred ccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 239 QYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
....+....+++++.++|.+||+.||.+|||+.++++.+..
T Consensus 241 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 281 (291)
T 1u46_A 241 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 281 (291)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 44445555789999999999999999999999999885544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=305.97 Aligned_cols=255 Identities=17% Similarity=0.260 Sum_probs=208.8
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcC
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP 89 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (288)
....++|++.+.||+|+||.||++.+. .++..||+|.+..... ....+.+|+.++++++||||+++++++...
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 344689999999999999999999876 3578899999875432 334678999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEE
Q 023058 90 THLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~ 159 (288)
+..++|||++++++|.+++... ..++...++.++.||+.||.+||+.|++|+||||+||+++.++. ++
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~--~k 178 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VK 178 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--EE
Confidence 9999999999999999988652 35789999999999999999999999999999999999987776 99
Q ss_pred EeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHH
Q 023058 160 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRI 235 (288)
Q Consensus 160 l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~ 235 (288)
|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||......... ..+
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~----~~~ 253 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVL----RFV 253 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHH----HHH
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhccCCCCch-hhHHHHHHHHHHHHhcCCCccccCCHHHHH----HHH
Confidence 999999875433322 223346788999999987777666 999999999999999 89999775432222 222
Q ss_pred hhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
..... .+....+++.+.++|.+||+.||.+|||+.++++.+..
T Consensus 254 ~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~ 296 (322)
T 1p4o_A 254 MEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296 (322)
T ss_dssp HTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred HcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 22221 22233789999999999999999999999999885443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=302.98 Aligned_cols=249 Identities=29% Similarity=0.445 Sum_probs=198.5
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
+..++|++.+.||+|+||.||++.+. ++.||+|.+... ...+.+.+|+.++++++||||+++++++.+ ..++|||
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 45689999999999999999999984 788999988643 345678899999999999999999998764 4789999
Q ss_pred ccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhh---cCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 98 YASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHS---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~LH~---~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
|+++++|.+++.... .++...++.++.|++.||.|||+ .|++|+||||+||+++.++. .++|+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQT 158 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEccccccccccc
Confidence 999999999997665 37899999999999999999999 89999999999999986654 379999999874432
Q ss_pred CCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
. .....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||........ ........ ....+....+|+.
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~ 232 (307)
T 2eva_A 159 H--MTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHN-GTRPPLIKNLPKP 232 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTH-HHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHHT-TCCCCCBTTCCHH
T ss_pred c--cccCCCCCceEChhhhCCCCCCcH-HHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHhc-CCCCCcccccCHH
Confidence 2 233458999999999988877766 9999999999999999999986543221 11111111 1122223478999
Q ss_pred HHHHHHHhcccCcCCccccccccccch
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
+.++|.+||+.||.+|||+.++++.+.
T Consensus 233 l~~li~~~l~~dp~~Rps~~ell~~L~ 259 (307)
T 2eva_A 233 IESLMTRCWSKDPSQRPSMEEIVKIMT 259 (307)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 999999999999999999999988543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=309.67 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=200.7
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe-----
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH----- 91 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~----- 91 (288)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 489999999999999999999999999999999987543 223567899999999999999999999987653
Q ss_pred -EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 92 -LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 92 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
++++||++. ++|.+.+. ..++...++.++.||+.||.+||+.|++|+||+|+||+++.++. ++|+|||++....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD 177 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC--
T ss_pred eEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCC
Confidence 599999997 48877663 35899999999999999999999999999999999999987776 9999999987543
Q ss_pred cCCCCCCCcCCCcccCCccccC-cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh------------
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------ 237 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 237 (288)
. ......+++.|+|||.+.+ ..++.+ +|+||||+++|+|++|..||...+..+...........
T Consensus 178 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 178 A--EMTGYVVTRWYRAPEVILSWMHYNQT-VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTT-HHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred C--CccccccCcCcCCHHHHhCcCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence 2 2334567899999999877 445454 99999999999999999999876544433333221100
Q ss_pred -------c-----ccCCC-CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 238 -------V-----QYSIP-DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 238 -------~-----~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
. ...+. ....+++++.+||.+||+.||.+|||+.++++ |+|++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~---hp~f~ 310 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT---HPFFE 310 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT---SGGGT
T ss_pred HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc---Ccchh
Confidence 0 00111 12357899999999999999999999988876 55554
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=314.73 Aligned_cols=256 Identities=24% Similarity=0.356 Sum_probs=202.3
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC-----------CCceeeEeEEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVIL 87 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~ 87 (288)
..++|++.+.||+|+||.||+|.+..+++.||+|++.......+.+.+|+.++++++ ||||+++++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 357999999999999999999999999999999999876666677889999998886 899999999988
Q ss_pred cCC----eEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhc-CceecCCCCCceEecCCC----CC
Q 023058 88 TPT----HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSP----AP 156 (288)
Q Consensus 88 ~~~----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~-~i~H~dl~p~nilv~~~~----~~ 156 (288)
..+ ..+++||++ +++|.+++... ..++...++.++.||+.||.|||+. ||+|+||||+||+++.++ ..
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 654 789999999 77999988763 4599999999999999999999998 999999999999995432 22
Q ss_pred CEEEeecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCch------hHHH
Q 023058 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK------NFRK 230 (288)
Q Consensus 157 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~------~~~~ 230 (288)
.++|+|||++..... ......+++.|+|||.+.+..++.+ +||||||+++|+|++|..||....... ....
T Consensus 176 ~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 252 (373)
T 1q8y_A 176 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252 (373)
T ss_dssp EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence 599999999875433 2344578999999999988888766 999999999999999999998654211 1111
Q ss_pred HHHHHh--------------------------------------hcccCCCCCCCCCHHHHHHHHHhcccCcCCcccccc
Q 023058 231 TIHRIL--------------------------------------SVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFH 272 (288)
Q Consensus 231 ~~~~~~--------------------------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 272 (288)
...... .....++ ...++++.+||.+||+.||.+|||+.+
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS--KDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCC--HHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCC--cchHHHHHHHHHHHhccCccccCCHHH
Confidence 111000 0001111 134578999999999999999999988
Q ss_pred ccccchhhhhh
Q 023058 273 ATGVYMHTKLQ 283 (288)
Q Consensus 273 ~l~~~~~~~~~ 283 (288)
+++ |+|+.
T Consensus 331 ll~---hp~f~ 338 (373)
T 1q8y_A 331 LVN---HPWLK 338 (373)
T ss_dssp HHT---CGGGT
T ss_pred Hhh---Chhhh
Confidence 877 55544
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=308.81 Aligned_cols=244 Identities=30% Similarity=0.454 Sum_probs=198.2
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc-------chHHHHHHHHHHhhC----CCCceeeEeEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSL----RHPNIVRFKEV 85 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l----~~~~i~~~~~~ 85 (288)
....++|++.+.||+|+||.||++.+..+++.||+|++..... ....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3445899999999999999999999999999999999876532 223455788988888 89999999999
Q ss_pred EEcCCeEEEEEec-cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEec-CCCCCCEEEeec
Q 023058 86 ILTPTHLAIVMEY-ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDF 163 (288)
Q Consensus 86 ~~~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~-~~~~~~~~l~df 163 (288)
+...+..++++|+ +.+++|.+++...+.++...++.++.||+.||.+||+.|++|+||+|+||+++ .++. ++|+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~--~kl~df 184 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--AKLIDF 184 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE--EEECCC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe--EEEEEc
Confidence 9998999999999 78889999998888899999999999999999999999999999999999998 5555 999999
Q ss_pred CCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC
Q 023058 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 243 (288)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
|++...... ......+++.|+|||.+.+..+...++|+||||+++|+|++|..||.... .+......++
T Consensus 185 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------~~~~~~~~~~ 253 (312)
T 2iwi_A 185 GSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------EILEAELHFP 253 (312)
T ss_dssp SSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHTCCCCC
T ss_pred chhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------HHhhhccCCc
Confidence 998755432 23445689999999998877776655999999999999999999996421 1222333444
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 244 DYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
. .+++.+.++|.+||+.||.+|||+.++++
T Consensus 254 ~--~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 254 A--HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp T--TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred c--cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 4 68999999999999999999999988876
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=306.68 Aligned_cols=254 Identities=20% Similarity=0.290 Sum_probs=202.7
Q ss_pred CCCCCeeeeeeeeccCceEEEEEE-----EcCCCcEEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMR-----DKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPT 90 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (288)
...++|++.+.||+|+||.||++. +..++..||+|.+... ......+.+|+.++++++||||+++++++....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 456899999999999999999999 5567889999998643 233456888999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-CCCEEEee
Q 023058 91 HLAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICD 162 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~-~~~~~l~d 162 (288)
..++|||++++++|.+++.... .++...++.++.|++.||.+||+.|++|+||+|+||+++.++ ...++|+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence 9999999999999999997653 489999999999999999999999999999999999998443 23599999
Q ss_pred cCCCcccccCC---CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhc
Q 023058 163 FGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV 238 (288)
Q Consensus 163 f~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 238 (288)
||++....... ......+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||....... ....+...
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~~~ 261 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEFVTSG 261 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHHHHTT
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCcCHHH----HHHHHhcC
Confidence 99886432222 2234457889999999987777666 999999999999998 999997654322 22222222
Q ss_pred ccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 239 QYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
. .......+++.+.++|.+||+.||.+|||+.++++.+
T Consensus 262 ~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 299 (327)
T 2yfx_A 262 G-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299 (327)
T ss_dssp C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred C-CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 2 2222337899999999999999999999999998844
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=314.36 Aligned_cols=258 Identities=26% Similarity=0.385 Sum_probs=185.3
Q ss_pred CCeee-eeeeeccCceEEEEEEEc--CCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEc--CCeEEEE
Q 023058 21 DRYEL-VRDIGSGNFGVARLMRDK--KTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIV 95 (288)
Q Consensus 21 ~~y~~-~~~lg~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 95 (288)
+.|++ .++||+|+||.||+|.+. .+++.||+|++.... ....+.+|+.++++++||||+++++++.. ....++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 45776 458999999999999966 468899999987543 34578899999999999999999999954 6789999
Q ss_pred EeccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC--CCCCCEEEeecC
Q 023058 96 MEYASGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG--SPAPRLKICDFG 164 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~--~~~~~~~l~df~ 164 (288)
|||+.+ +|.+.+... ..++...++.++.||+.||.|||+.||+||||||+||++.. +..+.++|+|||
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 999965 787776422 14899999999999999999999999999999999999942 222349999999
Q ss_pred CCcccccC----CCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCc---------hhHHHH
Q 023058 165 YSKSSVLH----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKT 231 (288)
Q Consensus 165 ~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~---------~~~~~~ 231 (288)
++...... .......+++.|+|||.+.+......++|||||||++|+|++|..||...... .....+
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 99755432 22234568999999999987654445599999999999999999999765431 111111
Q ss_pred HHHHhhc------------------------ccCC--------CCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 232 IHRILSV------------------------QYSI--------PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 232 ~~~~~~~------------------------~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
...+... .+.. ......++.+.+||.+||+.||.+|||+.|+++ |
T Consensus 258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~---h 334 (405)
T 3rgf_A 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ---D 334 (405)
T ss_dssp HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT---S
T ss_pred HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc---C
Confidence 1110000 0000 001123778999999999999999999988876 6
Q ss_pred hhhh
Q 023058 280 TKLQ 283 (288)
Q Consensus 280 ~~~~ 283 (288)
+|+.
T Consensus 335 p~f~ 338 (405)
T 3rgf_A 335 PYFL 338 (405)
T ss_dssp GGGT
T ss_pred hhhc
Confidence 6654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=300.93 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=201.5
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCC--CCceeeEeEEEEcCCe
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLR--HPNIVRFKEVILTPTH 91 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~ 91 (288)
....++|++.+.||+|+||.||++.+. ++..||+|++.... ...+.+.+|+.++++++ |+||+++++++..++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 345688999999999999999999986 48889999987543 23456789999999997 5999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
.+++|| +.+++|.+++.....++...++.++.|++.||.+||+.|++|+||+|+||+++. + .++|+|||++.....
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~--~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQP 178 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCC---
T ss_pred EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C--eEEEeeccccccccC
Confidence 999999 457799999998889999999999999999999999999999999999999964 4 499999999875543
Q ss_pred CCC---CCCCcCCCcccCCccccC-----------cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh
Q 023058 172 HSQ---PKSTVGTPAYIAPEVLLK-----------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237 (288)
Q Consensus 172 ~~~---~~~~~~~~~~~aPE~~~~-----------~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (288)
... .....+++.|+|||.+.+ ..++. ++|+||||+++|+|++|..||....... . .......
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~~~--~-~~~~~~~ 254 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP-KSDVWSLGCILYYMTYGKTPFQQIINQI--S-KLHAIID 254 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCH-HHHHHHHHHHHHHHHHSSCTTTTCCSHH--H-HHHHHHC
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCc-hHHHHHHHHHHHHHHhCCCchhhHHHHH--H-HHHHHHh
Confidence 322 234468999999999865 23433 4999999999999999999997654322 1 1222222
Q ss_pred cccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 238 VQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 238 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
...........++++.++|.+||+.||.+|||+.++++ |+|++
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~---h~~~~ 297 (313)
T 3cek_A 255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA---HPYVQ 297 (313)
T ss_dssp TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT---SHHHH
T ss_pred cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc---Ccccc
Confidence 22222223356899999999999999999999988866 55554
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=307.53 Aligned_cols=257 Identities=21% Similarity=0.254 Sum_probs=203.9
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
...++|++.+.||+|+||.||++.+. ++..||+|++.... .....+.+|+.++++++||||+++++++..++..++|
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 105 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLV 105 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEE
T ss_pred HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEE
Confidence 35689999999999999999999865 58899999987543 2234688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhc---CceecCCCCCceEecCCCCCCEEEeecCCCcc
Q 023058 96 MEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~---~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~ 168 (288)
||++.+++|.+++.... .++...+..++.|++.||.+||+. |++|+||||+||+++.++. ++|+|||++..
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~ 183 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKL 183 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCEE
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCccccc
Confidence 99999999999997643 489999999999999999999999 9999999999999987776 99999999875
Q ss_pred cccCCC--CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCC----CCCchhHHHHHHHHhhccc--
Q 023058 169 SVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED----PEEPKNFRKTIHRILSVQY-- 240 (288)
Q Consensus 169 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~----~~~~~~~~~~~~~~~~~~~-- 240 (288)
...... .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||.. ...................
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (326)
T 3uim_A 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 262 (326)
T ss_dssp CCSSSSCEECCCCSCGGGCCHHHHHHSEECHH-HHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCST
T ss_pred cCcccccccccccCCcCccCHHHhccCCCCcc-ccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhh
Confidence 543322 233458999999999988777666 9999999999999999999962 1111112222111111110
Q ss_pred CC-------CCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 241 SI-------PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 241 ~~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.. ......++.+.+++.+||+.||.+|||+.++++.+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 00 000112367999999999999999999999998664
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=305.66 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=186.6
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCC-CCceeeEeEEEE--------c
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVIL--------T 88 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~--------~ 88 (288)
...+|++.+.||+|+||.||++++..+++.||+|++.... ...+.+.+|+.+++++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3568999999999999999999999999999999886543 33456889999999996 999999999984 3
Q ss_pred CCeEEEEEeccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcC--ceecCCCCCceEecCCCCCCEEEeec
Q 023058 89 PTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDF 163 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~--i~H~dl~p~nilv~~~~~~~~~l~df 163 (288)
...++++||++. ++|.+++.. .+.++...++.++.||+.||.|||+.| ++|+||||+||+++.++. ++|+||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~Df 182 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDF 182 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEEecC
Confidence 346899999996 588887754 457999999999999999999999999 999999999999987776 999999
Q ss_pred CCCcccccCCCC-------------CCCcCCCcccCCccc---cCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchh
Q 023058 164 GYSKSSVLHSQP-------------KSTVGTPAYIAPEVL---LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 227 (288)
Q Consensus 164 ~~~~~~~~~~~~-------------~~~~~~~~~~aPE~~---~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~ 227 (288)
|++......... ....+++.|+|||.+ .+..++.+ +||||||+++|+|++|..||.......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~- 260 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK-QDIWALGCILYLLCFRQHPFEDGAKLR- 260 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHH-HHHHHHHHHHHHHHHSSCCC--------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChH-HhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence 998755433221 134588999999998 34445444 999999999999999999997643322
Q ss_pred HHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 228 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
+.......+.....++.+.+||.+||+.||.+|||+.++++.+.
T Consensus 261 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 261 -------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred -------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 12223334444567889999999999999999999999988543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=301.49 Aligned_cols=257 Identities=21% Similarity=0.234 Sum_probs=203.7
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCC---CcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEE-c
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVIL-T 88 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~ 88 (288)
.+.....+|++.+.||+|+||.||++.+..+ ...+++|.+.... ...+.+.+|+.++++++||||+++++++. .
T Consensus 19 ~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (298)
T 3f66_A 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98 (298)
T ss_dssp BCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred ecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence 3445567899999999999999999997543 3468999887533 33456889999999999999999999864 4
Q ss_pred CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 89 PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
++..+++||++++++|.+++... ..++...++.++.|++.||.+||+.|++|+||||+||+++.++. ++|+|||++.
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~a~ 176 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR 176 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSCGGGC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC--EEECcccccc
Confidence 56889999999999999999763 46899999999999999999999999999999999999987776 9999999987
Q ss_pred ccccCCC-----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccC
Q 023058 168 SSVLHSQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYS 241 (288)
Q Consensus 168 ~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
....... .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||............. ... .
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~----~~~-~ 250 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL----QGR-R 250 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH----TTC-C
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh----cCC-C
Confidence 5433221 223346778999999988777666 999999999999999 556666555444333221 122 1
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 242 IPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
......+++.+.++|.+||+.||.+|||+.++++.+..
T Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 288 (298)
T 3f66_A 251 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 22223689999999999999999999999999886544
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=307.93 Aligned_cols=250 Identities=17% Similarity=0.159 Sum_probs=201.0
Q ss_pred CCCCeeeeeeeeccCceEEEEE-----EEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC---CCceeeEeEEEEcCC
Q 023058 19 DSDRYELVRDIGSGNFGVARLM-----RDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPT 90 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~-----~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~ 90 (288)
..++|.+.+.||+|+||+||+| .+..+++.||+|++... ....+..|.+++++++ |+|++++++++...+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 4588999999999999999999 46678899999998754 3456778888888886 899999999999999
Q ss_pred eEEEEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC-----------CC
Q 023058 91 HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-----------SP 154 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~-----------~~ 154 (288)
..++||||+++++|.+++.. ...+++..++.++.||+.||+|||+.||+||||||+||+++. ++
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 99999999999999999974 456999999999999999999999999999999999999986 44
Q ss_pred CCCEEEeecCCCccccc---CCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 023058 155 APRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 231 (288)
Q Consensus 155 ~~~~~l~df~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~ 231 (288)
. ++|+|||++..... ........+|+.|+|||.+.+..++.+ +||||||+++|+|++|..||.......
T Consensus 221 ~--~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 221 G--LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp T--EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred C--EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 4 99999999964332 222344568999999999998888776 999999999999999999996543211
Q ss_pred HHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 232 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
......+... ..++.+.+++..||+.+|.+|++..+.+...++.+++
T Consensus 293 ----~~~~~~~~~~-~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 293 ----CKPEGLFRRL-PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ----EEECSCCTTC-SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ----eeechhcccc-CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 1111112221 3467899999999999999998776655544455544
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=313.58 Aligned_cols=255 Identities=22% Similarity=0.230 Sum_probs=206.6
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCC-CceeeEeEEEEcCCeEEEEEec
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
.++|++.+.||+|+||.||++.+..+++.||+|++..... ...+.+|+++++.+.| ++++.+..++...+..++|||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 5899999999999999999999999999999998775443 3468899999999976 5666777777788899999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEe---cCCCCCCEEEeecCCCcccccCCC
Q 023058 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv---~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
+ +++|.+++.. ...++...++.++.||+.||.|||+.||+||||||+||++ +.++. ++|+|||++........
T Consensus 85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~--vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKKYRDTST 161 (483)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTTT
T ss_pred C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe--EEEEeCCcceeccCCcc
Confidence 9 8899999975 5579999999999999999999999999999999999999 45555 99999999975544322
Q ss_pred --------CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC---
Q 023058 175 --------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--- 243 (288)
Q Consensus 175 --------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 243 (288)
.....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||............. .+........
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~-~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE-KISEKKVATSIEA 239 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHH-HHHHHHHHSCHHH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccchhHHHHHH-HHhhccccccHHH
Confidence 225568999999999988888766 999999999999999999998765533322221 1111111000
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCccccccccccchhh
Q 023058 244 DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHT 280 (288)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~ 280 (288)
....+++++.+||..||+.+|.+||++.++++.|..-
T Consensus 240 l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0126789999999999999999999999988855443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=322.96 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=209.2
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
.+..++|++.+.||+|+||.||++.+.. +..||+|++.......+.+.+|+.++++++||||+++++++.. +..++||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 3556889999999999999999999875 4679999998877667889999999999999999999999876 6789999
Q ss_pred eccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-
Q 023058 97 EYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 173 (288)
Q Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~- 173 (288)
||+.+++|.+++.. ...++..+++.++.||+.||+|||+.||+||||+|+||+++.++. +||+|||++.......
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEY 418 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCCHHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCCCce
Confidence 99999999999964 346899999999999999999999999999999999999987776 9999999987543221
Q ss_pred -CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHH
Q 023058 174 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 251 (288)
Q Consensus 174 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
......++..|+|||.+.+..++.+ +||||||+++|+|++ |..||.......... .+.. ....+....+++.
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~----~i~~-~~~~~~~~~~~~~ 492 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVER-GYRMPCPPECPES 492 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH----HHHT-TCCCCCCTTCCHH
T ss_pred ecccCCcCcccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHc-CCCCCCCCCCCHH
Confidence 1223345678999999988777666 999999999999999 999998765433222 2222 2233334478999
Q ss_pred HHHHHHHhcccCcCCccccccccccc
Q 023058 252 CRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 252 l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
+.+||.+||+.||.+|||+.++++.+
T Consensus 493 l~~li~~cl~~dP~~RPt~~~l~~~L 518 (535)
T 2h8h_A 493 LHDLMCQCWRKEPEERPTFEYLQAFL 518 (535)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 99999999999999999999887744
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=322.76 Aligned_cols=258 Identities=24% Similarity=0.329 Sum_probs=207.2
Q ss_pred CCCCCeeeee-eeeccCceEEEEEEEcC--CCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 18 HDSDRYELVR-DIGSGNFGVARLMRDKK--TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 18 ~~~~~y~~~~-~lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
...+++.+.+ .||+|+||.||++.+.. ++..||+|++.... ...+.+.+|++++++++||||+++++++.. +..
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 3445666666 89999999999998753 45679999987642 345778999999999999999999999976 568
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
++||||+.+++|.+++... ..++...++.++.||+.||+|||+.||+||||||+||+++.++. +||+|||++.....
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALGA 488 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCSTTTTCC-
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc--EEEeeccCcccccC
Confidence 9999999999999988654 45999999999999999999999999999999999999988776 99999999976543
Q ss_pred CCCC----CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCC
Q 023058 172 HSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (288)
Q Consensus 172 ~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
.... ....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||...+.......+ ... ...+...
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i----~~~-~~~~~p~ 562 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI----EQG-KRMECPP 562 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH----HTT-CCCCCCT
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcC-CCCCCCC
Confidence 3221 12234578999999988887776 999999999999998 99999887654433222 222 2222233
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
.+|+++.++|.+||+.||.+||++.++++.+..-+.+.
T Consensus 563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 78999999999999999999999999988776665543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=298.89 Aligned_cols=250 Identities=24% Similarity=0.306 Sum_probs=201.1
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC-----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
.|...+.||+|+||.||++.+ ++..||+|++... ....+.+.+|+.++++++||||+++++++...+..+++|
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence 345569999999999999987 5788999998653 233467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 97 EYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 97 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
|++++++|.+++.. ...++...++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT--AKISDFGLARASEKFA 187 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSCS
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc--EEEeeccccccccccc
Confidence 99999999998863 346899999999999999999999999999999999999987776 9999999987544322
Q ss_pred C---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccC--------C
Q 023058 174 Q---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--------I 242 (288)
Q Consensus 174 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~ 242 (288)
. .....+++.|+|||.+.+ .++.+ +|+||||+++|+|++|..||...............+...... .
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRG-EITPK-SDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTT-EECTH-HHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred ccccccccCCCcCcCChHHhcC-CCCcc-chhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence 2 234468999999998865 45555 999999999999999999998766544444433332222111 0
Q ss_pred C-CCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 243 P-DYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 243 ~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
+ .....++.+.++|.+||+.||.+|||+.++++.+
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L 301 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0 1112356799999999999999999999987644
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=322.69 Aligned_cols=250 Identities=23% Similarity=0.277 Sum_probs=201.7
Q ss_pred CCeeee-eeeeccCceEEEEEEE--cCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 21 DRYELV-RDIGSGNFGVARLMRD--KKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 21 ~~y~~~-~~lg~g~~~~v~~~~~--~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
+.+.+. +.||+|+||.||++.+ ..+++.||+|++.... ...+.+.+|++++++++||||+++++++.. +..++
T Consensus 368 ~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 368 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 334443 4799999999999954 4567889999987643 234678999999999999999999999975 45889
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
||||+.+++|.+++...+.++...++.++.||+.||+|||+.||+||||||+||+++.++. +||+|||++........
T Consensus 447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADEN 524 (635)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC---
T ss_pred EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCcc
Confidence 9999999999999998888999999999999999999999999999999999999998776 99999999875443322
Q ss_pred ----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 175 ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 175 ----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
.....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||........... +... ...+....+|
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~----i~~~-~~~~~p~~~~ 598 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM----LEKG-ERMGCPAGCP 598 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHTT-CCCCCCTTCC
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcC-CCCCCCCCCC
Confidence 122335678999999988888776 999999999999998 9999987654332222 2222 2222233789
Q ss_pred HHHHHHHHHhcccCcCCccccccccccchh
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
+++.++|.+||+.||.+|||+.++++.+..
T Consensus 599 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 599 REMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 999999999999999999999999886554
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=303.52 Aligned_cols=254 Identities=22% Similarity=0.243 Sum_probs=190.4
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEc-----CCe
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-----PTH 91 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 91 (288)
....++|++.+.||+|+||.||++.+ +++.||+|++............++..+..++||||+++++.+.. ...
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 34569999999999999999999977 68899999987654333333344444556899999999976542 236
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc---------CceecCCCCCceEecCCCCCCEEEee
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---------QVCHRDLKLENTLLDGSPAPRLKICD 162 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~---------~i~H~dl~p~nilv~~~~~~~~~l~d 162 (288)
+++||||+++++|.+++.... .+...++.++.||+.||.|||+. ||+||||||+||+++.++. ++|+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kL~D 163 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISD 163 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC--EEECC
T ss_pred EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc--EEEee
Confidence 789999999999999996654 58899999999999999999999 9999999999999987776 99999
Q ss_pred cCCCcccccCC---------CCCCCcCCCcccCCccccCc-------ccCCCccchhhHHHHHHHHHhCCCCCCCCCCch
Q 023058 163 FGYSKSSVLHS---------QPKSTVGTPAYIAPEVLLKK-------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226 (288)
Q Consensus 163 f~~~~~~~~~~---------~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~ 226 (288)
||++....... ......+++.|+|||.+.+. .++. ++||||||+++|+|++|..||.......
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK-QVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHH-HHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccccc-ccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 99997543321 12234689999999998763 3333 4899999999999999977765432211
Q ss_pred h--------------HHHHHHHHhh--cccCCCC----CCCCCHHHHHHHHHhcccCcCCcccccccccc
Q 023058 227 N--------------FRKTIHRILS--VQYSIPD----YVHISPECRHLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 227 ~--------------~~~~~~~~~~--~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
. .......... ....++. ...+++++.+||.+||+.||.+|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 1 1111111111 1112222 11234579999999999999999999999884
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=296.45 Aligned_cols=247 Identities=31% Similarity=0.494 Sum_probs=192.7
Q ss_pred CCCCCCCCCCCCCCeeee-eeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHH-hhCCCCceeeEeEEE
Q 023058 9 GPGMDMPIMHDSDRYELV-RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVI 86 (288)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~ 86 (288)
..|..+......++|.+. +.||+|+||.||++.+..+++.||+|++.. .....+|+.++ +..+||||+++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~ 80 (299)
T 3m2w_A 5 KSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVY 80 (299)
T ss_dssp CCCCCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred cccccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhh
Confidence 445666666677999998 779999999999999999999999999864 24567888887 666999999999998
Q ss_pred Ec----CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-CCCEE
Q 023058 87 LT----PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLK 159 (288)
Q Consensus 87 ~~----~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~-~~~~~ 159 (288)
.. ....++|||++++++|.+++.... .++...++.++.|++.||.|||+.|++|+||||+||+++.+. .+.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~k 160 (299)
T 3m2w_A 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 160 (299)
T ss_dssp EEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEE
T ss_pred hhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEE
Confidence 76 678999999999999999998754 699999999999999999999999999999999999998732 33599
Q ss_pred EeecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc
Q 023058 160 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 239 (288)
Q Consensus 160 l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (288)
|+|||++.... +..++.+ +|+||||+++|+|++|..||...............+....
T Consensus 161 l~Dfg~a~~~~---------------------~~~~~~~-~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 218 (299)
T 3m2w_A 161 LTDFGFAKETT---------------------GEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218 (299)
T ss_dssp ECCCTTCEECT---------------------TCGGGGH-HHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC
T ss_pred Eeccccccccc---------------------cccCCch-hhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc
Confidence 99999886322 2234344 9999999999999999999976543221111111111111
Q ss_pred cCCCC--CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 240 YSIPD--YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 240 ~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
..++. ...+++++.++|.+||+.||.+|||+.++++ |+|+..
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~---hp~~~~ 262 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN---HPWIMQ 262 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT---SHHHHT
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc---Chhhcc
Confidence 12221 1468999999999999999999999988866 666543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=306.78 Aligned_cols=254 Identities=21% Similarity=0.236 Sum_probs=196.7
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCC---cEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEc-CCe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTE---ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-PTH 91 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 91 (288)
.....|.+.+.||+|+||.||++.+..++ ..+|+|.+.... ...+.+.+|+.++++++||||+++++++.. ++.
T Consensus 86 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp STTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred hhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 34456889999999999999999975433 468999876532 334678899999999999999999998754 467
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.++||||+++++|.+++.... .++...++.++.||+.||.|||+.||+||||||+||+++.++. ++|+|||++....
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMY 243 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeecccccccc
Confidence 899999999999999997654 5889999999999999999999999999999999999987776 9999999987543
Q ss_pred cCCC-----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCC
Q 023058 171 LHSQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244 (288)
Q Consensus 171 ~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (288)
.... .....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||...+........ .... ....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~----~~~~-~~~~ 317 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGR-RLLQ 317 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH----HTTC-CCCC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcH-HHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH----HcCC-CCCC
Confidence 3221 122346678999999988877766 999999999999999 67788766554433322 1221 2222
Q ss_pred CCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 245 YVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 245 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
...+|+.+.++|.+||+.||.+|||+.++++.+..
T Consensus 318 p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 318 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 33689999999999999999999999999885543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=298.40 Aligned_cols=252 Identities=23% Similarity=0.285 Sum_probs=201.4
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhh--CCCCceeeEeEEEEcCC----eEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTPT----HLAI 94 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~----~~~l 94 (288)
++|++.+.||+|+||.||++.+ +++.||+|++... ....+.+|.++++. ++||||+++++++.... ..++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l 117 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 117 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence 7899999999999999999998 4889999998653 34567788888877 78999999999998876 8999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh--------hcCceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
|||++++++|.+++.. ..++...++.++.|++.||.+|| +.|++|+||||+||+++.++. ++|+|||++
T Consensus 118 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~ 194 (342)
T 1b6c_B 118 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLA 194 (342)
T ss_dssp EECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTTC
T ss_pred EEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCCc
Confidence 9999999999999966 46899999999999999999999 899999999999999987776 999999998
Q ss_pred cccccCC-----CCCCCcCCCcccCCccccCcccCC-----CccchhhHHHHHHHHHhC----------CCCCCCCCCch
Q 023058 167 KSSVLHS-----QPKSTVGTPAYIAPEVLLKKEYDG-----KIADVWSCGVTLYVMLVG----------AYPFEDPEEPK 226 (288)
Q Consensus 167 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~-----~~~Di~slG~~~~~l~~g----------~~pf~~~~~~~ 226 (288)
....... ......+++.|+|||.+.+..... .++|+||||+++|+|++| ..||.......
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 274 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence 7544433 234456899999999987653221 348999999999999999 78887654322
Q ss_pred h-HHHHHHHHhhccc--CCCC---CCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 227 N-FRKTIHRILSVQY--SIPD---YVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 227 ~-~~~~~~~~~~~~~--~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
. .......+..... ..+. ...+++.+.++|.+||+.||.+|||+.++++.+..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 2 2222222222221 1221 11234689999999999999999999999885543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=299.54 Aligned_cols=254 Identities=21% Similarity=0.307 Sum_probs=201.4
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
...+..++|++.+.||+|+||.||++.+.. .+++|++.... ...+.+.+|+.++++++||||+++++++.....
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 344557899999999999999999999854 48999887532 333567789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 92 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.+++||++++++|.+++...+ .++...++.++.|++.||.+||+.|++|+||+|+||+++ ++. ++|+|||++....
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~--~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGK--VVITDFGLFSISG 180 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---C--CEECCCSCCC---
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCC--EEEeecCCccccc
Confidence 999999999999999997655 699999999999999999999999999999999999998 444 9999999876432
Q ss_pred cC------CCCCCCcCCCcccCCccccCcc--------cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHh
Q 023058 171 LH------SQPKSTVGTPAYIAPEVLLKKE--------YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 236 (288)
Q Consensus 171 ~~------~~~~~~~~~~~~~aPE~~~~~~--------~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 236 (288)
.. .......+++.|+|||.+.+.. ....++|+||||+++|+|++|..||.......... .+.
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~ 256 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW----QMG 256 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH----HHH
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----Hhc
Confidence 21 1223345788999999986522 12334999999999999999999998755433222 222
Q ss_pred hcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 237 SVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 237 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
...........+++++.++|.+||+.||.+|||+.++++.+.
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 298 (319)
T 2y4i_B 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298 (319)
T ss_dssp TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 222222222367899999999999999999999999988443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=324.42 Aligned_cols=262 Identities=26% Similarity=0.364 Sum_probs=202.4
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEc------C
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT------P 89 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~ 89 (288)
...++|++.+.||+|+||.||++.+..+++.||+|++... ....+.+.+|+.++++++||||+++++++.. .
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 3448999999999999999999999999999999988654 2334568899999999999999999998765 6
Q ss_pred CeEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCC-CCEEEeecCC
Q 023058 90 THLAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGY 165 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~-~~~~l~df~~ 165 (288)
+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++. ..++|+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 67899999999999999997654 5899999999999999999999999999999999999986543 2489999999
Q ss_pred CcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH-----HHHH-----HH
Q 023058 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR-----KTIH-----RI 235 (288)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~-----~~~~-----~~ 235 (288)
+.............+++.|+|||.+.+..++.+ +|+||||+++|+|++|..||........+. .... ..
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD 249 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred ccccccccccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence 987666655566789999999999988888777 999999999999999999997532111000 0000 00
Q ss_pred hhcccCC----CC----CCCCCHHHHHHHHHhcccCcCCccccccccc-cchhh
Q 023058 236 LSVQYSI----PD----YVHISPECRHLISRIFVADPAKVSMHFHATG-VYMHT 280 (288)
Q Consensus 236 ~~~~~~~----~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~-~~~~~ 280 (288)
......+ +. ...+++.+.++|.+||+.||.+|||+.++++ .++..
T Consensus 250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0011111 11 1135688999999999999999999988876 44333
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=317.48 Aligned_cols=253 Identities=23% Similarity=0.344 Sum_probs=203.8
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCC---CcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
...++|++.+.||+|+||.||++.+..+ +..+|+|...... ...+.+.+|+.++++++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 3457899999999999999999998643 4579999876533 23357889999999999999999999985 4568
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 93 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
++||||+++++|.+++...+ .++...++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++.....
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMED 543 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC--EEEEecCCCeecCC
Confidence 99999999999999997654 6899999999999999999999999999999999999988776 99999999975543
Q ss_pred CCCC--CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCC
Q 023058 172 HSQP--KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 172 ~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
.... ....+++.|+|||.+.+..++.+ +|+||||+++|+|++ |..||............ .... ..+....+
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i----~~~~-~~~~~~~~ 617 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENGE-RLPMPPNC 617 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----HHTC-CCCCCTTC
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCch-hhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----HcCC-CCCCCccc
Confidence 3221 22345678999999987777666 999999999999997 99999876543333222 2221 22223378
Q ss_pred CHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
|+.+.++|.+||+.||.+|||+.++++.+..
T Consensus 618 ~~~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 9999999999999999999999999885543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=305.02 Aligned_cols=249 Identities=24% Similarity=0.294 Sum_probs=188.6
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
....+|.+.+.||+|+||+|+. ....+++.||+|++..... ....+|+.+++++ +||||+++++++.+....++||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 3446799999999999999764 3445789999999865432 3467899999999 7999999999999999999999
Q ss_pred eccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC---CCCCCEEEeecCCCcccccC
Q 023058 97 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~---~~~~~~~l~df~~~~~~~~~ 172 (288)
|++.+ +|.+++.... .++...++.++.||+.||.|||+.||+||||||+||+++. ++..+++|+|||++......
T Consensus 98 E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 99965 9998887654 4566677899999999999999999999999999999953 34445889999998755433
Q ss_pred C----CCCCCcCCCcccCCccccC---cccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccC-CC
Q 023058 173 S----QPKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYS-IP 243 (288)
Q Consensus 173 ~----~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~ 243 (288)
. ......+++.|+|||.+.+ ..++. ++|||||||++|+|++ |..||....... . .. ........ ..
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~-~~DiwSlG~il~ellt~g~~pf~~~~~~~-~-~~--~~~~~~~~~~~ 251 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTY-TVDIFSAGCVFYYVISEGSHPFGKSLQRQ-A-NI--LLGACSLDCLH 251 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCT-HHHHHHHHHHHHHHHTTSCBTTBSTTTHH-H-HH--HTTCCCCTTSC
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCc-HHHHHHHHHHHHHHHcCCCCCcchhhHHH-H-HH--HhccCCccccC
Confidence 2 2234568999999999874 33434 4999999999999999 999996543211 1 11 11111111 11
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 244 DYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.....+..+.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11233566899999999999999999998877
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=298.78 Aligned_cols=245 Identities=26% Similarity=0.325 Sum_probs=186.6
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEEEec
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
.+.|.+.+.||+|+||+||.+. ..+|+.||+|++.... .+...+|+.+++++ +||||+++++++..++..++|||+
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 4667788999999999998754 4578999999987543 35678899999876 899999999999999999999999
Q ss_pred cCCCchHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCC-----------CCCCEEE
Q 023058 99 ASGGELFERICNAGRF-------SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-----------PAPRLKI 160 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~-------~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~-----------~~~~~~l 160 (288)
++ ++|.+++...... +...++.++.||+.||+|||+.||+||||||+||+++.+ ....++|
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 96 5999999765432 233457799999999999999999999999999999754 2345999
Q ss_pred eecCCCcccccCCC-----CCCCcCCCcccCCccccC-------cccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchh
Q 023058 161 CDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLK-------KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN 227 (288)
Q Consensus 161 ~df~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~ 227 (288)
+|||++........ .....+++.|+|||.+.+ ..++.+ +|||||||++|+|++ |..||.......
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~-~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS-IDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTH-HHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchh-hhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 99999976544322 223468999999999865 344444 999999999999998 999997644321
Q ss_pred HHHHHHHHhhcccCCCCC-----CCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 228 FRKTIHRILSVQYSIPDY-----VHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.. +.......+.. ..+++++.++|.+||+.||.+|||+.++++
T Consensus 248 -~~----i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -SN----IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -HH----HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HH----HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 12 22222222221 123578999999999999999999998877
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=287.20 Aligned_cols=228 Identities=15% Similarity=0.105 Sum_probs=184.4
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc----hHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
..++|++.+.||+|+||.||++.+..+++.||+|++...... .+.+.+|+..+++++||||+++++++..++..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 558899999999999999999999999999999999865433 2678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
||||+++++|.+++... ....++..++.|++.||+|||+.||+|+||||+||+++.++. ++|++++.
T Consensus 109 v~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~~--------- 175 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPAT--------- 175 (286)
T ss_dssp EEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCCC---------
T ss_pred EEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEeccc---------
Confidence 99999999999998543 466678999999999999999999999999999999998877 88875542
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCC--CCCCCCCHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPEC 252 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 252 (288)
++| + ..++||||||+++|+|++|..||...+........... ....... .....+|+++
T Consensus 176 ----------~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 236 (286)
T 3uqc_A 176 ----------MPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD-TAGQPIEPADIDRDIPFQI 236 (286)
T ss_dssp ----------CTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC-TTSCBCCHHHHCTTSCHHH
T ss_pred ----------cCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH-hccCCCChhhcccCCCHHH
Confidence 222 3 33499999999999999999999876543211000000 0011100 0123689999
Q ss_pred HHHHHHhcccCcCCccccccccccchh
Q 023058 253 RHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
.++|.+||+.||.+| |+.++++.+..
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~L~~ 262 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNLMQQ 262 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred HHHHHHHcccCCccC-CHHHHHHHHHH
Confidence 999999999999999 99999885544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=298.01 Aligned_cols=246 Identities=14% Similarity=0.103 Sum_probs=187.6
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCC-Cc---------eeeEe-
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRH-PN---------IVRFK- 83 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~-~~---------i~~~~- 83 (288)
...+|.+.+.||+|+||+||+|.+..+++.||||++... ....+.+.+|+.+++.++| +| ++...
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345689999999999999999999999999999998733 2335678899999999976 21 11111
Q ss_pred -----------EEEEc-----CCeEEEEEeccCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHhhcCcee
Q 023058 84 -----------EVILT-----PTHLAIVMEYASGGELFERICN-------AGRFSEDEARFFFQQLISGVSYCHSMQVCH 140 (288)
Q Consensus 84 -----------~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H 140 (288)
.++.. ...++++|+.+ +++|.+++.. ...++...++.++.||+.||+|||+.||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 11111 12467888876 5689888741 224778899999999999999999999999
Q ss_pred cCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCcCCCcccCCccc----------cCcccCCCccchhhHHHHHH
Q 023058 141 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL----------LKKEYDGKIADVWSCGVTLY 210 (288)
Q Consensus 141 ~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~~Di~slG~~~~ 210 (288)
|||||+||+++.++. +||+|||++...... .....+ +.|+|||.+ .+..++.+ +||||||+++|
T Consensus 235 rDiKp~NILl~~~~~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~-~DvwSlGvil~ 308 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGG--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFA-FDTWTLGLAIY 308 (413)
T ss_dssp SCCCGGGEEECTTCC--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHH-HHHHHHHHHHH
T ss_pred CCcccceEEEecCCe--EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCch-hhHHHHHHHHH
Confidence 999999999998887 999999998754433 334456 999999998 44445555 99999999999
Q ss_pred HHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 211 VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 211 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
+|++|..||.......... ..+.....+|+++.+||.+||+.||.+|||+.++++ ++|++.
T Consensus 309 elltg~~Pf~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~---~~~~~~ 369 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSE----------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME---TPEYEQ 369 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSG----------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT---SHHHHH
T ss_pred HHHHCCCCCCCcchhhhHH----------HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh---CHHHHH
Confidence 9999999997654322111 122333468999999999999999999999988877 555443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=315.76 Aligned_cols=235 Identities=22% Similarity=0.262 Sum_probs=190.0
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcC-CCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe----
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKK-TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH---- 91 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 91 (288)
..++|++.+.||+|+||.||++.+.. +++.|++|++.... .....+.+|+.++++++||||+++++++...+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 34899999999999999999999976 78999999886542 333467899999999999999999999987654
Q ss_pred -EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 92 -LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 92 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.++||||+++++|.+.+.. .++..+++.++.||+.+|.|||+.||+||||||+||+++.+ .++|+|||++....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETT
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhcc
Confidence 7999999999999887654 79999999999999999999999999999999999999864 39999999987543
Q ss_pred cCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
.. ....+++.|+|||.+.+.. +.++||||||+++++|++|..||........ .........++
T Consensus 233 ~~---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------~~~~~~~~~~~ 295 (681)
T 2pzi_A 233 SF---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------PEDDPVLKTYD 295 (681)
T ss_dssp CC---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------CTTCHHHHHCH
T ss_pred cC---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccccc------------cccccccccCH
Confidence 32 4556899999999986554 4459999999999999999888764221100 00000012357
Q ss_pred HHHHHHHHhcccCcCCccccccccc
Q 023058 251 ECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
.+.++|.+||+.||.+||++.+.+.
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~ 320 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMS 320 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHH
Confidence 8999999999999999998866654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=291.81 Aligned_cols=247 Identities=18% Similarity=0.194 Sum_probs=186.0
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---------chHHHHHHHHHHhhCC---------CCce
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLR---------HPNI 79 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~---------~~~i 79 (288)
...++|++.+.||+|+||+||+|++ +++.||+|++..... ..+.+.+|+.+++.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 4458999999999999999999998 689999999986532 2267889999988885 7888
Q ss_pred eeEeEEEE------------------------------cCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHH
Q 023058 80 VRFKEVIL------------------------------TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129 (288)
Q Consensus 80 ~~~~~~~~------------------------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~ 129 (288)
+++.+++. ..+.+++||||++++++.+.+.. +.+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 87777643 26789999999998876655533 568999999999999999
Q ss_pred HHHHh-hcCceecCCCCCceEecCCCC------------------CCEEEeecCCCcccccCCCCCCCcCCCcccCCccc
Q 023058 130 VSYCH-SMQVCHRDLKLENTLLDGSPA------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190 (288)
Q Consensus 130 l~~LH-~~~i~H~dl~p~nilv~~~~~------------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~ 190 (288)
|+||| +.||+||||||+||+++.++. ..+||+|||++..... ....+|+.|+|||.+
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGG
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhh
Confidence 99999 999999999999999987751 1499999999985543 244789999999999
Q ss_pred cCcccCCCccchhhHHHH-HHHHHhCCCCCCCCCCchhHHHHHHHHhhc-ccCCCC----CCCCCHHHHHHHHHhcccCc
Q 023058 191 LKKEYDGKIADVWSCGVT-LYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPD----YVHISPECRHLISRIFVADP 264 (288)
Q Consensus 191 ~~~~~~~~~~Di~slG~~-~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~l~~li~~~l~~~p 264 (288)
.+.. + .++||||++++ .++++.|..||.... ........+... ...... ...+++++.+||.+||+.|
T Consensus 250 ~g~~-~-~~~Diwsl~~~~~~~~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d- 323 (336)
T 2vuw_A 250 TGDG-D-YQFDIYRLMKKENNNRWGEYHPYSNVL---WLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS- 323 (336)
T ss_dssp CCCS-S-HHHHHHHHHHHHHTTCTTSCCTHHHHH---HHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-
T ss_pred cCCC-c-cceehhhhhCCCCcccccccCCCcchh---hhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-
Confidence 8665 4 45999998777 667888988884210 001111121111 111111 1236788999999999976
Q ss_pred CCccccccccccchhhhhh
Q 023058 265 AKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 265 ~~Rpt~~~~l~~~~~~~~~ 283 (288)
|+.|++. .|+|++
T Consensus 324 ----sa~e~l~--~Hp~f~ 336 (336)
T 2vuw_A 324 ----SATDLLC--QHSLFK 336 (336)
T ss_dssp ----SHHHHHH--HCGGGC
T ss_pred ----CHHHHHh--cCCCcC
Confidence 7766650 477763
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=247.29 Aligned_cols=181 Identities=13% Similarity=0.047 Sum_probs=130.0
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeecCc-----------cchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeEEEE
Q 023058 28 DIGSGNFGVARLMRDKKTEELVAVKYIERGD-----------KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 28 ~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----------~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv 95 (288)
..+.|+.|.+..++....|+.|++|++.... ...+++.+|+++|+++ .|+||+++++++.+++..|+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 3456666777776766778999999987542 2224688999999999 799999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-C
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q 174 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~ 174 (288)
|||++|++|.+++...++++.. .|+.||+.||+|+|++||+||||||+|||++.++. +||+|||+++...... .
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCcc
Confidence 9999999999999998888775 47899999999999999999999999999988876 9999999987554332 2
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhC
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 215 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g 215 (288)
.....||+.|+|||++.+. +... +|+||+|++.+.+.++
T Consensus 396 ~~t~vGTp~YmAPE~l~g~-~~~~-~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAEN-KSWN-GFWRSAPVHPFNLPQP 434 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTT
T ss_pred ccCceechhhccHHHhCCC-CCCc-ccccccccchhhhccc
Confidence 3345689999999998764 3334 8999999988766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-28 Score=216.41 Aligned_cols=180 Identities=20% Similarity=0.127 Sum_probs=138.1
Q ss_pred eeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---------chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 25 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
..+.||+|+||+||++.. .+..+++|....... ..+++.+|++++++++||||+++..++...+..++|
T Consensus 340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 456899999999999954 467889998654221 123478999999999999999666666667777999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|||+++++|.+++.. +..++.|++.+|.|||+.||+||||||+||+++. +++|+|||+++........
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCcccc
Confidence 999999999998865 6689999999999999999999999999999986 4999999999865443221
Q ss_pred --------CCCcCCCcccCCccccC--cccCCCccchhhHHHHHHHHHhCCCCC
Q 023058 176 --------KSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPF 219 (288)
Q Consensus 176 --------~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~~~~l~~g~~pf 219 (288)
....+|+.|+|||.+.. ..|... .|+|+..+-..+-+.+..+|
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhcccc
Confidence 23468999999999876 455555 79999988888777665554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=182.71 Aligned_cols=143 Identities=17% Similarity=0.161 Sum_probs=113.0
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc-------------------chHHHHHHHHHHhhCCCCceeeE
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------------------IDENVQREIINHRSLRHPNIVRF 82 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------------------~~~~~~~e~~~l~~l~~~~i~~~ 82 (288)
.|++.+.||+|+||.||++.+ .++..||+|++..... ....+.+|+.++++++ | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 344559999999999999999 7899999999864321 2346889999999998 4 555
Q ss_pred eEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEee
Q 023058 83 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 162 (288)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~d 162 (288)
.+++.. +..++||||+++++|.+ +. ......++.|++.||.+||+.||+|+||||+||+++ ++. ++|+|
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~--vkl~D 235 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG--IWIID 235 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE--EEECC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc--EEEEE
Confidence 555433 45699999999999987 31 134557999999999999999999999999999999 665 99999
Q ss_pred cCCCcccccCCCCCCCcCCCcccCCcccc
Q 023058 163 FGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191 (288)
Q Consensus 163 f~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 191 (288)
||++.. +..+.|||.+.
T Consensus 236 FG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp CTTCEE------------TTSTTHHHHHH
T ss_pred CCCCeE------------CCCCCHHHHHH
Confidence 998863 23456788763
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=6.6e-22 Score=161.24 Aligned_cols=136 Identities=15% Similarity=0.097 Sum_probs=106.2
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcE--EEEEEeecCccc-------------------------hHHHHHHHHHHhhC
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGDKI-------------------------DENVQREIINHRSL 74 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~--~~iK~~~~~~~~-------------------------~~~~~~e~~~l~~l 74 (288)
-|++.+.||+|+||.||+|.+..+|.. ||+|++...... ...+.+|+..++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999999777888 999987543211 12578899999999
Q ss_pred CCCce--eeEeEEEEcCCeEEEEEeccCC-C----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHh-hcCceecCCCCC
Q 023058 75 RHPNI--VRFKEVILTPTHLAIVMEYASG-G----ELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLE 146 (288)
Q Consensus 75 ~~~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~i~H~dl~p~ 146 (288)
.|+++ +.+++. ...++||||+.+ + +|.+.... .+...+..++.|++.+|.+|| +.|++||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 88764 344432 356899999942 3 56655422 234577889999999999999 999999999999
Q ss_pred ceEecCCCCCCEEEeecCCCcc
Q 023058 147 NTLLDGSPAPRLKICDFGYSKS 168 (288)
Q Consensus 147 nilv~~~~~~~~~l~df~~~~~ 168 (288)
||+++. . ++|+|||++..
T Consensus 201 NILl~~--~--~~liDFG~a~~ 218 (258)
T 1zth_A 201 NIMYID--K--VYFIDMGQAVT 218 (258)
T ss_dssp SEEESS--S--EEECCCTTCEE
T ss_pred HEEEcC--c--EEEEECccccc
Confidence 999986 3 99999999863
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=6.2e-19 Score=149.60 Aligned_cols=137 Identities=15% Similarity=0.117 Sum_probs=99.2
Q ss_pred CeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc---------------hH--------HHHHHHHHHhhCCCCc
Q 023058 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI---------------DE--------NVQREIINHRSLRHPN 78 (288)
Q Consensus 22 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---------------~~--------~~~~e~~~l~~l~~~~ 78 (288)
-|++...||+|++|.||.|.+. +|+.||+|++...... .. ...+|...+.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4899999999999999999986 5899999987532110 00 1235677777775555
Q ss_pred eeeEeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCC--
Q 023058 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-- 156 (288)
Q Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~-- 156 (288)
+....-+... ..++||||+++.+|..+.. ......++.|++.++.+||+.|+|||||||.|||++.++.+
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 4322222111 2379999999888764431 12345688999999999999999999999999999876632
Q ss_pred ------CEEEeecCCCc
Q 023058 157 ------RLKICDFGYSK 167 (288)
Q Consensus 157 ------~~~l~df~~~~ 167 (288)
.+.++||+-+.
T Consensus 247 ~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMV 263 (397)
T ss_dssp TTSEEEEEEECCCTTCE
T ss_pred ccccccceEEEEeCCcc
Confidence 37899998654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.1e-13 Score=112.63 Aligned_cols=138 Identities=17% Similarity=0.128 Sum_probs=110.2
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCC-CCceeeEeEEEEcCCeEEEEEec
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
..|.+...++.|+.+.||++... +..+++|...... .....+.+|+..++.+. +..++++++++...+..++|||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 56899999999999999999864 6789999886532 23346889999999884 66788899999888899999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------------
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS------------------------------------------- 135 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~------------------------------------------- 135 (288)
++|.+|.+... +......++.+++.++..||+
T Consensus 92 i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 92 ADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp CSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred cCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 99988876521 122345788899999999998
Q ss_pred ----------------cCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 136 ----------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 136 ----------------~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
..++|+|++|.||+++.+.. +.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~--~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV--SGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEE--EEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcE--EEEEEchhcc
Confidence 45899999999999975432 5699998664
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.37 E-value=2.8e-12 Score=104.10 Aligned_cols=135 Identities=13% Similarity=0.108 Sum_probs=98.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCc--eeeEeEEEEcCCeEEEEEe
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e 97 (288)
...|.+....+.|..+.||++... +|..+++|..... ....+.+|+..++.+.+.+ +++++.+...++..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 345666555456667999999753 5677999987654 3356788999998885444 5668888888888999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ---------------------------------------- 137 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 137 (288)
+++|.++. . .... ...++.+++..+..||+..
T Consensus 96 ~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 96 EVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp CCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred ecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 99998874 1 1112 2356677777778887643
Q ss_pred ------------------ceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 138 ------------------VCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 138 ------------------i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
++|+|++|.||+++.+.. +.|+||+.+.
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~--~~liD~~~a~ 213 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRF--SGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEE--EEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcE--EEEEcchhcc
Confidence 999999999999975543 5699999765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.30 E-value=1.3e-11 Score=105.11 Aligned_cols=142 Identities=14% Similarity=0.206 Sum_probs=105.9
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEee--cCc--cchHHHHHHHHHHhhCCC--CceeeEeEEEEcC---CeEE
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIE--RGD--KIDENVQREIINHRSLRH--PNIVRFKEVILTP---THLA 93 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~--~~~--~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~---~~~~ 93 (288)
...++.|+.|.++.||++... +..+++|+.. ... .....+.+|+.+++.+.. ..+++++.++.+. +..+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 345778899999999999875 4678999776 432 234578889999998864 4577888888766 4589
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------
Q 023058 94 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------- 135 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-------------------------------------- 135 (288)
+|||++++..+.+. ....++..+...++.+++..|..||+
T Consensus 118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999998777431 12246788888999999999999997
Q ss_pred --------------------cCceecCCCCCceEecCCCCCCEEEeecCCCcc
Q 023058 136 --------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (288)
Q Consensus 136 --------------------~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~ 168 (288)
.+++|+|+++.||+++.++...+.++||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 359999999999999865432258999998763
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.09 E-value=8.8e-11 Score=97.61 Aligned_cols=186 Identities=17% Similarity=0.131 Sum_probs=119.1
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC-CCCc--eeeEeEEEEcCC---eEEEEEecc
Q 023058 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL-RHPN--IVRFKEVILTPT---HLAIVMEYA 99 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~--i~~~~~~~~~~~---~~~lv~e~~ 99 (288)
++.++.|....||++. ..+++|+... ......+.+|...++.+ .+.. +++++....... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~-~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH-SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS-HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC-cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4558999999999874 3589997543 33456788999999887 3333 445554443333 348899999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------------
Q 023058 100 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------- 135 (288)
Q Consensus 100 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-------------------------------------------- 135 (288)
+|.++..... ..++..+...++.+++..+..||+
T Consensus 99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 9988865332 246777788888888888888885
Q ss_pred --------------cCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCcCCCcccCCccccC--cccCCC-
Q 023058 136 --------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK--KEYDGK- 198 (288)
Q Consensus 136 --------------~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~- 198 (288)
..++|+|++|.||+++.+....+.++||+.+....+............-..|+.... ..|...
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~ 256 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD 256 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence 137999999999999874222378999998764322111100000000012221110 011111
Q ss_pred ----------ccchhhHHHHHHHHHhCCCCC
Q 023058 199 ----------IADVWSCGVTLYVMLVGAYPF 219 (288)
Q Consensus 199 ----------~~Di~slG~~~~~l~~g~~pf 219 (288)
..+.|+++.+++.+.+|..+|
T Consensus 257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 158999999999999997665
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=1.8e-08 Score=82.07 Aligned_cols=132 Identities=19% Similarity=0.207 Sum_probs=96.6
Q ss_pred eeeccCce-EEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC-CCceeeEeEEEEcCCeEEEEEeccCCCchH
Q 023058 28 DIGSGNFG-VARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELF 105 (288)
Q Consensus 28 ~lg~g~~~-~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (288)
.+..|..+ .||+......+..+++|..... ....+.+|...++.+. +--+++++.++.+.+..++||+++++.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34445444 6999988877888999976543 3456888999988774 333678888988889999999999998877
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------------------
Q 023058 106 ERICNAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------------- 135 (288)
Q Consensus 106 ~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-------------------------------------------------- 135 (288)
+..... ......+..++...|..||.
T Consensus 109 ~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 184 (272)
T 4gkh_A 109 QVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH 184 (272)
T ss_dssp HHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred ccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence 655432 12334556667777777764
Q ss_pred --------cCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 136 --------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 136 --------~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
..++|+|+.+.||+++.++. +-|+||+.+.
T Consensus 185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~~--~~viDwe~a~ 222 (272)
T 4gkh_A 185 KLLPFSPDSVVTHGDFSLDNLIFDEGKL--IGCIDVGRVG 222 (272)
T ss_dssp TTCCCCCCEEEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred hcccccCCcEEEcCCCCCCeEEEECCeE--EEEEECcccc
Confidence 12799999999999986553 6799998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=5.7e-08 Score=80.68 Aligned_cols=135 Identities=19% Similarity=0.143 Sum_probs=92.8
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCC---ceeeEeEEEE-cCCeEEEEEeccCC
Q 023058 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVIL-TPTHLAIVMEYASG 101 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~-~~~~~~lv~e~~~~ 101 (288)
++.++.|....||++ +..+++|+. ........+.+|...++.+.+. .+++++.++. ..+..+++|++++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~-~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFP-KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEE-SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEec-CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788888899988 456899974 3333456788999999998642 3667777764 45667899999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc---------------------------------------------
Q 023058 102 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--------------------------------------------- 136 (288)
Q Consensus 102 ~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------------- 136 (288)
.++....- ..++..+...++.++...|..||+.
T Consensus 98 ~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 98 QILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp EECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred eECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 88765321 1234455555555555555555531
Q ss_pred ---------------CceecCCCCCceEecC---CCCCCEEEeecCCCccc
Q 023058 137 ---------------QVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSS 169 (288)
Q Consensus 137 ---------------~i~H~dl~p~nilv~~---~~~~~~~l~df~~~~~~ 169 (288)
.++|+|+.|.||+++. ++. .+.|+||+.+...
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~-~~~~iD~~~a~~g 225 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTP-LTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCC-EEEECCCTTCEEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCc-eEEEEehhhcCCC
Confidence 3599999999999986 232 2479999977633
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=5.4e-07 Score=77.51 Aligned_cols=76 Identities=17% Similarity=0.095 Sum_probs=50.2
Q ss_pred eeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--------cchHHHHHHHHHHhhCCC--C-ceeeEeEEEEcCCeEE
Q 023058 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--------KIDENVQREIINHRSLRH--P-NIVRFKEVILTPTHLA 93 (288)
Q Consensus 25 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~e~~~l~~l~~--~-~i~~~~~~~~~~~~~~ 93 (288)
..+.||.|..+.||++....+++.+++|...+.. ...++...|.+.++.+.. + .+++++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 4678999999999999876567889999764321 233466788888887732 3 34455543 344568
Q ss_pred EEEeccCCC
Q 023058 94 IVMEYASGG 102 (288)
Q Consensus 94 lv~e~~~~~ 102 (288)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=6.2e-07 Score=75.94 Aligned_cols=82 Identities=9% Similarity=0.102 Sum_probs=56.2
Q ss_pred eeeeeee-eccCceEEEEEEEc---C---CCcEEEEEEeecCc---c-chHHHHHHHHHHhhCCC---CceeeEeEEEEc
Q 023058 23 YELVRDI-GSGNFGVARLMRDK---K---TEELVAVKYIERGD---K-IDENVQREIINHRSLRH---PNIVRFKEVILT 88 (288)
Q Consensus 23 y~~~~~l-g~g~~~~v~~~~~~---~---~~~~~~iK~~~~~~---~-~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~ 88 (288)
....+.| +.|....+|++... . ++..+++|...... . ....+.+|...++.+.. -.+++++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446777 78888999988764 1 15678999765433 1 23567888888887742 346777777665
Q ss_pred C---CeEEEEEeccCCCch
Q 023058 89 P---THLAIVMEYASGGEL 104 (288)
Q Consensus 89 ~---~~~~lv~e~~~~~~L 104 (288)
. +..++|||+++|.++
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 4 356899999987554
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.31 E-value=9.2e-06 Score=68.11 Aligned_cols=74 Identities=15% Similarity=0.200 Sum_probs=42.0
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCC--CceeeEeE------EEEcCCeEEEEEe
Q 023058 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKE------VILTPTHLAIVME 97 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~------~~~~~~~~~lv~e 97 (288)
++.|+.|..+.||++... +..+++|...... ..+..|...++.+.. -.+++++. +....+..+++|+
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 455666678899999874 3458999887532 344455555554421 12333332 1234567899999
Q ss_pred ccCCCch
Q 023058 98 YASGGEL 104 (288)
Q Consensus 98 ~~~~~~L 104 (288)
+++|.++
T Consensus 112 ~i~G~~~ 118 (346)
T 2q83_A 112 WIEGRPF 118 (346)
T ss_dssp CCCCBCC
T ss_pred eecCccC
Confidence 9987543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.18 E-value=2.7e-05 Score=64.47 Aligned_cols=77 Identities=18% Similarity=0.109 Sum_probs=61.0
Q ss_pred eeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC---CCceeeEeEEEEcCCeEEEEEeccC
Q 023058 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYAS 100 (288)
Q Consensus 24 ~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (288)
.-.+.|+.|....+|++.. ++..+++|..... ....+..|...++.+. ...+++++.++...+..++|||+++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3467889999999999986 3667899987643 3556788988888773 3568889988888889999999998
Q ss_pred CCch
Q 023058 101 GGEL 104 (288)
Q Consensus 101 ~~~L 104 (288)
+.++
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.17 E-value=3.4e-06 Score=69.64 Aligned_cols=71 Identities=13% Similarity=0.113 Sum_probs=45.6
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCce-eeEeEEEEcCCeEEEEEecc-CCCc
Q 023058 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYA-SGGE 103 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~-~~~~ 103 (288)
++.|+.|....+|++ ..+++|+........-...+|...++.+...++ ++++.. +.+..+++++++ ++.+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 788988999999999 458999876543222234567777766643233 455543 344457899999 6655
Q ss_pred h
Q 023058 104 L 104 (288)
Q Consensus 104 L 104 (288)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.02 E-value=2.7e-05 Score=67.43 Aligned_cols=73 Identities=14% Similarity=0.242 Sum_probs=44.7
Q ss_pred eeeeeeccCceEEEEEEEcCCCcEEEEEEeec-----Ccc-----chHHHHHHHHHHh-hCCCCceeeEeEEEEcCCeEE
Q 023058 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIER-----GDK-----IDENVQREIINHR-SLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 25 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~-----~~~-----~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~ 93 (288)
-.+.||.|..+.||++.. ++..+++|...+ ... ....+..|+..+. ......+++++.+. ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 467789999999999965 467899994321 111 1122333333222 22234566776665 45679
Q ss_pred EEEecc-CC
Q 023058 94 IVMEYA-SG 101 (288)
Q Consensus 94 lv~e~~-~~ 101 (288)
+|||++ ++
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 76
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=3.5e-05 Score=65.55 Aligned_cols=138 Identities=15% Similarity=0.146 Sum_probs=80.4
Q ss_pred eeeeeccCceEEEEEEEcC-------CCcEEEEEEeecCccchHHHHHHHHHHhhCCCCce-eeEeEEEEcCCeEEEEEe
Q 023058 26 VRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVME 97 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e 97 (288)
++.|..|-...+|++.... +++.+++|+............+|..+++.+...++ +++++.+.. .+||+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 4567668788999998742 35789999864433345567789998888743233 556655533 38999
Q ss_pred ccCCCchHH--------------H---HHhcC-----CCC--HHHHHHHHHHHHH-------------------HHHHHh
Q 023058 98 YASGGELFE--------------R---ICNAG-----RFS--EDEARFFFQQLIS-------------------GVSYCH 134 (288)
Q Consensus 98 ~~~~~~L~~--------------~---~~~~~-----~~~--~~~~~~i~~~i~~-------------------~l~~LH 134 (288)
|++|.++.. . ++... ... ..++..+..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998755421 1 11111 111 2445555544322 122222
Q ss_pred --------hcCceecCCCCCceEecCC--CCCCEEEeecCCCc
Q 023058 135 --------SMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSK 167 (288)
Q Consensus 135 --------~~~i~H~dl~p~nilv~~~--~~~~~~l~df~~~~ 167 (288)
...++|+|+.+.||+++.+ ....+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2359999999999999865 12248999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00026 Score=57.83 Aligned_cols=79 Identities=11% Similarity=0.029 Sum_probs=55.5
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCC---ceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHP---NIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~~~~lv~ 96 (288)
.+..-++.+|.|..+.||++... +|+.|++|+..... .....+..|...|+.+... -+++++.+. . .+++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEEE
Confidence 45667889999999999999875 57889999765443 2234577899988887422 344555542 2 37899
Q ss_pred eccCCCch
Q 023058 97 EYASGGEL 104 (288)
Q Consensus 97 e~~~~~~L 104 (288)
|++.+...
T Consensus 90 e~l~~~~~ 97 (288)
T 3f7w_A 90 EWVDERPP 97 (288)
T ss_dssp ECCCCCCC
T ss_pred EeecccCC
Confidence 99876543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.76 E-value=7.4e-05 Score=62.08 Aligned_cols=140 Identities=15% Similarity=0.106 Sum_probs=76.7
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCc--eeeEeEE------EEcCCeEEE
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAI 94 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~l 94 (288)
..-.+.|+.|....+|++.... ..+++|..... ...+.+..|..+++.+...+ +++++.. ....+..++
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~~--g~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTTK--DPLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp EEEEEEECC---EEEEEEEESS--CCEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred ceEeeccCCCcccceEEEEeCC--ccEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence 3446677778889999998643 36899987753 22345666777776663212 2333311 122456789
Q ss_pred EEeccCCCchH-----------H---HHHhc-CC--------CCHHHHHH---------------HHHHHHHHHHHHh--
Q 023058 95 VMEYASGGELF-----------E---RICNA-GR--------FSEDEARF---------------FFQQLISGVSYCH-- 134 (288)
Q Consensus 95 v~e~~~~~~L~-----------~---~~~~~-~~--------~~~~~~~~---------------i~~~i~~~l~~LH-- 134 (288)
++++++|..+. . .++.. .. ........ +...+...+..+.
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 99999875431 0 11111 01 01110000 0011333444444
Q ss_pred -----hcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 135 -----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 135 -----~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
..+++|+|+.+.||+++.+.. +.++||+.+.
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~~~--~~lIDf~~a~ 216 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 216 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred CcccCCcccCCCCCCccCEEEeCCce--EEEecchhcc
Confidence 246999999999999986542 4799998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00051 Score=57.08 Aligned_cols=75 Identities=9% Similarity=0.048 Sum_probs=48.9
Q ss_pred eeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCc--eeeEeEE-----EEcCCeEEEEEecc
Q 023058 27 RDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV-----ILTPTHLAIVMEYA 99 (288)
Q Consensus 27 ~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~-----~~~~~~~~lv~e~~ 99 (288)
..|+ |....||++... +|+.+++|.........+.+..|...++.+...+ +++++.. ....+..+++++++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 778899988764 4567999988755444566777888877764222 3344332 12245678899999
Q ss_pred CCCc
Q 023058 100 SGGE 103 (288)
Q Consensus 100 ~~~~ 103 (288)
+|.+
T Consensus 110 ~G~~ 113 (328)
T 1zyl_A 110 GGRQ 113 (328)
T ss_dssp CCEE
T ss_pred CCCC
Confidence 8754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00032 Score=54.19 Aligned_cols=122 Identities=16% Similarity=0.078 Sum_probs=76.1
Q ss_pred CchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCCc
Q 023058 102 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 179 (288)
Q Consensus 102 ~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 179 (288)
.+|.+++.. +.+++++++|.++.|++..|..+-. +.-...=+.|..|++..+|+ +.+.+ ..+. .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s~-----------~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AADD-----------A 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-cccc-----------c
Confidence 478888865 4589999999999999999887621 12123344568999988887 66553 1110 1
Q ss_pred CCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHh
Q 023058 180 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 259 (288)
Q Consensus 180 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 259 (288)
....+.+||... .....+.=|||||+++|.-+--..|-. .+ ..+++.|.+||..|
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e~---------------------eE--~eLS~~LE~LL~~M 153 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKEN---------------------EE--RELSPPLEQLIDHM 153 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCTT---------------------EE--ECCCHHHHHHHHHH
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCcc---------------------cc--hhhCHHHHHHHHHH
Confidence 122455777652 222334789999999998874332211 11 15789999999999
Q ss_pred ccc
Q 023058 260 FVA 262 (288)
Q Consensus 260 l~~ 262 (288)
..-
T Consensus 154 t~~ 156 (229)
T 2yle_A 154 ANT 156 (229)
T ss_dssp TTC
T ss_pred Hhc
Confidence 866
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00017 Score=62.61 Aligned_cols=74 Identities=12% Similarity=0.119 Sum_probs=49.9
Q ss_pred eeeeeeccCceEEEEEEEcC-------CCcEEEEEEeecCccchHHHHHHHHHHhhCCCCce-eeEeEEEEcCCeEEEEE
Q 023058 25 LVRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVM 96 (288)
Q Consensus 25 ~~~~lg~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~ 96 (288)
-++.|+.|-...+|++.... ++..+++|+.... ...+.+.+|..+++.+...++ +++++.+.. ++|+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 45678888889999998753 2578999987432 222456678888888753343 566665432 3889
Q ss_pred eccCCCc
Q 023058 97 EYASGGE 103 (288)
Q Consensus 97 e~~~~~~ 103 (288)
+|+++.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9987643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00017 Score=61.18 Aligned_cols=75 Identities=13% Similarity=0.018 Sum_probs=45.2
Q ss_pred eeeeeeccCceEEEEEEEcC--------CCcEEEEEEeecCccchHHHHHHHHHHhhCCCCc-eeeEeEEEEcCCeEEEE
Q 023058 25 LVRDIGSGNFGVARLMRDKK--------TEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIV 95 (288)
Q Consensus 25 ~~~~lg~g~~~~v~~~~~~~--------~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv 95 (288)
-.+.|+.|....+|++.... .++.+++|+.............|...++.+...+ .+++++.. .+ +++
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v 112 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRI 112 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEE
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEE
Confidence 45677778888999998753 1367899987654332223467777777774333 34565543 22 689
Q ss_pred EeccCCCc
Q 023058 96 MEYASGGE 103 (288)
Q Consensus 96 ~e~~~~~~ 103 (288)
++++++.+
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00061 Score=56.85 Aligned_cols=139 Identities=14% Similarity=0.105 Sum_probs=69.9
Q ss_pred eeeeeccCceE-EEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCC--CceeeEeEEEEcCCeEEEEEeccCCC
Q 023058 26 VRDIGSGNFGV-ARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGG 102 (288)
Q Consensus 26 ~~~lg~g~~~~-v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (288)
.+.|+.|.... +|++... +++.+++|...... ...+..|+.+++.+.. -.+++++.+....+ +++||++++.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECT-TCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcC-CCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 45565555554 6677642 25667887654432 1334556666665532 23455666533333 7899998776
Q ss_pred chHHHHHhc--------------------------CCCCHHHHHH--------HH------------HHHHHHHHHH---
Q 023058 103 ELFERICNA--------------------------GRFSEDEARF--------FF------------QQLISGVSYC--- 133 (288)
Q Consensus 103 ~L~~~~~~~--------------------------~~~~~~~~~~--------i~------------~~i~~~l~~L--- 133 (288)
.+.+.+... ..+....... +. ..+...+..+
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 654332110 1122211100 00 0111122222
Q ss_pred ---hhcCceecCCCCCceEecCCC--CCCEEEeecCCCccc
Q 023058 134 ---HSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSS 169 (288)
Q Consensus 134 ---H~~~i~H~dl~p~nilv~~~~--~~~~~l~df~~~~~~ 169 (288)
+...++|||+.+.||+++.+. ...+.++||+.+...
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 234699999999999997541 124899999987633
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0033 Score=52.59 Aligned_cols=72 Identities=11% Similarity=-0.041 Sum_probs=43.3
Q ss_pred eeeeecc--CceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhC---CCCceeeEeEE------EEcCCeEEE
Q 023058 26 VRDIGSG--NFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSL---RHPNIVRFKEV------ILTPTHLAI 94 (288)
Q Consensus 26 ~~~lg~g--~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~------~~~~~~~~l 94 (288)
.+.+..| ....||++.... + .+++|+...... .+|+..++.+ .-|++++++.. ....+..++
T Consensus 26 ~~~l~~G~g~~N~vy~v~~~~-g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~ 98 (339)
T 3i1a_A 26 AQFIQGGADTNAFAYQADSES-K-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKII 98 (339)
T ss_dssp EEEETTTSCSSCEEEEEECSS-C-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEE
T ss_pred eEEeeccCccccceEEEEeCC-C-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEE
Confidence 3445333 367999998653 4 899998766442 3444444444 22334444432 233567899
Q ss_pred EEeccCCCch
Q 023058 95 VMEYASGGEL 104 (288)
Q Consensus 95 v~e~~~~~~L 104 (288)
+|++++|..+
T Consensus 99 l~~~i~G~~~ 108 (339)
T 3i1a_A 99 AYPFIHAPNG 108 (339)
T ss_dssp EEECCCCCBT
T ss_pred EEeccCCCcC
Confidence 9999988655
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0035 Score=54.69 Aligned_cols=76 Identities=16% Similarity=0.097 Sum_probs=49.3
Q ss_pred eeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCce-eeEeEEEEcCCeEEEEEeccCCCc
Q 023058 25 LVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGE 103 (288)
Q Consensus 25 ~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~~ 103 (288)
-++.|+.|-...+|++.....+..+++|+........-.-.+|..+++.+...++ +++++.+. + ..|++|+++.+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4567888888999999986445789999875433222223688888888865554 46666652 2 35999998744
Q ss_pred h
Q 023058 104 L 104 (288)
Q Consensus 104 L 104 (288)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0031 Score=54.38 Aligned_cols=76 Identities=16% Similarity=0.076 Sum_probs=49.2
Q ss_pred eeeeeeccCceEEEEEEEcCC-------CcEEEEEEeecCccchHHHHHHHHHHhhCCCCc-eeeEeEEEEcCCeEEEEE
Q 023058 25 LVRDIGSGNFGVARLMRDKKT-------EELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 25 ~~~~lg~g~~~~v~~~~~~~~-------~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~ 96 (288)
-++.|..|-...+|++..... +..+++++........-+-.+|..+++.+...+ .+++++.+ .+ +.|+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ 149 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE 149 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence 456677788889999987531 578999986554333223467888887774333 34555433 22 7899
Q ss_pred eccCCCch
Q 023058 97 EYASGGEL 104 (288)
Q Consensus 97 e~~~~~~L 104 (288)
+|+++.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99988653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.97 E-value=0.028 Score=48.04 Aligned_cols=31 Identities=39% Similarity=0.570 Sum_probs=24.3
Q ss_pred CceecCCCCCceEecC----CCCCCEEEeecCCCc
Q 023058 137 QVCHRDLKLENTLLDG----SPAPRLKICDFGYSK 167 (288)
Q Consensus 137 ~i~H~dl~p~nilv~~----~~~~~~~l~df~~~~ 167 (288)
.++|+|+.+.||++.. +....+.++||.++.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 3789999999999943 222359999999886
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.30 E-value=1.1 Score=34.62 Aligned_cols=83 Identities=14% Similarity=0.070 Sum_probs=60.6
Q ss_pred CCCceeeEeEEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHhhcCceecCCCCCceEecCC
Q 023058 75 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS-YCHSMQVCHRDLKLENTLLDGS 153 (288)
Q Consensus 75 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~-~LH~~~i~H~dl~p~nilv~~~ 153 (288)
.||++ -..+-.+++.+.+.++.-++..-...+ ..++..+.++++.+|+.... +++ .-.|--+.|+|++++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~~--~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHSA--RRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCCS--SSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhhh--CceeEEEeCceEEEeCC
Confidence 67888 455557778888887765443323333 35789999999999998776 444 34788899999999988
Q ss_pred CCCCEEEeecCCC
Q 023058 154 PAPRLKICDFGYS 166 (288)
Q Consensus 154 ~~~~~~l~df~~~ 166 (288)
+. +++.-.|+-
T Consensus 121 ~~--p~i~hRGi~ 131 (219)
T 4ano_A 121 LE--PFFLHVGVK 131 (219)
T ss_dssp CC--EEESCCEET
T ss_pred Cc--EEEEEcCCc
Confidence 88 888766643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.77 E-value=0.77 Score=35.27 Aligned_cols=83 Identities=8% Similarity=0.036 Sum_probs=60.3
Q ss_pred CCCCceeeEeEEEEcCCeEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC
Q 023058 74 LRHPNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (288)
Q Consensus 74 l~~~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~ 152 (288)
..||++++. .+-..++.+.+.++.-+. .++.. -..++....++++.+|+....+++. -+|--+.|+|++++.
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELFFTR 114 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEEECT
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEEEcC
Confidence 368888876 566777777777765442 23322 2346889999999999998855443 478889999999998
Q ss_pred CCCCCEEEeecCC
Q 023058 153 SPAPRLKICDFGY 165 (288)
Q Consensus 153 ~~~~~~~l~df~~ 165 (288)
+.. +++.-.|+
T Consensus 115 ~~~--p~i~~RGi 125 (215)
T 4ann_A 115 DGL--PIAKTRGL 125 (215)
T ss_dssp TSC--EEESCCEE
T ss_pred CCC--EEEEEccC
Confidence 887 88876554
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 288 | ||||
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-75 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-73 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-73 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-72 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-71 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-70 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-70 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-68 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-67 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-67 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-67 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-66 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-65 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-63 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-63 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-62 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-60 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-60 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-58 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-58 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-55 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-54 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-52 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-52 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-51 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-51 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-51 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-51 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-51 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-50 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-50 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-49 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-48 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-47 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-41 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-40 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-35 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-14 |
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 230 bits (588), Expect = 9e-75
Identities = 68/250 (27%), Positives = 118/250 (47%), Gaps = 9/250 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPNI 79
D Y+++ ++GSG FGV +K T + K+I +D V+ EI L HP +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQV 138
+ + + +++E+ SGGELF+RI + SE E + +Q G+ + H +
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 198
H D+K EN + + A +KI DFG + K T T + APE++ ++
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-F 207
Query: 199 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLI 256
D+W+ GV YV+L G PF ++ +T+ + + + + +SPE + I
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAG----EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263
Query: 257 SRIFVADPAK 266
+ +P K
Sbjct: 264 KNLLQKEPRK 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (572), Expect = 1e-73
Identities = 82/250 (32%), Positives = 135/250 (54%), Gaps = 14/250 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENV----QREIINHRSLRH 76
+ +E+ R +G G FG L R+K+++ ++A+K + + V +RE+ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
PNI+R T + +++EYA G ++ + +F E + +L + +SYCHS
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+V HRD+K EN LL + LKI DFG+S + S+ + GT Y+ PE++ + +D
Sbjct: 126 RVIHRDIKPENLLLGSA--GELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
K D+WS GV Y LVG PFE +++T RI V+++ PD ++ R LI
Sbjct: 183 EK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPD--FVTEGARDLI 235
Query: 257 SRIFVADPAK 266
SR+ +P++
Sbjct: 236 SRLLKHNPSQ 245
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 226 bits (577), Expect = 3e-73
Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 9/259 (3%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIIN 70
+++ H D Y++ ++G+G FGV + ++ T A K++ + D E V++EI
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT 76
Query: 71 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISG 129
LRHP +V + + ++ E+ SGGELFE++ + + SEDEA + +Q+ G
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ + H H DLK EN + + LK+ DFG + K T GT + APEV
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196
Query: 190 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVH 247
K D+WS GV Y++L G PF +N +T+ + S +++ D +
Sbjct: 197 AEGKPVGYY-TDMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDWNMDDSAFSG 251
Query: 248 ISPECRHLISRIFVADPAK 266
IS + + I ++ +ADP
Sbjct: 252 ISEDGKDFIRKLLLADPNT 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 1e-72
Identities = 83/251 (33%), Positives = 134/251 (53%), Gaps = 10/251 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
+ ++LV+ +G G +G +L ++ TEE VAVK + +R EN+++EI ++ L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
+V+F + +EY SGGELF+RI E +A+ FF QL++GV Y H + +
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKKEY 195
HRD+K EN LLD LKI DFG + +++ + GT Y+APE+L ++E+
Sbjct: 125 THRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
+ DVWSCG+ L ML G P++ P + + + + + I L
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDWKEKKTYLNPWKKIDSAPLAL 239
Query: 256 ISRIFVADPAK 266
+ +I V +P+
Sbjct: 240 LHKILVENPSA 250
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 2e-71
Identities = 61/249 (24%), Positives = 113/249 (45%), Gaps = 8/249 (3%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 80
++Y + D+G G FG+ + +++ K+++ V++EI RH NI+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 81 RFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
E + L ++ E+ SG ++FERI +A +E E + Q+ + + HS +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 140 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI 199
H D++ EN + + +KI +FG ++ + P Y APEV
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA- 183
Query: 200 ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLIS 257
D+WS G +YV+L G PF + ++ I I++ +Y+ + + IS E +
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLA----ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 258 RIFVADPAK 266
R+ V +
Sbjct: 240 RLLVKERKS 248
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 218 bits (556), Expect = 1e-70
Identities = 88/252 (34%), Positives = 130/252 (51%), Gaps = 10/252 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRSLRHP 77
D Y+ +G+G F L DK+T++LVA+K I + + + +++ EI ++HP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV ++ + HL ++M+ SGGELF+RI G ++E +A Q++ V Y H +
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 138 VCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK EN L ++ I DFG SK S + GTP Y+APEVL +K Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRH 254
D WS GV Y++L G PF D +N K +IL +Y P + IS +
Sbjct: 188 KA-VDCWSIGVIAYILLCGYPPFYD----ENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242
Query: 255 LISRIFVADPAK 266
I + DP K
Sbjct: 243 FIRHLMEKDPEK 254
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 3e-70
Identities = 71/253 (28%), Positives = 115/253 (45%), Gaps = 16/253 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH----RSLRH 76
+ ++ + +G G+F L R+ T A+K +E+ I EN + L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P V+ L + YA GEL + I G F E RF+ +++S + Y H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLKK 193
+ HRDLK EN LL+ ++I DFG +K S+ VGT Y++PE+L +K
Sbjct: 128 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
+D+W+ G +Y ++ G PF N +I+ ++Y P+ P+ R
Sbjct: 186 SACKS-SDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEYDFPE--KFFPKAR 238
Query: 254 HLISRIFVADPAK 266
L+ ++ V D K
Sbjct: 239 DLVEKLLVLDATK 251
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 2e-68
Identities = 64/255 (25%), Positives = 118/255 (46%), Gaps = 14/255 (5%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
D +E++ ++G G FG ++K+T L A K I+ + + E+ EI S HPN
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHSMQ 137
IV+ + +L I++E+ +GG + + R +E + + +Q + ++Y H +
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 196
+ HRDLK N L +K+ DFG S + Q + + +GTP ++APEV++ +
Sbjct: 131 IIHRDLKAGNILFTLD--GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188
Query: 197 GKI----ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPE 251
+ ADVWS G+TL M P + N + + +I + ++ S
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHE----LNPMRVLLKIAKSEPPTLAQPSRWSSN 244
Query: 252 CRHLISRIFVADPAK 266
+ + + +
Sbjct: 245 FKDFLKKCLEKNVDA 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 8e-68
Identities = 67/249 (26%), Positives = 111/249 (44%), Gaps = 9/249 (3%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID-ENVQREIINHRSLRHPN 78
+Y IG G G D T + VA++ + + E + EI+ R ++PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 138
IV + + L L +VMEY +GG L + + E + ++ + + + HS QV
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 139 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDG 197
HRD+K +N LL +K+ DFG+ +ST VGTP ++APEV+ +K Y
Sbjct: 138 IHRDIKSDNILLGMD--GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257
K D+WS G+ M+ G P+ + + + + + +S R ++
Sbjct: 196 K-VDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFLN 251
Query: 258 RIFVADPAK 266
R D K
Sbjct: 252 RCLDMDVEK 260
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 1e-67
Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 45/287 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
D +E + ++G+GN GV + K + ++A K I E I + RE+ P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ- 137
IV F + ++I ME+ GG L + + AGR E +I G++Y
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRD+K N L++ +K+CDFG S ++ S S VGT +Y++PE L Y
Sbjct: 126 IMHRDVKPSNILVNSR--GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSV 182
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEE--------------------------------- 224
+ +D+WS G++L M VG YP P+
Sbjct: 183 Q-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241
Query: 225 -----PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
P + + I++ S E + +++ + +PA+
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 210 bits (536), Expect = 1e-67
Identities = 69/254 (27%), Positives = 112/254 (44%), Gaps = 17/254 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLR 75
+ +R+IG G+FG RD + E+VA+K + K +++ +E+ + LR
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HPN ++++ L +VMEY G + E E + G++Y HS
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---K 192
+ HRD+K N LL +K+ DFG + + + S VGTP ++APEV+L +
Sbjct: 134 HNMIHRDVKAGNILLSEP--GLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDE 188
Query: 193 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252
+YDGK DVWS G+T + P + N ++ I + H S
Sbjct: 189 GQYDGK-VDVWSLGITCIELAERKPPLFN----MNAMSALYHIAQNESPALQSGHWSEYF 243
Query: 253 RHLISRIFVADPAK 266
R+ + P
Sbjct: 244 RNFVDSCLQKIPQD 257
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 207 bits (528), Expect = 8e-67
Identities = 79/262 (30%), Positives = 121/262 (46%), Gaps = 20/262 (7%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----------ERGDKIDENVQREIIN 70
+ YE +G G V R K T + AVK I E ++ E +E+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 71 HRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
R + HPNI++ K+ T T +V + GELF+ + SE E R + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 189
+ H + + HRDLK EN LLD +K+ DFG+S + + GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 190 LLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
+ D GK D+WS GV +Y +L G+ PF ++ R + + Q+ P+
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPE 238
Query: 245 YVHISPECRHLISRIFVADPAK 266
+ S + L+SR V P K
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQK 260
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 6e-66
Identities = 85/258 (32%), Positives = 138/258 (53%), Gaps = 16/258 (6%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI-------ERGDKIDENVQREIINHR 72
D Y+ ++GSG F V + R+K T A K+I R E+++RE+ +
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
++HPN++ EV T + +++E +GGELF+ + +E+EA F +Q+++GV Y
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 133 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
HS+Q+ H DLK EN +L P PR+KI DFG + ++ K+ GTP ++APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248
+ AD+WS GV Y++L GA PF ++T+ + +V Y D + +
Sbjct: 189 NYEPLG-LEADMWSIGVITYILLSGASPFLG----DTKQETLANVSAVNYEFEDEYFSNT 243
Query: 249 SPECRHLISRIFVADPAK 266
S + I R+ V DP K
Sbjct: 244 SALAKDFIRRLLVKDPKK 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-65
Identities = 85/267 (31%), Positives = 133/267 (49%), Gaps = 16/267 (5%)
Query: 11 GMDMPIMHDSDRYELVRD-IGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREI- 68
G+ + D Y++ +G G G + +K+T+E A+K ++ K +RE+
Sbjct: 1 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVE 56
Query: 69 INHRSLRHPNIVRFKEVILTP----THLAIVMEYASGGELFERICNAG--RFSEDEARFF 122
++ R+ + P+IVR +V L IVME GGELF RI + G F+E EA
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 123 FQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGT 181
+ + + Y HS+ + HRD+K EN L P LK+ DFG++K + H+ + T
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241
P Y+APEVL ++YD D+WS GV +Y++L G PF RI QY
Sbjct: 177 PYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 242 IPD--YVHISPECRHLISRIFVADPAK 266
P+ + +S E + LI + +P +
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQ 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-64
Identities = 80/252 (31%), Positives = 128/252 (50%), Gaps = 15/252 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----DKIDENVQREIINHRSLR 75
+ + L + +G G+FG L KKT + A+K +++ D ++ + + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
HP + T +L VMEY +GG+L I + +F A F+ ++I G+ + HS
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 194
+ +RDLKL+N LLD +KI DFG K ++L +T GTP YIAPE+LL ++
Sbjct: 122 KGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
Y+ D WS GV LY ML+G PF ++ + H I P + E +
Sbjct: 180 YNHS-VDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRMDNPFYPR--WLEKEAKD 232
Query: 255 LISRIFVADPAK 266
L+ ++FV +P K
Sbjct: 233 LLVKLFVREPEK 244
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 4e-63
Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 23/261 (8%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLRHP 77
+ YE++ IG+G++G + +R K +++ K ++ G + Q E+ R L+HP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 78 NIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 131
NIVR+ + I+ T T L IVMEY GG+L I + E+ QL +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 132 YCH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG-TPAYI 185
CH V HRDLK N LDG +K+ DFG ++ + TP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 186 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245
+PE + + Y+ K +D+WS G LY + PF + ++ +I ++ Y
Sbjct: 182 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIPY 236
Query: 246 VHISPECRHLISRIFVADPAK 266
S E +I+R+
Sbjct: 237 -RYSDELNEIITRMLNLKDYH 256
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 197 bits (502), Expect = 8e-63
Identities = 62/259 (23%), Positives = 101/259 (38%), Gaps = 13/259 (5%)
Query: 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI----ERGDKIDENVQREIINHRS 73
H SDRYEL +G G L RD + VAVK + R +RE N +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 74 LRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 129
L HP IV + T IVMEY G L + + G + A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 130 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAP 187
+++ H + HRD+K N ++ + A ++ + S +Q + +GT Y++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
E D + +DV+S G LY +L G PF + + + +
Sbjct: 184 EQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE--G 240
Query: 248 ISPECRHLISRIFVADPAK 266
+S + ++ + +P
Sbjct: 241 LSADLDAVVLKALAKNPEN 259
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 197 bits (502), Expect = 8e-62
Identities = 72/253 (28%), Positives = 119/253 (47%), Gaps = 13/253 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHR-------S 73
+ + + R IG G FG R T ++ A+K +++ + + +N R +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 133
P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 134 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 193
H+ V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL K
Sbjct: 124 HNRFVVYRDLKPANILLD--EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKG 180
Query: 194 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253
AD +S G L+ +L G PF + K+ + L++ +PD SPE R
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPD--SFSPELR 237
Query: 254 HLISRIFVADPAK 266
L+ + D +
Sbjct: 238 SLLEGLLQRDVNR 250
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 192 bits (489), Expect = 2e-60
Identities = 76/250 (30%), Positives = 127/250 (50%), Gaps = 15/250 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
++++R +G+G+FG L+R + A+K +++ + E+ E + + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P I+R + ++M+Y GGELF + + RF A+F+ ++ + Y HS
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ +RDLK EN LLD + +KI DFG++K + + GTP YIAPEV+ K Y+
Sbjct: 124 DIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
D WS G+ +Y ML G PF D N KT +IL+ + P + + + L+
Sbjct: 180 KS-IDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELRFPP--FFNEDVKDLL 232
Query: 257 SRIFVADPAK 266
SR+ D ++
Sbjct: 233 SRLITRDLSQ 242
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 5e-60
Identities = 60/260 (23%), Positives = 111/260 (42%), Gaps = 16/260 (6%)
Query: 16 IMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHR 72
+ +D + +IG G+F D +T VA ++ + + E +
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 73 SLRHPNIVRFKEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 128
L+HPNIVRF + + + +V E + G L + R + +Q++
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123
Query: 129 GVSYCHSM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 186
G+ + H+ + HRDLK +N + G P +KI D G + S K+ +GTP ++A
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMA 181
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246
PE+ +++YD DV++ G+ + M YP+ + +N + R+ S
Sbjct: 182 PEM-YEEKYDES-VDVYAFGMCMLEMATSEYPYSE---CQNAAQIYRRVTSGVKPASFDK 236
Query: 247 HISPECRHLISRIFVADPAK 266
PE + +I + +
Sbjct: 237 VAIPEVKEIIEGCIRQNKDE 256
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 5e-60
Identities = 73/256 (28%), Positives = 112/256 (43%), Gaps = 24/256 (9%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN-------VQREIINHRS 73
+Y++ +GSG FG VA+K++E+ D V E++ +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 74 LR--HPNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGV 130
+ ++R + P +++E +LF+ I G E+ AR FF Q++ V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 131 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 190
+CH+ V HRD+K EN L+D + LK+ DFG + + GT Y PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
Y G+ A VWS G+ LY M+ G PFE EE I+ Q +S
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSS 229
Query: 251 ECRHLISRIFVADPAK 266
EC+HLI P+
Sbjct: 230 ECQHLIRWCLALRPSD 245
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 6e-58
Identities = 81/251 (32%), Positives = 127/251 (50%), Gaps = 14/251 (5%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDEN----VQREIINHRSLRH 76
+ ++ ++ +G G FG L+R+K T A+K + + I ++ E ++ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y HS
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEY 195
V +RD+KLEN +LD +KI DFG K + K+ GTP Y+APEVL +Y
Sbjct: 125 DVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
D W GV +Y M+ G PF + ++ + IL + P +SPE + L
Sbjct: 183 GRA-VDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILMEEIRFPR--TLSPEAKSL 235
Query: 256 ISRIFVADPAK 266
++ + DP +
Sbjct: 236 LAGLLKKDPKQ 246
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 7e-58
Identities = 57/257 (22%), Positives = 101/257 (39%), Gaps = 15/257 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQ---REIINHRSLR 75
+ + + IGSG+FG + VAVK + + +Q E+ R R
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 134
H NI+ F T LAIV ++ G L+ + +F + +Q G+ Y H
Sbjct: 63 HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 191
+ + HRDLK N L +KI DFG + Q + G+ ++APEV+
Sbjct: 122 AKSIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 192 KKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249
++ + +DV++ G+ LY ++ G P+ + + R +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 250 PECRHLISRIFVADPAK 266
+ L++ +
Sbjct: 240 KAMKRLMAECLKKKRDE 256
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (460), Expect = 9e-56
Identities = 72/250 (28%), Positives = 130/250 (52%), Gaps = 15/250 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID----ENVQREIINHRSLRH 76
D+++ ++ +G+G+FG L++ K++ A+K +++ + E+ E +++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 77 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ +RDLK EN L+D +++ DFG++K + + GTP +APE++L K Y+
Sbjct: 161 DLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYN 216
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 256
D W+ GV +Y M G PF + +I+S + P H S + + L+
Sbjct: 217 KA-VDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSGKVRFPS--HFSSDLKDLL 269
Query: 257 SRIFVADPAK 266
+ D K
Sbjct: 270 RNLLQVDLTK 279
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-55
Identities = 63/251 (25%), Positives = 99/251 (39%), Gaps = 15/251 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +L++ IG G FG L + + VAVK I + D + E LRH N
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 61
Query: 79 IVRFKEVIL-TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 135
+V+ VI+ L IV EY + G L + + + GR D F + + Y
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 136 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
HRDL N L+ K+ DFG +K S + + APE L +K++
Sbjct: 122 NNFVHRDLAARNVLVSED--NVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKF 177
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
K +DVWS G+ L+ + K+ + + + PD P +
Sbjct: 178 STK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--GYKMDAPD--GCPPAVYEV 232
Query: 256 ISRIFVADPAK 266
+ + D A
Sbjct: 233 MKNCWHLDAAM 243
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 2e-54
Identities = 73/292 (25%), Positives = 108/292 (36%), Gaps = 39/292 (13%)
Query: 7 TVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQR 66
T G G D P Y + IG+G+FGV + + ELVA+K + + R
Sbjct: 9 TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNR 62
Query: 67 EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGG---ELFERICNAGRFSED 117
E+ R L H NIVR + + +L +V++Y
Sbjct: 63 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ + QL ++Y HS +CHRD+K +N LLD A K+CDFG +K V S
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVS 181
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE------------- 224
+ + Y APE++ DVWS G L +L+G F
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 225 ----------PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
P +I + ++ PE L SR+ P
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 6e-54
Identities = 66/272 (24%), Positives = 108/272 (39%), Gaps = 31/272 (11%)
Query: 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG------DKIDENVQREIINHRSLRHP 77
E + +G G F RDK T ++VA+K I+ G D I+ REI + L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NI+ + +++++V ++ N+ + + + + G+ Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLKKEYD 196
+ HRDLK N LLD + LK+ DFG +KS + V T Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------QYSIPDYV--- 246
G D+W+ G L +L+ + + + + S+PDYV
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 247 ------------HISPECRHLISRIFVADPAK 266
+ LI +F+ +P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCA 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 4e-53
Identities = 51/252 (20%), Positives = 100/252 (39%), Gaps = 13/252 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D ++++G+G FGV + + + + VA+K I+ G ++ E +L H
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ 137
+V+ V + I+ EY + G L + RF + + + + Y S Q
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEY 195
HRDL N L++ +K+ DFG S+ + S + PEVL+ ++
Sbjct: 121 FLHRDLAARNCLVNDQ--GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 196 DGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
K +D+W+ GV ++ + +G P+E + + S +
Sbjct: 179 SSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-----LRLYRPHLASEKVYT 232
Query: 255 LISRIFVADPAK 266
++ + +
Sbjct: 233 IMYSCWHEKADE 244
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (436), Expect = 7e-53
Identities = 51/252 (20%), Positives = 96/252 (38%), Gaps = 11/252 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ + +G G +G KK VAVK ++ E +E + ++HPN
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSM 136
+V+ V I+ E+ + G L + + R S + Q+ S + Y
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRDL N L+ + +K+ DFG S+ + ++ + APE L +
Sbjct: 135 NFIHRDLAARNCLVGEN--HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
+ K +DVW+ GV L+ + + ++ +L Y + +
Sbjct: 193 FSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLEKDYRMERPEGCPEKVYE 247
Query: 255 LISRIFVADPAK 266
L+ + +P+
Sbjct: 248 LMRACWQWNPSD 259
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-52
Identities = 58/251 (23%), Positives = 102/251 (40%), Gaps = 11/251 (4%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
D V++IGSG FG+ L ++ VA+K I G +E+ E L HP
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPK 61
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+V+ V L + +V E+ G L + G F+ + + G++Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEY 195
V HRDL N L+ + +K+ DFG ++ ++ T + +PEV Y
Sbjct: 122 VIHRDLAARNCLVGEN--QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255
K +DVWS GV ++ + P E ++ + + I + + + S +
Sbjct: 180 SSK-SDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDIST-GFRLYKPRLASTHVYQI 234
Query: 256 ISRIFVADPAK 266
++ + P
Sbjct: 235 MNHCWKERPED 245
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 172 bits (436), Expect = 2e-52
Identities = 58/281 (20%), Positives = 113/281 (40%), Gaps = 41/281 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 79
D Y+LVR +G G + + E V VK ++ K + ++REI +LR PNI
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNI 92
Query: 80 VRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
+ +++ P A+V E+ + + + ++ + RF+ +++ + YCHSM
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 149
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 197
+ HRD+K N ++D +L++ D+G ++ + V + + PE+L+ +
Sbjct: 150 IMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 198 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY----------------- 240
D+WS G L M+ PF + + I ++L +
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 241 ---------------SIPDYVHISPECRHLISRIFVADPAK 266
+ +SPE + ++ D
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 309
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-52
Identities = 63/265 (23%), Positives = 105/265 (39%), Gaps = 19/265 (7%)
Query: 14 MPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKID----ENVQR 66
+ + L+ +G G+FGV VAVK ++ ++ R
Sbjct: 1 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 67 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQ 125
E+ SL H N++R V+LTP + +V E A G L +R+ + G F + Q
Sbjct: 61 EVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGT 181
+ G+ Y S + HRDL N LL +KI DFG + + + +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241
A+ APE L + + +D W GVTL+ M P N + +H+I
Sbjct: 178 FAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQE---PWIGLNGSQILHKIDKEGER 233
Query: 242 IPDYVHISPECRHLISRIFVADPAK 266
+P + +++ + + P
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPED 258
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 1e-51
Identities = 65/301 (21%), Positives = 112/301 (37%), Gaps = 52/301 (17%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREI 68
++ P + +YE + IG G FG R +KT + VA+K + + REI
Sbjct: 1 VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60
Query: 69 INHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAGRFSEDEAR 120
+ L+H N+V E+ T + +V ++ +F+ E +
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120
Query: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQP 175
Q L++G+ Y H ++ HRD+K N L+ LK+ DFG ++ + ++
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRY 178
Query: 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 235
+ V T Y PE+LL + G D+W G + M + + + + I
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG----NTEQHQLALI 234
Query: 236 LSVQYSIPDYVH------------------------------ISPECRHLISRIFVADPA 265
+ SI V P LI ++ V DPA
Sbjct: 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294
Query: 266 K 266
+
Sbjct: 295 Q 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-51
Identities = 55/252 (21%), Positives = 96/252 (38%), Gaps = 13/252 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ L +G G FG + T VA+K ++ G E +E + LRH
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 73
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSM 136
+V+ V+ + + IV EY S G L + + + Q+ SG++Y M
Sbjct: 74 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKE 194
HRDL+ N L+ + K+ DFG ++ ++ + + APE L
Sbjct: 133 NYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
+ K +DVWS G+ L + + + R Y +P
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPESLHD 245
Query: 255 LISRIFVADPAK 266
L+ + + +P +
Sbjct: 246 LMCQCWRKEPEE 257
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-51
Identities = 69/256 (26%), Positives = 120/256 (46%), Gaps = 12/256 (4%)
Query: 21 DRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGD-----KIDENVQREIINHR 72
+ +EL++ +G+G +G R + T +L A+K +++ K E+ + E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 73 SLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
+R P +V T T L ++++Y +GGELF + RF+E E + + +++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
+ H + + +RD+KLEN LLD + L + + GT Y+AP+++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 192 -KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
K D WS GV +Y +L GA PF E + + RIL + P +S
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSA 261
Query: 251 ECRHLISRIFVADPAK 266
+ LI R+ + DP K
Sbjct: 262 LAKDLIQRLLMKDPKK 277
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 3e-51
Identities = 62/268 (23%), Positives = 102/268 (38%), Gaps = 19/268 (7%)
Query: 12 MDMPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINH 71
M++ + +RY L R IGSG+FG L D E VA+K +E + E +
Sbjct: 1 MELRV---GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIY 56
Query: 72 RSLRHPN-IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 130
+ ++ I + + +VME + +FS Q+IS +
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 131 SYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGT 181
Y HS HRD+K +N L+ G + I DFG +K + + + K+ GT
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 182 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241
Y + L E + D+ S G L +G+ P++ + +K RI + S
Sbjct: 177 ARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMS 234
Query: 242 IPDYV---HISPECRHLISRIFVADPAK 266
P V E ++
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFDD 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 7e-51
Identities = 51/252 (20%), Positives = 96/252 (38%), Gaps = 13/252 (5%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN 78
+ +LV +G+G FG + + VAVK +++G + E + L+H
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69
Query: 79 IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHSM 136
+VR V+ T + I+ EY G L + + + + + ++ Q+ G+++
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 194
HRDL+ N L+ KI DFG ++ + + APE +
Sbjct: 129 NYIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 195 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254
+ K +DVWS G+ L ++ + + R Y + + E
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----GYRMVRPDNCPEELYQ 241
Query: 255 LISRIFVADPAK 266
L+ + P
Sbjct: 242 LMRLCWKERPED 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 7e-51
Identities = 70/285 (24%), Positives = 110/285 (38%), Gaps = 46/285 (16%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 78
RY + IG G +G+ D + VA+K I + REI RH N
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 79 IVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 134
I+ ++I PT ++ + G +L++ + S D +F Q++ G+ Y H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 126
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 190
S V HRDLK N LL+ + LKICDFG ++ V T Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD------ 244
L + K D+WS G L ML F K++ ++ IL + S
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPG----KHYLDQLNHILGILGSPSQEDLNCI 240
Query: 245 -----------------------YVHISPECRHLISRIFVADPAK 266
+ + + L+ ++ +P K
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 285
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-50
Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 30/274 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
+ ++ V IG G +GV R+K T E+VA+K I + + REI + L HP
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 78 NIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 136
NIV+ +VI T L +V E+ + F + + QL+ G+++CHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 195
+V HRDLK +N L++ +K+ DFG +++ + + + V T Y APE+LL +Y
Sbjct: 122 RVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 196 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH-------RILSVQYSIPDYV-- 246
D+WS G M+ F E + + S+PDY
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 247 --------------HISPECRHLISRIFVADPAK 266
+ + R L+S++ DP K
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 273
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-50
Identities = 61/280 (21%), Positives = 110/280 (39%), Gaps = 40/280 (14%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
Y ++ +GSG +G D +T VA+K + R + + RE+ + +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 78 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V T +VM + G ++ + ED +F Q++ G+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y H+ + HRDLK N ++ LKI DFG ++ S+ V T Y APEV+L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV----- 246
+ D+WS G + M+ G F+ + ++ + + +
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 247 --------------------HISPECRHLISRIFVADPAK 266
+ SP +L+ ++ V D +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 291
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (421), Expect = 2e-50
Identities = 59/261 (22%), Positives = 107/261 (40%), Gaps = 21/261 (8%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
D ++ + IG+G FG L K E VA+K ++ G +K + E
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSY 132
HPN++ + V+ T + I+ E+ G L N G+F+ + + + +G+ Y
Sbjct: 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIA 186
M HRDL N L++ + K+ DFG S+ S ++ + A
Sbjct: 144 LADMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 187 PEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 245
PE + +++ +DVWS G+ ++ ++ G P+ D + I+ I Y +P
Sbjct: 202 PEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD----MTNQDVINAIEQ-DYRLPPP 255
Query: 246 VHISPECRHLISRIFVADPAK 266
+ L+ + D
Sbjct: 256 MDCPSALHQLMLDCWQKDRNH 276
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-50
Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 16/256 (6%)
Query: 19 DSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERG--DKIDENVQREIINHRS 73
+R EL R IG G FG M + VA+K + D + E +E + R
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSY 132
HP+IV+ VI T + I+ME + GEL + + QL + ++Y
Sbjct: 65 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 190
S + HRD+ N L+ + +K+ DFG S+ + K++ ++APE +
Sbjct: 124 LESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 191 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250
+ + +DVW GV ++ +L+ P + I RI + + +P + P
Sbjct: 182 NFRRFTSA-SDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRIENGER-LPMPPNCPP 236
Query: 251 ECRHLISRIFVADPAK 266
L+++ + DP++
Sbjct: 237 TLYSLMTKCWAYDPSR 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-49
Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 30/274 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHP 77
+YE + IG G +G ++++T E+VA+K + D + + REI + L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIVR +V+ + L +V E+ G + + F QL+ G+ +CHS
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLKKEYD 196
V HRDLK +N L++ + LK+ +FG +++ + + S V T Y P+VL +
Sbjct: 122 VLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL--------SVQYSIPDYV-- 246
D+WS G + P + + K I R+L +PDY
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 247 --------------HISPECRHLISRIFVADPAK 266
++ R L+ + +P +
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-49
Identities = 54/283 (19%), Positives = 100/283 (35%), Gaps = 42/283 (14%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL-----VAVKYI--ERGDKIDENVQREIINH 71
+ E + +GSG FG + VAVK + + E + E+
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---------------------- 108
L H NIV + ++ EY G+L +
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 109 -CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167
+ + ++ F Q+ G+ + HRDL N L+ +KICDFG ++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLAR 212
Query: 168 ---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPE 223
S + + ++APE L + Y K +DVWS G+ L+ + +G P+
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPG-- 269
Query: 224 EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
++++ + + + + E ++ + D K
Sbjct: 270 --IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRK 310
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 161 bits (409), Expect = 6e-49
Identities = 67/273 (24%), Positives = 111/273 (40%), Gaps = 30/273 (10%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI---ERGDKIDENVQREIINHRSLRHP 77
++Y + IG G +GV ++ E A+K I + + I REI + L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 78 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ 137
NIV+ +VI T L +V E+ G A+ F QL++G++YCH +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 138 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYD 196
V HRDLK +N L++ LKI DFG +++ + + + + T Y AP+VL+ +
Sbjct: 121 VLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 197 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV---------- 246
D+WS G M+ G F E + + + V
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 247 -------------HISPECRHLISRIFVADPAK 266
+ L+S++ DP +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQ 271
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (408), Expect = 1e-48
Identities = 49/261 (18%), Positives = 93/261 (35%), Gaps = 18/261 (6%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 79
Y++ R IG G+FGV + + VA+K+ R ++ E ++ L I
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63
Query: 80 VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 139
H +V++ +FS +Q+++ V H +
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 140 HRDLKLENTLLDGSPAP---RLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 188
+RD+K +N L+ + + + DFG K + + + K+ GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 189 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV-- 246
L +E + D+ + G L G+ P++ + N +K RI + S P
Sbjct: 184 THLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQK-YERIGEKKQSTPLRELC 241
Query: 247 -HISPECRHLISRIFVADPAK 266
E +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDA 262
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-48
Identities = 60/260 (23%), Positives = 98/260 (37%), Gaps = 24/260 (9%)
Query: 21 DRYELV---RDIGSGNFGVARL--MRDKKTEELVAVKYIERG---DKIDENVQREIINHR 72
DR L +++GSGNFG + + KK + VAVK ++ + + + E +
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 132
L +P IVR + + + +VME A G L + + + Q+ G+ Y
Sbjct: 64 QLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 133 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPE 188
HRDL N LL KI DFG SK+ + + APE
Sbjct: 123 LEESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 189 VLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYV 246
+ ++ K +DVWS GV ++ G P+ + + + P
Sbjct: 181 CINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG----MKGSEVTAMLEKGERMGCPA-- 233
Query: 247 HISPECRHLISRIFVADPAK 266
E L++ + D
Sbjct: 234 GCPREMYDLMNLCWTYDVEN 253
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-48
Identities = 51/262 (19%), Positives = 100/262 (38%), Gaps = 17/262 (6%)
Query: 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYI------ERGDKIDENVQRE 67
+ I+ +++ ++ ++ +GSG FG E V + K ++ + E
Sbjct: 3 LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 68 IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
S+ +P++ R + LT T I G L + + Q+
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAY 184
G++Y ++ HRDL N L+ +KI DFG +K + + +
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 185 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 244
+A E +L + Y + +DVWS GVT++ ++ D I IL +P
Sbjct: 180 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGERLPQ 234
Query: 245 YVHISPECRHLISRIFVADPAK 266
+ + ++ + ++ D
Sbjct: 235 PPICTIDVYMIMVKCWMIDADS 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 4e-48
Identities = 65/258 (25%), Positives = 103/258 (39%), Gaps = 22/258 (8%)
Query: 21 DRYELV-RDIGSGNFGVARL--MRDKKTEELVAVKYIERGDKID--ENVQREIINHRSLR 75
D + ++G GNFG R R +K + VA+K +++G + E + RE L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67
Query: 76 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 134
+P IVR V L +VME A GG L + + Q+ G+ Y
Sbjct: 68 NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 126
Query: 135 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 190
HRDL N LL + I DFG SK ++ + + APE +
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184
Query: 191 LKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHI 248
+++ + +DVWS GVT++ L G P++ + + I + P
Sbjct: 185 NFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK----MKGPEVMAFIEQGKRMECPP--EC 237
Query: 249 SPECRHLISRIFVADPAK 266
PE L+S ++
Sbjct: 238 PPELYALMSDCWIYKWED 255
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 4e-48
Identities = 71/280 (25%), Positives = 106/280 (37%), Gaps = 37/280 (13%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYI---ERGDKIDENVQREIINHRSL-- 74
+YE V +IG G +G RD K VA+K + + + + RE+ R L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 75 -RHPNIVRFKEVILTP-----THLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLI 127
HPN+VR +V T L +V E+ + + + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ S V T Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL----------- 236
EVLL+ Y D+WS G M F + K + I
Sbjct: 185 EVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 237 ----------SVQYSIPDYVHISPECRHLISRIFVADPAK 266
S Q I + L+ + +PAK
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 283
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-47
Identities = 59/269 (21%), Positives = 97/269 (36%), Gaps = 28/269 (10%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERGDKID--ENVQREIINHRSL 74
D + + IG GNFG R KK A+K ++ D + E+ L
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 75 -RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSED 117
HPNI+ +L + +EYA G L + + A S
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 118 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 177
+ F + G+ Y Q HRDL N L+ + KI DFG S+ ++ +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTM 185
Query: 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237
++A E L Y +DVWS GV L+ ++ P + ++
Sbjct: 186 GRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGT---PYCGMTCAELYEKLPQ 241
Query: 238 VQYSIPDYVHISPECRHLISRIFVADPAK 266
Y + ++ E L+ + + P +
Sbjct: 242 -GYRLEKPLNCDDEVYDLMRQCWREKPYE 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 6e-47
Identities = 62/281 (22%), Positives = 107/281 (38%), Gaps = 43/281 (15%)
Query: 21 DRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYI--ERGDKIDENVQREIINHRS 73
+ E VRDIG G FG R + +VAVK + E + + QRE
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 74 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 113
+PNIV+ V + ++ EY + G+L E + +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 114 ----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-- 167
S E +Q+ +G++Y + HRDL N L+ + +KI DFG S+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNI 190
Query: 168 -SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 226
S+ + + ++ PE + Y + +DVW+ GV L+ + P
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQ---PYYGM 246
Query: 227 NFRKTIHRILSVQY-SIPDYVHISPECRHLISRIFVADPAK 266
+ I+ + + P+ + E +L+ + PA
Sbjct: 247 AHEEVIYYVRDGNILACPE--NCPLELYNLMRLCWSKLPAD 285
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-46
Identities = 60/280 (21%), Positives = 110/280 (39%), Gaps = 38/280 (13%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKID---ENVQREIINHRSLRH 76
+RY+ + +GSG +G D KT VAVK + R + + RE+ + ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 77 PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
N++ +V L ++ + G I + ++D +F Q++ G+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
Y HS + HRDLK N ++ LKI DFG ++ + V T Y APE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIML 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD------- 244
+ + D+WS G + +L G F + + + + + +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 245 ------------------YVHISPECRHLISRIFVADPAK 266
++ +P L+ ++ V D K
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-45
Identities = 55/277 (19%), Positives = 95/277 (34%), Gaps = 35/277 (12%)
Query: 19 DSDRYELVRDIGSGNFGV-----ARLMRDKKTEELVAVKYIERGDKID--ENVQREIINH 71
+R + +G+G FG A + VAVK ++ + E + E+
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 72 RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC------------------NAG 112
L H NIV ++ EY G+L + +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172
++ F Q+ G+++ S HRDL N LL KICDFG ++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICDFGLARDIKND 198
Query: 173 SQPKST---VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 229
S ++APE + Y + +DVWS G+ L+ +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGM---PVD 254
Query: 230 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
++++ + + H E ++ + ADP K
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 291
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 7e-45
Identities = 54/259 (20%), Positives = 99/259 (38%), Gaps = 18/259 (6%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKT----EELVAVKYIERG--DKIDENVQREIINHR 72
+ IG+G FG K + E VA+K ++ G +K + E
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64
Query: 73 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVS 131
H NI+R + VI + I+ EY G L + + G FS + + + +G+
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAP 187
Y +M HRDL N L++ + K+ DFG S+ + AP
Sbjct: 125 YLANMNYVHRDLAARNILVNSN--LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 188 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247
E + +++ +DVWS G+ ++ ++ K I+ + +P +
Sbjct: 183 EAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----GFRLPTPMD 237
Query: 248 ISPECRHLISRIFVADPAK 266
L+ + + + A+
Sbjct: 238 CPSAIYQLMMQCWQQERAR 256
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-44
Identities = 51/266 (19%), Positives = 94/266 (35%), Gaps = 19/266 (7%)
Query: 13 DMPIMHDSDRYELVRDIGSGNFGV---ARLMRDKKTEELVAVKYIERGDKIDE--NVQRE 67
+ I S IG G+FG L+ + + AVK + R I E E
Sbjct: 19 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 68 IINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQ 125
I + HPN++ + L + +V+ Y G+L + + F Q
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 126 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 180
+ G+ + S + HRDL N +LD +K+ DFG ++
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEK--FTVKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 240
++A E L +++ K +DVWS GV L+ ++ P + + +
Sbjct: 197 PVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----GR 251
Query: 241 SIPDYVHISPECRHLISRIFVADPAK 266
+ + ++ + +
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAEM 277
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-42
Identities = 54/276 (19%), Positives = 105/276 (38%), Gaps = 34/276 (12%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE-------LVAVKYI--ERGDKIDENVQREII 69
DR L + +G G FG L ++ VAVK + + +K ++ E+
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70
Query: 70 NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAG 112
+ + +H NI+ L +++EYAS G L E +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 113 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVL 171
+ S + Q+ G+ Y S + HRDL N L+ ++
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 230
+ + + ++APE L + Y + +DVWS GV L+ + +G P+ +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPV-----E 244
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
+ ++L + + + + E ++ + A P++
Sbjct: 245 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQ 280
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-41
Identities = 61/285 (21%), Positives = 99/285 (34%), Gaps = 43/285 (15%)
Query: 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI 79
+ L IG G FG + + E VAVK ++ + EI LRH NI
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFREAEIYQTVMLRHENI 59
Query: 80 VRFKEVI----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 135
+ F T T L +V +Y G LF+ + N + + SG+++ H
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 136 --------MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTP 182
+ HRDLK +N L+ + I D G S + + P VGT
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 183 AYIAPEVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 237
Y+APEVL +K K AD+++ G+ + + E+ + +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 238 VQYSIPDYV----------------HISPECRHLISRIFVADPAK 266
+ V ++ + A+ A
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-41
Identities = 65/291 (22%), Positives = 112/291 (38%), Gaps = 51/291 (17%)
Query: 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIER---GDKIDENVQREIINHRSLRHP 77
RY+ ++ IGSG G+ D + VA+K + R + RE++ + + H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 78 NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 131
NI+ V + +VME + + Q++ G+
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 133
Query: 132 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 191
+ HS + HRDLK N ++ LKI DFG ++++ V T Y APEV+L
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 192 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------VQYSIP 243
Y + D+WS G + M+ F + + K I ++ + +Q ++
Sbjct: 192 GMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 244 DYVH----------------------------ISPECRHLISRIFVADPAK 266
+YV + + R L+S++ V DPAK
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-41
Identities = 48/269 (17%), Positives = 102/269 (37%), Gaps = 29/269 (10%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDKIDE--NVQREIINH 71
++ + R++G G+FG+ K + E VA+K + + E E
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 72 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF----------SEDEARF 121
+ ++VR V+ ++ME + G+L + + S +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 122 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 178
++ G++Y ++ + HRDL N ++ +KI DFG ++ + + +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238
+ +++PE L + DVWS GV L+ + A P + + + + ++
Sbjct: 196 LLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQ---PYQGLSNEQVLRFVMEG 251
Query: 239 QY-SIPDYVHISPECRHLISRIFVADPAK 266
PD + L+ + +P
Sbjct: 252 GLLDKPD--NCPDMLFELMRMCWQYNPKM 278
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-40
Identities = 55/276 (19%), Positives = 100/276 (36%), Gaps = 34/276 (12%)
Query: 19 DSDRYELVRDIGSGNFGVARLMRDKKTEEL-----VAVKYIERGDKIDEN---VQREIIN 70
DR +L + +G G FG ++ VAVK ++ G E+ + I
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 71 HRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGR---------------- 113
H N+V P L +++E+ G L + +
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 114 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 170
+ + + Q+ G+ + S + HRDL N LL +KICDFG ++
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDP 188
Query: 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 230
+ + ++APE + + Y + +DVWS GV L+ + P +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGAS---PYPGVKIDE 244
Query: 231 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 266
R L + + +PE + + +P++
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQ 280
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 127 bits (318), Expect = 8e-35
Identities = 57/306 (18%), Positives = 102/306 (33%), Gaps = 62/306 (20%)
Query: 22 RYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 81
RY LVR +G G+F L +D VA+K + E + EI + + + +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 82 ---------------FKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQ 125
F H+ +V E L + + +Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 126 LISGVSYCHSMQ-VCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 182
L+ G+ Y H + H D+K EN L++ SP ++I + +++ T
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 183 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRILSVQY 240
Y +PEVLL + AD+WS ++ ++ G + F ++ I +I+ +
Sbjct: 194 EYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 241 SIPDYV----------------------------------------HISPECRHLISRIF 260
+P Y+ + E +S +
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312
Query: 261 VADPAK 266
DP K
Sbjct: 313 QLDPRK 318
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.5 bits (164), Expect = 3e-14
Identities = 29/202 (14%), Positives = 57/202 (28%), Gaps = 39/202 (19%)
Query: 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-----------DKIDENVQREIINH 71
+ + +G G +K E VK+ + G D D + I
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 72 RSLRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 127
+ + + + + + A++ME R + ++
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMEL-------IDAKELYRVRVENPDEVLDMIL 113
Query: 128 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 187
V+ + + H DL N L+ + I DF SV + +
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFP---QSVEVGEEGW----REILER 163
Query: 188 EVL-----LKKEYDGKIADVWS 204
+V + Y D+ S
Sbjct: 164 DVRNIITYFSRTY-RTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 288 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.84 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.53 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.46 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.82 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.67 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.45 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-59 Score=382.35 Aligned_cols=251 Identities=33% Similarity=0.599 Sum_probs=221.4
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
.++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999998753 34456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++..... ...
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~-~~~ 161 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRR 161 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCC-CCC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecCC-Ccc
Confidence 999999999999998889999999999999999999999999999999999999988776 99999999975443 233
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+. ......+....+.+|. .+|+++++|
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~l 234 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTY----QETYKRISRVEFTFPD--FVTEGARDL 234 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTTCCCCCT--TSCHHHHHH
T ss_pred cccCCCCcccCHHHHcCCCCCch-hhhhhHhHHHHHHhcCCCCCCCCCH----HHHHHHHHcCCCCCCc--cCCHHHHHH
Confidence 45578999999999999888776 9999999999999999999976543 3344455566666665 689999999
Q ss_pred HHHhcccCcCCccccccccccchhhhhh
Q 023058 256 ISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 256 i~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
|.+||+.||.+|||+.|+++ |+|++
T Consensus 235 i~~~L~~dp~~R~t~~eil~---hp~~~ 259 (263)
T d2j4za1 235 ISRLLKHNPSQRPMLREVLE---HPWIT 259 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHT---CHHHH
T ss_pred HHHHccCCHhHCcCHHHHHc---CcCcC
Confidence 99999999999999988865 78876
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-60 Score=385.13 Aligned_cols=256 Identities=32% Similarity=0.538 Sum_probs=217.3
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
.++|++++.||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 578999999999999999999999999999999987643 334578899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC---C
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---Q 174 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~---~ 174 (288)
|+++++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++....... .
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCcccc
Confidence 9999999999988888999999999999999999999999999999999999987776 9999999998654332 2
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
.....||+.|+|||.+.+..+.+.++||||||+++|+|++|..||............ ........+....+++++.+
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH---HHTTCTTSTTGGGSCHHHHH
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCCCCCCccccCCHHHHH
Confidence 344579999999999988887766699999999999999999999876543332222 22223333444578999999
Q ss_pred HHHHhcccCcCCccccccccccchhhhhh
Q 023058 255 LISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
||.+||+.||.+|||+.|+++ |+|++
T Consensus 239 li~~~L~~dP~~R~t~~eil~---hpwf~ 264 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKK---DRWYN 264 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTT---CTTTT
T ss_pred HHHHHcCCChhHCcCHHHHhc---CHhhC
Confidence 999999999999999988866 66664
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-59 Score=384.48 Aligned_cols=259 Identities=29% Similarity=0.487 Sum_probs=223.6
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
....++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+.+|++++++++||||+++++++.+++.+
T Consensus 4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 34557899999999999999999999999999999998753 34456789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
++||||+++++|.+++...+.+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+|||++......
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPE 161 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC--
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccC
Confidence 999999999999999999899999999999999999999999999999999999999988877 999999999765433
Q ss_pred CC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 173 SQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 173 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
.. .....||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+. ......+....+.++. .++
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s 234 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPE--KFF 234 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHTTCCCCCT--TCC
T ss_pred CcccccccccCCccccCceeeccCCCCcc-cceehhhHHHHHHhhCCCCCCCcCH----HHHHHHHHcCCCCCCc--cCC
Confidence 22 234569999999999988888776 9999999999999999999987543 3334445566666665 789
Q ss_pred HHHHHHHHHhcccCcCCccccccccc---cchhhhhhh
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATG---VYMHTKLQL 284 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~---~~~~~~~~~ 284 (288)
+++++||.+||+.||.+|||+.|+++ ...|+|++-
T Consensus 235 ~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 235 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp HHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 99999999999999999999999876 456777753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=380.64 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=217.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
.++|++.+.||+|+||+||+|++..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 478999999999999999999999999999999987643 3446789999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CCCC
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS 177 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~~~ 177 (288)
+++++|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++....... ....
T Consensus 99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCC
T ss_pred cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--Eeeccchhheeeccccccccc
Confidence 999999987765 46999999999999999999999999999999999999987776 9999999998654433 3345
Q ss_pred CcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHH
Q 023058 178 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 257 (288)
Q Consensus 178 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (288)
..||+.|+|||.+.+..++.+ +|||||||++|+|++|..||...+........ .......++.+..+|+++++||.
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~~li~ 251 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDFLN 251 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHHCSCCCSSGGGSCHHHHHHHH
T ss_pred cccCCCccChhhhcCCCCCch-hceehHhHHHHHHhhCCCCCCCCCHHHHHHHH---HhCCCCCCCCcccCCHHHHHHHH
Confidence 569999999999999888776 99999999999999999999875543333222 22333344444578999999999
Q ss_pred HhcccCcCCccccccccccchhhhhh
Q 023058 258 RIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 258 ~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+||+.||.+|||+.|+++ |+|++
T Consensus 252 ~~L~~dP~~R~s~~eil~---Hp~~~ 274 (293)
T d1yhwa1 252 RCLDMDVEKRGSAKELLQ---HQFLK 274 (293)
T ss_dssp HHTCSSTTTSCCHHHHTT---CGGGG
T ss_pred HHccCChhHCcCHHHHhc---CHhhC
Confidence 999999999999998876 55553
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-58 Score=385.45 Aligned_cols=256 Identities=35% Similarity=0.593 Sum_probs=203.1
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
.+.|++.+.||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999999999999999987643 233567799999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC-CCCCCEEEeecCCCcccccCCCCC
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~-~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
|+++++|.+++...+.+++.++..++.||+.||+|||+.||+||||||+||++.. +..+.+||+|||++..........
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 167 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 167 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeee
Confidence 9999999999998889999999999999999999999999999999999999964 233459999999998766665566
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCC--CCCCCCCHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRH 254 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 254 (288)
...||+.|+|||.+.+..++.+ +|||||||++|+|++|..||....... ....+......+ +....+|+++.+
T Consensus 168 ~~~GT~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~ 242 (307)
T d1a06a_ 168 TACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAK----LFEQILKAEYEFDSPYWDDISDSAKD 242 (307)
T ss_dssp -----CTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred eeeeCccccCcHHHcCCCCCcH-HHhhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHhccCCCCCCccccCCCHHHHH
Confidence 6779999999999998888776 999999999999999999998754433 333344444333 334578999999
Q ss_pred HHHHhcccCcCCccccccccccchhhhhh
Q 023058 255 LISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
||.+||+.||.+|||+.|+++ |+|++
T Consensus 243 li~~~L~~dP~~R~s~~eil~---hp~~~ 268 (307)
T d1a06a_ 243 FIRHLMEKDPEKRFTCEQALQ---HPWIA 268 (307)
T ss_dssp HHHHHSCSSGGGSCCHHHHHH---STTTT
T ss_pred HHHHHccCCHhHCcCHHHHhc---CHhhC
Confidence 999999999999999988866 55553
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=382.67 Aligned_cols=259 Identities=27% Similarity=0.409 Sum_probs=214.7
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
+..++|++++.||+|+||+||+|++..++..||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 34689999999999999999999999999999999987643 3346788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc-CceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
|||+++++|.+++.+.+.+++..++.++.|++.||.|||++ ||+||||||+||+++.++. +||+|||+|...... .
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~-~ 159 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-M 159 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH-T
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccCCC-c
Confidence 99999999999999888999999999999999999999975 9999999999999988776 999999999855432 2
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHH-------------------------
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR------------------------- 229 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~------------------------- 229 (288)
.....||+.|+|||++.+..++.+ +||||+||++|+|++|..||...+......
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred cccccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 345679999999999999999887 999999999999999999997654322110
Q ss_pred -------------HHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 230 -------------KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 230 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.....+............++.++.+||.+||+.||.+|||+.|+++ |+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~---Hpf~~ 302 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV---HAFIK 302 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT---SHHHH
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh---CHhhC
Confidence 0111111111111112246889999999999999999999988876 66664
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-58 Score=376.92 Aligned_cols=254 Identities=26% Similarity=0.402 Sum_probs=214.8
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC-ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG-DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
+.|++++.||+|+||+||+|++..++..||+|++... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5799999999999999999999999999999998764 344577899999999999999999999999999999999999
Q ss_pred CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCCCC
Q 023058 100 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS 177 (288)
Q Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~~~ 177 (288)
++++|.+++.+ .+.+++.++..++.||+.||.|||++||+||||||+||+++.++. +||+|||++...... .....
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHTC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCcccccc
Confidence 99999998765 457999999999999999999999999999999999999988876 999999998644332 22345
Q ss_pred CcCCCcccCCcccc-----CcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 178 TVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 178 ~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
..||+.|+|||.+. +..++.+ +|||||||++|+|++|..||...+........... ....++....+|+++
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k-~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~s~~~ 245 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS---EPPTLAQPSRWSSNF 245 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTH-HHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS---CCCCCSSGGGSCHHH
T ss_pred cccccccCCHHHHhhcccCCCCCChh-hhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC---CCCCCCccccCCHHH
Confidence 67899999999984 3345555 99999999999999999999887665544443322 222334445789999
Q ss_pred HHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 253 RHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
++||.+||+.||.+|||+.|+++ |+|++
T Consensus 246 ~~li~~~L~~dp~~R~t~~ell~---hp~~~ 273 (288)
T d2jfla1 246 KDFLKKCLEKNVDARWTTSQLLQ---HPFVT 273 (288)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTT---SGGGC
T ss_pred HHHHHHHccCChhHCcCHHHHhc---CcccC
Confidence 99999999999999999998876 55553
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.7e-58 Score=387.84 Aligned_cols=257 Identities=30% Similarity=0.524 Sum_probs=220.6
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
..++|++.+.||+|+||+||+|++..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3478999999999999999999999999999999987653 334568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
|+++++|.+.+.. .+++++..+..++.||+.||+|||++||+||||||+||+++.+..+.+||+|||++..........
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 9999999998854 457999999999999999999999999999999999999976555569999999998766655556
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC--CCCCCHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRH 254 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ 254 (288)
...+|+.|+|||++.+..++.+ +|||||||++|+|++|..||...+.... ...+......++. ...+++++++
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDET----LRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred eecCcccccCHHHHcCCCCChh-HhhhhhhHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCcccccCCCHHHHH
Confidence 6789999999999998888766 9999999999999999999986554333 3334444444332 2468999999
Q ss_pred HHHHhcccCcCCccccccccccchhhhhh
Q 023058 255 LISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
||.+||+.||.+|||+.|+++ |+|++
T Consensus 259 li~~~L~~dP~~R~t~~eil~---hp~~~ 284 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALE---HPWLT 284 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHH---STTTS
T ss_pred HHHHHccCChhHCcCHHHHhc---CcccC
Confidence 999999999999999988866 66654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=377.25 Aligned_cols=256 Identities=33% Similarity=0.592 Sum_probs=221.7
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-------cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
.++|++.+.||+|+||+||+|++..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 478999999999999999999999999999999987532 2346789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCC--CCEEEeecCCCcccc
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSV 170 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~--~~~~l~df~~~~~~~ 170 (288)
++||||+++++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++. ..+|++|||++....
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 999999999999999988889999999999999999999999999999999999999976653 359999999998776
Q ss_pred cCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC--CCCC
Q 023058 171 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHI 248 (288)
Q Consensus 171 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 248 (288)
.........+++.|+|||++.+..++.+ +||||+||++|+|++|..||...+... ....+......++. ...+
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~ 243 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQE----TLANVSAVNYEFEDEYFSNT 243 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHTTCCCCCHHHHTTS
T ss_pred CCccccccCCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCCCCCCHHH----HHHHHHhcCCCCCchhcCCC
Confidence 6666667789999999999988888776 999999999999999999998755433 33334444444332 2468
Q ss_pred CHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
|+++++||.+||+.||.+|||+.|+++ |+|++
T Consensus 244 s~~~~~li~~~L~~dP~~R~s~~eil~---hp~~~ 275 (293)
T d1jksa_ 244 SALAKDFIRRLLVKDPKKRMTIQDSLQ---HPWIK 275 (293)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHH---STTTC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc---CcccC
Confidence 999999999999999999999988866 56654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-57 Score=385.22 Aligned_cols=257 Identities=27% Similarity=0.475 Sum_probs=220.8
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
..++|++++.||+|+||+||+|++..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3478999999999999999999999999999999987654 334567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
|+++++|.+.+... .++++.+++.++.||+.||+|||+.||+||||||+||+++....+++||+|||++..........
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 99999998877554 46999999999999999999999999999999999999985555569999999998776666566
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC--CCCCCCHHHHH
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRH 254 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 254 (288)
...+++.|+|||++.+..++.+ +|||||||++|+|++|..||...+.... ...+......++ ....+|+++.+
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLET----LQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred eccCcccccCHHHHcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCcccccCCCHHHHH
Confidence 6789999999999998888777 9999999999999999999987654333 333444444433 23478999999
Q ss_pred HHHHhcccCcCCccccccccccchhhhhh
Q 023058 255 LISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
||.+||+.||.+|||+.|+++ |+|++
T Consensus 262 li~~~L~~dp~~R~s~~eil~---Hp~~~ 287 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALE---HPWLK 287 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHT---STTTS
T ss_pred HHHHHccCChhHCcCHHHHhc---CHhhC
Confidence 999999999999999988866 55553
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=366.80 Aligned_cols=253 Identities=24% Similarity=0.369 Sum_probs=208.8
Q ss_pred CCCe-eeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEc----CCe
Q 023058 20 SDRY-ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTH 91 (288)
Q Consensus 20 ~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 91 (288)
.++| ++.++||+|+||+||+|.+..++..||+|.+.... ...+.+.+|++++++++||||+++++++.+ +..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 3455 77889999999999999999999999999987643 233568899999999999999999999865 356
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC--ceecCCCCCceEecC-CCCCCEEEeecCCCcc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKS 168 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--i~H~dl~p~nilv~~-~~~~~~~l~df~~~~~ 168 (288)
+++||||+++++|.+++.+...+++..++.++.||+.||+|||++| |+||||||+||+++. ++. +||+|||++..
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla~~ 164 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATL 164 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGG
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC--EEEeecCccee
Confidence 8999999999999999998889999999999999999999999999 999999999999964 455 99999999874
Q ss_pred cccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCC
Q 023058 169 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 248 (288)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (288)
... .......||+.|+|||.+.+ .++.+ +|||||||++|+|++|..||......... ...+.............
T Consensus 165 ~~~-~~~~~~~GT~~Y~aPE~~~~-~~~~~-~DIwSlGvilyel~~g~~Pf~~~~~~~~~---~~~i~~~~~~~~~~~~~ 238 (270)
T d1t4ha_ 165 KRA-SFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQI---YRRVTSGVKPASFDKVA 238 (270)
T ss_dssp CCT-TSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHH---HHHHTTTCCCGGGGGCC
T ss_pred ccC-CccCCcccCccccCHHHhCC-CCCCc-CchhhHHHHHHHHHHCCCCCCCcccHHHH---HHHHHcCCCCcccCccC
Confidence 322 23345679999999998865 47665 99999999999999999999765443332 23333332222223367
Q ss_pred CHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 249 SPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 249 ~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
++++.+||.+||++||.+|||+.|+++ |+|++
T Consensus 239 ~~~~~~li~~~l~~dp~~R~s~~ell~---Hp~fk 270 (270)
T d1t4ha_ 239 IPEVKEIIEGCIRQNKDERYSIKDLLN---HAFFQ 270 (270)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT---SGGGC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhC---CcccC
Confidence 899999999999999999999988865 77764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=380.99 Aligned_cols=256 Identities=25% Similarity=0.445 Sum_probs=223.8
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEecc
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (288)
.++|++.+.||+|+||+||+|.+..+++.||+|++.........+.+|+.++++++||||+++++++.+++.+|+||||+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 47899999999999999999999999999999999887666667889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCCCC
Q 023058 100 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178 (288)
Q Consensus 100 ~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~~~ 178 (288)
++++|.+++...+ ++++.+++.++.||+.||+|||+.||+||||||+||+++.++..+++|+|||++............
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~ 163 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccccc
Confidence 9999999997665 799999999999999999999999999999999999998777667999999999866555555566
Q ss_pred cCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCC--CCCCCHHHHHHH
Q 023058 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLI 256 (288)
Q Consensus 179 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li 256 (288)
.+++.|+|||.+.+..++.+ +|||||||++|+|++|..||...+... ....+....+.++. +..+|+++++||
T Consensus 164 ~~t~~y~ape~~~~~~~~~~-~DiWSlGvily~ll~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T d1tkia_ 164 FTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQ----IIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp ESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred ccccccccchhccCCCCCch-hhcccHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence 78999999999988888776 999999999999999999998765433 33344444544442 236899999999
Q ss_pred HHhcccCcCCccccccccccchhhhhh
Q 023058 257 SRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 257 ~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
.+||+.||.+|||+.|+++ |+|++
T Consensus 239 ~~~L~~dp~~R~s~~eil~---hp~~~ 262 (321)
T d1tkia_ 239 DRLLVKERKSRMTASEALQ---HPWLK 262 (321)
T ss_dssp HTTSCSSGGGSCCHHHHHH---SHHHH
T ss_pred HHHccCChhHCcCHHHHhc---CHhhc
Confidence 9999999999999988865 66664
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-56 Score=373.51 Aligned_cols=256 Identities=32% Similarity=0.548 Sum_probs=221.4
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
..++|++++.||+|+||.||+|++..+++.||+|++.+. ....+.+.+|+.++++++||||+++++++.+++.+++
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 347899999999999999999999999999999999753 3345678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-C
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S 173 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~ 173 (288)
||||+++++|..++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++...... .
T Consensus 83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTC
T ss_pred ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccCCc
Confidence 9999999999999999999999999999999999999999999999999999999988876 999999999865443 3
Q ss_pred CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
......||+.|+|||++.+..++.+ +|+|||||++|+|++|..||...+. ......+......+|. .++++++
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~ 233 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFPR--TLSPEAK 233 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcCH----HHHHHHHhcCCCCCCc--cCCHHHH
Confidence 3445679999999999999999776 9999999999999999999987654 3334445556666666 7999999
Q ss_pred HHHHHhcccCcCCcccccc--ccccchhhhhh
Q 023058 254 HLISRIFVADPAKVSMHFH--ATGVYMHTKLQ 283 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~--~l~~~~~~~~~ 283 (288)
+||.+||++||.+|++... +.+.+.|+|+.
T Consensus 234 dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~ 265 (337)
T d1o6la_ 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265 (337)
T ss_dssp HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred HHHHhhccCCchhhcccccccHHHHHcCcccc
Confidence 9999999999999996321 22234466653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-56 Score=371.82 Aligned_cols=249 Identities=28% Similarity=0.397 Sum_probs=212.3
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc----chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 96 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (288)
+.|++++.||+|+||+||+|++..+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 359999999999999999999999999999999876542 2246789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCCC
Q 023058 97 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 176 (288)
Q Consensus 97 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~~ 176 (288)
||+.+++|..++...+++++.+++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++..... ..
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~---~~ 169 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---AN 169 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---BC
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccCC---CC
Confidence 99999999877778888999999999999999999999999999999999999988776 99999999975433 34
Q ss_pred CCcCCCcccCCccccC---cccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 177 STVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
...||+.|+|||.+.+ ..++.+ +|||||||++|+|++|..||...+..... ..+............+|+++.
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~-~DiwSlGvilyel~~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~s~~~~ 244 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSAL----YHIAQNESPALQSGHWSEYFR 244 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHHHSCCCCCSCTTSCHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCch-hhhhhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhCCCCCCCCCCCCHHHH
Confidence 5679999999999864 345555 99999999999999999999875543332 233333333334447899999
Q ss_pred HHHHHhcccCcCCccccccccccchhhhh
Q 023058 254 HLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
+||.+||+.||.+|||+.++++ |+|+
T Consensus 245 ~li~~~L~~dP~~Rpt~~ell~---Hp~~ 270 (309)
T d1u5ra_ 245 NFVDSCLQKIPQDRPTSEVLLK---HRFV 270 (309)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTT---CHHH
T ss_pred HHHHHHCcCChhHCcCHHHHHh---CHHh
Confidence 9999999999999999998876 5555
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.3e-56 Score=366.08 Aligned_cols=256 Identities=32% Similarity=0.476 Sum_probs=218.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccc----------hHHHHHHHHHHhhCC-CCceeeEeEEEEc
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKI----------DENVQREIINHRSLR-HPNIVRFKEVILT 88 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~----------~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 88 (288)
.++|++.+.||+|+||+||+|++..+++.||+|++...... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47999999999999999999999999999999998764321 235778999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcc
Q 023058 89 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 168 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~ 168 (288)
++..++||||+++++|.+++...+++++.+++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++..
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeE
Confidence 9999999999999999999998889999999999999999999999999999999999999987777 99999999987
Q ss_pred cccCCCCCCCcCCCcccCCccccCc------ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc--
Q 023058 169 SVLHSQPKSTVGTPAYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-- 240 (288)
Q Consensus 169 ~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 240 (288)
...........+|+.|.|||.+.+. .++. ++||||+||++|+|++|..||...+....... +.....
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~-~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~----i~~~~~~~ 234 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK-EVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQF 234 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCC
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCc-hheEcccchhhhhhccCCCCCCCCCHHHHHHH----HHhCCCCC
Confidence 7666555667799999999998643 2334 49999999999999999999987654333333 333333
Q ss_pred CCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 241 SIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 241 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
..+....+|+++++||.+||++||.+|||+.|+++ |+|++..
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~---h~~~~~~ 276 (277)
T d1phka_ 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA---HPFFQQY 276 (277)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT---SGGGCTT
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc---CHHHHHh
Confidence 33344578999999999999999999999988765 7777643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-57 Score=368.80 Aligned_cols=252 Identities=30% Similarity=0.483 Sum_probs=202.1
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc---chHHHHHHHHHHhhCCCCceeeEeEEEEc--CCeEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLA 93 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 93 (288)
..++|++++.||+|+||+||+|++..+|+.||+|++..... ..+.+.+|++++++++||||+++++++.+ ++.++
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 35789999999999999999999999999999999876542 23467899999999999999999999865 45689
Q ss_pred EEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC-----ceecCCCCCceEecCCCCCCEEEeecC
Q 023058 94 IVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFG 164 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~-----i~H~dl~p~nilv~~~~~~~~~l~df~ 164 (288)
+||||+++++|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+||+++.++. +||+|||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG 159 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFG 159 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeecc
Confidence 99999999999998853 457999999999999999999999987 999999999999988776 9999999
Q ss_pred CCcccccCC-CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-CC
Q 023058 165 YSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SI 242 (288)
Q Consensus 165 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~ 242 (288)
++....... ......+|+.|+|||.+.+..++.+ +||||||+++|+|++|..||...+... ....+..... ..
T Consensus 160 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyel~tg~~Pf~~~~~~~----~~~~i~~~~~~~~ 234 (269)
T d2java1 160 LARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKE----LAGKIREGKFRRI 234 (269)
T ss_dssp HHHHC-----------CCCSCCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHTCCCCC
T ss_pred ceeecccCCCccccCCCCcccCCHHHHcCCCCChH-HHHHhhCHHHHHHhhCCCCCCCCCHHH----HHHHHHcCCCCCC
Confidence 987654433 2345678999999999988888766 999999999999999999998754433 3333333333 23
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 243 PDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 243 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
+ ..+|+++.+||.+||+.||.+|||+.|+++ |+|+
T Consensus 235 ~--~~~s~~l~~li~~~L~~dp~~Rps~~ell~---hp~i 269 (269)
T d2java1 235 P--YRYSDELNEIITRMLNLKDYHRPSVEEILE---NPLI 269 (269)
T ss_dssp C--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT---STTC
T ss_pred C--cccCHHHHHHHHHHcCCChhHCcCHHHHHh---CCcC
Confidence 3 378999999999999999999999988865 6663
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-55 Score=368.86 Aligned_cols=250 Identities=31% Similarity=0.540 Sum_probs=218.5
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
.++|++++.||+|+||+||+|++..+|+.||+|++... ....+.+.+|+.++++++||||+++++++.+++.+++|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 47899999999999999999999999999999998753 34456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|||+.+++|...+.....++...++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++..... ..
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~~--~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--VT 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--CB
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEecc--cc
Confidence 999999999999999999999999999999999999999999999999999999988776 99999999985543 23
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+.. .....+......++. .+|+++.++
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~~l 231 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTM----KTYEKILNAELRFPP--FFNEDVKDL 231 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHHCCCCCCT--TSCHHHHHH
T ss_pred ccccCcccccCHHHHcCCCCCch-hhccccchhHHHHHhCCCCCCCcCHH----HHHHHHHcCCCCCCC--CCCHHHHHH
Confidence 45679999999999998888876 99999999999999999999875443 333444555566655 789999999
Q ss_pred HHHhcccCcCCcc-----ccccccccchhhhhh
Q 023058 256 ISRIFVADPAKVS-----MHFHATGVYMHTKLQ 283 (288)
Q Consensus 256 i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~~ 283 (288)
|.+||+.||.+|+ |++++++ |+|++
T Consensus 232 i~~~L~~dp~~R~~~~r~t~~~il~---Hp~f~ 261 (316)
T d1fota_ 232 LSRLITRDLSQRLGNLQNGTEDVKN---HPWFK 261 (316)
T ss_dssp HHHHTCSCTTTCTTSSTTTTHHHHT---SGGGS
T ss_pred HHHHhhhCHHhccccchhhHHHHHc---Ccccc
Confidence 9999999999997 6666654 66654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-56 Score=365.87 Aligned_cols=252 Identities=19% Similarity=0.262 Sum_probs=215.6
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
+..++|++.+.||+|+||+||+|.+..++..||+|++..+....+++.+|+.++++++||||+++++++.+++..++|||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 45689999999999999999999999999999999998877777889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 98 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|+++++|..++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||+++........
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSSSE
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCCce
Confidence 99999999998764 46899999999999999999999999999999999999988876 999999999855433222
Q ss_pred --CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 176 --KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 176 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
....+++.|+|||.+.+..++.+ +||||||+++|+|++|..||..........+.. ......+....+|+++.
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k-~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i----~~~~~~~~~~~~~~~l~ 246 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDYRMERPEGCPEKVY 246 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----HTTCCCCCCTTCCHHHH
T ss_pred eeccccccccccChHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH----hcCCCCCCCccchHHHH
Confidence 22347889999999988888766 999999999999999877766554433333322 22333344447999999
Q ss_pred HHHHHhcccCcCCcccccccccc
Q 023058 254 HLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
+||.+||+.||.+|||+.++++.
T Consensus 247 ~li~~cl~~dP~~Rps~~ei~~~ 269 (287)
T d1opja_ 247 ELMRACWQWNPSDRPSFAEIHQA 269 (287)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999998763
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-55 Score=370.97 Aligned_cols=250 Identities=30% Similarity=0.511 Sum_probs=218.6
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
.++|++++.||+|+||+||+|++..+|+.||+|++... ....+.+.+|+.++++++||||+++++++......++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 47999999999999999999999999999999998753 34446788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
||++.+++|...+...+.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++..... ..
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~~--~~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--RT 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--CB
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC--EEeeeceeeeeccc--cc
Confidence 999999999999998889999999999999999999999999999999999999988776 99999999986543 23
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 255 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (288)
....||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+. ......+.......+. .+++++.+|
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~l 268 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQP----IQIYEKIVSGKVRFPS--HFSSDLKDL 268 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TCCHHHHHH
T ss_pred ccccCccccCCHHHHcCCCCCcc-ccccchhHHHHHHHhCCCCCCCcCH----HHHHHHHhcCCCCCCc--cCCHHHHHH
Confidence 45679999999999999888776 9999999999999999999986543 3344445555555555 799999999
Q ss_pred HHHhcccCcCCcc-----ccccccccchhhhhh
Q 023058 256 ISRIFVADPAKVS-----MHFHATGVYMHTKLQ 283 (288)
Q Consensus 256 i~~~l~~~p~~Rp-----t~~~~l~~~~~~~~~ 283 (288)
|.+||+.||.+|+ |+.++++ |+||+
T Consensus 269 i~~~L~~dP~kR~~~~r~t~~ell~---Hp~f~ 298 (350)
T d1rdqe_ 269 LRNLLQVDLTKRFGNLKNGVNDIKN---HKWFA 298 (350)
T ss_dssp HHHHSCSCTTTCTTSSTTTTHHHHT---SGGGT
T ss_pred HHHHhhhCHHhccccccccHHHHHc---Ccccc
Confidence 9999999999995 7777765 66553
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-56 Score=373.50 Aligned_cols=265 Identities=31% Similarity=0.488 Sum_probs=218.7
Q ss_pred CCCCCCCCCCCCeeeee-eeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhh-CCCCceeeEeEEEEc
Q 023058 11 GMDMPIMHDSDRYELVR-DIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRS-LRHPNIVRFKEVILT 88 (288)
Q Consensus 11 ~~~~~~~~~~~~y~~~~-~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~ 88 (288)
|.++......++|++.. .||+|+||+||+|++..+++.||+|++.. .....+|+.++.+ .+||||++++++|.+
T Consensus 1 ~~~~~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 1 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp CCCCBCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CccCCCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 45556666678999986 59999999999999999999999999864 3467789988655 589999999999875
Q ss_pred ----CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCC-CCCEEEe
Q 023058 89 ----PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKIC 161 (288)
Q Consensus 89 ----~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~-~~~~~l~ 161 (288)
...+++|||||++++|.+++... ..+++.+++.++.||+.||+|||+.||+||||||+||+++.+. .+.+||+
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccc
Confidence 46789999999999999999764 3699999999999999999999999999999999999997533 3469999
Q ss_pred ecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccC
Q 023058 162 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 241 (288)
Q Consensus 162 df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
|||++.............||+.|+|||.+.+..++.+ +|||||||++|+|++|..||...+...........+......
T Consensus 157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235 (335)
T ss_dssp CCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred ccceeeeccCCCccccccCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 9999987776666677889999999999998888777 999999999999999999998776655555555555555555
Q ss_pred CCC--CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 242 IPD--YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 242 ~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
++. +..+|+++.+||.+||+.||.+|||+.|+++ |+|+.
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~---hp~~~ 276 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN---HPWIM 276 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH---SHHHH
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc---CHHhh
Confidence 543 2357899999999999999999999988755 66664
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-55 Score=364.32 Aligned_cols=251 Identities=33% Similarity=0.536 Sum_probs=216.1
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC----ccchHHHHHHHHHHh-hCCCCceeeEeEEEEcCCeEEEE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG----DKIDENVQREIINHR-SLRHPNIVRFKEVILTPTHLAIV 95 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv 95 (288)
++|++.+.||+|+||+||+|.+..+++.||+|++.++ ....+....|..++. .++||||+++++++.+++.+++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6899999999999999999999999999999999753 233445666776664 68999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~- 174 (288)
|||+++++|.+++.....+++.+++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++........
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAK 159 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhccccccc
Confidence 999999999999999899999999999999999999999999999999999999987776 99999999986544333
Q ss_pred CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 175 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 175 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+.. .....+....+.+|. .+|+++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~PF~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~d 232 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSIRMDNPFYPR--WLEKEAKD 232 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCT--TSCHHHHH
T ss_pred ccccCCCCCcCCHHHHcCCCCCch-hhhhhhhHHHHHHHhCCCCCCCCCHH----HHHHHHHcCCCCCCc--cCCHHHHH
Confidence 344578999999999999999876 99999999999999999999875543 334444555666665 68999999
Q ss_pred HHHHhcccCcCCccccc-cccccchhhhhh
Q 023058 255 LISRIFVADPAKVSMHF-HATGVYMHTKLQ 283 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~-~~l~~~~~~~~~ 283 (288)
||.+||+.||.+|||+. ++++ |+|++
T Consensus 233 li~~~L~~dP~~R~s~~~~l~~---hpff~ 259 (320)
T d1xjda_ 233 LLVKLFVREPEKRLGVRGDIRQ---HPLFR 259 (320)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGG---SGGGT
T ss_pred HHHHhcccCCCCCcCHHHHHHh---Cchhc
Confidence 99999999999999996 5654 55553
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.5e-55 Score=371.61 Aligned_cols=258 Identities=28% Similarity=0.435 Sum_probs=212.1
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHH---HHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENV---QREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~---~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
..++|++.+.||+|+||.||+|++..+|+.||+|++.... ...... .+++.+++.++||||+++++++..++.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 3578999999999999999999999999999999987532 112223 345777788899999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
+++||||+++++|.+++.....+++..++.++.||+.||+|||+.||+||||||+||+++.++. +||+|||++.....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCC
Confidence 9999999999999999998889999999999999999999999999999999999999988777 99999999985543
Q ss_pred CCCCCCCcCCCcccCCccccCc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCH
Q 023058 172 HSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 250 (288)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
. ......||+.|+|||++.++ .++.+ +|||||||++|+|++|..||....... ..............++. .+|+
T Consensus 160 ~-~~~~~~GT~~y~APE~~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~--~~s~ 234 (364)
T d1omwa3 160 K-KPHASVGTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPD--SFSP 234 (364)
T ss_dssp S-CCCSCCSCGGGCCHHHHSTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCSSCSSC-HHHHHHHSSSCCCCCCS--SSCH
T ss_pred C-cccccccccccchhHHhhcCCCCCcc-cchhHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcccCCCCCCC--CCCH
Confidence 3 34556799999999998755 45555 999999999999999999998765433 23333333344444444 7899
Q ss_pred HHHHHHHHhcccCcCCcccccc--ccccchhhhhh
Q 023058 251 ECRHLISRIFVADPAKVSMHFH--ATGVYMHTKLQ 283 (288)
Q Consensus 251 ~l~~li~~~l~~~p~~Rpt~~~--~l~~~~~~~~~ 283 (288)
++++||.+||+.||.+|||..+ +.+.+.|+|++
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~ 269 (364)
T d1omwa3 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269 (364)
T ss_dssp HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGT
T ss_pred HHHHHHHHHcccCHHHhCCCcccCHHHHHcCcccc
Confidence 9999999999999999999521 22234466654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-55 Score=355.71 Aligned_cols=251 Identities=23% Similarity=0.377 Sum_probs=202.7
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++.++|++.+.||+|+||+||+|.+. ++..||||++..+....+++.+|++++++++||||+++++++..++..++|||
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 45789999999999999999999987 46789999998877777889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC-
Q 023058 98 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~- 175 (288)
|+++++|.+++... ..++...+..++.||+.||+|||+.+|+||||||+||+++.++. +||+|||+++........
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCcee
Confidence 99999999988654 46899999999999999999999999999999999999998877 999999999755443322
Q ss_pred -CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhC-CCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 176 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 176 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
....+++.|+|||.+.+..++.+ +||||||+++|||+++ ..||..... .. ....+... ...+.+..+++++.
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k-~DVwS~Gvil~el~t~~~~~~~~~~~-~~---~~~~i~~~-~~~~~p~~~~~~l~ 232 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSN-SE---VVEDISTG-FRLYKPRLASTHVY 232 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSCCH-HH---HHHHHHHT-CCCCCCTTSCHHHH
T ss_pred ecceecCcccCChHHhcCCCCCch-hhhcchHHHHHHHHHCCCCCCCCCCH-HH---HHHHHHhc-CCCCCccccCHHHH
Confidence 23457899999999998888776 9999999999999995 444544332 22 22222222 22223347899999
Q ss_pred HHHHHhcccCcCCccccccccccc
Q 023058 254 HLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
+||.+||+.||.+|||+.++++.|
T Consensus 233 ~li~~cl~~~p~~Rps~~~il~~L 256 (263)
T d1sm2a_ 233 QIMNHCWKERPEDRPAFSRLLRQL 256 (263)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHccCCHhHCcCHHHHHHHH
Confidence 999999999999999999998753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=352.27 Aligned_cols=250 Identities=20% Similarity=0.337 Sum_probs=214.4
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEec
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+.++|++.++||+|+||+||+++++ ++..||+|++..+....+.+.+|+.++++++||||+++++++.+++.+++||||
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 4689999999999999999999986 678899999998888888999999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC--
Q 023058 99 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 175 (288)
Q Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~-- 175 (288)
+++++|..++.. ...+++..++.++.|++.||+|||+.||+||||||+||+++.++. +||+|||++.........
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCC
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceee
Confidence 999999888654 457899999999999999999999999999999999999988776 999999999754443322
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHHH
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 254 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 254 (288)
....+++.|+|||.+.+..++.+ +||||||+++|||++ |..||...+..+.. ..+... ...+.+..+++.+.+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~k-sDiwS~G~~l~el~t~g~~Pf~~~~~~~~~----~~i~~~-~~~~~p~~~~~~l~~ 232 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETA----EHIAQG-LRLYRPHLASEKVYT 232 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHH----HHHHTT-CCCCCCTTCCHHHHH
T ss_pred cccCCCCCcCCcHHhcCCCCCcc-eeecccchhhHhHHhcCCCCCCCCCHHHHH----HHHHhC-CCCCCcccccHHHHH
Confidence 23457889999999998888776 999999999999998 79999876643332 223332 233344478999999
Q ss_pred HHHHhcccCcCCccccccccccc
Q 023058 255 LISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 255 li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
||.+||+.||.+|||+.++++.+
T Consensus 233 li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 233 IMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHHHh
Confidence 99999999999999999887744
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.7e-55 Score=358.26 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=202.4
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc----cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC----e
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPT----H 91 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 91 (288)
.++|++.+.||+|+||+||+|++..+++.||+|++.... ...+.+.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 578999999999999999999999999999999997543 23346889999999999999999999987643 4
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
+|+||||+++++|...+...+++++.+++.++.||+.||+|||+.||+||||||+||+++.++. .+++|||.+.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC-
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhcc
Confidence 8999999999999999988889999999999999999999999999999999999999988887 99999998764433
Q ss_pred CC----CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCC--CCC
Q 023058 172 HS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDY 245 (288)
Q Consensus 172 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~ 245 (288)
.. ......||+.|+|||.+.+..++.+ +||||||+++|+|++|..||...+......+. ....... ...
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~ 238 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH----VREDPIPPSARH 238 (277)
T ss_dssp ---------------TTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----HHCCCCCGGGTS
T ss_pred ccccccccccccCcccccCHHHHcCCCCCcc-eecccchHHHHHHHhCCCCCCCcCHHHHHHHH----HhcCCCCCchhc
Confidence 22 2334568999999999988888776 99999999999999999999876543333332 2222221 223
Q ss_pred CCCCHHHHHHHHHhcccCcCCcc-ccccccc
Q 023058 246 VHISPECRHLISRIFVADPAKVS-MHFHATG 275 (288)
Q Consensus 246 ~~~~~~l~~li~~~l~~~p~~Rp-t~~~~l~ 275 (288)
..+|+++.++|.+||++||.+|| |+.++++
T Consensus 239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~ 269 (277)
T d1o6ya_ 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRA 269 (277)
T ss_dssp SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred cCCCHHHHHHHHHHccCCHhHCHhHHHHHHH
Confidence 47899999999999999999999 4555443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-54 Score=353.21 Aligned_cols=254 Identities=20% Similarity=0.263 Sum_probs=208.7
Q ss_pred CCCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 14 MPIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
-..-+..++|++.+.||+|+||+||+|.++ ++..||||++.......+.+.+|+.++++++||||+++++++.. +..+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 334455689999999999999999999986 56789999998877777889999999999999999999998754 5678
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 94 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
+||||+++++|.+.+... .+++...+..++.||+.||.|||+.||+||||||+||+++.++. +||+|||+++....
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIED 161 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSS
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccC
Confidence 999999999998876443 36999999999999999999999999999999999999988776 99999999986543
Q ss_pred CC--CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 172 HS--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 172 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
.. ......+++.|+|||.+.+..++.+ +||||||+++|||++|..|+........ ....+.. ....+....+|
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~-sDvwS~Gvvl~ellt~~~~~~~~~~~~~---~~~~i~~-~~~~~~p~~~~ 236 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNLER-GYRMVRPDNCP 236 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT-TCCCCCCTTCC
T ss_pred CccccccccCCcccccChHHHhCCCCCch-hhhhhhHHHHHHHHhCCCCCCCCCCHHH---HHHHHHh-cCCCCCcccCh
Confidence 32 2234568889999999988888766 9999999999999996655544333222 2222222 22233334789
Q ss_pred HHHHHHHHHhcccCcCCcccccccccc
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
+++.+||.+||+.||.+|||+.++++.
T Consensus 237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~ 263 (272)
T d1qpca_ 237 EELYQLMRLCWKERPEDRPTFDYLRSV 263 (272)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999998763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=355.33 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=201.7
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
+..++|++.+.||+|+||+||+|+.. ..||||++... ....+.+.+|+.++++++||||+++++++.. ..+++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 44689999999999999999999864 35999998654 3344678899999999999999999998754 56899
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 95 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
||||+++++|.+++... .+++...+..++.||+.||+|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC-----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccC
Confidence 99999999999998754 56999999999999999999999999999999999999988876 9999999997554322
Q ss_pred ---CCCCCcCCCcccCCccccCc---ccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 174 ---QPKSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 174 ---~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
......+|+.|+|||.+.+. .++.+ +||||||+++|||++|..||...+...........-............
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~-sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ-SDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCch-hhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 22345689999999998653 34444 999999999999999999998776544444333221111111112336
Q ss_pred CCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
+|+++.+||.+||+.||.+|||+.++++.+
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 899999999999999999999999988743
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=355.77 Aligned_cols=247 Identities=30% Similarity=0.462 Sum_probs=209.8
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc-------chHHHHHHHHHHhhCC--CCceeeEeEEEEcCC
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------IDENVQREIINHRSLR--HPNIVRFKEVILTPT 90 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~ 90 (288)
.++|++.+.||+|+||+||+|++..+++.||+|++..... ...++.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 5789999999999999999999999999999999875421 1234678999999986 899999999999999
Q ss_pred eEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 91 HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 91 ~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
..++|||++.+ +++.+++.....+++.+++.++.||+.||+|||+.||+||||||+||+++.+. +.++|+|||++...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEEC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECccccceec
Confidence 99999999975 57788888888999999999999999999999999999999999999998543 24999999999754
Q ss_pred ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
.. .......||+.|+|||.+.+..+.+.++|||||||++|+|++|..||...+ .+......++. .+|
T Consensus 162 ~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~i~~~~~~~~~--~~s 228 (273)
T d1xwsa_ 162 KD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFRQ--RVS 228 (273)
T ss_dssp CS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCCCCCSS--CCC
T ss_pred cc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------HHhhcccCCCC--CCC
Confidence 33 233456799999999999887776666899999999999999999997421 23344445554 689
Q ss_pred HHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
+++++||.+||+.||.+|||+.|+++ |+|++
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~---hp~~~ 259 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQN---HPWMQ 259 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHT---SGGGS
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhc---CHhhC
Confidence 99999999999999999999988866 66654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-54 Score=358.73 Aligned_cols=253 Identities=21% Similarity=0.347 Sum_probs=200.9
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCc---EEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
.+..++|++.+.||+|+||+||+|.+..+++ .||+|.+.... ...+.+.+|++++++++||||+++++++..++.
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 3456889999999999999999999876654 58888876542 334578899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
+++||||+++++|.+++... +.+++.++..++.||+.||+|||+.||+||||||+||+++.++. +||+|||+++...
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLE 179 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEcc
Confidence 99999999999999988764 46999999999999999999999999999999999999988777 9999999997554
Q ss_pred cCCCCC------CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCC
Q 023058 171 LHSQPK------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIP 243 (288)
Q Consensus 171 ~~~~~~------~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
...... ...+++.|+|||.+.+..++.+ +|||||||++|||++ |..||......... ..+.. ....+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~----~~i~~-~~~~~ 253 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVI----NAIEQ-DYRLP 253 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHT-TCCCC
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCCCCCCHHHHH----HHHHc-CCCCC
Confidence 332221 1346889999999988888776 999999999999998 89999876543322 22222 23334
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 244 DYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
....+|+++.+||.+||+.||.+|||+.++++.+
T Consensus 254 ~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L 287 (299)
T d1jpaa_ 254 PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287 (299)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 4457999999999999999999999999988754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-54 Score=355.82 Aligned_cols=260 Identities=29% Similarity=0.408 Sum_probs=210.8
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++|++++.||+|+||+||+|.+..+++.||+|++.... ...+.+.+|++++++++||||+++++++.++..+++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999999999999999986543 335678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC-CCC
Q 023058 98 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP 175 (288)
Q Consensus 98 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~-~~~ 175 (288)
++.++.+...... ...+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++...... ...
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBCT
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCcccc
Confidence 9976444333333 456999999999999999999999999999999999999987776 999999999765433 334
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc--------------C
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------------S 241 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------~ 241 (288)
....+++.|+|||.+....+.+.++|+||+|+++|+|++|..||...+..+.............. .
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence 45679999999999888777666699999999999999999999876554444443322111110 0
Q ss_pred CCC---------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 242 IPD---------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 242 ~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
++. ...+++++.+||.+||++||.+|||+.|+++ |+|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~---H~ff~~~ 289 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA---HPFFQDV 289 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT---SGGGTTC
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC---CHhhccC
Confidence 000 1256789999999999999999999988865 7777654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-54 Score=352.99 Aligned_cols=260 Identities=25% Similarity=0.356 Sum_probs=214.3
Q ss_pred CCCCCCeeeee-eeeccCceEEEEEEEcC--CCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 17 MHDSDRYELVR-DIGSGNFGVARLMRDKK--TEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 17 ~~~~~~y~~~~-~lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
.+..++|.+.+ +||+|+||+||+|.+.. ++..||||++.... ...+++.+|++++++++||||+++++++.. +.
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 34557899988 49999999999998754 34579999987543 334678899999999999999999999875 45
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
+++||||+++++|.+++... ..++...+..++.||+.||+|||++||+||||||+||+++.++. +||+|||+++...
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALG 160 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECT
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhccc
Confidence 78999999999999987654 57999999999999999999999999999999999999988776 9999999997554
Q ss_pred cCCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhc-ccCCCC
Q 023058 171 LHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV-QYSIPD 244 (288)
Q Consensus 171 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~ 244 (288)
.... .....+++.|+|||.+.+..++.+ +||||||+++|||++ |..||......+... .+..+ ....|
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~----~i~~~~~~~~p- 234 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIEQGKRMECP- 234 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH----HHHTTCCCCCC-
T ss_pred ccccccccccccccCccccChHHHhCCCCCcc-chhhcchHHHHHHHhCCCCCCCCCCHHHHHH----HHHcCCCCCCC-
Confidence 3322 233457889999999988888776 999999999999998 899998766533322 22222 22333
Q ss_pred CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhhh
Q 023058 245 YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLLV 286 (288)
Q Consensus 245 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~ 286 (288)
..+|+++.+||.+||+.||.+|||+.++.+.+.+.+.++..
T Consensus 235 -~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 235 -PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp -TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred -CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 47999999999999999999999999999988887776543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=353.48 Aligned_cols=255 Identities=22% Similarity=0.266 Sum_probs=206.2
Q ss_pred CCeeee-eeeeccCceEEEEEEEcC--CCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEE
Q 023058 21 DRYELV-RDIGSGNFGVARLMRDKK--TEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 94 (288)
Q Consensus 21 ~~y~~~-~~lg~g~~~~v~~~~~~~--~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (288)
+.+.+. ++||+|+||+||+|.+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++..+ ..++
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~l 84 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWML 84 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEE
T ss_pred hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEE
Confidence 334444 469999999999998653 45789999986532 2345788999999999999999999998654 5789
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC
Q 023058 95 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 174 (288)
Q Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~ 174 (288)
||||+++++|.+++.....+++..+..++.||+.||+|||+.||+||||||+||+++.++. ++|+|||+++.......
T Consensus 85 vmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADEN 162 (277)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCS
T ss_pred EEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhcccccc
Confidence 9999999999999999889999999999999999999999999999999999999998877 99999999975443322
Q ss_pred ----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 175 ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 175 ----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
.....+++.|+|||.+.+..++.+ +||||||+++|||++ |..||...+... ....+..+ ...+.+..+|
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~~~~----~~~~i~~~-~~~~~p~~~~ 236 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEKG-ERMGCPAGCP 236 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHHHHTT-CCCCCCTTCC
T ss_pred ccccccccCCCceecCchhhcCCCCCch-hhhccchhhhhHHhhCCCCCCCCCCHHH----HHHHHHcC-CCCCCCcccC
Confidence 233457889999999988888776 999999999999997 899998765432 22222222 2223334799
Q ss_pred HHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
+++.+||.+||+.||.+|||+.++.+.+.+.+++.
T Consensus 237 ~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 237 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 99999999999999999999999988776666554
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=357.98 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=206.7
Q ss_pred eeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc------chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 24 ELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 24 ~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
+.++.||+|+||+||+|++..+|+.||+|++..... ..+.+.+|+.++++++||||+++++++..++.+++|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 357899999999999999999999999999865432 23468899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC-CCC
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 176 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~-~~~ 176 (288)
|+.++++..+......+++..+..+++||+.||+|||++||+||||||+||+++.++. +||+|||++....... ...
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCccccc
Confidence 9988777777666778999999999999999999999999999999999999987776 9999999997554433 334
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-CCC------------
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIP------------ 243 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~------------ 243 (288)
...+|+.|+|||.+.+......++||||+||++|+|++|..||...+..+....+......... .++
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 5578999999999876654444499999999999999999999877655544444332211110 000
Q ss_pred ---C------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 244 ---D------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 244 ---~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
. ...+++++.+||.+||+.||.+|||+.|+++ |+|++
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~---Hp~f~ 284 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK---MKYFS 284 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT---SGGGT
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC---CHhhC
Confidence 0 1246889999999999999999999998866 66664
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=357.35 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=210.0
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCc-----EEEEEEeecC--ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEE-----LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~iK~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (288)
+..++|++.+.||+|+||+||+|++..+++ .||+|.+... ......+.+|+.+++++ +||||+++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 345789999999999999999999875543 6899988643 34446788999999998 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCC
Q 023058 90 THLAIVMEYASGGELFERICNA-----------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 146 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~ 146 (288)
+..++||||+++++|.+++... ..++...++.++.||+.||+|||++||+||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 9999999999999999998654 24789999999999999999999999999999999
Q ss_pred ceEecCCCCCCEEEeecCCCcccccCCCC---CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 023058 147 NTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDP 222 (288)
Q Consensus 147 nilv~~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~ 222 (288)
||+++.++. +||+|||+++........ ....+|+.|+|||.+.+..++.+ +|||||||++|||++ |..||...
T Consensus 194 Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 194 NVLVTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GEEEETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ccccccCCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc-eeccchhHHHHHHHhCCCCCCCCC
Confidence 999988876 999999999755444332 23457899999999988888776 999999999999997 89999877
Q ss_pred CCchhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 223 EEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.......+.. ......+.+..+|+++++||.+||+.||.+|||+.|+++.|
T Consensus 271 ~~~~~~~~~~----~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 271 PVDANFYKLI----QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp CCSHHHHHHH----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHH----hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 6655544443 23334444457899999999999999999999999987643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.9e-53 Score=349.19 Aligned_cols=257 Identities=26% Similarity=0.386 Sum_probs=209.4
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++|++++.||+|+||+||+|+++ +++.||+|++.... ...+++.+|+.++++++||||+++++++.+++..+++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 69999999999999999999997 68999999987542 335688999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-CC
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK 176 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~-~~ 176 (288)
++.++.+..+....+.+++..+..++.||+.||+|||+.||+||||||+||+++.++. +|++|||.+........ ..
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC------
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCccccc
Confidence 9988777777777788999999999999999999999999999999999999988877 99999999876544332 34
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc--------------CC
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------------SI 242 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------~~ 242 (288)
...+++.|+|||.+.+..+.+.++|+||||+++|+|++|..||...+..+...+.......... ..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 4568999999999987766555699999999999999999999876554444443322111100 00
Q ss_pred C---------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 243 P---------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 243 ~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
. ....+++++.+||++||+.||.+|||+.|+++ |+|++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~---Hp~f~ 285 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE---HAYFK 285 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT---SGGGG
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc---CcccC
Confidence 0 01357889999999999999999999988865 77775
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=344.63 Aligned_cols=253 Identities=21% Similarity=0.286 Sum_probs=201.5
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCC----cEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTE----ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH 91 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (288)
+..+.|++.+.||+|+||+||+|....++ ..||||++.... .....+.+|+.++++++||||+++++++...+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 45678999999999999999999987554 479999987543 333467899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 92 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.++|||++.++++.+.+... +.++..++..++.||+.||+|||+.||+||||||+||+++.++. +||+|||+++...
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhccc
Confidence 99999999999998877654 57999999999999999999999999999999999999988877 9999999997654
Q ss_pred cCCCC----CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCC
Q 023058 171 LHSQP----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 246 (288)
Q Consensus 171 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
..... ....+++.|+|||.+.+..++.+ +||||||+++|||++|..|+......... ...+.. ....+...
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-sDI~S~Gvil~el~t~~~~~~~~~~~~~~---~~~i~~-~~~~~~~~ 236 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEV---MKAIND-GFRLPTPM 236 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHT-TCCCCCCT
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCc-ccccccHHHHHHHHhCCCCccccCCHHHH---HHHHhc-cCCCCCch
Confidence 33221 22357889999999988888776 99999999999999976665544332322 222222 23334444
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
.+|+.+.+||.+||+.||.+|||+.++++.+
T Consensus 237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~~L 267 (283)
T d1mqba_ 237 DCPSAIYQLMMQCWQQERARRPKFADIVSIL 267 (283)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHH
Confidence 7899999999999999999999999998744
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-53 Score=345.76 Aligned_cols=249 Identities=22% Similarity=0.282 Sum_probs=203.2
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
+..++|++.+.||+|+||+||+|.+..+ ..||+|++.......+.+.+|+.++++++||||+++++++. ++..++|||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~E 91 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 91 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEE
Confidence 4568999999999999999999998754 57999999887777788999999999999999999999985 456789999
Q ss_pred ccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCC-
Q 023058 98 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 174 (288)
Q Consensus 98 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~- 174 (288)
|+++++|..++.. .+.+++.+++.++.||+.||+|||+.|++||||||+||+++.++. +||+|||+++.......
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC--------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCce
Confidence 9999999888754 356999999999999999999999999999999999999988876 99999999975543332
Q ss_pred -CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 175 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 175 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
.....+++.|+|||.+.+..++.+ +||||||+++|||++|..|+........... .+.. ....+....+|++++
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~S~Giil~el~t~~~p~~~~~~~~~~~~---~i~~-~~~~~~~~~~~~~l~ 244 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLD---QVER-GYRMPCPPECPESLH 244 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHHT-TCCCCCCTTSCHHHH
T ss_pred eeccccccccccChHHHhCCCCCcH-HhhhcchHHHHHHHhCCCCCCCCCCHHHHHH---HHHh-cCCCCCCcccCHHHH
Confidence 223458899999999988888766 9999999999999997766655443332222 2222 223333447899999
Q ss_pred HHHHHhcccCcCCccccccccc
Q 023058 254 HLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
++|.+||+.||.+|||+.++++
T Consensus 245 ~li~~cl~~dP~~Rps~~~i~~ 266 (285)
T d1fmka3 245 DLMCQCWRKEPEERPTFEYLQA 266 (285)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcccCHhHCcCHHHHHH
Confidence 9999999999999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=349.59 Aligned_cols=263 Identities=28% Similarity=0.374 Sum_probs=211.2
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCC-CcEEEEEEeecCc---cchHHHHHHHHHHhhC---CCCceeeEeEEEEc-
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKT-EELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILT- 88 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~- 88 (288)
+...++|++++.||+|+||+||+|++..+ ++.||+|++.... .......+|+.+++.+ +||||+++++++..
T Consensus 3 c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 3 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 34568999999999999999999999655 6779999986532 2334566777776665 79999999999853
Q ss_pred ----CCeEEEEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeec
Q 023058 89 ----PTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (288)
Q Consensus 89 ----~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df 163 (288)
....+++||+++++.+..... ....+++..++.++.|++.||+|||+.||+||||||+||+++.++. ++|+||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~df 160 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADF 160 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSC
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecch
Confidence 347899999998876654443 3346899999999999999999999999999999999999987776 999999
Q ss_pred CCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc-CC
Q 023058 164 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SI 242 (288)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~ 242 (288)
|++.............||+.|+|||.+.+..++.+ +||||+||++|+|++|..||...+..+.............. .+
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 99887666666677889999999999999888877 99999999999999999999877655544444332211100 00
Q ss_pred C--------------------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 243 P--------------------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 243 ~--------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
+ ....+++.+.+||.+||++||.+|||+.|+++ |+|++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~---Hpff~~i 299 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS---HPYFQDL 299 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT---SGGGTTC
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc---ChhhcCc
Confidence 0 12357899999999999999999999988755 8888755
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-52 Score=351.16 Aligned_cols=264 Identities=28% Similarity=0.403 Sum_probs=208.2
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcC-----
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP----- 89 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (288)
|.....-+|+.++.||+|+||+||+|++..+++.||+|++...... ..+|+.++++++||||+++++++...
T Consensus 14 p~~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 14 PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp SCCCEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred CCCcccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence 3333345799999999999999999999999999999999765432 34799999999999999999998543
Q ss_pred -CeEEEEEeccCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCC
Q 023058 90 -THLAIVMEYASGGELFER---ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 165 (288)
Q Consensus 90 -~~~~lv~e~~~~~~L~~~---~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~ 165 (288)
.++++||||++++.+..+ ......+++.+++.++.||+.||+|||+.||+||||||+||+++.++. .+||+|||+
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~ 169 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGS 169 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTT
T ss_pred ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccc
Confidence 358999999977543333 234557999999999999999999999999999999999999986652 399999999
Q ss_pred CcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh--------
Q 023058 166 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-------- 237 (288)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 237 (288)
+.............+++.|+|||.+.+......++||||+||++|+|++|..||...+..+...........
T Consensus 170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 170 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 987766666677789999999999876544344499999999999999999999876654444333221100
Q ss_pred ---c--ccCCC----------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 238 ---V--QYSIP----------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 238 ---~--~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
. ...++ .....++++.+||.+||+.||.+|||+.|+++ |+||+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~---Hp~f~~~ 309 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA---HSFFDEL 309 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT---SGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc---CHhhccc
Confidence 0 00111 12357899999999999999999999988866 6666543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=338.71 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=214.2
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEEEEEe
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 97 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (288)
++|++++.||+|+||+||+|++..+++.||+|++.... ...+++.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 68999999999999999999999999999999987543 334678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC-C
Q 023058 98 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-K 176 (288)
Q Consensus 98 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~-~ 176 (288)
++.++++..++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++. ++|+|||.+......... .
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCCC
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccce
Confidence 9999999888888889999999999999999999999999999999999999987776 999999999866554433 3
Q ss_pred CCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhccc----------------
Q 023058 177 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY---------------- 240 (288)
Q Consensus 177 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------- 240 (288)
...+++.|.|||.+.+..+.+.++||||+||++|+|++|..||....+................
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence 4456788899999877765455599999999999999999997655443332222222111110
Q ss_pred --------CCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhh
Q 023058 241 --------SIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLL 285 (288)
Q Consensus 241 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~ 285 (288)
.......+++.+.+||.+||+.||.+|||+.|+++ |+||+.+
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~---Hp~f~~~ 289 (292)
T d1unla_ 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ---HPYFSDF 289 (292)
T ss_dssp CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT---SGGGSSC
T ss_pred ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc---ChhhcCC
Confidence 00012356789999999999999999999988755 7777643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=341.51 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=202.9
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCC-C--cEEEEEEeecC----ccchHHHHHHHHHHhhCCCCceeeEeEEEE
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKT-E--ELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVIL 87 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-~--~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (288)
+..+..++|++.+.||+|+||+||+|+...+ + ..||+|++... ....+++.+|+.++++++||||+++++++.
T Consensus 2 t~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~ 81 (273)
T d1u46a_ 2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81 (273)
T ss_dssp CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ceEEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 3456678999999999999999999986532 2 46899988653 333457889999999999999999999997
Q ss_pred cCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCC
Q 023058 88 TPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 166 (288)
Q Consensus 88 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~ 166 (288)
++ ..++||||++++++.+.+.. .+.++...+..++.||+.||.|||+.||+||||||+||+++.++. +||+|||++
T Consensus 82 ~~-~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~ 158 (273)
T d1u46a_ 82 TP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLM 158 (273)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTC
T ss_pred ec-chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhh
Confidence 64 67899999999999877654 456999999999999999999999999999999999999998876 999999999
Q ss_pred cccccCCC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccC
Q 023058 167 KSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYS 241 (288)
Q Consensus 167 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
........ .....++..|+|||.+.+..++.+ +||||||+++|||++ |..||...+... ....+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~~~~----~~~~i~~~~~~ 233 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKEGER 233 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTSCCC
T ss_pred hhcccCCCcceecCccccCcccCCHHHHhCCCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcCHHH----HHHHHHhCCCC
Confidence 86544333 223346778999999988888766 999999999999998 899998765433 33344455555
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 242 IPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 242 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.+....+|+++.+||.+||+.||.+|||+.++.+.|.
T Consensus 234 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~ 270 (273)
T d1u46a_ 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270 (273)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 5555689999999999999999999999999876543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-51 Score=346.49 Aligned_cols=259 Identities=23% Similarity=0.408 Sum_probs=211.7
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC-CCceeeEeEEEEcC--CeEEEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIV 95 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv 95 (288)
..++|++++.||+|+||+||+|++..+++.||+|++.... .+++.+|+.++++++ ||||+++++++... ...++|
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 4578999999999999999999999999999999987543 467889999999995 99999999999754 569999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 175 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~ 175 (288)
|||+.+++|.... +.+++.+++.++.||+.||+|||++||+||||||+||+++.++. .++|+|||++.........
T Consensus 111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCC
T ss_pred EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcc
Confidence 9999999987653 56999999999999999999999999999999999999986543 3899999999877666666
Q ss_pred CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc----------c------
Q 023058 176 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV----------Q------ 239 (288)
Q Consensus 176 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------~------ 239 (288)
....+|+.|+|||.+.+....+.++|+||+||++++|++|..||................... .
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 266 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence 777899999999998876644445999999999999999999998765533222221111100 0
Q ss_pred ----------------cCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhhhh
Q 023058 240 ----------------YSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQLLV 286 (288)
Q Consensus 240 ----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~~~ 286 (288)
...+....+++++.+||.+||++||.+|||++|+++ |+||+-++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~---Hp~F~~v~ 326 (328)
T d3bqca1 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME---HPYFYTVV 326 (328)
T ss_dssp GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT---SGGGTTSC
T ss_pred cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc---CcccCCCC
Confidence 000112346889999999999999999999988866 88887654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=338.10 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=200.1
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEc-CCeEEEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIV 95 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv 95 (288)
.+..++|++.+.||+|+||.||+|..+ |..||+|++..+ ...+.+.+|+.++++++||||+++++++.. .+.+++|
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 345688999999999999999999984 778999998654 455789999999999999999999999865 4568999
Q ss_pred EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCC
Q 023058 96 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 173 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~ 173 (288)
|||+++++|.+++.... .++...++.++.||+.||.|||+.+++||||+|+||+++.++. ++++|||++......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST- 156 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC--------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecCCC-
Confidence 99999999999986543 5899999999999999999999999999999999999998877 999999998754332
Q ss_pred CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHH
Q 023058 174 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 252 (288)
Q Consensus 174 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 252 (288)
.....+++.|+|||.+.+..++.+ +||||||+++|||++ |..||...+.......... ...+.++. .+++.+
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~-sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~---~~~~~~~~--~~~~~~ 229 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPD--GCPPAV 229 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT---TCCCCCCT--TCCHHH
T ss_pred -CccccccccCCChHHHhCCCCChH-HHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---CCCCCCCc--cCCHHH
Confidence 334467889999999988888766 999999999999998 6788876654443333211 12334443 789999
Q ss_pred HHHHHHhcccCcCCccccccccccch
Q 023058 253 RHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 253 ~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
++||.+||+.||.+|||+.++++.+.
T Consensus 230 ~~li~~cl~~dP~~Rps~~~l~~~L~ 255 (262)
T d1byga_ 230 YEVMKNCWHLDAAMRPSFLQLREQLE 255 (262)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 99999999999999999999877543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-52 Score=339.44 Aligned_cols=250 Identities=23% Similarity=0.347 Sum_probs=197.6
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCC---CcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeEE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKT---EELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 93 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (288)
..++|++.+.||+|+||+||+|.+..+ +..||+|.+.... ...+.+.+|+.++++++||||+++++++. ++.++
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 357999999999999999999998654 3568888876432 33456889999999999999999999985 56789
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 94 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
+||||+++++|..++.. ...+++..++.++.||+.||.|||+.|++||||||+||+++.++. +||+|||++......
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC----------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccCC
Confidence 99999999999987755 446999999999999999999999999999999999999998877 999999999755433
Q ss_pred CC--CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCC
Q 023058 173 SQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 249 (288)
Q Consensus 173 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
.. .....+++.|+|||.+.+..++.+ +||||||+++|||++ |..||...+........ ... ...+.+..+|
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~-~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i----~~~-~~~~~~~~~~ 235 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENG-ERLPMPPNCP 235 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTT-CCCCCCTTCC
T ss_pred cceeccceecCcccchhhHhccCCCCCc-cccccchHHHHHHHhcCCCCCCCCCHHHHHHHH----HcC-CCCCCCCCCC
Confidence 22 234457889999999988888776 999999999999997 89999877654444333 222 2223344799
Q ss_pred HHHHHHHHHhcccCcCCccccccccccc
Q 023058 250 PECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 250 ~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
+++.+||.+||+.||.+|||+.++++.+
T Consensus 236 ~~~~~li~~cl~~dp~~Rps~~ei~~~L 263 (273)
T d1mp8a_ 236 PTLYSLMTKCWAYDPSRRPRFTELKAQL 263 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 9999999999999999999999998754
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-51 Score=342.70 Aligned_cols=264 Identities=25% Similarity=0.326 Sum_probs=207.0
Q ss_pred CCCCCCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecC---ccchHHHHHHHHHHhhCCCCceeeEeEEEEc---
Q 023058 15 PIMHDSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT--- 88 (288)
Q Consensus 15 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 88 (288)
|-+...++|+++++||+|+||+||+|++..+|+.||||++... .....++.+|+.++++++|||++++++++..
T Consensus 4 ~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 4 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83 (318)
T ss_dssp TTSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred CCCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence 4456679999999999999999999999999999999998643 3344678899999999999999999999865
Q ss_pred -----CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeec
Q 023058 89 -----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (288)
Q Consensus 89 -----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df 163 (288)
+...+++||++.++.+.........++...++.+++|++.||.|||+.||+||||||+||+++.++. ++++||
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~df 161 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADF 161 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCC
T ss_pred cccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeec
Confidence 3468999999988766666566678999999999999999999999999999999999999988877 999999
Q ss_pred CCCcccccCC-----CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc
Q 023058 164 GYSKSSVLHS-----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 238 (288)
Q Consensus 164 ~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (288)
|++....... ......+|+.|+|||.+.+......++||||+||++|+|++|..||...+...............
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9986443322 22334689999999998766433344999999999999999999998765544444333322211
Q ss_pred ccCCCCC--------------------------CCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 239 QYSIPDY--------------------------VHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 239 ~~~~~~~--------------------------~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
....... ...++++.+||.+||++||.+|||+.|+++ |+||+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~---Hpff~ 309 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN---HDFFW 309 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH---SGGGS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc---Chhhc
Confidence 1110000 013667889999999999999999988865 77764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=342.24 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=208.1
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcCCCcE--EEEEEeecC--ccchHHHHHHHHHHhhC-CCCceeeEeEEEEcCCeE
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKKTEEL--VAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~--~~iK~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (288)
++.++|++.+.||+|+||+||+|.+..++.. ||||.+... ....+.+.+|+++++++ +||||+++++++..++.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 4568999999999999999999999887764 677776543 33445789999999998 799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCC
Q 023058 93 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 156 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~ 156 (288)
++||||+++++|.++++.. ..++...+..++.||+.||.|||+.|++||||||+||+++.++.
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~- 165 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV- 165 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC-
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc-
Confidence 9999999999999998654 46899999999999999999999999999999999999988876
Q ss_pred CEEEeecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCC-CCCCCCCCchhHHHHHHHH
Q 023058 157 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEEPKNFRKTIHRI 235 (288)
Q Consensus 157 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~-~pf~~~~~~~~~~~~~~~~ 235 (288)
+||+|||++.............++..|+|||.+.+..++.+ +||||||+++|+|++|. .||...+. ......+
T Consensus 166 -~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~~~~~p~~~~~~----~~~~~~i 239 (309)
T d1fvra_ 166 -AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEKL 239 (309)
T ss_dssp -EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHHG
T ss_pred -eEEccccccccccccccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHhcCCCCCCCCCH----HHHHHHH
Confidence 99999999986666666666678999999999998888776 99999999999999976 46665432 2233333
Q ss_pred hhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
... ...+.+..+++++.+||.+||+.||.+|||+.++++.|
T Consensus 240 ~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 240 PQG-YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp GGT-CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred Hhc-CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 332 23333447899999999999999999999999998753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=344.56 Aligned_cols=260 Identities=30% Similarity=0.508 Sum_probs=218.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEE---cCCCcEEEEEEeecC-----ccchHHHHHHHHHHhhCCC-CceeeEeEEEEcCC
Q 023058 20 SDRYELVRDIGSGNFGVARLMRD---KKTEELVAVKYIERG-----DKIDENVQREIINHRSLRH-PNIVRFKEVILTPT 90 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~---~~~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~ 90 (288)
.++|++++.||+|+||+||+|.+ +.+|+.||+|++... ....+.+.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 37899999999999999999987 346899999998643 2344678899999999976 89999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccc
Q 023058 91 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 170 (288)
Q Consensus 91 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~ 170 (288)
.++++||++.+++|.+.+...+.+++..+..++.||+.||+|||++|++||||||+||+++.++. ++|+|||++....
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECC
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhhhc
Confidence 99999999999999999999989999999999999999999999999999999999999988776 9999999986543
Q ss_pred cC--CCCCCCcCCCcccCCccccCcc-cCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 171 LH--SQPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 171 ~~--~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
.. .......+++.|++||.+.+.. +...++|||||||++|+|++|..||......................++. .
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~--~ 258 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--E 258 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--T
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc--c
Confidence 32 2334567899999999987654 23444999999999999999999999887777777777666666665555 7
Q ss_pred CCHHHHHHHHHhcccCcCCccccc--cccccchhhhhh
Q 023058 248 ISPECRHLISRIFVADPAKVSMHF--HATGVYMHTKLQ 283 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~--~~l~~~~~~~~~ 283 (288)
+++++.+||.+||++||.+|||+. .+-+.+.|+|++
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~ 296 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhc
Confidence 899999999999999999999642 123345577764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-51 Score=345.89 Aligned_cols=257 Identities=24% Similarity=0.364 Sum_probs=202.3
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC-----
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT----- 90 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 90 (288)
..++|++++.||+|+||+||+|.+..+|+.||+|++.... ...+.+.+|+.++++++||||+++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3589999999999999999999999999999999987543 33456889999999999999999999998654
Q ss_pred -eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccc
Q 023058 91 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 169 (288)
Q Consensus 91 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~ 169 (288)
.+++||||+ +.+|..... .+++++..++.++.||+.||+|||++||+||||||+||+++.++. ++++|||++...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceecc
Confidence 579999999 556766654 467999999999999999999999999999999999999988877 999999999754
Q ss_pred ccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc-----------
Q 023058 170 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV----------- 238 (288)
Q Consensus 170 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 238 (288)
.. ......+++.|+|||.+.+..+...++||||+||++|+|++|..||...+...............
T Consensus 172 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 172 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred CC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 33 33456789999999998876665555999999999999999999998765443333222211100
Q ss_pred --------ccCCC------CCCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 239 --------QYSIP------DYVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 239 --------~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
..... ....+++++.+||.+||+.||.+|||+.|+++ |+|++-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~---Hp~f~~ 306 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA---HPYFES 306 (346)
T ss_dssp HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH---SGGGTT
T ss_pred hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc---ChhhCc
Confidence 00000 12357899999999999999999999988865 666653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=343.06 Aligned_cols=257 Identities=28% Similarity=0.424 Sum_probs=201.7
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc--cchHHHHHHHHHHhhCCCCceeeEeEEEEcCC-----eE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HL 92 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 92 (288)
.++|++++.||+|+||+||+|.+..+++.||||++.... ...+.+.+|++++++++|||++++++++.... .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 478999999999999999999999999999999987543 33456889999999999999999999987643 34
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccC
Q 023058 93 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 172 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~ 172 (288)
++++ ++.+++|.+++... .+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||++......
T Consensus 87 ~l~~-~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVT-HLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPD 162 (345)
T ss_dssp EEEE-ECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGG
T ss_pred EEEE-eecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccCC
Confidence 5555 55688999998654 6999999999999999999999999999999999999987776 999999998754443
Q ss_pred CC----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhc----------
Q 023058 173 SQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------- 238 (288)
Q Consensus 173 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 238 (288)
.. .....+++.|+|||.+........++||||+|+++|+|++|..||...+..+............
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 22 3455689999999998666555555999999999999999999998765433332222111000
Q ss_pred ------ccCCCC---------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhh
Q 023058 239 ------QYSIPD---------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQ 283 (288)
Q Consensus 239 ------~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~ 283 (288)
....+. ...+++++.+||.+||+.||.+|||+.|+++ |+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~---hpf~~ 299 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA---HPYLE 299 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT---SGGGT
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc---CHhhc
Confidence 000110 2356789999999999999999999988876 66655
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-51 Score=339.84 Aligned_cols=250 Identities=19% Similarity=0.307 Sum_probs=201.2
Q ss_pred CCCCeeeeeeeeccCceEEEEEEEcCCCc----EEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 19 DSDRYELVRDIGSGNFGVARLMRDKKTEE----LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 19 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
..+.|++++.||+|+||+||+|.+..+|+ +||+|.+... ....+.+.+|+.++++++||||+++++++..+ ..
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 44679999999999999999999987765 5888887643 34456799999999999999999999999865 45
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 93 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
+++++++.+++|.+.+... ..++...++.++.||+.||+|||+.||+||||||+||+++.++. +||+|||++.....
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceeccc
Confidence 6778888888998877654 57999999999999999999999999999999999999998876 99999999876544
Q ss_pred CCCC---CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHHhhcccCCCCCCC
Q 023058 172 HSQP---KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 247 (288)
Q Consensus 172 ~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
.... ....+|+.|+|||.+.+..++.+ +||||||+++|||++ |..||...+........ .. ....+.+..
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i----~~-~~~~~~p~~ 237 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----EK-GERLPQPPI 237 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH----HH-TCCCCCCTT
T ss_pred ccccccccccccCccccChHHHhcCCCChh-hhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH----Hc-CCCCCCCcc
Confidence 3322 23357899999999988888766 999999999999998 78888876543333222 11 222333347
Q ss_pred CCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 248 ISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 248 ~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
+|+++.+||.+||+.||.+|||+.++++.+
T Consensus 238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 238 CTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 899999999999999999999999988744
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-51 Score=337.05 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=205.2
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcCCC-------cEEEEEEeecCcc--chHHHHHHHHHHhhC-CCCceeeEeEEE
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKKTE-------ELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI 86 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-------~~~~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 86 (288)
.+..++|++.+.||+|+||.||+|++..++ ..||+|++..+.. ....+.+|...+.++ +||||+++++++
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 345689999999999999999999976543 4799999876543 345678898888888 799999999999
Q ss_pred EcCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEe
Q 023058 87 LTPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (288)
Q Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv 150 (288)
.+++..++||||+++++|.+++... ..++..+++.++.||+.||+|||+.||+||||||+||++
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 9999999999999999999998644 248999999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCch
Q 023058 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (288)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~ 226 (288)
+.++. +||+|||++........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||.......
T Consensus 169 ~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 169 TEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp CTTCC--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred cCCCC--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch-hhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 98877 99999999885544332 344568889999999988888777 999999999999998 688887654322
Q ss_pred hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
....+. .....+.+..+++++.+||.+||+.||.+|||+.|+++.+
T Consensus 246 ----~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 246 ----LFKLLK-EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp ----HHHHHH-TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ----HHHHHH-cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 222222 2333344447899999999999999999999999998854
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-51 Score=339.76 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=206.5
Q ss_pred CCCeeeeeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCcc--chHHHHHHHHHHhhCCCCceeeEeEEEEcCCeE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 92 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (288)
.++|++.+.||+|+||+||+|+.. .++..||||++..... ..+++.+|++++++++||||+++++++......
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 468999999999999999999975 3567899999875432 345689999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCce
Q 023058 93 AIVMEYASGGELFERICNAG------------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 148 (288)
Q Consensus 93 ~lv~e~~~~~~L~~~~~~~~------------------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~ni 148 (288)
+++||++.+++|.+++.... .++..+++.++.|++.||+|||+.|++||||||+||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence 99999999999999886432 378899999999999999999999999999999999
Q ss_pred EecCCCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCC-CCCCCCCC
Q 023058 149 LLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEE 224 (288)
Q Consensus 149 lv~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~-~pf~~~~~ 224 (288)
+++.++. +||+|||++........ .....+++.|+|||.+.+..++.+ +||||||+++|||++|. .||.....
T Consensus 172 Lld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~k-sDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 172 LVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp EECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred EECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChh-hhhccchhhHHHHHccCCCCCCCCCH
Confidence 9988776 99999999875433322 234567889999999998888766 99999999999999986 56766544
Q ss_pred chhHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 225 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.+... .+.... ..+.+..+|+++.+||.+||+.||.+|||+.|+++.+.
T Consensus 249 ~e~~~----~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 249 EEVIY----YVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp HHHHH----HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHH----HHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 33322 233332 22233478999999999999999999999999876443
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=335.53 Aligned_cols=253 Identities=22% Similarity=0.339 Sum_probs=196.5
Q ss_pred CCCCCeeeeeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCc--cchHHHHHHHHHHhhC-CCCceeeEeEEEEcC
Q 023058 18 HDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTP 89 (288)
Q Consensus 18 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (288)
+..++|++.+.||+|+||.||+|.+.. +++.||+|++.... ...+.+.+|...+.++ +|+||+.+++++..+
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 345789999999999999999999754 34689999987543 3334567777777776 689999999988664
Q ss_pred -CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecC
Q 023058 90 -THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 152 (288)
Q Consensus 90 -~~~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~ 152 (288)
..+++||||+++++|.+++... ..+++.++..++.||+.||+|||++||+||||||+||+++.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 4689999999999999998643 24889999999999999999999999999999999999988
Q ss_pred CCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhC-CCCCCCCCCchhH
Q 023058 153 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNF 228 (288)
Q Consensus 153 ~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g-~~pf~~~~~~~~~ 228 (288)
++. +||+|||+++....... .....+|+.|+|||.+.+..++.+ +||||+|+++|+|++| ..||........+
T Consensus 170 ~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gvil~ellt~~~~p~~~~~~~~~~ 246 (299)
T d1ywna1 170 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246 (299)
T ss_dssp GGC--EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCc--EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcc-cceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 777 99999999975433322 234568999999999988888766 9999999999999986 4678766554444
Q ss_pred HHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 229 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
...... ....+....+++++.++|.+||+.||.+|||+.|+++.+
T Consensus 247 ~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L 291 (299)
T d1ywna1 247 CRRLKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291 (299)
T ss_dssp HHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhc----CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 433322 222233337899999999999999999999999998743
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=342.97 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=195.5
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcC------Ce
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------TH 91 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 91 (288)
++|++++.||+|+||+||+|.+..+|+.||+|++.... ....++.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 78999999999999999999999999999999997643 3334688999999999999999999999643 68
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
+|+||||+.++ +...+ ...+++..++.+++||+.||.|||++||+||||||+||+++.++. ++++|||++.....
T Consensus 97 ~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT 171 (355)
T ss_dssp EEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC------
T ss_pred eEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhcccc
Confidence 89999999764 44444 346899999999999999999999999999999999999988777 99999999887777
Q ss_pred CCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhh--------------
Q 023058 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-------------- 237 (288)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------- 237 (288)
........+|+.|+|||.+.+..++.+ +||||+||++++|++|..||...+..............
T Consensus 172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 172 SFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ---------CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred ccccccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 666677789999999999998888777 99999999999999999999876544433333222111
Q ss_pred ----cccCCCC------------------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 238 ----VQYSIPD------------------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 238 ----~~~~~~~------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
....... ....++++.+||++||+.||.+|||++|+++ |+|++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~---Hpw~~~ 316 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ---HPYINV 316 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT---STTTGG
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc---CcccCC
Confidence 1100000 0113567899999999999999999999876 666554
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=332.86 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=210.8
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEc-----CCCcEEEEEEeecCcc--chHHHHHHHHHHhhC-CCCceeeEeEEEEc
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDK-----KTEELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT 88 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (288)
.+..++|++.+.||+|+||.||+|+.. .+++.||+|++..... ....+.+|+.+++++ +||||+++++++..
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 345689999999999999999999863 4667899999976543 334678999999999 69999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEe
Q 023058 89 PTHLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 150 (288)
Q Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv 150 (288)
+...+++|||+++++|.+++.... .++...+..++.||+.|++|||++|++||||||+||++
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 999999999999999999986543 58899999999999999999999999999999999999
Q ss_pred cCCCCCCEEEeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHh-CCCCCCCCCCch
Q 023058 151 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPK 226 (288)
Q Consensus 151 ~~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~-g~~pf~~~~~~~ 226 (288)
+.++. ++++|||.+........ .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||.......
T Consensus 179 ~~~~~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 179 THGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp ETTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cccCc--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCc-ccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 87776 99999999875543322 233467899999999988888776 999999999999998 555565655544
Q ss_pred hHHHHHHHHhhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccchh
Q 023058 227 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYMH 279 (288)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~ 279 (288)
.+.+.... .........+|+++.+||.+||++||.+|||+.++++.+.+
T Consensus 256 ~~~~~i~~----~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 256 KFYKMIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHHHHHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhc----CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 44444322 22233334689999999999999999999999999885443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=341.99 Aligned_cols=257 Identities=24% Similarity=0.393 Sum_probs=204.5
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc---cchHHHHHHHHHHhhCCCCceeeEeEEEEcC-----Ce
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP-----TH 91 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 91 (288)
+++|++++.||+|+||+||+|++..+|+.||||++.... ...+++.+|++++++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 578999999999999999999999999999999987643 2335678999999999999999999998643 23
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCccccc
Q 023058 92 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 171 (288)
Q Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~ 171 (288)
.+++++++.+++|.+++.. +++++.+++.++.||+.||+|||++||+||||||+||+++.++. ++++|||.+....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTD- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCT-
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhcccC-
Confidence 4556667778899998854 57999999999999999999999999999999999999988877 9999999987443
Q ss_pred CCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcc------------
Q 023058 172 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------------ 239 (288)
Q Consensus 172 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 239 (288)
.......+++.|+|||.+.+..+...++|+||||+++|+|++|..||...+................
T Consensus 173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (348)
T d2gfsa1 173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251 (348)
T ss_dssp -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence 2334566888999999987776655559999999999999999999987665444443332211110
Q ss_pred -------cCCCC------CCCCCHHHHHHHHHhcccCcCCccccccccccchhhhhhh
Q 023058 240 -------YSIPD------YVHISPECRHLISRIFVADPAKVSMHFHATGVYMHTKLQL 284 (288)
Q Consensus 240 -------~~~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~~~ 284 (288)
...+. ...+++++.+||.+||+.||.+|||+.|+++ |+|++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~---Hp~f~~ 306 (348)
T d2gfsa1 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA---HAYFAQ 306 (348)
T ss_dssp HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT---SGGGTT
T ss_pred hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc---CHhhCC
Confidence 00000 1357899999999999999999999988865 777764
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-49 Score=328.74 Aligned_cols=258 Identities=22% Similarity=0.196 Sum_probs=201.4
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCc-eeeEeEEEEcCCeEEEEEecc
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEYA 99 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~ 99 (288)
++|++.+.||+|+||+||+|++..+++.||+|++.... ..+.+..|++++++++|++ ++.+.+++...+..++|||++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 68999999999999999999999999999999877643 3356889999999997665 556667777888999999999
Q ss_pred CCCchHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCC-CCCCEEEeecCCCcccccCCC---
Q 023058 100 SGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ--- 174 (288)
Q Consensus 100 ~~~~L~~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~-~~~~~~l~df~~~~~~~~~~~--- 174 (288)
++ ++...+ .....++...+..++.|++.||+|||++||+||||||+||+++.. ....++|+|||++........
T Consensus 86 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (299)
T d1ckia_ 86 GP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164 (299)
T ss_dssp CC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred CC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence 55 555554 445679999999999999999999999999999999999998532 233599999999975543322
Q ss_pred -----CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC---CCC
Q 023058 175 -----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP---DYV 246 (288)
Q Consensus 175 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 246 (288)
.....||+.|+|||.+.+..++.+ +|||||||++|+|++|..||............... .......+ ...
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 242 (299)
T d1ckia_ 165 IPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI-SEKKMSTPIEVLCK 242 (299)
T ss_dssp CCCCBCCSCCCCSSSCCHHHHTTBCCCHH-HHHHHHHHHHHHHHHSSCTTCCCC-------HHHH-HHHHHHSCHHHHTT
T ss_pred eeccccCCcCCCccccCHHHHhCCCCCCh-hhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh-hcccCCCChhHhcc
Confidence 234568999999999998888766 99999999999999999999876554333222111 11111111 123
Q ss_pred CCCHHHHHHHHHhcccCcCCccccccccccchhhhh
Q 023058 247 HISPECRHLISRIFVADPAKVSMHFHATGVYMHTKL 282 (288)
Q Consensus 247 ~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~~~~~ 282 (288)
.+|+++.++|.+||+.+|.+||++.++.+.+.+.+.
T Consensus 243 ~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 689999999999999999999999888776655544
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=328.72 Aligned_cols=254 Identities=18% Similarity=0.258 Sum_probs=207.6
Q ss_pred CCCCCCeeeeeeeeccCceEEEEEEEcC-----CCcEEEEEEeecCccc--hHHHHHHHHHHhhCCCCceeeEeEEEEcC
Q 023058 17 MHDSDRYELVRDIGSGNFGVARLMRDKK-----TEELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTP 89 (288)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (288)
.+..++|++.+.||+|+||+||+|.+.. ++..||||++...... ...+.+|++++++++||||+++++++..+
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 3446899999999999999999998752 3578999998754322 23578999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEE
Q 023058 90 THLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 159 (288)
Q Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~ 159 (288)
...++|||++++++|.+++... ..++...+..++.|++.||.|||+.+|+||||||+||+++.+.. +|
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~K 173 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VK 173 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EE
Confidence 9999999999999999887532 24688999999999999999999999999999999999987776 99
Q ss_pred EeecCCCcccccCCC---CCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCC-CCCCCCCCchhHHHHHHHH
Q 023058 160 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEEPKNFRKTIHRI 235 (288)
Q Consensus 160 l~df~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~-~pf~~~~~~~~~~~~~~~~ 235 (288)
|+|||++........ .....+++.|+|||.+.+..++.+ +|+||||+++|||++|. .||...+..... ..+
T Consensus 174 l~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~-~Dv~S~G~il~El~t~~~~p~~~~~~~~~~----~~i 248 (308)
T d1p4oa_ 174 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVL----RFV 248 (308)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHH----HHH
T ss_pred EeecccceeccCCcceeeccceecccccCCHHHHccCCCCcc-cccccHHHHHHHHHhCCCCCCCCCCHHHHH----HHH
Confidence 999999975443332 233457899999999988888766 99999999999999985 677655433322 222
Q ss_pred hhcccCCCCCCCCCHHHHHHHHHhcccCcCCccccccccccch
Q 023058 236 LSVQYSIPDYVHISPECRHLISRIFVADPAKVSMHFHATGVYM 278 (288)
Q Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~~ 278 (288)
.... ..+....+|+.+.++|.+||+.||.+|||+.++++.+.
T Consensus 249 ~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~ 290 (308)
T d1p4oa_ 249 MEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290 (308)
T ss_dssp HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred HhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 3322 22233478999999999999999999999999987443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-49 Score=325.99 Aligned_cols=245 Identities=20% Similarity=0.229 Sum_probs=196.4
Q ss_pred eeeeeccCceEEEEEEEcCCC---cEEEEEEeecC--ccchHHHHHHHHHHhhCCCCceeeEeEEEEc-CCeEEEEEecc
Q 023058 26 VRDIGSGNFGVARLMRDKKTE---ELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVMEYA 99 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~---~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~ 99 (288)
.+.||+|+||+||+|.+..++ ..||||.+... ....+++.+|++++++++||||+++++++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 678999999999999986543 36899998643 3344679999999999999999999999765 56899999999
Q ss_pred CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeecCCCcccccCCCC---
Q 023058 100 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--- 175 (288)
Q Consensus 100 ~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~~~~~~~~~--- 175 (288)
++++|.+++.... .++...+..++.|++.||.|||+.||+||||||+||+++.++. +||+|||++.........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~~~ 189 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVH 189 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCCTT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhccccccccce
Confidence 9999999887544 5788899999999999999999999999999999999988776 999999999755433222
Q ss_pred --CCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCCCCCCCCHHHH
Q 023058 176 --KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 253 (288)
Q Consensus 176 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 253 (288)
....+++.|+|||.+.+..++.+ +||||||+++|||++|..||........... .+..+. .......+++++.
T Consensus 190 ~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~~~~~~~~~~~---~i~~g~-~~~~p~~~~~~l~ 264 (311)
T d1r0pa_ 190 NKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQGR-RLLQPEYCPDPLY 264 (311)
T ss_dssp CTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCC------CHH---HHHTTC-CCCCCTTCCHHHH
T ss_pred ecccccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH---HHHcCC-CCCCcccCcHHHH
Confidence 22457889999999988888776 9999999999999998888765433222222 222222 2223347899999
Q ss_pred HHHHHhcccCcCCccccccccccc
Q 023058 254 HLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 254 ~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
+||.+||+.||.+|||+.|+++.+
T Consensus 265 ~li~~cl~~dP~~RPs~~ei~~~L 288 (311)
T d1r0pa_ 265 EVMLKCWHPKAEMRPSFSELVSRI 288 (311)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHH
Confidence 999999999999999999998753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.9e-48 Score=319.72 Aligned_cols=252 Identities=21% Similarity=0.229 Sum_probs=204.7
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCC-CceeeEeEEEEcCCeEEEEEec
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
+++|++.+.||+|+||+||+|++..+++.||+|++.... ..+.+.+|++.++.+.| +|++.+++++..+...++|||+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 589999999999999999999999999999999876543 34567889999999965 8999999999999999999999
Q ss_pred cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCC---CCCCEEEeecCCCcccccCC-
Q 023058 99 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS---PAPRLKICDFGYSKSSVLHS- 173 (288)
Q Consensus 99 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~---~~~~~~l~df~~~~~~~~~~- 173 (288)
+ +++|.+.+...+ .++..++..++.|++.||++||+.||+||||||+||+++.+ ..+.++|+|||+++......
T Consensus 83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 9 569988886654 69999999999999999999999999999999999999742 23459999999997543321
Q ss_pred -------CCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchhHHHHHHHHhhcccCCC---
Q 023058 174 -------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--- 243 (288)
Q Consensus 174 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--- 243 (288)
......||+.|+|||.+.+..++.+ +||||||+++|+|++|..||............. .+.......+
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~-~i~~~~~~~~~~~ 239 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE-RIGEKKQSTPLRE 239 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH-HHHHHHHHSCHHH
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChH-HHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH-HHHhccCCCChHH
Confidence 2234569999999999998888766 999999999999999999998765543332221 1111111111
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCccccccccc
Q 023058 244 DYVHISPECRHLISRIFVADPAKVSMHFHATG 275 (288)
Q Consensus 244 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~ 275 (288)
-...+|+++.+++..|++.+|.+||+...+.+
T Consensus 240 l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 12368999999999999999999999876655
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-48 Score=319.12 Aligned_cols=252 Identities=22% Similarity=0.257 Sum_probs=191.9
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCceeeEeEEEEcCC----eEEEE
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIV 95 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv 95 (288)
.+.|.+.+.||+|+||+||+|+. +|..||+|++............|+..+++++||||+++++++..++ .+++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 36799999999999999999987 5889999998765443333444555667789999999999997653 68999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh--------cCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 96 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~--------~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
|||+++++|.+++... .++...++.++.|++.||.|||+ .||+||||||+||+++.++. +||+|||++.
T Consensus 80 ~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCE
T ss_pred EecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCccc
Confidence 9999999999999764 68999999999999999999996 59999999999999988776 9999999987
Q ss_pred ccccCC-----CCCCCcCCCcccCCccccCcc------cCCCccchhhHHHHHHHHHhCCCCCCCCCCc-----------
Q 023058 168 SSVLHS-----QPKSTVGTPAYIAPEVLLKKE------YDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----------- 225 (288)
Q Consensus 168 ~~~~~~-----~~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~----------- 225 (288)
...... ......+|+.|+|||.+.+.. ++.+ +||||||+++|||++|..||......
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k-~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHH-HHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcc-hhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 554332 223456899999999986543 3333 89999999999999998877532211
Q ss_pred hhHHHHHHHHhhccc--CCCC---CCCCCHHHHHHHHHhcccCcCCccccccccccc
Q 023058 226 KNFRKTIHRILSVQY--SIPD---YVHISPECRHLISRIFVADPAKVSMHFHATGVY 277 (288)
Q Consensus 226 ~~~~~~~~~~~~~~~--~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~~ 277 (288)
............... .++. ....+..+.+|+.+||+.||.+|||+.|+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L 292 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 112222222222221 1111 111234689999999999999999999987754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-44 Score=305.81 Aligned_cols=260 Identities=23% Similarity=0.323 Sum_probs=194.4
Q ss_pred CCCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCC-----------CCceeeEeEEEEc
Q 023058 20 SDRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVILT 88 (288)
Q Consensus 20 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~~ 88 (288)
.++|+++++||+|+||+||+|++..+|+.||||++.......+...+|+.+++.++ |+||+++++++..
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35799999999999999999999999999999999877666677888999888774 5789999998865
Q ss_pred C--CeEEEEEeccCCCchH-HHH--HhcCCCCHHHHHHHHHHHHHHHHHHhh-cCceecCCCCCceEecCCCC----CCE
Q 023058 89 P--THLAIVMEYASGGELF-ERI--CNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPA----PRL 158 (288)
Q Consensus 89 ~--~~~~lv~e~~~~~~L~-~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~i~H~dl~p~nilv~~~~~----~~~ 158 (288)
. ...++++.++...... ... .....+++..++.++.||+.||.+||+ .||+||||||+||+++.++. ..+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 3 4566666665444332 222 234578999999999999999999997 89999999999999976543 248
Q ss_pred EEeecCCCcccccCCCCCCCcCCCcccCCccccCcccCCCccchhhHHHHHHHHHhCCCCCCCCCCchh------HHHHH
Q 023058 159 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN------FRKTI 232 (288)
Q Consensus 159 ~l~df~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~~~~l~~g~~pf~~~~~~~~------~~~~~ 232 (288)
+++|||.+.... .......+++.|+|||.+.+..++.+ +|+||+|+++++|++|..||........ .....
T Consensus 172 kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~ 248 (362)
T d1q8ya_ 172 KIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248 (362)
T ss_dssp EECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred eEeecccccccc--cccccccccccccChhhccccCCCcc-ccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence 999999987443 33456679999999999998888776 9999999999999999999975433111 11111
Q ss_pred HHHhh--------------------cccCCC----------------CCCCCCHHHHHHHHHhcccCcCCcccccccccc
Q 023058 233 HRILS--------------------VQYSIP----------------DYVHISPECRHLISRIFVADPAKVSMHFHATGV 276 (288)
Q Consensus 233 ~~~~~--------------------~~~~~~----------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~~l~~ 276 (288)
..+.. ...... .....++++.+||.+||.+||.+|||+.|+++
T Consensus 249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~- 327 (362)
T d1q8ya_ 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN- 327 (362)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT-
T ss_pred HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc-
Confidence 00000 000000 01123578999999999999999999988865
Q ss_pred chhhhhhhh
Q 023058 277 YMHTKLQLL 285 (288)
Q Consensus 277 ~~~~~~~~~ 285 (288)
|+||+.+
T Consensus 328 --Hp~f~~~ 334 (362)
T d1q8ya_ 328 --HPWLKDT 334 (362)
T ss_dssp --CGGGTTC
T ss_pred --CcccCCC
Confidence 7777643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.2e-25 Score=173.39 Aligned_cols=164 Identities=15% Similarity=0.143 Sum_probs=119.7
Q ss_pred eeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCcc-------------------chHHHHHHHHHHhhCCCCceeeEe
Q 023058 23 YELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDK-------------------IDENVQREIINHRSLRHPNIVRFK 83 (288)
Q Consensus 23 y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------------------~~~~~~~e~~~l~~l~~~~i~~~~ 83 (288)
+.+.++||+|+||+||+|.+. +|+.||+|++..+.. ......+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468899999999999999986 688999998753211 112345688899999999999887
Q ss_pred EEEEcCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCceecCCCCCceEecCCCCCCEEEeec
Q 023058 84 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 163 (288)
Q Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~i~H~dl~p~nilv~~~~~~~~~l~df 163 (288)
++.. .+++||++++..+.. ++......++.|++.++.+||+.||+||||||+||+++.++ ++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCC
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEEC
Confidence 6642 279999998765432 44556678999999999999999999999999999998544 899999
Q ss_pred CCCcccccCCCCCCCcCCCcccCCc-----cccCcccCCCccchhhHHHHH
Q 023058 164 GYSKSSVLHSQPKSTVGTPAYIAPE-----VLLKKEYDGKIADVWSCGVTL 209 (288)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~aPE-----~~~~~~~~~~~~Di~slG~~~ 209 (288)
|.+.....+.. ..|.... .+....+... +|+||+.-.+
T Consensus 147 G~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~-~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGW-------REILERDVRNIITYFSRTYRTE-KDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCC-CCHHHHHHHH
T ss_pred CCcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCc-ccHHHHHHHH
Confidence 98864322111 0111110 1224556666 8999976544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.84 E-value=1.6e-08 Score=79.96 Aligned_cols=138 Identities=17% Similarity=0.129 Sum_probs=93.0
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCc-cchHHHHHHHHHHhhCC-CCceeeEeEEEEcCCeEEEEEec
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEY 98 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~ 98 (288)
++|+.++..+.++.+.||++.. ++..+++|...... .....+.+|...+..+. +--+++++.+...++..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 5677777655555678998864 45567888776543 34446788888887764 33367788888888899999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------------
Q 023058 99 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS------------------------------------------- 135 (288)
Q Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~------------------------------------------- 135 (288)
+++.++...... ......++.++...+..||+
T Consensus 92 l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 92 ADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp CSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred cccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 988776543211 11122234444444444442
Q ss_pred ----------------cCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 136 ----------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 136 ----------------~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
..++|+|+.|.||+++.++. +.|+||+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~--~~lIDwe~a~ 212 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV--SGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCce--EEEeechhcc
Confidence 23899999999999986543 5699998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.53 E-value=3e-07 Score=72.06 Aligned_cols=73 Identities=14% Similarity=0.054 Sum_probs=51.6
Q ss_pred eeccC-ceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCC--CceeeEeEEEEcCCeEEEEEeccCCCch
Q 023058 29 IGSGN-FGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGGEL 104 (288)
Q Consensus 29 lg~g~-~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~L 104 (288)
+..|. .+.||++... ++..+++|...... ...+..|...++.+.. -.+++++.+..+++..++||+++++.++
T Consensus 18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECT-TSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeC-CCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 33444 4689999865 46668889765443 3457778887776643 3366788888888899999999987655
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.46 E-value=6.8e-07 Score=74.69 Aligned_cols=77 Identities=17% Similarity=0.105 Sum_probs=49.9
Q ss_pred eeeeeccCceEEEEEEEcCCCcEEEEEEeecC--------ccchHHHHHHHHHHhhCC--CC-ceeeEeEEEEcCCeEEE
Q 023058 26 VRDIGSGNFGVARLMRDKKTEELVAVKYIERG--------DKIDENVQREIINHRSLR--HP-NIVRFKEVILTPTHLAI 94 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~--------~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~l 94 (288)
.+.||.|....||++.+..+++.+++|.-.+. .....+...|.+.++.+. .| .+++++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56789999999999998888889999975421 123345667888877663 23 35555543 4455688
Q ss_pred EEeccCCCch
Q 023058 95 VMEYASGGEL 104 (288)
Q Consensus 95 v~e~~~~~~L 104 (288)
+||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.82 E-value=5.2e-05 Score=61.26 Aligned_cols=130 Identities=12% Similarity=0.058 Sum_probs=78.0
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCcee--eEe-----EEEEcCCeEEEEEeccCCCchH
Q 023058 33 NFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNIV--RFK-----EVILTPTHLAIVMEYASGGELF 105 (288)
Q Consensus 33 ~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~--~~~-----~~~~~~~~~~lv~e~~~~~~L~ 105 (288)
....||+++.. +|..|++|+..++....+.+..|...+..+...++. ..+ ..+..++..+.++++++|..+.
T Consensus 34 ~EN~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 34 YENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ccceeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 34689999875 578899998877766777888898888777422222 111 1123456788899998764321
Q ss_pred -----H------HH---Hh---c------CCCC-------------------H---HHHHHHHHHHHHHHHHHh----hc
Q 023058 106 -----E------RI---CN---A------GRFS-------------------E---DEARFFFQQLISGVSYCH----SM 136 (288)
Q Consensus 106 -----~------~~---~~---~------~~~~-------------------~---~~~~~i~~~i~~~l~~LH----~~ 136 (288)
. .+ +. . ...+ . ......+.++...+...- ..
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 11 10 0 0111 1 112223333333333321 24
Q ss_pred CceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 137 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 137 ~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
+++|+|+.+.||+++. + ..++||+-++
T Consensus 193 ~liHgDlh~~NvL~~~-~---~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G---PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESS-S---EEECCCTTCC
T ss_pred eeecCCCCcccEEEeC-C---ceEEechhcc
Confidence 6899999999999963 3 4589999776
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.67 E-value=0.00017 Score=59.84 Aligned_cols=74 Identities=14% Similarity=0.152 Sum_probs=50.7
Q ss_pred eeeeeccCceEEEEEEEcC-------CCcEEEEEEeecCccchHHHHHHHHHHhhCCCCce-eeEeEEEEcCCeEEEEEe
Q 023058 26 VRDIGSGNFGVARLMRDKK-------TEELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVME 97 (288)
Q Consensus 26 ~~~lg~g~~~~v~~~~~~~-------~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e 97 (288)
++.|+.|-.-.+|++.... ..+.|+++++. .....-...+|..+++.+.-.++ +++++++.. +.|++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4678878888999998753 23567788766 33344456788888888853344 467776642 67899
Q ss_pred ccCCCch
Q 023058 98 YASGGEL 104 (288)
Q Consensus 98 ~~~~~~L 104 (288)
|+++.++
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9876544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.45 E-value=0.00036 Score=55.76 Aligned_cols=142 Identities=15% Similarity=0.079 Sum_probs=74.5
Q ss_pred CCeeeeeeeeccCceEEEEEEEcCCCcEEEEEEeecCccchHHHHHHHHHHhhCCCCce--eeEeE------EEEcCCeE
Q 023058 21 DRYELVRDIGSGNFGVARLMRDKKTEELVAVKYIERGDKIDENVQREIINHRSLRHPNI--VRFKE------VILTPTHL 92 (288)
Q Consensus 21 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~------~~~~~~~~ 92 (288)
++..-.+.|..|-..+.|.+.... ..|++|+++.. ...+.+..|+.++..+...++ +..+. +.......
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t~~--g~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~ 94 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHTTK--DPLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 94 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEESS--CCEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred CCceEeecCCCCcccCeEEEEECC--CcEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeeccc
Confidence 345556667777778999998753 35899988653 234566677777766632221 11110 11123455
Q ss_pred EEEEeccCCCch-----HH---------HHHhc-C--------CC------------------CHHHHHHHHHHHHHHHH
Q 023058 93 AIVMEYASGGEL-----FE---------RICNA-G--------RF------------------SEDEARFFFQQLISGVS 131 (288)
Q Consensus 93 ~lv~e~~~~~~L-----~~---------~~~~~-~--------~~------------------~~~~~~~i~~~i~~~l~ 131 (288)
+.++.+..+... .. .++.. . .. ........+..+...+.
T Consensus 95 ~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 174 (316)
T d2ppqa1 95 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 174 (316)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred ceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhh
Confidence 666666544222 00 00000 0 00 01111112223333333
Q ss_pred HHh----hcCceecCCCCCceEecCCCCCCEEEeecCCCc
Q 023058 132 YCH----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 167 (288)
Q Consensus 132 ~LH----~~~i~H~dl~p~nilv~~~~~~~~~l~df~~~~ 167 (288)
..+ ..|++|+|+.++||+++.+.. .-++||+.++
T Consensus 175 ~~~~~~L~~giIHgDl~~dNvl~~~~~v--~gvIDF~~~~ 212 (316)
T d2ppqa1 175 AHWPKDLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 212 (316)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred ccCccccccccccCCcchhhhhcccccc--eeEecccccc
Confidence 333 367999999999999987654 6899999876
|